Citrus Sinensis ID: 005343
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 701 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.580 | 0.481 | 0.481 | 1e-107 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.593 | 0.498 | 0.474 | 1e-106 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.901 | 0.789 | 0.361 | 1e-105 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.566 | 0.498 | 0.466 | 1e-102 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.808 | 0.692 | 0.358 | 3e-96 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.788 | 0.663 | 0.347 | 7e-84 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.380 | 0.331 | 0.414 | 3e-58 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.413 | 0.332 | 0.392 | 1e-52 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.372 | 0.503 | 0.379 | 3e-52 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.413 | 0.329 | 0.380 | 2e-50 |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 390 bits (1001), Expect = e-107, Method: Compositional matrix adjust.
Identities = 197/409 (48%), Positives = 270/409 (66%), Gaps = 2/409 (0%)
Query: 265 LEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALAL 324
L EI++LR ELK E+Y E V S+ +L QR+ EE+ KL E + EE A
Sbjct: 359 LNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDT 418
Query: 325 VKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKY 384
E+Q+ AM+ A + L+ EA+ R AE KA ++ EK + ++ V+Y+ Y
Sbjct: 419 ASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHY 478
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILG 444
T EEI AAT F+ + KIG G YG VYK L HT+ A+KVL +Q +QF QE+EIL
Sbjct: 479 TWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILS 538
Query: 445 SMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+RH ++V+LLGACPE GCLVYEYM+NGSL+DRL +++PPI W RF+IA E+A+AL+
Sbjct: 539 KIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALV 598
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
FLH++KP P++HRDLKP NILLD N+VSK+ DVGL+ +V + T + T+ GT C
Sbjct: 599 FLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLC 658
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI-RNGTFSELLDPTVT 623
YIDPEYQ+TG++ KSD+YSLGVV+LQLITA+PA+ ++H VE+AI + F +LD
Sbjct: 659 YIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAG 718
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAEN 672
WP+ +A L L C E+R+RDRPDL ++P L RLR + + A+N
Sbjct: 719 SWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVA-DKAQN 766
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 199/419 (47%), Positives = 268/419 (63%), Gaps = 3/419 (0%)
Query: 265 LEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALAL 324
L E+++LR EL+ E+Y E S+ +L QR+ EEA+KLEE +L E A L
Sbjct: 349 LNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEAREL 408
Query: 325 VKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKY 384
+ E+Q A A + E E +R AE K+ ++ +EK+ + + ++Y+ +
Sbjct: 409 AEKEKQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHF 468
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILG 444
EEI AAT FS KIG G YG VYK L HT+ +KVL +Q +QF+QE+EIL
Sbjct: 469 AWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILS 528
Query: 445 SMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+RH ++V+LLGACPE G LVYEYMENGSLEDRLFQ +NSPP+ W RF+IA E+A AL+
Sbjct: 529 KIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALV 588
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT-ITQYHMTTAAGTF 563
FLH++KP+P++HRDLKPANILLD N+VSK+ DVGL+ +V T T Y T+ GT
Sbjct: 589 FLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTL 648
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI-RNGTFSELLDPTV 622
CYIDPEYQ+TG + KSD+YS G++LLQL+TA+PA+ L+H VE A+ N F ++LD
Sbjct: 649 CYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKA 708
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVVTP 681
WP+E +A LAL C ELR +DRPDL +LP L L+ + E A N + P
Sbjct: 709 GNWPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVA-EKARNSFSGVSTQP 766
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-105, Method: Compositional matrix adjust.
Identities = 251/695 (36%), Positives = 375/695 (53%), Gaps = 63/695 (9%)
Query: 34 SQYAVKWAVDNLLNETSQYVLLHV-RNHSSNPRGRPATNDELQKLFLPYRGLFARKRI-- 90
S+ AV+WAVDNLL + ++V++HV +S P T + L +F + A R+
Sbjct: 41 SRRAVRWAVDNLLPKADKFVMIHVIPTITSIP-----TPNILILMFTRMWVVTAGDRLPV 95
Query: 91 -----LAREVVLQDI--DVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLK 143
E+ ++D+ + + + ++K + R +R+ + +P ++L+
Sbjct: 96 EEVEESVVEMYVRDVKKEYETVFVPFLKMCKSTR----STKRYFRSRRTKGTGVPLTVLR 151
Query: 144 SAPESCAVYIIS-------SKGKLQSSRPAAS-QPQMLSGDALIPKQPPLGERPSVIQPD 195
APE+C VYI+ S L + P S + D L S PD
Sbjct: 152 YAPETCEVYIVCKDRITTKSMDPLINREPCTSPHAAATAHDFLRDWAASFHTLRSPTLPD 211
Query: 196 SPRSVEIG--RS-----------DYSCDTDSHMQNS----------FNSESESDI----- 227
+S E G RS +C+ Q+S F SDI
Sbjct: 212 PRQSTEAGTRRSASARELRFEALSLTCNKPKTPQSSKASSATTPEIFRRRRGSDIPQLNY 271
Query: 228 SDFSVPVSYQSTEISENIDFSSLSKSSKDHFPQSPKG-----LEAEIKRLRLELKQSMEI 282
SDF + + + ENI S + S P++ + +E E++RL+ EL+ ++
Sbjct: 272 SDFDKTCTKPQSNV-ENI--VSEHRDSDRSPPETSRKSKKVEIEEEVERLKNELQSTVFK 328
Query: 283 YNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMA 342
Y +E ST L E+ ++ A EE E+++ A++ A
Sbjct: 329 YKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKERYMKAVKEVETA 388
Query: 343 QRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKI 402
+ L+ E +R+IAE+ A++ EKK V++ + + RYRKYTIEEI AT+ FS + I
Sbjct: 389 KALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIVTATEGFSPEKVI 448
Query: 403 GEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYG 462
GEGGYG VY+ LD T A+KV+ D + ++F +EVE+L +RH ++V+LLGACPE G
Sbjct: 449 GEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENG 508
Query: 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPA 522
CLVYEY+ENGSLE+ +F + N PP+ W IRF++ E+A L FLH +KPEP+VHRDLKP
Sbjct: 509 CLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPG 568
Query: 523 NILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDL 582
NILL++NYVSKI+DVGLA+LV A D +T Y + AGT YIDPEY +TG + KSDL
Sbjct: 569 NILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDL 628
Query: 583 YSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCE 642
Y+ G+++LQL+TAR G+ VE A++ GT +E+LD +VT WP+ +A++ L+C E
Sbjct: 629 YAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAE 688
Query: 643 LRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNI 677
R RDRPDL S V+P L RL + + + N+
Sbjct: 689 FRCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNL 723
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (955), Expect = e-102, Method: Compositional matrix adjust.
Identities = 192/412 (46%), Positives = 273/412 (66%), Gaps = 15/412 (3%)
Query: 268 EIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKS 327
E+++L++EL+ +Y E + S+ L QR+ EEA +L+ + EE A +V+
Sbjct: 298 ELEKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEM 357
Query: 328 ERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMA---YKNVRYRKY 384
ER++ A A + + +E E +R AE +A + +EK+ + +A+ + +Y K+
Sbjct: 358 ERERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKF 417
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILG 444
EEI AT FS KIG GGYG VY+ L HT+VA+KVL D S +QF QE+EIL
Sbjct: 418 EWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILS 477
Query: 445 SMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKD------NSPPIHWSIRFKIAAE 498
+RH ++++LLGACPE G LVYEYM NGSLE+RL ++ PP+ W RF+IA E
Sbjct: 478 KIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWE 537
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV--PPSAADTITQYHM 556
IA+AL FLH N+P P+VHRDLKPANILLD+N VSKI DVGL+++V PS A T+ ++
Sbjct: 538 IASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHASTV--FNE 595
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN--GTF 614
T GTF YIDPEYQ+TG++ +SD+Y+ G++LLQL+TAR AMGL+H +E+A+R+ G F
Sbjct: 596 TGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKF 655
Query: 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666
+E+LD T WPV+ A + + L+C E+RKRDRPDL +LP L RL+++
Sbjct: 656 TEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVA 707
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (905), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 235/655 (35%), Positives = 344/655 (52%), Gaps = 88/655 (13%)
Query: 75 QKLFLPYRGLFARKRILAREV--------------VLQDIDVSSALIYYVKNNSVGNIVA 120
+ L P++ + RK++ E VL+ V+ A+ V + + N++
Sbjct: 106 ETLLKPFKKMCERKKLKIDETRFESSLTKVAVELQVLESNSVAVAITKEVNQHLISNLII 165
Query: 121 GGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIISSKG----KLQSSRPAASQPQMLSG- 175
G SS+ RN D+ +S+ S C VY++S+ G +S + + SG
Sbjct: 166 GRSSQ---AASSRNYDITASISASVSNLCTVYVVSNGGVHILAKDTSDTERNDTSIESGF 222
Query: 176 -------------------DALIPKQPPLGERPSVIQPDSPRSVEIGRSDYSCDTDSHMQ 216
+AL L + P R V + S ++D +
Sbjct: 223 ERTSSSCSSGSGANSDVMSNALKSNPHTLSNKRMQNLPTIVRGVSVPMETSSTESDETKK 282
Query: 217 NSFNSESESDISDFSVPVSYQS-----------------TEISENIDFSSLSKSSKDHFP 259
S S++ + S S P + +S + +S N ++ ++ +F
Sbjct: 283 RS--SDAAEEASKRSSPETSRSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFT 340
Query: 260 QSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEE 319
+ L EI +LR EL+ + E+Y AV+ +T L +K LK EE L E
Sbjct: 341 DNQDTLN-EISKLRAELRHAHEMY------AVAQVET---LDASRKLNELKFEELTLLEH 390
Query: 320 AALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYK-N 378
+ K E +K +R E EA +R AE+KA E +EK+ + E+
Sbjct: 391 ETKGIAKKETEK--------FEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPK 442
Query: 379 VRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQ 438
++Y+++T EEI AT FS KIG G YG VYK L HT A+KVL S +QF Q
Sbjct: 443 LQYQEFTWEEIINATSSFSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQ 502
Query: 439 EVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
E+EIL +RH ++V+LLGACP++G LVYEYMENGSLEDRLFQ ++S PI W +R +IA E
Sbjct: 503 ELEILSKIRHPHLVLLLGACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWE 562
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI----TQY 554
+A+AL+FLH++KP P++HRDLKPANILL+ N+VSK+ DVGL+ ++ AAD + T Y
Sbjct: 563 VASALVFLHKSKPTPIIHRDLKPANILLNHNFVSKVGDVGLSTMI--QAADPLSTKFTMY 620
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTF 614
T+ GT CYIDPEYQ+TG + KSD+Y+ G+++LQL+T + AM L++ VE A+ N
Sbjct: 621 KQTSPVGTLCYIDPEYQRTGRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNND 680
Query: 615 SEL---LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666
EL LD WP+E +A LALQC ELR +DRPDL +LP L L+ +
Sbjct: 681 DELIQILDEKAGNWPIEETRQLAALALQCTELRSKDRPDLEDQILPVLESLKKVA 735
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 219/630 (34%), Positives = 327/630 (51%), Gaps = 77/630 (12%)
Query: 82 RGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSL 141
RG+ A K + E + + ++ + + +V G ++ +R+ +L ++
Sbjct: 128 RGVRAEKMFIEME------SIENGIVQLISELGIRKLVMGAAADRHYSRRMTDLKSRKAI 181
Query: 142 L--KSAPESCAVYIISSKGKLQSSRPA----------ASQPQMLSGDALIPKQPPLGERP 189
+ AP C ++ + KG L +R A + +P + + D L P E
Sbjct: 182 FVRREAPTLCQIWF-TCKGYLIHTREATMDDTESEYASPRPSISASDLLQTFSTPESEHQ 240
Query: 190 SVIQPDSPRSVE-----------IGR-SDYSCDTDSHMQNSFNSESESDISDFSVPVSYQ 237
+ + S SV+ GR SD S +TD E ESD S+ + +
Sbjct: 241 HISRVQSTDSVQQLVSNGSSTEQSGRVSDGSLNTD-------EEERESDGSEVTGSATVM 293
Query: 238 STEISENIDF----------------SSLSKSSKDHFPQSPKGLEAEIKRLRL--ELKQS 279
S+ S F S S ++ F ++ + +AE L KQS
Sbjct: 294 SSGHSSPSSFPDGVDDSFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQS 353
Query: 280 MEIYNSVSKEAVSTSQTAVKLQQR----KKEEALKLEEARLAEEAALALVKSERQKTRAA 335
Y+ K T K ++R K E+ + +EE + A A A+++S+ K+
Sbjct: 354 ESAYSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQSAM-AQKAMLESQIAKSDGT 412
Query: 336 MEAALMAQRL----VELEAMKREIAEL-----KAMQEEEEKKIVMEAMAYKNVRY-RKYT 385
ME + Q+L L+ ++ E EL +A++E EE + E + +Y ++
Sbjct: 413 MEK--LNQKLDIAVKLLQKLRDEREELQTERDRALREAEELRSHAETSTLQLPQYFTDFS 470
Query: 386 IEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS 445
EIE AT++F + KIGEGGYG +Y L HT VAIK+L P+ SQGP +++QEV++L
Sbjct: 471 FSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSK 530
Query: 446 MRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
MRH N++ L+GACPE LVYEY+ GSLEDRL KDNSPP+ W R +IA EI AL+F
Sbjct: 531 MRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVF 590
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH NK LVH DLKPANILLD N VSK+SD G L+ P+ + ++ T GT Y
Sbjct: 591 LHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKSVR----TDVTGTVAY 646
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625
+DPE +G L KSD+YS G++LL+L+T RPA+ +S++V+ A+ NGT ++LLDP W
Sbjct: 647 LDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDW 706
Query: 626 PVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P A +A+LAL+CCE +RPDL + V
Sbjct: 707 PFVQAEQLARLALRCCETVSENRPDLGTEV 736
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 116/280 (41%), Positives = 172/280 (61%), Gaps = 13/280 (4%)
Query: 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEIL 443
Y+ EI AT+ F S K+GEG YG VYK L H VA+K+L S +F++ VEIL
Sbjct: 448 YSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEIL 507
Query: 444 GSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+RH N+V L+GACPE L+Y+Y+ NGSLED ++N P + W R +IA+EI +AL
Sbjct: 508 SRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSAL 567
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
LFLH N P ++H +LKP+ ILLD N V+KI+D G+++L+P D
Sbjct: 568 LFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGLDKSDP---------- 616
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623
++DP Y + + ++SD+Y+ G++LLQL+T RP G+ V+ A+ N S +LD +
Sbjct: 617 -HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAG 675
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663
WPV +A +A++CC+ +RPDL +VVL + R++
Sbjct: 676 DWPVARGKKLANVAIRCCKKNPMNRPDL-AVVLRFIDRMK 714
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 123/313 (39%), Positives = 186/313 (59%), Gaps = 23/313 (7%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQE 439
R+++I EI++AT+ F IG GG+G VYK Q+D T VA+K L +QG ++F+ E
Sbjct: 504 RRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETE 563
Query: 440 VEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNS--PPIHWSIRFKI 495
+E+L +RH ++V L+G C E LVYEYM +G+L+D LF++D + PP+ W R +I
Sbjct: 564 LEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEI 623
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
A L +LH ++HRD+K NILLD+N+V+K+SD GL+R+ P SA+ Q H
Sbjct: 624 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSAS----QTH 679
Query: 556 MTTAA-GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA------ 608
++T GTF Y+DPEY + +L KSD+YS GVVLL+++ RP S EQA
Sbjct: 680 VSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWV 739
Query: 609 ---IRNGTFSELLDPTVTGWPVEAAL-SIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664
R GT +++D ++ +L ++A++C + R +RP + VV L+
Sbjct: 740 KSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQ- 798
Query: 665 LGFENAENKNDNI 677
E A+ KNDN+
Sbjct: 799 -LHETAKKKNDNV 810
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (526), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 109/287 (37%), Positives = 164/287 (57%), Gaps = 26/287 (9%)
Query: 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEIL 443
++ +++E AT++F +R++G+ YG YK + + V IK +S + F+QEV IL
Sbjct: 147 FSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIK-----LSSSQKLFQQEVSIL 201
Query: 444 GSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
RH N++ +G C E LVYE++ NG+LEDR+ +NS P+ W R +I EI AL
Sbjct: 202 RQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCAL 261
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL------VPPSAADTITQYHMT 557
LFLH NK LVH DL+P NIL+D NY SKI + G++ L PP+ +
Sbjct: 262 LFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPNLTARLP----- 316
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617
Y+DPE+ TG L SD+YSLGV++L+L+T P + LS +V +A+ + + L
Sbjct: 317 -------YMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLL 369
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDL---VSVVLPELIR 661
+D + WP A +A + L C + ++ RPDL V +V+ L R
Sbjct: 370 IDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTR 416
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 119/313 (38%), Positives = 183/313 (58%), Gaps = 23/313 (7%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQE 439
R+++I EI++AT+ F IG GG+G VYK ++D T VA+K L +QG ++F E
Sbjct: 511 RRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTE 570
Query: 440 VEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNS--PPIHWSIRFKI 495
+E+L +RH ++V L+G C + LVYEYM +G+L+D LF++D + PP+ W R +I
Sbjct: 571 LEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEI 630
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
A L +LH ++HRD+K NILLD+N+V+K+SD GL+R+ P SA+ Q H
Sbjct: 631 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSAS----QTH 686
Query: 556 MTTAA-GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA------ 608
++T GTF Y+DPEY + +L KSD+YS GVVLL+++ RP S EQA
Sbjct: 687 VSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWV 746
Query: 609 ---IRNGTFSELLDPTVTGWPVEAAL-SIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664
T +++D +T ++ ++A++C + R +RP + VV L+
Sbjct: 747 KSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQ- 805
Query: 665 LGFENAENKNDNI 677
E A+ KNDN+
Sbjct: 806 -LHETAKKKNDNV 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 701 | ||||||
| 225442229 | 722 | PREDICTED: U-box domain-containing prote | 0.928 | 0.901 | 0.580 | 0.0 | |
| 297743051 | 716 | unnamed protein product [Vitis vinifera] | 0.888 | 0.870 | 0.589 | 0.0 | |
| 359475954 | 782 | PREDICTED: U-box domain-containing prote | 0.948 | 0.850 | 0.548 | 0.0 | |
| 343887272 | 763 | serine threonine kinase [Citrus unshiu] | 0.922 | 0.847 | 0.546 | 0.0 | |
| 449448106 | 724 | PREDICTED: U-box domain-containing prote | 0.902 | 0.874 | 0.569 | 0.0 | |
| 224141575 | 679 | predicted protein [Populus trichocarpa] | 0.915 | 0.945 | 0.558 | 0.0 | |
| 255560711 | 803 | kinase, putative [Ricinus communis] gi|2 | 0.960 | 0.838 | 0.518 | 0.0 | |
| 255584917 | 752 | kinase, putative [Ricinus communis] gi|2 | 0.904 | 0.843 | 0.548 | 0.0 | |
| 15239600 | 703 | protein kinase-like protein [Arabidopsis | 0.924 | 0.921 | 0.542 | 0.0 | |
| 79511817 | 701 | Protein kinase protein with adenine nucl | 0.911 | 0.911 | 0.549 | 0.0 |
| >gi|225442229|ref|XP_002274879.1| PREDICTED: U-box domain-containing protein 34-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/708 (58%), Positives = 504/708 (71%), Gaps = 57/708 (8%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRG 83
T +AID DKSSQYAVKWAVDNLL++TS L+HVR+ +S RGRP T E+Q+LFLP+RG
Sbjct: 16 TIIAIDKDKSSQYAVKWAVDNLLSKTSITTLIHVRSVNSQTRGRPPTETEMQQLFLPFRG 75
Query: 84 LFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLK 143
ARK I A+EVVL D+D++SAL+ Y+ NNS+GNIV G S+R++LTRKFRN D+P+ L K
Sbjct: 76 FCARKGIEAKEVVLHDLDIASALVDYISNNSIGNIVVGASNRSVLTRKFRNPDVPTCLAK 135
Query: 144 SAPESCAVYIISSKGKLQSSRPA-----------ASQPQMLSGDALIPKQPPLGERPSVI 192
SAPESCAVY+I SKGK+QS R A + Q + + P+ P RP +
Sbjct: 136 SAPESCAVYVI-SKGKIQSVRSAIRFQTPTSSVSSGVTQFQTPKGMSPRGPSNLGRPPQL 194
Query: 193 QPDSPRSVEIGRSDYSCDTDS-HMQNSFNSESESDISD------------FSVPVS---- 235
+SP + ++GRS + S N F S + FS P S
Sbjct: 195 PTESPTTEDMGRSAFRGSWRSVEPDNGFFDRSTDSVQTTPRDKIMSSSKLFSPPQSRVNL 254
Query: 236 YQSTEISENIDF-SSLSKSSKDHFP-------------------------QSPKGLEAEI 269
+ ISEN S+S SS P Q+ ++AE+
Sbjct: 255 HHRLRISENSSHQGSVSGSSNYSGPSSLRSSNSSSENLEFSGSSGSSLSSQTQNEMDAEM 314
Query: 270 KRLRLELKQSMEIYNSVSKEAVSTSQ--TAVKLQQRKKEEALKLEEARLAEEAALALVKS 327
RL+LELKQSM+ YNS SKEA++ +Q A + QRK EEA + EAR+ EE ALA+V+
Sbjct: 315 NRLKLELKQSMDAYNSASKEAMTATQRHRARDIHQRKTEEARRFPEARIGEETALAIVEL 374
Query: 328 ERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIE 387
E+QK+R AM+AA MAQRL ELEA KR+ ELKA +E E M+ +++ ++RYRKYTIE
Sbjct: 375 EKQKSRKAMQAAQMAQRLAELEAHKRKNTELKAKREAEASGRAMDKLSHNDIRYRKYTIE 434
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR 447
+IE ATDYFS S KIGEGGYGPVYK LDHT VAIKVL PD+SQG +QFKQEVE+L MR
Sbjct: 435 DIEVATDYFSNSLKIGEGGYGPVYKGSLDHTPVAIKVLRPDVSQGLKQFKQEVEVLSCMR 494
Query: 448 HTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
H NMV+L+GACPEYGCLVYEYMENGSL+DRLF+++N+ P+ W+ RFKIA+EIA+ALLFLH
Sbjct: 495 HPNMVLLVGACPEYGCLVYEYMENGSLDDRLFRRNNTLPLPWATRFKIASEIASALLFLH 554
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
Q KP PLVHRDLKPANILL +NYVSKISDVGLARLVP S AD++TQYHMT AAGTFCYID
Sbjct: 555 QTKPAPLVHRDLKPANILLGRNYVSKISDVGLARLVPASVADSVTQYHMTAAAGTFCYID 614
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627
PEYQQTGMLGVKSD+YSLGV+LLQ+ITA+P MGL+HQV ++I GTF+E+LDPTV WPV
Sbjct: 615 PEYQQTGMLGVKSDVYSLGVLLLQIITAKPPMGLTHQVARSIERGTFAEMLDPTVEDWPV 674
Query: 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKND 675
E ALS AK+AL CCELRK+DRPDL SVVLPEL RLRDLG ++ + D
Sbjct: 675 EEALSFAKMALNCCELRKKDRPDLGSVVLPELNRLRDLGLDHEGSLQD 722
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743051|emb|CBI35918.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/674 (58%), Positives = 481/674 (71%), Gaps = 51/674 (7%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR--------GRPATNDELQ 75
T +AID DKSSQYAVKWAVDNLL++TS L+HVR+ +S + GRP T E+Q
Sbjct: 16 TIIAIDKDKSSQYAVKWAVDNLLSKTSITTLIHVRSVNSQTQDVNMAPKGGRPPTETEMQ 75
Query: 76 KLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNL 135
+LFLP+RG ARK I A+EVVL D+D++SAL+ Y+ NNS+GNIV G S+RN RKFRN
Sbjct: 76 QLFLPFRGFCARKGIEAKEVVLHDLDIASALVDYISNNSIGNIVVGASNRNRWHRKFRNP 135
Query: 136 DLPSSLLKSAPESCAVYIISSKGKLQSSRPAA--SQPQMLSGDALIPKQPPLGERPSVIQ 193
D+P+ L KSAPESCAVY+IS KGK+QS R A P + Q P G
Sbjct: 136 DVPTCLAKSAPESCAVYVIS-KGKIQSVRSAIRFQTPTSSVSSGVTQFQTPKGM------ 188
Query: 194 PDSPRSVEIGRSDYSCDTDSHMQNSFNSESESDISDFSVPVS----YQSTEISENIDF-S 248
S RSVE + TDS +Q + + S FS P S + ISEN
Sbjct: 189 -GSWRSVEPDNGFFDRSTDS-VQTTPRDKIMSSSKLFSPPQSRVNLHHRLRISENSSHQG 246
Query: 249 SLSKSSKDHFP-------------------------QSPKGLEAEIKRLRLELKQSMEIY 283
S+S SS P Q+ ++AE+ RL+LELKQSM+ Y
Sbjct: 247 SVSGSSNYSGPSSLRSSNSSSENLEFSGSSGSSLSSQTQNEMDAEMNRLKLELKQSMDAY 306
Query: 284 NSVSKEAVSTSQT--AVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALM 341
NS SKEA++ +Q A + QRK EEA + EAR+ EE ALA+V+ E+QK+R AM+AA M
Sbjct: 307 NSASKEAMTATQRHRARDIHQRKTEEARRFPEARIGEETALAIVELEKQKSRKAMQAAQM 366
Query: 342 AQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRK 401
AQRL ELEA KR+ ELKA +E E M+ +++ ++RYRKYTIE+IE ATDYFS S K
Sbjct: 367 AQRLAELEAHKRKNTELKAKREAEASGRAMDKLSHNDIRYRKYTIEDIEVATDYFSNSLK 426
Query: 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY 461
IGEGGYGPVYK LDHT VAIKVL PD+SQG +QFKQEVE+L MRH NMV+L+GACPEY
Sbjct: 427 IGEGGYGPVYKGSLDHTPVAIKVLRPDVSQGLKQFKQEVEVLSCMRHPNMVLLVGACPEY 486
Query: 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKP 521
GCLVYEYMENGSL+DRLF+++N+ P+ W+ RFKIA+EIA+ALLFLHQ KP PLVHRDLKP
Sbjct: 487 GCLVYEYMENGSLDDRLFRRNNTLPLPWATRFKIASEIASALLFLHQTKPAPLVHRDLKP 546
Query: 522 ANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSD 581
ANILL +NYVSKISDVGLARLVP S AD++TQYHMT AAGTFCYIDPEYQQTGMLGVKSD
Sbjct: 547 ANILLGRNYVSKISDVGLARLVPASVADSVTQYHMTAAAGTFCYIDPEYQQTGMLGVKSD 606
Query: 582 LYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCC 641
+YSLGV+LLQ+ITA+P MGL+HQV ++I GTF+E+LDPTV WPVE ALS AK+AL CC
Sbjct: 607 VYSLGVLLLQIITAKPPMGLTHQVARSIERGTFAEMLDPTVEDWPVEEALSFAKMALNCC 666
Query: 642 ELRKRDRPDLVSVV 655
ELRK+DRPDL SV+
Sbjct: 667 ELRKKDRPDLGSVM 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475954|ref|XP_002279357.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/702 (54%), Positives = 501/702 (71%), Gaps = 37/702 (5%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRN----HSSNPRGRPATNDELQKLFL 79
T VAID DK+S YAV+W +D+LL Q +L+HVR+ H + G + D Q+LF+
Sbjct: 17 TVVAIDKDKNSHYAVRWTIDHLLINNPQIILIHVRHKYLQHHAGEGGGESETDA-QQLFI 75
Query: 80 PYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPS 139
YRG ARK I +E+VL D+DVS A+I Y+ N + NIV G S++N LTRKFRN D+ +
Sbjct: 76 AYRGYCARKAIQLKEIVLDDVDVSRAIIDYITRNRIKNIVVGASTKNALTRKFRNYDVST 135
Query: 140 SLLKSAPESCAVYIISSKGKLQSSRPAASQPQMLSGDALIPKQP-PLGERPSVIQPDSPR 198
S+ KSAP+ C+VY+IS KGK+ S R +A +P + A+ PK P P G P + PD+P
Sbjct: 136 SITKSAPDFCSVYVIS-KGKVVSVR-SAQRP--VVNTAVPPKLPSPRGLPPQAL-PDNPE 190
Query: 199 SVEIGR-------------------SDYSCDTDSHMQNSFNSESESDISDFSVPVSYQST 239
++ R ++ S D + S + +S SD DFS P+ + S
Sbjct: 191 LEDVARVTFERTNNNMRVPRARSAPTNLSIDNIDLQRPSTSRDSVSDDLDFSTPIRFASV 250
Query: 240 EIS-ENIDFSSLSKSSKDHF-PQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTA 297
++S +++DFS S S +D P S K L AE+KRL+LELKQ+M++Y++ KEA++ Q A
Sbjct: 251 DLSSQDMDFSITSDSGRDSLTPTSAKELAAEMKRLKLELKQTMDMYSTACKEAITAKQKA 310
Query: 298 VKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAE 357
+L Q + EEA + +EARL+EEAALA+ + E+ + +AA+EAA +AQ+L E EA +R AE
Sbjct: 311 KELHQWRMEEARRFKEARLSEEAALAMAEMEKARCKAAIEAAEVAQKLAEKEAQRRRYAE 370
Query: 358 LKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH 417
LKA +E EEK + A+A+ +VRYRKY IEEIE AT+ FS + KIGEGGYGPVY+ +LDH
Sbjct: 371 LKASREAEEKARALTALAHNDVRYRKYAIEEIEVATEKFSQAMKIGEGGYGPVYRGKLDH 430
Query: 418 TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDR 477
T VAIKVL PD +QG RQF+QE+E+L MRH NMV+LLGACPEYGCLVYEYM NGSLEDR
Sbjct: 431 TPVAIKVLRPDAAQGMRQFQQEIEVLSCMRHPNMVLLLGACPEYGCLVYEYMSNGSLEDR 490
Query: 478 LFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537
L ++ ++P I W +RFKIAAEIATALLFLHQ KPEP VHRDLKPANILLD+NYVSKISDV
Sbjct: 491 LLRRGDTPSIPWRMRFKIAAEIATALLFLHQAKPEPFVHRDLKPANILLDRNYVSKISDV 550
Query: 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GLARLVPPS AD++TQYHMT+AAGTFCYIDPEYQQTGMLG KSD+YS+G++LLQ+ITA+P
Sbjct: 551 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLGTKSDVYSMGIMLLQIITAKP 610
Query: 598 AMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657
MGL+H V +AI GTF+++LD TV WPVE AL+ A LAL+C ELRK+DRPDL SVVLP
Sbjct: 611 PMGLTHHVRRAIEKGTFADMLDQTVPDWPVEEALAFANLALKCSELRKKDRPDLGSVVLP 670
Query: 658 ELIRLRDLGFENAENKNDNIVVTPGPYNSVSEMKQVSGNNMR 699
EL RL G +++ N + + +N + SG++ R
Sbjct: 671 ELNRLSGFGMDSSGPDNSSNM-----FNGYASYTHRSGSHPR 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|343887272|dbj|BAK61818.1| serine threonine kinase [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/695 (54%), Positives = 491/695 (70%), Gaps = 48/695 (6%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVR---NHSSNPRGRPATNDELQKLFLP 80
TAVAID DK+S +AV+WA+D+L+ +LLH+R NH ++ G ++ E+Q+LF P
Sbjct: 14 TAVAIDKDKNSPHAVRWAIDHLIISNPLIILLHIRQKYNHQNSNGGYVESDSEMQQLFTP 73
Query: 81 YRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSS 140
+RG ARK +L +EVV+ D DV A++ Y+ N + NIV G S+RN L RKF+ +D+ ++
Sbjct: 74 FRGYCARKGVLLKEVVIDDNDVPKAILEYIGRNLLNNIVVGASTRNALARKFKGVDISTT 133
Query: 141 LLKSAPESCAVYIISSKGKLQSSRPAASQPQMLSGDALIPKQPPLGERPSVIQPDS---- 196
++KSAP+ C+VYIIS KGK+ S R A +P + A P+QP G P +
Sbjct: 134 VMKSAPDFCSVYIIS-KGKILSVR-TAQRPA--ANTATPPRQPSPGIPPQIPSDHGELDD 189
Query: 197 ----------PRSVEIGRSDY--------SCDTDSHM-----------------QNSFNS 221
PR + R + + D H + S
Sbjct: 190 PFRGQGMRGIPRGLATERLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGR 249
Query: 222 ESESDISDFSVPVSYQSTEIS-ENIDFSSLSKSSK-DHFPQSPKGLEAEIKRLRLELKQS 279
+S SD SD+S P++ S +IS +N+DFSS+ S + QS + LEAE++RL+LEL+Q+
Sbjct: 250 DSFSDESDYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQT 309
Query: 280 MEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAA 339
ME+Y++ KEA++ + A +L Q K EEA + EEAR+AEE ALA+ + E+ K RAA+EAA
Sbjct: 310 MEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAA 369
Query: 340 LMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSIS 399
AQ+L + EA +R+ AELKA +E EEK + A+A+ +VRYRKYTIEEIE ATD FS +
Sbjct: 370 EKAQKLADAEAQRRKQAELKAKREAEEKNRALTALAHNDVRYRKYTIEEIEEATDKFSEA 429
Query: 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
KIGEGGYGPVY+ +LDHT VAIKVL PD +QG RQF+QEVE+L S+RH NMV+LLGACP
Sbjct: 430 MKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 489
Query: 460 EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDL 519
+YGCLVYEYM NGSLEDRL ++ N+P I W RFKIAAEIATALLFLHQ KPEPLVHRDL
Sbjct: 490 DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDL 549
Query: 520 KPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK 579
KPANILLD+NYVSKISDVGLARLVPPS AD++TQYHMT+AAGTFCYIDPEYQQTGML K
Sbjct: 550 KPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK 609
Query: 580 SDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQ 639
SD+YS G++LLQ+ITAR MGL+H V +AI GT +E+LDP VT WP EAA S +KLA+Q
Sbjct: 610 SDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQ 669
Query: 640 CCELRKRDRPDLVSVVLPELIRLRDLGFENAENKN 674
C ELRK+DRPDL +V++PEL RL+DLG + NK+
Sbjct: 670 CAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKS 704
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448106|ref|XP_004141807.1| PREDICTED: U-box domain-containing protein 51-like [Cucumis sativus] gi|449480701|ref|XP_004155971.1| PREDICTED: U-box domain-containing protein 51-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/664 (56%), Positives = 478/664 (71%), Gaps = 31/664 (4%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNE--TSQYVLLHVRNHSSNPRG--------RPATNDE 73
T +AI DK+S YAVKWAV++L N T + VL+HVR S +P+ RP T E
Sbjct: 19 TVIAISRDKNSHYAVKWAVEHLFNRKNTGECVLIHVRTQSLHPQEVDTIPKEFRPPTEAE 78
Query: 74 LQKLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFR 133
L + FLPYRG ARK I+A+E+++ DIDV +ALI ++ +S+ NIV G S+RN + RK +
Sbjct: 79 LHQFFLPYRGFCARKGIVAKEIIIHDIDVPNALIDHISKHSISNIVVGASNRNPIMRKLK 138
Query: 134 NLDLPSSLLKSAPESCAVYIISSKGKLQSSR---PAASQPQMLSGDALIPKQPPLGERPS 190
N D+ + LLKSAPESC+VY+I+ +GK+ + R SQ M P+ + S
Sbjct: 139 NPDVATCLLKSAPESCSVYVIA-RGKVHTKRLRKRNKSQTDMTETQTGTPR---ISGSLS 194
Query: 191 VIQPDSPRSVEIGRSDYSCDTDSHMQNSFNS-ESESDISDFSVPVSYQSTEIS-ENIDFS 248
Q + S+ G+S+ D + +S S +S S ISDFS P+S++S E S EN DFS
Sbjct: 195 KTQKSAYSSIS-GQSE-----DKYRYSSGTSNDSTSGISDFSGPLSFKSIETSFENQDFS 248
Query: 249 -SLSKSSKDHFPQS--PKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRK- 304
S S++S + S P +E E+K+LR ELK+ ME+Y+S KEA Q A +L+ K
Sbjct: 249 LSSSETSTRSYVSSSTPPTIEYEMKKLRFELKKMMEMYDSACKEAAVAKQKAKELRHLKM 308
Query: 305 -KEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMK-REIAELKAMQ 362
KEE K+E + EA L + E+QK +A EA L+AQ+L ELE K R I E KA
Sbjct: 309 EKEEDNKIECGKSTYEALTTLAEFEKQKNKAEAEATLVAQKLAELETQKKRIITEEKARI 368
Query: 363 EEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAI 422
E EE+K ME N+ YR+++I++IE ATD+F+ S KIGEGGYGPVY+A L+HTSVAI
Sbjct: 369 EAEERKKTMELFERSNICYRRFSIDQIEVATDHFNESNKIGEGGYGPVYQALLEHTSVAI 428
Query: 423 KVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKD 482
K+L PD S G RQF+QE+E+L MRH NMV+LLGACPEYGCLVYEYMENGSLEDRLF+KD
Sbjct: 429 KILRPDRSHGQRQFQQEIEVLSRMRHPNMVLLLGACPEYGCLVYEYMENGSLEDRLFRKD 488
Query: 483 NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
N+PPI W IRF+IA +IATALLFLHQ KPEP+VHRDLKPANILLD NYVSKI DVGLARL
Sbjct: 489 NTPPIPWRIRFRIACDIATALLFLHQMKPEPVVHRDLKPANILLDHNYVSKIGDVGLARL 548
Query: 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS 602
VPP+ AD++TQYHMT AAGTFCYIDPEYQQTGMLGVKSD+YS GV+LLQLITAR MGLS
Sbjct: 549 VPPTVADSVTQYHMTAAAGTFCYIDPEYQQTGMLGVKSDIYSFGVLLLQLITARSPMGLS 608
Query: 603 HQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
+QVE+AI +G F E+LDPT+T WP+E L +A+LAL+CCELRKRDRPDL +V++PEL RL
Sbjct: 609 YQVEEAIEHGKFPEILDPTITDWPIEDTLGLAQLALKCCELRKRDRPDLCTVLMPELSRL 668
Query: 663 RDLG 666
++LG
Sbjct: 669 KNLG 672
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141575|ref|XP_002324143.1| predicted protein [Populus trichocarpa] gi|222865577|gb|EEF02708.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1845), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/673 (55%), Positives = 476/673 (70%), Gaps = 31/673 (4%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVR--NHSSNPRGRPAT-NDELQKLFLP 80
T+VAID DK+SQ+AV+WAVDNL + S VL+HV+ NH G+ +DE +LF P
Sbjct: 6 TSVAIDKDKNSQHAVRWAVDNLASNNSVLVLIHVKHKNHQYLANGQDGDGDDEAHQLFTP 65
Query: 81 YRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSS 140
YRG ARK + +EVVL DIDV+ A+ Y+ N +GNIV G S RN+LTRKF+N D+P+S
Sbjct: 66 YRGYCARKGVRLKEVVLDDIDVARAVADYININLIGNIVFGASGRNVLTRKFKNQDVPTS 125
Query: 141 LLKSAPESCAVYIISSKGKLQSSR-----PAASQPQMLSGDALIPKQP----------PL 185
+K AP+ C+VY+I+ KGK+ S++ P + PQ + +IP Q PL
Sbjct: 126 FMKIAPDFCSVYVIT-KGKILSTQKAQRTPTYNVPQKTASMPVIPSQRGWRSAEAGGFPL 184
Query: 186 GERPSVIQPDSPRSVEIGRSDYSCDT----DSHMQNSFNSESESDISDFS-------VPV 234
+ ++ P S++S D+ S + S + S SD S+FS +
Sbjct: 185 DKVNDSMRGSQPERGRNSISNFSMDSTYLPSSCGRPSTSRVSTSDGSEFSGLFATSIMDS 244
Query: 235 SYQSTEISENIDFSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTS 294
S QS++ S S+L++S+ LE E++RLRLELKQ+ME+Y++ KEA+S
Sbjct: 245 SAQSSDFSV-ASASNLNESNAVSAKWCSDHLEVEMRRLRLELKQTMEMYSTACKEALSAK 303
Query: 295 QTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMKRE 354
Q A +L Q K +E K EEA+LA EAALA+ + E+ K + A+EAA +Q+L ELE KR+
Sbjct: 304 QKASELNQWKIDEVRKFEEAKLAGEAALAVAELEKAKCKVAIEAAEKSQKLAELEGQKRK 363
Query: 355 IAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQ 414
AE KA +E EEK + A+A+ +VRYR+YTIEEIE ATD FS S KIGEGGYGPVYK +
Sbjct: 364 HAEKKAERETEEKNRALNALAHNDVRYRRYTIEEIEEATDKFSPSNKIGEGGYGPVYKGK 423
Query: 415 LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSL 474
LDHT VAIK L PD +QG +QF+QEVE+L +RH +MV+LLGACPEYG LVYEYM+NGSL
Sbjct: 424 LDHTPVAIKALRPDAAQGKKQFQQEVEVLSCIRHPHMVLLLGACPEYGILVYEYMDNGSL 483
Query: 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534
EDRL QK N+PPI W IRFKIAAEIATALLFLHQ KPEPLVHRDLKPANILLD NYV KI
Sbjct: 484 EDRLLQKHNTPPIPWGIRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDSNYVCKI 543
Query: 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
SDVGLARLVP S AD++TQYHMT+AAGTFCYIDPEYQQTGML +SD+YSLG++ LQ+IT
Sbjct: 544 SDVGLARLVPLSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTRSDIYSLGIMFLQIIT 603
Query: 595 ARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSV 654
A+P MGL+HQV +AI G F+++LD TV WPVE AL A LAL+C ELRK+DRP L +V
Sbjct: 604 AKPPMGLAHQVGRAIERGKFADMLDQTVPDWPVEEALRFAALALKCAELRKKDRPSLATV 663
Query: 655 VLPELIRLRDLGF 667
++PEL RLRDLG
Sbjct: 664 IVPELNRLRDLGM 676
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560711|ref|XP_002521369.1| kinase, putative [Ricinus communis] gi|223539447|gb|EEF41037.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/737 (51%), Positives = 494/737 (67%), Gaps = 64/737 (8%)
Query: 13 SSANAITANAITAVAIDADKSSQYAVKWAVDNLLN-ETSQYVLLHVRNHSSNP-----RG 66
S A A+ T +AID DK+S+ AVKWA+DNL+N + +L+HV+ + +P G
Sbjct: 6 SEPKADEAHGATVIAIDCDKNSKCAVKWAIDNLVNNKKPNCILVHVQCKTLHPGHIPKEG 65
Query: 67 RPATNDELQKLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRN 126
RP T ELQ+ FLPYRG AR+ I + VVL DIDV SAL YV N NIV G S RN
Sbjct: 66 RPPTQQELQQFFLPYRGYCARRGIETKNVVLHDIDVPSALTNYVVLNKASNIVLGASRRN 125
Query: 127 LLTRKFRNLDLPSSLLKSAPESCAVYIISSKGKLQSSRPAA------------------- 167
LTRKF+N D PS+LLKSAPESCAVY+I SKGKLQ+ RPA+
Sbjct: 126 ALTRKFKNPDAPSTLLKSAPESCAVYVI-SKGKLQTLRPASRPLTASDSTSSNISSDSSQ 184
Query: 168 --SQPQMLSGDALIPKQPPLGERP--SVIQP----------------DSPRSVEIGRSDY 207
P + +A +Q E P S I P DS E ++
Sbjct: 185 QHHSPPATTNNASSTRQHNHLEVPQSSSIPPSELHRKSDETFPDRGSDSMHRAEHEYYEF 244
Query: 208 SCDT-------DSHMQNSFNSESESDISDFSV-PVSYQSTEIS-ENIDFSSLSKSSKDHF 258
S T D H + + +S SD ++ S P+S +S ++S EN+DFS S S K+
Sbjct: 245 SSKTHSPAPSIDDHSSDLLHRDSISDGNEISSGPISIRSADMSYENVDFSPKSGSLKN-- 302
Query: 259 PQSPK-GLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLA 317
P S + + AE++RL+LEL+ SM+++ +V+ E V Q ++L + + E+ K EE++LA
Sbjct: 303 PNSSQLAVNAEMRRLKLELQHSMQLFRTVTNETVLAKQMVMELHRLESLESQKSEESKLA 362
Query: 318 EEAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYK 377
E AAL L + E+ K + A EA ++L +LEA KR AE++A ++K ME MA
Sbjct: 363 ERAALTLAEMEKHKKKVASEAVQAVKKLADLEAQKRN-AEMRA-----QRKKNMETMAND 416
Query: 378 NVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFK 437
+ R R+YTI+EIE AT +F+ S KIGEG YGPV++ L+H +VAIK+L PD+SQG +QF+
Sbjct: 417 DFRCRRYTIDEIEVATQHFAPSHKIGEGAYGPVFRGMLNHIAVAIKILRPDLSQGLKQFR 476
Query: 438 QEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
QEV++L S+RH +MVILLGACPEYGCLVYEYMENG+LEDRLF+KDN+ PI W RFKIA
Sbjct: 477 QEVDVLSSLRHPHMVILLGACPEYGCLVYEYMENGNLEDRLFRKDNTLPIPWRTRFKIAY 536
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
EIA ALLFLH+ KPEPLVHRDLKPANILLD+NYVSKISDVGLARLVPPSAA+ ++QY MT
Sbjct: 537 EIAAALLFLHETKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSAANNVSQYRMT 596
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617
AAGTF YIDPEYQQTG+LGVKSDLYS GVVLLQL+TA+P MGLS QVE +I+NGTFS++
Sbjct: 597 AAAGTFYYIDPEYQQTGLLGVKSDLYSFGVVLLQLLTAKPPMGLSCQVEDSIQNGTFSDV 656
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNI 677
LDP +T WPVE LS+AK+ ++CCELRK+DRP+L +V+LPEL RL DL N + +
Sbjct: 657 LDPALTDWPVEDCLSLAKIGVKCCELRKKDRPNLANVILPELERLTDLAMANEAIEPETT 716
Query: 678 VVTPGPYNSVSEMKQVS 694
+ P + +SE ++ S
Sbjct: 717 IPLTSPIDLISEAQRYS 733
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584917|ref|XP_002533173.1| kinase, putative [Ricinus communis] gi|223527022|gb|EEF29210.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/686 (54%), Positives = 492/686 (71%), Gaps = 52/686 (7%)
Query: 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRN-----HSSNPRGRPATNDELQ 75
NAI AVAID DK+SQ+ V+WA+D+L+ +L+HVR+ H++N G +DE+Q
Sbjct: 14 NAI-AVAIDKDKNSQHVVRWAIDHLIINNPVIILVHVRHKNHQHHANN--GNDVDSDEVQ 70
Query: 76 KLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNL 135
+LF+P+RG ARK + +E++L+D DV+ AL+ Y+ N +G+IV G S+RN TRKF+N
Sbjct: 71 QLFVPFRGYCARKGVQLKEIILEDNDVARALLDYISKNFLGSIVVGASTRNAFTRKFKNQ 130
Query: 136 DLPSSLLKSAPESCAVYIISSKGKLQS----SRPAASQPQMLSGDALIPKQPPLGERPSV 191
D+PSSL+KS P+ C+VY+I SKGK+ S RPA + P + PK P + P
Sbjct: 131 DVPSSLIKSTPDFCSVYVI-SKGKIASVRTAQRPANNPP-------IPPKVPNMLALPGP 182
Query: 192 IQPD------------------------------SPRSVEIGRSDYSCDTDSHMQNSFNS 221
D +P ++ + D S + + S +
Sbjct: 183 TPHDHSDYYDDGIRFPYERSNDPMRGQLIRDRTRTPSNLSMDSIDISFPGGAAPRISTSR 242
Query: 222 ESESDISDFSVPVSYQSTEI-SENIDFSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSM 280
S + DFS P + S +I S+N DF SL Q+ + +EAE++RLR+ELKQ++
Sbjct: 243 VSTYEDHDFSSPFALGSIDISSQNPDF-SLGSPKDLAASQAARDIEAEMRRLRVELKQTI 301
Query: 281 EIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAAL 340
++Y++ +EA++ + A +L Q K EEA + EEAR AEEAALA+ + E+ K +AA+EAA
Sbjct: 302 DMYSTACREALTAKKKANELHQWKMEEARRFEEARHAEEAALAIAEMEKAKCKAAIEAAE 361
Query: 341 MAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISR 400
AQRL ++EA KR+ AELKA +E EEK + A+A+ +VRYRKYTIEEIE AT+ FS S
Sbjct: 362 KAQRLAKMEAQKRKYAELKAKREAEEKNRALTALAHNDVRYRKYTIEEIEDATEKFSQSN 421
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE 460
KIGEGGYGPVYK LDHT+VAIKVL PD +QG +QF+QEVE+L +RH +MV+LLGACPE
Sbjct: 422 KIGEGGYGPVYKGTLDHTAVAIKVLRPDAAQGKKQFQQEVEVLSCIRHPHMVLLLGACPE 481
Query: 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520
YGCLVYEYM+NGSLEDRL Q+DN+PPI W RFKIAAEI+TALLFLHQ KPEPLVHRDLK
Sbjct: 482 YGCLVYEYMDNGSLEDRLLQRDNTPPISWRRRFKIAAEISTALLFLHQAKPEPLVHRDLK 541
Query: 521 PANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS 580
PANILLD+NYVSKISDVGLARLVPPS AD++TQYHMT+AAGTFCYIDPEYQQTGML +S
Sbjct: 542 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTRS 601
Query: 581 DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQC 640
D+YSLG++LLQ+ITA+P MGL+H V +AI GTF ++LDP+V WPVE AL+ AKLAL+C
Sbjct: 602 DIYSLGILLLQIITAKPPMGLAHHVGKAIERGTFEKMLDPSVVDWPVEEALNFAKLALKC 661
Query: 641 CELRKRDRPDLVSVVLPELIRLRDLG 666
ELRK+DRP+L++V++PEL R+RDLG
Sbjct: 662 AELRKKDRPNLLTVIVPELSRIRDLG 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15239600|ref|NP_197987.1| protein kinase-like protein [Arabidopsis thaliana] gi|332006147|gb|AED93530.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/693 (54%), Positives = 477/693 (68%), Gaps = 45/693 (6%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLN--ETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPY 81
T VAID +K S YAV+WAVD+LLN +L+HVR +SN G ND+L +LF+PY
Sbjct: 17 TVVAIDKEKHSSYAVRWAVDHLLNMIHNPVMILVHVRTKNSN-HGANLNNDDLNQLFIPY 75
Query: 82 RGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKF---RNLDLP 138
RG ARK VVL D DV+ ++ YV NN V N+V G S++N R F + ++
Sbjct: 76 RGYCARK-----GVVLDDSDVAKTILDYVNNNLVNNLVLGASTKNTFARSFMFSKPHEVQ 130
Query: 139 SSLLKSAPESCAVYIISSKGKLQSSRPAA-------SQPQMLSG-----------DALIP 180
SS++KS P+ C+VY+IS GK+QSSRPA + P++ S LIP
Sbjct: 131 SSIMKSTPDFCSVYVISKGGKVQSSRPAQRPITNTLAPPRVPSSGFLIQSLSDSEQDLIP 190
Query: 181 K-QPPLGERPS-VIQPDSPRSVEIGRSDYSCDTDSHM--QNSFN----------SESESD 226
+ Q +P+ P + + + Y + M N FN S SD
Sbjct: 191 RVQRSARNKPNETTYPHNRAAFNTTQKGYKSPINGSMDFNNGFNQAAFQRNPTLQSSFSD 250
Query: 227 ISDFSVPVSYQSTEISEN-IDF-SSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIYN 284
SD V S+N +DF S SS++ PQS K +EAE++RL+LELKQ+M++Y+
Sbjct: 251 ESDGGFGVMGSVDLSSQNSMDFYHGASSSSEESIPQSTKDIEAEMRRLKLELKQTMDMYS 310
Query: 285 SVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQR 344
S KEA++ + A +L Q K EEA K E+ARL+EEAALA+ + E+ K R A+EAA AQR
Sbjct: 311 SACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKCRTAVEAAEKAQR 370
Query: 345 LVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGE 404
+ ELE +R+ AE+KA+ EE++K + A+A+ +VRYRKY+IEEIE AT+ F+ RKIGE
Sbjct: 371 MAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEATERFANHRKIGE 430
Query: 405 GGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCL 464
GGYGPVY +LDHT VAIKVL PD +QG +QF+QEVE+L S+RH +MV+LLGACPEYGCL
Sbjct: 431 GGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMVLLLGACPEYGCL 490
Query: 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANI 524
VYE+MENGSLEDRLF+ NSPP+ W RF+IAAEIATAL FLHQ KPEPLVHRDLKPANI
Sbjct: 491 VYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPEPLVHRDLKPANI 550
Query: 525 LLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYS 584
LLD+NYVSKISDVGLARLVP S AD++TQ+HMT+AAGTFCYIDPEYQQTGML KSD+YS
Sbjct: 551 LLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQTGMLTTKSDVYS 610
Query: 585 LGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELR 644
LG++LLQ+IT RP MGL+HQV +AI GTF E+LDP V WPV+ A S A LAL+C ELR
Sbjct: 611 LGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQSFATLALKCAELR 670
Query: 645 KRDRPDLVSVVLPELIRLRDLGFENAENKNDNI 677
KRDRPDL V+P LIRL++ G + E N+ I
Sbjct: 671 KRDRPDLGKEVVPHLIRLKNFGNDGDERTNEWI 703
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79511817|ref|NP_196761.2| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] gi|110741831|dbj|BAE98858.1| putative receptor - like kinase [Arabidopsis thaliana] gi|332004366|gb|AED91749.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/686 (54%), Positives = 474/686 (69%), Gaps = 47/686 (6%)
Query: 24 TAVAIDADKSSQYAVKWAVDNLLNE--TSQYVLLHVRNHSSNPRGRPATNDELQKLFLPY 81
T VAID DK+S +AV+WAVD+L N S+ +LLHVR +SN G + EL +LF+PY
Sbjct: 17 TVVAIDKDKNSHFAVRWAVDHLFNMIINSKMILLHVRLKNSN-HGGNIDDSELNQLFVPY 75
Query: 82 RGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTR--KF-RNLDLP 138
RG ARK I EV+L D DVS A++ YV NN V N+V G SS++ R KF ++ D+
Sbjct: 76 RGYCARKGISMMEVILDDTDVSKAVLDYVNNNLVTNLVLGSSSKSPFARSLKFTKSHDVA 135
Query: 139 SSLLKSAPESCAVYIISSKGKLQSSRPAASQPQMLSGDALIPKQPPLG--ERPSVIQPDS 196
SS+LKS PE C+VY+I SKGK+ SSR A Q + L+P + P P S
Sbjct: 136 SSVLKSTPEFCSVYVI-SKGKVHSSRTA----QRPITNTLVPPRVPSSTFHLPDPDHDRS 190
Query: 197 PRSVEIGRSDYSCDTDSHMQNSF----------------------------NSESESDIS 228
PRS GR+ + SH F NS S S
Sbjct: 191 PRSQRNGRNTVP-ERYSHENKGFKPVREMHKIPTNGSLDFNYEFRQGKGQRNSTGRSSFS 249
Query: 229 DFSVPVS----YQSTEIS-ENIDFSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIY 283
D S V S ++S EN D S SS + QS + +EAE+KRL++ELKQ+M++Y
Sbjct: 250 DESSDVGSMMMMGSIDLSAENFDMVGGSGSSDESASQSTRDIEAEMKRLKIELKQTMDMY 309
Query: 284 NSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQ 343
+S KEA++ + A +L Q K EEA + EEAR AEEAALA+ + E+ K RAA+EAA AQ
Sbjct: 310 SSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAALEAAEKAQ 369
Query: 344 RLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIG 403
R+ ELE +R+ AE+KA +E +EK + A+ +VRYRKY+I+EIE AT+ F+ +RKIG
Sbjct: 370 RMAELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIG 429
Query: 404 EGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGC 463
EGGYGPVY LDHT VAIKVL PD +QG +QF+QEVE+L S+RH +MV+LLGACPEYGC
Sbjct: 430 EGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGC 489
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
LVYE+M+NGSLEDRLF++ NSPP+ W RF+IAAEIATAL FLHQ KPEPLVHRDLKPAN
Sbjct: 490 LVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPAN 549
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLY 583
ILLD+NYVSKISDVGLARLVP S A+T+TQYHMT+AAGTFCYIDPEYQQTG L KSD++
Sbjct: 550 ILLDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIF 609
Query: 584 SLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCEL 643
SLG++LLQ+ITA+ MGL+H V +AI GTF ++LDP V WPVE AL+ AKL L+C EL
Sbjct: 610 SLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAEL 669
Query: 644 RKRDRPDLVSVVLPELIRLRDLGFEN 669
RKRDRPDL ++PEL+RLR+LG +N
Sbjct: 670 RKRDRPDLGKEIVPELLRLRNLGKDN 695
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 701 | ||||||
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.643 | 0.643 | 0.585 | 3e-170 | |
| TAIR|locus:2030245 | 697 | AT1G72760 [Arabidopsis thalian | 0.898 | 0.903 | 0.491 | 7.2e-155 | |
| TAIR|locus:2182613 | 731 | AT5G35380 [Arabidopsis thalian | 0.660 | 0.633 | 0.556 | 6.4e-153 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.711 | 0.633 | 0.548 | 4.8e-144 | |
| TAIR|locus:2180677 | 703 | AT5G26150 [Arabidopsis thalian | 0.650 | 0.648 | 0.591 | 2.4e-140 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.669 | 0.613 | 0.547 | 4.4e-139 | |
| TAIR|locus:2087610 | 780 | AT3G20200 [Arabidopsis thalian | 0.620 | 0.557 | 0.493 | 3.7e-133 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.659 | 0.609 | 0.529 | 2e-127 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.650 | 0.651 | 0.547 | 7e-125 | |
| TAIR|locus:2007908 | 728 | AT1G17540 [Arabidopsis thalian | 0.710 | 0.684 | 0.496 | 1.2e-122 |
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1351 (480.6 bits), Expect = 3.0e-170, Sum P(2) = 3.0e-170
Identities = 266/454 (58%), Positives = 337/454 (74%)
Query: 216 QNSFNSESESDISDFSVPVSYQSTEISENIDFSSLSKSSKDHFPQSPKGLEAEIKRLRLE 275
++SF+ ES SD+ + S + +EN D S SS + QS + +EAE+KRL++E
Sbjct: 245 RSSFSDES-SDVGSMMMMGSIDLS--AENFDMVGGSGSSDESASQSTRDIEAEMKRLKIE 301
Query: 276 LKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXXXXXXXXXXVKSERQKTRAA 335
LKQ+M++Y+S KEA++ + A + E+ K RAA
Sbjct: 302 LKQTMDMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAA 361
Query: 336 MEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDY 395
+EAA AQR+ ELE +R+ AE+KA +E +EK + A+ +VRYRKY+I+EIE AT+
Sbjct: 362 LEAAEKAQRMAELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATER 421
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
F+ +RKIGEGGYGPVY LDHT VAIKVL PD +QG +QF+QEVE+L S+RH +MV+LL
Sbjct: 422 FANNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLL 481
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
GACPEYGCLVYE+M+NGSLEDRLF++ NSPP+ W RF+IAAEIATAL FLHQ KPEPLV
Sbjct: 482 GACPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLV 541
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRDLKPANILLD+NYVSKISDVGLARLVP S A+T+TQYHMT+AAGTFCYIDPEYQQTG
Sbjct: 542 HRDLKPANILLDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGK 601
Query: 576 LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAK 635
L KSD++SLG++LLQ+ITA+ MGL+H V +AI GTF ++LDP V WPVE AL+ AK
Sbjct: 602 LTTKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAK 661
Query: 636 LALQCCELRKRDRPDLVSVVLPELIRLRDLGFEN 669
L L+C ELRKRDRPDL ++PEL+RLR+LG +N
Sbjct: 662 LCLRCAELRKRDRPDLGKEIVPELLRLRNLGKDN 695
|
|
| TAIR|locus:2030245 AT1G72760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1510 (536.6 bits), Expect = 7.2e-155, P = 7.2e-155
Identities = 332/675 (49%), Positives = 440/675 (65%)
Query: 32 KSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRIL 91
K+SQ+A+KWAV+N++ + Q VL+HV+ + DE + FLP+RG ARK I+
Sbjct: 25 KNSQHALKWAVENIVADAPQCVLIHVQLGDTGGHFHQDNPDEAHEFFLPFRGFCARKGII 84
Query: 92 AREVVLQDIDVSSALIYYVKNNS-VGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCA 150
A+EV+L DID+S+A++ Y+ NN + N+V G S+RN +KF++ D+P++LLK+ PE+CA
Sbjct: 85 AKEVILHDIDISNAIVNYITNNYYIANLVVGASARNSFLKKFQSPDVPTTLLKTTPETCA 144
Query: 151 VYIISSKGKLQSSRPAA-----SQPQMLSG-----DALIPKQPPLGERPSVIQPDSPRSV 200
V++++ KGKL SR A+ S+ Q LS I P Q + P S
Sbjct: 145 VFVVT-KGKLLKSRSASHRHKLSRQQNLSSLLYNSTNSIDSDSASISSPVSTQTNKPNSN 203
Query: 201 EIGRSDYSCDTDSHMQNSFNSESESDISDF-SVPVSYQSTEISENIDFSSLSKSSKD--- 256
+ T M SE+++ D S SY ++ S I SS+S +S +
Sbjct: 204 FFQPNSPRISTPQSMSEISQSETDNGSCDMVSTVSSYTVSDSSTTIG-SSISSTSTESPL 262
Query: 257 ---HFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXX 313
+ Q + LEAE++RLRLELKQ +N K+ +T+Q
Sbjct: 263 VGNYVEQQNQNLEAEVRRLRLELKQ----FN---KDKDTTNQKENSQETPWSDEKIELPR 315
Query: 314 XXXXXXXXXXXVKSERQKTR-AAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVME 372
E QKT+ AA +AA +A+R+ ++E+ KR + E++A +++
Sbjct: 316 ALSDR---------ETQKTQSAAFQAAEIAKRIAKMESQKRRLLEMQANLDKQ------- 359
Query: 373 AMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG 432
M + V YR+Y+I+++E AT FS + KIGEGGYGPVYKA LD+TSVAIK+L I++G
Sbjct: 360 -MMFTTVSYRRYSIKDVEDATYGFSDALKIGEGGYGPVYKAVLDYTSVAIKILKSGITEG 418
Query: 433 PRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR 492
+QF+QE+E+L SMRH NMVILLGACPEYGCLVYEYMENG+LEDRLF K+N+PP+ W R
Sbjct: 419 LKQFQQEIEVLSSMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKNNTPPLSWRAR 478
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
F+IA+EIAT LLFLHQ KPEPLVHRDLKPANILLD++ KISDVGLARLVPP+ ADT +
Sbjct: 479 FRIASEIATGLLFLHQAKPEPLVHRDLKPANILLDKHLTCKISDVGLARLVPPAVADTYS 538
Query: 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNG 612
YHMT+AAGTFCYIDPEYQQTGMLGVKSDLYS GVVLLQ+ITA+PAMGL H+VE A+ N
Sbjct: 539 NYHMTSAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAQPAMGLGHKVEMAVENN 598
Query: 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAEN 672
E+LDPTV+ WP E L +AKLALQCCELRK+DRPDL V+LP L RL++ E+ E
Sbjct: 599 NLREILDPTVSEWPEEETLELAKLALQCCELRKKDRPDLALVLLPALNRLKEFATEDHER 658
Query: 673 KNDNIVVTPGPYNSV 687
D +NSV
Sbjct: 659 IQDRTSHVSHEHNSV 673
|
|
| TAIR|locus:2182613 AT5G35380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 6.4e-153, Sum P(2) = 6.4e-153
Identities = 266/478 (55%), Positives = 335/478 (70%)
Query: 218 SFNSESESDISDFSVPVSYQSTEI-SENIDFSSLS-KSSKDHFP-QSPKGLEAEIKRLRL 274
S SE + F+ S QS ++ S SS S +S + F Q LE E++RL++
Sbjct: 243 SVTSEYGENRLSFATTYSKQSIDLGSPYAPNSSTSFESGRQSFSLQGQDELETEMRRLKM 302
Query: 275 ELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXXXXXXXXXXVKSERQKTRA 334
ELK +ME+YNS KEA+S + A + E++K+RA
Sbjct: 303 ELKHTMEMYNSACKEAISAKKAANELLKWKAEKEHKLEEVRLSKEAAMAMAEREKEKSRA 362
Query: 335 AMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATD 394
AMEAA+ AQ+L +LEA KR K ++ +EKK A ++RYRKYTIEEIE AT+
Sbjct: 363 AMEAAVAAQKLSDLEAEKR-----KHIETVDEKK-----RAVSSLRYRKYTIEEIEEATE 412
Query: 395 YFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
FS SRK+GEGGYGPVYK LD+T VAIKVL PD +QG QF++EVE+L MRH NMV+L
Sbjct: 413 DFSPSRKVGEGGYGPVYKGTLDYTKVAIKVLRPDAAQGRSQFQREVEVLTCMRHPNMVLL 472
Query: 455 LGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
LGACPEYGCLVYEYM NGSL+D LF++ NSP + W +RF+IA+EIAT L FLHQ KPEPL
Sbjct: 473 LGACPEYGCLVYEYMANGSLDDCLFRRGNSPILSWQLRFRIASEIATGLHFLHQMKPEPL 532
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
VHRDLKP NILLDQ++VSKISDVGLARLVPPS ADT TQY MT+ AGTF YIDPEYQQTG
Sbjct: 533 VHRDLKPGNILLDQHFVSKISDVGLARLVPPSVADTATQYRMTSTAGTFFYIDPEYQQTG 592
Query: 575 MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIA 634
MLG KSD+YS G++LLQ++TA+P MGL+H VE+AI GTF+E+LDP V WP E AL+ A
Sbjct: 593 MLGTKSDIYSFGIMLLQILTAKPPMGLTHHVEKAIEKGTFAEMLDPAVPDWPFEEALAAA 652
Query: 635 KLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAEN--KNDNIVVTPGPYNSVSEM 690
KLALQC +LR++DRPDL ++VLPEL +LRDL E+ + + + + + G S+ E+
Sbjct: 653 KLALQCAKLRRKDRPDLGNIVLPELKKLRDLAEESIKFGVRQPSPIRSSGSATSIQEI 710
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 4.8e-144, Sum P(2) = 4.8e-144
Identities = 277/505 (54%), Positives = 345/505 (68%)
Query: 190 SVIQPDSPRSVEIGRSDYSCDTDSHMQNSFNSESESDIS---DFSVPVSYQSTEISENID 246
S I P I S Y + S ++ S+ D S D S +S +++ D
Sbjct: 274 SFISSGRPSIDRIFPSLYDNNDPSRTPPRLSNFSDMDYSSSLDQSSNYGRRSVDMNSPTD 333
Query: 247 FSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXX 306
F S SS QS +EAE++RL+LELKQ+ME+Y++ KEA++ Q A
Sbjct: 334 FESERFSSAS---QSIDDVEAEMRRLKLELKQTMEMYSTACKEALTAKQKATELQRWKLE 390
Query: 307 XXXXXXXXXXXXXXXXXXVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEE 366
+ E+ K++AAMEAA AQR+ ELEA KR AE+KA++E EE
Sbjct: 391 EERKLEEARNAEEAALAIAEKEKAKSKAAMEAAEAAQRIAELEAKKRVNAEMKALKESEE 450
Query: 367 KKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLG 426
K + A+A +VRYRKY+IE+IE AT++F+ KIGEGGYGPVYK LDHT VA+KVL
Sbjct: 451 KTKALTALANSDVRYRKYSIEDIELATEFFAEKYKIGEGGYGPVYKCYLDHTPVAVKVLR 510
Query: 427 PDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPP 486
PD +QG QF+QEVE+L +RH NMV+LLGACPE GCLVYE+M NGSLEDRLF+ NSPP
Sbjct: 511 PDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRLGNSPP 570
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
+ W +RF+IAAEI T LLFLHQ KPEPLVHRDLKP NILLD+N+VSKISDVGLARLVPP+
Sbjct: 571 LSWQMRFRIAAEIGTGLLFLHQAKPEPLVHRDLKPGNILLDRNFVSKISDVGLARLVPPT 630
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606
ADT+TQY MT+ AGTFCYIDPEYQQTGMLGVKSD+YSLG++ LQLITA+P MGL+H VE
Sbjct: 631 VADTVTQYRMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITAKPPMGLTHYVE 690
Query: 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666
+A+ GT +LLDP V+ WP+E AKLAL+C ELR++DRPDL V+LPEL RLR L
Sbjct: 691 RALEKGTLVDLLDPVVSDWPMEDTEEFAKLALKCAELRRKDRPDLAKVILPELNRLRTLA 750
Query: 667 FENAENKNDNIVVTPGPYNSVSEMK 691
E++ + P P S S +K
Sbjct: 751 DESSHSVVVGNSPLPSPTGSQSSLK 775
|
|
| TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 274/463 (59%), Positives = 343/463 (74%)
Query: 215 MQNSFNSESESDISDF-SVPVSYQSTEISENIDF-SSLSKSSKDHFPQSPKGLEAEIKRL 272
+Q+SF+ ES+ SV +S Q++ +DF S SS++ PQS K +EAE++RL
Sbjct: 244 LQSSFSDESDGGFGVMGSVDLSSQNS-----MDFYHGASSSSEESIPQSTKDIEAEMRRL 298
Query: 273 RLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXXXXXXXXXXVKSERQKT 332
+LELKQ+M++Y+S KEA++ + A + E+ K
Sbjct: 299 KLELKQTMDMYSSACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKC 358
Query: 333 RAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAA 392
R A+EAA AQR+ ELE +R+ AE+KA+ EE++K + A+A+ +VRYRKY+IEEIE A
Sbjct: 359 RTAVEAAEKAQRMAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEA 418
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
T+ F+ RKIGEGGYGPVY +LDHT VAIKVL PD +QG +QF+QEVE+L S+RH +MV
Sbjct: 419 TERFANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMV 478
Query: 453 ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
+LLGACPEYGCLVYE+MENGSLEDRLF+ NSPP+ W RF+IAAEIATAL FLHQ KPE
Sbjct: 479 LLLGACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPE 538
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
PLVHRDLKPANILLD+NYVSKISDVGLARLVP S AD++TQ+HMT+AAGTFCYIDPEYQQ
Sbjct: 539 PLVHRDLKPANILLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQ 598
Query: 573 TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALS 632
TGML KSD+YSLG++LLQ+IT RP MGL+HQV +AI GTF E+LDP V WPV+ A S
Sbjct: 599 TGMLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQS 658
Query: 633 IAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKND 675
A LAL+C ELRKRDRPDL V+P LIRL++ G + E N+
Sbjct: 659 FATLALKCAELRKRDRPDLGKEVVPHLIRLKNFGNDGDERTNE 701
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 4.4e-139, Sum P(2) = 4.4e-139
Identities = 265/484 (54%), Positives = 335/484 (69%)
Query: 189 PSVIQPDSPRSVEIGRSDYSCDTDSHMQNSFNSESESDIS-DFSVPVSYQSTEISENIDF 247
PS+ P S++S D D SF S + S D S P ++ ST EN F
Sbjct: 273 PSLYDNSDPNRTPPRLSNFS-DVD---YCSFESMTFGRRSMDLSSPTAF-STGSFENERF 327
Query: 248 SSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXX 307
SS S+ D +EAE++RL+LELKQ+ME+Y++ KEA++ A
Sbjct: 328 SSASQGGDD--------VEAEMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAE 379
Query: 308 XXXXXXXXXXXXXXXXXVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEK 367
+ E+ K++AAMEAA AQR+ ++E+ KR AE KA++E E +
Sbjct: 380 ERKFEEAKLAEEAALAIAEKEKAKSKAAMEAAEAAQRIADIESRKRVDAETKALKESEAR 439
Query: 368 KIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGP 427
+ A+A K+VRYRKY+IEEIE AT++F KIGEG YGPVYK LDHT VA+K L P
Sbjct: 440 TKAVNALA-KDVRYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRP 498
Query: 428 DISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPI 487
D +QG QF++EVE+L S+RH NMV+LLGACPE GCLVYE+M NGSLEDRLF++ +SP +
Sbjct: 499 DAAQGRSQFQKEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPAL 558
Query: 488 HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547
W RF+IAAEI T LLFLHQ KPEPLVHRDLKPANILLD+N+VSK++DVGLARLVPPS
Sbjct: 559 SWQTRFRIAAEIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSV 618
Query: 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607
A+T+TQYHMT+ AGTFCYIDPEYQQTGMLGVKSD+YSLG++ LQLIT +P MGL+H VE+
Sbjct: 619 ANTVTQYHMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVER 678
Query: 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGF 667
A+ G +LLDP V+ WPVE AKLAL+C E+R++DRPDL V+LPEL RLR L
Sbjct: 679 ALEKGNLKDLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAE 738
Query: 668 ENAE 671
E+ +
Sbjct: 739 ESTQ 742
|
|
| TAIR|locus:2087610 AT3G20200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
Identities = 223/452 (49%), Positives = 297/452 (65%)
Query: 222 ESESDISDFSVPVSYQSTEISENIDFSSLS--KSSKDHFPQSPKGLEAEIKRLRLELKQS 279
ES S + + + T I + F S +SS PQ+ + +EAE++RL+ ELK +
Sbjct: 291 ESTSSGHSMRLGIRFNDTNIQHDFSFVSQDSGRSSCSCSPQNLEEVEAEMRRLKQELKHA 350
Query: 280 MEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXXXXXXXXXXVKSERQKTRAAMEAA 339
+++Y S +EA++ Q A V+ ER +AA +A+
Sbjct: 351 IDMYGSACREALAAKQEAKELQRQKIEEEGWVQEGQLSEKSTKSIVEKERAH-KAAKDAS 409
Query: 340 LMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSIS 399
A ++ ELE +R I + + ++RYR+Y I EIE AT+ F +
Sbjct: 410 ETAGKIAELETQRRAIEAAGSFSDS-------------SLRYRRYVIGEIEEATNSFDKA 456
Query: 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
KIGEGGYGPVYK LDHT VAIK L D QG QF++EVE+L +RH +MV+L+GACP
Sbjct: 457 NKIGEGGYGPVYKGYLDHTPVAIKALKADAVQGRSQFQREVEVLSCIRHPHMVLLIGACP 516
Query: 460 EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDL 519
EYG LVYEYM GSL DRL++ N+PP+ W +RF+IAAE+AT LLFLHQ KPEP+VHRDL
Sbjct: 517 EYGVLVYEYMAKGSLADRLYKYGNTPPLSWELRFRIAAEVATGLLFLHQTKPEPIVHRDL 576
Query: 520 KPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK 579
KP NIL+DQNYVSKI DVGLA+LVP + A+ +TQ H+++ AGTFCYIDPEYQQTGMLGVK
Sbjct: 577 KPGNILIDQNYVSKIGDVGLAKLVP-AVAENVTQCHVSSTAGTFCYIDPEYQQTGMLGVK 635
Query: 580 SDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQ 639
SD+YS G++LL+L+TA+ GL++ VEQA+ G F ++LDP V WPVE A+S+AK+AL+
Sbjct: 636 SDVYSFGILLLELLTAKRPTGLAYTVEQAMEQGKFKDMLDPAVPNWPVEEAMSLAKIALK 695
Query: 640 CCELRKRDRPDLVSVVLPELIRLRDLGFENAE 671
C +LR++DRPDL VLPEL +LR N E
Sbjct: 696 CAQLRRKDRPDLGKEVLPELNKLRARADTNME 727
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 252/476 (52%), Positives = 333/476 (69%)
Query: 202 IGRSDYSCDTDSHMQNS-FNSESESDISDFSVPVSYQSTEISENIDFSSLS----KSSKD 256
+ RS ++ D + S ++ SE I + + + T++S SS+S ++S
Sbjct: 259 VDRSSFTYDLPESARTSRMSTSSEQSIGSHRLGIKF--TDLSYLNGSSSVSDESGRTSCS 316
Query: 257 HFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXX 316
QS +EA++KRLRLELKQ+M++Y+S +EA++ A
Sbjct: 317 FSSQSLNDVEAQMKRLRLELKQTMDMYSSACREALTARNEATELQKLRTEEERRLEELKM 376
Query: 317 XXXXXXXXVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAY 376
V++ER K + A+EAA A RL E+EA +R AE+K ++E + +
Sbjct: 377 TEETAMSIVENERAKAKTALEAAEAANRLAEVEAKRRVHAEMKVLKESDSFS------RH 430
Query: 377 KNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQF 436
VRYRKY+++EIE T F+ SRK+GEGGYGPV++ LDHTSVA+KVL PD +QG QF
Sbjct: 431 SIVRYRKYSVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQF 490
Query: 437 KQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
+EVE+L +RH NMV+LLGACPEYG LVYEYM GSL+DRLF++ N+PPI W +RF+IA
Sbjct: 491 HKEVEVLSCIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIA 550
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
AEIAT LLFLHQ KPEP+VHRDLKP N+LLD NYVSKISDVGLARLVP + A+ +TQY +
Sbjct: 551 AEIATGLLFLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVP-AVAENVTQYRV 609
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSE 616
T+AAGTFCYIDPEYQQTGMLGVKSD+YSLG++LLQL+TA+ MGL++ VEQAI GT +
Sbjct: 610 TSAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKD 669
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAEN 672
+LDP V WP+E ALS+AKL+LQC ELR++DRPDL V+PEL RLR++G E+ ++
Sbjct: 670 MLDPAVPDWPLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGEESLDS 725
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
Identities = 254/464 (54%), Positives = 317/464 (68%)
Query: 206 DYSCDTDSHMQNSFNSESESDISDFSVPVSYQSTEISENIDFSSLSKSSKDHFPQSPKGL 265
D+ D S+ S +S SE D S ST E+ SSLS S+D +
Sbjct: 237 DWFEDNRSNYATS-SSSSEKQSIDLCSSYSAFSTSSQESGRLSSLSMYSQDD-------V 288
Query: 266 EAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVXXXXXXXXXXXXXXXXXXXXXXXXXXV 325
E+E++RL+LELK +M++YNS KEA++ +T +
Sbjct: 289 ESEMRRLKLELKYTMDMYNSACKEAIAAKKTTIELHKWKEERKHKLEEAILAKEAAMAIA 348
Query: 326 KSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYT 385
++E+ K+RAAMEA A R+ E EA KR+ E A++E E + M A+ + N YRKYT
Sbjct: 349 ENEKAKSRAAMEALEAAHRMAETEAQKRKQIETAALREVEHENKAMHALPHSNRMYRKYT 408
Query: 386 IEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS 445
IEEIE T FS S KIGEG YG VYK LD+T VAIKV+ PD +QG QF+QEVE+L
Sbjct: 409 IEEIEQGTTKFSDSHKIGEGSYGTVYKGTLDYTPVAIKVVRPDATQGRSQFQQEVEVLTC 468
Query: 446 MRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
+RH NMV+LLGAC EYGCLVYEYM NGSL+D L ++ NSP + W +RF+IAAEIAT+L F
Sbjct: 469 IRHPNMVLLLGACAEYGCLVYEYMSNGSLDDCLLRRGNSPVLSWQLRFRIAAEIATSLNF 528
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LHQ KPEPLVHRDLKPANILLDQ+ VSKISDVGLARLVPP+ D T Y MT+ AGT CY
Sbjct: 529 LHQLKPEPLVHRDLKPANILLDQHMVSKISDVGLARLVPPTIDDIATHYRMTSTAGTLCY 588
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625
IDPEYQQTGMLG KSD+YS G+VLLQ++TA+ MGL++QVE+AI G F+++LDP VT W
Sbjct: 589 IDPEYQQTGMLGTKSDIYSFGIVLLQILTAKTPMGLTNQVEKAIEEGNFAKILDPLVTDW 648
Query: 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFEN 669
P+E AL +AK+ LQC ELR++DRPDL +VVLP L RL +L EN
Sbjct: 649 PIEEALILAKIGLQCAELRRKDRPDLGTVVLPGLKRLMNLAEEN 692
|
|
| TAIR|locus:2007908 AT1G17540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1206 (429.6 bits), Expect = 1.2e-122, P = 1.2e-122
Identities = 271/546 (49%), Positives = 353/546 (64%)
Query: 162 SSRPAASQ-PQMLSGDAL--IPKQPPL-GERPSVIQ---PDSPRSVEIGRSDYSCDTD-- 212
+SRP Q P G P+ PP + PS++ P S S E GRS + + +
Sbjct: 161 ASRPQTPQGPHTPQGPQTPQAPQHPPHPSKHPSMMSDPGPTSSTSSESGRSSPALNGELS 220
Query: 213 ---------------SHMQNSFNSE--SESDISDFSV--PVSYQSTEISENIDFSSLSKS 253
S + N F S+ +ES+ S +S+ +Y + S + + +S
Sbjct: 221 PPTPHYKPSLYRSSMSELSNEFPSDHSAESNASFYSILGRSTYGGSSHSSMSEITDGEES 280
Query: 254 -SKDHFPQSP-KGLEAEIKRLRLELKQSMEIYN-SVSKEAVSTSQTAVXXXXXXXXXXXX 310
S + + + LEAE++RLR EL+Q +N S+S+E+
Sbjct: 281 LSGGNITEHQNQNLEAEVRRLRFELQQ----FNASMSRESAPH-----LLGPRATAETER 331
Query: 311 XXXXXXXXXXXXXXVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIV 370
+ ++QKT+ A++A +AQRL E+E KR + E++A +E+
Sbjct: 332 LEEAKAAREMLRALSEMDKQKTQTAIQATEVAQRLAEIETQKRRLVEMQARFKEQN---- 387
Query: 371 MEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS 430
MA ++ YR+Y+I ++E ATD FS + KIGEGGYGPVYKA L++TSVAIK+L D+S
Sbjct: 388 ---MA-DSISYRRYSIRDVEGATDGFSDALKIGEGGYGPVYKAVLENTSVAIKLLKSDVS 443
Query: 431 QGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS 490
QG +QF QE+E+L MRH NMVILLGACPEYGCLVYEYMENG+LEDRLF KDN+PP+ W
Sbjct: 444 QGLKQFNQEIEVLSCMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKDNTPPLSWR 503
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
RF+IAAEIAT LLFLHQ KPEPLVHRDLKPANIL+D+++ SKISDVGLARLVP + AD+
Sbjct: 504 ARFRIAAEIATGLLFLHQAKPEPLVHRDLKPANILIDRHFTSKISDVGLARLVPAAVADS 563
Query: 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610
+ YHMT AAGTFCYIDPEYQQTGMLGVKSDLYS GVVLLQ+ITA PAMGLSH+VE+AI
Sbjct: 564 FSNYHMTAAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAMPAMGLSHRVEKAIE 623
Query: 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENA 670
E+LDP ++ WP E + +A+LALQCCELRK+DRPDL SV+LP L +LR+ E+
Sbjct: 624 KKKLREVLDPKISDWPEEETMVLAQLALQCCELRKKDRPDLASVLLPALSKLREFATEDH 683
Query: 671 ENKNDN 676
E N +
Sbjct: 684 EVHNSD 689
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 701 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 3e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| TIGR04211 | 198 | TIGR04211, SH3_and_anchor, SH3 domain protein | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 9e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 75/207 (36%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMV 452
+ I K+GEG +G VY A+ T VAIKV+ I + + +E++IL ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 453 ILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
L + LV EY E G L D L ++ RF +I +AL +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARF-YLRQILSALEYLHSKG 117
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
+VHRDLKP NILLD++ K++D GLAR + P +TT GT Y+ PE
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-------EKLTTFVGTPEYMAPEV 167
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARP 597
G D++SLGV+L +L+T +P
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 73/198 (36%), Positives = 105/198 (53%), Gaps = 18/198 (9%)
Query: 402 IGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMVILLGAC 458
+GEGG+G VY A + VAIK++ + S + +E+EIL + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 459 --PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516
+ LV EY E GSL+D L K+N + +I +I L +LH N ++H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 517 RDLKPANILLDQ-NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQQTG 574
RDLKP NILLD N K++D GL++L+ + + T GT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD------KSLLKTIVGTPAYMAPEVLLGKG 169
Query: 575 MLGVKSDLYSLGVVLLQL 592
KSD++SLGV+L +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 78/209 (37%), Positives = 114/209 (54%), Gaps = 19/209 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD--ISQGPRQFKQEVEILGSMRHTNM 451
+ + RK+G G +G VYKA+ T VA+K+L S+ + ++E+ IL + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 452 VILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V L+ A ++ LV EY E G L D L + P+ KIA +I L +LH N
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRDLKP NILLD+N V KI+D GLA+ + + +TT GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKL------LKSSSSLTTFVGTPWYMAPE 168
Query: 570 -YQQTGMLGVKSDLYSLGVVLLQLITARP 597
G K D++SLGV+L +L+T +P
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 84/265 (31%), Positives = 122/265 (46%), Gaps = 30/265 (11%)
Query: 397 SISRKIGEGGYGPVYKAQLDHTS------VAIKVLGPDIS-QGPRQFKQEVEILGSMRHT 449
++ +K+GEG +G VYK +L VA+K L D S Q +F +E I+ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N+V LLG C E +V EYME G L L + N P + S A +IA + +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+HRDL N L+ +N V KISD GL+R + Y ++
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYRKRGGKLPIRWMA 171
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTG 624
PE + G KSD++S GV+L ++ T +P G+S +V + ++NG L
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ---- 224
Query: 625 WPVEAALSIAKLALQCCELRKRDRP 649
P + L LQC DRP
Sbjct: 225 -PPNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 56/147 (38%), Positives = 86/147 (58%), Gaps = 12/147 (8%)
Query: 23 ITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSS---NPRGRPAT--------N 71
AVA+D DK S+ A+KWA+DNL + VL+HV + + G+ +
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 72 DELQKLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRK 131
E ++L LPYR +RK + +VVL+D DV+ A++ YV ++ + +V G SS N + K
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 132 FRNLDLPSSLLKSAPESCAVYIISSKG 158
F+ D+ SS+LK AP+ C VY++ SKG
Sbjct: 121 FKKSDVASSVLKEAPDFCTVYVV-SKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 80/267 (29%), Positives = 120/267 (44%), Gaps = 31/267 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
+ +K+GEG +G VYK L T VA+K L S+ R+ F +E I+ + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 449 TNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V LLG C + +V EYM G L D L + + ++A +IA + +L
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYL 118
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT-FCY 565
VHRDL N L+ +N V KISD GL+R + Y +
Sbjct: 119 ESKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKW 170
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTV 622
+ PE + G KSD++S GV+L ++ T +P G+S +V + + +G L
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPR-- 225
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRP 649
P + +L LQC DRP
Sbjct: 226 ---PENCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 83/265 (31%), Positives = 121/265 (45%), Gaps = 29/265 (10%)
Query: 397 SISRKIGEGGYGPVYKAQLDHTS------VAIKVLGPDIS-QGPRQFKQEVEILGSMRHT 449
++ +K+GEG +G VYK L VA+K L D S Q +F +E I+ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N+V LLG C E +V EYM G L D L +K+ + S A +IA + +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+HRDL N L+ +N V KISD GL+R + Y + ++
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYKVKGGKLPIRWMA 172
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTG 624
PE + G KSD++S GV+L ++ T P G+S +V + ++ G L
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK---- 225
Query: 625 WPVEAALSIAKLALQCCELRKRDRP 649
P + KL LQC DRP
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 86/299 (28%), Positives = 138/299 (46%), Gaps = 20/299 (6%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMV 452
+ I RK+GEG +G VY A+ D VA+KVL + S+ +F +E++IL S+ H +
Sbjct: 2 YRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 453 ILL---GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
+ L LV EY++ GSLED L + P+ S I A+I +AL +LH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 510 KPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++HRD+KP NILLD++ V K+ D GLA+L+P + + +T+ GT Y+ P
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 569 EY---QQTGMLGVKSDLYSLGVVLLQLITARP------AMGLSHQVEQAIRNGTFSELLD 619
E SD++SLG+ L +L+T P + Q + I L
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIV 678
P P + + + L + ++R S + +L+ L + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
|
Length = 384 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 1e-35
Identities = 93/281 (33%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 400 RKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVI 453
+K+GEG +G VYK +L T VA+K L D S+ R F +E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 454 LLGACPEYG--CLVYEYMENGSLEDRL------FQKDNSPPIHWSIRFKIAAEIATALLF 505
LLG C E LV EYME G L D L F + A +IA + +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA------ 559
L K VHRDL N L+ ++ V KISD GL+R V Y T
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-----DYYRKKTGGKLPIR 172
Query: 560 --AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTF 614
A PE + G+ KSD++S GV+L ++ T A P GLS +V + +R G
Sbjct: 173 WMA-------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225
Query: 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
L P P E + +L L C +L DRP +V
Sbjct: 226 --LPKP--EYCPDE----LYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKV--LGPDISQGPRQFKQEVEILGSMRHTNM 451
++ +G G +G VY A T +A+K L D + ++E+ IL S++H N+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 452 VILLGAC----PEYGCLVYEYMENGSLEDRL--FQKDNSPPIHWSIRFKIAAEIATALLF 505
V G+ + EY+ GSL L F K P I ++ +I L +
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKY--TRQILEGLAY 116
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH N +VHRD+K ANIL+D + V K++D G A+ + D T + GT +
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL----GDIETGEGTGSVRGTPYW 169
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ PE + G +D++SLG ++++ T +P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 69/226 (30%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ-----EVEILGSM-R 447
F + IGEG + V A+ T+ AIK+L D Q ++ K E E+L +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 448 HTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
H ++ L + L V EY NG L +K S RF AAEI AL +
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQ-YIRKYGSLDEKC-TRF-YAAEILLALEY 117
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP----------SAADTITQYH 555
LH ++HRDLKP NILLD++ KI+D G A+++ P +
Sbjct: 118 LHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 556 MTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+F Y+ PE G SDL++LG ++ Q++T +P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVL-GPDISQGPRQFKQEVEILGSMRHTN 450
+ +G+G G VYK + T A+K + + +Q +E++ L S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 451 MVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V GA + G +V EYM+ GSL D L + P + IA +I L +LH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHT 117
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ ++HRD+KP+N+L++ KI+D G+++++ + T GT Y+ P
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC------NTFVGTVTYMSP 169
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITAR 596
E Q +D++SLG+ LL+ +
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 395 YFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
F I KIG+GG+G VYKA+ VAIKV+ + + + E++IL +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 453 ILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
G+ + +V E+ GSL+D L K + + S + E+ L +LH N
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRD+K ANILL + K+ D GL+ + +DT + M GT ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQL----SDTKARNTM---VGTPYWMAPEV 168
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARP 597
K+D++SLG+ ++L +P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 85/269 (31%), Positives = 120/269 (44%), Gaps = 42/269 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQ-LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+ RK+G G +G V+ T VA+K L P + P F QE +I+ +RH +V L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 455 LGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
C P Y +V EYM GSL D L + + +AA+IA + +L
Sbjct: 67 YAVCSEEEPIY--IVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID--- 567
+HRDL NIL+ +N V KI+D GLARL I T G I
Sbjct: 124 ---YIHRDLAARNILVGENLVCKIADFGLARL--------IEDDEYTAREGAKFPIKWTA 172
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT-AR-PAMGLS-----HQVEQAIRNGTFSELLDP 620
PE G +KSD++S G++L +++T R P G++ QVE+ R P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM--------P 224
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRP 649
P E + L LQC + +RP
Sbjct: 225 RPPNCPEE----LYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFK----QEVEILGSMRHT 449
+ I ++IG+G +G VY + D +K + D+S + + EV+IL + H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHP 59
Query: 450 NMVILLGACPEYGCL--VYEYMENGSLEDRL--FQKDNSPP-----IHWSIRFKIAAEIA 500
N++ + E G L V EY + G L ++ +K+ P + W + ++
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV------QLC 113
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
AL +LH K ++HRD+KP NI L N + K+ D G+++++ + T T
Sbjct: 114 LALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL------SSTVDLAKTVV 164
Query: 561 GTFCYIDPE------YQQTGMLGVKSDLYSLGVVLLQLITARPA 598
GT Y+ PE Y KSD++SLG VL +L T +
Sbjct: 165 GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS------VAIKVLGPD-ISQGPRQFKQEVEILGSM 446
+ +++GEG +G V + D VA+K L Q F++E+EIL ++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 447 RHTNMVILLGACPEYG----CLVYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIAT 501
H N+V G C + G L+ EY+ +GSL D L +D I+ +++I
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
+ +L + +HRDL NIL++ + KISD GLA+++P Y+ G
Sbjct: 121 GMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED-----KDYYYVKEPG 172
Query: 562 ---TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
F Y PE +T SD++S GV L +L T
Sbjct: 173 ESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 46/272 (16%)
Query: 396 FSISRKIGEGGYGPVYKAQ-LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
F++ RK+G G +G V++ + VAIK+L D + F++EV+ L +RH +++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 455 LGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPP---IHWSIRFKIAAEIATALLFLH 507
C P Y ++ E ME GSL L SP + + +A ++A + +L
Sbjct: 68 FAVCSVGEPVY--IITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP---SAADTITQYHMTTAAGTFC 564
+ +HRDL NIL+ ++ V K++D GLARL+ ++D Y T
Sbjct: 122 EQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA------ 172
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSELLDPTV 622
PE G KSD++S G++L ++ T P G+++ E+ D
Sbjct: 173 ---PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----------EVYDQIT 218
Query: 623 TGW----PVEAALSIAKLALQCCELRKRDRPD 650
G+ P + I K+ L+C DRP
Sbjct: 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIK--VLGPDISQGPRQFKQEVEILGSMRHTNM 451
+ + IG G +G VYK T VAIK L + + QE+++L +++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 452 VILLGACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V +G+ + ++ EY ENGSL + +K P + ++ L +LH+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVY--VYQVLQGLAYLHEQ 118
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRD+K ANIL ++ V K++D G+A + + D + GT ++ PE
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD------ASVVGTPYWMAPE 169
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ SD++SLG +++L+T P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 75/240 (31%), Positives = 118/240 (49%), Gaps = 37/240 (15%)
Query: 399 SRKIGEGGYGPVYKAQL------DH-TSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTN 450
++GEG +G VYK +L TSVAIK L + +Q F+QE E++ ++H N
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSP---------------PIHWSIRF 493
+V LLG C + C+++EY+ +G L + L + NSP + S
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR--NSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ 553
IA +IA + +L + VHRDL N L+ + KISD GL+R + +AD
Sbjct: 128 HIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI--YSADYYRV 182
Query: 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-VEQAIR 610
+ + ++ PE G +SD++S GVVL ++ + +P G S+Q V + IR
Sbjct: 183 --QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLG-PDISQGPRQFK-QEVEILGSMRHTNM 451
F + +K+G+G YG VYK + D+ A+K + +SQ R+ E+ IL S+ H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 452 V-----ILLGACPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLF 505
+ L G C+V EY G L + + K I ++I ++ L
Sbjct: 62 ISYKEAFLDG---NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH+ K ++HRDLK ANILL N + KI D+G+++++ + A T GT Y
Sbjct: 119 LHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--------GTPHY 167
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
+ PE + KSD++SLG +L ++ T P
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 69/241 (28%), Positives = 108/241 (44%), Gaps = 37/241 (15%)
Query: 400 RKIGEGGYGPVYKAQLDHTS-------VAIKVL-GPDISQGPRQFKQEVEILGSMRHTNM 451
R++GEG +G V+ + H VA+K L + + F++E E+L + +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 452 VILLGACPEYGCL--VYEYMENGSLED----------RLFQKDNSP-PIHWSIRFKIAAE 498
V G C E V+EYME+G L L D+ + S +IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
IA+ +++L VHRDL N L+ + V KI D G++R D T +
Sbjct: 131 IASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRV 180
Query: 559 AAGTFC---YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
T ++ PE +SD++S GVVL ++ T +P GLS +V + I G
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240
Query: 613 T 613
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 21/235 (8%)
Query: 400 RKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDI-SQG-PRQFKQEVEILGSMRHTNMVILL 455
KIGEG YG VYKA+ L VAIK + S+G P+ +E+++L + H N++ LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 456 GACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
G LV+E+M+ + KD + S+ ++ L F H +
Sbjct: 65 DVFRHKGDLYLVFEFMDTDLYK---LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRDLKP N+L++ V K++D GLAR T T Y PE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP------VRPYTHYVVTRWYRAPELLLG 172
Query: 574 -GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627
D++S+G + +L++ RP +++Q + F L P WP
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK--IFRTLGTPDPEVWPK 225
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 55/291 (18%)
Query: 400 RKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNM 451
R IG+G +G V++A+ T VA+K+L + S F++E ++ H N+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 452 VILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSP---------------------PIH 488
V LLG C CL++EYM G L + F + SP P+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNE--FLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
+ + IA ++A + +L + K VHRDL N L+ +N V KI+D GL+R + +A
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI--YSA 183
Query: 549 DTITQYHMTTA--AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH- 603
D Y+ + A ++ PE +SD+++ GVVL ++ + +P G++H
Sbjct: 184 D----YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSV 654
+V +R+G V P L + L C DRP S+
Sbjct: 240 EVIYYVRDG--------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 79/258 (30%), Positives = 124/258 (48%), Gaps = 31/258 (12%)
Query: 401 KIGEGGYGPVYKAQLDHTS-VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
K+G+G +G V+ + T+ VAIK L P + P F QE +++ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 460 EYGC-LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
E +V EYM GSL D L + + + +AA+IA+ + ++ + VHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLG 577
L+ ANIL+ +N V K++D GLARL+ + +Y A + PE G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 578 VKSDLYSLGVVLLQLITAR--PAMGLSHQVEQAIRNGTFSELLDPTVTGW----PVEAAL 631
+KSD++S G++L +L T P G+ ++ E+LD G+ P E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNR-----------EVLDQVERGYRMPCPPECPE 230
Query: 632 SIAKLALQCCELRKRDRP 649
S+ L QC +RP
Sbjct: 231 SLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 48/253 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIK-VLGPDISQG-PRQFKQEVEILGSMRHTNM 451
+ +IGEG YG VYKA+ T VA+K + + +G P +E+++L +RH N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 452 VILLGACPEYGC----LVYEYME---NGSLEDRLFQKDNSPPIHWS---IRFKIAAEIAT 501
V L G +V+EYM+ G L+ SP + ++ I+ ++
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD--------SPEVKFTESQIKC-YMKQLLE 111
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR-LVPPSAADTITQYHMTTAA 560
L +LH N ++HRD+K +NIL++ + V K++D GLAR ++AD T
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD------YTNRV 162
Query: 561 GTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGT 613
T Y PE +LG D++S+G +L +L +P S ++EQ I
Sbjct: 163 ITLWYRPPEL----LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI---- 214
Query: 614 FSELLDPTVTGWP 626
F PT WP
Sbjct: 215 FELCGSPTDENWP 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG--PRQFKQEVEILGSMRHTNM 451
+ K+GEG YG VYKA+ T VA+K + D + P +E+ +L ++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 452 VILLGACPEYGC--LVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
V LL LV+EY + D + + P+ ++ I ++ L + H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++ ++HRDLKP NIL++++ V K++D GLAR I T T Y P
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAF------GIPLRTYTHEVVTLWYRAP 167
Query: 569 EYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
E +LG K D++S+G + ++IT +P
Sbjct: 168 EI----LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 39/272 (14%)
Query: 397 SISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
++ K+G G YG VY+ + +VA+K L D + +F +E ++ ++H N+V L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 455 LGAC----PEYGCLVYEYMENGSLEDRLFQKDNS--PPIHWSIRFKIAAEIATALLFLHQ 508
LG C P Y ++ E+M G+L D L + + + + +A +I++A+ +L +
Sbjct: 68 LGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK 122
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC--YI 566
+HRDL N L+ +N++ K++D GL+RL+ DT T + A F +
Sbjct: 123 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAH----AGAKFPIKWT 172
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT----ARPAMGLSHQVEQAIRNGTFSELLDPTV 622
PE +KSD+++ GV+L ++ T P + LS V + + G E
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMER----- 226
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSV 654
P + +L C + DRP +
Sbjct: 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 34/261 (13%)
Query: 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC 458
RK+G G +G V++ + T VA+K L P + P+ F E +I+ +RH ++ L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 459 ----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH-QNKPEP 513
P Y +V E M+ GSL + L Q + +AA++A+ + +L QN
Sbjct: 71 TLEEPIY--IVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---- 123
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPS--AADTITQYHMTTAAGTFCYIDPEYQ 571
+HRDL N+L+ +N + K++D GLAR++ A ++ + A PE
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA-------PEAA 176
Query: 572 QTGMLGVKSDLYSLGVVLLQLIT-AR-PAMGLS-HQVEQAIRNGTFSELLDPTVTGWPVE 628
+KSD++S G++L +++T R P G++ +V Q + G P G P E
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----PCPPGCPKE 232
Query: 629 AALSIAKLALQCCELRKRDRP 649
+ + L C + DRP
Sbjct: 233 ----LYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 81/277 (29%), Positives = 119/277 (42%), Gaps = 40/277 (14%)
Query: 401 KIGEGGYGPVYKAQL-----DHTSVAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMVIL 454
K+G+G +G V + + VA+K L D +S F +E I+ S+ H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 455 LGACPEYGC-------LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
YG +V E GSL DRL +KD S A +IA + +L
Sbjct: 62 ------YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ +HRDL NILL + KI D GL R +P + + + H+ F +
Sbjct: 115 SKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP---FAWCA 168
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAI-RNGTFSELLDPTVT 623
PE +T SD++ GV L ++ T P GLS Q+ + I + G E L+
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---ERLER--- 222
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPE 658
P I + LQC DRP ++ LPE
Sbjct: 223 --PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 32/275 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDISQGPR-QFKQEVEILGSMR 447
Y +I + IG G +G V + +L VAIK L S R F E I+G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 448 HTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
H N++ L G + ++ EYMENGSL+ L + D + IA+ + +
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKY 121
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC- 564
L + VHRDL NIL++ N V K+SD GL+R + S A Y TT G
Sbjct: 122 LSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA----TY--TTKGGKIPI 172
Query: 565 -YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-VEQAIRNGTFSELLDP 620
+ PE SD++S G+V+ ++++ RP +S+Q V +A+ +G L P
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPP 229
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P++ ++ +L L C + + +RP +V
Sbjct: 230 -----PMDCPSALYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIK-VLGPDISQG-PRQFKQEVEILGSMRHTNM 451
+ I +IGEG +G V+KA+ T +VA+K V + G P Q +E++ L + +H +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 452 VILLGACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V LL P LV EYM L + L ++ P ++ + + ++H N
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA-QVK-SYMRMLLKGVAYMHAN 118
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRDLKPAN+L+ + V KI+D GLARL + + Y + T Y PE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLF---SEEEPRLY--SHQVATRWYRAPE 170
Query: 570 Y---QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
+ GV DL+++G + +L+ P + +EQ F L P WP
Sbjct: 171 LLYGARKYDPGV--DLWAVGCIFAELLNGSPLFPGENDIEQLAI--VFRTLGTPNEETWP 226
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 73/252 (28%), Positives = 109/252 (43%), Gaps = 54/252 (21%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ---------EVEILGSMRH 448
+K+GEG Y VYKA+ T VAIK I G R+ + E+++L ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 449 TNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK------IAAEIA 500
N++ LL LV+E+ME LE + KD S I
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVI--KDKS------IVLTPADIKSYMLMTL 112
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP-PSAADTITQYHMTTA 559
L +LH N ++HRDLKP N+L+ + V K++D GLAR P+ MT
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-------RKMTHQ 162
Query: 560 AGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTF 614
T Y PE + G + D++S+G + +L+ P + ++Q + F
Sbjct: 163 VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK--IF 216
Query: 615 SELLDPTVTGWP 626
L PT WP
Sbjct: 217 EALGTPTEENWP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 66/203 (32%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLG 456
+G+G +G V + T A+KVL + E IL + H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
A E LV EY G L L K+ RF AAEI AL +LH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEER-ARF-YAAEIVLALEYLHSLG---I 114
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
++RDLKP NILLD + K++D GLA+ + + T T GT Y+ PE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT------NTFCGTPEYLAPEVLLGK 168
Query: 575 MLGVKSDLYSLGVVLLQLITARP 597
G D +SLGV+L +++T +P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLG 456
++G G G V K T +A+K + +I +Q +E++IL +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 457 ACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
A G C+ EYM+ GSL+ K+ I I KIA + L +LH+
Sbjct: 67 AFYNNGDISICM--EYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
++HRD+KP+NIL++ K+ D G++ + S A T GT Y+ PE Q
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--------VGTSSYMAPERIQ 172
Query: 573 TGMLGVKSDLYSLGVVLLQLITAR 596
VKSD++SLG+ L++L T R
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 79/268 (29%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH 448
E + + +K+G G +G V+ + +T VA+K L P + P F +E +I+ +RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRH 60
Query: 449 TNMVILLGACPEYGC-LVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFL 506
+V L E +V EYM GSL D F KD + +AA++A + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TFCY 565
+ +HRDL+ ANIL+ V KI+D GLARL+ + +Y A +
Sbjct: 119 ERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN------EYTARQGAKFPIKW 169
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITA----RPAMGLSHQVEQAIRNGTFSELLDPT 621
PE G +KSD++S G++L +L+T P M +EQ R P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-----PC 224
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRP 649
P+ S+ +L LQC + +RP
Sbjct: 225 PQDCPI----SLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 77/269 (28%), Positives = 122/269 (45%), Gaps = 38/269 (14%)
Query: 396 FSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQ----EVEILGSMRHT 449
F I KIG+G +G V+K + D A+K + D+S+ R+ ++ E +L + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDSS 59
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
++ + + G +V EY ENG L L + P + ++ +I L LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLH 118
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA--ADTITQYHMTTAAGTFCY 565
K ++HRD+K N+ LD KI D+G+A+L+ + A+TI GT Y
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GTPYY 167
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVT 623
+ PE + KSD+++LGVVL + T + ++Q I G F
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-------- 219
Query: 624 GWPVEAALS--IAKLALQCCELRKRDRPD 650
PV S +A+L QC R RPD
Sbjct: 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 397 SISRK--IGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
I+++ IG G +G V++ L +VAIK L P ++ RQ F E I+G H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 449 TNMVILLGACPEY--GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N++ L G ++ ++ EYMENG+L+ L D + + + IA + +L
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV--GMLRGIAAGMKYL 123
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC-- 564
VHRDL NIL++ N K+SD GL+R++ T TT+ G
Sbjct: 124 SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-----YTTSGGKIPIR 175
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPT 621
+ PE SD++S G+V+ ++++ RP +S H+V +AI +G P
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLPA 231
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P++ ++ +L LQC + + RP V +V
Sbjct: 232 ----PMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI-SQGPRQFKQEVEILGSMRHT 449
+ + KIGEG G VYKA T VAIK + + Q E+ I+ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELIINEILIMKDCKHP 75
Query: 450 NMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKD---NSPPIHWSIRFKIAAEIATALL 504
N+V + + +V EYM+ GSL D + Q N P I + + E+ L
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLE 130
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+LH ++HRD+K NILL ++ K++D G A A T + + GT
Sbjct: 131 YLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA------AQLTKEKSKRNSVVGTPY 181
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE + G K D++SLG++ +++ P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 76/252 (30%), Positives = 106/252 (42%), Gaps = 28/252 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGP---DISQGPRQFKQEVEILGSMRHTN 450
F + R IG+G +G V Q T A+K + R E IL + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 451 MVILLGACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWS---IRFKIAAEIATALLF 505
+V L + E LV + + G L L QK + +S ++F EI AL +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-----VKFSEEQVKF-WICEIVLALEY 115
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH ++HRD+KP NILLD+ I+D +A V P DT+T T+ +GT Y
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLT----TSTSGTPGY 165
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAIRNGTFSELLDPTVTG 624
+ PE V D +SLGV + + RP G S + IR
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-KQETADVLYPAT 224
Query: 625 WPVEAALSIAKL 636
W EA +I KL
Sbjct: 225 WSTEAIDAINKL 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 399 SRKIGEGGYGPVYKA-QLD-HTSVAIKVLGPDISQGP--RQFKQEVEILGSMRHTNMVIL 454
KIG G +G VY A LD +A+K + + ++ E+++L ++H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 455 LGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G E + EY G+LE+ L IR ++ L +LH +
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH--VIR-VYTLQLLEGLAYLHSHG-- 119
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLA-RLVPPSAADTITQYHMTTAAGTFCYIDPEYQ 571
+VHRD+KPANI LD N V K+ D G A +L + + GT Y+ PE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA---GTPAYMAPEVI 175
Query: 572 QTGML---GVKSDLYSLGVVLLQLITARP 597
G G +D++SLG V+L++ T +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 76/260 (29%), Positives = 112/260 (43%), Gaps = 30/260 (11%)
Query: 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMVILLGA 457
KIG+G +G VYK L +T VA+K + ++ F QE EIL H N+V L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 458 C----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
C P Y +V E + GSL L +K N + ++ + A A + +L
Sbjct: 61 CVQKQPIY--IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA--AAGMEYLESKN--- 113
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
+HRDL N L+ +N V KISD G++R I + PE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 574 GMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629
G +SD++S G++L + + P G+S+Q E+ P P E
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-----PAPQLCPEE- 223
Query: 630 ALSIAKLALQCCELRKRDRP 649
I +L LQC +RP
Sbjct: 224 ---IYRLMLQCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 71/256 (27%), Positives = 112/256 (43%), Gaps = 33/256 (12%)
Query: 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--- 458
IG+G +G V VA+K L D S + F E ++ ++RH N+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 459 -PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517
P Y +V EYM GSL D L + + I + + A ++ + +L + VHR
Sbjct: 73 NPLY--IVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 518 DLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLG 577
DL N+L+ ++ V+K+SD GLA+ + + PE +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEA---------SQGQDSGKLPVKWTAPEALREKKFS 177
Query: 578 VKSDLYSLGVVLLQLIT-AR---PAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSI 633
KSD++S G++L ++ + R P + L V + G E + G P E +
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKGYRMEAPE----GCPPE----V 228
Query: 634 AKLALQCCELRKRDRP 649
K+ C EL RP
Sbjct: 229 YKVMKDCWELDPAKRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 79/256 (30%), Positives = 120/256 (46%), Gaps = 27/256 (10%)
Query: 401 KIGEGGYGPVYKAQLDHTS-VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
K+G+G +G V+ + T+ VAIK L P + P F QE +I+ +RH +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 460 EYGC-LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
E +V E+M GSL D L + D + +AA+IA + ++ + +HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLG 577
L+ ANIL+ N V KI+D GLARL+ + +Y A + PE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 578 VKSDLYSLGVVLLQLITA----RPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSI 633
+KSD++S G++L +L+T P M +EQ R P G P S+
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----PCPQGCPE----SL 232
Query: 634 AKLALQCCELRKRDRP 649
+L C + +RP
Sbjct: 233 HELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 45/278 (16%)
Query: 396 FSISRKIGEGGYGPVY--KAQLDHTSVAIKVLGPDISQGPRQFKQ----EVEILGSMRHT 449
+ I +KIGEG +G +Y KA+ D IK + D+++ P + K+ EV +L M+H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI--DLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 450 NMVILLGACPEYGCL--VYEYMENGSLEDR-------LFQKDNSPPIHWSIRFKIAAEIA 500
N+V + E G L V EY + G L R LF +D + W + +I+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSWFV------QIS 111
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTA 559
L +H K ++HRD+K NI L +N V+K+ D G+AR + S T
Sbjct: 112 LGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME------LAYTC 162
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLS-HQVEQAIRNGTFSEL 617
GT Y+ PE Q K+D++SLG VL +L T + P G + HQ+ I G F+
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-- 220
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P + + I++L ++ RDRP + S++
Sbjct: 221 --PISPNFSRDLRSLISQLF----KVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 40/279 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQ-LDHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHT 449
++ ++IG G +G V+ L+ VAIK I +G F +E +++ + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKT----IREGAMSEEDFIEEAQVMMKLSHP 59
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+V L G C E CLV+E+ME+G L D L + + ++ + +L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLE 117
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT---FC 564
+ ++HRDL N L+ +N V K+SD G+ R V QY T++ GT
Sbjct: 118 SSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD------QY--TSSTGTKFPVK 166
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624
+ PE KSD++S GV++ ++ + + + N + SE+++ G
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS---------EGKTPYENRSNSEVVETINAG 217
Query: 625 W----PVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659
+ P A+ S+ +L C + R DRP S++L +L
Sbjct: 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSF-SLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 398 ISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQGPR-QFKQEVEILGSMRHT 449
+ R++G+G +G VY+ T VAIK + + S R +F E ++
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 450 NMVILLGAC----PEYGCLVYEYMENGSLEDRLFQK-------DNSPPIHWSIRFKIAAE 498
++V LLG P +V E M G L+ L + P ++AAE
Sbjct: 70 HVVRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
IA + +L K VHRDL N ++ ++ KI D G+ R + T Y+
Sbjct: 128 IADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI------YETDYYRKG 178
Query: 559 AAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTF 614
G ++ PE + G+ KSD++S GVVL ++ T +P GLS+ E+ ++
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID 236
Query: 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP---DLVSVVLP 657
LD P + +L C + + RP ++VS +
Sbjct: 237 GGHLDL-----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH 448
E + + +K+G G +G V+ + HT VAIK L S P F E ++ ++H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 449 TNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
+V L P Y ++ EYMENGSL D L + + + +AA+IA + F
Sbjct: 61 PRLVRLYAVVTQEPIY--IITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TFC 564
+ + +HRDL+ ANIL+ + KI+D GLARL+ + +Y A
Sbjct: 118 IERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIK 168
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
+ PE G +KSD++S G++L +++T
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 56/174 (32%), Positives = 81/174 (46%), Gaps = 32/174 (18%)
Query: 397 SISRKIGEGGYGPVYKAQLDHTS------------------VAIKVLGPDISQGPRQ-FK 437
+ K+GEG +G V+ + D VA+KVL PD S R+ F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 438 QEVEILGSMRHTNMVILLGACP--EYGCLVYEYMENGSLEDRL--------FQKDNSPPI 487
+EV+IL + N+ LLG C C++ EYMENG L L NS +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 488 HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+S +A +IA+ + +L VHRDL N L+ +NY KI+D G++R
Sbjct: 128 SFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ-------------EVEILGS 445
+GEG YG V K + T VAIK +FK+ EV++L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-----------KFKESEDDEDVKKTALREVKVLRQ 56
Query: 446 MRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+RH N+V L A G LV+EY+E LE L P ++R ++ A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPD-AVR-SYIWQLLQAI 113
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT--AAG 561
+ H + ++HRD+KP NIL+ ++ V K+ D G AR + A +T Y T A
Sbjct: 114 AYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
D Y G D++++G ++ +L+ P
Sbjct: 171 ELLVGDTNY------GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
+ + + ++IG G YG VYKA+ T VAIKV+ + +QE+ +L RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 452 VILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V G+ L V EY GSL+D ++Q P I + + E L +LH+
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCRETLKGLAYLHET 120
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+HRD+K ANILL ++ K++D G+ SA T T + GT ++ PE
Sbjct: 121 G---KIHRDIKGANILLTEDGDVKLADFGV------SAQLTATIAKRKSFIGTPYWMAPE 171
Query: 570 YQQTGMLG---VKSDLYSLGVVLLQLITARPAM 599
G K D+++LG+ ++L +P M
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ------EVEILGSMR 447
F + +G G +G V + + A+K+L ++ + KQ E IL S+R
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKL-KQVEHVLNEKRILQSIR 59
Query: 448 HTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
H +V L G+ LV EY+ G L L +K P + RF AA++ AL +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVA-RF-YAAQVVLALEY 116
Query: 506 LHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
LH +V+RDLKP N+LLD + Y+ KI+D G A+ V Y T GT
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYI-KITDFGFAKRVKGRT------Y---TLCGTPE 163
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
Y+ PE + G D ++LG+++ +++ P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 32/260 (12%)
Query: 402 IGEGGYGPVYKA--QLDHTSVAIKV--LGPDISQGP---RQFKQEVEILGSMRHTNMVIL 454
+G G +G VY+ D A+K L D G +Q +QE+ +L ++H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 455 LGACPEYG--CLVYEYMENGSLEDRL--FQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LG E + E + GSL L + P I R +I L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDRN 122
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
VHRD+K ANIL+D N V K++D G+A+ V + + G+ ++ PE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQV-------VEFSFAKSFKGSPYWMAPEV 172
Query: 571 -QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEA 629
Q G G+ +D++SLG +L++ T +P V + G EL P + P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPI---PDHL 227
Query: 630 ALSIAKLALQCCELRKRDRP 649
+ L+C + RP
Sbjct: 228 SDEAKDFILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 64/205 (31%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ---EVEILGSMRHTNMVILLG 456
I +G YG V+ A+ T AIKV+ Q Q E +IL + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
+ + LV EY+ G L L + S R AEI AL +LH N +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDV-ARI-YIAEIVLALEYLHSNG---I 114
Query: 515 VHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
+HRDLKP NIL+D N K++D GL++ LV + GT YI PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 573 TGMLGVKSDLYSLGVVLLQLITARP 597
D +SLG +L + + P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 37/263 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
++ IGEG +G V + + VA+K + D++ + F +E ++ + H N+V LL
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLL 65
Query: 456 GACPEYGC-LVYEYMENGSLEDRLFQKDNSP-PIHWSIRFKIAAEIATALLFLHQNKPEP 513
G G +V E M G+L + L + + + ++F + ++A + +L K
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGMEYLESKK--- 120
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
LVHRDL NIL+ ++ V+K+SD GLAR V D TA PE +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWTA--------PEALKH 171
Query: 574 GMLGVKSDLYSLGVVLLQLIT----ARPAMGL---SHQVEQAIRNGTFSELLDPTVTGWP 626
KSD++S GV+L ++ + P M L VE+ R ++P P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------MEP-----P 219
Query: 627 VEAALSIAKLALQCCELRKRDRP 649
+ L C E + RP
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH 448
E + + +K+G G +G V+ A + HT VA+K + P S F E ++ +++H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 449 TNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALL 504
+V L P Y ++ E+M GSL D L + + P+ I F +A+IA +
Sbjct: 61 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMA 116
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TF 563
F+ Q +HRDL+ ANIL+ + V KI+D GLAR++ + +Y A
Sbjct: 117 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPI 167
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVEQAIRNGTFSELLDP 620
+ PE G +KSD++S G++L++++T P G+S+ +V +A+ G P
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----P 223
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRP 649
P E + + ++C + R +RP
Sbjct: 224 RPENCPEE----LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 45/282 (15%)
Query: 395 YFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
I IG G +G V + +L VAIK L ++ R+ F E I+G H
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 449 TNMVILLG----ACPEYGCLVYEYMENGSLEDRLFQKDNS-PPIHWSIRFKIAAEIATAL 503
N++ L G + P ++ E+MENG+L+ L Q D I + IA +
Sbjct: 65 PNIIHLEGVVTKSRPVM--IITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGM 119
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-- 561
+L + VHRDL NIL++ N V K+SD GL+R + +D T++ G
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT----YTSSLGGK 172
Query: 562 -TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-----VEQAIRNGT 613
+ PE SD++S G+V+ ++++ RP +S+Q +EQ R
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--- 229
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
L P P++ ++ +L L C + + RP +V
Sbjct: 230 ----LPP-----PMDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 402 IGEGGYGPVYK---------AQLDHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNM 451
+G G +G VYK ++ VAIKVL + S + ++ E ++ S+ H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIP---VAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 452 VILLGACP-EYGCLVYEYMENGSLEDRLFQ-KDNSPPIH---WSIRFKIAAEIATALLFL 506
V LLG C L+ + M G L D + KDN + W + +IA + +L
Sbjct: 72 VRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYL 125
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+ + LVHRDL N+L+ KI+D GLA+L+ +YH ++
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGGKVPIKWM 178
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL 601
E + KSD++S GV + +L+T A+P G+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP-RQFKQEVEILGSMRHTNMVILLG 456
++GEG G V K +L +T A+K + D + +Q +E+EI S + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 457 AC-PEYGCLVY---EYMENGSLEDRLFQK--DNSPPIHWSIRFKIAAEIATALLFLHQNK 510
A E + EY E GSL D +++K I + KIA + L +LH K
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRD+KP+NILL + K+ D G++ + S A T T GT Y+ PE
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--------GTSFYMAPER 174
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITAR 596
Q + SD++SLG+ LL++ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 398 ISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+ R++GEG +G V+ A+ D VA+K L + F +E E+L +++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 451 MVILLGACPEYGCL--VYEYMENGSLE--------DRLFQKDNSPP--IHWSIRFKIAAE 498
+V G C E L V+EYM++G L D + + + P + S IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
IA +++L + VHRDL N L+ +N + KI D G++R V + + + M
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
++ PE +SD++SLGVVL ++ T
Sbjct: 186 IR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 402 IGEGGYGPVYKA-------QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+G+G +G VY +L V P+ + + E+++L +++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 455 LGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G E + EYM GS++D+L + ++ K +I + +LH N
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM-- 124
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLA-RLVPPSAADTI--TQYHMTTAAGTFCYIDPE 569
+VHRD+K ANIL D K+ D G + RL TI + M + GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRL------QTICSSGTGMKSVTGTPYWMSPE 177
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARP 597
G K+D++S+G +++++T +P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 85/289 (29%), Positives = 134/289 (46%), Gaps = 39/289 (13%)
Query: 389 IEAATDYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQGPRQ-FKQEVEI 442
I+A+ I + IG G +G V +L VAIK L ++ R+ F E I
Sbjct: 1 IDASC--IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 443 LGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+G H N++ L G + +V EYMENGSL+ L + D + + + IA
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV--GMLRGIA 116
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP--PSAADTITQYHMTT 558
+ + +L VHRDL NIL++ N V K+SD GL+R++ P AA TT
Sbjct: 117 SGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-------YTT 166
Query: 559 AAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-VEQAIRNGT 613
G + PE SD++S G+V+ ++++ RP +S+Q V +AI G
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELI 660
L P++ ++ +L L C + + +RP +V L +LI
Sbjct: 227 ---RLPA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 72/223 (32%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSM-RH 448
T F + IGEG YG VYKA+ T VAIK++ I + K+E IL H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 449 TNMVILLGA--------CPEYGCLVYEYMENGSLED---RLFQKDNSPPIHWSIRFKIAA 497
N+ GA + LV E GS+ D L +K W I + I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-ILR 120
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
E L +LH+NK ++HRD+K NILL +N K+ D G+ SA T
Sbjct: 121 ETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV------SAQLDSTLGRRN 171
Query: 558 TAAGTFCYIDPE-----YQQTGMLGVKSDLYSLGVVLLQLITA 595
T GT ++ PE Q +SD++SLG ITA
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------ITA 208
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 395 YFSISRKIGEGGYGPV----YKAQLDHTS--VAIKVLGPDISQGPRQ-FKQEVEILGSMR 447
Y R +GEG +G V Y D T VA+K L + Q +K+E+ IL ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 448 HTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
H N+V G C E G L+ EY+ GSL D L K ++ + A +I +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK---LNLAQLLLFAQQICEGM 120
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-- 561
+LH +HRDL N+LLD + + KI D GLA+ VP +Y+ G
Sbjct: 121 AYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-----EGHEYYRVREDGDS 172
Query: 562 -TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
F Y E + SD++S GV L +L+T
Sbjct: 173 PVFWYA-VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 31/169 (18%)
Query: 401 KIGEGGYGPVYKAQLDHTS----------------VAIKVLGPDISQGPRQ-FKQEVEIL 443
K+GEG +G V+ + + + VA+K+L D+++ R F +E++I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 444 GSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKD---------NSPPIHWSIR 492
+++ N++ LLG C C++ EYMENG L L Q++ N P + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+A +IA+ + +L VHRDL N L+ +Y KI+D G++R
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 72/281 (25%), Positives = 133/281 (47%), Gaps = 32/281 (11%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRH 448
E + + +K+G G +G V+ ++ T VA+K L P + + F +E ++ +++H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 449 TNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+V L P Y ++ EYM GSL D L + D + +A+IA +
Sbjct: 61 DKLVRLYAVVTKEEPIY--IITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG-TF 563
++ + +HRDL+ AN+L+ ++ + KI+D GLAR++ + +Y A
Sbjct: 118 YIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPI 168
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVEQAIRNGTFSELLDP 620
+ PE G +KSD++S G++L +++T P G+S+ V A++ G P
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----P 224
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRP--DLVSVVLPEL 659
+ P E + + C + + +RP D + VL +
Sbjct: 225 RMENCPDE----LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 402 IGEGGYGPV----YKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
+G+G +G V Y D+T VA+K L ++ R F++E+EIL S++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 456 GACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
G C G LV EY+ GSL D L QK + + A++I + +L +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL-QK-HRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG---TFCYIDP 568
VHRDL NIL++ KI D GL +++P +Y+ G F Y P
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQD-----KEYYKVREPGESPIFWYA-P 180
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLIT 594
E V SD++S GVVL +L T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 29/235 (12%)
Query: 401 KIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQ----EVEILGSMRHTNMV-- 452
IG+G +G V K + D + K + D + KQ EV IL ++H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 453 ----ILLGACPEYGCLVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
I Y +V EY E G L + +K+ I ++I ++ AL
Sbjct: 65 YDRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYEC 121
Query: 507 H--QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
H + ++HRDLKPANI LD N K+ D GLA+++ T GT
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL------GHDSSFAKTYVGTPY 175
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSEL 617
Y+ PE KSD++SLG ++ +L P +Q++ I+ G F +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 51/223 (22%)
Query: 396 FSISRKIGEGGYGPVYKA--QLDHTSVAIKVL--GPDISQGPRQFKQEVEILGSMRHTNM 451
F I K+GEG YG VYKA + VAIKV+ D+ + +E+ IL +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE----IIKEISILKQCDSPYI 60
Query: 452 VILLGACPEYGC--------LVYEYMENGSLEDRLFQKDNSPPIHWSIRFK--IAAEIAT 501
V YG +V EY GS+ D + I K EIA
Sbjct: 61 V------KYYGSYFKNTDLWIVMEYCGAGSVSDIM-----------KITNKTLTEEEIAA 103
Query: 502 ALL-------FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554
L +LH NK +HRD+K NILL++ +K++D G+ S T T
Sbjct: 104 ILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGV------SGQLTDTMA 154
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T GT ++ PE Q K+D++SLG+ +++ +P
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 42/277 (15%)
Query: 400 RKIGEGGYGP--VYKAQLDHTSVAIKVLG-PDISQGPRQ-FKQEVEILGSMRHTNMVILL 455
+KIGEG +G + K++ D IK + +S R+ ++EV +L +M+H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 456 GACPEYGCL--VYEYMENGSLEDR-------LFQKDNSPPIHWSIRFKIAAEIATALLFL 506
+ E G L V +Y E G L + LF +D + W + +I AL +
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFV------QICLALKHV 117
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H K ++HRD+K NI L ++ K+ D G+AR++ T T GT Y+
Sbjct: 118 HDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTPYYL 168
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT---ARPAMGLSHQVEQAIRNGTFSELLDPTVT 623
PE + KSD+++LG VL ++ T A A + + V + IR G++ P V
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSY-----PPV- 221
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660
+ + L Q + RDRP + S++ I
Sbjct: 222 --SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLG 456
+G+GG+G V Q+ T A K L +G + E +IL + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
A + CLV M G L+ ++ F AA+I L LHQ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAAQIICGLEHLHQ---RRI 116
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
V+RDLKP N+LLD + +ISD+GLA V I AGT Y+ PE Q
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-----AGTPGYMAPEVLQGE 169
Query: 575 MLGVKSDLYSLGVVLLQLITAR 596
+ D ++LG L ++I R
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 49/227 (21%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK-VLGPDISQG-PRQFKQEVEILGSMRHTNMVILLG 456
KIG+G +G V+KA+ T VA+K VL + +G P +E++IL ++H N+V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 457 AC-----PEYGC-----LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIAT--- 501
C P LV+E+ E+ D L N ++F ++ EI
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKN-------VKFTLS-EIKKVMK 126
Query: 502 ----ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
L ++H+NK ++HRD+K ANIL+ ++ + K++D GLAR S +Y T
Sbjct: 127 MLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY--T 181
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAM 599
T Y PE +LG + D++ G ++ ++ T P M
Sbjct: 182 NRVVTLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 70/223 (31%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 401 KIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILL 455
+IGEG YG VY+A+ D TS VA+K + D + P +E+ +L ++RH N+V L
Sbjct: 14 RIGEGTYGIVYRAR-DTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 456 ----GACPEYGCLVYEYMEN--GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
G + LV EY E SL D + P S + ++ L +LH+N
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRDLK +N+LL KI+D GLAR A MT T Y PE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK------PMTPKVVTLWYRAPE 178
Query: 570 YQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQ 607
+LG + D++++G +L +L+ +P + ++EQ
Sbjct: 179 L----LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 67/262 (25%), Positives = 118/262 (45%), Gaps = 37/262 (14%)
Query: 400 RKIGEGGYGPVYKAQ-LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC 458
+++G G +G V+ + VAIK++ + + F +E +++ + H N+V L G C
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 459 PEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516
+ +V EYM NG L + L ++ W + + +++ A+ +L N +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAMEYLESNG---FIH 123
Query: 517 RDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID---PEYQQT 573
RDL N L+ ++ V K+SD GLAR V QY T++ GT + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDD------QY--TSSQGTKFPVKWAPPEVFDY 175
Query: 574 GMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSELLDPTVTGW----PV 627
KSD++S GV++ ++ + P S+ SE+++ G+ P
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----------SEVVESVSAGYRLYRPK 224
Query: 628 EAALSIAKLALQCCELRKRDRP 649
A + + C + DRP
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 55/293 (18%)
Query: 401 KIGEGGYGPVYKAQLDHTS------------------VAIKVLGPDISQGPRQ-FKQEVE 441
K+GEG +G V+ ++ + VA+K+L PD ++ R F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 442 ILGSMRHTNMVILLGACPEYG--CLVYEYMENGSL----------------EDRLFQKDN 483
IL ++ N++ LLG C + C++ EYMENG L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 484 SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
P I +S +A +IA+ + +L VHRDL N L+ +N KI+D G++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 544 PPSAADTITQYHMTTAAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVL---LQLITARPA 598
A D Y+ ++ E G SD+++ GV L L L +P
Sbjct: 189 --YAGD----YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 599 MGLSHQVEQAIRNG--TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
L+ EQ I N F + P + +L LQC R+RP
Sbjct: 243 GELTD--EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLG--PDISQGPRQ-FKQEVEILGSMR 447
F I +KIG+G + VYKA LD VA+K + + RQ +E+++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 448 HTNMVILLGACPEYGCL--VYEYMENGSLEDRL---FQKDNSPPIHWSIRFKIAAEIATA 502
H N++ L + E L V E + G L R+ F+K +I +K ++ +A
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTI-WKYFVQLCSA 118
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA-- 560
L +H + ++HRD+KPAN+ + V K+ D+GL R TTAA
Sbjct: 119 LEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----------TTAAHS 165
Query: 561 --GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQL 592
GT Y+ PE KSD++SLG +L ++
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 28/162 (17%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK--------QEVEILGSM-RH 448
+++G+G +G VY A+ T VAIK + ++F +EV+ L + H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V L E L V+EYME G+L L + P S+ I +I L +
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV---PP 545
H++ HRDLKP N+L+ V KI+D GLAR + PP
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 400 RKIGEGGYGPVYKAQLDHTS-----VAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMVI 453
+++G G +G V K S VA+K L + I+ G ++F +E ++ + H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 454 LLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
L+G C LV E G L L ++ P +A ++A + +L
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH-- 115
Query: 513 PLVHRDLKPANILL-DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC--YIDPE 569
VHRDL N+LL +++ KISD G++R A + Y+ T AG + + PE
Sbjct: 116 -FVHRDLAARNVLLVNRHQA-KISDFGMSR-----ALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTGWP 626
G KSD++S GV L + + A+P + +V + +G E L P
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ERLPR-----P 220
Query: 627 VEAALSIAKLALQCCELRKRDRPDLVSVVL 656
E I + L C + R DRP +
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELES 250
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 398 ISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+ R++GEG +G V+ A+ D VA+K L + F++E E+L +++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 451 MVILLGACPEYGCL--VYEYMENGSLE--------DRLFQKDNSP-----PIHWSIRFKI 495
+V G C + L V+EYM++G L D + D P + S I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
A++IA+ +++L + VHRDL N L+ N + KI D G++R V + + +
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
M ++ PE +SD++S GV+L ++ T
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 69/230 (30%), Positives = 113/230 (49%), Gaps = 22/230 (9%)
Query: 400 RKIGEGGYGPVY--KAQLDHTSVAIKVLGPD-ISQGPRQFKQ-EVEILGSMRHTNMVILL 455
R +G G +G V+ + + D V IK + + +++ R Q E ++L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 456 GACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
E L V EY G+L + + ++ NS +I +I AL +H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI-LHFFVQILLALHHVHTKL--- 121
Query: 514 LVHRDLKPANILLDQN-YVSKISDVGLAR-LVPPSAADTITQYHMTTAAGTFCYIDPEYQ 571
++HRDLK NILLD++ V KI D G+++ L S A T+ GT CYI PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--------GTPCYISPELC 173
Query: 572 QTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLD 619
+ KSD+++LG VL +L + + A ++ + I +GTF+ + D
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVL-GPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
+IG G G VYK T A+KV+ G RQ +E+EIL + H N+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 457 ACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAEIATALLFLHQNKPE 512
G + + E+M+ GSLE +F +A +I + + +LH+
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHRRH-- 188
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
+VHRD+KP+N+L++ KI+D G++R++ A T+ ++ GT Y+ PE
Sbjct: 189 -IVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDP--CNSSVGTIAYMSPERIN 241
Query: 573 T----GML-GVKSDLYSLGVVLLQLITARPAMGLSHQ 604
T G G D++SLGV +L+ R G+ Q
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSV----AIKVLGPDISQG---PRQFKQEVEILGSMRH 448
+ I IG G YG VYKA+ + AIK D Q + +E+ +L ++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 449 TNMVILLGACPEYGC----LVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATAL 503
N+V L+ E+ L+++Y E+ + F + I S+ + +I +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 504 LFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLAR-----LVPPSAADTITQY 554
+LH N ++HRDLKPANIL+ + V KI D+GLAR L P + D +
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV- 177
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
T Y PE +LG + D++++G + +L+T P
Sbjct: 178 -------TIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 401 KIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMV 452
++GEG +G V+ A+ D VA+K L + S+ RQ F++E E+L ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIV 70
Query: 453 ILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSP--------------PIHWSIRFKIA 496
G C E L V+EYM +G L F + + P + IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
++IA+ +++L VHRDL N L+ Q V KI D G++R D + +
Sbjct: 129 SQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYY 178
Query: 557 TTAAGTFC---YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
T ++ PE +SD++S GVVL ++ T
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 400 RKIGEGGYGPVYKAQL-----DHTSVAIKVLG--PDISQGPRQFKQEVEILGSMRHTNMV 452
R IG+G +G VY L A+K L D+ + QF +E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVL 59
Query: 453 ILLGAC-PEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
LLG C P G +V YM++G L + + + ++P + I F + ++A + +L
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK 117
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
K VHRDL N +LD+++ K++D GLAR + ++ + A ++ E
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWMALE 172
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLIT 594
QT KSD++S GV+L +L+T
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 402 IGEGGYGPVYKAQLDHTSVAIKV----LGPDISQGPRQ--------FKQEVEILGSMRHT 449
IG+G YG VY A T + V L I+ + E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 450 NMVILLG--ACPEYGCLVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIATALLF 505
N+V LG EY + EY+ GS+ R + + +RF ++ L +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ----LVRF-FTEQVLEGLAY 123
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH + ++HRDLK N+L+D + + KISD G+++ + D + G+ +
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGSVFW 176
Query: 566 IDPEYQQTGMLG--VKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623
+ PE + G K D++SLG V+L++ R + + G P +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA--PPI- 233
Query: 624 GWPVEAALSIAKLALQ----CCELRKRDRP 649
P + +++++ +AL C + +RP
Sbjct: 234 --PPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF-KQEVEILGSMRHTNMV 452
F++ IG+G +G VYKA T+ VAIKV+ + ++ + +QE++ L R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR----- 57
Query: 453 ILLGACPE----YGC--------LVYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEI 499
P YG ++ EY GS D L K + I + +R E+
Sbjct: 58 -----SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EV 107
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
L +LH+ +HRD+K ANILL + K++D G+ S T T T
Sbjct: 108 LLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTF 158
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT ++ PE + K+D++SLG+ ++L P
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
D + I ++G+G +G VYKAQ T + A K++ + + F E++IL +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L A L + E+ + G+L D + + IR+ + ++ AL FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+K ++HRDLK NILL + K++D G+ SA + T T GT ++ P
Sbjct: 122 HK---VIHRDLKAGNILLTLDGDVKLADFGV------SAKNKSTLQKRDTFIGTPYWMAP 172
Query: 569 EYQQTGML-----GVKSDLYSLGVVLLQLITARP 597
E K+D++SLG+ L++L P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 72/269 (26%), Positives = 111/269 (41%), Gaps = 56/269 (20%)
Query: 395 YFSISRKIGEGGYGPVYKAQ--LDHTSVAIK-VLGPDISQGPRQFKQ------------- 438
Y +GEG YG V KA L VAIK V +IS + +Q
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 439 EVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK-- 494
E++I+ ++H N++ L+ E + LV + M + D + IR
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS----------DLKKVVDRKIRLTES 119
Query: 495 ----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR------LVP 544
I +I L LH+ +HRDL PANI ++ + KI+D GLAR
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 545 PSAADTITQ--YHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
+ D Q MT+ T Y PE ++G + D++S+G + +L+T +P
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPEL----LMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 598 AMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
++++Q R F L P WP
Sbjct: 233 LFPGENEIDQLGR--IFELLGTPNEDNWP 259
|
Length = 335 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK---QEVEILGSMRH 448
D + + IG G VY A + VAIK + D+ + +EV+ + H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNH 58
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V + L V Y+ GSL D + + +I + E+ L +L
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM--TTAAGTFC 564
H N +HRD+K NILL ++ KI+D G V S AD + T GT C
Sbjct: 119 HSNG---QIHRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPC 171
Query: 565 YIDPE--YQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE Q G K+D++S G+ ++L T
Sbjct: 172 WMAPEVMEQVHGY-DFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 72/269 (26%), Positives = 103/269 (38%), Gaps = 53/269 (19%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNMVIL 454
+ I +G +G VY A+ T AIKVL Q K E I+ + V
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 455 LGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L +Y LV EY+ G L + P W+ ++ AE+ + LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRD+KP N+L+DQ K++D GL+R L GT Y+ PE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------------FVGTPDYLAPE 163
Query: 570 YQQTGMLGV----KSDLYSLGVVLLQLITARPAM--GLSHQVEQAIRNGTFSELLDPTVT 623
+LGV SD +SLG V+ + + P V I +
Sbjct: 164 T----ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR---------RI 210
Query: 624 GWPVEAALSIAKLA------LQCCELRKR 646
WP E + A L C + KR
Sbjct: 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 37/287 (12%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKA-------QLDHTSVAIKVLGPDISQGPR-QFKQEVE 441
E A + ++SR++G+G +G VY+ T VAIK + S R +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 442 ILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLF----QKDNSP---PIHWSIR 492
++ ++V LLG + ++ E M G L+ L + +N+P P
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
++A EIA + +L+ NK VHRDL N ++ +++ KI D G+ R + T
Sbjct: 122 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE------T 172
Query: 553 QYHMTTAAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQA 608
Y+ G ++ PE + G+ SD++S GVVL ++ T +P G+S+ EQ
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQV 230
Query: 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+R LLD P + +L C + + RP + ++
Sbjct: 231 LRFVMEGGLLDK-----PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 36/213 (16%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
+G+G YG VY A+ T V AIK + S+ + +E+ + ++H N+V LG+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 460 EYGCLVYEYMEN---GSLEDRLFQK-----DNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
E G +ME GSL L K DN I + + +I L +LH N+
Sbjct: 76 ENGFFKI-FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHDNQ- 128
Query: 512 EPLVHRDLKPANILLDQ-NYVSKISDVG----LARLVPPSAADTITQYHMTTAAGTFCYI 566
+VHRD+K N+L++ + V KISD G LA + P +T T GT Y+
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT--------GTLQYM 176
Query: 567 DPEYQQTGM--LGVKSDLYSLGVVLLQLITARP 597
PE G G +D++SLG ++++ T +P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDI-SQGPRQFKQEVEILGSMRHT---NMVILL 455
IG G YG VY+ + T VA+K++ D ++EV +L +R + N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 456 GACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G G ++ EY E GS+ R K + PI I E+ AL ++H+
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSV--RTLMK--AGPIAEKYISVIIREVLVALKYIHKV--- 120
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
++HRD+K ANIL+ K+ D G+A L+ +T GT ++ PE
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFVGTPYWMAPEVIT 174
Query: 573 TG-MLGVKSDLYSLGVVLLQLITARPAM 599
G K+D++SLG+ + ++ T P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 400 RKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVILLG 456
+G G G V K + T +A KV+ R Q +E++I+ R +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 457 ACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
A C+ E+M+ GSL DR+++K PI I KIA + L +L+ +
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRI 125
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
+HRD+KP+NIL++ K+ D G++ + S ADT GT Y+ PE Q G
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--------GTSTYMSPERIQGG 177
Query: 575 MLGVKSDLYSLGVVLLQLITAR 596
VKSD++SLG+ +++L +
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 34/230 (14%)
Query: 401 KIGEGGYGPVYKAQL-----DHTS-VAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMV 452
++GE +G +YK L DH VAIK L DI+ Q +F+QE ++ + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 453 ILLGACPEYG--CLVYEYMENGSLEDRLFQK----------DNSPPIHWSIR----FKIA 496
LLG + C+++EY+ G L + L + D + S+ IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
+IA + +L + VH+DL NIL+ + KISD+GL+R + + + +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ 604
++ PE G SD++S GVVL ++ + +P G S+Q
Sbjct: 188 LPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 48/282 (17%)
Query: 402 IGEGGYGPVYKAQLDHTSV----AIKVLGPDISQGP-RQFKQEVEILGSM-RHTNMVILL 455
IGEG +G V KA++ + AIK + S+ R F E+E+L + H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 456 GACPEYGCL--VYEYMENGSLED-----RLFQKDNSPPIHWSIR--------FKIAAEIA 500
GAC G L EY +G+L D R+ + D + I S AA++A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
+ +L Q + +HRDL NIL+ +NYV+KI+D GL+R T+ + +
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 188
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSELL 618
++ E + SD++S GV+L ++++ P G+ T +EL
Sbjct: 189 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----------TCAELY 233
Query: 619 DPTVTGWPVEAALS----IAKLALQCCELRKRDRPDLVSVVL 656
+ G+ +E L+ + L QC + +RP +++
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 275
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 28/240 (11%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGA 457
K+GEG Y VYK + T VA+K + D +G P +E+ ++ ++H N+V L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 458 CPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
LV+EYM+ L+ + + + ++ + F H+N+ ++
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRDLKP N+L+++ K++D GLAR A I + T Y P+ +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRAPDV----L 172
Query: 576 LGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFSELLDPTVTGWP 626
LG ++ D++S+G ++ ++IT RP ++ +Q ++ GT +E P ++ P
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 73/258 (28%), Positives = 115/258 (44%), Gaps = 49/258 (18%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLG--PDISQGPRQFKQEVEILGSMRHTNMV---- 452
+I EG YG VY+A+ T VA+K L + P +E+ IL ++H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 453 ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL-------F 505
+++G+ + +V EY+E+ L+ + + F + E+ +L
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLM---ETMKQ-----PFLQS-EVKCLMLQLLSGVAH 121
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV--PPSAADTITQYHMTTAAGTF 563
LH N ++HRDLK +N+LL+ + KI D GLAR P T T
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--------PYTQLVVTL 170
Query: 564 CYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618
Y PE +LG K D++S+G + +L+T +P +++Q N F L
Sbjct: 171 WYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL--NKIFKLLG 224
Query: 619 DPTVTGWPVEAALSIAKL 636
PT WP + L AK
Sbjct: 225 TPTEKIWPGFSELPGAKK 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 42/271 (15%)
Query: 402 IGEGGYGPVYKAQL-------DHTSVAIKVLGP-DISQGPRQFKQEVEILGSMRHTNMVI 453
+G G +G V+ A+ T V +K L +F++E+++ + H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 454 LLGACPEYG--CLVYEYMENGSLEDRL------FQKDNSPPIHWSIRFKIAAEIATALLF 505
LLG C E ++ EY + G L+ L +K PP+ + + +IA +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ--YHMTTAAGTF 563
L + VHRDL N L+ K+S + L++ D Y + A
Sbjct: 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK-------DVYNSEYYKLRNALIPL 182
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA--RPAMGLSH-QVEQAIRNGTFSELLDP 620
++ PE Q KSD++S GV++ ++ T P GLS +V ++ G
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE----- 237
Query: 621 TVTGWPVEAAL--SIAKLALQCCELRKRDRP 649
PV + KL +C + +DRP
Sbjct: 238 ----LPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 76/290 (26%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 402 IGEGGYGPVYKAQL----DHTSVAIKVLGPDISQGP-RQFKQEVEILGSM-RHTNMVILL 455
IGEG +G V +A + + AIK+L S+ R F E+E+L + H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 456 GACPEYGCL--VYEYMENGSLEDRL-----------FQKDNSPPIHWSIR--FKIAAEIA 500
GAC G L EY G+L D L F K++ + + + A+++A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
T + +L + + +HRDL N+L+ +N SKI+D GL+R T+ + +
Sbjct: 130 TGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSELL 618
++ E + KSD++S GV+L ++++ P G+ T +EL
Sbjct: 184 ----WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-----------TCAELY 228
Query: 619 DPTVTGWPVEAALS----IAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664
+ G+ +E + + +L QC R +RP + + +L R+ +
Sbjct: 229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV-QLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 402 IGEGGYGPVY-----KAQLDHTSVAIKVLGPDIS------QGPRQFKQEVEILGSMRHTN 450
+G+G YG VY + QL +A+K + D S + + ++EV++L S++H N
Sbjct: 8 LGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 451 MVILLGACPEYGCLVYEYME---NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+V LG C + + +ME GS+ L + P + K +I + +LH
Sbjct: 64 IVQYLGTCLD-DNTISIFMEFVPGGSISSILNRFGPLPEP---VFCKYTKQILDGVAYLH 119
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
N +VHRD+K N++L N + K+ D G AR + + + GT ++
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE G KSD++S+G + ++ T +P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 33/245 (13%)
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG----PRQFKQEVEILGSMRHTNMVILLG 456
KIGEG YG VYKA+ T+ I + + Q P +E+ +L M+H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 457 ACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAEIATALLFLHQNKPE 512
LV+EY++ D D+SP + R +I + + H ++
Sbjct: 69 VVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-- 122
Query: 513 PLVHRDLKPANILLDQNYVS-KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQ 571
++HRDLKP N+L+D+ + K++D GLAR A I T T Y PE
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWYRAPEI- 174
Query: 572 QTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
+LG + D++S+G + +++ +P ++++ + F L P WP
Sbjct: 175 ---LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWP 229
Query: 627 VEAAL 631
+L
Sbjct: 230 GVTSL 234
|
Length = 294 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 36/241 (14%)
Query: 401 KIGEGGYGPVYKAQ--LDHTSVAIKV--LGPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
KIGEG YG VYKA+ L VA+K L + P +E+ +L + H N+V LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 457 ACPEYGCL--VYEY--MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
L V+E+ ++ D PP+ S +++ IA + H ++
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YCHSHR-- 119
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRDLKP N+L+D+ K++D GLAR VP + Y T T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP------VRTY--THEVVTLWYRAPEI 170
Query: 571 QQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625
+LG + D++S+G + +++ RP +++Q R F L P W
Sbjct: 171 ----LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVW 224
Query: 626 P 626
P
Sbjct: 225 P 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 18/194 (9%)
Query: 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA-CPE 460
IG+G +G V VA+K + D + + F E ++ +RH+N+V LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 461 YGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
G L V EYM GSL D L + S + K + ++ A+ +L N VHRD
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGV 578
L N+L+ ++ V+K+SD GL + S DT TA PE +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA--------PEALREKKFST 178
Query: 579 KSDLYSLGVVLLQL 592
KSD++S G++L ++
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 46/254 (18%)
Query: 402 IGEGGYGPVYKAQ--LDHTSVAIK-VLGPDISQG-PRQFKQEVEILGSMR---HTNMVIL 454
IGEG YG VYKA+ VA+K V P +G P +E+ +L + H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 455 LGACPEYGC---------LVYEYMENGSLEDRLFQKDNSPPI---HWSIRFKIAAEIATA 502
L C +G LV+E+++ L L P +I+ + ++
Sbjct: 67 LDVC--HGPRTDRELKLTLVFEHVDQ-DLATYL---SKCPKPGLPPETIKD-LMRQLLRG 119
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM--TTAA 560
+ FLH ++ +VHRDLKP NIL+ + KI+D GLAR I + M T+
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---------IYSFEMALTSVV 167
Query: 561 GTFCYIDPE--YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618
T Y PE Q + V D++S+G + +L RP + + +Q + F +
Sbjct: 168 VTLWYRAPEVLLQSSYATPV--DMWSVGCIFAELFRRRPLFRGTSEADQLDK--IFDVIG 223
Query: 619 DPTVTGWPVEAALS 632
P+ WP +L
Sbjct: 224 LPSEEEWPRNVSLP 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 43/294 (14%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS------------------VAIKVLGPDISQ 431
E + K+GEG +G V+ + + VA+K+L D ++
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 432 GPRQ-FKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRL--------FQ 480
R F +E++I+ ++ N++ LL C C++ EYMENG L L +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 481 KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540
K + I +S +A +IA+ + +L VHRDL N L+ +NY KI+D G++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT---ARP 597
R + I A ++ E G SD+++ GV L +++T +P
Sbjct: 178 RNLYSGDYYRI----QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233
Query: 598 AMGLSHQVEQAIRNGT--FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
LS EQ I N F + P S+ KL L C ++RP
Sbjct: 234 YSQLSD--EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 52/216 (24%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 400 RKIGEGGYGP--VYKAQLDHTSVAIKVLG-PDISQGPRQFKQ-EVEILGSMRHTNMVILL 455
R +G+G +G +Y+ D + V K + +S+ R+ E+ IL ++H N++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 456 GACPEYGCLV--YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA--EIATALLFLHQNKP 511
+ L+ EY G+L D++ ++ + + +I +A+ ++H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT-TAAGTFCYIDPEY 570
++HRD+K NI L + + K+ D G+++++ ++Y M T GT Y+ PE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-------SEYSMAETVVGTPYYMSPEL 172
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606
Q KSD+++LG VL +L+T + ++ +
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 48/282 (17%)
Query: 402 IGEGGYGPVYKAQLDH----TSVAIKVLGPDISQGP-RQFKQEVEILGSM-RHTNMVILL 455
IGEG +G V KA++ AIK + S+ R F E+E+L + H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 456 GACPEYGCL--VYEYMENGSLEDRL-----------FQKDNSPPIHWSIR--FKIAAEIA 500
GAC G L EY +G+L D L F NS S + AA++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
+ +L Q + +HRDL NIL+ +NYV+KI+D GL+R T+ + +
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 176
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSELL 618
++ E + SD++S GV+L ++++ P G+ T +EL
Sbjct: 177 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----------TCAELY 221
Query: 619 DPTVTGWPVEAALS----IAKLALQCCELRKRDRPDLVSVVL 656
+ G+ +E L+ + L QC + +RP +++
Sbjct: 222 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 44/277 (15%)
Query: 401 KIGEGGYGPVYKAQL--DHTSVAIK----VLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+IG G +G V+ +L D+T VA+K L PD+ +F QE IL H N+V L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 58
Query: 455 LGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
+G C P Y +V E ++ G F + P + ++ A + +L +
Sbjct: 59 IGVCTQKQPIY--IVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYL---E 111
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
+ +HRDL N L+ + V KISD G++R D + + PE
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 571 QQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-----VEQAIRNGTFSELLDPTVT 623
G +SD++S G++L + + A P LS+Q +EQ +R L
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------LPC--- 217
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660
P ++ +L +C E RP S V EL
Sbjct: 218 --PELCPDAVYRLMERCWEYDPGQRPSF-STVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 49/269 (18%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIK-VLGPDISQG-PRQFKQEVEILGSMRH 448
DY I K+GEG +G VYKA+ VA+K +L + G P +E++IL ++H
Sbjct: 8 RDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 449 TNMVILLGACPEY--------GC--LVYEYME---NGSLEDRLFQKDNSPPIHWS---IR 492
N+V L+ E G +V YM+ +G LE+ P + + I+
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--------PSVKLTESQIK 118
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
++ + +LH+N ++HRD+K ANIL+D + KI+D GLAR +
Sbjct: 119 C-YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 553 QYHMTTAAGTFC-----YIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLS 602
T T Y PE +LG + D++ +G V ++ T RP +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 603 HQVEQAIRNGTFSELLDPTVTGWPVEAAL 631
++Q + F PT WP +L
Sbjct: 231 SDIDQL--HLIFKLCGTPTEETWPGWRSL 257
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 396 FSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGP---DISQGPRQFKQEVEILGSMRHTN 450
+ + + IG G YG V A + VAIK + D+ R + E+++L +RH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHEN 60
Query: 451 MV----ILLGACPE-----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
++ IL PE Y +V E ME L + H I++ +I
Sbjct: 61 IIGLLDILRPPSPEDFNDVY--IVTELMET-DLHKVIKSPQPLTDDH--IQY-FLYQILR 114
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L +LH ++HRDLKP+NIL++ N KI D GLAR V P D + +T
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP---DEDEKGFLTEYVV 168
Query: 562 TFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
T Y PE +L D++S+G + +L+T +P
Sbjct: 169 TRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 65/269 (24%), Positives = 118/269 (43%), Gaps = 35/269 (13%)
Query: 400 RKIGEGGYGPV--YKAQLDHTSVAIKVLG--PDISQGPRQFKQEVEILGSMRHTNMVILL 455
R +G+G YG V + + D IK L + + +QE ++L ++H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 456 GACPEYGCLVYEYM---ENGSLEDRLFQKD-----NSPPIHWSIRFKIAAEIATALLFLH 507
+ L+Y M E G L +L ++ + + W + +IA AL +LH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV------QIAMALQYLH 119
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM-TTAAGTFCYI 566
+ + ++HRDLK N+ L + + K+ D+G+AR++ Q M +T GT Y+
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-------NQCDMASTLIGTPYYM 169
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
PE KSD+++LG + ++ T L H N +++ + P
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMAT------LKHAFNAKDMNSLVYRIIEGKLPPMP 223
Query: 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ + + +L R RP + S++
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVL--GPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
+GEG YG V K + T VAIK D + +E+ +L +RH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 457 ACPE----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
Y LV+E++++ L+D L + N + S K +I + F H +
Sbjct: 68 VFRRKKRLY--LVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT--AAGTFCYIDPEY 570
++HRD+KP NIL+ Q+ V K+ D G AR + + + T Y T A D +Y
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARP 597
G D++++G ++ +++T P
Sbjct: 179 ------GRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 51/286 (17%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS---VAIK---VLGPDISQGPRQFKQEVE-------- 441
+++ +G G +G VYK + + +A+K V P + R+ + +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 442 ILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAE 498
I +RH N+V E L V + +E L + K+ + I +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
+ AL +LH+ K +VHRDL P NI+L ++ I+D GLA+ P + +T+
Sbjct: 122 MVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTS 172
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP----------AMGLSHQVEQA 608
GT Y PE + G K+D+++ G +L Q+ T +P A + V +
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
Query: 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSV 654
+ G +SE + +T C RPD++ V
Sbjct: 233 LPEGMYSEDVTDVIT---------------SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 41/263 (15%)
Query: 402 IGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVILLGAC- 458
+G+G +G V+K L D T VA+K D+ Q + +F E IL H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 459 ---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
P Y +V E + G L +K + ++F + A A + +L +
Sbjct: 63 QRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDA--AAGMAYLESKN---CI 115
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPS--AADTITQYHMTTAAGTFCYIDPEYQQT 573
HRDL N L+ +N V KISD G++R ++ + Q + A PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA-------PEALNY 168
Query: 574 GMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-----QVEQAIRNGTFSELLDPTVTGWP 626
G +SD++S G++L + + P G+++ QVE+ R P
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC------------P 216
Query: 627 VEAALSIAKLALQCCELRKRDRP 649
+ + K+ +C + + +RP
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 75/246 (30%), Positives = 114/246 (46%), Gaps = 36/246 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI-SQG-PRQFKQEVEILGSMRHTNM 451
F KIGEG YG VYKA+ T VA+K + D ++G P +E+ +L + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 452 VILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPP--IHWSIRFKIAAEIATALLFLH 507
V LL LV+E++ + L+ + D SP I + ++ L F H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAGTFCY 565
++ ++HRDLKP N+L++ K++D GLAR VP + Y T T Y
Sbjct: 118 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTY--THEVVTLWY 166
Query: 566 IDPEYQQTGMLGVK-----SDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
PE +LG K D++SLG + +++T R +++Q R F L P
Sbjct: 167 RAPEI----LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTP 220
Query: 621 TVTGWP 626
WP
Sbjct: 221 DEVVWP 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 41/224 (18%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI-SQGPRQFKQEVEILGSMRHTN 450
D + ++G G YG V K + T +A+K + + SQ ++ +++I SMR +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI--SMRSVD 58
Query: 451 MVILLGACPE----YGCL-----VYEYME--NGSLEDRLFQKDNSPPIHW--SIRFKIAA 497
CP YG L V+ ME + SL D+ ++K + I KIA
Sbjct: 59 -------CPYTVTFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAV 110
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
I AL +LH ++HRD+KP+N+L+++N K+ D G++ + S A TI
Sbjct: 111 SIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID----- 163
Query: 558 TAAGTFCY-----IDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
AG Y I+PE Q G VKSD++SLG+ +++L T R
Sbjct: 164 --AGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
+++ I ++G+G +G VYKAQ T V A KV+ + + E++IL S H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 452 VILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V LL A L + E+ G+++ + + + P IR + + AL +LH+N
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRV-VCKQTLEALNYLHEN 122
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
K ++HRDLK NIL + K++D G+ SA +T T + GT ++ PE
Sbjct: 123 K---IIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 570 Y-----QQTGMLGVKSDLYSLGVVLLQLITARP 597
+ K+D++SLG+ L+++ P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 59/191 (30%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 420 VAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNMVILL--GACPEYGCL--VYEYMENG 472
VAIK+L D + Q F++E + + H N+V LL G P G L V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGR 64
Query: 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV- 531
+L + L P ++ ++ AL H +VHRDLKP NI++ Q V
Sbjct: 65 TLREVLAADGALPAGETG---RLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVR 118
Query: 532 --SKISDVGLARLVPPS-AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVV 588
+K+ D G+ L+P AD T T GT Y PE + + SDLY+ G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 589 LLQLITARPAM 599
L+ +T + +
Sbjct: 179 FLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 41/269 (15%)
Query: 402 IGEGGYGPVYKAQ--LDHTSVAIKVL------GPDISQGPRQFKQEVEILGSMRHTNMVI 453
+G G + Y+A+ T +A+K + + + ++E+ ++ + H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 454 LLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
+LGA E L E+M GS+ L ++ ++ L +LH+N+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123
Query: 512 EPLVHRDLKPANILLDQN-YVSKISDVGLA-RLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRD+K AN+L+D +I+D G A RL +A T GT ++ PE
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARPAMG---------LSHQVEQAIRNGTFSELLDP 620
+ G D++S+G V++++ TA+P L ++ A + E L P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ + L+C EL+ DRP
Sbjct: 239 GLR-----------DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTS-------VAIKVLGPDISQGP--RQFKQ 438
EI +T F ++GE +G VYK L T+ VAIK L D ++GP +FK
Sbjct: 1 EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKH 57
Query: 439 EVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQK---------DNSPPI 487
E + ++H N+V LLG + +++ Y + L + L + D+ +
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 488 HWSIR----FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
++ I +IA + FL + +VH+DL N+L+ KISD+GL R V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 544 PPSAADTITQYH--MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAM 599
AAD Y+ M + ++ PE G + SD++S GVVL ++ + +P
Sbjct: 175 --YAAD----YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 600 GLSHQ-VEQAIRN 611
G S+Q V + IRN
Sbjct: 229 GYSNQDVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 41/289 (14%)
Query: 390 EAATDYFSISRKIGEGGYGPVY--------KAQLDHTSVAIKVLGPDISQGPR-QFKQEV 440
E + + ++ R++G+G +G VY K + + T VA+K + S R +F E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEA 60
Query: 441 EILGSMRHTNMVILLGACP--EYGCLVYEYMENGSLED--RLFQKD-----NSPPIHWSI 491
++ ++V LLG + +V E M +G L+ R + + PP
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
++AAEIA + +L+ K VHRDL N ++ ++ KI D G+ R +
Sbjct: 121 MIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE------ 171
Query: 552 TQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVE 606
T Y+ G ++ PE + G+ SD++S GVVL ++ + +P GLS+ QV
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
Query: 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ + +G + LD P + L C + + RP + +V
Sbjct: 232 KFVMDGGY---LDQ-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS-------VAIKVLGPDISQGPRQ--FKQEV 440
E D ++ R +G G +G VY+ VA+K L P+ + F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEA 60
Query: 441 EILGSMRHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSP------PIHWS 490
I+ H N+V L+G P + ++ E M G L+ F ++N P +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF--ILLELMAGGDLKS--FLRENRPRPERPSSLTMK 116
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGLARLVPPSA 547
A ++A +L +N +HRD+ N LL V+KI+D G+AR + ++
Sbjct: 117 DLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173
Query: 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQV 605
M ++ PE G+ K+D++S GV+L ++ + P G ++Q
Sbjct: 174 YYRKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ- 228
Query: 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ + T LDP P + ++ C + DRP+ +++
Sbjct: 229 -EVMEFVTGGGRLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 74/249 (29%), Positives = 113/249 (45%), Gaps = 38/249 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKV--LGPDISQGPRQFKQEVEILGSMRHT 449
DY I KIGEG YG VYK + T VA+K L + P +E+ +L ++H
Sbjct: 1 DYTKI-EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHP 59
Query: 450 NMVILLGACPE----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATA 502
N+V L + Y L++E++ L+ L D+ P + + + +I
Sbjct: 60 NIVCLQDVLMQESRLY--LIFEFLSM-DLKKYL---DSLPKGQYMDAELVKSYLYQILQG 113
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
+LF H + ++HRDLKP N+L+D V K++D GLAR A I T T
Sbjct: 114 ILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVT 164
Query: 563 FCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617
Y PE +LG D++S+G + ++ T +P +++Q R F L
Sbjct: 165 LWYRAPEV----LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR--IFRIL 218
Query: 618 LDPTVTGWP 626
PT WP
Sbjct: 219 GTPTEDVWP 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 62/248 (25%)
Query: 395 YFSISRKIGEGGYGPVYKAQLD---HTSVAIK-VLGP--DISQGPRQFKQEVEILGSMR- 447
+ I +K+G+G YG V+KA +D VA+K + + + R F+ E+ L +
Sbjct: 8 KYEILQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD 65
Query: 448 HTNMVILLGACPE------YGCLVYEYMEN--------GSLEDRLFQKDNSPPIHWSIRF 493
H N+V LL Y LV+EYME LED +H R+
Sbjct: 66 HPNIVKLLNVIKAENDKDIY--LVFEYMETDLHAVIRANILED----------VH--KRY 111
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ 553
I ++ AL ++H ++HRDLKP+NILL+ + K++D GLAR + + +
Sbjct: 112 -IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL-----SELEE 162
Query: 554 YH----MTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAM-GLS- 602
+T T Y PE +LG D++S+G +L +++ +P G S
Sbjct: 163 NPENPVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218
Query: 603 -HQVEQAI 609
+Q+E+ I
Sbjct: 219 LNQLEKII 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 400 RKIGEGGYGPV----YKAQLDHTS--VAIKVLGPDISQGPR--QFKQEVEILGSMRHTNM 451
R +GEG +G V Y + D+T VA+K L P+ S G K+E+EIL ++ H N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENI 68
Query: 452 VILLGACPEYGC----LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
V G C E G L+ E++ +GSL++ L + N I+ + K A +I + +L
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLG 126
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT---AAGTFC 564
+ VHRDL N+L++ + KI D GL + A +T +Y+ + F
Sbjct: 127 SRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSPVFW 178
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
Y PE + SD++S GV L +L+T
Sbjct: 179 YA-PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 402 IGEGGYGPVYKAQLDHTS---VAIKVL---GPDISQGPRQ------FKQEVEILGSMRHT 449
IG G +G VY ++ +S +A+K + S R+ +E+ +L ++H
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N+V LG+ ++ + EY+ GS+ L +N ++ +I L +LH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
++HRD+K ANIL+D KISD G+++ + ++ T T + G+ ++
Sbjct: 124 NRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
PE + K+D++SLG ++++++T +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK--VLGPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
KIGEG YG V+K + T VAIK V D + +E+ +L ++H N+V L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 457 ACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
LV+EY ++ ++ + L + P H I+ KI + A+ F H++
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEH-LIK-KIIWQTLQAVNFCHKHN---C 121
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE----- 569
+HRD+KP NIL+ + K+ D G AR++ D T Y T Y PE
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDY-----VATRWYRAPELLVGD 175
Query: 570 --YQQTGMLGVKSDLYSLGVVLLQLITARP 597
Y G D++++G V +L+T +P
Sbjct: 176 TQY------GPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIK---VLGPDISQGPRQFKQEVEILGSMRHTN 450
F I +KIG G + VY+A LD VA+K + ++ +E+++L + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 451 MVILLGACPEYGCL--VYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
++ + E L V E + G L + F+K I +K ++ +AL +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHM 122
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H + ++HRD+KPAN+ + V K+ D+GL R + T H + GT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAH--SLVGTPYYM 173
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQL 592
PE KSD++SLG +L ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 37/235 (15%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDIS-QGPRQFKQ 438
E E D ++ + +GEG +G V KA+ + ++VA+K+L D + +
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 439 EVEILGSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPP--------- 486
E+E++ + +H N++ LLG C + G L V EY +G+L D F + PP
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD--FLRARRPPGEYASPDDP 122
Query: 487 --IHWSIRFK----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540
++ K A ++A + FL K +HRDL N+L+ +++V KI+D GLA
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 541 RLVPPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
R + I Y TT ++ PE + +SD++S GV+L ++ T
Sbjct: 180 RDI-----HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 20/231 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQ----EVEILGSMRHTNM 451
F + +GEG YG V K + T + + S+ + K+ E+++L +++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 452 VILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V L A G LV+EY+E LE + PP +R I ++ A+ + H+N
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE--KVRSYIY-QLIKAIHWCHKN 119
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+VHRD+KP N+L+ N V K+ D G AR + + T+Y T Y PE
Sbjct: 120 D---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPE 171
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
G D++S+G +L +L +P +++Q T ++L P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF---TIQKVLGP 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQFKQEVEILGSMRHTN 450
F I ++G+GGYG V+ A+ T VA+K + + R E +IL + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHW-SIRFKIAAEIATALLFLH 507
+V LL A EY L EY+ G L +N + RF +A E+ A+ LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ +HRDLKP N L+D + K++D GL + +T + + G+ Y+
Sbjct: 119 ELG---YIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYAN--SVVGSPDYMA 166
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE + D +SLG +L + + P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 76/311 (24%), Positives = 130/311 (41%), Gaps = 40/311 (12%)
Query: 353 REIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYK 412
R ELK ++ E+ E + + + TI +I ++ ++ I G G YK
Sbjct: 655 RNNLELKRVENEDG---TWELQFFDSKVSKSITINDILSSLKEENV---ISRGKKGASYK 708
Query: 413 AQLDHTSVAIKVLG-PDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGC--LVYEYM 469
+ + V D++ P + +G ++H N+V L+G C L++EY+
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529
E +L + L + W R KIA IA AL FLH +V +L P I++D
Sbjct: 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819
Query: 530 YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
+ RL P T T+ +++A Y+ PE ++T + KSD+Y G++L
Sbjct: 820 DEPHL------RLSLPGLLCTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLIL 868
Query: 590 LQLITARPAMGLSHQVEQAI--------RNGTFSELLDPTVTGWPV---EAALSIAKLAL 638
++L+T + V +I + +DP++ G + + LAL
Sbjct: 869 IELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928
Query: 639 QCCELRKRDRP 649
C RP
Sbjct: 929 HCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILGSMRHT 449
+ +G+G +G V A+L T A+KVL D I Q +VE +L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKH 55
Query: 450 NMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK------IAAEIA 500
+ L +C + V EY+ G L +F I S RF AAEI
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFH------IQRSGRFDEPRARFYAAEIV 106
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
L FLH+ +++RDLK N+LLD KI+D G+ + + I +TT+
Sbjct: 107 LGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGIL-GGVTTS- 154
Query: 561 GTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
TFC YI PE G D ++LGV+L +++ +
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
+ + I ++G+G +G VYKA+ T A KV+ + + E+EIL + H +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 452 VILLGACPEYGCL--VYEYMENGSLEDRLFQKD---NSPPIHWSIRFKIAAEIATALLFL 506
V LLGA G L + E+ G+++ + + D P I I ++ AL +L
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYL 126
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H K ++HRDLK N+LL + K++D G+ SA + T + GT ++
Sbjct: 127 HSMK---IIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWM 177
Query: 567 DPEYQQTGML-----GVKSDLYSLGVVLLQLITARP 597
PE + K+D++SLG+ L+++ P
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 78/268 (29%), Positives = 118/268 (44%), Gaps = 58/268 (21%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG--PRQFKQEVEILGS 445
+ D F I +IGEG YG VYKA+ T VA+K + D + P +E++IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 446 MRHTNMVIL----------LGACPEYGC--LVYEYMEN---GSLEDRL--FQKDNSPPIH 488
+ H N+V L L + G LV+EYM++ G LE L F +D+
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF- 121
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
K ++ L + H+ +HRD+K +NILL+ K++D GLARL +
Sbjct: 122 ----MK---QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY---NS 168
Query: 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSH 603
+ Y T T Y PE +LG + D++S G +L +L T +P +
Sbjct: 169 EESRPY--TNKVITLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222
Query: 604 QVEQAIRNGTFSELLD-----PTVTGWP 626
++ Q EL+ P WP
Sbjct: 223 ELAQL-------ELISRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 401 KIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLG 456
KIG+G G VY A T VAIK + ++ Q P++ E+ ++ +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 457 A---CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATALLFLHQNK 510
+ E +V EY+ GSL D + + IAA E AL FLH N+
Sbjct: 84 SYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQALEFLHSNQ 135
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRD+K NILL + K++D G + P Q +T GT ++ PE
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEV 186
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARP 597
G K D++SLG++ ++++ P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT 449
A + +IG G G VYK + T + V Q R +E E +
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAV-----KQMRRTGNKE-ENKRILMDL 64
Query: 450 NMVILLGACPE----YGCLVYEY-----ME-NGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
++V+ CP YG + + ME + D+L ++ P I I K+ I
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-IPEDILGKMTVAI 123
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA-RLVPPSAADTITQYHMTT 558
AL +L + ++HRD+KP+NILLD + K+ D G++ RLV A T
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--------TR 173
Query: 559 AAGTFCYIDPEY----QQTGMLGVKSDLYSLGVVLLQLITAR 596
+AG Y+ PE +++D++SLG+ L++L T +
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 29/280 (10%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQ---LDHT----SVAIKVLGPDISQGPRQ-FKQEVE 441
E + S + +G G +G V +A L + VA+K+L P R+ E++
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 442 ILGSM-RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
I+ + H N+V LLGAC G ++ EY G L + L +K S + + +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQ 149
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
+A + FL +HRDL N+LL + KI D GLAR D + +
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-------DIMNDSNYVV 199
Query: 559 AAGTFC---YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFS 615
++ PE + +SD++S G++L ++ + +G + + + +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYK 255
Query: 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ + P A I + C + RP +V
Sbjct: 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK---QEVEILGSMRHTNMVILLG 456
+G+G +G V A+L T AIKVL D+ E IL + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 457 AC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
C + V EY+ G L +FQ S AAE+ AL+FLH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPE 569
+++RDLK NILLD K++D G+ + + I TT TFC YI PE
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTT---TFCGTPDYIAPE 166
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARP 597
Q G D ++LGV++ +++ +P
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 402 IGEGGYGPVYKA-------QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+G+G +G VY +L V P+ S+ + E+++L +++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 455 LGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
G + + EYM GS++D+L + S+ K +I + +LH N
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
+VHRD+K ANIL D K+ D G ++ + ++ + + GT ++ PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWMSPEV 180
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITARP 597
G K+D++SLG +++++T +P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRH 448
T+ + + +G G +G V A QL +VAIK + S ++ +E+++L +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 449 TNMVIL--LGACP-EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
N++ L + P E V E + G+ RL S P+ +I L +
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKY 123
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
+H +VHRDLKP+NIL+++N KI D GLAR+ P MT T Y
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP---------QMTGYVSTRYY 171
Query: 566 IDPEYQQTGM-LGVKSDLYSLGVVLLQLITARP 597
PE T V+ D++S G + +++ +P
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 396 FSISRKIGEGGYGP---VYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+++ R +GEG +G V D ++ P S ++E +L M+H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 453 ILLGACPEYGCL--VYEYMENGSL-------EDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+ G L V EY + G L +LF +D + W + ++ +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFV------QMCLGV 113
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+H+ + ++HRD+K NI L QN K+ D G ARL+ A + T GT
Sbjct: 114 QHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA------YACTYVGTP 164
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
Y+ PE + KSD++SLG +L +L T +
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF---KQEVEILGSMRHTN 450
F+ +IG+G +G VYK + T VAIK++ D+ + + +QE+ +L
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ G+ + L + EY+ GS D L P+ + I EI L +LH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS 119
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ +HRD+K AN+LL + K++D G+A + T TQ T GT ++ P
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + K+D++SLG+ ++L P
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILL 455
+++G G +G V+ + VAIK I++G F +E +++ + H +V L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA----INEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 456 GAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
G C P Y +V E+MENG L + L Q+ + + + ++ + +L +N
Sbjct: 66 GVCTQQKPLY--IVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC--YIDPE 569
+HRDL N L+ V K+SD G+ R V + + +++ F + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSPPE 171
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLIT 594
KSD++S GV++ ++ T
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ + +++G G YG VYKA+ HT A+K++ + +QE+ ++ +H N+V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 454 LLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
G+ E + EY GSL+D P I + + E L +LH
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK 127
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-- 569
+HRD+K ANILL N K++D G+A A T T + GT ++ PE
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVA------AKITATIAKRKSFIGTPYWMAPEVA 178
Query: 570 -YQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
++ G D++++G+ ++L +P M
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQ----EVEILGSMRHT 449
+ IGEG YG V A T VAIK + P Q F Q E++IL +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHE 63
Query: 450 NMV-ILLGACPEYGC------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIA 500
N++ IL P +V E ME D +L + + H I++ + +I
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLSNDH--IQYFLY-QIL 116
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
L ++H ++HRDLKP+N+LL+ N KI D GLAR+ P T +T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF---LTEYV 170
Query: 561 GTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
T Y PE ML K D++S+G +L ++++ RP
Sbjct: 171 ATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 401 KIGEGGYGPVYK--AQLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVIL--L 455
K+GEG Y VYK ++L VA+K + + +G P +EV +L ++H N+V L +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
+ LV+EY++ L+ L NS +H F ++ L + H+ K ++
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF--QLLRGLNYCHRRK---VL 126
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRDLKP N+L+++ K++D GLAR A +I + T Y P+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPDI----L 176
Query: 576 LG-----VKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
LG + D++ +G + ++ T RP S EQ + F L PT WP
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL--HFIFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 44/242 (18%)
Query: 398 ISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQGP-RQFKQEVEILGSMRHT 449
+ + +GEG +G V KA T+VA+K+L + S R E +L + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLED--RLFQK-------------------DNSPP 486
+++ L GAC + G L+ EY + GSL R +K +
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
+ A +I+ + +L + K LVHRDL N+L+ + KISD GL+R V
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 547 AADTITQYHMTTAAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS 602
+ ++ + G ++ E + +SD++S GV+L +++T P G++
Sbjct: 181 DS------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 603 HQ 604
+
Sbjct: 235 PE 236
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 401 KIGEGGYGPVYK--AQLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGA 457
K+GEG Y V+K ++L VA+K + + +G P +EV +L +++H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 458 CPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
CL V+EY+++ L+ L N +H F ++ L + H+ K ++
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKRK---IL 125
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRDLKP N+L+++ K++D GLAR A ++ + T Y P+ +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPPDV----L 175
Query: 576 LGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
LG D++ +G +L ++ T RP S E+ + F L PT WP
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL--HLIFRLLGTPTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 402 IGEGGYGPVYKAQL--------DHTSVAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMV 452
+G G +G VY+ VA+K L Q ++F +E ++ + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 453 ILLGAC----PEYGCLVYEYMENGS----LEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
LLG C P+Y ++ E ME G L D ++ P + I ++A +
Sbjct: 63 KLLGVCLLNEPQY--IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 505 FLHQNKPEPLVHRDLKPANILL-----DQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+L Q +HRDL N L+ D + V KI D GLAR + S Y+
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS------DYYRKEG 171
Query: 560 AGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-VEQAIRNG 612
G ++ PE G +SD++S GV++ +++T +P L++Q V Q + G
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQ---LDH------TSVAIKVLGPDISQGP-RQFKQE 439
E D + + +GEG +G V A+ LD T VA+K+L D ++ E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 440 VEILGSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRL-----------FQKDNSP 485
+E++ + +H N++ LLGAC + G L + EY G+L + L + P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 486 PIHWSIR--FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
S + A ++A + +L K +HRDL N+L+ ++ V KI+D GLAR +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 544 PPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
I Y TT ++ PE + +SD++S GV+L ++ T
Sbjct: 191 -----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 46/216 (21%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIKVLGPD-ISQG--PRQFKQEVEILGSMRHTNMV---- 452
+G GG+G V ++ + A+K + I + E EIL H +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 453 ---------ILLGACPEYGCLVYEYM-ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
+L+ C G ++ + + G ++ ++ RF A + A
Sbjct: 61 TFKDKKYIYMLMEYCL--GGELWTILRDRGLFDE------------YTARF-YIACVVLA 105
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT-TAAG 561
+LH +++RDLKP N+LLD N K+ D G A+ + T T G
Sbjct: 106 FEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK--------KLKSGQKTWTFCG 154
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T Y+ PE D +SLG++L +L+T RP
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 402 IGEGGYGPVYKAQ--LDHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGA- 457
+G G G VYKA L +A+KV+ DI+ + +Q E+EIL ++ GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA----LLFLHQNKPE 512
+ E+M+ GSL+ ++ I + IA A L +L K
Sbjct: 69 FVENRISICTEFMDGGSLD-----------VYRKIPEHVLGRIAVAVVKGLTYLWSLK-- 115
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
++HRD+KP+N+L++ K+ D G++ + S A T GT Y+ PE
Sbjct: 116 -ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--------KTYVGTNAYMAPERIS 166
Query: 573 TGMLGVKSDLYSLGVVLLQLITAR 596
G+ SD++SLG+ ++L R
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIK---VLGPDISQGPRQFKQEVEILGSMRHTN 450
F I +KIG G + VY+A LD VA+K + ++ + +E+++L + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIATALLFLH 507
++ L + E L V E + G L + + K I +K ++ +A+ +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA----GTF 563
+ ++HRD+KPAN+ + V K+ D+GL R TTAA GT
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----------TTAAHSLVGTP 170
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA--------MGLSHQVEQ 607
Y+ PE KSD++SLG +L ++ + L ++EQ
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 402 IGEGGYGPVYKA------QLDHTSVAIKVLGPDISQGPR---QFKQEVEILGSMRHTNMV 452
+G G +G VYK + VAIK+L + GP+ +F E I+ SM H ++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNE--TTGPKANVEFMDEALIMASMDHPHLV 72
Query: 453 ILLGAC--PEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQN 509
LLG C P LV + M +G L D + + KDN I + +IA +++L +
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEER 128
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+ LVHRDL N+L+ KI+D GLARL+ +Y+ ++ E
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE----KEYNADGGKMPIKWMALE 181
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLIT 594
+SD++S GV + +L+T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 34/229 (14%)
Query: 402 IGEGGYGPVYKA------QLDHTSVAIKVLGPDISQGPRQFKQEVE----ILGSMRHTNM 451
+G G +G V+K VAIK + + RQ QE+ +GS+ H +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ---DRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 452 VILLGACPEYGC-LVYEYMENGSLEDRLFQ-KDNSPP---IHWSIRFKIAAEIATALLFL 506
V LLG CP LV + GSL D + Q +D+ P ++W + +IA + +L
Sbjct: 72 VRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV------QIAKGMYYL 125
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+++ +VHR+L NILL + + +I+D G+A L+ P +Y + ++
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD----KKYFYSEHKTPIKWM 178
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
E G +SD++S GV + ++++ A P G+ H+V + G
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 389 IEAATDYFSISRKIGEGGYGPVYKA-----QLDHTSVAIKVLGPDISQGPRQ-FKQEVEI 442
E + ++ R IGEG +G VY+ + + +VA+K S R+ F QE I
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 443 LGSMRHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
+ H ++V L+G P + +V E G L L S + I + + ++
Sbjct: 61 MRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILY--SYQL 116
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
+TAL +L + VHRD+ N+L+ K+ D GL+R +
Sbjct: 117 STALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 38/251 (15%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK-VLGPDISQG-PRQFKQEVEILGSMR---HTNMVI 453
+IG G YG VYKA+ H+ VA+K V G P +EV +L + H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 454 LLGACPEYGC-------LVYEYMENGSLEDRLFQKDNSPPIHW---SIRFKIAAEIATAL 503
L+ C LV+E+++ +D D PP +I+ + + L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIK-DLMRQFLRGL 121
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM--TTAAG 561
FLH N +VHRDLKP NIL+ K++D GLAR I M T
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVV 169
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621
T Y PE D++S+G + ++ +P + + +Q + F + P
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFDLIGLPP 227
Query: 622 VTGWPVEAALS 632
WP + L
Sbjct: 228 EDDWPRDVTLP 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 391 AATDYFSISRKIGEGGYGPVYK--AQLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMR 447
AAT Y ++ K+GEG Y VYK ++++ VA+KV+ +G P +E +L ++
Sbjct: 3 AATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 448 HTNMVIL--LGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
H N+V+L + E V+EYM L + Q + F ++ L +
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMF--QLLRGLAY 118
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
+H ++HRDLKP N+L+ K++D GLAR A +I ++ T Y
Sbjct: 119 IHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWY 169
Query: 566 IDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAM-GLSHQVEQAIRNGTFSELLD 619
P+ +LG D++ G + ++++ +PA G+S EQ + ++ L
Sbjct: 170 RPPDV----LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK--IWTVLGV 223
Query: 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661
PT WP ++KL E +P + VV L R
Sbjct: 224 PTEDTWP-----GVSKLPNYKPEWFLPCKPQQLRVVWKRLSR 260
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
F + ++IG G YG VYKA+ +T AIKV+ + + +QE+ ++ +H+N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 454 LLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
G+ L E+ GSL+D P I + ++ E L +LH +K
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAY-VSRETLQGLYYLH-SKG 126
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-- 569
+ +HRD+K ANILL N K++D G+ SA T T + GT ++ PE
Sbjct: 127 K--MHRDIKGANILLTDNGHVKLADFGV------SAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 570 -YQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
++ G D++++G+ ++L +P M
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK---QEVEILGSMRHTN 450
F+ R+IG G +G VY A+ T+ VAIK + Q +++ +EV L +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 451 MVILLGACPEY-GC--------LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+ EY GC LV EY GS D L + + P+ +IAA
Sbjct: 77 TI-------EYKGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQ---EVEIAAICHG 123
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
AL L +HRD+K NILL + K++D G A LV P+ + T Y M A
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWM--APE 181
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+D E Q G K D++SLG+ ++L +P
Sbjct: 182 VILAMD-EGQYDG----KVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFK---QEVEILGSMRHTNMVIL 454
R +G+G +G V A+L A+KVL D+ + E IL R+ +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 455 LGAC---PEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
L C P+ V E++ G L + R F + + RF AAEI +AL+FL
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF-YAAEITSALMFL 112
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC-- 564
H + +++RDLK N+LLD K++D G+ + TFC
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK----------EGIFNGKTTSTFCGT 159
Query: 565 --YIDPEYQQTGMLGVKSDLYSLGVVLLQLI 593
YI PE Q + G D +++GV+L +++
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 37/233 (15%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDISQGP-RQFKQE 439
E + D ++ + +GEG +G V A+ + +VA+K+L D ++ E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 440 VEILGSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWS------ 490
+E++ + +H N++ LLGAC + G L + EY G+L + L + P + +S
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARV 129
Query: 491 ----IRFK----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
+ FK ++A + +L K +HRDL N+L+ +N V KI+D GLAR
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 543 VPPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
V + I Y TT ++ PE + +SD++S GV++ ++ T
Sbjct: 187 V-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLG 456
+G+GG+G V Q+ T A K L +G E IL + H+ ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 457 ACPEYG---CLVYEYMENGSLEDRLFQKD-NSP--PIHWSIRFKIAAEIATALLFLHQNK 510
+ CLV M G L ++ D +P P + + A+I + L LHQ +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY--TAQIISGLEHLHQRR 117
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
+++RDLKP N+LLD + +ISD+GLA V + T+ + AGT ++ PE
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGY----AGTPGFMAPEL 168
Query: 571 QQTGMLGVKSDLYSLGVVLLQLITAR 596
Q D ++LGV L ++I AR
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF---KQEVEILGSMRH 448
+ F+ +IG+G +G V+K + T VAIK++ D+ + + +QE+ +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATAL 503
+ G+ + L + EY+ GS D L + P F+IA EI L
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGL 114
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+LH K +HRD+K AN+LL + K++D G+A + T TQ T GT
Sbjct: 115 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTP 165
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE Q K+D++SLG+ ++L P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 58/262 (22%), Positives = 106/262 (40%), Gaps = 36/262 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQL--DHTS---VAIKVLGPDISQGP--RQFKQEVEILGSMRH 448
+ + +GEG +G V + QL D S VA+K + DI +F E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 449 TNMVILLGAC--------PEYGCLVYEYMENGSLEDRLFQ---KDNSPPIHWSIRFKIAA 497
N++ L+G C ++ +M++G L L + K
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+IA + +L +HRDL N +L ++ ++D GL++ + + D Q +
Sbjct: 121 DIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRI- 174
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL-SHQVEQAIRNGT- 613
A +I E + KSD+++ GV + ++ T P G+ +H++ +R+G
Sbjct: 175 -AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233
Query: 614 -------FSELLDPTVTGWPVE 628
EL D + W +
Sbjct: 234 LKQPEDCLDELYDLMYSCWRAD 255
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 54/229 (23%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLG-P--DISQGPRQFKQEVEILGSMRH 448
D + +G G YG V A T VAIK L P R ++ E+ +L M H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 449 TNMVILLGA-CPE---------YGCLVYEYME---NGSLEDRLFQKDNSPPIHWSIRFKI 495
N++ LL P Y LV M N ++ + D+ I+F +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVY--LVTHLMGADLNNIVKCQKLSDDH-------IQF-L 123
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
+I L ++H ++HRDLKP+NI ++++ KI D GLAR T
Sbjct: 124 VYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH---------TDDE 171
Query: 556 MTTAAGTFCYIDPE-------YQQTGMLGVKSDLYSLGVVLLQLITARP 597
MT T Y PE Y QT D++S+G ++ +L+T +
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 398 ISRKIGEGGYGPVYKA-------QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+ + +G+G +G VY +L V P+ S+ + E+++L ++ H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 451 MVILLGACPEYGCL----------VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+V YGCL E+M GS++D+L + + ++ K +I
Sbjct: 66 IV------QYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQIL 116
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
+ +LH N +VHRD+K ANIL D K+ D G ++ + ++ M +
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVT 170
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT ++ PE G K+D++S+G +++++T +P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 402 IGEGGYGPV--YKAQLDHTSVAIKVLGPDISQGPRQFKQ---EVEILGSMRHTNMVILLG 456
+G+G +G V + + A+K+L ++ + E +L + RH + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 457 A--CPEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
+ + C V EY+ G L +R+F +D + RF AEI +AL +LH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-------RF-YGAEIVSALDYLHSG 114
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
K +V+RDLK N++LD++ KI+D GL + AA M T GT Y+ PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT------MKTFCGTPEYLAPE 165
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ G D + LGVV+ +++ R
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLGA- 457
KIG+G G VY A T + + ++ Q P++ E+ ++ ++ N+V L +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATALLFLHQNKPEP 513
+ +V EY+ GSL D + + +IAA E AL FLH N+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAVCRECLQALDFLHSNQ--- 135
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRD+K NILL + K++D G + P Q +T GT ++ PE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTR 189
Query: 574 GMLGVKSDLYSLGVVLLQLITARP 597
G K D++SLG++ ++++ P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 35/215 (16%)
Query: 400 RKIGEGGYGPVYKAQLDHTS-----VAIKVL-GPDISQGPR---QFKQEVEILGSMRHTN 450
+ +G+GGYG V++ + + A+KVL I + + K E IL +++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 451 MVILLGACPEYG--CLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+V L+ A G L+ EY+ G L + +F +D + F ++ EI+ AL
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-------CFYLS-EISLAL 113
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT-TAAGT 562
LHQ + +++RDLKP NILLD K++D GL + ++I + +T T GT
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCGT 163
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
Y+ PE G D +SLG ++ ++T P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 45/233 (19%)
Query: 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLG---PDISQGPRQFK 437
+Y I+E+ IG+G YG V A HT VAIK + +S R +
Sbjct: 1 RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR 48
Query: 438 QEVEILGSMRHTNMV----ILLGACPE-----YGCLVYEYMENGSLEDRLFQKDNSPPIH 488
E+++L +RH ++V I+L Y +V+E ME+ L + D+ P H
Sbjct: 49 -EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY--VVFELMES-DLHQVIKANDDLTPEH 104
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
++ AL ++H + HRDLKP NIL + + KI D GLAR +
Sbjct: 105 HQF---FLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR---VAFN 155
Query: 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS----DLYSLGVVLLQLITARP 597
DT T T T Y PE G K D++S+G + +++T +P
Sbjct: 156 DTPTAIFWTDYVATRWYRAPEL--CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 34/131 (25%), Positives = 55/131 (41%), Gaps = 6/131 (4%)
Query: 26 VAIDADKSSQYAVKWAVDNLLNETSQYVLLHV--RNHSSNPRGRPATNDELQKLFLPYRG 83
VA+D + S+ A++WA ++ VLLHV SS +E + L R
Sbjct: 4 VAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEALRE 63
Query: 84 LFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLK 143
A + VVL+ D + A++ + IV G R+ L R + +L+
Sbjct: 64 ALAEAGVKVETVVLEG-DPAEAILEAAEELGADLIVMGSRGRSGLRRLLLG-SVAERVLR 121
Query: 144 SAPESCAVYII 154
AP C V ++
Sbjct: 122 HAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 380 RYRKYT--IEEIEAATDYFSISRKIGEGGYGPV--YKAQLDHTSVAIKVLGP--DISQGP 433
RY K I +++ + + + + IG G +G V + + A+K+L I +
Sbjct: 27 RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD 86
Query: 434 RQF-KQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWS 490
F +E +I+ +V L A + Y +V EYM G L + + D P W+
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA 144
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
+ AE+ AL +H L+HRD+KP N+LLD++ K++D G D
Sbjct: 145 KFY--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM-----KMDE 194
Query: 551 ITQYHMTTAAGTFCYIDPEYQQT----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606
TA GT YI PE ++ G G + D +S+GV L +++ V
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV- 253
Query: 607 QAIRNGTFSELLD-PTVTGWPVEAALSIAKLALQCCELRKRD 647
GT+S+++D +P + +S L C L R+
Sbjct: 254 -----GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDRE 290
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 35/208 (16%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVL------GPDISQGPRQFKQEVEILGSMRHTNMVI 453
+G G +G V A+ T AIK L D + K+ E S RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 454 LLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
L AC ++ C V EY G L + S P F AA + L +LH+NK
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVF-YAACVVLGLQYLHENK 121
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
+V+RDLK N+LLD KI+D GL + + T TFC PE+
Sbjct: 122 ---IVYRDLKLDNLLLDTEGFVKIADFGLCK--------EGMGFGDRT--STFCGT-PEF 167
Query: 571 QQTGMLGVKS-----DLYSLGVVLLQLI 593
+L S D + LGV++ +++
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLGA- 457
KIG+G G VY A T + + ++ Q P++ E+ ++ ++ N+V L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATALLFLHQNKPEP 513
+ +V EY+ GSL D + + +IAA E AL FLH N+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAVCRECLQALEFLHSNQ--- 136
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRD+K NILL + K++D G + P Q +T GT ++ PE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTR 190
Query: 574 GMLGVKSDLYSLGVVLLQLITARP 597
G K D++SLG++ +++I P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 53/224 (23%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
+G+G +G V A+L T+ AIK L D+ ++ ++ +M ++ L P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDV------VLEDDDVECTMVERRVLALAWEHP 56
Query: 460 ------------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI------AAEIAT 501
E+ V EY+ G L +F I S RF AAEI
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDL---MFH------IQSSGRFDEARARFYAAEIIC 107
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L FLH+ +++RDLK N+LLD++ KI+D G+ + + A
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK----------ENMNGEGKAS 154
Query: 562 TFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQ-LITARPAMG 600
TFC YI PE + D +S GV+L + LI P G
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLG 456
+G+GG+G V Q+ +T A K L + G + E EIL + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQK-----DNSPPIHWSIRFKIAAEIATALLFLHQN 509
A + CLV M G L+ ++ + IH+S A+I +L LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS------AQITCGILHLHSM 114
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+V+RD+KP N+LLD ++SD+GLA + TITQ AGT Y+ PE
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQ-----RAGTNGYMAPE 164
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ D +++G + +++ R
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTN 450
F R +G+GG+G V Q+ T A K L +G E +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 451 MVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L A + CLV M G L+ ++ N P AAEI L LH+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR 120
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
E V+RDLKP NILLD +ISD+GLA +P + + GT Y+ P
Sbjct: 121 ---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-------IRGRVGTVGYMAP 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQVEQ 607
E + D + LG ++ ++I + P G +V++
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 68/242 (28%), Positives = 104/242 (42%), Gaps = 36/242 (14%)
Query: 386 IEEIEAATDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQEVEIL 443
+E + TD + I IG+G YG VYK + D + A+K+L P IS + + E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 444 GSM-RHTNMVILLGACPEYG-------CLVYEYMENGSLED------RLFQKDNSPPIHW 489
S+ H N+V G + LV E GS+ + Q+ + I +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 490 SIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549
I L LH N+ ++HRD+K NILL K+ D G+ SA
Sbjct: 133 -----ILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV------SAQL 178
Query: 550 TITQYHMTTAAGTFCYIDPEY-----QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ 604
T T+ T+ GT ++ PE Q + D++SLG+ ++L P + H
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
Query: 605 VE 606
V+
Sbjct: 239 VK 240
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 29/246 (11%)
Query: 401 KIGEGGYGPVYKAQ-LDHTS--VAIKVLGPDISQG--PRQFKQEVEIL---GSMRHTNMV 452
+IGEG YG V+KA+ L + VA+K + + P +EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 453 ILLGACP-------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
L C LV+E+++ L L K P + + ++ L F
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH ++ +VHRDLKP NIL+ + K++D GLAR+ A +T+ T Y
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-------LTSVVVTLWY 175
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625
PE DL+S+G + ++ +P S V+Q + + P W
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK--ILDVIGLPGEEDW 233
Query: 626 PVEAAL 631
P + AL
Sbjct: 234 PRDVAL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 71/256 (27%), Positives = 104/256 (40%), Gaps = 44/256 (17%)
Query: 400 RKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQ---EVEILGSMRHTNMVIL 454
+ +G+G G V+ +L T A+KVL + K+ E EIL ++ H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 455 LG--ACPEYGCLVYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
Y CLV +Y G L L Q RF AAE+ AL +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARF-YAAEVLLALEYLHLLG- 123
Query: 512 EPLVHRDLKPANILLDQNY--------VSKISDVGLARLV-----PPSAADTITQYHMTT 558
+V+RDLKP NILL ++ +SK SDV + + + T
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 559 AA----------GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQVEQ 607
+ GT YI PE G D ++LG++L +++ P G +
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN----- 236
Query: 608 AIRNGTFSELLDPTVT 623
R+ TFS +L VT
Sbjct: 237 --RDETFSNILKKEVT 250
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 401 KIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGP-RQFKQEVEILGSMRHTNMVILLGA 457
++G+G YG VYK T V A+K + ++ + Q E++IL +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 458 CPEYGCLVY--EYMENGSLEDRLFQKDNSPP-IHWSIRFKIAAEIATALLFLHQNKPEPL 514
G + EYM+ GSL D+L+ + I + +I + L FL + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY---- 570
+HRD+KP N+L++ N K+ D G++ + S A T G Y+ PE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--------KTNIGCQSYMAPERIKSG 176
Query: 571 --QQTGMLGVKSDLYSLGVVLLQLITAR 596
Q V+SD++SLG+ +L++ R
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP-RQFKQEVEILGSMRHTN 450
+ F+ KIG+G +G V+K + T VAIK++ + ++ +QE+ +L
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ G+ + L + EY+ GS D L P+ + I EI L +LH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
K +HRD+K AN+LL ++ K++D G+A + T TQ T GT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + K+D++SLG+ ++L P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
IG GG+G VY + T A+K L + + KQ + + R ++ G CP
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL----DKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 460 EYGCLVYEY------------MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
C+ Y + M G L L Q + +RF A EI L +H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRF-YATEIILGLEHMH 114
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+V+RDLKPANILLD++ +ISD+GLA ++ + GT Y+
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHGYMA 163
Query: 568 PEYQQTGM-LGVKSDLYSLGVVLLQLI 593
PE Q G +D +SLG +L +L+
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 39/238 (16%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDIS-QGPRQFKQE 439
E + ++ + +GEG +G V A+ +VA+K+L D + + E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 440 VEILGSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPP-IHWS----- 490
+E++ + +H N++ LLGAC + G L + EY G+L R + + PP + +S
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL--REYLRARRPPGMDYSFDTCK 125
Query: 491 -----IRFK----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+ FK A ++A + +L K +HRDL N+L+ ++ V KI+D GLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 542 LVPPSAADTITQYHMTTAAG-TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA 598
V I Y TT ++ PE + +SD++S GV+L ++ T +
Sbjct: 183 DV-----HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 48/139 (34%), Positives = 69/139 (49%), Gaps = 21/139 (15%)
Query: 463 CLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517
C V EY G L +R+F +D + RF AEI +AL +LH K +V+R
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSEDRA-------RF-YGAEIVSALDYLHSEKN--VVYR 120
Query: 518 DLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLG 577
DLK N++LD++ KI+D GL + D T M T GT Y+ PE + G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK---EGIKDGAT---MKTFCGTPEYLAPEVLEDNDYG 174
Query: 578 VKSDLYSLGVVLLQLITAR 596
D + LGVV+ +++ R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPRQFKQ---EVEILGSMRHT 449
+ IG G YG V A +D S VAIK + P P K+ E++IL +H
Sbjct: 7 YKPIENIGSGAYGVVCSA-IDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 450 NMV----ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS-------IRFKIAAE 498
N++ IL + VY M+ L + D IH IR+ +
Sbjct: 65 NIIAIRDILRPPGAD-FKDVYVVMD-------LMESDLHHIIHSDQPLTEEHIRY-FLYQ 115
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
+ L ++H ++HRDLKP+N+L++++ +I D G+AR + S + +Y MT
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE--HKYFMTE 170
Query: 559 AAGTFCYIDPEYQQTGMLGV-----KSDLYSLGVVLLQLITARP 597
T Y PE +L + D++S+G + +++ R
Sbjct: 171 YVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 40/248 (16%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK--VLGPDISQGPRQFKQEVEILGSMRHTNMVILL- 455
KIGEG YG VYKA+ +T VA+K L D P +E+ +L + + ++ L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 456 ---------GACPEYGCLVYEYMENG--SLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
G Y LV+EY+++ D + P+ ++ +
Sbjct: 68 DVEHVEEKNGKPSLY--LVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 505 FLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
H++ ++HRDLKP N+L+D Q + KI+D+GL R A +I T T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVTL 175
Query: 564 CYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618
Y PE +LG D++S+G + ++ +P +++Q + F L
Sbjct: 176 WYRAPEV----LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH--IFKLLG 229
Query: 619 DPTVTGWP 626
PT WP
Sbjct: 230 TPTEQVWP 237
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDISQGPRQ-FKQEVE 441
E++ + I R +G G +G + + L S VAI L S R+ F E
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 442 ILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
LG H+N+V L G + V EYM NG+L+ F + + + + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGL 116
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
A+ + +L + VH+ L +L++ + V KIS G RL ++ I Y +
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKIS--GFRRL-QEDKSEAI--YTTMSG 168
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQ-VEQAIRNGTFSE 616
+ PE Q SD++S G+V+ ++++ RP +S Q V +A+ +G F
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FR- 226
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
L P + +L L C + + +RP
Sbjct: 227 -LPA-----PRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ--FKQEVEI 442
TI I ++ KIG+G G V+ A T + + ++ + P++ E+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 443 LGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQK--DNSPPIHWSIRFKIAA- 497
+ +++ N+V L + + +V EY+ GSL D + + D + +IAA
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA---------QIAAV 120
Query: 498 --EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
E AL FLH N+ ++HRD+K N+LL + K++D G + P Q
Sbjct: 121 CRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------QSK 171
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+T GT ++ PE G K D++SLG++ ++++ P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 40/234 (17%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGP--DISQGPRQFKQEVEILGSMR- 447
+D + I IG+G YG V+K + + + A+K+L P DI + + + E IL ++
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSD 73
Query: 448 HTNMVILLGACPEYGC-------LVYEYMENGSLED------RLFQKDNSPPIHWSIRFK 494
H N+V G + LV E GS+ D + ++ P I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----- 128
Query: 495 IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554
I E L LH NK +HRD+K NILL K+ D G+ SA T T+
Sbjct: 129 ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGV------SAQLTSTRL 179
Query: 555 HMTTAAGTFCYIDPEY-----QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH 603
T+ GT ++ PE Q + D++SLG+ ++L P + H
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNM 451
F + +G G YG VYK + T AIKV+ D++ + KQE+ +L H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNI 65
Query: 452 VILLGA--------CPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATA 502
GA + LV E+ GS+ D + K N+ W I + I EI
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-ICREILRG 123
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
L LHQ+K ++HRD+K N+LL +N K+ D G+ SA T T GT
Sbjct: 124 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV------SAQLDRTVGRRNTFIGT 174
Query: 563 FCYIDPEY-----QQTGMLGVKSDLYSLGVVLLQLITARPAM 599
++ PE KSDL+SLG+ +++ P +
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 71/233 (30%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLG 456
IG GG+G VY + T A+K L + QG E I+ S+ T G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVST------G 54
Query: 457 ACPEYGCLVYEY------------MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
CP C+ Y + M G L L Q + +RF AAEI L
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRF-YAAEIILGLE 111
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+H +V+RDLKPANILLD++ +ISD+GL A D ++ + GT
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGL-------ACD-FSKKKPHASVGTHG 160
Query: 565 YIDPEYQQTGMLGVKS-DLYSLGVVLLQLITAR-PAMGLSHQVEQAIRNGTFS 615
Y+ PE Q G+ S D +SLG +L +L+ P + + I T +
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 32/157 (20%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK-VLGPDISQG-PRQFKQEVEILGSMRHTNMVILLG 456
KIGEG YG V+KA+ T VA+K V D +G P +E+ +L ++H N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 457 A--CPEYGCLVYEYME----------NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+ LV+EY + NG ++ P I S F++ +A
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDID---------PEIVKSFMFQLLKGLA---- 113
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
F H ++HRDLKP N+L+++N K++D GLAR
Sbjct: 114 FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 37/233 (15%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQL--------DHTS-VAIKVLGPDIS-QGPRQFKQE 439
E D + + +GEG +G V +A+ D T VA+K+L + + + E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 440 VEILGSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQK-----DNSPPIHWS- 490
+E++ + +H N++ LLG C + G L + EY G+L + L + D + I
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 491 ---IRFK----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
+ FK A ++A + +L + +HRDL N+L+ ++ V KI+D GLAR V
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 544 PPSAADTITQYHMTTAAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
Y+ T+ G ++ PE + +SD++S G+++ ++ T
Sbjct: 185 HD------IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVA---IKVLGPDISQG---PR---QFKQEVEILGSM 446
+ + +++G+G +G VY + D +VA +KVL +I G P Q QE ++L +
Sbjct: 2 YILQQRLGKGSFGTVYLVK-DKKAVAEERLKVL-KEIPVGELNPNETVQANQEAQLLSKL 59
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQ-----KDNSPP--IHWSIRFKIAA 497
H +V + E C++ EY E L+ +L + K S W I+ +
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++HQ + ++HRDLK NI L N + KI D G++RL+ S T
Sbjct: 120 H------YMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA------T 163
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQL 592
T GT Y+ PE + KSD++SLG +L ++
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 401 KIGEGGYGPVYK--AQLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVIL--L 455
K+GEG Y V+K ++L VA+K + + +G P +EV +L ++H N+V L +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
+ LV+EY++ L+ + N +H F +I L + H+ K ++
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY--QILRGLAYCHRRK---VL 126
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRDLKP N+L+++ K++D GLAR A ++ + T Y P+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPPDV----L 176
Query: 576 LG-----VKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
LG + D++ +G + ++ + RP S VE + + F L PT WP
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS-TVEDEL-HLIFRLLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 47/139 (33%), Positives = 68/139 (48%), Gaps = 22/139 (15%)
Query: 463 CLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517
C V EY G L +R+F +D + RF AEI +AL +LH +V+R
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSEDRA-------RF-YGAEIVSALGYLHSCD---VVYR 119
Query: 518 DLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLG 577
DLK N++LD++ KI+D GL + S T M T GT Y+ PE + G
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-EGISDGAT-----MKTFCGTPEYLAPEVLEDNDYG 173
Query: 578 VKSDLYSLGVVLLQLITAR 596
D + LGVV+ +++ R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQFKQ---EVEILGSMRHTNMVILLG 456
+G+G +G V + T A+K+L ++ + E +L + RH + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 457 ACPEYG--CLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
A + C V EY G L +R+F ++ + RF AEI +AL +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF-YGAEIVSALEYLHSR 114
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+V+RD+K N++LD++ KI+D GL + +D T M T GT Y+ PE
Sbjct: 115 D---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGAT---MKTFCGTPEYLAPE 165
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ G D + LGVV+ +++ R
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
LL +H + ++HRD+K ANILL N + K+ D G +++ + +D + + T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR----TFCGT 208
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS-HQVEQAIRNGTFSELLDP 620
Y+ PE + K+D++SLGV+L +L+T RP G + +V G + L
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268
Query: 621 T 621
Sbjct: 269 I 269
|
Length = 496 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 400 RKIGEGGYGPV----YKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
+++G G +G V ++ Q D VAIK++ + S +F +E +++ + H +V L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 456 GAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
G C P Y +V EYM NG L + L + S ++ ++ + +L +
Sbjct: 66 GVCTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESKQ- 120
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT---FCYIDP 568
+HRDL N L+D K+SD GL+R V +Y T++ G+ + P
Sbjct: 121 --FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD------EY--TSSVGSKFPVRWSPP 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLIT 594
E KSD+++ GV++ ++ +
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF---KQEVEILGSMRHTNMVIL 454
R IG G Y V +L A+KV+ ++ + E + ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 455 LGACPEYGC---LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L +C + LV EY+ G L + ++ P H RF AAEI AL FLH+
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH--ARF-YAAEICIALNFLHE--- 114
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQYHMTTAAGTFCYIDPE 569
+++RDLK N+LLD + K++D G+ + L P DT +T GT YI PE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---GDT-----TSTFCGTPNYIAPE 166
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ G D ++LGV++ +++ R
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
L+ +Y+ G L L+Q+++ +R IA EI AL LHQ +++RD+K N
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLALDHLHQLG---IIYRDIKLEN 135
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS--D 581
ILLD ++D GL++ + + GT Y+ PE + G G D
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSF-----CGTIEYMAPEVIRGGSGGHDKAVD 190
Query: 582 LYSLGVVLLQLIT 594
+SLGV+ +L+T
Sbjct: 191 WWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTN 450
F R +G+GG+G V Q+ T A K L +G E +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 451 MVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L A + CLV M G L+ ++ + F AAEI L LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ 120
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
E +V+RDLKP NILLD + +ISD+GLA VP + GT Y+ P
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-------IKGRVGTVGYMAP 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITAR 596
E + D ++LG +L ++I +
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 37/248 (14%)
Query: 394 DYFSISRKIGEGGYGPVYK--AQLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTN 450
D + K+GEG Y VYK ++++ VA+KV+ +G P +E +L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 451 MVIL--LGACPEYGCLVYEYMENGSLEDRLFQKDNSPP-IHWSIRFKIAAEIATALLFLH 507
+V+L + E LV+EY+ D D P +H ++ L ++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
Q ++HRDLKP N+L+ K++D GLAR A ++ + + T Y
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNEVVTLWYRP 171
Query: 568 PEYQQTGMLGVKS-----DLYSLGVVLLQLI---TARPAM-GLSHQVEQAIRNGTFSELL 618
P+ +LG D++ +G + +++I A P M + Q+E+ F L
Sbjct: 172 PDV----LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER-----IFLVLG 222
Query: 619 DPTVTGWP 626
P WP
Sbjct: 223 TPNEDTWP 230
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR-QFKQEVEILGSM 446
E D F ++G G G V+K + +A K++ +I R Q +E+++L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+V GA G + E+M+ GSL D++ +K P I K++ + L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLT 117
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+L + ++HRD+KP+NIL++ K+ D G++ + S A++ GT
Sbjct: 118 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GTRS 167
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
Y+ PE Q V+SD++S+G+ L+++ R
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPR-QFKQEVEILGSM 446
E D F ++G G G V K Q + + A K++ +I R Q +E+++L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+V GA G + E+M+ GSL+ L + P I K++ + L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLA 117
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+L + ++HRD+KP+NIL++ K+ D G++ + S A++ GT
Sbjct: 118 YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GTRS 167
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
Y+ PE Q V+SD++S+G+ L++L R
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 40/233 (17%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR---QFKQEVEILGSMRHTN 450
+ I R IG+GG G VY A S VA+K + D+S+ P +F +E +I + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 451 MVILLGACPEYGCLVY---EYMENGSLEDRL---FQKDN---------SPPIHWSIRFKI 495
+V + C + G VY Y+E +L+ L +QK++ S SI KI
Sbjct: 64 IVPVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR--------LVPPSA 547
A I ++H + ++HRDLKP NILL I D G A L+
Sbjct: 123 CATIE----YVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 548 ADTITQYH-MTTAA---GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ Y MT GT Y+ PE +D+Y+LGV+L Q++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228
|
Length = 932 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVL---GPDISQGPRQFKQEVEILGSMRHTNMVILL 455
+IG G +G VY A HT+ VA+K + G ++ + +EV+ L ++H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI--- 84
Query: 456 GACPEY-GC--------LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
EY GC LV EY GS D L + + P+ +IAA AL L
Sbjct: 85 ----EYKGCYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQ---EVEIAAITHGALQGL 134
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
++HRD+K NILL + K++D G A P+ + T Y M A +
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWM--APEVILAM 192
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
D E Q G K D++SLG+ ++L +P +
Sbjct: 193 D-EGQYDG----KVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK---QEVEILGSMRHTN 450
F+ R+IG G +G VY A+ T+ VAIK + Q +++ +EV+ L ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 451 MVILLGACPEY-GCLVYEY-----MEN--GSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
+ EY GC + E+ ME GS D L + + P+ +IAA A
Sbjct: 87 SI-------EYKGCYLREHTAWLVMEYCLGSASDLL--EVHKKPLQ---EVEIAAITHGA 134
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
L L ++HRD+K NILL + K++D G A + P+ + T Y M A
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWM--APEV 192
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
+D E Q G K D++SLG+ ++L +P +
Sbjct: 193 ILAMD-EGQYDG----KVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 88/298 (29%), Positives = 130/298 (43%), Gaps = 53/298 (17%)
Query: 377 KNV-----RYRKYTIEEIEA----ATDYFSISRKIGEGGYGPVYKAQL-DHTSV----AI 422
KN+ RY K E+I A D+ I + IG G +G V QL H S A+
Sbjct: 19 KNIDNFLSRYEK-AAEKITKLRMKAEDFDVI-KVIGRGAFGEV---QLVRHKSSKQVYAM 73
Query: 423 KVLGPD--ISQGPRQFK-QEVEILGSMRHTN---MVILLGAC--PEYGCLVYEYMENGSL 474
K+L I + F +E +I M H N +V L A +Y +V EYM G L
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDI---MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL 130
Query: 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534
+ + D P W+ RF A E+ AL +H +HRD+KP N+LLD++ K+
Sbjct: 131 VNLMSNYD--IPEKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183
Query: 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT----GMLGVKSDLYSLGVVLL 590
+D G + D TA GT YI PE ++ G G + D +S+GV L
Sbjct: 184 ADFGTCMKM-----DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 591 QLITARPAMGLSHQVEQAIRNGTFSELLD-PTVTGWPVEAALSIAKLALQCCELRKRD 647
+++ V GT+S+++D +P + +S L C L R+
Sbjct: 239 EMLVGDTPFYADSLV------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 402 IGEGGYGPVY--KAQLDHTSVAIKVLGPDISQGPRQFKQEVE----ILGSMRHTNMVILL 455
IG+G +G V K +LD A+KVL I ++ K + +L +++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 456 GA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
+ E V +++ G L L Q++ S P RF AAEIA+AL +LH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFP-EPRARF-YAAEIASALGYLHSIN--- 116
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
+V+RDLKP NILLD ++D GL + + +DT TT GT Y+ PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-----TTTFCGTPEYLAPEVIRK 170
Query: 574 GMLGVKSDLYSLGVVLLQLITARP 597
D + LG VL +++ P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 402 IGEGGYGPVYKAQLDHTSVAIKV----LGPDISQGPRQ---FKQEVEILGSMRHTNMVIL 454
+G G +G VY T + V PD + ++ + E+++L ++RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV-- 67
Query: 455 LGACPEYGCL----------VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
YGCL EYM GS++D+L + ++ + +I +
Sbjct: 68 ----QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVS 120
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+LH N +VHRD+K ANIL D K+ D G ++ + ++ + + GT
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPY 174
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE G K+D++S+ +++++T +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLG 456
KIGEG G V A T VA+K + D+ + R+ EV I+ +H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
+ + +V E++E G+L D + + N I + + AL FLH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG--- 135
Query: 514 LVHRDLKPANILLDQNYVSKISDVG----LARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRD+K +ILL + K+SD G +++ VP + T Y M PE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA----------PE 185
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN 611
G + D++SLG+++++++ P + QA++
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPY-FNEPPLQAMKR 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 64/240 (26%), Positives = 112/240 (46%), Gaps = 35/240 (14%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRH-----TNMV 452
R IG G Y V +L T A+KV+ ++ ++++ + + +H +N
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND----DEDIDWVQTEKHVFETASNHP 56
Query: 453 ILLG--AC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
L+G +C V E++ G L + ++ P H RF +AEI+ AL FLH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEH--ARF-YSAEISLALNFLH 113
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQYHMTTAAGTFCY 565
+ +++RDLK N+LLD K++D G+ + + P DT +T GT Y
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GDT-----TSTFCGTPNY 162
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA---MGLSHQVEQAIRNGTFSELLDPTV 622
I PE + G D ++LGV++ +++ R +G+S +Q + F +L+ +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVILLGAC 458
+G G G V K + + A K++ +I R Q +E+++L +V GA
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 459 PEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516
G + E+M+ GSL D++ +K P +I KI+ + L +L + ++H
Sbjct: 69 YSDGEISICMEHMDGGSL-DQVLKKAGRIP--ENILGKISIAVLRGLTYLREKHK--IMH 123
Query: 517 RDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGML 576
RD+KP+NIL++ K+ D G++ + S A++ GT Y+ PE Q
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GTRSYMSPERLQGTHY 175
Query: 577 GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSE 616
V+SD++SLG+ L+++ R + E G
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 401 KIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR----HTNMVIL 454
KIGEG + V KAQ AIK + + Q EI ++R H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQ-ALRRLSPHPNILRL 63
Query: 455 LGAC--PEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
+ + G LV+E M+ +L + L + P ++ ++ +L +H+N
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYE-LIKGRKRPLPEKRVK-SYMYQLLKSLDHMHRNG 120
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLV---PPSAADTITQYHMTTAAGTFCYID 567
+ HRD+KP NIL+ + + K++D G R + PP T+Y T Y
Sbjct: 121 ---IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPP-----YTEY-----ISTRWYRA 166
Query: 568 PEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607
PE T G G K D++++G V ++++ P +++++Q
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFK---QEVEILGSMRHTN 450
FS R+IG G +G VY A+ + VAIK + Q +++ +EV L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 451 MVILLGACPEY-GCLVYEY-----MEN--GSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
+ +Y GC + E+ ME GS D L + + P+ +IAA A
Sbjct: 77 TI-------QYRGCYLREHTAWLVMEYCLGSASDLL--EVHKKPLQ---EVEIAAVTHGA 124
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
L L ++HRD+K NILL + + K+ D G A ++ P+ T Y M A
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWM--APEV 182
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599
+D E Q G K D++SLG+ ++L +P +
Sbjct: 183 ILAMD-EGQYDG----KVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 33/239 (13%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVIL--L 455
K+GEG Y VYK + T VA+K + + +G P +E +L ++H N+V L +
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPI--HWSIRFKIAAEIATALLFLHQNKPEP 513
+ LV+EY++ D D+ ++R ++ L + HQ +
Sbjct: 72 IHTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYCHQRR--- 123
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRDLKP N+L+ + K++D GLAR A ++ + T Y P+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR------AKSVPSKTYSNEVVTLWYRPPDV--- 174
Query: 574 GMLGVKS-----DLYSLGVVLLQLITARPAM-GLSHQVEQAIRNGTFSELLDPTVTGWP 626
+LG D++ +G + ++ T RP G + +Q + F L PT WP
Sbjct: 175 -LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK--IFRVLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 66/265 (24%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 401 KIGEGGYG----PVYKAQLDHTSVAIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVILL 455
++G G +G VYK + VAIKVL + + R + +E EI+ + + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 456 GAC-PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
G C E LV E G L L K + + S ++ +++ + +L
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGKN---F 116
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC--YIDPEYQQ 572
VHRDL N+LL + +KISD GL++ + AD Y+ +AG + + PE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKAL---GAD--DSYYKARSAGKWPLKWYAPECIN 171
Query: 573 TGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTGWPVEA 629
+SD++S G+ + + + +P + +V I G + P E
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC--------PAEC 223
Query: 630 ALSIAKLALQCCELRKRDRPDLVSV 654
+ L C + DRP+ V
Sbjct: 224 PPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 41/236 (17%)
Query: 395 YFSISRKIGEGGYGPV----YKAQLDHTSVAIK----VLGPDISQGPRQFKQEVEILGSM 446
+ + +++G+G YG V + +VAIK V I ++ +E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILA--KRALRELKLLRHF 58
Query: 447 R-HTNMVILLGA-CPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA----- 497
R H N+ L G +Y Y E L + D I A
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEE-------LMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 498 -EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
+I L ++H ++HRDLKP N+L++ + KI D GLAR + + M
Sbjct: 112 YQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE--NAGFM 166
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQ 607
T T Y PE ML +S D++S+G +L +L+ +P V+Q
Sbjct: 167 TEYVATRWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFK---QEVEILGSMRHTN 450
F + +G G +G V A+ T AIK L +Q + QE IL + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 451 MVILLGACPE----YGCLVYEYMENGSLEDRL-----FQKDNSPPIHWSIRFKIAAEIAT 501
+V ++ + + Y + E++ G L L F D + H AE+
Sbjct: 80 IVNMMCSFQDENRVY--FLLEFVVGGELFTHLRKAGRFPNDVAKFYH--------AELVL 129
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
A +LH +++RDLKP N+LLD K++D G A+ VP T G
Sbjct: 130 AFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---------FTLCG 177
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T Y+ PE Q+ G D +++GV+L + I P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF---KQEVEILGSMRHTNMVIL 454
R IG G Y V +L T A+KV+ ++ + E + + ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 455 LGACPEYGC---LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L +C + V EY+ G L + ++ P H RF +AEI+ AL +LH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--ARF-YSAEISLALNYLHERG- 116
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQYHMTTAAGTFCYIDPE 569
+++RDLK N+LLD K++D G+ + L P DT + + GT YI PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTF-----CGTPNYIAPE 166
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARPA---MGLSHQVEQAIRNGTFSELLDPTV 622
+ G D ++LGV++ +++ R +G S +Q + F +L+ +
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLG-PDI--SQGPRQFKQEVEILGSMRH 448
D + +G G +G V+ + + A+KV+ P++ + + E +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
++ L + L + EY+ G L L NS S A+EI AL +L
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H + +V+RDLKP NILLD+ K++D G A+ + T GT Y+
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---------WTLCGTPEYL 165
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE Q+ D ++LG+++ +++ P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 31/233 (13%)
Query: 400 RKIGEGGYGPVYKAQLDH----TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVIL 454
+IG G +G V + V +K L + F QEV+ + H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 455 LGACPEYG--CLVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LG C E LV E+ G L++ R + + + ++A E+A+ LL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC--YIDP 568
+H DL N L + KI D GLA P Y++T ++ P
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE------DYYITKDCHAVPLRWLAP 171
Query: 569 EY---QQTGMLGVK----SDLYSLGVVLLQLITA--RPAMGLSHQ--VEQAIR 610
E + +L S+++SLGV + +L TA +P LS + ++Q +R
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 61/206 (29%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRHTN 450
F R +G+GG+G V Q+ T A K L +G E IL + ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSR 60
Query: 451 MVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
V+ L E CLV M G L+ ++ N P AAE+ L L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQ 119
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ E +V+RDLKP NILLD +ISD+GLA +P +T+ GT Y+
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETV-----RGRVGTVGYMA 169
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLI 593
PE D + LG ++ ++I
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 46/225 (20%)
Query: 401 KIGEGGYGPVYKAQL----DHTSVAIK-VLGPDISQGPRQFKQEVEILGSMRHTNMV--- 452
K+G G YG VYKA+ D A+K + G IS +E+ +L ++H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELKHPNVIALQ 64
Query: 453 -ILLGACPEYGCLVYEYMENGSLEDRLFQ---KDNSPPIHW--SIRFKIAAEIATALLFL 506
+ L L+++Y E+ F K N P+ S+ + +I + +L
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 507 HQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLV-----PPSAADTITQYHMT 557
H N ++HRDLKPANIL+ + KI+D+G ARL P + D +
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV---- 177
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
TF Y PE +LG + D++++G + +L+T+ P
Sbjct: 178 ----TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 66/234 (28%), Positives = 99/234 (42%), Gaps = 37/234 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGP-DISQGP--RQFKQEVEILGSMRH 448
D+ I IG G +G V+ + T A+KVL D+ + + E +IL
Sbjct: 2 DFEVIKV-IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 449 TNMVILLGACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
+V L + E+ LV EYM G L + L +KD P RF IA E+ AL +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ET-ARFYIA-ELVLALDSV 117
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA--------------RLVPPSAADTIT 552
H+ +HRD+KP NIL+D + K++D GL D +
Sbjct: 118 HKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 553 QYHMT---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ GT YI PE + G++ D +SLGV+L +++ P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 69/237 (29%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
IG+G +G VY+ + T A+KVL S+ K+EV R+ + LL P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL----SKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 460 --------------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
Y LV +YM G L L QK+ +F IA E+ AL
Sbjct: 57 FIVGLKFSFQTDSDLY--LVTDYMSGGELFWHL-QKEGRFS-EDRAKFYIA-ELVLALEH 111
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH+ +V+RDLKP NILLD + D GL++ + T T GT Y
Sbjct: 112 LHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTN----TFCGTTEY 162
Query: 566 IDPE--YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
+ PE + G D +SLGV++ ++ + +Q RN F ++ P
Sbjct: 163 LAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFGKVRFP 217
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 46/225 (20%)
Query: 401 KIGEGGYGPVYKAQL----DHTSVAIK-VLGPDISQGPRQFKQEVEILGSMRHTNMV--- 452
K+G G YG VYKA+ D A+K + G IS +E+ +L ++H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 64
Query: 453 -ILLGACPEYGCLVYEYMENGSLEDRLFQ---KDNSPPIHW--SIRFKIAAEIATALLFL 506
+ L L+++Y E+ F K N P+ + + +I + +L
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 507 HQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLV-----PPSAADTITQYHMT 557
H N ++HRDLKPANIL+ + KI+D+G ARL P + D +
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV---- 177
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
TF Y PE +LG + D++++G + +L+T+ P
Sbjct: 178 ----TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 64/232 (27%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
F+ +G+G +G V A+ T AIK+L D+ Q+ ++ +M ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV------IIQDDDVECTMVEKRVLA 55
Query: 454 LLGACP----EYGCL--------VYEYMENGSLEDRLFQKDNSPPIHWSIRFK------I 495
L G P + C V EY+ G L ++ I +FK
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYH------IQQVGKFKEPHAVFY 106
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR--LVPPSAADTITQ 553
AAEIA L FLH + +++RDLK N++LD KI+D G+ + +
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK------- 156
Query: 554 YHMTTAAGTFC----YIDPE---YQQTGMLGVKS-DLYSLGVVLLQLITARP 597
TT TFC YI PE YQ G KS D ++ GV+L +++ +P
Sbjct: 157 ---TTR--TFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVL---------GPDISQGPRQFKQEVEILG 444
F R +G+GG+G V Q+ T A K L G ++ +Q ++V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--- 58
Query: 445 SMRHTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+ V+ L E CLV M G L+ ++ N F AAEI
Sbjct: 59 ----SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-YAAEITC 113
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L LH+ E +V+RDLKP NILLD +ISD+GLA +P +TI G
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETI-----RGRVG 163
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLI 593
T Y+ PE + D + LG ++ ++I
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 49/220 (22%)
Query: 402 IGEGGYGPVYKAQLDHTSV--AIK-VLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC 458
IG G +G V K + A+K + + ++ +++++ MR ++ C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSD-------C 62
Query: 459 PE----YGCLVYE-----YME--NGSLEDRLF------QKDNSPPIHWSIRFKIAAEIAT 501
P YG L E ME + SL D+ + K P I KIA
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISL-DKFYKYVYEVLKSVIPE---EILGKIAVATVK 118
Query: 502 ALLFLHQNKPE-PLVHRDLKPANILLDQNYVSKISDVGLA-RLVPPSAADTITQYHMTTA 559
AL +L K E ++HRD+KP+NILLD+N K+ D G++ +LV D+I + T
Sbjct: 119 ALNYL---KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAK---TRD 167
Query: 560 AGTFCYIDPEYQQTGMLG---VKSDLYSLGVVLLQLITAR 596
AG Y+ PE V+SD++SLG+ L ++ T +
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 54/174 (31%), Positives = 74/174 (42%), Gaps = 28/174 (16%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
LV EY G L L + +F +A E+ A+ +HQ VHRD+KP N
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG---YVHRDIKPEN 132
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHM--TTAAGTFCYIDPEYQQT------GM 575
+L+D+ K++D G SAA + GT YI PE T G
Sbjct: 133 VLIDRTGHIKLADFG-------SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 576 LGVKSDLYSLGVVLLQLITARP--AMGLSHQVEQAIRNGTFSELL----DPTVT 623
GV+ D +SLGV+ ++I R G S + I N F L DP V+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN--FQRFLKFPEDPKVS 237
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ-FKQEVEILGSM-RHTNM 451
F + +G G YG VYK + T AIKV+ D+++ + K E+ +L H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNI 75
Query: 452 VILLGACPEYG--------CLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATA 502
GA + LV E+ GS+ D + K N+ W I + I EI
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-IAY-ICREILRG 133
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
L LH +K ++HRD+K N+LL +N K+ D G+ SA T T GT
Sbjct: 134 LAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGV------SAQLDRTVGRRNTFIGT 184
Query: 563 FCYIDPEY-----QQTGMLGVKSDLYSLGVVLLQLITARPAM 599
++ PE +SD++SLG+ +++ P +
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 400 RKIGEGGYGPVYKA------QLDHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMV 452
+ +G G +G VYK + VAIKVL + S + ++ E ++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 453 ILLGAC-----------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
LLG C YGCL+ EN +DR+ +D ++W + +IA
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVREN---KDRIGSQD---LLNWCV------QIAK 120
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
+ +L + + LVHRDL N+L+ KI+D GLARL+ T+YH
Sbjct: 121 GMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKV 173
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL 601
++ E +SD++S GV + +L+T A+P G+
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA 457
+ +G+G +G V+ A+L T+ AIK L D+ +VE +M ++ L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL----MDDDVEC--TMVEKRVLSLAWE 54
Query: 458 CP------------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
P E V EY+ G L +F + AAEI L F
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH + +V+RDLK NILLD + KI+D G+ + + + T GT Y
Sbjct: 112 LHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDY 162
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQ-LITARPAMGL-SHQVEQAIR 610
I PE D +S GV+L + LI P G ++ Q+IR
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 400 RKIGEGGYGPVYKAQ----LDHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVIL 454
++IG G +G V + V +K L S Q +F +E + S++H+N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 455 LGACPEYG--CLVYEYMENGSLEDRL---FQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
LG C E LV E+ G L+ L + + P +++ ++A EIA LL LH+N
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLLHLHKN 119
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
+H DL N LL + KI D GL+
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
D F I + IG G +G V ++ HT A+K+L + + E R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK------WEMLKRAET-ACFREERN 53
Query: 452 VILLGAC------------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
V++ G C Y LV +Y G L L + ++ P + RF IA E+
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIA-EM 111
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
A+ +HQ VHRD+KP N+LLD N +++D G + D Q + A
Sbjct: 112 VLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM---NQDGTVQ--SSVA 163
Query: 560 AGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLI 593
GT YI PE Q G G + D +SLGV + +++
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 396 FSISRKIGEGGYGPVYKA------QLDHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRH 448
F + +G G +G VYK + VAIK L S + ++ E ++ S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 449 TNMVILLGACPEYGC-LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
++ LLG C L+ + M G L D + + ++ + + + + +IA + +L
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYLE 126
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ + LVHRDL N+L+ KI+D GLA+L+ AD +YH ++
Sbjct: 127 ERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADE-KEYHAEGGKVPIKWMA 179
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT 594
E + +SD++S GV + +L+T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 402 IGEGGYGPVY--KAQLDHTSVAIKVLGPDISQGPRQFKQEVE----ILGSMRHTNMVILL 455
IG+G +G V K + D A+KVL ++ K + +L +++H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 456 GA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
+ + V +Y+ G L L Q++ S P + RF AAEIA+AL +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEPRA-RF-YAAEIASALGYLHSLN--- 116
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPE 569
+++RDLKP NILLD ++D GL + + I T+ TFC Y+ PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTS---TFCGTPEYLAPE 166
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ D + LG VL +++ P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 380 RYRKYTIEEIE----AATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGP--DISQ 431
RY+ TI +I A DY + + IG G +G V + T A+K+L I +
Sbjct: 27 RYKD-TINKIRDLRMKAEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 432 GPRQF-KQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIH 488
F +E +I+ +V L A + Y +V EYM G L + + D P
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEK 142
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
W+ RF AE+ AL +H +HRD+KP N+LLD++ K++D G +
Sbjct: 143 WA-RF-YTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196
Query: 549 DTITQYHMTTAAGTFCYIDPEYQQT----GMLGVKSDLYSLGVVLLQLITA 595
TA GT YI PE ++ G G + D +S+GV L +++
Sbjct: 197 ----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 400 RKIGEGGYGPVYKAQLDH---TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
R +G G G V+ A +D VA+K + Q + +E++I+ + H N+V +
Sbjct: 11 RPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 457 ACPEYG----------------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
G +V EYME + ++ H + ++
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLA--NVLEQGPLSEEHARL---FMYQLL 124
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPSAADTITQYHMTTA 559
L ++H ++HRDLKPAN+ ++ + V KI D GLAR+V P + +++
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP---HYSHKGYLSEG 178
Query: 560 AGTFCYIDPE-------YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607
T Y P Y + D+++ G + +++T +P +H++EQ
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
F+ +G+G +G V A+ T AIK+L D+ Q+ ++ +M ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV------VIQDDDVECTMVEKRVLA 55
Query: 454 LLGACP----EYGCL--------VYEYMENGSLEDRLFQKDNSPPIHWSIRFK------I 495
L G P + C V EY+ G L ++Q I RFK
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQ------IQQVGRFKEPHAVFY 106
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
AAEIA L FLH + +++RDLK N++LD KI+D G+ + + D +T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVT--- 157
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T GT YI PE G D ++ GV+L +++ +
Sbjct: 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQL---DHTSVAIKVLGPDISQGPRQFKQ------EVEILGSM 446
F+ R +G G +G V A D VAIK + S+ +Q KQ E +IL +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF--EKSKIIKQ-KQVDHVFSERKILNYI 88
Query: 447 RHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
H V L G+ + Y LV E++ G L + P + AA+I
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQIVLIFE 145
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+L +V+RDLKP N+LLD++ K++D G A++V DT T T GT
Sbjct: 146 YLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTY----TLCGTPE 193
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
YI PE G +D ++LG+ + +++ P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 401 KIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA- 457
KIGEG G V A+ H+ VA+K++ Q EV I+ +H N+V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
E ++ E+++ G+L D + Q + N I + + AL +LH + ++
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGVI 139
Query: 516 HRDLKPANILLDQNYVSKISDVG----LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQ 571
HRD+K +ILL + K+SD G +++ VP + T Y M PE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA----------PEVI 189
Query: 572 QTGMLGVKSDLYSLGVVLLQLITARP 597
G + D++SLG+++++++ P
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 402 IGEGGYGPVY--KAQLDHTSVAIKVLGPD-ISQGPRQFKQEVE---ILGSMRHTNMVILL 455
IG+G +G V K + D + A+KVL I + Q E +L +++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 456 GA--CPEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ E V +Y+ G L +R F + + RF AAE+A+A+ +LH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-------RF-YAAEVASAIGYLHS 114
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARL-VPPSAADTITQYHMTTAAGTFCYID 567
+++RDLKP NILLD ++D GL + V P +T GT Y+
Sbjct: 115 LN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-------TSTFCGTPEYLA 164
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE + D + LG VL +++ P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLGA- 457
KIGEG G V A HT + V D+ + R+ EV I+ H N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
+ +V E++E G+L D + + N I + + AL +LH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGVI 140
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRD+K +ILL + K+SD G V + GT ++ PE
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLP 194
Query: 576 LGVKSDLYSLGVVLLQLITARP 597
G + D++SLG++++++I P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 42/137 (30%), Positives = 71/137 (51%), Gaps = 16/137 (11%)
Query: 418 TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLE 475
SV +KVLG D + F + ++ + H ++V L G C E +V EY++ G L+
Sbjct: 31 VSVVLKVLGSD-HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLD 88
Query: 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL-----DQNY 530
L ++ N+ +HW + +A ++A+AL +L K LVH ++ NIL+ ++ Y
Sbjct: 89 VFLHREKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGY 143
Query: 531 V--SKISDVGLARLVPP 545
V K+SD G+ V
Sbjct: 144 VPFIKLSDPGIPITVLS 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 16/150 (10%)
Query: 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM----VILL 455
+ + G VY +K+ + ++EV IL + + V+
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
G + L+ E++E +L++ + IA ++A L LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLDEV---SEEEKE-------DIAEQLAELLAKLHQLPLLVLC 111
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPP 545
H DL P NIL+D + I D A PP
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 48/172 (27%), Positives = 71/172 (41%), Gaps = 40/172 (23%)
Query: 459 PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
Y L+ EY+ G + L +KD RF IA E A+ +H+ +HRD
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFT--EEETRFYIA-ETILAIDSIHKLG---YIHRD 126
Query: 519 LKPANILLDQNYVSKISDVGL------------ARLVP---PSAADTITQYHMT------ 557
+KP N+LLD K+SD GL R++ PS M+
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 558 -----------TAAGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ GT YI PE + QTG + D +SLGV++ +++ P
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 23/180 (12%)
Query: 464 LVYEYMENGSLEDRLFQ--KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKP 521
L+ EY G L ++ Q K++ P + + + +I AL +H K ++HRDLK
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKS 197
Query: 522 ANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSD 581
ANI L + K+ D G ++ +D+++ ++ GT Y+ PE + K+D
Sbjct: 198 ANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 582 LYSLGVVLLQLITA-RPAMGLSH-QVEQAIRNG-----------TFSELLDPTVTGWPVE 628
++SLGV+L +L+T RP G S ++ Q + G LLDP ++ P
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPAL 313
|
Length = 478 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 31/274 (11%)
Query: 401 KIGEGGYGPV----YKAQLDHTSVAIKVLGPDISQGP--RQFKQEVEILGSMRHTNMVIL 454
++G G +G V YK + +VA+K+L D + + +E ++ + + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 455 LGACP-EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
+G C E LV E E G L ++ QK+ ++ +++ + +L +
Sbjct: 62 IGICEAESWMLVMELAELGPL-NKFLQKNKHVTEKNIT--ELVHQVSMGMKYLEETN--- 115
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
VHRDL N+LL + +KISD GL++ + AD T + PE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKAL---GADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 574 GMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTGWPVEAA 630
KSD++S GV++ + + +P G+ ++V Q I +G E P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC--------PQRCP 224
Query: 631 LSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664
+ L C +RP V L RLR+
Sbjct: 225 PEMYDLMKLCWTYGVDERPGFAVVEL----RLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
F+ +G+G +G V A+ T AIK+L D+ Q+ ++ +M ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV------VIQDDDVECTMVEKRVLA 55
Query: 454 LLGACP----EYGCL--------VYEYMENGSLEDRLFQ--KDNSPPIHWSIRFKIAAEI 499
L P + C V EY+ G L + Q K P + AAEI
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEI 110
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ L FLH+ +++RDLK N++LD KI+D G+ + D +T T
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVT---TRTF 161
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT YI PE G D ++ GV+L +++ +P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 52/221 (23%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDI--SQGPRQFKQEVEILGSMRH 448
F++ R +G+G +G V +AQL VA+K+L DI S +F +E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 449 TNMVILLGACPE--------YGCLVYEYMENGSLE-----DRLFQKDNSPPIHWSIRFKI 495
N++ L+G ++ +M++G L R+ ++ + P+ +RF I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
+IA+ + +L +HRDL N +L++N ++D GL++ + + D Y+
Sbjct: 121 --DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGD----YY 169
Query: 556 MTTAAGTFC--YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A ++ E + SD+++ GV + +++T
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 400 RKIGEGGYGPVY--KAQLDHTSVAIKVLGPDISQG----PRQFKQEVEILGSMRHTNMVI 453
R IG G +G V+ D VA+K + P++ Q R F+ E+++L +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFR-ELKMLCFFKHDNVLS 63
Query: 454 LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI-AAEIATALLFLHQNK 510
L P Y+ ++ L + SP S K+ +I L +LH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRD+KP N+L++ N V KI D GLAR+ P HMT T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-----ESKHMTQEVVTQYYRAPEI 175
Query: 571 QQTGMLGVKS-----DLYSLGVVLLQLITAR 596
++G + D++S+G + +L+ R
Sbjct: 176 ----LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 17/136 (12%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
LV +Y G L L + ++ P + RF +A E+ A+ +HQ VHRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLA-EMVLAIDSVHQLG---YVHRDIKPDN 132
Query: 524 ILLDQNYVSKISDVG-LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLG 577
+LLD+N +++D G RL+ + A GT YI PE Q G G
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQS------NVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 578 VKSDLYSLGVVLLQLI 593
+ D +SLGV + +++
Sbjct: 187 PECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 41/276 (14%)
Query: 397 SISRKIGEGGYGPVYKAQLDHT----SVAIKVLGPDISQGPR--QFKQEVEILGSMRHTN 450
++ + +GEG +G V + QL+ VA+K + I F E + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 451 MVILLGACPEYG--------CLVYEYMENGSLED-RLFQKDNSPPIHWSIRF--KIAAEI 499
++ L+G C + ++ +M++G L L+ + P + + K +I
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
A+ + +L +HRDL N +L++N ++D GL++ + D Q + A
Sbjct: 122 ASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI--YNGDYYRQGRI--A 174
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIRNGTFSEL 617
+I E + KSD++S GV + ++ T P G+ + SE+
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----------SEI 223
Query: 618 LDPTVTG----WPVEAALSIAKLALQCCELRKRDRP 649
D G P + + L C L +DRP
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLG---PDISQGPRQ 435
YR+ + I + + +G G YG V A T VA+K L I R
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 63
Query: 436 FKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS----- 490
++ E+ +L M+H N++ LL L E + L L D + +
Sbjct: 64 YR-ELRLLKHMKHENVIGLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 491 -IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549
++F I +I L ++H ++HRDLKP+N+ ++++ KI D GLAR
Sbjct: 121 HVQFLIY-QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH------- 169
Query: 550 TITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITAR---PAMGLSHQV 605
T MT T Y PE M D++S+G ++ +L+T R P Q+
Sbjct: 170 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227
Query: 606 EQAIR 610
+ +R
Sbjct: 228 KLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 49/216 (22%)
Query: 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDISQ---------------GPRQFKQEVEILGSM 446
+G+G +G V+ + K+ GPD Q + K E +IL +
Sbjct: 4 LGQGSFGKVFLVR--------KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV 55
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRL-----FQKDNSPPIHWSIRFKIAAEI 499
H +V L A G L+ +++ G L RL F +++ ++F +A E+
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-------VKFYLA-EL 107
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
A AL LH +++RDLKP NILLD+ K++D GL++ ++I +
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYS 157
Query: 560 -AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
GT Y+ PE +D +S GV++ +++T
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP 459
+G+G +G V A+L A+K L D+ +VE +M ++ L P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVL----IDDDVEC--TMVEKRVLALAWENP 56
Query: 460 ------------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI------AAEIAT 501
E+ V E++ G L + K RF + AAEI
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVC 107
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L FLH +++RDLK N++LD++ KI+D G+ + + +T G
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNRASTFCG 158
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQ-LITARPAMG 600
T YI PE Q D +S GV+L + LI P G
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 77/243 (31%)
Query: 396 FSISRK------IGEGGYGPVYKAQLDHT--SVAIKVLG---PDISQGPRQFKQEVEILG 444
F + K IG G YG V A+ T VAIK + + R + E+++L
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLR 59
Query: 445 SMRHTNMV----ILLGACPE-----YGCLVYEYME---------NGSLEDR-----LFQK 481
+ H N++ I+ E Y +VYE M+ + +L D L+Q
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVY--IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ- 116
Query: 482 DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+ L ++H ++HRDLKP+N+LL+ N KI D GLAR
Sbjct: 117 -----------------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
Query: 542 LVPPSAADTITQYHMTTAAGTFCYIDPE-------YQQTGMLGVKSDLYSLGVVLLQLIT 594
D +T+Y +T Y PE Y D++S+G + +L+
Sbjct: 157 -TTSEKGDFMTEYVVTR-----WYRAPELLLNCSEY------TTAIDVWSVGCIFAELLG 204
Query: 595 ARP 597
+P
Sbjct: 205 RKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 41/225 (18%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLG---PDISQGPRQFKQEVEILG 444
E + Y S+ K + +YK ++ V I+ + E++ L
Sbjct: 16 ESDDIDKYTSVLIKENDQNS--IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLR 73
Query: 445 SMRHTNMVILLGACPE------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
+ N++ + G + L+ EY G L + L D + + + +A +
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAID 130
Query: 499 IATALLFLHQ--NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
L L++ NKP +++L + L+ +NY KI GL +++ +
Sbjct: 131 CCKGLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN---- 182
Query: 557 TTAAGTFCYIDPEYQQTGMLG-------VKSDLYSLGVVLLQLIT 594
Y + ML +K D+YSLGVVL ++ T
Sbjct: 183 -----FMVYFSYK-----MLNDIFSEYTIKDDIYSLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 396 FSISRKIGEGGYGPVY--KAQLDHTSVAIKVLGPDISQGPRQFKQ---EVEILGSMRHTN 450
F + I G YG VY + + A+K + Q +Q E +IL +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL-TFAENP 61
Query: 451 MVILLGACPE---YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
V+ + E + C+V EY+E G L N + + AE AL +LH
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVDMARMYFAETVLALEYLH 118
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA------- 560
+VHRDLKP N+L+ K++D GL+++ S + + H+
Sbjct: 119 NYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 561 --GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLI 593
GT YI PE G D +++G++L + +
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 31/186 (16%)
Query: 420 VAIKVLGP---DISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEYMENGSL 474
V +KVL P DIS F + ++ + H ++V+L G C +V E++E G L
Sbjct: 35 VILKVLDPSHRDISLA---FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS-- 532
+ LF S + +FK+A ++A+AL +L LVH ++ NILL + +
Sbjct: 92 D--LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGE 146
Query: 533 -----KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQQTGMLGVKSDLYSLG 586
K+SD G+ IT +I PE + + L + +D +S G
Sbjct: 147 CGPFIKLSDPGIP----------ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFG 196
Query: 587 VVLLQL 592
L ++
Sbjct: 197 TTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 81/324 (25%), Positives = 132/324 (40%), Gaps = 86/324 (26%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH---TSVAIKVL-GPDISQ--GPR 434
YR+ + I D + +++G G YG V A LD VAIK L P S+ R
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 435 QFKQEVEILGSMRHTNMVILLGA----------------CPEYGCLVYEYMENGSL-EDR 477
++ E+ +L M+H N++ LL P G + + M++ L EDR
Sbjct: 61 AYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR 119
Query: 478 LFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537
I+F + ++ L ++H ++HRDLKP N+ ++++ KI D
Sbjct: 120 -------------IQF-LVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162
Query: 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPE-------YQQTGMLGVKSDLYSLGVVLL 590
GLAR T MT T Y PE Y QT D++S+G ++
Sbjct: 163 GLARQ---------TDSEMTGYVVTRWYRAPEVILNWMHYTQT------VDIWSVGCIMA 207
Query: 591 QLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV----------EAALSIAKLALQC 640
+++T +P ++Q E++ VTG P +A + KL
Sbjct: 208 EMLTGKPLFKGHDHLDQ------LMEIM--KVTGTPSKEFVQKLQSEDAKNYVKKLP--- 256
Query: 641 CELRKRDRPDLVSVVLPELIRLRD 664
RK+D L+ P + + +
Sbjct: 257 -RFRKKDFRSLLPNANPLAVNVLE 279
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGP-DISQGPRQ--FKQEVEILGSMRHTN 450
F I + IG G +G V +L + A+K+L ++ + F++E ++L + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 451 MVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ L A + LV +Y G L L + ++ P + RF +A E+ A+ +HQ
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLA-EMVIAIDSVHQ 120
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVG-LARLVPPSAADTITQYHMTTAAGTFCYID 567
VHRD+KP NIL+D N +++D G +L+ + + A GT YI
Sbjct: 121 LH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS------SVAVGTPDYIS 171
Query: 568 PEYQQT-----GMLGVKSDLYSLGVVLLQLI 593
PE Q G G + D +SLGV + +++
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 47/177 (26%), Positives = 70/177 (39%), Gaps = 49/177 (27%)
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++A + FL K +HRDL NILL +N V KI D GLAR +
Sbjct: 181 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-------------- 223
Query: 558 TAAGTFCYIDPEYQQTG-----------------MLGVKSDLYSLGVVLLQLIT--ARPA 598
Y DP+Y + G + +SD++S GV+L ++ + A P
Sbjct: 224 -------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
Query: 599 MGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
G+ Q+++ L + T P A I + L C DRP +V
Sbjct: 277 PGV--QIDEEFCR----RLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 404 EGGYGPVYKAQLDHTS------VAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMVILLG 456
EG +G ++ L V +K + S+ QE +L + H N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 457 ACPEYG---CLVYEYMENGSLEDRLFQ-KDNSPPIHWSIR----FKIAAEIATALLFLHQ 508
C E G ++Y YM G+L+ L Q + ++ +A +IA + +LH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++H+D+ N ++D+ KI+D L+R + P YH C D
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPM------DYH--------CLGDN 178
Query: 569 EYQQTGMLGVK----------SDLYSLGVVLLQLIT 594
E + + ++ SD++S GV+L +L+T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 402 IGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQEVE----ILGSMRHTNMVILL 455
IG+G +G V A + + A+KVL ++ K + +L +++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 456 GACPEYGCL--VYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ L V +Y+ G L +R F + + RF AAEIA+AL +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RF-YAAEIASALGYLHS 114
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARL-VPPSAADTITQYHMTTAAGTFCYID 567
+V+RDLKP NILLD ++D GL + + + +T GT Y+
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-------TSTFCGTPEYLA 164
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE D + LG VL +++ P
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 402 IGEGGYGPVYKA---------QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+G+G + ++K +L T V +KVL F + ++ + H ++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 453 ILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
+ G C + +V EY++ GSL+ L + N I W + ++A ++A AL FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
L H ++ N+LL + K + +L P + T+
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVILLGA- 457
KIGEG G V A + + + V D+ + R+ EV I+ +H N+V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
+ +V E++E G+L D + + N I + + AL LH + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM 575
HRD+K +ILL + K+SD G V + GT ++ PE
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKSLVGTPYWMAPELISRLP 192
Query: 576 LGVKSDLYSLGVVLLQLITARP 597
G + D++SLG+++++++ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 52/241 (21%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV- 452
+ + IG G +G VY+A TS VAIK + Q P+ +E+ I+ ++ H N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIF 123
Query: 453 ----------------ILLGACPEY-GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI 495
I L E+ V++YM++ + + +++ P+ +
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA------RNNHALPLFLVKLY-- 175
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQY 554
+ ++ AL ++H + + HRDLKP N+L+D N + K+ D G SA + +
Sbjct: 176 SYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG-------SAKNLLAGQ 225
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAI 609
+ + Y PE MLG + DL+SLG ++ ++I P V+Q +
Sbjct: 226 RSVSYICSRFYRAPEL----MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
Query: 610 R 610
R
Sbjct: 282 R 282
|
Length = 440 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 23/73 (31%), Positives = 28/73 (38%), Gaps = 13/73 (17%)
Query: 459 PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV--H 516
PE G L+ E++E L F KIA + LH + LV H
Sbjct: 63 PETGVLITEFIEGSELLTEDFSDPE-------NLEKIAKLLKK----LHSSPLPDLVPCH 111
Query: 517 RDLKPANILLDQN 529
DL P N LLD
Sbjct: 112 NDLLPGNFLLDDG 124
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 48/177 (27%), Positives = 72/177 (40%), Gaps = 49/177 (27%)
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++A + FL K +HRDL NILL +N V KI D GLAR +
Sbjct: 182 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-------------- 224
Query: 558 TAAGTFCYIDPEYQQTG-----------------MLGVKSDLYSLGVVLLQLIT--ARPA 598
Y DP+Y + G + +SD++S GV+L ++ + A P
Sbjct: 225 -------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 599 MGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
G+ E R L D T P A I ++ L C + ++RP ++V
Sbjct: 278 PGVQINEEFCQR------LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 30/135 (22%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 26 VAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLF 85
VA+D + S+ A++WA++ ++ +LLHV + + A +E ++
Sbjct: 7 VAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEEEAEA 66
Query: 86 ARKRILAR------EVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPS 139
A EVV++ D + A++ + IV G R+ L R +
Sbjct: 67 EALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSGLRRLLLG-SVAE 125
Query: 140 SLLKSAPESCAVYII 154
+L+ AP C V ++
Sbjct: 126 KVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 18/135 (13%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
L+ +Y+ G + L+Q+DN +RF + EI AL LH+ +V+RD+K N
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSED--EVRF-YSGEIILALEHLHKLG---IVYRDIKLEN 135
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA--GTFCYIDPEY--QQTGMLGVK 579
ILLD ++D GL++ + +++ T + GT Y+ PE + G G
Sbjct: 136 ILLDSEGHVVLTDFGLSK-------EFLSEEKERTYSFCGTIEYMAPEIIRGKGGH-GKA 187
Query: 580 SDLYSLGVVLLQLIT 594
D +SLG+++ +L+T
Sbjct: 188 VDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 402 IGEGGYGPVYKAQLDHT--SVAIKVLG-PDISQ--GPRQFKQEVEILGSMRHTNMVILLG 456
+G G YG V A T VAIK L P S+ R ++ E+ +L M+H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 457 ---ACPEYG-----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ LV YM+ QK P+ + ++ L ++H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++HRDLKP N+ ++++ KI D GLAR AD MT T Y P
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADA----EMTGYVVTRWYRAP 183
Query: 569 E-------YQQTGMLGVKSDLYSLGVVLLQLITAR 596
E Y QT D++S+G ++ +++T +
Sbjct: 184 EVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 34/135 (25%), Positives = 55/135 (40%), Gaps = 21/135 (15%)
Query: 459 PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
P Y +Y Y+ S P+ I +I L +LH + ++HRD
Sbjct: 137 PHYSSDLYTYLTK-----------RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRD 182
Query: 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGV 578
+K NI ++ I D+G A+ P A + AGT PE
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQF-PVVAPAFL------GLAGTVETNAPEVLARDKYNS 235
Query: 579 KSDLYSLGVVLLQLI 593
K+D++S G+VL +++
Sbjct: 236 KADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 10/106 (9%)
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
RF A E+ AL LH+ +++RDLKP NILLD + D GL +L + D
Sbjct: 96 RFYTA-ELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDD 148
Query: 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T GT Y+ PE D ++LGV+L +++T P
Sbjct: 149 K---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 12/152 (7%)
Query: 246 DFSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQ-RK 304
DF + + D + G E K+ + ++EA ++ A K ++ RK
Sbjct: 1080 DFDAKEDNRADEATEEAFGKAEEAKKTETGKAEE----ARKAEEAKKKAEDARKAEEARK 1135
Query: 305 KEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKA--MQ 362
E+A K EEAR AE+A + + + R A E A A+ + EA ++ KA ++
Sbjct: 1136 AEDARKAEEARKAEDAKRVEIARKAEDARKA-EEARKAEDAKKAEAARKAEEVRKAEELR 1194
Query: 363 EEEEKKIVMEAMAYKNVRYRKYTIEEIEAATD 394
+ E+ + A + R EE A D
Sbjct: 1195 KAEDARKAEAARKAEEER----KAEEARKAED 1222
|
Length = 2084 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 69/262 (26%), Positives = 96/262 (36%), Gaps = 84/262 (32%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQ-----EVEILGSMRH 448
D F + +K+GEG +G VYKA L + +G K+ VEI + R
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNK--------QSKKEGKYVLKKATEYGAVEIWMNER- 182
Query: 449 TNMVILLGACPEYGC--------------------LVYEYMENGSLEDRLFQKD---NSP 485
+ ACP C LV+ Y +L D + K+ N
Sbjct: 183 -----VRRACPNS-CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236
Query: 486 PIHW--------------SIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531
P I I +I AL LH +VHRD+KP NI+ +
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSG 293
Query: 532 S-KISDVGLAR--------------LVPPSAADTITQYHMTT------AAGTFCYIDPEY 570
S KI D+G A L P AA QY M+T +A + P
Sbjct: 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP--EQYIMSTQTPSAPSAPVATALSPVL 351
Query: 571 QQTGMLGVKSDLYSLGVVLLQL 592
Q L + D+YS G++ LQ+
Sbjct: 352 WQLN-LPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 35/214 (16%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKV--LGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
I + + + K + +T VA+K L + + +QE+ ++H N++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--- 62
Query: 456 GACPEYGC--------LVYEYMENGSLEDRL---FQKDNSPPIHWSIRFKIAAEIATALL 504
P +V M GS ED L F + P + +I F I ++ AL
Sbjct: 63 ---PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPEL--AIAF-ILKDVLNALD 115
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR-LVPPSAADTITQYHMTTAAGTF 563
++H +HR +K ++ILL + +S + + ++ + ++
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 564 CYIDPEYQQTGMLG--VKSDLYSLGVVLLQLITA 595
++ PE Q + G KSD+YS+G ITA
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVG------ITA 200
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 396 FSISRKIGEGGYGPVY--KAQLDHTS---VAIKVLG-PDISQGPR---QFKQEVEILGSM 446
F + + +G G YG V+ + H S A+KVL I Q + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 447 RHTNMVILLGACPEYGC---LVYEYMENGSLEDRLFQKDNSPPIHWSIRFK------IAA 497
R + ++ L + L+ +Y+ G L L Q++ RFK +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSG 112
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
EI AL LH+ +++RD+K NILLD N ++D GL++ D + + +
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAY-- 164
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS--DLYSLGVVLLQLITA 595
+ GT Y+ P+ + G G D +S+GV++ +L+T
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 38/260 (14%)
Query: 400 RKIGEGGYGPV---YKAQLDHTSVAIKVLG---PDISQGPRQFKQEVEILGSMRHTNMVI 453
+ IG G G V Y A LD +VAIK L + + R ++ E+ ++ + H N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDR-NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIS 80
Query: 454 LLGACPEYGCL-----VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
LL L VY ME ++ L Q H + + + ++ + LH
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVME--LMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHS 137
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++HRDLKP+NI++ + KI D GLAR T + MT T Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------TSFMMTPYVVTRYYRAP 187
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITAR---PAMGLSHQVEQAIRN-GT----FSELLDP 620
E D++S+G ++ +++ + P Q + I GT F + L P
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 621 TVTGW----PVEAALSIAKL 636
TV + P A L+ KL
Sbjct: 248 TVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 40/142 (28%), Positives = 56/142 (39%), Gaps = 33/142 (23%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPP---IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520
LV ++ E G L + + N P W AAE+ AL LH+ E +V RDL
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRW------AAEMVVALDALHR---EGIVCRDLN 112
Query: 521 PANILLDQ------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
P NILLD Y S+ S+V + + Y PE
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVE-----DSCDGEAVENM----------YCAPEVGGIS 157
Query: 575 MLGVKSDLYSLGVVLLQLITAR 596
D +SLG +L +L+T +
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 30/170 (17%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD--ISQG-PRQFKQE 439
+IEE F I + I G +G VY + + S A+KV+ I++ Q + E
Sbjct: 2 SIEE-------FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE 54
Query: 440 VEILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRL-----FQKDNSPPIHWSIR 492
+ L + +V L + LV EY+ G ++ L F ++ +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------- 106
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
K +E+A AL +LH++ ++HRDLKP N+L+ K++D GL+++
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 31/186 (16%)
Query: 420 VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC---PEYGCLVYEYMENGSLED 476
V +KVL P F + ++ + H ++ + G C E +V E++E+G L+
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSE-NIMVEEFVEHGPLDV 105
Query: 477 RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS---- 532
L ++ P+ W + +A ++A+AL +L ++K LVH ++ NILL + ++
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYL-EDK--NLVHGNVCAKNILLARLGLAEGTS 160
Query: 533 ---KISD--VGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQQTGMLGVKSDLYSLG 586
K+SD V L + I +I PE L +D +S G
Sbjct: 161 PFIKLSDPGVSFTALSREERVERIP------------WIAPECVPGGNSLSTAADKWSFG 208
Query: 587 VVLLQL 592
LL++
Sbjct: 209 TTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 73/353 (20%), Positives = 127/353 (35%), Gaps = 77/353 (21%)
Query: 283 YNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMA 342
+ K S S R A + R E A + AA
Sbjct: 28 SGNSPKANNSASTGQTT--SRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATT 85
Query: 343 QRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTI---EEIEAATDYFSIS 399
+ +KK V A+ ++ + + E+I+ +T F I
Sbjct: 86 T-----------PTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKIL 134
Query: 400 RKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN------- 450
+GEG +G V +A + A+K++ ++ + R K E++ + +R +
Sbjct: 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIV-RNVPKYTRDAKIEIQFMEKVRQADPADRFPL 193
Query: 451 -------------MVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
M I++ P+YG CL+ M++G R H + +I
Sbjct: 194 MKIQRYFQNETGHMCIVM---PKYGPCLLDWIMKHGPFSHR----------HLA---QII 237
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA--------A 548
+ AL + H L+H DLKP NIL++ + D R +PP
Sbjct: 238 FQTGVALDYFHTEL--HLMHTDLKPENILMETSDTV--VDPVTNRALPPDPCRVRICDLG 293
Query: 549 DTITQYHMTTA-AGTFCYIDPEYQQTGMLGV----KSDLYSLGVVLLQLITAR 596
+ H TA T Y PE +LG+ +D++S+G ++ +L T +
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEV----VLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 43/123 (34%)
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++A + FL K +HRDL NILL +N V KI D GLAR +
Sbjct: 187 QVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-------------- 229
Query: 558 TAAGTFCYIDPEYQQTG-----------------MLGVKSDLYSLGVVLLQLIT--ARPA 598
Y DP+Y + G + ++SD++S GV+L ++ + A P
Sbjct: 230 -------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 599 MGL 601
G+
Sbjct: 283 PGV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 37/164 (22%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
L+ E++ G + L +KD + +F IA E A+ +HQ +HRD+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLS--EEATQFYIA-ETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 524 ILLDQNYVSKISDVGLARLV---------------PPS-----------AADTITQYHMT 557
+LLD K+SD GL + PPS A+T +
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 558 TA---AGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARP 597
A GT YI PE + QTG + D +SLGV++ +++ P
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 25/188 (13%)
Query: 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535
R + SP + + + ++A + FL VHRDL N+L+ + + KI
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKIC 281
Query: 536 DVGLARLVPPSAADTITQYHMTTAAGTFC---YIDPEYQQTGMLGVKSDLYSLGVVLLQL 592
D GLAR D + + + TF ++ PE + SD++S G++L ++
Sbjct: 282 DFGLAR-------DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
Query: 593 I----TARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDR 648
T P + ++ Q AI+ G P A+ I ++ +C E + R
Sbjct: 335 FTLGGTPYPELPMNEQFYNAIKRG--------YRMAKPAHASDEIYEIMQKCWEEKFEIR 386
Query: 649 PDLVSVVL 656
PD +V
Sbjct: 387 PDFSQLVH 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234501 TIGR04211, SH3_and_anchor, SH3 domain protein | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/112 (19%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 265 LEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALAL 324
L+ E+ L+ EL + E + +E Q L+ + +L + A+ L
Sbjct: 71 LQQELAELQEELAELQEQLAELQQENQELKQELSTLEAELERLQKELARIKQLSANAIEL 130
Query: 325 VKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAY 376
E ++ R EL +K+E L+A E ++ Y
Sbjct: 131 -DEENRELRE------------ELAELKQENEALEAENERLQENEQRRWFLY 169
|
Members of this protein family have a signal peptide, a strongly conserved SH3 domain, a variable region, and then a C-terminal hydrophobic transmembrane alpha helix region. Length = 198 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 62/252 (24%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSV--AIKVL-GPDI--SQGPRQFKQEVEILGSMRHTN 450
F + IG G +G V + T+ A+K L D+ K E +IL +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L + + L V +Y+ G + L + RF IA E+ A+ +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL--ARFYIA-ELTCAIESVHK 119
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLA---------------------RLVPPSA 547
+HRD+KP NIL+D++ K++D GL + P
Sbjct: 120 MG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 548 ADTITQYHMTTA----------------AGTFCYIDPE------YQQTGMLGVKSDLYSL 585
I + + GT YI PE Y Q D +S+
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL------CDWWSV 230
Query: 586 GVVLLQLITARP 597
GV+L +++ +P
Sbjct: 231 GVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 26/123 (21%), Positives = 46/123 (37%), Gaps = 6/123 (4%)
Query: 275 ELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKTRA 334
+ ++ + K+ + ++ E L + A++A LA + ER+KT A
Sbjct: 158 ARAERIDALKATLKQLAAVRAEI----AAEQAELTTLLSEQRAQQAKLAQLLEERKKTLA 213
Query: 335 AMEAALMA--QRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAA 392
+ + L A ++L EL A + + A E K A A + R E
Sbjct: 214 QLNSELSADQKKLEELRANESRLKNEIASAEAAAAKAREAAAAAEAAAARARAAEAKRTG 273
Query: 393 TDY 395
Y
Sbjct: 274 ETY 276
|
Length = 420 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 15/87 (17%)
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRDLKP+NI++ + KI D GLAR T + MT T Y PE
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEV--- 188
Query: 574 GMLGV----KSDLYSLGVVLLQLITAR 596
+LG+ D++S+G ++ ++I
Sbjct: 189 -ILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 37/164 (22%)
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
L+ E++ G + L +KD +F IA E A+ +HQ +HRD+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTL--TEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDN 131
Query: 524 ILLDQNYVSKISDVGLA------------RLVPPSAADTITQYHMT-------------- 557
+LLD K+SD GL R + S T +M
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 558 ---TAAGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ GT YI PE + QTG + D +SLGV++ +++ P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 44/235 (18%)
Query: 396 FSISRKIGEGGYGPVY----KAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
++I + G G V+ V +K + G + +E++IL ++ H +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-----TGGKTPGREIDILKTISHRAI 148
Query: 452 VILLGA-------C---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+ L+ A C P+Y C ++ Y+ D S P+ I +
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKCDLFTYV------------DRSGPLPLEQAITIQRRLLE 196
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
AL +LH ++HRD+K NI LD+ + + D G A + DT Y +G
Sbjct: 197 ALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-PDTPQCYGW---SG 249
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM------GLSHQVEQAIR 610
T PE K+D++S G+VL ++ + S Q+ IR
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-04
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 8/110 (7%)
Query: 265 LEAEIKRLRLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLA-EEAALA 323
L AE+ L E E S+ + +T + L+++ +E + +E EE
Sbjct: 808 LRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEELEEL 867
Query: 324 LVKSERQ-----KTRAAMEAALMAQRLVELEAMKREIAEL-KAMQEEEEK 367
+ + E + RA++E AL R ELE + E+ EL E +
Sbjct: 868 IEELESELEALLNERASLEEALALLRS-ELEELSEELRELESKRSELRRE 916
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 15/84 (17%)
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRDLKP+NI++ + KI D GLAR T + MT T Y PE
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TACTNFMMTPYVVTRYYRAPEV--- 193
Query: 574 GMLGVK----SDLYSLGVVLLQLI 593
+LG+ D++S+G ++ +L+
Sbjct: 194 -ILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 24/79 (30%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 301 QQRKKEEALKL--EEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAEL 358
Q+++ EEA K + + AEEAA + + K A + A A + EA K+ AE
Sbjct: 116 QKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEAEA 175
Query: 359 KAMQEEEEKKIVMEAMAYK 377
E KK A K
Sbjct: 176 AKKAAAEAKKKAEAEAAAK 194
|
Length = 387 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 45/137 (32%), Positives = 62/137 (45%), Gaps = 23/137 (16%)
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++HRDLKP+NI++ + KI D GLAR T + MT T Y PE
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------TSFMMTPYVVTRYYRAPEV-IL 198
Query: 574 GMLGVKS--DLYSLGVVLLQLITAR---PAMGLSHQVEQAIRN-GT----FSELLDPTVT 623
GM G K D++S+G ++ ++I P Q + I GT F + L PTV
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 624 GW----PVEAALSIAKL 636
+ P A S KL
Sbjct: 258 TYVENRPKYAGYSFEKL 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 14/105 (13%)
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC---YIDPEYQ 571
VHRDL N+LL Q + KI D GLAR D + + + TF ++ PE
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLAR-------DIMHDSNYVSKGSTFLPVKWMAPESI 311
Query: 572 QTGMLGVKSDLYSLGVVLLQLI----TARPAMGLSHQVEQAIRNG 612
+ SD++S G++L ++ T P M + I++G
Sbjct: 312 FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 58/258 (22%), Positives = 102/258 (39%), Gaps = 51/258 (19%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDISQGPRQFKQEVEILG 444
E+ + + + +KIG G +G V+ + T AI G + Q EV ++
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMR 67
Query: 445 SMRHTNMVI----LLGACPEYGCLVYEYMENGSLED------RLFQKDNSPPIHWSIRFK 494
++H N+V L + ++ E+ + G L ++F K I
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VD 122
Query: 495 IAAEIATALLFLHQNKPEP----LVHRDLKPANILLDQNY-----------------VSK 533
I ++ AL + H K P ++HRDLKP NI L ++K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE--YQQTGMLGVKSDLYSLGVVLLQ 591
I D GL++ + + + GT Y PE +T KSD+++LG ++ +
Sbjct: 183 IGDFGLSKNIG-------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 592 LITARPAMGLSHQVEQAI 609
L + + ++ Q I
Sbjct: 236 LCSGKTPFHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 400 RKIGEGGYGPV---YKAQLDHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVIL 454
+G G YG V Y +L VA+K L R+ +E+ +L M+H N++ L
Sbjct: 21 TPVGSGAYGSVCSAYDTRL-RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 455 LGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS------IRFKIAAEIATALLFLHQ 508
L + E L L D + + ++F I ++ L ++H
Sbjct: 80 LDVFTPATSI--ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY-QLLRGLKYIHS 136
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
++HRDLKP+N+ ++++ +I D GLAR A D +T Y T Y P
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGY-----VATRWYRAP 184
Query: 569 E-------YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610
E Y QT D++S+G ++ +L+ + + ++Q R
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 701 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.8 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.79 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.74 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.67 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.6 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 98.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.06 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.66 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=429.40 Aligned_cols=268 Identities=46% Similarity=0.787 Sum_probs=233.5
Q ss_pred cccccCHHHHHHhhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee
Q 005343 380 RYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC 458 (701)
Q Consensus 380 ~~~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 458 (701)
....|++.++..+|++|...+.||+||||.||+|...+ +.||||.+.........+|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999966 78999988776543145699999999999999999999999
Q ss_pred cCC---CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 459 PEY---GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 459 ~~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
.+. .+||||||++|+|.+.|+..... +++|..|++||.++|.||.|||...+.|||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 542 58999999999999999876554 89999999999999999999999888899999999999999999999999
Q ss_pred eeccccccCC-CCCccccccccccc-ccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc---------hH
Q 005343 536 DVGLARLVPP-SAADTITQYHMTTA-AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS---------HQ 604 (701)
Q Consensus 536 DFGla~~~~~-~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~---------~~ 604 (701)
|||+|+..+. .. ..... .||++|+||||..++.++.++|||||||+|+||+||++|.+.. .+
T Consensus 220 DFGLa~~~~~~~~-------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT-------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCcccc-------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976643 11 11222 8999999999999999999999999999999999999887632 23
Q ss_pred HHHHHHcCccccccCccCC--CCCH-HHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 605 VEQAIRNGTFSELLDPTVT--GWPV-EAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 605 ~~~~i~~~~~~~~ld~~~~--~~p~-~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
....+.++.+.+++|+.+. .++. .....+..++.+|++.+|++||+|.+|+
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 4567788899999999985 4443 4666799999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=394.05 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=212.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-------hHHHHHHHHHHHhCCCCcEEEEecee--cC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-------PRQFKQEVEILGSMRHTNMVILLGAC--PE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~g~~--~~ 460 (701)
..+.|.+.+.||+|+||.|-+|... ++.||||++++..... .....+|++||++|+|||||+++++| ++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567999999999999999999885 4569999998765332 12357999999999999999999999 45
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEee
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDV 537 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DF 537 (701)
+.||||||++||+|.+.+..+. .+.+....-++.|++.||.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 5699999999999999996654 3566677889999999999999999 9999999999999766 88999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM---LGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRN 611 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~ 611 (701)
|+|+.... ...+.+.|||+.|.|||++.+.. +..++|+||+|||||-+|+|+|||.... ...+.+..
T Consensus 324 GlAK~~g~-------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGE-------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhcccc-------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99997642 23467899999999999987765 3458899999999999999999997543 25666777
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
|++... | ..| .....+..+||.+||..||++||++.++|.|+|++.-.+
T Consensus 397 G~y~f~--p--~~w-~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 397 GRYAFG--P--LQW-DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred Cccccc--C--hhh-hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 776422 1 112 345667899999999999999999999999999996443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=389.21 Aligned_cols=248 Identities=29% Similarity=0.398 Sum_probs=207.0
Q ss_pred eeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC---CceEEeecC
Q 005343 397 SISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY---GCLVYEYME 470 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~---~~lV~Ey~~ 470 (701)
+.++.||+|..|+|||++++.+ -+|+|++...... ..+++.+|+++++.++||+||.+||+|... .+|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 3457899999999999999744 5999999665433 356799999999999999999999998443 479999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
+|||++++..- ..+++....+|+.+|++||.|||. .+ ||||||||+|||++..|.+||||||.++.+..+
T Consensus 162 gGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999988443 458999999999999999999995 78 999999999999999999999999999876433
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHcCccccccCccCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS-----HQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~-----~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
...+.+||..|||||.+.+..|+.++||||||+.++||.+|+.||... ..++- +..+.+..-+.
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------l~~Iv~~ppP~ 301 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------LCAIVDEPPPR 301 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------HHHHhcCCCCC
Confidence 346789999999999999999999999999999999999999888654 11111 01122212233
Q ss_pred CCHH-HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 625 WPVE-AALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 625 ~p~~-~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.|.. .+.+|..|+..||+.+|.+||++.+++.|+|.+-..
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 4443 667899999999999999999999999999998533
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=401.06 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=213.3
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.+|...+.||+|||..||.+++ .+..||+|++.+... ...+.+.+||+|.+.|+|||||+++++|.+. .|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999998 455699999977432 2345689999999999999999999999764 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|+|.+|+|..++. ...++++.+.+.++.||+.||.|||+++ |||||||..|+||+.+.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999885 3457999999999999999999999999 999999999999999999999999999988543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 624 (701)
. .+..+.|||+.|+|||++....++..+||||+|||||.||+|+|||.... +.-..|....+ .
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------~ 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------S 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------c
Confidence 2 34578899999999999999999999999999999999999999998653 23333443332 2
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.|.....+..+||..+|+.+|.+||++.+||.|+|++
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 3445556789999999999999999999999999994
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=393.32 Aligned_cols=244 Identities=34% Similarity=0.559 Sum_probs=206.2
Q ss_pred ceeeeeeeecCceeEEEEEECCce-EEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC---CceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHTS-VAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY---GCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~~-vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~---~~lV~Ey~ 469 (701)
+.+.+.||.|+||+||+|.+.++. ||||++....... ...|.+|+.+|.+++|||||.|+|+|.+. .++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999998 9999998765333 34899999999999999999999999664 58999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccccCCCCC
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVPPSAA 548 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~~~~~~ 548 (701)
++|+|..+|... ....+++..+++|+.|||.||.|||+.++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999775 45679999999999999999999999986 99999999999999997 99999999998764321
Q ss_pred cccccccccccccCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--H-HcCccccccCccCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ--TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--I-RNGTFSELLDPTVT 623 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i-~~~~~~~~ld~~~~ 623 (701)
...+...||+.|||||++. ...|+.++|||||||+||||+||+.||........+ + ..+. ..
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~--------Rp 265 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL--------RP 265 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC--------CC
Confidence 2335578999999999999 568999999999999999999999999876642222 2 2222 12
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..|..++..+..++.+||..+|..||++.+|+.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 334446667999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=380.30 Aligned_cols=252 Identities=30% Similarity=0.484 Sum_probs=205.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV 465 (701)
..++|.+.+.||.|+||+||+|++ .++.||||.+.+.. ....+.+..|+.||+.++|||||.|++++. +..|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 356799999999999999999998 45679999887763 233455889999999999999999999984 455899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC------CcEEEEeecc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN------YVSKISDVGL 539 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~------~~~KL~DFGl 539 (701)
||||+||+|.+++..++ .+++.+...++.||+.||++||+++ ||||||||+||||+.+ -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999996654 5889999999999999999999999 9999999999999764 5689999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSEL 617 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ 617 (701)
|+.+.+.. ...+.||++.|||||+++..+|+.|+|+||+|+|||+|++|++||.... +....++.++-
T Consensus 162 AR~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~--- 231 (429)
T KOG0595|consen 162 ARFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE--- 231 (429)
T ss_pred hhhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc---
Confidence 99986432 3467899999999999999999999999999999999999999997443 23333343331
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....+......+.+++...++.+|.+|-++.+-+.|.+..-
T Consensus 232 ---~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ---IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 111222233334668888888888888888887777766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.86 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=209.8
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEec-eecCC---CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLG-ACPEY---GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g-~~~~~---~~lV 465 (701)
.+|.++++||+|.||+||++.. ++..||.|.++....+. ......|+.+|++|+|||||++++ .|.+. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3588999999999999999987 66779999988665443 345889999999999999999998 44332 4799
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPE-PLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
||||.+|+|...+... .....+++..+++++.|++.||..+|+.-+. .|+||||||.||+|+.+|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988653 3445789999999999999999999984332 4899999999999999999999999999998
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
.... ....+.+|||.||+||.+...+|+.++||||+||++|||+.-.+||.+.+ .....|.+|.+..
T Consensus 179 ~s~~------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~----- 247 (375)
T KOG0591|consen 179 SSKT------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP----- 247 (375)
T ss_pred cchh------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC-----
Confidence 5432 22467899999999999999999999999999999999999999998775 4566778886543
Q ss_pred CCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 622 VTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 622 ~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.| .-.+..+..||..|+..||..||+...++.
T Consensus 248 ---~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 248 ---LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred ---CcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 23 456677999999999999999999755543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.95 Aligned_cols=260 Identities=24% Similarity=0.309 Sum_probs=208.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|.++..||+|+||.||+|+-+.|+ +|+|++++...... ..+..|-.||...++|+||+||-.|.+ +.||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5678999999999999999999986665 99999998765443 447889999999999999999999954 5689
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||++||++..+|.+. ..|++.....++.+++.||..||+.| ||||||||+|+|||..|++||+|||||.-+.
T Consensus 219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999554 46888888999999999999999999 9999999999999999999999999995432
Q ss_pred CCCC-------------------cccc------c----------------ccccccccCCCccCcccccCCCCCchhhHH
Q 005343 545 PSAA-------------------DTIT------Q----------------YHMTTAAGTFCYIDPEYQQTGMLGVKSDLY 583 (701)
Q Consensus 545 ~~~~-------------------~~~~------~----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvw 583 (701)
.... .... . ......+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1000 0000 0 001357999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCH--HHHHHHHHHHHHhhccCcCCCCC---hhhhhh
Q 005343 584 SLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPV--EAALSIAKLALQCCELRKRDRPD---LVSVVL 656 (701)
Q Consensus 584 SlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~--~~~~~l~~li~~cl~~~P~~RPt---~~~vl~ 656 (701)
|||||+||||.|+|||...... .+.|.... ..+ .+|. ....+..+||.+||. +|..|-- +.+|-.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l-----~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--ETL-----KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhc-----cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999999999866543 22232221 111 1221 223568999999999 9999986 889999
Q ss_pred HHHHHHHhc
Q 005343 657 PELIRLRDL 665 (701)
Q Consensus 657 ~~~~~l~~~ 665 (701)
|+||+--++
T Consensus 445 HPfF~~v~W 453 (550)
T KOG0605|consen 445 HPFFKGVDW 453 (550)
T ss_pred CCccccCCc
Confidence 988775443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.36 Aligned_cols=253 Identities=27% Similarity=0.326 Sum_probs=209.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|++++.||+|+||+||.++..++. +|+|++++.... ..+....|..||..++||+||.++-.|.+ ..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567999999999999999999986554 999999876532 34568999999999999999999999865 4599
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|+||+.||.|...|.+. ..|++....-++.+|+.||.|||+.+ ||||||||+|||||..|+++|+|||||+..-
T Consensus 103 Vld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999988543 45888888889999999999999999 9999999999999999999999999998532
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
... ....+.|||+.|||||++....|+..+|||||||++||||+|.|||...+. ..+.+..++.
T Consensus 177 ~~~------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------- 242 (357)
T KOG0598|consen 177 KDG------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------- 242 (357)
T ss_pred cCC------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC--------
Confidence 211 123558999999999999999999999999999999999999999987653 3444444441
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCC----ChhhhhhHHHHHHHh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRP----DLVSVVLPELIRLRD 664 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RP----t~~~vl~~~~~~l~~ 664 (701)
...|.-.+....+++...|..+|+.|- ++.+|=.|++++-.+
T Consensus 243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 111222334578999999999999994 688888887776544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=356.87 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=206.1
Q ss_pred cCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
+.|+.+.++|+|+||.||||++++|+ ||||.+.....+ ..+...+||.+|++++|||+|.|+.+|... .+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35788899999999999999997665 999998766432 234579999999999999999999999554 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||+..-|.+ |.+.. ..++.....+++.|++.|+.|+|+++ +|||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dhTvL~e-Le~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHH-HHhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998765554 43333 35788899999999999999999999 9999999999999999999999999999886321
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----------------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---------------- 610 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---------------- 610 (701)
...+..+.|.||+|||.+.+ ..|++.+||||+||++.||+||.|.|.+.+++++...
T Consensus 156 ------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 156 ------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred ------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 12467789999999998877 6799999999999999999999999998888776542
Q ss_pred --cCccccccCccCCC-CC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 611 --NGTFSELLDPTVTG-WP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 611 --~~~~~~~ld~~~~~-~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
++.|..+--|.... .| .....-+.+|+..||..||.+|++-.+++.|+.|
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 11222221121111 01 1223358899999999999999999999999887
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.06 Aligned_cols=255 Identities=31% Similarity=0.400 Sum_probs=208.2
Q ss_pred cCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV 465 (701)
+.|+.+++||+|.||.||+|++..+ .||+|.+..+. ........+||.||++|+||||++|.+...+ ..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577889999999999999998554 49999998876 3345668999999999999999999998743 34899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+|||++ +|.-++.. ..-.|+..++..++.||+.||.|||.++ |+|||||.+|||||++|.+||+|||||+++.+
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 77666632 2346999999999999999999999999 99999999999999999999999999998866
Q ss_pred CCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.... ..+..+-|+||+|||++.+. .|+..+|+||.||||.||++|+|.|.+..++++.-.- |.....|....
T Consensus 271 ~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI--fklcGSP~e~~ 343 (560)
T KOG0600|consen 271 SGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI--FKLCGSPTEDY 343 (560)
T ss_pred CCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH--HHHhCCCChhc
Confidence 5432 25788999999999987664 6999999999999999999999999999888775431 11111111111
Q ss_pred CC------------------------HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WP------------------------VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p------------------------~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
|+ ...+....+|+..+|.+||.+|.|+.++|.++||.
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 21 01123567999999999999999999999999884
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=348.53 Aligned_cols=248 Identities=27% Similarity=0.347 Sum_probs=211.8
Q ss_pred cCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChH---HHHHHHHHHHhCCCCcEEEEeceecCCC--ceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR---QFKQEVEILGSMRHTNMVILLGACPEYG--CLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV~ 466 (701)
++|..++.||.|+||+|.+++.+.+ .+|+|++.+...-..+ ...+|..+|+.+.||+++++++.|.+.. +|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4588899999999999999998544 4999999876544433 3678999999999999999999996654 8999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||.+||.|..+|.+ ...|+......++.||+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999944 346889999999999999999999999 999999999999999999999999999987432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
..+.|||+.|+|||+++...|+..+|+|||||++|||+.|+|||...+.. -+.|-++.+ .
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------~ 259 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------K 259 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------c
Confidence 46789999999999999999999999999999999999999999877652 233334432 4
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCC-----CChhhhhhHHHHHHHhc
Q 005343 625 WPVEAALSIAKLALQCCELRKRDR-----PDLVSVVLPELIRLRDL 665 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~R-----Pt~~~vl~~~~~~l~~~ 665 (701)
+|.-....+.+|+...|+.|-..| +...+|-.|+|++--++
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 566666678999999999999999 45678999999984443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.19 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=211.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-C-hHHHHHHHHHHHhCCCCcEEEEeceecCCC--ceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-G-PRQFKQEVEILGSMRHTNMVILLGACPEYG--CLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV~E 467 (701)
++|...++||+|.||.||+|++. ++.||||.++..... + .....+||..|+.++||||+.|+++|++.. .||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 45777889999999999999984 556999988766432 2 346899999999999999999999997654 68999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||+ .+|+..+. +....++...+..++.+++.||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.+..
T Consensus 82 fm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 69998884 34467999999999999999999999999 9999999999999999999999999999986543
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
. ..+..+-|.||+|||++.+ ..|+..+|+||.|||+.||+-|.|.|.+.+++++.-. .|.-+..|....||
T Consensus 156 ~------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~--If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 156 R------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK--IFRALGTPTPDQWP 227 (318)
T ss_pred c------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH--HHHHcCCCCcccCc
Confidence 2 1234488999999997654 5699999999999999999999999999988877644 22223333333333
Q ss_pred H-----------------------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 V-----------------------EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~-----------------------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
. .+.....+|+..|+..+|.+|+++.+.+.|.+++-
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 1 22345789999999999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.89 Aligned_cols=261 Identities=27% Similarity=0.351 Sum_probs=214.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--Cce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~l 464 (701)
..+|.+++.||+|+|++||+|+.. ++.||||++.+.-. ...+-+.+|-++|.+| .||.|++||-.|.|. .|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 356888999999999999999985 45699999876531 1223478899999999 899999999999664 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|+||+++|+|.++|.+. ..|++.....++.+|+.||+|||++| ||||||||+|||||.++++||+|||.|+.++
T Consensus 152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999654 45888888889999999999999999 9999999999999999999999999999987
Q ss_pred CCCCc-------ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccc
Q 005343 545 PSAAD-------TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617 (701)
Q Consensus 545 ~~~~~-------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ 617 (701)
+.... ........+++||..|.+||++..+..++.+|+|+||||||+|+.|.|||...++....-+ +
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk------I 299 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK------I 299 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH------H
Confidence 65432 1112223679999999999999999999999999999999999999999987765321111 1
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
+ .....||...+....+|+.+.|-.+|.+|++..+|-.|+||.--++.
T Consensus 300 ~-~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 300 Q-ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred H-HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 1 01123444455668999999999999999999999999998865553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.01 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEece--ecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA--CPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~--~~~--~~~lV~E 467 (701)
.+|...+.||+|+||.||++.... ...|||..........+.+.+|+.+|++++|||||+++|. ..+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999999954 6699998876633335678999999999999999999996 344 3689999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~ 546 (701)
|+++|+|.+++.+.+. .|++..+.++..||++||.|||+++ ||||||||+|||++. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999966544 6999999999999999999999999 999999999999999 799999999999876431
Q ss_pred CCcccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPAMGL-SHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~-~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
...........||+.|||||++..+. .+.++|||||||+++||+||++||.. .......+..+.- ...+.
T Consensus 172 ---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----~~~P~ 243 (313)
T KOG0198|consen 172 ---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----DSLPE 243 (313)
T ss_pred ---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-----CCCCC
Confidence 11111234678999999999998644 34599999999999999999999976 3333333333321 12235
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
+|...+....+|+.+|+..+|..|||+.++|.|+|.+....
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 56666677999999999999999999999999999986443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=371.25 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=217.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey 468 (701)
...|....+||+|+.|.||.+... +..||||.+........+-+.+|+.+|+..+|+|||.++..| .+..+.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 345777789999999999999874 455999999888767777799999999999999999999887 4567999999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|+||+|.|.+.. ..+++.++..|+.+++.||.|||.++ |||||||.+|||++.+|.+||+|||+|..+....
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 999999998833 34899999999999999999999999 9999999999999999999999999999875533
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.+..+.+||++|||||+.....|++++||||||++++||+-|.|||=..+.+...+.-. ....|.+ ..+..
T Consensus 424 -----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa---~ng~P~l-k~~~k 494 (550)
T KOG0578|consen 424 -----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPKL-KNPEK 494 (550)
T ss_pred -----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh---hcCCCCc-CCccc
Confidence 25678899999999999999999999999999999999999999996655544433211 1122333 23455
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.+..|.+|+.+||..|+.+||++.++|.|+|+++..
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 667799999999999999999999999999997643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=366.27 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=213.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChH-HHHHHHHHHHhCC-CCcEEEEeceecCCC---ce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPR-QFKQEVEILGSMR-HTNMVILLGACPEYG---CL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~-~~~~Ei~il~~l~-HpnIv~l~g~~~~~~---~l 464 (701)
..++|.++++||.|.||.||+|+.. +..||||.++.......+ .-.+|+..|++|+ |||||+|..++.|.. ++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467999999999999999999974 445999988766533222 2478999999998 999999999985544 79
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||||+ .+|..++..+ ..+|++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+||||||-+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 6898887554 578999999999999999999999999 9999999999999999999999999999774
Q ss_pred CCCCcccccccccccccCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQ-QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~ 623 (701)
.. ...+..+.|.||+|||++ +.+.|+.++|+||+|||++|+.+-+|.|.+.++++++++-=. -+..|...
T Consensus 162 Sk-------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~--VLGtP~~~ 232 (538)
T KOG0661|consen 162 SK-------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE--VLGTPDKD 232 (538)
T ss_pred cC-------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH--HhCCCccc
Confidence 32 234677899999999965 567799999999999999999999999999998887765100 01111111
Q ss_pred CCC-------------------------HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 624 GWP-------------------------VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 624 ~~p-------------------------~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
.|+ .....+..+++.+||++||.+|||+.+.+.|++++.....
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 111 1244568999999999999999999999999999985543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.40 Aligned_cols=242 Identities=30% Similarity=0.472 Sum_probs=204.0
Q ss_pred CceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEeecCC
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEYMEN 471 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey~~~ 471 (701)
.+.+++.||+|-||.||.|.++++ .||+|.++.. ......|.+|+++|++|+|+|||+|+|+|... .+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 356678999999999999999877 7999999775 35667899999999999999999999999653 4999999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.++|.. .....+...+.+.++.|||+|++||++++ +|||||-..||||+++..+||+|||||+.+..+...
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-- 359 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-- 359 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee--
Confidence 999999965 34456888999999999999999999999 999999999999999999999999999965432211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCCCHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.....--...|.|||.+..+.++.+||||||||+||||+| |+.|++... ++-..+..|-- ...|..
T Consensus 360 ---~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR--------lp~P~~ 428 (468)
T KOG0197|consen 360 ---ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR--------LPRPEG 428 (468)
T ss_pred ---ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc--------CCCCCC
Confidence 1122223467999999999999999999999999999999 888877553 45555666531 245667
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSV 654 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~v 654 (701)
|+..+.+++..||..+|++|||+..+
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 77889999999999999999999844
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.20 Aligned_cols=251 Identities=29% Similarity=0.403 Sum_probs=210.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCC----CC-CChHHHHHHHHHHHhCC-CCcEEEEecee--cCC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPD----IS-QGPRQFKQEVEILGSMR-HTNMVILLGAC--PEY 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~----~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~--~~~ 461 (701)
..+.|.+.+.||+|+||.|+.|.+ .+..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++ ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 467899999999999999999988 4567999987664 12 23456788999999999 99999999998 445
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeeccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLA 540 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFGla 540 (701)
.++||||+.||+|.+++.. ..++.+....+++.|++.|+.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 6899999999999999966 345778899999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM-L-GVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSE 616 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~ 616 (701)
.... .......+.+||+.|+|||++.+.. | +.++||||+||+||-|++|+.||...+... ..+..+.+
T Consensus 169 ~~~~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-- 240 (370)
T KOG0583|consen 169 AISP------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-- 240 (370)
T ss_pred cccC------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--
Confidence 8763 1122457889999999999999877 7 589999999999999999999998755322 22333332
Q ss_pred ccCccCCCCCHHH-HHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 617 LLDPTVTGWPVEA-ALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 617 ~ld~~~~~~p~~~-~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+|... ..++..|+.+||..+|..|+++.+|+.|+|++..
T Consensus 241 -------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 241 -------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred -------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 223333 5678999999999999999999999999999973
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=346.93 Aligned_cols=256 Identities=27% Similarity=0.336 Sum_probs=206.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEece----ecCCCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGA----CPEYGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~----~~~~~~l 464 (701)
.+.|..++.|++|.||.||+|++..+ -||+|.++.+.... +-...+||.+|.+++|||||.+-.+ .-+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34588899999999999999999654 49999998775322 2346899999999999999987554 3566799
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||||+. +|..++.... .+|...+...++.|++.||.|||.+. |+||||||+|+|++..|.+||+||||||.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 7887775433 57999999999999999999999999 9999999999999999999999999999885
Q ss_pred CCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~ 623 (701)
... ..++..+.|+||+|||++.+. .|++.+|+||+|||+.||++++|.|.+..+.++.-. .|..+..|...
T Consensus 229 sp~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~--If~llGtPte~ 300 (419)
T KOG0663|consen 229 SPL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK--IFKLLGTPSEA 300 (419)
T ss_pred CCc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH--HHHHhCCCccc
Confidence 432 235778899999999987664 599999999999999999999999998877665433 11112222222
Q ss_pred CCCH-----------------H----------HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPV-----------------E----------AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~-----------------~----------~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.||. . ....-.+|+..+|.+||.+|.|+.+.|.|.|+.=
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 2210 0 1134578999999999999999999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.58 Aligned_cols=249 Identities=29% Similarity=0.394 Sum_probs=212.1
Q ss_pred cCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|.+.+.||+|+||.||||+.+.+. ||||.+.+.... ..+.+.+|++|++.++|||||.+++.|.. +.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999987664 999998776533 34568999999999999999999999954 5589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+.| +|..+|... ..++++.+..|+.+++.||.|||+++ |+|||+||.|||++.+|++|+||||+|+-+...
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9966 999999543 45899999999999999999999999 999999999999999999999999999976432
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCH
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
....+..-||+.|||||+..+..|+..+|+||+|||||||++|+|||-.. .+.+.++. +...-..||.
T Consensus 154 -----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~------I~~d~v~~p~ 221 (808)
T KOG0597|consen 154 -----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKS------ILKDPVKPPS 221 (808)
T ss_pred -----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHH------HhcCCCCCcc
Confidence 22357788999999999999999999999999999999999999999533 22222221 1111235788
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....+.+|+...|..||..|.+..+++.|+|-+=
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 88889999999999999999999999999988774
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.09 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=216.8
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~E 467 (701)
.+.|++...||.|.-+.||+|+. .+..||||++..+.... ...+.+|+..|+.++||||+.++..| .+..++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999998 45669999998876544 47899999999999999999999887 455689999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||.+||+.+.+...-. ..+.+..+..|+.+++.||.|||++| .||||||+.||||+.+|.|||+|||.+..+..+.
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999998865433 34899999999999999999999999 9999999999999999999999999987775544
Q ss_pred CcccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVT 623 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~ 623 (701)
.....++.+.+||++|||||+++. ..|+.|+|||||||+.+||.+|..||.......-.+. ++.....+.....
T Consensus 181 --~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 181 --DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred --ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 223334478899999999998433 4599999999999999999999999987665544333 2222211111110
Q ss_pred -CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 624 -GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 624 -~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+........+.+++..||..||+.||++.+++.|.||+...
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 01122344799999999999999999999999999999743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.59 Aligned_cols=252 Identities=25% Similarity=0.293 Sum_probs=210.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCC---CChHHHHHHHHHHHhC-CCCcEEEEecee--cCCCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS---QGPRQFKQEVEILGSM-RHTNMVILLGAC--PEYGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~--~~~~~ 463 (701)
..++|.+++.||+|+||+|+++.++++. +|||+++++.. ++.+....|-.|+... +||.++.|+..| .++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999996654 99999998863 4456688899998877 499999999998 45679
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+.||++... .....|++.....++++|+.||.|||+++ |||||||.+|||||..|++||+|||||+-.
T Consensus 446 fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999994332 33456899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~ 621 (701)
- ......++.|||+.|||||++....|+..+|||||||+|||||.|.+||.++++-+ ..|... +
T Consensus 519 m------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~-- 584 (694)
T KOG0694|consen 519 M------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------E-- 584 (694)
T ss_pred C------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------C--
Confidence 2 12234578999999999999999999999999999999999999999998776421 222211 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHHHhc
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRLRDL 665 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l~~~ 665 (701)
.-+|...+.+...++.++|..+|+.|.-. .+|..|+||+--++
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 13556667779999999999999999875 67888888876554
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=332.68 Aligned_cols=249 Identities=29% Similarity=0.392 Sum_probs=210.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCCC--ceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEYG--CLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV 465 (701)
.++|++.+.||+|.||.||.|+.+.+. ||+|++-+.. .....++.+|++|.+.|+||||+++||+|.+.. ||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356999999999999999999986554 9999986653 234567999999999999999999999996654 999
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+||..+|+|...|... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999988532 3445788888899999999999999999 9999999999999999999999999987543
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
..+..+.|||+.|++||...+..++..+|+|++|++.||+|.|.|||..... .-+.|..-. .
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~---------~ 239 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD---------L 239 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---------c
Confidence 2245788999999999999999999999999999999999999999975542 222233222 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+|...+....++|.+|+..+|.+|..+.+++.|+|..-
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 234555567899999999999999999999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=352.66 Aligned_cols=247 Identities=24% Similarity=0.312 Sum_probs=205.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|.+.+.||+|+||.||+|... ++.||+|++..... .....+.+|+.+++.++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46899999999999999999985 66799999865422 2234588999999999999999999988543 47999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999988543 35888999999999999999999999 999999999999999999999999999865321
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
....+||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+..+.. .
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------~ 216 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------E 216 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------C
Confidence 12457999999999999989999999999999999999999999765432 222332221 2
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRD 664 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~ 664 (701)
+|......+.+++.+||..+|.+||+ +.+++.|+|+.--+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 33334556899999999999999995 99999999997433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.04 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=202.7
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|+..+.||+|+||.||+|.+ .++.||+|++..... .....+.+|+.++..++||||+.+++.|.+ ..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478899999999999999987 466799998865432 223457889999999999999999998844 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988775432 346899999999999999999999999 9999999999999999999999999998753221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
......||..|+|||++.+..++.++|||||||+||+|++|++||...... ...+.... . .....+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~----~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-K----EDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-h----cccccC
Confidence 123457999999999999999999999999999999999999999754321 11111100 0 001122
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l 662 (701)
+...+..+.+|+.+||+.+|.+||+ +.+++.|+|+.-
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 3334556899999999999999997 899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.72 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=212.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
+-|++++.||+|+.|.|.+|++. |+.+|||++.+.... ....+.+||-||+.+.|||++.||+.+.+ +.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45889999999999999999995 455999999776322 24458999999999999999999999965 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||++||-|.++|..++ +|++....+++.||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-.++
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999997664 5888999999999999999999999 999999999999999888999999999875433
Q ss_pred CCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
. ...+.||.+.|.+||+..+.+| +.++||||.|||||.||||+.||++++- +-.-+..|.|
T Consensus 166 k-------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 K-------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--------- 229 (786)
T ss_pred c-------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------
Confidence 2 3567899999999999999988 6799999999999999999999986542 2233445654
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|.+.+.+.++|+.+|+..||..|.|+.+|+.|+|..=
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 345666677899999999999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.61 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=217.7
Q ss_pred HhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--C-----hHHHHHHHHHHHhCCCCcEEEEecee---
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--G-----PRQFKQEVEILGSMRHTNMVILLGAC--- 458 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~-----~~~~~~Ei~il~~l~HpnIv~l~g~~--- 458 (701)
...++|-++.+||+|||+.||+|.+ .++.||+|+....... . .+...+|..|.+.|+||.||++|++|
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3557899999999999999999987 5677999987654322 1 13367899999999999999999998
Q ss_pred cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEE
Q 005343 459 PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKIS 535 (701)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~ 535 (701)
.+.+|-|+|||+|.+|+-+|.++ ..+++.....|+.||+.||.||.... .||||-||||.||||- ..|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 45679999999999999999554 35788999999999999999999877 5899999999999994 45889999
Q ss_pred eeccccccCCCCCcccccc-cccccccCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 005343 536 DVGLARLVPPSAADTITQY-HMTTAAGTFCYIDPEYQQTG----MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~ 610 (701)
||||++.++....+..... ..+..+||.||++||+|.-+ +.+.++||||+|||||++|.|+.|||.......++.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999999976654433332 24568999999999987655 478899999999999999999999999888777777
Q ss_pred cCccccccCccCCCCCH--HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 NGTFSELLDPTVTGWPV--EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~--~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.++ +......+|. ....+...||.+||+...++|.+..++-.++++.=
T Consensus 696 eNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 7664 3333334442 23445889999999999999999999988877754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=351.94 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=208.2
Q ss_pred cCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
..|...+.||+|.||.||+|.+..+ .||||++..+... ..+.+++|+.+|.+++++||..+||.+- ...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577788999999999999999654 4999999877643 4577999999999999999999999873 445899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|.||++.+.|. ....+.+..+..|+.+++.||.|||..+ .+|||||+.|||+..+|.+||+|||++..+..
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~--- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN--- 163 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec---
Confidence 99999999883 3344577777889999999999999999 99999999999999999999999999987632
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
+..+..+++||+.|||||+++...|+.++||||||++.+||++|.||+...+.+...+. +...-.|.+. ..
T Consensus 164 ---~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---Ipk~~PP~L~---~~ 234 (467)
T KOG0201|consen 164 ---TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---IPKSAPPRLD---GD 234 (467)
T ss_pred ---hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---ccCCCCCccc---cc
Confidence 33344788999999999999988999999999999999999999999976654321111 1111112222 24
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
....|.+|+..||..+|+.||++.++|.|.|.+-
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 5567999999999999999999999999998875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.77 Aligned_cols=235 Identities=26% Similarity=0.431 Sum_probs=199.9
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEeecCCCChh
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEYMENGSLE 475 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey~~~gsL~ 475 (701)
.++.||.|+.|-||+|++.+..||||.++.-. ..+|.-|++|+||||+.|.|+|... +|||||||..|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 35679999999999999999999999775432 4578889999999999999999654 47999999999999
Q ss_pred hHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccc
Q 005343 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555 (701)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~ 555 (701)
++|.. ..+++......+..+||.|+.|||.++ |||||||+-||||..+..+||+|||-++....- ..
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-------ST 267 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-------ST 267 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-------hh
Confidence 99943 346888888999999999999999999 999999999999999999999999998865321 12
Q ss_pred ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC-CCCCHHHHHHHH
Q 005343 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV-TGWPVEAALSIA 634 (701)
Q Consensus 556 ~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~-~~~p~~~~~~l~ 634 (701)
+-.++||..|||||++.+.+.+.|+|||||||+|||||||..||..-+...-+|--|+ ..+ ...|..++.-|.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs------NsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS------NSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC------CcccccCcccCchHHH
Confidence 4578999999999999999999999999999999999999999976554433333332 121 134667777899
Q ss_pred HHHHHhhccCcCCCCChhhhhhHH
Q 005343 635 KLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 635 ~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
-|+.+||+-.|++||++.+|+.|.
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999999883
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.30 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=203.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|++. ++.||+|++..... .....+.+|+.+++.++||||+++++.+.+ ..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56999999999999999999984 55699999865421 234568899999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999988543 35788889999999999999999999 999999999999999999999999999866332
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+..+.+ .
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------~ 233 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------K 233 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence 12357999999999999999999999999999999999999999765432 223333322 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l 662 (701)
+|......+.+|+.+||+.+|.+||+ +.+++.|+|++-
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 22223345889999999999999997 799999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=352.62 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=198.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+|..+ +||||+.++|+|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567999999999999999999752 245999998754322 235689999999999 89999999998854
Q ss_pred -CCceEEeecCCCChhhHhcccCC--------------------------------------------------------
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN-------------------------------------------------------- 483 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 483 (701)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 34799999999999998864321
Q ss_pred ---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccc
Q 005343 484 ---SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560 (701)
Q Consensus 484 ---~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 560 (701)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~ 237 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSAR 237 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc----hhcccCCC
Confidence 135888899999999999999999999 99999999999999999999999999986532211 11123345
Q ss_pred cCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---HHHHHHHcCccccccCccCCCCCHHHHHHHHHH
Q 005343 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH---QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKL 636 (701)
Q Consensus 561 gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~l 636 (701)
++..|+|||++.+..++.++|||||||+||||++ |.+||.... .....+..+... ..|...+..+.++
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l 309 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--------RAPENATPEIYRI 309 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--------CCCCCCCHHHHHH
Confidence 6788999999999999999999999999999997 999997543 223333333211 1122334568999
Q ss_pred HHHhhccCcCCCCChhhhhh
Q 005343 637 ALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 637 i~~cl~~~P~~RPt~~~vl~ 656 (701)
+.+||+.+|.+||++.+++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 310 MLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=343.25 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=202.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--------------CChHHHHHHHHHHHhCCCCcEEEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--------------QGPRQFKQEVEILGSMRHTNMVILL 455 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~ 455 (701)
..++|++...||+|.||.|-+|+. .++-||||++.+... ...+...+||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999998 566799999865421 1124689999999999999999999
Q ss_pred ceec----CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 456 GACP----EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 456 g~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
.+.. +..|||+|||..|.+... ....+.++..+.++|+.++..||.|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 8863 456999999998887542 233334999999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHH-
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM----LGVKSDLYSLGVVLLQLITARPAMGLSHQVE- 606 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~pf~~~~~~~- 606 (701)
+||+|||.+..++.+. ...........+||+.|+|||...++. .+.+.||||+||+||.|+.|+-||-.....+
T Consensus 249 VKIsDFGVs~~~~~~~-~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS-DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EEeeccceeeecccCC-ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998764432 112222345589999999999776633 4678999999999999999999997665432
Q ss_pred --HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 607 --QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 607 --~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.++.+. +.-| ..| +....+.+||.++|..||..|.++.+|.+|+|--
T Consensus 328 ~~KIvn~p----L~fP---~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 328 FDKIVNDP----LEFP---ENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHhcCc----ccCC---Ccc-cccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 222211 1111 111 3455699999999999999999999999999965
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.97 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=205.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|++.+.||+|+||.||++++. +..||+|++...... ....+.+|+++|+.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999985 455999998765322 23568999999999999999999999844 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999988543 3588999999999999999999985 5 999999999999999999999999998765322
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCcccc--------
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSE-------- 616 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~-------- 616 (701)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+.......
T Consensus 158 --------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred --------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence 12345799999999999999999999999999999999999999965432 211111100000
Q ss_pred ------------------------------ccCccCCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 617 ------------------------------LLDPTVTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 617 ------------------------------~ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
+........+ ......+.+|+.+||..+|++||++.+++.|+|++-...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 0000000000 123456899999999999999999999999999986554
Q ss_pred c
Q 005343 666 G 666 (701)
Q Consensus 666 ~ 666 (701)
.
T Consensus 310 ~ 310 (331)
T cd06649 310 E 310 (331)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.66 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=204.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|++. +..||||++..... .....+.+|+.++..++||||+++++++.+ ..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999984 56799999875431 234568899999999999999999998854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999998543 35888999999999999999999999 99999999999999999999999999976532
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~ 624 (701)
.....+||+.|+|||++.+..++.++|||||||++|+|++|++||......+. .+..... .+..+....
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~ 224 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDD 224 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-cccCCCCCc
Confidence 22456799999999999999999999999999999999999999976543222 2221110 011111111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....+..+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 01123456899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.64 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=198.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|... ++.||||++...... ....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999984 567999998765432 23467889999999999999999999844 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6887777543 245788899999999999999999999 9999999999999999999999999987543211
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc-----Ccccc-----
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN-----GTFSE----- 616 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~-----~~~~~----- 616 (701)
.......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........+.. +....
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 11244578999999998765 45899999999999999999999999765432221110 00000
Q ss_pred -----ccCcc-CCC-CCH---------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 -----LLDPT-VTG-WPV---------EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 -----~ld~~-~~~-~p~---------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..++. ... .+. .....+.+|+.+||+.+|++|||+.+++.|+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 00000 000 000 0123578999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.21 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=198.3
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-------CCc
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-------YGC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~~~ 463 (701)
+|.+.+.||+|+||.||+|.+. +..||||.+..... .....+.+|+.+++.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4889999999999999999984 56699999875322 234568899999999999999999998721 248
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+ +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 57898887432 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------------
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA------------- 608 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~------------- 608 (701)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 154 ~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTP---TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccC---ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 32211 1112245679999999998876 67899999999999999999999999755432110
Q ss_pred ----HHcCccccccC----ccCCCC---CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 609 ----IRNGTFSELLD----PTVTGW---PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 609 ----i~~~~~~~~ld----~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+........+. .....+ ....+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000000000 000000 0012345789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.16 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=197.8
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 472 (701)
+.||+|+||.||+|.. .+..||||++..... .....+.+|+.+++.++||||+.+++.|.+ ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999998 456699999875432 223457889999999999999999998854 448999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 148 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------ 148 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------
Confidence 999888543 46889999999999999999999999 999999999999999999999999998753211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
.......+||+.|+|||++.+..++.++|||||||++|||+||++||...+.. ...+..+. ..+|...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~ 219 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLS 219 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCC
Confidence 11224567999999999999999999999999999999999999999655432 12222221 12333445
Q ss_pred HHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
..+.+++.+||..+|++|| ++.+++.|+|+.-
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 5689999999999999999 8999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.44 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=207.3
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCc-EEEEeceecC--------
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTN-MVILLGACPE-------- 460 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~-------- 460 (701)
..|..+++||+|+||+||+|+.. +..||+|.+..+... .+....+|+.+|+.++|+| ||.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44777788999999999999984 556999998877543 4566899999999999999 9999999843
Q ss_pred CCceEEeecCCCChhhHhcccCCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNS-PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++|+||+ .-+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 236899999 46899988654422 35677889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcccccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~l 618 (701)
|+-+.-. ....+..++|.||+|||++.+. .|+..+||||+|||++||+++++.|.+..+.++...- |.-+.
T Consensus 167 Ara~~ip------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I--f~~lG 238 (323)
T KOG0594|consen 167 ARAFSIP------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI--FRLLG 238 (323)
T ss_pred HHHhcCC------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH--HHHcC
Confidence 9965422 1225778999999999988776 6999999999999999999999999988877665541 11111
Q ss_pred CccCCCCCH----------------------HHH---HHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 619 DPTVTGWPV----------------------EAA---LSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 619 d~~~~~~p~----------------------~~~---~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.|....||. ..+ ....+++.+||+.+|..|.++..+|.|+++.-
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 222222211 001 25789999999999999999999999998874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.15 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=200.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|.+.+.||+|+||.||+|++. +..||+|++..... .....+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999985 45699999876532 234568899999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|++++++..+. . ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~-~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLE-E--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHH-h--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987776543 2 2245889999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cc----------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GT---------- 613 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~---------- 613 (701)
. .......||+.|+|||++.+..++.++|||||||++|+|++|++||............ +.
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 N-----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred c-----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 1 1123457899999999999888999999999999999999999999765432221110 00
Q ss_pred ----cccccCccCC-------CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 ----FSELLDPTVT-------GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 ----~~~~ld~~~~-------~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+.....+... .+....+..+.+|+.+||+.+|++||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000000 0011234569999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.80 Aligned_cols=240 Identities=20% Similarity=0.293 Sum_probs=196.4
Q ss_pred eeeeecCceeEEEEEECCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC------CCceEEeecC
Q 005343 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE------YGCLVYEYME 470 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~lV~Ey~~ 470 (701)
..||+|++|.||+|.++++.||||++....... .+.|.+|+.+|.+++||||++++|+|.+ ..++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999998764433 3568899999999999999999999855 3479999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
+|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 99999998543 3588999999999999999999985 6 889999999999999999999999999865321
Q ss_pred ccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
.....||..|+|||++.. ..++.++|||||||++|||+||+.||...... ...+..+... ...
T Consensus 177 ------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------~~~ 243 (283)
T PHA02988 177 ------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS-------LKL 243 (283)
T ss_pred ------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC-------CCC
Confidence 123468899999999876 67999999999999999999999999765422 2222211111 112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|..++..+.+++.+||+.+|.+||++.+++ +.|..+
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell-~~l~~~ 279 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEIL-YNLSLY 279 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHH-HHHHHH
Confidence 334456799999999999999999999996 444444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=354.90 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=203.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC---ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--Cce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH---TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~---~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~l 464 (701)
.++|.+.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++||||++++++|.+. .|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3569999999999999999998743 359999886532 22345688999999999999999999998554 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999988543 35889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~ 622 (701)
.. ....+||+.|+|||++.+..++.++|||||||++|+|+||++||...+.. ...+..+..
T Consensus 183 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-------- 245 (340)
T PTZ00426 183 TR---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-------- 245 (340)
T ss_pred CC---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------
Confidence 21 13457999999999999989999999999999999999999999766542 222333321
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||+.+|.+|+ ++.+++.|+|++-
T Consensus 246 -~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 246 -YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 12333344588999999999999995 8999999999863
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.25 Aligned_cols=272 Identities=24% Similarity=0.318 Sum_probs=207.1
Q ss_pred CceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec----C---CCceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----E---YGCLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~---~~~lV 465 (701)
.|...+++|.|+||.||+|.... ..||||..-.+.. --.+|++||+.++|||||.|.-+|. . ..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 47888999999999999999854 4699998765542 2368999999999999999988772 1 22689
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeecccccc
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLV 543 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFGla~~~ 543 (701)
||||+. +|..++... .....++.-.+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999964 788877542 22345666777789999999999999999 9999999999999975 99999999999988
Q ss_pred CCCCCcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH------------
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR------------ 610 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~------------ 610 (701)
.++... .+...|..|+|||.+. ...|+.++||||.|||+.||+-|+|.|.+.+.+.+...
T Consensus 177 ~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 177 VKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred ccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 655432 3456789999999655 45699999999999999999999999988776555432
Q ss_pred ----cCccccccCccCC-----C-CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCCcccC
Q 005343 611 ----NGTFSELLDPTVT-----G-WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVVT 680 (701)
Q Consensus 611 ----~~~~~~~ld~~~~-----~-~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~~~~~ 680 (701)
+.+..+...|.+. . +....+.++.+|+.++|..+|.+|.+..+++.|+++...... .....++.+.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~----~~~l~~g~~l 325 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP----NTKLPNGRPL 325 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc----CccCcCCCcC
Confidence 1111122222221 1 233456679999999999999999999999999988742221 2223344466
Q ss_pred CCCCC
Q 005343 681 PGPYN 685 (701)
Q Consensus 681 ~~~~~ 685 (701)
|+-++
T Consensus 326 p~lf~ 330 (364)
T KOG0658|consen 326 PPLFN 330 (364)
T ss_pred CCccC
Confidence 66554
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=339.62 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=196.7
Q ss_pred CceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCCC--ChHHHHHHHHHHHhC---CCCcEEEEeceec-------
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDISQ--GPRQFKQEVEILGSM---RHTNMVILLGACP------- 459 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~------- 459 (701)
+|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6889999999999999999873 456999988755422 234567788887766 6999999999873
Q ss_pred CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 460 EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
...++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 23479999995 68988885433 345889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcC----
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNG---- 612 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~---- 612 (701)
++..... .......||+.|+|||.+....++.++|||||||++|+|++|++||......... +...
T Consensus 157 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9865432 1224567899999999998889999999999999999999999999866543221 1100
Q ss_pred --cccc-------ccCccCC----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 --TFSE-------LLDPTVT----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 --~~~~-------~ld~~~~----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+.. .+.+... .+....+..+.+++.+||+.+|++||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0000 0000000 0011233457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.18 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=197.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
++|.+.+.||.|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999984 45699999875432 2345678999999999999999999998554 4799999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 97 58988875432 35788899999999999999999999 9999999999999999999999999997643211
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HH-cC-----------
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IR-NG----------- 612 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~-~~----------- 612 (701)
.......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......+.. +. .+
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 11244578999999998765 56899999999999999999999999765422111 10 00
Q ss_pred ---ccccccCccCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 ---TFSELLDPTVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 ---~~~~~ld~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+...+.+.....+ ......+.+|+.+||..+|.+|||+.+++.|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 01111111110000 1123457899999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=337.53 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=206.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeC--CCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLG--PDISQGPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
....|..++.||+|+||.|..+.+. +..||||.+. .......+...+|+.+|+.++|+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4566777899999999999999984 5569999887 3444456778999999999999999999998732
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..|+|+|+| +.+|...+.. ...|+......++.|++.||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 238999999 6788888733 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCcc-
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTF- 614 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~- 614 (701)
+..+.. .....++..+.|.||+|||++. ...|+..+||||.||||.|||+|+|.|.+.+.+.+.-. -|+.
T Consensus 173 R~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 173 RYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred eecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 988543 2233457889999999999754 56799999999999999999999999988765544321 0110
Q ss_pred ------------cccc--CccCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 ------------SELL--DPTVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 ------------~~~l--d~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+ -|.....| ........+|+.+||..||.+|+|+.+.|.|+...-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 0000 01111111 123345789999999999999999999999998874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=361.62 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=206.0
Q ss_pred CceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.|.+.+.||+|+||.||+|... +..|++|.+..........+.+|+.+|+.++||||++++++|.+ ..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999873 44588887755443334557889999999999999999999843 458999999
Q ss_pred CCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 470 ENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 470 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++|+|.+++... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543 33456889999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p 626 (701)
.......+||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+... ..|
T Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 292 (478)
T PTZ00267 225 ----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------PFP 292 (478)
T ss_pred ----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 112345679999999999999999999999999999999999999997654321 222222221 122
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+++.+||..+|..||++.+++.++|.+.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 334456899999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.62 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=212.6
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..+|++.+.||+|.||.|-+|+. .++.||||.++++...+. -.+.+||+||+.|+||||+.+|.+|.+. ..||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35688899999999999999986 677899999988765543 4589999999999999999999999654 4799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||..+|.|.||+... ..|++.....++.||..|+.|+|.++ ++|||||.+|||||.|+.+||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999554 35899999999999999999999999 99999999999999999999999999988743
Q ss_pred CCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
. ....++||++-|.+||+..+.+| ++.+|-|||||+||.|+.|..||++.+. +-..|..|.+.+-
T Consensus 206 ~-------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP----- 273 (668)
T KOG0611|consen 206 K-------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP----- 273 (668)
T ss_pred c-------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----
Confidence 3 23578999999999999999887 7899999999999999999999987653 3344556665442
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|. ...-||.+||-.+|.+|-|+.+|-.|.|...
T Consensus 274 -~~PS----dA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 274 -ETPS----DASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred -CCCc----hHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 2222 2578999999999999999999999999865
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.98 Aligned_cols=241 Identities=24% Similarity=0.304 Sum_probs=196.3
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 472 (701)
+.||+|+||.||++.. .+..||+|++..... .....+.+|+.+++.++||||+.+++.|.. ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999997 456799999876432 233457789999999999999999998844 458999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 149 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----
Confidence 998888443 35889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..+..+.. .+|...+
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---------~~p~~~~ 219 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RFPRTLS 219 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCCC
Confidence 11234679999999999999999999999999999999999999996554321 12221111 2233445
Q ss_pred HHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRP-----DLVSVVLPELIR 661 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~ 661 (701)
..+.+++.+||..+|.+|| ++.+++.|.|+.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 5689999999999999998 899999998775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.09 Aligned_cols=240 Identities=23% Similarity=0.246 Sum_probs=195.9
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||+|+||.||+|.+. +..||+|++.... ......+.+|+.++..++||||+++++.|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 4569999986532 2234567889999999999999999998854 45899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~ 148 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------D 148 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC------C
Confidence 9988543 35889999999999999999999999 9999999999999999999999999997542211 1
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
.....+||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+. ..+|...+..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------LRFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------CCCCCcCCHH
Confidence 1245679999999999999999999999999999999999999997654322 1111111 1233344556
Q ss_pred HHHHHHHhhccCcCCCC---ChhhhhhHHHHHH
Q 005343 633 IAKLALQCCELRKRDRP---DLVSVVLPELIRL 662 (701)
Q Consensus 633 l~~li~~cl~~~P~~RP---t~~~vl~~~~~~l 662 (701)
+.+++.+||..+|.+|| ++.+++.|+|+.-
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 89999999999999997 4789999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.94 Aligned_cols=279 Identities=22% Similarity=0.337 Sum_probs=210.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--Cc----eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HT----SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~----~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
.+|++.+.||+|+||.||+|.+. +. .||+|++..... .....+.+|+.+++.++||||++++|+|.. ..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 45899999999999999999872 22 389999875432 234568899999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999986543 35788899999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
... ........++..|++||++....++.++|||||||++|||+| |++||..... ....+..+...
T Consensus 162 ~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (316)
T cd05108 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 230 (316)
T ss_pred CCc----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 221 111223345678999999999999999999999999999998 9999975432 23333332211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCCcccCCCCCCChhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVVTPGPYNSVSEM 690 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (701)
..+..+...+.+++.+||..+|.+||++.+++.+ +.++..................|+|..++.+.
T Consensus 231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (316)
T cd05108 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 296 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH-HHHHHcCCchheEecCCcccCCCCCchhHHHh
Confidence 1122234468999999999999999999999865 44443332222222222333445555544443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.61 Aligned_cols=257 Identities=24% Similarity=0.284 Sum_probs=201.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|++. ++.||||++.... ......+.+|+.+|..++||||+++++.|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999984 5679999987542 1223457889999999999999999999854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999988543 35899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCccc--------------------------------ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 005343 547 AADTI--------------------------------TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594 (701)
Q Consensus 547 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt 594 (701)
..... ........+||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHH--HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHH
Q 005343 595 ARPAMGLSHQVEQA--IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRL 662 (701)
Q Consensus 595 G~~pf~~~~~~~~~--i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l 662 (701)
|++||......... +..... .+..+... ..+..+.+++.+|+. +|.+|++ +.+++.|+|++-
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKE-TLQFPDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-ccCCCCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999766543222 211110 01111111 123457899999996 9999998 999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=349.79 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=205.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|++. +..||||++..... .....+..|+.++..++||||+++++++.+ ..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 66799999875431 234568899999999999999999998854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 46889999999999999999999999 999999999999999999999999999876433
Q ss_pred CCc-----------------------ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 005343 547 AAD-----------------------TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH 603 (701)
Q Consensus 547 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 603 (701)
... ...........||+.|+|||++.+..++.++|||||||+||+|++|++||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000112345679999999999999999999999999999999999999997665
Q ss_pred HHHHHHHcCcc-ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-hhhhhhHHHHHH
Q 005343 604 QVEQAIRNGTF-SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD-LVSVVLPELIRL 662 (701)
Q Consensus 604 ~~~~~i~~~~~-~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-~~~vl~~~~~~l 662 (701)
..........+ ..+..+.... .+..+.+++.+|+. +|.+||+ +.+++.|+|++-
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 33222111111 0011111111 34568999999997 9999999 999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=350.00 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=193.6
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
|...++||+|+||.||+|++. ++.||||++...... ....+.+|+++++.++||||++++++|.+ ..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 455678999999999999984 567999998654322 23568999999999999999999999854 3479999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+.. .+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 99986532 2456777889999999999999999 9999999999999999999999999998764221
Q ss_pred cccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... .......... ....
T Consensus 223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~ 294 (353)
T PLN00034 223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----SQPP 294 (353)
T ss_pred ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----cCCC
Confidence 11244579999999998743 2345789999999999999999999974321 1111111000 0011
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..+......+.+|+.+||..+|.+||++.+++.|+|+.-..
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 12233445689999999999999999999999999988643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.32 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=196.4
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 472 (701)
+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+.+++.+.+ ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999984 56799999876432 234567889999999999999999988844 458999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------ 148 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------ 148 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc------
Confidence 999888443 45889999999999999999999999 999999999999999999999999998753211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
.......+||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+. ..+|...+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~ 219 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---------IKFPRTLS 219 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---------ccCCCCCC
Confidence 112244679999999999999999999999999999999999999996554321 1111111 12333444
Q ss_pred HHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRP-----DLVSVVLPELIR 661 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~ 661 (701)
..+.+++.+||..+|.+|| ++.+++.|+|+.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 5689999999999999997 899999998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.30 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=213.0
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCCC---ceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEYG---CLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---~lV~ 466 (701)
++|..++.||+|+||.++.+++ +++.+++|.+....... .+...+|+.++++++|||||.+.+.|.+.. ||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999998887 55679999987766443 335899999999999999999999995543 7999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
+|++||+|.+.+.+.. ...|+++.+..++.|++.|+.|||++. |+|||||+.|||++.++.+||+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986654 556999999999999999999999988 999999999999999999999999999988654
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
. ....+.+||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+...-... ..... ....|
T Consensus 160 ~------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k--i~~~~----~~Plp 227 (426)
T KOG0589|consen 160 D------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK--INRGL----YSPLP 227 (426)
T ss_pred h------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH--Hhhcc----CCCCC
Confidence 2 124678999999999999999999999999999999999999999987764332222 11111 22344
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....+|..++..|+..+|..||++.++|.++...
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 55666799999999999999999999999886555
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.25 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=209.8
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC----
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE---- 460 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---- 460 (701)
.....++|.+.+.||+|+||.||+|.+ .+..||||++...... ....+.+|+.++..++|+||+.+.+.+..
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 334567999999999999999999987 5677999998765422 23458899999999999999998876521
Q ss_pred ------CCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEE
Q 005343 461 ------YGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 136899999999999988653 23456899999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHc
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRN 611 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~ 611 (701)
|+|||+++.+..... .......+||+.|+|||++.+..++.++|||||||+||||++|++||....... ..+..
T Consensus 184 L~DFGls~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVS----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred EEecccCeecccccc----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999999987643211 112245679999999999999999999999999999999999999997654322 22222
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.+ ...|...+..+.+++.+||..+|.+||++.+++.|+|.+.
T Consensus 260 ~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 260 GRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 222 1123344556899999999999999999999999998775
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.56 Aligned_cols=264 Identities=26% Similarity=0.461 Sum_probs=211.4
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC-Cc
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY-GC 463 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~ 463 (701)
++++...+.+.+...||+|.||+||+|.|-| .||||+++.+.... .+.|++|+..+++-+|.||+.++|+|-.. ..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 5666677778889999999999999999865 59999998776433 45699999999999999999999999543 37
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+|..+|+|-+|..+|+-.. ..|...+.+.|+.||++|+.|||.++ |||||||+.||||.+++.|||+||||+..-
T Consensus 464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999986543 56888999999999999999999999 999999999999999999999999998542
Q ss_pred CCCCCcccccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-HHcCccccccC
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA-IRNGTFSELLD 619 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~-i~~~~~~~~ld 619 (701)
..- .........-|...|||||++.. .+|+..+|||||||++|||+||..||...+ .+++ +..|.- .+-
T Consensus 539 ~~w----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIifmVGrG--~l~ 611 (678)
T KOG0193|consen 539 TRW----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQIIFMVGRG--YLM 611 (678)
T ss_pred eee----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheEEEeccc--ccC
Confidence 111 11122345568889999997653 468999999999999999999999998333 2332 233322 222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
+.+.....+++.++.+|+..||..++++||.+.+|+......++
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 33333345677789999999999999999999999865444443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.79 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=204.8
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~E 467 (701)
+|++.+.||+|+||.||++.+. ++.||+|++...... ....+.+|+.+++.++||||+.+++.+. +..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999984 567999998654322 2345778999999999999999999884 34689999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2346899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+... + .......
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~----~~~~~~~ 224 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-V----KEDQEEY 224 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-h----hhccccc
Confidence 1234578999999999998899999999999999999999999997643211 111111 0 0111123
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHhc
Q 005343 626 PVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRDL 665 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~~ 665 (701)
+...+..+.+++.+||..+|.+|| ++.+++.|+|+.-.++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 334455689999999999999999 8889999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.10 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=197.3
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..++||||+++++.+.+. .|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999984 55699999875421 2234578899999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998543 45889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCcc-----------------------------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 005343 547 AADT-----------------------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597 (701)
Q Consensus 547 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~ 597 (701)
.... .........+||+.|+|||++.+..++.++|||||||+||||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00001134689999999999999999999999999999999999999
Q ss_pred CCCCchHHH--HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhc--cCcCCCCChhhhhhHHHHHH
Q 005343 598 AMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCE--LRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 598 pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~--~~P~~RPt~~~vl~~~~~~l 662 (701)
||....... ..+...... +..+.... ....+.+++.+++. .++..||++.+|+.|+|++-
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 235 PFCSETPQETYKKVMNWKET-LIFPPEVP----ISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCc-ccCCCcCC----CCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence 997654332 222221111 11111111 22346777776543 23335799999999998763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.90 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=194.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC------------------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH------------------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~------------------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~ 453 (701)
.++|.+.++||+|+||.||+|.+++ ..||+|++....... ...|.+|+.+|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998632 249999987654322 346899999999999999999
Q ss_pred EeceecC--CCceEEeecCCCChhhHhcccC----------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCee
Q 005343 454 LLGACPE--YGCLVYEYMENGSLEDRLFQKD----------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515 (701)
Q Consensus 454 l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 515 (701)
++|+|.+ ..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999854 4589999999999999885431 1235788899999999999999999999 99
Q ss_pred ecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-
Q 005343 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT- 594 (701)
Q Consensus 516 HrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt- 594 (701)
||||||+|||++.++.+||+|||+++.+..... ........++..|+|||++..+.++.++|||||||++|+|++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999986533211 111234456889999999988899999999999999999997
Q ss_pred -CCCCCCCchHHHH--HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 595 -ARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 595 -G~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
|..||........ .... .+...........|..++..+.+++.+||..+|.+||++.+|.
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGE-FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHH-HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 4567764332111 1110 0000000001112233445689999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.28 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=200.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
+.|++++.||+|+||.||+|+.. ++.||||++.... ......+.+|+++|..++||||+++++.|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46999999999999999999984 4569999986532 1224558899999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998543 35788888899999999999999999 999999999999999999999999998533110
Q ss_pred CCcc-------------------------------------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHH
Q 005343 547 AADT-------------------------------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589 (701)
Q Consensus 547 ~~~~-------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil 589 (701)
.... .........+||+.|+|||++.+..++.++|||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0000 000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCchHHHHHHHcCccccc-cCccCCCCCHHHHHHHHHHHHHhhccCcCCCC---ChhhhhhHHHHHHHh
Q 005343 590 LQLITARPAMGLSHQVEQAIRNGTFSEL-LDPTVTGWPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIRLRD 664 (701)
Q Consensus 590 ~elltG~~pf~~~~~~~~~i~~~~~~~~-ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP---t~~~vl~~~~~~l~~ 664 (701)
|+|+||++||.................. ..+.. ...+..+.+++.+|+ .+|.+|| ++.+++.|+|++-.+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 9999999999876543322221111111 11111 123345778888876 4999999 999999999987533
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.47 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=198.0
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|.+++.||+|+||.||+|++. +..||||++..... .....+.+|+.+++.++||||+++++.|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6899999999999999999984 45699999875432 223468899999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999988543 35788888999999999999999999 9999999999999999999999999986432110
Q ss_pred Cccc-----------------------------------------ccccccccccCCCccCcccccCCCCCchhhHHHHH
Q 005343 548 ADTI-----------------------------------------TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLG 586 (701)
Q Consensus 548 ~~~~-----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlG 586 (701)
.... ........+||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 00011245799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHH--hhccCcCCCCChhhhhhHHHHHH
Q 005343 587 VVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQ--CCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 587 vil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~--cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|++|||+||++||.................. ..... .......+.+++.+ |+..+|..||++.+++.|+|+.-
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENT--LHIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccc--cCCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999999999765543222211110000 00111 11223457888887 44556666999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=351.71 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=199.9
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|.+++.||+|+||.||+|+.. +..||+|++..... .....+.+|+.+++.++||||+++++.|.+ ..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999984 45699999875422 123458899999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 35788888999999999999999999 9999999999999999999999999986432100
Q ss_pred Ccc-----------------------------------------cccccccccccCCCccCcccccCCCCCchhhHHHHH
Q 005343 548 ADT-----------------------------------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLG 586 (701)
Q Consensus 548 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlG 586 (701)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 000 000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHHcCcccc-ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHH
Q 005343 587 VVLLQLITARPAMGLSHQVEQAIRNGTFSE-LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRL 662 (701)
Q Consensus 587 vil~elltG~~pf~~~~~~~~~i~~~~~~~-~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l 662 (701)
|+||||+||++||................. ...+.. ......+.+++.+|+ .+|.+|++ +.+++.|+|++-
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999999987654333222111110 111111 122345678887776 49999997 999999999875
Q ss_pred Hhc
Q 005343 663 RDL 665 (701)
Q Consensus 663 ~~~ 665 (701)
.++
T Consensus 311 ~~~ 313 (382)
T cd05625 311 IDF 313 (382)
T ss_pred cCh
Confidence 443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=354.38 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=195.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC----------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---------- 460 (701)
..+|.+.+.||+|+||.||+|.+. +..||||++.... ....+|+.+|+.++||||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999984 4569999885432 335679999999999999999887521
Q ss_pred CCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeec
Q 005343 461 YGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVG 538 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFG 538 (701)
..++||||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 1358999996 4676666432 23456899999999999999999999999 9999999999999865 479999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cC-
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NG- 612 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~- 612 (701)
+|+.+.... ......||+.|+|||++.+ ..|+.++|||||||+||||+||++||........... .+
T Consensus 217 la~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred cchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 998764321 1234578999999998765 4699999999999999999999999976643322211 01
Q ss_pred -----------ccccccCccCC------CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 613 -----------TFSELLDPTVT------GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 613 -----------~~~~~ld~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..+..+... .+|...+..+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01111001110 112223456899999999999999999999999999863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.26 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=202.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|++.++||+|+||.||++.+. +..+|+|++...... ....+.+|+++++.++||||++++++|.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999985 456899988765322 23568999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|+++|+|.+++... ..+++.....++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999988543 3578889999999999999999975 6 999999999999999999999999998765321
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHH---cCccccc----
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIR---NGTFSEL---- 617 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~---~~~~~~~---- 617 (701)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+. .+.....
T Consensus 158 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred c--------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 1 13457899999999999889999999999999999999999999754321 11110 0000000
Q ss_pred -----------------------------cCccCCCCCH-HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 618 -----------------------------LDPTVTGWPV-EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 618 -----------------------------ld~~~~~~p~-~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
........+. ....++.+|+.+||+.+|.+||++.+++.|+|++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000000000 1234588999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.51 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=197.9
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||++.. .+..||||++.... ......+.+|+++++.++||||++++++|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4689999999999999999988 45569999986532 1223568889999999999999999999854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988543 45888899999999999999999999 999999999999999999999999999643211
Q ss_pred CCcc----------cc-------------------------------cccccccccCCCccCcccccCCCCCchhhHHHH
Q 005343 547 AADT----------IT-------------------------------QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSL 585 (701)
Q Consensus 547 ~~~~----------~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSl 585 (701)
.... .. .......+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000113579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCC---CChhhhhhHHHHH
Q 005343 586 GVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDR---PDLVSVVLPELIR 661 (701)
Q Consensus 586 Gvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R---Pt~~~vl~~~~~~ 661 (701)
||+||||+||++||..............+...+ .+... ......+.+++.+||. +|.+| |++.+++.|+|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~-~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETL--YFPDD-IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--CCCCC-CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999999999997655432211111111100 01110 1233468899999997 66665 6999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.94 Aligned_cols=247 Identities=32% Similarity=0.559 Sum_probs=208.1
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
..+-...+.||+|.||+||+|+..+ +-||||.++..... ...+|++|+++|..|+|||||+|+|+|.+ ..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455677899999999999998632 34999999887755 45679999999999999999999999954 45
Q ss_pred ceEEeecCCCChhhHhcccC-------C----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 463 CLVYEYMENGSLEDRLFQKD-------N----SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
|+|+|||..|||.++|.... . .++|+..+.+.||.|||.|+.||-++. +|||||-..|+|+..+..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999996432 1 234889999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCccccccccc-ccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC-Cc-hHHHH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMT-TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMG-LS-HQVEQ 607 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~-~~-~~~~~ 607 (701)
|||+||||++.+-.. ..|+.. ...-...||+||.+..++++++||||||||+|||++| |+.|+. .. .++-+
T Consensus 642 VKIsDfGLsRdiYss-----DYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSS-----DYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred EEecccccchhhhhh-----hhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 999999999865221 223322 3445678999999999999999999999999999998 777764 33 36777
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+++|.+ -..|.+++.++..|+..||+..|++||++.+|=
T Consensus 717 ~i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 7888764 256778888899999999999999999999984
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.43 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=194.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|... ...+.+|+++|+.++||||++++++|. ...|+||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 356999999999999999999984 4569999643 235789999999999999999999884 345899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+ +++|..++... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~-~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 165 Y-KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred C-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 9 57888887443 35789999999999999999999999 999999999999999999999999999754221
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----------HHHHHHH-cCcccc-
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----------QVEQAIR-NGTFSE- 616 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----------~~~~~i~-~~~~~~- 616 (701)
........+||+.|+|||++....++.++|||||||+||+|+||++||-... .....+. .|....
T Consensus 236 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 236 ---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ---cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 1112345689999999999999999999999999999999999997653211 1111111 010000
Q ss_pred --------------------ccCcc-CCCCC--HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 --------------------LLDPT-VTGWP--VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 --------------------~ld~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+. ...|. ...+..+.+|+.+||+.+|.+||++.++|.|+|++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 00000 01111 12345689999999999999999999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=348.17 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=195.1
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 472 (701)
+.||+|+||.||++.. .+..||+|++..... .....+..|+.++..++||||+.+++.+.+ ..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999997 455699999876432 223457889999999999999999988844 448999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
+|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 150 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---- 150 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----
Confidence 999887443 358899999999999999999997 67 9999999999999999999999999987542211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......||+.|+|||++.+..++.++|||||||+||+|+||+.||...... ...+..+.+ .+|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~ 219 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------RFPRTL 219 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------CCCCCC
Confidence 1123457999999999999999999999999999999999999999655431 222222111 122333
Q ss_pred HHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRP-----DLVSVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~ 661 (701)
...+.+++.+||+.+|++|| ++.+++.|+|+.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 45689999999999999996 899999999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.22 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=198.5
Q ss_pred CceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCC-cEEEEeceec--CCCceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHT-NMVILLGACP--EYGCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~--~~~~lV~ 466 (701)
+|.+.+.||+|+||.||+|...+ ..||||++.... ......+..|+.++..+.|+ +|+.+++.+. +..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999854 469999987642 23345678899999999775 5777887774 3458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 35788999999999999999999999 999999999999999999999999998743211
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
. ......+||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+.... ..
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (324)
T cd05587 155 G------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (324)
T ss_pred C------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence 1 1123457999999999999999999999999999999999999999765432 22222221 12
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l 662 (701)
+|...+..+.+++.+||..+|.+||+. .+++.|+|++-
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 233344568999999999999999987 78888887653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.66 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=198.2
Q ss_pred CceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCC----CCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--C
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDI----SQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--G 462 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~ 462 (701)
+|++.+.||+|+||.||+++. .+..||+|++.... ......+..|+.++..+ +||||+.+++.+.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999986 35669999986532 12234578899999999 599999999888543 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 7999999999999988543 35889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGTFS 615 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~~~ 615 (701)
+..... ......+||+.|+|||++.+. .++.++|||||||+||+|+||+.||.... .+...+...
T Consensus 155 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEK-----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--- 226 (332)
T ss_pred ccccCC-----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence 532211 112346799999999998765 47899999999999999999999996432 111111111
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
++ ..+...+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 227 ---~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 227 ---DP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred ---CC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 11 22233445689999999999999999 7889999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.64 Aligned_cols=245 Identities=24% Similarity=0.284 Sum_probs=197.1
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHH---HhCCCCcEEEEeceecC--CCceE
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEIL---GSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
|++.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++ +.++||||+++++++.+ ..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999984 5669999987542 12234566776665 56789999999998844 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887732 35899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~ 623 (701)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+..+..
T Consensus 154 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05589 154 F------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------- 218 (324)
T ss_pred C------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 1 11234567999999999999999999999999999999999999999765432 222222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 12333445689999999999999999 6888999888753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.18 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=197.7
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||+|+||.||++.+. +..||+|.+...... ....+..|+.+++.++||||+.+.+++.. ..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999884 557999998654322 23457889999999999999999988744 45899999999999
Q ss_pred hhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccc
Q 005343 475 EDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ 553 (701)
Q Consensus 475 ~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~ 553 (701)
.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 8887543 23456899999999999999999999999 99999999999999999999999999976643211
Q ss_pred ccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHHHH
Q 005343 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 554 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+....+ .. ...++...+.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL----ND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----cc-CCCCcccCCH
Confidence 123457899999999999999999999999999999999999999754321 111111111 11 1123344556
Q ss_pred HHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 632 SIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+.+++.+||+.+|.+|| ++.+++.|+|++-
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 789999999999999999 7789999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.88 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=196.3
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+. ++.||||++.... ......+..|+.++..+ +||||+++++++.+ ..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 5569999987542 22345577899998876 69999999998854 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 9999888543 35889999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||...+.. ...+..+.. ..|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------VYPTWL 219 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCC
Confidence 1224567999999999999999999999999999999999999999766532 222322221 122223
Q ss_pred HHHHHHHHHHhhccCcCCCCCh------hhhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDL------VSVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~------~~vl~~~~~~l 662 (701)
+..+.+++.+||+.+|.+||+. .+++.|+|++-
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 4568999999999999999998 88999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.69 Aligned_cols=242 Identities=27% Similarity=0.360 Sum_probs=196.5
Q ss_pred eeeeecCceeEEEEEE-----CCceEEEEEeCCCC----CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 400 RKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDI----SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+.||+|+||.||+++. .++.||+|++.... ......+..|+.+|+.++||||+++++.|.+ ..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999986 35569999987532 1223457889999999999999999998854 34899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999988543 35778888889999999999999999 9999999999999999999999999987542211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p 626 (701)
.......||+.|+|||++.+..++.++|||||||+||+|++|++||...+... ..+..+.+ ..|
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------~~~ 220 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------NLP 220 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence 11234579999999999999889999999999999999999999997665332 22222221 223
Q ss_pred HHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
...+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 33345689999999999999999 8999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=341.02 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=198.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999884 56699999875432 234568899999999999999999998732
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..|+||||+.+ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 24899999965 5665552 23788888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HH------
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IR------ 610 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~------ 610 (701)
++..... .......||+.|+|||++.+..++.++|||||||++|+|+||++||...+..... +.
T Consensus 170 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTN-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccC-------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9754321 1224457899999999999999999999999999999999999999755432111 00
Q ss_pred ----------------c-Cccccc-cCccCCCC--------CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 ----------------N-GTFSEL-LDPTVTGW--------PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 ----------------~-~~~~~~-ld~~~~~~--------p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
. ..+... +......| +......+.+|+.+||..+|++||++.+++.|+|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0 000000 00000011 1112345899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.65 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=195.9
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhC---CCCcEEEEeceecC-------
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSM---RHTNMVILLGACPE------- 460 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~------- 460 (701)
+|.+.+.||+|+||.||+|.+. ++.||+|.+...... ....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4889999999999999999985 456999998764322 234567788887766 79999999998742
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 2479999996 58888775432 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHc-C----
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRN-G---- 612 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~-~---- 612 (701)
+.+.... ......||..|+|||++.+..++.++|||||||++|+|++|++||........ .+.. +
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8764221 12345789999999999988999999999999999999999999976543221 1110 0
Q ss_pred -cccc-------ccCccC----CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 -TFSE-------LLDPTV----TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 -~~~~-------~ld~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+.. ...+.. ..+.......+.+++.+||+.||.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 000000 00111234457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=355.25 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=195.7
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC------cEEEEeceecC
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT------NMVILLGACPE 460 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~g~~~~ 460 (701)
+....++|.+.++||+|+||.||+|.+. +..||||+++... .....+..|+.++..++|. +++.++++|..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445788999999999999999999884 4569999986432 2334567788888777654 58888888743
Q ss_pred ---CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCC------
Q 005343 461 ---YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNY------ 530 (701)
Q Consensus 461 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~------ 530 (701)
..|+||+++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 358999988 78898888543 368999999999999999999997 58 99999999999998765
Q ss_pred ----------cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005343 531 ----------VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 531 ----------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 600 (701)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||+||++||.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764321 1245689999999999999999999999999999999999999997
Q ss_pred CchHHHHH--HH--cCcccc-------------c------cCccCC-----------CCC-HHHHHHHHHHHHHhhccCc
Q 005343 601 LSHQVEQA--IR--NGTFSE-------------L------LDPTVT-----------GWP-VEAALSIAKLALQCCELRK 645 (701)
Q Consensus 601 ~~~~~~~~--i~--~~~~~~-------------~------ld~~~~-----------~~p-~~~~~~l~~li~~cl~~~P 645 (701)
..+..+.. +. .|.+.. + +.+... .+. ......+.+|+.+||..||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 65432211 10 011100 0 000000 000 0112347899999999999
Q ss_pred CCCCChhhhhhHHHHHH
Q 005343 646 RDRPDLVSVVLPELIRL 662 (701)
Q Consensus 646 ~~RPt~~~vl~~~~~~l 662 (701)
.+||++.++|.|+|+.-
T Consensus 427 ~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 427 QKRLNARQMTTHPYVLK 443 (467)
T ss_pred hhCCCHHHHhcCccccc
Confidence 99999999999999974
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.00 Aligned_cols=247 Identities=23% Similarity=0.277 Sum_probs=199.2
Q ss_pred CceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCC---CChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDIS---QGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~ 466 (701)
+|.+.+.||+|+||.||+|.+.+ ..||||++..... .....+..|..++..+ +||+|+.+++.+.+ ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999854 4699999876432 2234567788888777 58889999888744 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 35889999999999999999999999 999999999999999999999999999754221
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
. ......+||+.|+|||++....++.++|||||||++|+|+||++||...+.. ...+..+. ..
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05616 155 G------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 219 (323)
T ss_pred C------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1 1124567999999999999999999999999999999999999999765432 22222222 12
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l 662 (701)
+|...+..+.+++.+||+.+|.+|++. .+++.|+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 333445568999999999999999985 78888877754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.80 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=201.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--Cce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~l 464 (701)
..++|.+.+.||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+.+++++.+. .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999984 5569999986532 12334578899999999999999999988543 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24778888899999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCcccccc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTG----MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELL 618 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~l 618 (701)
... .......+||+.|+|||++... .++.++|||||||+||+|++|++||........ .+..+.. .+.
T Consensus 194 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~~ 267 (370)
T cd05596 194 ANG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-SLT 267 (370)
T ss_pred CCC-----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-cCC
Confidence 321 1122456799999999987653 478999999999999999999999986654322 1211110 011
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRL 662 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l 662 (701)
.+ .. ...+..+.+++.+||..+|.+ ||++.+++.|+|++-
T Consensus 268 ~~---~~-~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 268 FP---DD-IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CC---Cc-CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 11 11 123456899999999999988 999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.72 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=192.5
Q ss_pred eeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHh-CCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGS-MRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+.+ ..||+|+++... ......+..|..++.. .+||||+++++++.. ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999854 459999987643 2233456667777765 489999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 9999888543 35888999999999999999999999 9999999999999999999999999997642211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..+.... ...|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---------PHFPRWI 219 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CCCCCCC
Confidence 12245679999999999999999999999999999999999999997654322 1222111 1223334
Q ss_pred HHHHHHHHHHhhccCcCCCCChh-hhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLV-SVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~-~vl~~~~~~l 662 (701)
+..+.+++.+||..+|.+||++. +++.|+|++-
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 45688999999999999999975 7778887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.31 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=196.1
Q ss_pred eeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|++.+ +.||+|++.... ......+..|..++..+ +||||+.++++|.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999854 569999987642 22334577899999866 89999999999854 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 9999888543 35888999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......||+.|+|||++.+..++.++|||||||++|+|+||++||...+... ..+..+.. ..|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~ 219 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------LYPVWL 219 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCC
Confidence 12245679999999999999999999999999999999999999997665322 22222211 122223
Q ss_pred HHHHHHHHHHhhccCcCCCC-------ChhhhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRP-------DLVSVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RP-------t~~~vl~~~~~~l 662 (701)
+..+.+++.+||..+|.+|| ++.+++.|+|+.-
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 45689999999999999999 8999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.40 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=203.4
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCCh---------HHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGP---------RQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~---------~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
+|.+...||.|+||.||+|.+ .++.|++|.+........ +.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999987 456799998876543321 357899999999999999999999844 4
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 58999999999999988443 45888899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCcc
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~ 621 (701)
.+.................|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~---~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---N---A 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---c---C
Confidence 774321111111122345688999999999988899999999999999999999999976654443332111 1 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
....|...+..+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 112233445568999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.79 Aligned_cols=243 Identities=23% Similarity=0.306 Sum_probs=194.4
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+. ++.||+|++...... ....+..|+.++..+ +||||+.+++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999984 456999998765322 234578899988876 89999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 9998887433 45889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----------HHHHHHHcCccccccCc
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----------QVEQAIRNGTFSELLDP 620 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----------~~~~~i~~~~~~~~ld~ 620 (701)
.......||+.|+|||++.+..++.++|||||||++|+|+||++||.... .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 221 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 221 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------
Confidence 11234679999999999999999999999999999999999999995210 1111122111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCC------hhhhhhHHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPD------LVSVVLPELIRLR 663 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt------~~~vl~~~~~~l~ 663 (701)
...|......+.+++.+||..+|.+||+ +.+++.|+|++-.
T Consensus 222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 222 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1233344456899999999999999998 5799999988643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=342.64 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=198.0
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-------CCc
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-------YGC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~~~ 463 (701)
+|++.+.||+|+||.||+|.+ .++.||||.+..... .....+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999997 467799998865422 234568899999999999999999998843 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999995 678777743 346899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---Hc-C--cc--
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RN-G--TF-- 614 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~-~--~~-- 614 (701)
..... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||...+.....- .. | ..
T Consensus 154 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCcc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 43211 122445789999999988764 58999999999999999999999997654322110 00 0 00
Q ss_pred -------------ccccC-cc---CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 -------------SELLD-PT---VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 -------------~~~ld-~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..... +. ...........+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 00000 00 00111122446889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=339.62 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=199.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||++.+. +..||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4678999999999999999999874 566999998764322 23567889999999999999999998732
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 24899999965 6666552 24788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-----
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN----- 611 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~----- 611 (701)
++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..... +..
T Consensus 166 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 166 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98653221 123457899999999999989999999999999999999999999765432111 000
Q ss_pred ------------------Ccccccc---------CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 ------------------GTFSELL---------DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 ------------------~~~~~~l---------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+..+. .+....++......+.+|+.+||..+|++||++.+++.|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0000000 00001111122346889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=338.81 Aligned_cols=251 Identities=30% Similarity=0.447 Sum_probs=214.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCC---hHHHHHHHHHHHhCC-CCcEEEEeceecCCC--c
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQG---PRQFKQEVEILGSMR-HTNMVILLGACPEYG--C 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~ 463 (701)
..+.|.+.+.||+|.||.||+++... +.+|+|++.+..... ...+.+|+.||+.+. |||||.++++|.+.. +
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45679999999999999999999854 559999998776443 357999999999998 999999999996544 8
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC----CCcEEEEeecc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ----NYVSKISDVGL 539 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~----~~~~KL~DFGl 539 (701)
+|||++.||.|.+.+... . +++.....++.|++.++.|||+.| |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999776 2 899999999999999999999999 999999999999953 35899999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSEL 617 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ 617 (701)
+..+.+ .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..... ....+..+.+ .+
T Consensus 186 a~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f 257 (382)
T KOG0032|consen 186 AKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DF 257 (382)
T ss_pred ceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CC
Confidence 998754 2345788999999999999999999999999999999999999999987763 3344555654 12
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....|+ .....+.+++..|+..+|..|+++.++|.|+|.+
T Consensus 258 ---~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 258 ---TSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred ---CCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 222343 3356689999999999999999999999999954
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.83 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=199.3
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||.|+||.||+|+.. +..||+|++...... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4888999999999999999984 566999998654322 23568899999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 688888765544467899999999999999999999999 9999999999999999999999999997653221
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Ccc---------
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTF--------- 614 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~--------- 614 (701)
.......+++.|+|||++.+ ..++.++|||||||++|+|+||++||............ +..
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 11234467899999998765 45789999999999999999999999766543322210 000
Q ss_pred ---------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 615 ---------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 615 ---------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...............+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000000000011123467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.56 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=198.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
++|.+.+.||+|+||.||+|++. +..||+|.+...... ....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999884 456999998755432 3346789999999999999999999984 345899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 96 48887775432 35788889999999999999999999 9999999999999999999999999997643221
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHc-Cc----------
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRN-GT---------- 613 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~-~~---------- 613 (701)
.......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||......+. .... +.
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 11234568999999998754 5689999999999999999999999975542211 1110 00
Q ss_pred ----cccccCccCC-----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 ----FSELLDPTVT-----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ----~~~~ld~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.....+... ......+..+.+++.+||..+|.+|||+.+++.|+|++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0000000000 000123446789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.85 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=201.5
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|.. .+..||+|++..... .....+.+|+.+++.++||||+.+++.+.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4699999999999999999998 456699999876432 234458899999999999999999998854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999885542 36899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCc
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQ------TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~ 620 (701)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||............-.....+.
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 229 (330)
T cd05601 156 KM-----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK- 229 (330)
T ss_pred Cc-----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC-
Confidence 21 1123457999999999876 45688999999999999999999999976543322111001111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.... ...+..+.+|+..||. +|.+||++.+++.|+|+.-
T Consensus 230 -~~~~-~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 230 -FPED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred -CCCC-CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 0111 1234458899999998 9999999999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.78 Aligned_cols=249 Identities=28% Similarity=0.476 Sum_probs=200.4
Q ss_pred cCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
++|.+.+.||+|+||.||+|...+ ..|++|.+...... ....|.+|+.++..++||||+++++++.+ ..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 358889999999999999998743 34999988755322 23458999999999999999999999854 358
Q ss_pred eEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC
Q 005343 464 LVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865422 145888999999999999999999999 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHH
Q 005343 531 VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQ 607 (701)
Q Consensus 531 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~ 607 (701)
.+||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADY----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEECCCcceeecccccc----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999986532211 111234467889999999998999999999999999999998 999986443 2333
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+..+.. ...|..++..+.+|+.+||+.+|.+||++.+|+.+
T Consensus 238 ~i~~~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQL--------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCc--------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3343322 12234556679999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.11 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=197.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-------CCceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-------~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|++.+.||+|+||.||+|++ .+..||||+++.... .....+.+|+.+|..+ +||||++++|+|.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345799999999999999999974 233699999876542 2345688999999999 89999999999854
Q ss_pred CCceEEeecCCCChhhHhcccCC---------------------------------------------------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDN--------------------------------------------------------- 483 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (701)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 45899999999999998854321
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 484 ---------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 484 ---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 125788999999999999999999999 99999999999999999999999999986643211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---HHHHHHHcCccccccCccCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH---QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~ 624 (701)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||.... .....+..+... .
T Consensus 270 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------~ 337 (375)
T cd05104 270 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------L 337 (375)
T ss_pred ----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------C
Confidence 011123345678999999999999999999999999999998 889986542 223333333211 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.|...+..+.+++.+||..+|.+||++.+|+..
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 112223468999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.21 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=198.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+.+++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999974 56699999876432 234568899999999999999999988732
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..|+||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 2389999996 46776663 23788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-C---
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-G--- 612 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~--- 612 (701)
++...... ......||..|+|||++.+..++.++|||||||+||+|++|+.||...+..... +.. +
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98653221 123457899999999999999999999999999999999999999765432211 110 0
Q ss_pred -------------------ccc---------cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 613 -------------------TFS---------ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 613 -------------------~~~---------~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+. ..+.+............+.+|+.+||..||.+|||+.+++.|+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 000 0000000011111234588999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.96 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=203.3
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-----ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-----GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
++|.+.+.||+|+||.||+|.. .+..|++|.+...... ....+.+|++++++++||||+++++++.+ ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999987 4567999988654321 23458899999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 35788999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.... .........|+..|+|||++.+..++.++||||||+++|+|++|++||............... .....
T Consensus 156 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----~~~~~ 227 (263)
T cd06625 156 TICS---SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-----PTNPQ 227 (263)
T ss_pred cccc---ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----CCCCC
Confidence 2211 011113456889999999999988999999999999999999999999765443332221111 11112
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.|...+..+.+++.+||..+|.+||++.+++.|.|+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 333445568999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=312.41 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=209.9
Q ss_pred cCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCC----Ch----HHHHHHHHHHHhC-CCCcEEEEeceecCCC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQ----GP----RQFKQEVEILGSM-RHTNMVILLGACPEYG 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~----~~----~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 462 (701)
..|...+.||+|..+.|.++.++.+ .+|+|++...... .. +.-.+|+.||+++ .||+|+.+.++|....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4466667899999999999988544 4888887543321 12 2357899999998 6999999999996544
Q ss_pred --ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 463 --CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 463 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
++|+|.|+.|.|.|+|. ..-.+++....+|+.|++.|+.|||.++ ||||||||+|||+++|..+||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 68999999999999994 3456889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcC
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNG 612 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~ 612 (701)
+.++++. +....|||++|+|||.+... .|+..+|+|++|||+|.||.|.|||-...+ +-..|.+|
T Consensus 171 ~~l~~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 171 CQLEPGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred eccCCch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 9886653 46788999999999976543 488899999999999999999999976654 35677888
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+++ +-.|. | .+.+....+||.+||+.||..|.|..++|.|+|+.-..
T Consensus 244 kyq-F~spe---W-adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 244 KYQ-FRSPE---W-ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ccc-cCCcc---h-hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 864 33333 3 34455689999999999999999999999999996533
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.35 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=195.1
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+. +..||+|++..... .....+..|+.++..+ +||||+.+++.|.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999984 55699999976432 2234578899999998 79999999999854 44899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----- 149 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----- 149 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-----
Confidence 9998887443 46899999999999999999999999 999999999999999999999999998743111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----------HHHHHHHcCccccccCc
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----------QVEQAIRNGTFSELLDP 620 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----------~~~~~i~~~~~~~~ld~ 620 (701)
.......+||+.|+|||++.+..++.++|||||||++|+|+||++||.... .....+..+.+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------
Confidence 112245679999999999999999999999999999999999999995311 11122222211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCC------hhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPD------LVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt------~~~vl~~~~~~l 662 (701)
..|...+..+.+++.+||..+|.+||+ +.+++.|+|+.-
T Consensus 223 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 223 ---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 122233456899999999999999997 789999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.27 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=194.8
Q ss_pred eeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHh-CCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGS-MRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|++.+ ..||||++.... ......+..|..++.. ++||||+++++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999854 569999987642 2334456778888876 499999999999854 45799999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 9999988542 45888999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+..+. +. +|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------~~---~~~~~ 219 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN------PC---YPRWL 219 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC---CCccC
Confidence 1123457999999999999999999999999999999999999999765432 22222211 11 12223
Q ss_pred HHHHHHHHHHhhccCcCCCCChh-hhhhHHHHHHHh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLV-SVVLPELIRLRD 664 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~-~vl~~~~~~l~~ 664 (701)
...+.+++.+||..+|.+||++. +++.|+|++-.+
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 34588999999999999999997 888898876533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=326.04 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=201.9
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC-------
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE------- 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~------- 460 (701)
.+++.|.+.+.||+|+||.||+|... ++.||+|++.... .....+.+|+.++..+ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677889999999999999999884 5569999986543 3456789999999998 79999999999842
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 247999999999999988543 2346889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~ 614 (701)
+..+.... .......|++.|+|||++. ...++.++|||||||++|+|++|++||..............
T Consensus 158 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~- 230 (272)
T cd06637 158 SAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 230 (272)
T ss_pred ceeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-
Confidence 98653221 1124567899999999875 34588899999999999999999999965443322222111
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...+... +...+..+.+|+.+||..+|.+||++.+++.|+|+
T Consensus 231 --~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 --NPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --CCCCCCC--CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0011111 11233468999999999999999999999999884
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.95 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=209.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++.|++.+.||+|.|+.||++.+. ++.+|+|+++... ..+.+.+.+|+.|-..|+|||||.|...+.+. .+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999999884 4558888765433 23567799999999999999999999988544 37999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGla~~~ 543 (701)
|+|.||+|..-+..+ ..+++...-.++.||+.||.|+|.++ |||||+||.|+||. .+--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999998777655 34677788889999999999999999 99999999999994 4567899999999887
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--hHHHHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS--HQVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~--~~~~~~i~~~~~~~~ld~~ 621 (701)
..+ ......+||+.|||||++...+|+..+|||+.|||||-||.|++||.+. +.+-+.|..|.+. -.
T Consensus 164 ~~g-------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----~~ 232 (355)
T KOG0033|consen 164 NDG-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----YP 232 (355)
T ss_pred CCc-------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----CC
Confidence 522 2246789999999999999999999999999999999999999999763 3445556666542 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
-+.|+ ...++..+|+.+||..||.+|.|+.+.|.|+|.+-++
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 22343 3455689999999999999999999999999988665
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.15 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=199.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|++.+.||+|+||.||++.+. +..||+|++.+.. ......+.+|+.+++.++||||+++++.+.+ ..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567999999999999999999985 4569999986432 1223458899999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 24788889999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCcccccc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTG----MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELL 618 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~l 618 (701)
... .......+||+.|+|||++... .++.++|||||||+||+|+||++||...+.... .+.....
T Consensus 194 ~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05621 194 ETG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred cCC-----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence 221 1123456899999999988654 378999999999999999999999976654322 1111110
Q ss_pred CccCCCCCH--HHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHH
Q 005343 619 DPTVTGWPV--EAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRL 662 (701)
Q Consensus 619 d~~~~~~p~--~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l 662 (701)
...+|. ..+..+.+++..||..++.+ ||++.+++.|+|++-
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 011222 23445889999999855544 899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.81 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=194.7
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++.+ ..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999985 4569999987642 22344567788888754 89999999999854 44899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 9999888543 35788999999999999999999999 9999999999999999999999999987432111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+. +. .|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------~~---~~~~~ 219 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------PH---YPRWI 219 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC---CCCCC
Confidence 1224567999999999999999999999999999999999999999765432 12222211 11 22223
Q ss_pred HHHHHHHHHHhhccCcCCCCChh-hhhhHHHHHHHh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLV-SVVLPELIRLRD 664 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~-~vl~~~~~~l~~ 664 (701)
...+.+++.+||..+|.+||++. +++.|+|++-.+
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 44689999999999999999984 787899986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=327.29 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=207.7
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
..+|.+.+.||+|+||.||+|.. .+..|++|.+..........+.+|+.+++.++||||+++++.|.. ..|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999987 456799999877665556778999999999999999999998843 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999998843 34788999999999999999999999 9999999999999999999999999987653321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.......|++.|+|||++.+..++.++|||||||++|+|++|++||............... ..+.. ..+..
T Consensus 171 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~-~~~~~ 241 (296)
T cd06654 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPEL-QNPEK 241 (296)
T ss_pred -----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC---CCCCC-CCccc
Confidence 1123457899999999999888999999999999999999999999765543222211110 00111 12233
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
....+.+++.+||..+|.+||++.+++.|+|+...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 44568999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.22 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=203.1
Q ss_pred CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC------hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG------PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
+|.+.+.||.|+||.||+|.. .+..+|+|.+....... ...+.+|+++++.++||||++++++|.+. .++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987 55669999886543221 24588999999999999999999998544 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++.+. .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 35788999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
...............|+..|+|||++.+..++.++|||||||++|+|++|++||................... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----PRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----CCC
Confidence 2111111112234578999999999999899999999999999999999999997655443332221111111 112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 23344568999999999999999999999999884
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.47 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=203.3
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|+..+.||+|+||.||+|.+. ++.||+|.+...... ....+.+|+++|+.++|+||+.+.+.+.+ ..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3778899999999999999984 566999998654322 23457889999999999999999988743 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998875433 346899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
......|+..|+|||++.+..++.++|+|||||++|+|+||++||....... ..+... .... ...+
T Consensus 157 -------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-~~~~----~~~~ 224 (285)
T cd05632 157 -------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-VLET----EEVY 224 (285)
T ss_pred -------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hhcc----cccc
Confidence 1234578999999999998999999999999999999999999997554321 111111 1100 0112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHhc
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRDL 665 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~~ 665 (701)
+...+..+.+|+..||..+|.+||+ +.+++.|.|++..++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 2233446899999999999999999 889999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.19 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=197.4
Q ss_pred cCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
++|.+.+.||+|+||.||++.+.. ..+|+|.+.... .....+.+|+.+|+.++||||++++++|.+ ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458889999999999999999854 469999876443 345678999999999999999999999854 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence 999999885433 35889999999999999999999999 99999999999999999999999999986532211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......++..|+|||++.+..++.++||||||+++|+|++ |++||...... ...+..+.. . ..|.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--~------~~~~ 224 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--L------YRPK 224 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--C------CCCC
Confidence 01123345678999999988889999999999999999999 89999765432 223333321 1 1122
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23446899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.51 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=196.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|.++...... ...|.+|+.++..++||||++++|++.. ..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999863 3469999987654322 3468899999999999999999999844 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999885432 46899999999999999999999999 9999999999999999999999999876532
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
... ........++..|+|||++.+..++.++|||||||++|||++ |.+||...... ...+..+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 226 (266)
T cd05064 159 SEA-----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR------- 226 (266)
T ss_pred ccc-----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------
Confidence 111 111123345678999999999999999999999999999875 99999755432 223333321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...|..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 227 -~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 -LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1123344556899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.46 Aligned_cols=243 Identities=24% Similarity=0.294 Sum_probs=197.1
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+. +..||||++.... ......+..|+.++..+ +||||+++++++.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 4569999987642 22345577899999888 79999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 9999887543 35899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|+||+.||...+... ..+..... .+|...
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------RYPRWL 219 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------CCCCcC
Confidence 11234579999999999999999999999999999999999999997654322 22222211 122334
Q ss_pred HHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRLR 663 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l~ 663 (701)
+..+.+++.+||..+|.+||++ .+++.|+|++-.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 4568999999999999999999 999999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.46 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=208.6
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
..+|.+.+.||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++|||++.+++.|.+ ..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34699999999999999999987 566799999876655556678999999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 999999998743 35899999999999999999999999 9999999999999999999999999987653321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.......|+..|+|||.+.+..++.++|||||||++|+|++|++||...+............ .+. ...+..
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~---~~~-~~~~~~ 240 (296)
T cd06655 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPE-LQNPEK 240 (296)
T ss_pred -----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---Ccc-cCCccc
Confidence 11234578899999999998889999999999999999999999998765543322211100 001 111233
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.+..+.+++.+||..+|.+||++.+++.|+|++...
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 445688999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.55 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
..++|++.+.||+|+||.||+|.+.+ ..||+|++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 56789999999999999999998643 3599998865432 223458899999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 462 GCLVYEYMENGSLEDRLFQKDN-------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 5899999999999998854321 234678889999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHc
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRN 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~ 611 (701)
+|||+++.+..... ........++..|+|||++..+.++.++|||||||++|||++ |.+||...... ...+..
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999976533211 111123356788999999998899999999999999999999 78898655432 222222
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
+.+. ..+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2221 1222334568999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.06 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=198.7
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|.. .+..||+|++..........+.+|+.++..++||||+++++.+.. ..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35689999999999999999997 456699999976654555678899999999999999999998843 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++... .++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 9999999988432 35889999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVT 623 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~ 623 (701)
.......|++.|+|||.+. ...++.++|||||||++|+|++|++||........... ...+ ..+...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF---QPPKLK 232 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC---CCCCCc
Confidence 1123456889999999874 44578899999999999999999999854332221111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.+...+..+.+++.+||..+|.+||++.+++.|.|
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11223456899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.18 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=203.1
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
+|.+.+.||+|+||.||+|.. .+..|++|.+..... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999998 456799998865432 2345688999999999999999999998544 5899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988653 2356899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p 626 (701)
......|++.|+|||++.+..++.++|+|||||++|+|+||+.||........ .+..+.+ ...+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--------PPVS 222 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCCc
Confidence 12345688999999999999999999999999999999999999976653221 1222221 1122
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
...+..+.+++.+||+.+|++||++.+++.|+|
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 234556999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=324.80 Aligned_cols=264 Identities=25% Similarity=0.295 Sum_probs=211.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceec--CCCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACP--EYGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV 465 (701)
.+.|++++.||.|.-|+||+++++++ .+|+|++.+..... ..+.+.|-+||+.++||.+..||..|. +..|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 34578889999999999999999775 59999998765433 345778999999999999999999994 455999
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||||+||+|..++ +++....|++..+..++.+++.||+|||..| ||+|||||+||||-++|++.|+||.|+.....
T Consensus 156 meyCpGGdL~~Lr-qkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLR-QKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHH-hhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999998755 5566678999999999999999999999999 99999999999999999999999999854311
Q ss_pred CC-------------------------------C-c------------------ccccccccccccCCCccCcccccCCC
Q 005343 546 SA-------------------------------A-D------------------TITQYHMTTAAGTFCYIDPEYQQTGM 575 (701)
Q Consensus 546 ~~-------------------------------~-~------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~ 575 (701)
.. . . .....+....+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 0 00011224679999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC----h
Q 005343 576 LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD----L 651 (701)
Q Consensus 576 ~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt----~ 651 (701)
.+.++|||+|||+|||||.|..||.+.+.-+...+- .. .+....+.| .....+.+||.+.|.+||++|.. +
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-v~---~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-VG---QPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-hc---CCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccch
Confidence 999999999999999999999999877643322220 00 112223333 44556899999999999999999 9
Q ss_pred hhhhhHHHHHHHhc
Q 005343 652 VSVVLPELIRLRDL 665 (701)
Q Consensus 652 ~~vl~~~~~~l~~~ 665 (701)
.+|=.|+||+=-++
T Consensus 387 ~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNW 400 (459)
T ss_pred HHhhcCccccCCCh
Confidence 99999999875444
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.40 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=201.5
Q ss_pred ceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
|++.+.||.|+||.||+|.+.. ..+++|.+..........+.+|+++++.++|||+++++++|.. ..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6778899999999999999854 4588888865543445678899999999999999999998844 44899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|..++... ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 9998877542 246899999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCCC
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVTG 624 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~~ 624 (701)
.......|++.|+|||++. ...++.++|||||||++|+|++|++||........... .+....+ .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 229 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------A 229 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------C
Confidence 1123457899999999874 44578899999999999999999999976554333222 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.|...+..+.+++.+||..+|.+||++.+++.|+|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 122334568999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.70 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=192.9
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||+|+||.||++... +..||+|.+..... .....+..|+++++.++||||+++++.+.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 56799998865321 123346679999999999999999988854 45899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 98875433 345889999999999999999999999 9999999999999999999999999997654321
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
......||..|+|||++.+..++.++|||||||++|+|++|++||..... ....+....+....... ....+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE----HQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc----cccCCHH
Confidence 12345789999999999998999999999999999999999999975321 11111111111111100 1123445
Q ss_pred HHHHHHHhhccCcCCCCCh----hhhhhHHHHHH
Q 005343 633 IAKLALQCCELRKRDRPDL----VSVVLPELIRL 662 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~----~~vl~~~~~~l 662 (701)
+.+++.+||+.+|.+||++ .+++.|+|++.
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 8999999999999999999 66778999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.28 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=205.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||.|+||.||+|... ++.+++|++..........+.+|+.+++.++||||++++|++.+ ..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467999999999999999999984 56699999987655566789999999999999999999998743 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999987543 245889999999999999999999999 9999999999999999999999999997654321
Q ss_pred cccccccccccccCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG---MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.......++..|+|||.+... .++.++|||||||++|+|+||++||.............. ..+ .+.....
T Consensus 156 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~ 228 (262)
T cd06613 156 -----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SNF-PPPKLKD 228 (262)
T ss_pred -----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccC-CCccccc
Confidence 112345788999999998776 889999999999999999999999976543333222111 001 1111112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 2344567999999999999999999999998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.04 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=187.5
Q ss_pred eeeeeecCceeEEEEEEC----CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceEEeecC
Q 005343 399 SRKIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLVYEYME 470 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV~Ey~~ 470 (701)
..+||+|+||.||+|... +..||+|.+... .....+.+|+.+|+.++||||+++++.+.. ..|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999863 356999988654 233557899999999999999999998732 3479999985
Q ss_pred CCChhhHhcccC------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE----cCCCcEEEEeeccc
Q 005343 471 NGSLEDRLFQKD------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLA 540 (701)
Q Consensus 471 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~~KL~DFGla 540 (701)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68887764321 2235889999999999999999999999 9999999999999 45689999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH------------HHH
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ------------VEQ 607 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~------------~~~ 607 (701)
+.+..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ...
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred eccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 87643211 1112345678999999998876 4589999999999999999999999964321 111
Q ss_pred HHHc-Cc-----------cc---ccc----CccCCCCC---------HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 608 AIRN-GT-----------FS---ELL----DPTVTGWP---------VEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 608 ~i~~-~~-----------~~---~~l----d~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.+.. |. +. ... .......+ ......+.+|+.+||+.||.+|||+.+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1110 00 00 000 00000000 001124779999999999999999999999998
Q ss_pred H
Q 005343 660 I 660 (701)
Q Consensus 660 ~ 660 (701)
+
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.76 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=197.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||++++++|..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4577999999999999999999874 456999998754322 23457889999999999999999987732
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..|++++++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 237899988 889988763 235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H-cCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R-NGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~-~~~~ 614 (701)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+...... . .+..
T Consensus 165 ~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 165 ARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred ceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9865321 234578999999998876 568999999999999999999999997654322111 0 0000
Q ss_pred -ccccC-----------ccCCCCCH--------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 -SELLD-----------PTVTGWPV--------EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 -~~~ld-----------~~~~~~p~--------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+. ..+...+. .....+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00000 00001110 11234789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=340.89 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|++.+.||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++.+.+ ..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999984 5569999986532 2234568889999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.+. ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999988543 35889999999999999999999999 999999999999999999999999998765321
Q ss_pred CCcc-----------------------------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 005343 547 AADT-----------------------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597 (701)
Q Consensus 547 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~ 597 (701)
.... .........+||+.|+|||++.+..++.++|||||||++|||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001124589999999999999999999999999999999999999
Q ss_pred CCCCchHHHH--HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHH
Q 005343 598 AMGLSHQVEQ--AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRL 662 (701)
Q Consensus 598 pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l 662 (701)
||........ .+..... .+..+... .....+.+++.+|+. +|.+|++ +.+++.|+|+.-
T Consensus 235 Pf~~~~~~~~~~~i~~~~~-~~~~p~~~----~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 235 PFCSETPQETYRKVMNWKE-TLVFPPEV----PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCHHHHHHHHHcCCC-ceecCCCC----CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9976554322 1221110 01111111 123357888888774 9999984 789999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.74 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=206.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-C-ceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEecee-----cCC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-H-TSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGAC-----PEY-- 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~-----~~~-- 461 (701)
...++++.+.|.+|||+.||.|.+. + +.||+|.+-.......+.+.+||++|+.|. |||||.+++.+ .+.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3456888999999999999999984 3 679999887776677788999999999997 99999999943 112
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..|.||||.||+|-|++..+.... |++.++++|+.|+++|+.+||... .||||||||-+||||+.+|..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 258999999999999997665444 999999999999999999999987 5899999999999999999999999999
Q ss_pred ccccCCCCCc--ccc-cccccccccCCCccCccc---ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCc
Q 005343 540 ARLVPPSAAD--TIT-QYHMTTAAGTFCYIDPEY---QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGT 613 (701)
Q Consensus 540 a~~~~~~~~~--~~~-~~~~~~~~gt~~Y~aPE~---~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~ 613 (701)
|.-....... ... ...--....|+.|++||+ +.+...+.|+|||+|||+||-|+....||+..-.+ +|-+|+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aIlng~ 270 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AILNGN 270 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eEEecc
Confidence 8644222110 000 001122356899999995 45677999999999999999999999999755322 334444
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
|.- +.. ..+...|.+||..||+.+|.+||++.+|+ +.+++|..
T Consensus 271 Y~~------P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~-~~~~~l~~ 313 (738)
T KOG1989|consen 271 YSF------PPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVL-EEIFELAN 313 (738)
T ss_pred ccC------CCC-ccHHHHHHHHHHHHhccCcccCCCHHHHH-HHHHHHhc
Confidence 321 111 35566799999999999999999999996 45666644
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.00 Aligned_cols=258 Identities=26% Similarity=0.347 Sum_probs=206.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChHHHHHHHHHHHhCC-C-----CcEEEEecee--cCCC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMR-H-----TNMVILLGAC--PEYG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~--~~~~ 462 (701)
..+|.+.+.||+|.||.|.+|.+.++ .||||+++... .-..+...|+.||..|+ | -|+|.++++| .++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 34799999999999999999998654 49999997653 44567788999999997 3 3899999987 5677
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--CCcEEEEeeccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--NYVSKISDVGLA 540 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~~KL~DFGla 540 (701)
|||+|.+ ..+|.++|..+ +..+|+...+..|+.||+.||.+||+.+ |||+||||+||||.. ...+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999 67999988554 4456999999999999999999999999 999999999999964 347899999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----------
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---------- 610 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---------- 610 (701)
+..... ..+.+.+..|+|||++.+.+|+.++||||||||+.||+||.|.|.+.++.++.-.
T Consensus 339 c~~~q~---------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 339 CFESQR---------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred cccCCc---------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 875332 1256788999999999999999999999999999999999999988876544321
Q ss_pred ----cC----cccc---------------------------------ccCc-cCCCC----CHHHHHHHHHHHHHhhccC
Q 005343 611 ----NG----TFSE---------------------------------LLDP-TVTGW----PVEAALSIAKLALQCCELR 644 (701)
Q Consensus 611 ----~~----~~~~---------------------------------~ld~-~~~~~----p~~~~~~l~~li~~cl~~~ 644 (701)
.+ .|.. ..-| ....+ +......|.+++.+||.+|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 00 0000 0001 01111 1123356899999999999
Q ss_pred cCCCCChhhhhhHHHHHHHhc
Q 005343 645 KRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 645 P~~RPt~~~vl~~~~~~l~~~ 665 (701)
|..|+|..+.+.|+|+.....
T Consensus 490 P~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred chhcCCHHHHhcCcccccccc
Confidence 999999999999999995443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=324.18 Aligned_cols=244 Identities=34% Similarity=0.560 Sum_probs=190.7
Q ss_pred eeeeeeeecCceeEEEEEEC------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 397 SISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~~------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.+.+.||.|.||.||+|.+. +..|+||+++..... ..+.|.+|++++++++||||++++|+|.+ ..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999997 556999999664322 25679999999999999999999999963 3489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.++|... ....+++..+..|+.||+.||.|||+.+ ++|+||+|+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999765 2356899999999999999999999999 9999999999999999999999999998762211
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 624 (701)
. ........+...|+|||.+....++.++||||||+++|||+| |+.||..... ....+.++... .
T Consensus 158 ~----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------~ 225 (259)
T PF07714_consen 158 K----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------P 225 (259)
T ss_dssp S----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------T
T ss_pred c----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------e
Confidence 1 112234457788999999999999999999999999999999 7788865432 22333443321 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+..++..+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22233445899999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=362.79 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC----C
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE----Y 461 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~ 461 (701)
....++|.+++.||+|+||.||+|.+.. ..||+|++...... ....|..|+.+|..|+|||||.++++|.+ .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3456789999999999999999999854 45899988754322 24568999999999999999999998732 3
Q ss_pred CceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCCeeEcC--------
Q 005343 462 GCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKP----EPLVHRDLKPANILLDQ-------- 528 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~iiHrDLKp~NILl~~-------- 528 (701)
.||||||+++|+|.++|... .....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 48999999999999988653 223569999999999999999999998653 34999999999999964
Q ss_pred ---------CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCC
Q 005343 529 ---------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARP 597 (701)
Q Consensus 529 ---------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~ 597 (701)
.+.+||+|||++..+.... .....+||+.|+|||++.. ..++.++||||||||||+|+||++
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999998653221 1234579999999998754 458999999999999999999999
Q ss_pred CCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 598 AMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 598 pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
||.........+..... ....... ..+..+.+||..||..+|.+||++.++|.|+|++..
T Consensus 242 PF~~~~~~~qli~~lk~--~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKR--GPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhc--CCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99765544333322110 0001111 123468999999999999999999999999998743
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.87 Aligned_cols=241 Identities=24% Similarity=0.293 Sum_probs=195.9
Q ss_pred eeeeecCceeEEEEEE-----CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 400 RKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
+.||+|+||.||++.. .++.||+|++..... .....+.+|+++|++++||||++++++|.+ ..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 356799999875432 223457889999999999999999999854 3489999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--- 152 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--- 152 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---
Confidence 99999988443 45899999999999999999999999 9999999999999999999999999987653221
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCCHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.......||+.|+|||++....++.++|||||||++|+|+||+.||........ .+..+.+ ..|..
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------~~p~~ 220 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------GMPQF 220 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------CCCCC
Confidence 112346799999999999988899999999999999999999999976543222 2222211 22333
Q ss_pred HHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPD-----LVSVVLPELIR 661 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~ 661 (701)
.+..+.+++.+||+.+|.+||+ +.+++.|+|++
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence 4456899999999999999999 67788888764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.27 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=198.8
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYM 469 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 469 (701)
++|.+.+.||+|+||.||+|.+ .++.||+|++..........+.+|+.+++.++||||+++++.+. +..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999988 45679999987665445566889999999999999999999874 3458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988443 35889999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--HcCccccccCccCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--RNGTFSELLDPTVTG 624 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~~~~~~~~ld~~~~~ 624 (701)
.......|+..|+|||++. .+.++.++|||||||++|+|++|.+||.......... ....+.. +....
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---PKLKD 233 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC---Ccccc
Confidence 1123457899999999874 4568899999999999999999999985443222111 1111111 11110
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
....+..+.+++.+||..+|.+||++.+++.|+|
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0112335889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.39 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=202.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..+.|++++.||.|+||.||+|.+. +..|++|++..........+.+|+.+++.++||||+++++.|.. ..|+|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3467999999999999999999984 45699999876654455678999999999999999999998743 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|..++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999988775433 35899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
.......+++.|+|||++. ...++.++|||||||++|+|++|++||...+.......... ...+..
T Consensus 165 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 235 (292)
T cd06644 165 ------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL 235 (292)
T ss_pred ------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCccC
Confidence 1123456889999999874 44578899999999999999999999976553322222111 011111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+...+..+.+++.+||..+|.+||++.+++.|+|+.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 273 (292)
T cd06644 236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273 (292)
T ss_pred -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 11223344689999999999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.55 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=201.0
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|+..+.||+|+||.||++.+. ++.||+|.+....... ...+.+|+.+++.++|+|++.+++.+.+ ..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999985 4569999886543222 2457789999999999999999998854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999885432 245889999999999999999999999 9999999999999999999999999987653221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
......||..|+|||++.+..++.++|||||||++|+|++|++||...... ...... .+.......
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----LVKEVQEEY 224 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-----hhhhhhhhc
Confidence 123457999999999999999999999999999999999999999754211 111110 000000112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l 662 (701)
+......+.+|+.+||+.+|.+||+ +.+++.|+|++-
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 2233456899999999999999999 899999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.97 Aligned_cols=258 Identities=23% Similarity=0.285 Sum_probs=200.3
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC-
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY- 461 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 461 (701)
++....++|.+.+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++.+.+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33445678999999999999999999985 4569999986422 12234578899999999999999999998543
Q ss_pred -CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 462 -GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
.++||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 4899999999999998843 24788888899999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCcc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG----MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTF 614 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~ 614 (701)
+.+.... .......+||+.|+|||++... .++.++|||||||+||+|++|++||...+.... .+.....
T Consensus 190 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 190 MKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred eEcCcCC-----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 8764321 1122456799999999988653 378999999999999999999999987654321 1221110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRL 662 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l 662 (701)
.+ .... +...+..+.+++..||...+.+ ||++.+++.|.|++-
T Consensus 265 -~~---~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 265 -SL---TFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred -cc---cCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 00 0111 1123456889999999844433 789999999998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.28 Aligned_cols=262 Identities=26% Similarity=0.366 Sum_probs=208.3
Q ss_pred cCHHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 384 ~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
++..++..++++|.+.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.++.++ +|||+++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44566667889999999999999999999998 45679999986542 2345688899999999 89999999998742
Q ss_pred -------CCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 461 -------YGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 461 -------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 358999999999999987532 23356899999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM-----LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~sDvwSlGvil~elltG~~pf~~~~~~~~ 607 (701)
||+|||++..+.... .......|+..|+|||++.... ++.++|||||||++|+|++|++||........
T Consensus 168 kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEeecccchhccccc------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 999999988653221 1123456899999999875443 68899999999999999999999976554333
Q ss_pred HHH--cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 608 AIR--NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 608 ~i~--~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
... .+....+. .+......+.+++.+||+.+|.+||++.+++.|+|++
T Consensus 242 ~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 242 LFKIPRNPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHhcCCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 222 11111111 1222334689999999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.71 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=206.9
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
..+|.+.+.||.|+||.||+|.. .+..||+|.+........+.+.+|+.+++.++||||+++++.|.. ..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35799999999999999999987 467799999876655556678999999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998843 34788899999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
......+++.|+|||.+.+..++.++|+|||||++|+|++|++||...+........... ..+. ...|..
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~-~~~~~~ 240 (297)
T cd06656 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPE-LQNPER 240 (297)
T ss_pred ------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC---CCCC-CCCccc
Confidence 123456889999999999988999999999999999999999999765433221111100 0011 112333
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..+.+++.+||..+|.+||++.+++.|+|++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 4456899999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.72 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=201.3
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
+..++++.....||+|+||.||+|.+. +..|++|.+..........+.+|+.+++.++||||++++|++.. ..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345667777789999999999999974 45699998876655556679999999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~ 544 (701)
|||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999998865322212277888899999999999999999 999999999999976 6799999999987653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMGLSHQVE-QAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~-~~i~~~~~~~~ld~~ 621 (701)
.... ......|+..|+|||++.... ++.++||||||+++|+|++|++||....... .....+.. ..
T Consensus 161 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~ 229 (268)
T cd06624 161 GINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-----KI 229 (268)
T ss_pred cCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----cc
Confidence 2211 122345889999999986654 7899999999999999999999996433211 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
....|......+.+++.+||..+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 122344455668999999999999999999999999884
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.03 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=195.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|.+.+.||+|+||.||+|++.. ..||+|++...... ....+.+|+.+++.+ +||||++++|+|.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 44579999999999999999998522 35999999765432 234588999999999 89999999999854
Q ss_pred CCceEEeecCCCChhhHhcccC----------------------------------------------------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKD---------------------------------------------------------- 482 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 482 (701)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 4589999999999999885421
Q ss_pred ---------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccc
Q 005343 483 ---------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ 553 (701)
Q Consensus 483 ---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~ 553 (701)
...++++..+.+|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~ 268 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----Y 268 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----e
Confidence 1135788899999999999999999999 99999999999999999999999999986533211 1
Q ss_pred ccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH---HHHHHcCccccccCccCCCCCHHH
Q 005343 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV---EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 554 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~---~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......++..|+|||++....++.++|||||||++|+|++ |++||...... ...+..+ + .+. .|...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-~----~~~---~~~~~ 340 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-Y----QMS---RPDFA 340 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-c----Ccc---CCCCC
Confidence 11223345678999999998999999999999999999997 99999654321 1222221 1 111 11222
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+..+.+++.+||+.+|.+||++.+++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 45689999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.23 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=187.3
Q ss_pred eeeeeecCceeEEEEEECC----ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec----CCCceEEeecC
Q 005343 399 SRKIGEGGYGPVYKAQLDH----TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----EYGCLVYEYME 470 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~----~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~lV~Ey~~ 470 (701)
..+||+|+||.||+|...+ ..||+|.+.... ....+.+|+.+++.++||||++++++|. ...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999743 469999886542 3346789999999999999999999873 23479999985
Q ss_pred CCChhhHhccc------CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE----cCCCcEEEEeeccc
Q 005343 471 NGSLEDRLFQK------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLA 540 (701)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~~KL~DFGla 540 (701)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777776422 12235889999999999999999999999 9999999999999 56789999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH------------HHH
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ------------VEQ 607 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~------------~~~ 607 (701)
+.+..... .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ...
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred eccCCCcc---cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 87643221 1112245678999999998876 4589999999999999999999999964321 111
Q ss_pred HHHc-C--------------ccccccC----c-----cC----CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 608 AIRN-G--------------TFSELLD----P-----TV----TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 608 ~i~~-~--------------~~~~~ld----~-----~~----~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.+.. + .+..... . .. ..........+.+|+.+||..||.+|||+.+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 1110 0 0000000 0 00 0000011234778999999999999999999999998
Q ss_pred H
Q 005343 660 I 660 (701)
Q Consensus 660 ~ 660 (701)
+
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.29 Aligned_cols=244 Identities=21% Similarity=0.363 Sum_probs=197.0
Q ss_pred cCceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
++|.+.+.||+|+||.||+|.+.+. .+|+|.+.... .....+.+|+.++..++||||++++++|.+ ..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3588999999999999999988654 59999887543 345679999999999999999999999854 3489999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 999999885433 26899999999999999999999999 99999999999999999999999999986633211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......++..|++||++.+..++.++|||||||++|+|+| |+.||..... ....+..+... ..+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 224 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------YRPH 224 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--------CCCC
Confidence 11123346678999999998889999999999999999999 9999875443 22222222211 1112
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 23456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.94 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=202.6
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-C--CceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-Y--GCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~--~~lV~E 467 (701)
.|++.+.||+|+||.||++... +..|++|.+..... .....+.+|++++++++|||++++++.+.. . .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999884 45699999865432 234568899999999999999999988743 2 379999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|.+.+... ....+++.++..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988643 2346899999999999999999999999 9999999999999999999999999998663221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..+..+.+. ..
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--------PM 222 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------CC
Confidence 1 1234568899999999999999999999999999999999999997654322 122233221 12
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+...+..+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 23445569999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.21 Aligned_cols=241 Identities=25% Similarity=0.293 Sum_probs=191.2
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHH-HHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVE-ILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+ .++.||+|++..... .....+..|.. +++.++||||+++++.+.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999998 456799999865421 12234555555 4678999999999988744 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 9999888543 45888999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.. ...+..+.. ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------RLKPNI 219 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCC
Confidence 1224557999999999999999999999999999999999999999765432 122222221 111223
Q ss_pred HHHHHHHHHHhhccCcCCCCCh----hhhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDL----VSVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~----~~vl~~~~~~ 661 (701)
+..+.+++.+||+.+|.+||+. .+++.|+|+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 4568999999999999999987 5889998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.49 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=197.2
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~ 466 (701)
+|...+.||+|+||.||+|... +..||+|++.... ......+..|+.++..+. ||+|+.+++.+.+ ..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999984 5569999987542 123345788999998886 4667778877743 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988543 35899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
. .......||+.|+|||++.+..++.++|||||||++|+|+||++||...... ...+..+.. .
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---------~ 219 (323)
T cd05615 155 G------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---------S 219 (323)
T ss_pred C------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------C
Confidence 1 1123457999999999999999999999999999999999999999765432 222222221 2
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l 662 (701)
+|...+..+.+++.+||+.+|.+|++. .++..|+|++-
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 233344568999999999999999984 67888877764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.31 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=193.9
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|... ++.||+|++...... ....+.+|+.++.++ +||||+.+++.+.+ ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999984 456999999765322 234578899999888 69999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 9999887433 35899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---------HHHHHHHcCccccccCccC
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---------QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---------~~~~~i~~~~~~~~ld~~~ 622 (701)
......+||+.|+|||++.+..++.++|||||||+||+|+||++||.... ...+.+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------- 219 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------
Confidence 11245679999999999999999999999999999999999999995321 1122222111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCC------hhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPD------LVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt------~~~vl~~~~~~l 662 (701)
...|...+..+.+++.+||..+|.+||+ +.+++.|+|++-
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 1123334456899999999999999998 469999988764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.02 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=196.8
Q ss_pred cCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
+.|++.+.||+|+||.||+|.+ .+..|++|.+...... ....+.+|+.+++.++||||+++++++.. ..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999985 2346999988754322 23568899999999999999999998743 4589
Q ss_pred EEeecCCCChhhHhcccCC--------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC
Q 005343 465 VYEYMENGSLEDRLFQKDN--------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
||||+++|+|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853321 235788899999999999999999999 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHH
Q 005343 531 VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQ 607 (701)
Q Consensus 531 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~ 607 (701)
.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |.+||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999866432111 11234456778999999988889999999999999999999 9999865432 233
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+..+... ..+...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 238 MVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 33332211 122334456899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.51 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=198.3
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||.|+||.||+|.+. +..||+|.+...... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56999999999999999999884 566999998755422 34467889999999999999999999844 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 96 6888877543 235788999999999999999999999 9999999999999999999999999997643211
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H------cCcccccc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R------NGTFSELL 618 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~------~~~~~~~l 618 (701)
.......+++.|+|||++.+ ..++.++|||||||++|+|+||++||...+..+... . ...+..++
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 11234467899999998765 458899999999999999999999997654321110 0 00000000
Q ss_pred ---------CccC-----CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 619 ---------DPTV-----TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 619 ---------d~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+.. ..+....+..+.+|+.+||..+|.+||++.+++.|+|++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 0011122345789999999999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.13 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=204.7
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceec----
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACP---- 459 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~---- 459 (701)
+.+..+.++|.+.+.||+|+||.||+|.. .++.+++|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44556788999999999999999999988 45669999876532 2345688999999999 7999999999872
Q ss_pred ---CCCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 460 ---EYGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 460 ---~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
+..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 2348999999999999887532 23356888999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~ 610 (701)
|||+++.+.... .......|++.|+|||++. ...++.++|||||||++|+|++|++||...........
T Consensus 167 dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 167 DFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred cCCceeecccCC------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 999998763321 1123457899999999875 34578999999999999999999999976654433322
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..... .+.. ..|...+..+.+++.+||+.+|.+||++.+++.|.|+
T Consensus 241 ~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 241 IPRNP---PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccccC---CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11110 0111 1122223458999999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.47 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||.|+||.||+|.+. +..|++|++..........+.+|+++++.++||||+++++.+.+ ..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999984 56699999876544455678999999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 99999999885433 35899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCcc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPT 621 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~ 621 (701)
.......|++.|++||.+. ...++.++|||||||++|+|++|++||........... .+.. +.
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 227 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-----PT 227 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-----CC
Confidence 1123456899999999864 34578899999999999999999999976554332222 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+ ..+...+..+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 L-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred c-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 1 112223446899999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=325.04 Aligned_cols=254 Identities=25% Similarity=0.317 Sum_probs=199.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||+|+||.||++.+. +..+++|.+...... ....+.+|++++++++||||+++++.|.+ ..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46999999999999999999985 445888988654322 23458899999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++|+|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998543 458899999999999999999997 46 9999999999999999999999999987653221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCc-----
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDP----- 620 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~----- 620 (701)
.....|+..|+|||.+.+..++.++|||||||++|+|+||++||....... ..+... ......+
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRP 225 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCccc
Confidence 234578999999999988889999999999999999999999986443211 111100 0000000
Q ss_pred ------------------------cCCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 ------------------------TVTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ------------------------~~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....| ...+..+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000000 013446899999999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=319.88 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=196.7
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
+|.+.+.||+|+||.||+|.+ .+..||+|++...... ....+.+|++++.+++||||+++++.|.. ..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999987 4556999998655322 23468899999999999999999999844 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999996542 4678888899999999999999999 999999999999999999999999999765322
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---------HHHHHHcCccccccCc
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ---------VEQAIRNGTFSELLDP 620 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~---------~~~~i~~~~~~~~ld~ 620 (701)
......||..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..... +
T Consensus 149 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~ 218 (279)
T cd06619 149 -----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----P 218 (279)
T ss_pred -----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----C
Confidence 12345789999999999998999999999999999999999999854221 1111111110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
... ....+..+.+++.+||+.+|..||++.+++.|+|++..+
T Consensus 219 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 219 VLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 110 012234589999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=320.86 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=198.5
Q ss_pred cCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
+.|.+.+.||+|+||.||+|.+.+ ..||+|++...... ....+.+|+++|+.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998632 46999998765443 34679999999999999999999999854 458
Q ss_pred eEEeecCCCChhhHhcccC-----------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 464 LVYEYMENGSLEDRLFQKD-----------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
+||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 2345789999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i 609 (701)
||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||..... ....+
T Consensus 162 kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcc----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999976532211 011123456788999999999999999999999999999998 9999864432 22233
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+.... .+...+..+.+++.+||..+|.+||++.+++.
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQ--------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3333211 12233456899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.74 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=199.8
Q ss_pred ceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChH--HHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR--QFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~--~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
|++.+.||+|+||.||++...++ .||+|++......... ...+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78899999999999999999554 5999999876533222 24569999999999999999999844 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++++|.+++. ....+++..+..++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--- 151 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--- 151 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST---
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---
Confidence 9999999996 3346899999999999999999999999 999999999999999999999999998764111
Q ss_pred ccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
........+|..|+|||++. ...++.++||||||+++|+|++|..||.... .....+............. . .
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~ 226 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-Q-S 226 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-S-H
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-c-c
Confidence 11235667899999999988 8889999999999999999999999998762 2222222111101100000 0 0
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
......+.+++.+||+.+|++||++.+++.|+|+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0112569999999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=314.25 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=204.8
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
++|.+.+.||.|+||.||+|... +..|++|.+..... ...+.+|+++++.++||||+++++.+.+ ..|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57889999999999999999985 46799999876532 6789999999999999999999999854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999988543 246899999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......|+..|+|||++.+..++.++|||||||++|+|+||++||............... ..+. ...+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPT-LSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCC-CCchhhc
Confidence 123445888999999999889999999999999999999999999765543333221111 0011 1112334
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 4568999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.85 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=204.3
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||.|+||.||+|.+ .++.|++|++.... ......+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3688889999999999999998 45679999987654 2334568899999999999999999998854 34799999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988432 6899999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~~~~~~p 626 (701)
.......|++.|+|||++.+..++.++|||||||++|+|+||++||...+..... +..+. .+.....
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~- 221 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-----PPSLEGN- 221 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----CCCCccc-
Confidence 1224457889999999999888999999999999999999999999765432221 12221 1111111
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 13446899999999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.53 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=200.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-----ChHHHHHHHHHHHhCCCCcEEEEeceecC----CC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-----GPRQFKQEVEILGSMRHTNMVILLGACPE----YG 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~ 462 (701)
.+|...+.||+|+||.||+|... ++.|++|.+...... ....+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999974 567999988654321 12458889999999999999999998743 23
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+++|||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 7899999999999988543 34788999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
+..... .........++..|+|||++.+..++.++|||||||++|+|++|++||.............. .+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-----~~~~ 227 (266)
T cd06651 156 LQTICM---SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTN 227 (266)
T ss_pred cccccc---cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-----CCCC
Confidence 532110 01112335688999999999988899999999999999999999999976544333322111 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...|......+..++ +||..+|.+||++.+|+.|+|++
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 233334445577777 78889999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.27 Aligned_cols=254 Identities=26% Similarity=0.295 Sum_probs=195.8
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||++... ++.||+|++.+.. ......+.+|+.++..++||||+.++++|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999984 5669999986522 1233458899999999999999999998854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988543 235888999999999999999999999 999999999999999999999999998765332
Q ss_pred CCcccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLD 619 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld 619 (701)
.. ......+||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+. .+.......-+.
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GT-----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CC-----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 11 11123469999999998763 5578899999999999999999999976543322 111111000011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcC--CCCChhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKR--DRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~--~RPt~~~vl~~~~~~ 661 (701)
+... ..+..+.+++.+|+...++ .||++.+++.|+|+.
T Consensus 231 ~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 231 PDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred CccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 1111 1344578888887765443 488999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.00 Aligned_cols=245 Identities=24% Similarity=0.435 Sum_probs=197.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.++|++.++||+|+||.||+|... ++.|++|.+.... ...+.+.+|+.+++.++||||+++++.+.+ ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 457999999999999999999874 4569999876543 345679999999999999999999988744 447999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 9999999886532 345888999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.......++..|+|||++..+.++.++|||||||++|+|+| |+.||..... ....+..+.. .+...
T Consensus 159 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~--- 227 (261)
T cd05072 159 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----MPRME--- 227 (261)
T ss_pred ----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CCCCC---
Confidence 11123446778999999988889999999999999999998 9999965432 2223332211 11112
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..+..+.+++.+||..+|++||++.+++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 228 -NCPDELYDIMKTCWKEKAEERPTFDYLQ 255 (261)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 2334589999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.32 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|++++.||+|+||.||++.+. +..||+|.+...... ....+.+|+.++++++||||+++++.+.. ..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999985 667999988654322 23568899999999999999999998744 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++++|..++........+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999998887554334468999999999999999999996 47 999999999999999999999999998765321
Q ss_pred CcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLD 619 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld 619 (701)
......|+..|+|||++.+. .++.++|||||||++|+|+||+.||....... ..+. .+.+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~ 224 (286)
T cd06622 157 -------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVD 224 (286)
T ss_pred -------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhh
Confidence 12344688899999987544 35889999999999999999999996443211 1111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
......+......+.+++.+||..+|.+||++.+++.|+|+.-.+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 1112234445667899999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.85 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=196.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC----ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH----TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~----~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
..+|.+.+.||+|+||.||++...+ ..|++|.+... ..+.+|+.+|+.++||||+++++++.. ..|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999998633 45899987543 345789999999999999999998854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+. ++|.+++. ....+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9994 68888873 3356899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHc-Cc----cc
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRN-GT----FS 615 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~-~~----~~ 615 (701)
.. ........||+.|+|||++....|+.++|||||||+||||++|+.||.... .....+.. +. +.
T Consensus 239 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PD----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cc----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 11 112245679999999999999999999999999999999999998885431 11111110 00 00
Q ss_pred c------------ccCccCCCC--C-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 616 E------------LLDPTVTGW--P-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 616 ~------------~ld~~~~~~--p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
. ........+ | ......+.+++.+||..+|++||++.+++.|+|++-
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0 000000000 0 012346889999999999999999999999999964
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.51 Aligned_cols=242 Identities=26% Similarity=0.306 Sum_probs=191.0
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHH-HHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVE-ILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.. .+..||+|++..... .....+..|.. +++.++||||+++++.+.. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999998 456799999865422 22234555655 4677999999999988844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 999888743 346889999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+... ..+..+.. ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~ 219 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------VLRPGA 219 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------cCCCCC
Confidence 11245679999999999999999999999999999999999999997654321 22222211 111123
Q ss_pred HHHHHHHHHHhhccCcCCCCCh----hhhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDL----VSVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~----~~vl~~~~~~l 662 (701)
...+.+++.+||..+|.+||++ .+++.|+|+.-
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 3457899999999999999987 48889988764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.68 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=203.5
Q ss_pred HHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceec---
Q 005343 386 IEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACP--- 459 (701)
Q Consensus 386 ~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~--- 459 (701)
..++....+.|++.+.||.|+||.||+|.+ .+..||+|++.... .....+..|+.++.++ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 345555678899999999999999999998 45569999886543 2345688999999998 7999999999873
Q ss_pred -----CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 460 -----EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 460 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
+..|++|||+.+|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 23489999999999999885432 345788888999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI 609 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i 609 (701)
+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|++||..........
T Consensus 163 ~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 163 VDFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred eeCcchhhhhccc------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999987653211 1123457899999999875 3468889999999999999999999996554333222
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.... ...+.. .+...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 237 ~~~~---~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 237 LIPR---NPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hHhh---CCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1111 001111 112234569999999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.20 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=197.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCC-CCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMR-HTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~g~~~~-- 460 (701)
..+.|.+.++||+|+||.||+|.+.+ ..||||++....... ...+.+|+.+|+.+. ||||++++|+|.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45689999999999999999998632 249999997654332 356899999999996 9999999999954
Q ss_pred CCceEEeecCCCChhhHhcccC----------------------------------------------------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKD---------------------------------------------------------- 482 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 482 (701)
..||||||+++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 4589999999999999885421
Q ss_pred -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc
Q 005343 483 -----------------------------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD 527 (701)
Q Consensus 483 -----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~ 527 (701)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 1134788889999999999999999999 99999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---
Q 005343 528 QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--- 603 (701)
Q Consensus 528 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--- 603 (701)
.++.+||+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999986532211 111234457788999999998899999999999999999997 888886432
Q ss_pred HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 604 ~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.....+..+.. ...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 348 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22222332211 1122334556899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.39 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=198.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|.+.... .....+.+|+.++++++||||+++++++.. ..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3467999999999999999999974 4569999987653 345679999999999999999999998854 35899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985533 346899999999999999999999999 99999999999999999999999999987642211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
. .......+..|+|||++.+..++.++||||||+++|+|+| |++||...... ...+..+ +. . ..
T Consensus 159 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~---~----~~ 225 (261)
T cd05068 159 E-----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YR---M----PC 225 (261)
T ss_pred c-----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC---C----CC
Confidence 0 1112223467999999999999999999999999999999 99999754432 2222221 11 0 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2233456899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.78 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=197.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+.. ..|+||++...... ....|.+|+.+++.++||||+++++++.+ ..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568999999999999999998842 35999988765432 23468899999999999999999998844 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999985533 36899999999999999999999999 9999999999999999999999999998774
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ....+..+.. .+
T Consensus 158 ~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~- 228 (266)
T cd05033 158 DSEA----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR----LP- 228 (266)
T ss_pred cccc----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CC-
Confidence 2111 111123345678999999998899999999999999999998 9999854332 2223332211 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122334568999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.20 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=204.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee-------cCCC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC-------PEYG 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-------~~~~ 462 (701)
..++|++.+.||+|||+.||++.. .+..+|+|.+......+.+...+|++..++++|||++++++++ .+..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 457899999999999999999986 4455999999888777888899999999999999999999876 2234
Q ss_pred ceEEeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 463 CLVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
||+++|...|+|.+.+.... .+..+++.+++.|+.+|+.||.+||...| |+.||||||+|||+...+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999999999997653 34479999999999999999999999885 89999999999999999999999999998
Q ss_pred ccCCCCCcc---cccccccccccCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcC-cc
Q 005343 542 LVPPSAADT---ITQYHMTTAAGTFCYIDPEYQQTG---MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNG-TF 614 (701)
Q Consensus 542 ~~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~-~~ 614 (701)
..+-..... ...........|..|+|||.+.-. ..+.++|||||||+||.|+.|..||.. ....| .+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------~~~~GgSl 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------IYQQGGSL 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------HhhcCCeE
Confidence 764322111 111122345678999999987654 468899999999999999999999942 22222 22
Q ss_pred ccccCccCCCCCH--HHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 615 SELLDPTVTGWPV--EAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 615 ~~~ld~~~~~~p~--~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.......-..||. ..+..+.+++..|++.||.+||++.+++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111110112221 245569999999999999999999999854
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.86 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=200.8
Q ss_pred cCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.+|.+.+.||+|+||.||++... +..+|+|.+..........+.+|+.++++++||||++++++|.+ ..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46889999999999999999852 23488998876544445678999999999999999999999853 4589
Q ss_pred EEeecCCCChhhHhcccC----------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 465 VYEYMENGSLEDRLFQKD----------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885432 2235899999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHc
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRN 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~ 611 (701)
+|||+++.+.... .........++..|+|||++.+..++.++|||||||++|+|+| |.+||..... ....+..
T Consensus 162 ~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCc----eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999998653221 1111234456788999999998899999999999999999998 9999865432 2233444
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.... .+...+..+.+++.+||+.+|.+||++.+++ ..+..+
T Consensus 238 ~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~-~~l~~~ 279 (288)
T cd05093 238 GRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIH-SLLQNL 279 (288)
T ss_pred CCcCC--------CCCCCCHHHHHHHHHHccCChhhCCCHHHHH-HHHHHH
Confidence 43221 1122334689999999999999999999985 345544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.82 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=198.7
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCc----eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC-CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHT----SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY-GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~----~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~lV 465 (701)
+.|++.+.||+|+||.||+|.+ .+. .|++|.+...... ....+..|+.+++.++||||++++|++... .+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 4588889999999999999998 333 3777877543221 234678888899999999999999998543 4799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.+
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999986433 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
... ........++..|++||++.++.++.++|||||||++|||+| |++||.... .....+..+....
T Consensus 162 ~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 231 (279)
T cd05111 162 DDK----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA------ 231 (279)
T ss_pred CCc----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC------
Confidence 221 112234567788999999998999999999999999999998 999997543 2334444443211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..++..+..++.+||..+|..||++.+++. .+..+
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~-~l~~~ 268 (279)
T cd05111 232 --QPQICTIDVYMVMVKCWMIDENVRPTFKELAN-EFTRM 268 (279)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH-HHHHH
Confidence 11123345788999999999999999999864 55554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.94 Aligned_cols=245 Identities=30% Similarity=0.452 Sum_probs=197.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYME 470 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~ 470 (701)
.++|.+.++||+|+||.||+|.+.+ ..||+|++.... .....+.+|+.+++.++||||+++++.+.+ ..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 4569999999999999999998854 469999987543 345678999999999999999999998744 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998643 2345789999999999999999999999 999999999999999999999999999876432210
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
......++..|++||+..+..++.++|||||||++|+|+| |++||...... ...+..+.. ...+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 226 (262)
T cd05071 159 ----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPP 226 (262)
T ss_pred ----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------CCCcc
Confidence 1123456778999999988899999999999999999999 88899654322 122221110 01123
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..+..+.+++.+|++.+|.+||++.+++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~ 254 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQ 254 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 4455689999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.11 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=198.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|++...||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++|||+++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46899999999999999999984 56799998865432 223568899999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999888776532 235899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Ccc--------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTF-------- 614 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~-------- 614 (701)
. ......++..|+|||++.+ ..++.++|||||||++|+|+||++||......+..... +..
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1234467889999998765 55889999999999999999999999765543322110 000
Q ss_pred ------ccccCccCCC-CC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 615 ------SELLDPTVTG-WP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 615 ------~~~ld~~~~~-~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.....+.... .+ ...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000 00 1124568899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.07 Aligned_cols=261 Identities=18% Similarity=0.207 Sum_probs=195.3
Q ss_pred eeeeeeec--CceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeec
Q 005343 398 ISRKIGEG--GYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYM 469 (701)
Q Consensus 398 ~~~~IG~G--~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 469 (701)
++++||+| +||+||++... +..||+|.+....... ...+.+|+.+++.++||||++++++|. +..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999884 4569999987654322 345788999999999999999999984 3458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC-
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA- 548 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~- 548 (701)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 235889999999999999999999999 99999999999999999999999987644321110
Q ss_pred cccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--HcCccccccCcc---
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--RNGTFSELLDPT--- 621 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~~~~~~~~ld~~--- 621 (701)
............++..|+|||++.+ ..++.++|||||||++|+|++|++||.......... ..+......+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0000011123457788999999876 458999999999999999999999997543221111 111111111100
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 ----------------------------------VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ----------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+.......+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00011123456899999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.79 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=212.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey 468 (701)
.+.|.++..||.|+||.||+|..+.+. .|-|++........+.|.-||+||..++||+||+|+++| ....+++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345778889999999999999998776 567888776667778899999999999999999999875 4455899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|.||-.+..+...+ .+|++.++..++.|++.||.|||+.+ |||||||..|||++-+|.++|+|||.+...
T Consensus 111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn----- 180 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN----- 180 (1187)
T ss_pred cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc-----
Confidence 99999988876544 46899999999999999999999999 999999999999999999999999987542
Q ss_pred cccccccccccccCCCccCccc-----ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEY-----QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~-----~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~ 623 (701)
..+..+..+++||++|||||+ +...+|+.++||||||++|.||..+.||....+.++..+.-.+- -.|.+
T Consensus 181 -~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTL- 255 (1187)
T KOG0579|consen 181 -KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTL- 255 (1187)
T ss_pred -hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcc-
Confidence 233445578899999999996 55678999999999999999999999998777666655543221 11221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
-.|......|.+|+.+||..+|+.||++.+++.|+|..
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 22445556799999999999999999999999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.13 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=197.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYME 470 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~ 470 (701)
.++|.+.++||+|+||.||+|... +..||+|.+.... .....+.+|+.++++++|||++++++++.+ ..+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 356888999999999999999874 4569999987654 345679999999999999999999998854 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 99999988543 2345899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......++..|+|||++.+..++.++||||||+++|+|++ |++||......+ ..+..+. ....+.
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 226 (260)
T cd05070 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------RMPCPQ 226 (260)
T ss_pred ---ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCCC
Confidence 01122345678999999988889999999999999999999 899996544322 2222211 011233
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..+..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 4455699999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=320.07 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=201.9
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.|...+.||+|+||.||+|.+. +..||+|.+..... .....+.+|+.+++.++||||+++++.|.. ..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3667788999999999999874 55699999875542 223468999999999999999999998844 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 99999988732 45889999999999999999999999 9999999999999999999999999997664321
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCCH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......|+..|+|||++.+..++.++|||||||++|+|+||++||........ .+..+. ....+.
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--------PPTLEG 223 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--------CCCCCc
Confidence 112334688999999999998999999999999999999999999864432211 111111 112223
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..+..+.+++.+||..+|.+||++.+++.|+|+.-..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 4455689999999999999999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=352.54 Aligned_cols=264 Identities=24% Similarity=0.299 Sum_probs=204.0
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.++||+|+||.||+|.+. ++.||||++....... ...+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999984 5679999997654332 3468999999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccC--------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 467 EYMENGSLEDRLFQKD--------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
||++||+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1234567788899999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcc------------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 005343 539 LARLVPPSAADT------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606 (701)
Q Consensus 539 la~~~~~~~~~~------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~ 606 (701)
+++......... .........+||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762111000 00011234579999999999999999999999999999999999999997543221
Q ss_pred HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 607 ~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.... .. +.++....-....+..+.+++.+|+..+|++||+..+.+...+.....
T Consensus 239 i~~~-~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 11 111111000113345689999999999999999988888887777643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.30 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=193.6
Q ss_pred ceeeeeeeecCceeEEEEEECCc----eEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--------C
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHT----SVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--------Y 461 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~----~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 461 (701)
|.+.+.||+|+||.||+|.+... .||+|.+..... .....+.+|+.+++.++||||++++++|.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678899999999999998543 489998876532 224568899999999999999999998632 2
Q ss_pred CceEEeecCCCChhhHhccc---CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 462 GCLVYEYMENGSLEDRLFQK---DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
.+++|||+.+|+|.+++... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 37999999999999887432 22345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFS 615 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~ 615 (701)
+++.+...... .......+++.|++||++....++.++|||||||++|+|++ |++||..... ....+..+...
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 158 LSKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred cccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99876432210 01123346778999999999999999999999999999999 8899975433 22233333211
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
..+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 --------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112234458999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.38 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=197.8
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||++.+. +..||+|++.... ......+.+|+.++..++||||+.+++++.+ ..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999984 4569999986532 1223457889999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999986532 35788899999999999999999999 999999999999999999999999999866432
Q ss_pred CCcccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLD 619 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld 619 (701)
.. .......||+.|+|||++.+ +.++.++|||||||+||+|++|++||...+..... +.......-+.
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GT-----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred Cc-----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 11 11234579999999998875 56889999999999999999999999765433221 11111000011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRL 662 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l 662 (701)
+.. ...+..+.+++.+|+...+++ |+++.+++.|+|++-
T Consensus 231 ~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 231 SHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred Ccc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 111 122446889999998866554 578999999988753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.28 Aligned_cols=246 Identities=27% Similarity=0.468 Sum_probs=200.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
...+|.+.++||.|+||.||+|.+. +..+++|++..........+..|+.+++.++||||+++++++.+ ..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3456888999999999999999985 45699999887665556789999999999999999999998844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999986543 346899999999999999999999999 99999999999999999999999999987633211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
......++..|++||.+....++.++||||||+++|+|++ |+.||...... -..+..+. ....
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 225 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--------RMPC 225 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC--------cCCC
Confidence 1123446778999999988899999999999999999998 89999655422 12222111 0112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 234445689999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.36 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=196.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|.+.+.||+|+||.||+|.+.+ ..|++|.+....... ...|.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999854 458888876543222 3458999999999999999999998744 45
Q ss_pred ceEEeecCCCChhhHhcccCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEE
Q 005343 463 CLVYEYMENGSLEDRLFQKDN----SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---VSKIS 535 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~ 535 (701)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 899999999999998865432 235899999999999999999999999 99999999999998654 68999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcC
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNG 612 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~ 612 (701)
|||+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ....+..+
T Consensus 162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 162 DFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred cCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999987632211 011122334568999999999999999999999999999997 9999975432 22222211
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
. ...+|...+..+.+++.+||+.+|.+||++.+++.|
T Consensus 238 ~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 G--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 112233445578999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.34 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=189.5
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHH-HHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVE-ILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|++. +..||+|++..... .....+..|+. +++.++||||+++++.|.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 56699999865421 12234555554 6788999999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 9998887442 35788888899999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.. ...+..+. ...|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------LQLPGGK 219 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------CCCCCCC
Confidence 1124457999999999999989999999999999999999999999765432 12222111 1223334
Q ss_pred HHHHHHHHHHhhccCcCCCCCh----hhhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDL----VSVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~----~~vl~~~~~~ 661 (701)
...+.+++.+||+.+|.+||+. .+++.|.|+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence 4568999999999999999975 4888887764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.24 Aligned_cols=239 Identities=24% Similarity=0.362 Sum_probs=191.7
Q ss_pred eeeecCceeEEEEEE----CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec-CCCceEEeecCCCC
Q 005343 401 KIGEGGYGPVYKAQL----DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP-EYGCLVYEYMENGS 473 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~----~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~lV~Ey~~~gs 473 (701)
.||+|+||.||+|.+ .+..+|+|++...... ....+.+|+.+++.++||||++++|++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999976 2456999998755422 2356899999999999999999999984 44589999999999
Q ss_pred hhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccc
Q 005343 474 LEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQ 553 (701)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~ 553 (701)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 82 L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---~ 152 (257)
T cd05116 82 LNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---Y 152 (257)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe---e
Confidence 99988533 35889999999999999999999999 999999999999999999999999999876432211 0
Q ss_pred ccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHH
Q 005343 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 554 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
.......++..|+|||.+....++.++|||||||++|||+| |++||..... ....+..+... ..|...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM--------ECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCC
Confidence 11123345678999999988889999999999999999998 9999975432 33344433211 2233345
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+.+++.+||+.+|.+||++.+|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHH
Confidence 56899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.66 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=208.2
Q ss_pred eeeecCceeEEEEEECCce--EEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCCCc--eEEeecCCCChhh
Q 005343 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGC--LVYEYMENGSLED 476 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--lV~Ey~~~gsL~~ 476 (701)
.||+|.||+||-|++.++. +|||-+.........-+..||.+.+.|+|.|||+++|.|.++++ +.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999997776 68887766555556668999999999999999999999988775 7999999999999
Q ss_pred HhcccCCCCCC--ChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEEEEeeccccccCCCCCccccc
Q 005343 477 RLFQKDNSPPI--HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTITQ 553 (701)
Q Consensus 477 ~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~~~~~~~~~~~~ 553 (701)
+|..+ ..|+ .+.+.-.+..||++||.|||.+. |||||||-+|+|++ -.|.+||+|||-++.+..-.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 98544 3455 77888889999999999999999 99999999999996 58999999999998763221
Q ss_pred ccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHcCccccccCccCCCCCHHHH
Q 005343 554 YHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMG-LSHQVEQAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 554 ~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~-~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
....++.||+.|||||++..+. |+..+|||||||++.||.||+|||- +.+....+++-|.+. .-+..|.+.+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPeels 805 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEELS 805 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHHHH
Confidence 1235678999999999987764 9999999999999999999999995 333334456666543 2346678888
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+...+|.+|+..+|.+||++.++|..+|.+-.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 889999999999999999999999999998875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=330.08 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=196.4
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.++||+|+||.||++.+.+ ..||+|++.+.. ......+..|+.++..++||||+.+++.+.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468999999999999999999854 459999986422 1223347889999999999999999998844 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999986432 35888899999999999999999999 999999999999999999999999998765322
Q ss_pred CCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLD 619 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld 619 (701)
.. ......+||+.|+|||++. ...++.++|||||||+||||++|++||...+..... +...... .
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~-- 227 (332)
T cd05623 156 GT-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-F-- 227 (332)
T ss_pred Cc-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-c--
Confidence 11 1123457999999999876 356899999999999999999999999765533222 2111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~ 661 (701)
.....+...+..+.+++.+|+..++.+ ||++.+++.|+|+.
T Consensus 228 -~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 228 -QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred -cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 011111233456888999988654444 78999999998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.04 Aligned_cols=253 Identities=21% Similarity=0.262 Sum_probs=196.3
Q ss_pred hcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
...|.+.+.||+|+||.||+|.+.. ..||||... ...+.+|+++|++++|||||++++++.. ..|+||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999854 559999532 2346789999999999999999998743 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+ .++|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 578888875432 36899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCc---------hHHHHHHHcCcccccc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA-MGLS---------HQVEQAIRNGTFSELL 618 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p-f~~~---------~~~~~~i~~~~~~~~l 618 (701)
.......+||+.|+|||++.+..++.++|||||||+||||++|..| |... ..+...+....+....
T Consensus 316 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 ----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred ----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1112346799999999999999999999999999999999998754 3321 2233344332211000
Q ss_pred Cc-----------------------cCCCCCH--HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 DP-----------------------TVTGWPV--EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 d~-----------------------~~~~~p~--~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+ ....|.. .....+.+|+.+||+.||++||++.++|.|+|++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 00 0011211 1123578999999999999999999999999985
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.01 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=200.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--Cc----eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HT----SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~----~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+. +. .||+|++...... ....+.+|+.++..+.||||+.++++|.. ..++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 356899999999999999999873 32 3899998765432 24568899999999999999999999854 4579
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
+|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999988543 245899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
.... ........+++.|++||...+..++.++|||||||++|||+| |.+||.... .....+..+....
T Consensus 161 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----- 231 (279)
T cd05109 161 IDET----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP----- 231 (279)
T ss_pred cccc----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-----
Confidence 3221 111223345678999999988899999999999999999998 999996543 2333344332111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+...+..+.+++.+||..+|..||++.+++ +.|..+
T Consensus 232 ---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~-~~l~~~ 268 (279)
T cd05109 232 ---QPPICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRM 268 (279)
T ss_pred ---CCccCCHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHh
Confidence 1223345689999999999999999999987 555554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.06 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=201.0
Q ss_pred cCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.+|.+.+.||+|+||.||+|... ...+++|.+..........+.+|+.+++.++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35888999999999999999853 23488888865544445679999999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 465 VYEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1234899999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQA 608 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~ 608 (701)
+||+|||++....... .........++..|+|||++....++.++|||||||++|+|+| |++||..... ....
T Consensus 162 ~~l~dfg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCc----eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999997653221 1111234567889999999999999999999999999999999 9999854432 2223
Q ss_pred HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 609 i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+..+.... .+...+..+.+++.+||+.+|.+||++.+++ ..+..+
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~-~~l~~~ 282 (291)
T cd05094 238 ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIY-KILHAL 282 (291)
T ss_pred HhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHHHHH-HHHHHH
Confidence 33333221 1223345689999999999999999999996 455554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=330.29 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=198.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|++.+.||+|+||.||+|...+ +.||+|++...... ....+.+|+.++.++ +||||++++++|..
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 34579999999999999999997532 45999998754322 234578899999999 89999999998843
Q ss_pred -CCceEEeecCCCChhhHhcccCC--------------------------------------------------------
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN-------------------------------------------------------- 483 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 483 (701)
..+++|||+++|+|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 34789999999999998854321
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccccccccc
Q 005343 484 --SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561 (701)
Q Consensus 484 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~g 561 (701)
..++++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+..... ........+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~~~ 237 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARL 237 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCCCC
Confidence 136899999999999999999999999 99999999999999999999999999987633211 111234456
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---HHHHHHHcCccccccCccCCCCCHHHHHHHHHHH
Q 005343 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH---QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLA 637 (701)
Q Consensus 562 t~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li 637 (701)
+..|+|||++.+..++.++|||||||+||+|++ |.+||.... .....+..+... ..|......+.+++
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~ 309 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------RAPEYATPEIYSIM 309 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------CCCccCCHHHHHHH
Confidence 778999999999999999999999999999998 999986432 223333333221 11223345689999
Q ss_pred HHhhccCcCCCCChhhhhhH
Q 005343 638 LQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 638 ~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+||+.+|.+||++.+++.+
T Consensus 310 ~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.69 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=194.7
Q ss_pred CceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+|++.+.||+|+||.||+|.+... .+|+|++.... .....+.+|+++++.++||||+++++++.+ ..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999988544 59999886543 334578899999999999999999998854 44799999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 99999886543 36899999999999999999999999 99999999999999999999999999986532110
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCccCCCCCHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.......++..|+|||++.+..++.++||||||+++|+|+| |++||....... ..+..+. . ...|..
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~ 225 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----R---LYRPKL 225 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----c---CCCCCC
Confidence 01112234567999999999999999999999999999999 899997544322 2222221 0 112233
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+..+.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4556999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.97 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=196.7
Q ss_pred CceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.|.+.+.||+|+||.||+|.+.+ ..||+|++....... ...+.+|+.++..++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 47778899999999999998732 459999987654322 3458899999999999999999999854 4579
Q ss_pred EEeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 465 VYEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999885321 1235888899999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQA 608 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~ 608 (701)
+||+|||+++.+..... ........+++.|+|||.+..+.++.++|||||||++|||+| |.+||..... ....
T Consensus 163 ~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred eEecccccccccccchh----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999886532211 111234456789999999988889999999999999999998 8888865432 2223
Q ss_pred HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 609 i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+..+.. ...+..++..+.+++..||+.+|.+||++.+|+.
T Consensus 239 i~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQV--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCc--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333322 1223445556899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.49 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=199.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeec
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYM 469 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~ 469 (701)
..+.|.+.++||+|+||.||+|.. +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+ ..+++|||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence 346799999999999999999998 45679999987654 345679999999999999999999998744 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
.+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999885543 346899999999999999999999999 99999999999999999999999999987642211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p 626 (701)
.......++..|+|||++....++.++||||||+++|+|++ |++||...... ...+..+... ..+
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~ 225 (260)
T cd05067 158 ----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------PRP 225 (260)
T ss_pred ----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------CCC
Confidence 11123346778999999998899999999999999999999 99999654432 2222222111 112
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
...+..+.+++.+||..+|++||++.+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLR 254 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 22344699999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.92 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=197.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
..|.+.+.||+|+||.||+|.+. ++.|++|++.... .....+.+|++++..++||||++++++|.. ..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888999999999999999984 5669999987542 345678999999999999999999999844 447999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 9999999885432 345899999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p 626 (701)
.......++..|+|||++.+..++.++|||||||++|||++ |.+||...... ...+..+. ....+
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 227 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------RMERP 227 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCCC
Confidence 11122334668999999999999999999999999999998 99999754432 12222221 01223
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 334456999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.62 Aligned_cols=260 Identities=25% Similarity=0.288 Sum_probs=206.0
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|... +..||+|.+...... ....+..|++++..++||||+++++.+.+ ..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36899999999999999999984 567999998765433 34568899999999999999999999854 348999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999987543 3356899999999999999999999999 999999999999999999999999998765322
Q ss_pred CCccc-----------------------ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 005343 547 AADTI-----------------------TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH 603 (701)
Q Consensus 547 ~~~~~-----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 603 (701)
..... .........||..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11000 0011224578999999999998889999999999999999999999997665
Q ss_pred HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC----hhhhhhHHHHHH
Q 005343 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD----LVSVVLPELIRL 662 (701)
Q Consensus 604 ~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt----~~~vl~~~~~~l 662 (701)
......... .... ..... ...+..+.+++.+||..+|.+||+ +.+++.|+|++-
T Consensus 237 ~~~~~~~~~-~~~~---~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNIL-KKEV---TFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHHh-cCCc---cCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 432221110 0000 01110 113556999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=310.10 Aligned_cols=244 Identities=30% Similarity=0.470 Sum_probs=197.2
Q ss_pred cCceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecCC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYMEN 471 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~~ 471 (701)
++|.+.+.||+|+||.||+|.+.+. .+++|.+.... .....+.+|+.+++.++|||++++++++.+ ..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 5689999999999999999998554 69999876543 345678999999999999999999998854 44899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 99999886532 345889999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCccCCCCCHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.......++..|+|||+..+..++.++|||||||++|+|+| |++||....... ..+..+ +. ...+..
T Consensus 158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-------~~~~~~ 227 (260)
T cd05069 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YR-------MPCPQG 227 (260)
T ss_pred --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC-------CCCCcc
Confidence 01123346778999999988899999999999999999999 899997554322 122211 10 112234
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+..+.+++.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~ 254 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQ 254 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 455699999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.98 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=198.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|.+.+.||+|+||.||+|.+.+ ..|++|.+..... .....+.+|+.+++.++||||++++|++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4679999999999999999998743 4599999865532 223468899999999999999999999844 45
Q ss_pred ceEEeecCCCChhhHhcccCC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 463 CLVYEYMENGSLEDRLFQKDN-------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999865322 234788999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcC
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNG 612 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~ 612 (701)
|||+++.+...... .......++..|+|||.+.++.++.++|||||||++|||+| |.+||..... ....+..+
T Consensus 162 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999865432110 11233456789999999988889999999999999999998 9999965432 22222222
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.. ...|...+..+.+++.+||..+|.+||++.+++.
T Consensus 238 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 21 1122333556899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.79 Aligned_cols=240 Identities=26% Similarity=0.413 Sum_probs=196.7
Q ss_pred cCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec---CCCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP---EYGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~---~~~~lV~Ey~~ 470 (701)
.+|.+.+.||+|+||.||++...++.|++|.+... .....+.+|+.+++.++|||++++++++. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 46889999999999999999999999999998654 33567899999999999999999999753 23589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999885533 345889999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
....++..|+|||++....++.++|||||||++|+|++ |++||..... ....+..+... ..+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------DAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------CCCC
Confidence 22344568999999998899999999999999999998 9999865432 22333332111 1222
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.43 Aligned_cols=241 Identities=25% Similarity=0.278 Sum_probs=188.0
Q ss_pred eeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHH-HHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVE-ILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|++. +..||+|++..... .....+..|.. +++.++||||+.+++.+.+ ..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999984 45599999865321 12233444444 5678999999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 9999988543 34778888889999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+..... ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------QLKPNI 219 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---------CCCCCC
Confidence 11245679999999999999999999999999999999999999997654332 22222111 111233
Q ss_pred HHHHHHHHHHhhccCcCCCCChh----hhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLV----SVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~----~vl~~~~~~ 661 (701)
+..+.+++.+||+.+|.+||+.. +++.|.|+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~ 255 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS 255 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence 44689999999999999999876 677776653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=353.79 Aligned_cols=247 Identities=28% Similarity=0.455 Sum_probs=203.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC---Cc----eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD---HT----SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--G 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~---~~----~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 462 (701)
..+-.+.+.||+|+||.||.|... +. .||||.+..... +....|.+|..+|+.++|||||+++|+|.+. .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445677889999999999999973 22 399999877643 3456799999999999999999999999653 4
Q ss_pred ceEEeecCCCChhhHhcccC----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 463 CLVYEYMENGSLEDRLFQKD----NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
++++|||+||+|..+|.... ....++....+.++.|||.|+.||++++ +|||||-..|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 89999999999999996541 2456889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccc-ccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---HHcCc
Q 005343 539 LARLVPPSAADTITQYHMTTA-AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQA---IRNGT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~---i~~~~ 613 (701)
||+.+-.. ..|+.... .-...|||||.++.+.++.++|||||||+|||++| |..||+..+..+-. .+.|+
T Consensus 848 lArDiy~~-----~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 848 LARDIYDK-----DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred hhHhhhhc-----hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 99954221 11222222 23458999999999999999999999999999999 88999877654332 33442
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+.|..|+..+.+++.+||+.+|.+||++..|+.
T Consensus 923 ---------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ---------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2346677778999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.84 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=205.3
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.|...+.||.|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++.+.+ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4777889999999999999874 56799999875432 234568899999999999999999999854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.. .++++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 99999998843 35788899999999999999999999 9999999999999999999999999997663321
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.......++..|+|||++.+..++.++|+|||||++|+|+||.+||............ .. ......+...
T Consensus 156 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~---~~~~~~~~~~ 225 (277)
T cd06640 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---PK---NNPPTLTGEF 225 (277)
T ss_pred ----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---hc---CCCCCCchhh
Confidence 1123346888999999998888999999999999999999999999754432211110 00 0012233456
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
+..+.+++.+||..+|.+||++.+++.|+|+......
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 6779999999999999999999999999998765554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.08 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=195.1
Q ss_pred ceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
|.+.+.||+|+||.||+|.+.. ..||+|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998732 45999998765432 23568999999999999999999998732
Q ss_pred CCceEEeecCCCChhhHhcccC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 461 YGCLVYEYMENGSLEDRLFQKD---NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
..+++|||+++|+|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 2479999999999999885432 2246899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCcc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTF 614 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~ 614 (701)
|+++.+...... .......++..|+|||++....++.++|||||||++|||++ |.+||...... ...+..+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred cceeeccccccc----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999876432211 11122345678999999988889999999999999999999 88998655432 222222221
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...|...+..+.+++.+||..+|.+||++.+++.
T Consensus 234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223344557999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.30 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=205.2
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
++|++.+.||.|+||.||+|.. .+..+++|++..... .....+.+|+.+++.++|||++++++.+. +..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999997 455699999875442 24567899999999999999999999874 345899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++........+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865443356899999999999999999999999 99999999999999999999999999987644321
Q ss_pred cccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCC-
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP- 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p- 626 (701)
.. ........|+..|++||++... .++.++|+|||||++|+|++|+.||............... ..+......
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccc
Confidence 10 0112345689999999988777 7899999999999999999999999765443222111000 111111111
Q ss_pred -HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 627 -VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 627 -~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 2334568999999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.82 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=202.7
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~~ 471 (701)
|.....||+|+||.||+|.. .++.|++|++..........+.+|+.++..++||||++++++|. +..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999987 46779999987655555667899999999999999999999874 455899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--- 172 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--- 172 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc---
Confidence 999987632 35889999999999999999999999 99999999999999999999999999876533211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
......|+..|+|||++.+..++.++|||||||++|+|++|++||................ .+.... +...+.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~ 245 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKN-AHKISP 245 (297)
T ss_pred ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CCCccc-cCCCCH
Confidence 1234578999999999998899999999999999999999999997554433222111100 011111 112234
Q ss_pred HHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 632 SIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
.+.+++.+||+.+|.+||++.+++.|+|+.-...
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 5899999999999999999999999999875444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.40 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=196.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.+|...++||+|+||.||++... +..+++|.+..........+.+|+++++.++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45788899999999999999742 34589998776544445679999999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCC------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 465 VYEYMENGSLEDRLFQKDN------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
+|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865421 135889999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i 609 (701)
||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |++||....... ..+
T Consensus 162 kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999976532211 011233445788999999999999999999999999999998 899986543322 222
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+... ..+...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGREL--------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222111 112233456899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.28 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=198.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|.+.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+++++.++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46899999999999999999984 566999987654332 24568899999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|..+... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999988876532 234899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cccc-------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTFS------- 615 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~~------- 615 (701)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|++||............ +.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1234568899999998765 45788999999999999999999999765543221110 0000
Q ss_pred -------cccCccCCC------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 616 -------ELLDPTVTG------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 616 -------~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
....+.... .....+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000011000 011234568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=319.06 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=211.0
Q ss_pred ceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
|.++++||+|+||.||++.++. .-+|||.+..+ .+..++.+|+.||.+++.|++|++||.|.. ..++|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 7888999999999999999854 45899987544 678899999999999999999999998744 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+..|.+..+ ..+|++..+..++...+.||.|||... -||||||..||||+.+|+.||+|||.|..+..
T Consensus 113 GSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD------ 181 (502)
T KOG0574|consen 113 GSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD------ 181 (502)
T ss_pred CcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh------
Confidence 9999988543 357999999999999999999999998 89999999999999999999999999976632
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
+--+..+..||+.|||||++..-.|+.++||||||+...||.-|+||+..-+..+.++--.+- -.|.. .-|...+.
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~---PPPTF-~KPE~WS~ 257 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK---PPPTF-KKPEEWSS 257 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC---CCCCC-CChHhhhh
Confidence 223457789999999999999999999999999999999999999999877765443322111 11111 12445566
Q ss_pred HHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 632 SIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+.+++..||-.+|++|-++.+++.|.|.+
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 799999999999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.18 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=196.9
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|+..+.||.|+||.||+|+. .++.|+||.+...... ....+.+|++++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588999999999999999998 4567999988754322 23568899999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68888775433 346899999999999999999999999 99999999999999999999999999886533211
Q ss_pred cccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---c-Cc----------
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---N-GT---------- 613 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---~-~~---------- 613 (701)
......+++.|+|||++.+.. ++.++|||||||++|+|+||++||........... . +.
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 123345788999999876544 68899999999999999999999976554322211 0 00
Q ss_pred --------cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 --------FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 --------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+..................+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00000000000011123457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.55 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=200.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-----ChHHHHHHHHHHHhCCCCcEEEEeceecC----CC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-----GPRQFKQEVEILGSMRHTNMVILLGACPE----YG 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~ 462 (701)
.+|.+.+.||+|+||.||+|.+. +..|+||.+...... ....+.+|+.++..++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999984 566999988643211 12457889999999999999999998854 23
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 6899999999999988543 34788888999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
+..... .........|+..|+|||.+.+..++.++|||||||++|+|++|++||............ . ..+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~----~~~~~ 227 (265)
T cd06652 156 LQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-A----TQPTN 227 (265)
T ss_pred cccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-h----cCCCC
Confidence 532110 011123456899999999998888999999999999999999999999765443332221 1 11112
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...|......+.+++.+|+ .+|.+||++.+|+.|+|.
T Consensus 228 ~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264 (265)
T ss_pred CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCccc
Confidence 2334455566889999999 499999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.93 Aligned_cols=255 Identities=28% Similarity=0.358 Sum_probs=202.4
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV~ 466 (701)
++|...+.||.|+||.||+|.+ .++.+|+|.+..... .....+.+|+++++.++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4689999999999999999998 456699999876543 234568999999999999999999998843 348999
Q ss_pred eecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23456888999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHcCcccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-------QVEQAIRNGTFSELL 618 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-------~~~~~i~~~~~~~~l 618 (701)
.. .....++..|++||.+.+..++.++|||||||++|+|++|+.||.... .....+.......+.
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 21 123457889999999999999999999999999999999999997551 111222211111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+..... ...+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 230 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 230 DEPGNG--IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred cCCCCC--CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 110000 12234689999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.75 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=196.9
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-- 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 460 (701)
...++|.+.+.||+|+||.||+|... ...||+|.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999763 235999987654322 22357889999999999999999998844
Q ss_pred CCceEEeecCCCChhhHhcccC-------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEE
Q 005343 461 YGCLVYEYMENGSLEDRLFQKD-------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
..++||||+++|+|.+++.... ..+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 4589999999999999996532 1345677888999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHH
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIR 610 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~ 610 (701)
|+|||+++.+..... ........++..|+|||.+.++.++.++|||||||++|||++ |.+||..... ....+.
T Consensus 160 L~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred ECcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999986533211 111123345778999999999999999999999999999998 7889865442 222222
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+... ..+...+..+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 236 DGGYL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred cCCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22211 122233456999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.45 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=216.6
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
.+-|.+.+.||+|.|..|-+|++ .+..||||++.+...+. ..++.+|+..|+.++|||||.||.+... ..|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688889999999999999987 67779999998766443 4568999999999999999999999754 459999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE-cCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL-DQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl-~~~~~~KL~DFGla~~~~~ 545 (701)
|+-++|+|.|++.++.. .+.+....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|.+||+|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999988764 4889999999999999999999999 9999999999977 4679999999999987765
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLG-VKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
+. +.++.||++.|-|||++.+..|+ +.+||||||||||-|++|++||...++-+. +.-++|-. ..
T Consensus 172 G~-------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LTmImDCK-Yt 237 (864)
T KOG4717|consen 172 GK-------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LTMIMDCK-YT 237 (864)
T ss_pred cc-------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hhhhhccc-cc
Confidence 43 46788999999999999999885 689999999999999999999986655332 22233332 24
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.|.....+..+||..||..+|++|.++.+|+.+.|.+--|
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 5777788899999999999999999999999999998644
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=310.54 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=197.7
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|+. .++.||||.+....... ...+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999997 56779999876533222 3458899999999999999999998743 458999
Q ss_pred eecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+++|+|.+++.... ....++...+..++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 2345788999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHcCccccccCcc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----~~~~~i~~~~~~~~ld~~ 621 (701)
.. .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... .....+..+.+ +.
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~ 227 (267)
T cd08228 159 KT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----PP 227 (267)
T ss_pred hh------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-----CC
Confidence 21 11234568899999999988889999999999999999999999985432 12222222221 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
. .+...+..+.+++.+||..+|.+||++.+|+.
T Consensus 228 ~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 L--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred C--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1 11234456899999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.85 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=201.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecC
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYME 470 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 470 (701)
.|.....||+|+||.||++.. .+..||||.+..........+.+|+.+++.++||||+++++.+. +..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 455557799999999999987 45669999987655445567899999999999999999999874 45589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999987732 24789999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
......|+..|+|||++....++.++|||||||++|||++|+.||............ .....+.... .....
T Consensus 174 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~ 245 (292)
T cd06658 174 ----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRVKD-SHKVS 245 (292)
T ss_pred ----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCcccc-ccccC
Confidence 123456899999999998888999999999999999999999999765433221110 0011111111 11234
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+.+++.+||..+|.+||++.+++.|+|++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 46889999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.16 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=207.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
.++|.+.+.||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++||||+++++.|. +..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36799999999999999999987 45679999987655455567899999999999999999999984 455899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 24788899999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
......|++.|++||++....++.++|||||||++|+|++|++||...+........+... .+... .+..
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~~-~~~~ 240 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPELQ-NPEK 240 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC---CCCCC-Cccc
Confidence 1234568899999999988889999999999999999999999997665433222111100 01111 1223
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.+..+.+++.+||..+|.+||++.+++.|+|++...
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 345689999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=309.83 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=198.7
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
+|.+.+.||+|+||.||++.+. +..|++|.+.... ....+.+.+|+.+++.++||||+++++.+.+ ..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999984 5569999886543 2334568899999999999999999998854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++... ....+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999999887543 3345789999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......|++.|+|||++.+..++.++|+||||+++|+|++|++||...+... ..+..+.+.. .+.
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--------LPS 222 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC--------CCc
Confidence 11234578999999999999899999999999999999999999997655322 2223333221 122
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 33445899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.83 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=200.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||.|+||.||+|.+ .++.|++|++..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488999999999999999998 466799999876542 234678999999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+ +++|.+++.... .++++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885433 56899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-Cc--------cc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-GT--------FS 615 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~~--------~~ 615 (701)
.......|+..|+|||++.+. .++.++|||||||++|+|+||.+||......... +.. +. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345789999999987654 4689999999999999999999998765432211 110 00 00
Q ss_pred c------ccCccCC-----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 616 E------LLDPTVT-----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 616 ~------~ld~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+ +..+... ....+....+.+++.+||..+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0 0000000 0011234678999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.25 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=189.9
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.+|.+.+.||+|+||.||+|...+ ..||+|+.... ....|+.+++.++||||++++++|.+ ..|+||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 469999999999999999999854 46999975432 23579999999999999999999844 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
.|+|.+++... ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 140 -~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 140 -SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred -CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 56888887543 346899999999999999999999999 999999999999999999999999999753211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCch------------HHHHHHHc-Cccc
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH------------QVEQAIRN-GTFS 615 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~------------~~~~~i~~-~~~~ 615 (701)
.......||+.|+|||++.+..++.++|||||||++|||+++. ++|.... .....+.. +...
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 211 ----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1123457999999999999999999999999999999999854 4544321 01111110 0000
Q ss_pred cccC--c-----------------cCCCCC----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 ELLD--P-----------------TVTGWP----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~ld--~-----------------~~~~~p----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+. + ....++ ...+..+..++.+||+.||.+|||+.++|.|+|++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0000 0 000000 01123456799999999999999999999999986
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.12 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=192.8
Q ss_pred ceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC----CCce
Q 005343 396 FSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCL 464 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~l 464 (701)
|.+.+.||+|+||.||++.+ .+..||+|++..... .....+.+|+++|+.++||||++++++|.. ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48899999999999988764 345699999876532 234568899999999999999999998743 2479
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 24899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHcC-------cccc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQAIRNG-------TFSE 616 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~i~~~-------~~~~ 616 (701)
..... ........++..|+|||++....++.++|||||||++|+|+||..|+..... ....+... .+..
T Consensus 159 ~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred Ccchh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 32110 0011223456779999999888899999999999999999999988864321 11111100 0000
Q ss_pred ccCcc-CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 617 LLDPT-VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 617 ~ld~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.++.. ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11110 01123334567999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.95 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=201.6
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|++.+.||+|+||.||++.. .+..|++|.+..... .....+.+|+.++++++||||+++++.+.+ ..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488999999999999999988 456799998865422 234568999999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+.+++|.+.+.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 99999999885432 345789999999999999999999999 9999999999999999999999999997653211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~~~~~~p 626 (701)
.......|++.|+|||++.+..++.++|+|||||++|+|+||+.||......... +..+.. ...+
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY--------PPVS 222 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC--------CCCc
Confidence 1123346888999999999888999999999999999999999999755432221 122221 1122
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...+..+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 3345568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.99 Aligned_cols=247 Identities=22% Similarity=0.347 Sum_probs=202.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
+|+..+.||.|+||.||.+.. ++..+++|.+.... ......+.+|++++++++||||+++++++.+. .+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999998887 45669999876543 23345688999999999999999999998554 3789999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+.+.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999886543 356899999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p 626 (701)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+. .+..+.+.. .+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--------VV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------Cc
Confidence 12345789999999999888899999999999999999999999976543222 223333221 12
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
...+..+.+++.+||..+|.+||++.+++.|.|
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 233456899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.99 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=197.5
Q ss_pred hcCceeeeeeeecCceeEEEEEECC------------------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH------------------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~------------------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~ 453 (701)
..+|++.+.||+|+||.||+|.+.. ..||+|.+...... ....+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568999999999999999998743 34899998766433 3456889999999999999999
Q ss_pred EeceecC--CCceEEeecCCCChhhHhcccC--------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 005343 454 LLGACPE--YGCLVYEYMENGSLEDRLFQKD--------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523 (701)
Q Consensus 454 l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~N 523 (701)
++++|.. ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999854 4589999999999999986543 1236899999999999999999999999 9999999999
Q ss_pred eeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 005343 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL 601 (701)
Q Consensus 524 ILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~pf~~ 601 (701)
||++.++.+||+|||+++.+..... ........+++.|+|||++..+.++.++|||||||++|+|++ |.+||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcc----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999976532211 111234456788999999988899999999999999999998 6788865
Q ss_pred chHHHH--HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 602 SHQVEQ--AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 602 ~~~~~~--~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
...... ..... +...........+...+..+.+++.+||+.+|.+||++.+|+
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 237 LTDQQVIENAGHF-FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred cChHHHHHHHHhc-cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 432211 11111 000000111112233345799999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.76 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=199.6
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-----ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-----GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
+|.+.+.||+|+||.||+|.+. ++.|+||.+...... ....+..|+++++.++||||+++++++.+ ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999984 567999998765433 22346789999999999999999999865 44899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++..+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999885432 36899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-C--------
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-G-------- 612 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~-------- 612 (701)
.. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||......... ... +
T Consensus 155 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PN------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CC------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 21 11233467889999998754 45789999999999999999999988655432211 110 0
Q ss_pred ---ccccccC------ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 613 ---TFSELLD------PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 613 ---~~~~~ld------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
....... ..........+..+.+++.+||..+|++||++.+++.|+|++=
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0000000 0000011223456899999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.49 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=206.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||+|+||.||+|... +..|++|++..... .....+.+|+.++..++|||++++++++.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999985 56699999877654 335679999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++++|.+++... .++++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 99 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
. ......++..|+|||.+.+..++.++|+||||+++|+|+||++||.... .....+..-. ......+
T Consensus 155 ~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 223 (264)
T cd06623 155 D------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-----DGPPPSL 223 (264)
T ss_pred C------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-----cCCCCCC
Confidence 1 1124568899999999999999999999999999999999999997653 2222221111 1111122
Q ss_pred CHH-HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVE-AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~-~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.. .+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 223 4557999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.68 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=200.0
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecCC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPEY 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 461 (701)
...++|.+.+.||+|+||.||++.+.+ ..+|+|.+..... .....+.+|++++..+ +||||++++++|...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345679999999999999999998742 3599999876432 2234588999999999 899999999998544
Q ss_pred --CceEEeecCCCChhhHhccc-------------CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 462 --GCLVYEYMENGSLEDRLFQK-------------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
.+++|||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 48999999999999998543 22456899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH-
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ- 604 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~- 604 (701)
+.++.+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCccccccccccccc----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999987643211 011122345678999999988899999999999999999998 9999865432
Q ss_pred -HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 605 -VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 605 -~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
....+..+.. ...+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2233332221 12233344568999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.38 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=193.8
Q ss_pred cCceeeeeeeecCceeEEEEEECC--------------c--eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--------------T--SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLG 456 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--------------~--~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g 456 (701)
++|++.+.||+|+||.||++...+ + .||+|.+...... ....|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568999999999999999997632 1 3899998765332 2346899999999999999999999
Q ss_pred eec--CCCceEEeecCCCChhhHhcccC---------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 457 ACP--EYGCLVYEYMENGSLEDRLFQKD---------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 457 ~~~--~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
++. ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 984 34589999999999999885432 1234788999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCch
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH 603 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~~ 603 (701)
++.++.+||+|||++..+..... ........++..|+|||++..+.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999976533211 111233456788999999998999999999999999999998 567886543
Q ss_pred HHHHHHHc-Cc-cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 604 QVEQAIRN-GT-FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 604 ~~~~~i~~-~~-~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
... .+.. .. +...........+...+..+.+|+.+||+.+|.+||++.+|+
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 238 DEQ-VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred hHH-HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 211 1110 00 000000011111222345699999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.93 Aligned_cols=234 Identities=25% Similarity=0.414 Sum_probs=184.0
Q ss_pred eeeeecCceeEEEEEECC--------------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 400 RKIGEGGYGPVYKAQLDH--------------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--------------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
+.||+|+||.||+|.... ..|++|++..........|.+|+.++..++||||+++++++.+ ..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2488898876554445578899999999999999999999844 458
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc-------EEEEe
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV-------SKISD 536 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-------~KL~D 536 (701)
+||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998877543 245899999999999999999999999 999999999999987654 89999
Q ss_pred eccccccCCCCCcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCchHHHHH-HHcCc
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLI-TARPAMGLSHQVEQA-IRNGT 613 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~-i~~~~ 613 (701)
||++..+.. .....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+.. +..+.
T Consensus 156 ~g~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (262)
T cd05077 156 PGIPITVLS----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ 225 (262)
T ss_pred CCCCccccC----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC
Confidence 999865421 12346788999999876 466899999999999999998 588888654322211 11111
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
+. . . ......+.+|+.+||+.+|.+||++.+|+.+
T Consensus 226 ~~-~----~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 CM-L----V----TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cc-C----C----CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11 1 1 1112458999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.13 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=192.9
Q ss_pred cCceeeeeeeecCceeEEEEEECCc----eEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT----SVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~----~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV 465 (701)
++|.+.+.||+|+||.||+|..... .+++|.++.... .....+.+|+.++.++ +||||+++++++.+. .++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 5688999999999999999987432 368888764322 2345689999999999 799999999998543 4899
Q ss_pred EeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 466 YEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
|||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985432 1235889999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i 609 (701)
||+|||++...... ........+..|+|||++....++.++|||||||++|+|+| |.+||...... ...+
T Consensus 159 kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVY-------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCccccce-------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998643211 01112233567999999988899999999999999999998 99999654322 1222
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
..+.. ...+...+..+.+++.+||..+|.+||++.+++..
T Consensus 232 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 PQGYR--------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hcCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22211 11222344568999999999999999999999755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.82 Aligned_cols=243 Identities=33% Similarity=0.499 Sum_probs=199.1
Q ss_pred eeeeecCceeEEEEEEC-----CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|... +..|++|++....... ...+.+|++++..++|||++++++++.+ ..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999985 5679999998765443 5678999999999999999999999855 44899999999
Q ss_pred CChhhHhcccCC------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 472 GSLEDRLFQKDN------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 472 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
... ........+++.|+|||.+....++.++|||||||++|+|++ |.+||..... ....+..+. .
T Consensus 158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~ 225 (262)
T cd00192 158 DDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------R 225 (262)
T ss_pred ccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 321 112244567889999999988899999999999999999999 6999976543 222222221 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233445679999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.03 Aligned_cols=239 Identities=27% Similarity=0.415 Sum_probs=191.6
Q ss_pred eeeeecCceeEEEEEECC-----ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~~g 472 (701)
++||+|+||.||+|.+.. ..||+|.+...... ....+.+|+.+++.+.||||+++++++.. ..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 469999999999998722 45999998766543 34568999999999999999999998843 458999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+++.... .+++..+..++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 9999985433 6899999999999999999999999 999999999999999999999999999876432211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
........++..|+|||.+....++.++|||||||++|+|++ |++||..... +...+..+.. ...|...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER--------LPRPEEC 223 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--------CCCCCCC
Confidence 001112234568999999998899999999999999999998 9999975443 2233333221 1122334
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~ 249 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELE 249 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 45689999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.49 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=202.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE-------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-------- 460 (701)
.+++|.+.+.||.|+||.||+|... +..+++|++.... .....+.+|+.+++++ .||||++++++|.+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999984 4569999987654 2346789999999999 79999999999833
Q ss_pred CCceEEeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 2479999999999999885432 2456899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cC
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NG 612 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~ 612 (701)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|+||++||........... .+
T Consensus 160 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 160 SAQLDSTL------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ceecccch------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 87653321 11234568999999998753 3477899999999999999999999975443222221 11
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.. +.. ..+...+..+.+++.+||..+|.+||++.+++.|+|.
T Consensus 234 ~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11 111 1122344568999999999999999999999999873
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.28 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=198.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC---C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE---Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~ 461 (701)
..++|.+.+.||+|+||.||+|.+.. ..|++|++...... ....+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35679999999999999999999844 56999988654322 23558899999999999999999998743 4
Q ss_pred CceEEeecCCCChhhHhcccCCC-----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNS-----PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
.+++++|+.+|+|.+++...... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 58999999999999998654322 56899999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCc
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGT 613 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~ 613 (701)
||+++.+.+.... .......++..|+|||++....++.++|||||||++|+|++ |++||...... ...+..+.
T Consensus 161 ~g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 161 NALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred CCCcccccCCceE----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999866433211 11123346778999999988889999999999999999999 99999755432 22222221
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
. ...+..++..+.+++.+||..+|++||++.+++
T Consensus 237 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 237 R--------LAQPINCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred C--------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 1 011223345689999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=308.78 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=202.4
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV~ 466 (701)
+|.+.+.||.|+||.||++.+ .+..|++|++...... ....+..|+.+++.++||||+++++++.. ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478899999999999999988 4456999988754322 23458889999999999999999987632 237999
Q ss_pred eecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 467 EYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLH-----QNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
||+++++|.+++... ....++++..+..++.||+.||.||| +.+ |+|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988653 23457899999999999999999999 667 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCcccccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELL 618 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~l 618 (701)
..+..... ......|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+. ....+..+.+
T Consensus 158 ~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 227 (265)
T cd08217 158 KILGHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---- 227 (265)
T ss_pred ccccCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC----
Confidence 87643211 12345789999999999988899999999999999999999999976542 2233333322
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
...+...+..+.+++.+|+..+|.+||++.+|+.|+|
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 2233344567899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.89 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=201.4
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-----CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-----QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
+|...+.||+|+||.||+|.. ++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 367778999999999999998 467799998865432 134568999999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999988543 35889999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCcccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.. ......|+..|++||.+.... ++.++|+|||||++|+|++|++||+...........+.... ...
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CCC
Confidence 21 123456889999999887766 89999999999999999999999976654444333222111 112
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.+......+.+++.+||..+|.+||++.+++.|+|
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 22334456899999999999999999999999886
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.83 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=195.7
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|.+.+.||.|+||.||+|.. .++.||||.+...... ....+.+|+++++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999998 4567999998765432 23457789999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+. ++|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 997 58988875433 36889999999999999999999999 9999999999999999999999999987542211
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH----Hc-C-----c---
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI----RN-G-----T--- 613 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i----~~-~-----~--- 613 (701)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+ .. + .
T Consensus 158 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 158 ------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 11123457889999998765 458999999999999999999999996554211111 10 0 0
Q ss_pred ------cccccCccCCC------CC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 ------FSELLDPTVTG------WP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 ------~~~~ld~~~~~------~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+.....+.... ++ ......+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000000 00 0011457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=313.96 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=199.2
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
+|++.+.||.|+||.||+|++. +..||||++...... ....+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999984 566999998766433 34567889999999999999999999854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
+ |+|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 588888765554457899999999999999999999999 99999999999999999999999999976532211
Q ss_pred ccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHcC-------------
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRNG------------- 612 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~~------------- 612 (701)
......++..|++||++.+ ..++.++|||||||++|+|++|++||......+. .+...
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1234467889999998765 4578999999999999999999999976543221 11100
Q ss_pred ------ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 ------TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 ------~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+....+.....+....+..+.+++.+|++.+|.+||++.+++.|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000000000000111224458899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.37 Aligned_cols=239 Identities=24% Similarity=0.369 Sum_probs=190.3
Q ss_pred eeeecCceeEEEEEEC----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecCCCCh
Q 005343 401 KIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYMENGSL 474 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~~gsL 474 (701)
.||+|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||++++++|.. ..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999863 234999998765432 23568999999999999999999999854 45899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+...... ..
T Consensus 82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~ 153 (257)
T cd05115 82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YK 153 (257)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc---ee
Confidence 9988543 246899999999999999999999999 999999999999999999999999999865332110 01
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
......+++.|+|||++....++.++|||||||++|+|++ |.+||..... +...+..+.. ...|..++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 225 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------LDCPAECPP 225 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------CCCCCCCCH
Confidence 1122334678999999988889999999999999999996 9999965432 2233333321 122334456
Q ss_pred HHHHHHHHhhccCcCCCCChhhhh
Q 005343 632 SIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+.+++.+||..+|++||++.+|.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVE 249 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHH
Confidence 789999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.60 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=199.5
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYME 470 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 470 (701)
.++|.+.+.||.|+||.||+|...++.|++|.+..... ....+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 34688899999999999999999999999999976643 4667999999999999999999999985 34589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999998855432 35899999999999999999999999 9999999999999999999999999998763211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
....++..|+|||++..+.++.++||||||+++|+|++ |+.||..... ....+..+.. ...+.
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------MEAPE 222 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------CCCcc
Confidence 12345678999999998899999999999999999997 9999865532 2222222211 01122
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 33456899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.06 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=193.6
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ce--EEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TS--VAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~--vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV 465 (701)
++|.+.+.||+|+||.||+|.+.. .. +++|.+..... .....+.+|+.++.++ +||||++++++|.+ ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 568999999999999999999743 32 57777654322 2345688999999999 89999999999854 45899
Q ss_pred EeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 466 YEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
|||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i 609 (701)
||+|||++...... .......++..|+|||++....++.++|||||||++|+|+| |.+||......+ ..+
T Consensus 164 kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchh-------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999998632110 01122234677999999988889999999999999999998 999986443221 112
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..+. ....+...+..+.+++.+||+.+|.+||++.+++.....
T Consensus 237 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred hcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1110 011122234468999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=314.93 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=194.8
Q ss_pred CceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
+|.+.+.||+|+||.||+|.... ..+++|.+...... ....+.+|+.+++.++||||+++++.|.. ..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998632 34888888655422 23568899999999999999999999844 4589
Q ss_pred EEeecCCCChhhHhcccC---------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 005343 465 VYEYMENGSLEDRLFQKD---------------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~N 523 (701)
||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999999 9999999999
Q ss_pred eeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005343 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS 602 (701)
Q Consensus 524 ILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 602 (701)
||++.++.+||+|||+++.+..... ........++..|+|||++.+..++.++||||||+++|+|+| |.+||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986533211 111233456778999999988889999999999999999999 99999754
Q ss_pred hHH--HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 603 HQV--EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 603 ~~~--~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
... ...+..+.. ...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 322 222222210 1112233456899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.82 Aligned_cols=239 Identities=25% Similarity=0.393 Sum_probs=189.2
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
+.||+|+||.||+|++ .++.||+|.+...... ....+.+|+++++.++||||++++++|.. ..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999988 5677999987654322 24568999999999999999999999844 44899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 151 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA----S 151 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc----c
Confidence 9988543 245889999999999999999999999 999999999999999999999999998765321100 0
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
......++..|+|||++.++.++.++|||||||++|+|++ |.+||..... ....+..+.. ...+...+.
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 223 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------LPCPELCPD 223 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--------CCCcccCCH
Confidence 0112233567999999999999999999999999999998 8899864332 2222222111 112333455
Q ss_pred HHHHHHHHhhccCcCCCCChhhhh
Q 005343 632 SIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHH
Confidence 689999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.47 Aligned_cols=241 Identities=24% Similarity=0.228 Sum_probs=189.4
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhC---CCCcEEEEeceecC--CCceEEeecCC
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSM---RHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
||+|+||.||+|++. +..||+|++..... .....+..|..++..+ +||||+.+++.+.+ ..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999984 56799999864321 1223456677777665 69999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 9999888543 45889999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
......+||+.|+|||++.+. .++.++|||||||++|+|+||+.||...... ...+..+... +.. ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~~--~~ 220 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR------FPK--NV 220 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC------CCC--cc
Confidence 112456799999999988754 4899999999999999999999999765432 2223333211 110 11
Q ss_pred HHHHHHHHHHHhhccCcCCCC----ChhhhhhHHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRP----DLVSVVLPELIRL 662 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RP----t~~~vl~~~~~~l 662 (701)
.+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 234578999999999999998 6899999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.57 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=197.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCC-CCcEEEEeceecC--C-----
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMR-HTNMVILLGACPE--Y----- 461 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~----- 461 (701)
++|++.+.||+|+||.||+|.+. ++.||+|.+...... ....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999984 567999987665322 2356888999999995 6999999998732 2
Q ss_pred CceEEeecCCCChhhHhcccCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeec
Q 005343 462 GCLVYEYMENGSLEDRLFQKDN--SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVG 538 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFG 538 (701)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 4799999975 78888754322 356899999999999999999999999 999999999999998 8999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~ 613 (701)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...........- +.
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9986532211 1233467889999998755 45799999999999999999999999766544332210 00
Q ss_pred cccccCcc---------CCCC--------CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 FSELLDPT---------VTGW--------PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 ~~~~ld~~---------~~~~--------p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
......+. ...+ ....+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00000000 0000 012345689999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=314.03 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=193.7
Q ss_pred cCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec----CCCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----EYGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~ 463 (701)
..|++.+.||+|+||.||+|.. .+..|++|.+..........+.+|+++++.++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999985 24569999987665444567899999999999999999999863 2347
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999885432 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHcCccc-------
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQAIRNGTFS------- 615 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~i~~~~~~------- 615 (701)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+..... ....+......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 4322110 011122345569999999988999999999999999999998866543321 11111100000
Q ss_pred -cccC-ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 616 -ELLD-PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 616 -~~ld-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+. ......+...+..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000 0000112233456999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.02 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=198.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||+|... ++.|++|.++..... ....+.+|++++++++|+|++++++.+.+ ..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999984 677999988653322 24568999999999999999999998844 448999
Q ss_pred eecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 23456899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHcCccccccCcc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ----VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~----~~~~i~~~~~~~~ld~~ 621 (701)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.+.
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 226 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP------ 226 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC------
Confidence 211 11334688999999999888899999999999999999999999854321 11222222221
Q ss_pred CCCCCH-HHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 622 VTGWPV-EAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 622 ~~~~p~-~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..|. ..+..+.+++.+||..+|.+||++.+|+
T Consensus 227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il 259 (267)
T cd08224 227 --PLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259 (267)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 1222 3445689999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.14 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=201.1
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
-|.+.+.||.|+||.||+|.. .+..||+|++..... .....+.+|+.++++++||||++++++|.+ ..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 377888999999999999987 456799998765432 223568899999999999999999999844 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 99999988742 35889999999999999999999999 9999999999999999999999999987664321
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCCH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......|+..|++||++.+..++.++|+|||||++|+|++|.+||........ .+..+. ....+.
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--------PPTLEG 223 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--------CCCCCc
Confidence 112345688999999999988899999999999999999999999975443221 111111 111223
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+..+.+++.+||..+|..||++.+++.|+|+.-
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 34456899999999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.86 Aligned_cols=243 Identities=27% Similarity=0.377 Sum_probs=194.5
Q ss_pred eeeeecCceeEEEEEECC---c--eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLDH---T--SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~---~--~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~~g 472 (701)
+.||+|+||.||+|.+.. + .||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ..++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998733 2 489999987765 445679999999999999999999998855 347999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+.+..... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999866443 56899999999999999999999999 999999999999999999999999999877432211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
........++..|+|||++.+..++.++|||||||++|+|+| |++||......+ ..+.... .....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 226 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-------ERLERPEAC 226 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------CcCCCCccC
Confidence 011123567889999999999999999999999999999999 999996443222 1111100 001122233
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.18 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=199.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|++.+.||+|+||.||++... ++.||+|++..... .....+.+|+++++.++||||+++++.+.+ ..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999985 66799998865532 234678999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++|+|.+++... .++++..+..++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999887442 358999999999999999999997 46 9999999999999999999999999986542211
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----------HHHHHcCccccc
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV----------EQAIRNGTFSEL 617 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~----------~~~i~~~~~~~~ 617 (701)
.....|+..|+|||++.+..++.++|||||||++|+|+||++||...... ...+.. +
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 225 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-----I 225 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-----H
Confidence 12457899999999998889999999999999999999999999754321 111111 1
Q ss_pred cCccCCCCCH-HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 LDPTVTGWPV-EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ld~~~~~~p~-~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
........+. ..+..+.+++.+||..+|.+||++.+++.+.|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 1111111111 2445689999999999999999999999987763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.53 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=201.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|++.+.||.|+||.||+|.+. +..|++|.+..... .....+.+|+++++.++||||+++++.|.+ ..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999985 45699998865432 234678999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|++++.+..++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9988777655422 234889999999999999999999999 9999999999999999999999999998764332
Q ss_pred CcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCc-------------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGT------------- 613 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~------------- 613 (701)
. .......++..|+|||++.+. .++.++||||||+++|+|++|++||..............
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 122345788999999998888 889999999999999999999999976654433221100
Q ss_pred -----cc--cccCccC-----CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 -----FS--ELLDPTV-----TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 -----~~--~~ld~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+. ....... ..++...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 0000000 01122235679999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.05 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=199.1
Q ss_pred hcCceeeeeeeecCceeEEEEEECC---------ceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC-
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 460 (701)
.++|.+.+.||+|+||.||++.+.+ ..+|+|.+..... .....+..|+.++..+ +||||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999998632 3599999876532 2345688899999999 79999999999854
Q ss_pred -CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 44899999999999999965421 235889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH-
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ- 604 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~- 604 (701)
+.++.+||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccch----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999876532110 001122234578999999988899999999999999999998 8899865442
Q ss_pred -HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 605 -VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 605 -~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+...+..+.. ...|...+..+.+++.+||..+|.+||++.+++. .+.++
T Consensus 250 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~-~l~~~ 299 (307)
T cd05098 250 ELFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRI 299 (307)
T ss_pred HHHHHHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH-HHHHH
Confidence 2222332221 1223334457899999999999999999999974 44443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=312.87 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=196.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHH-HHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEI-LGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|.+.+.||+|+||.||+|.+. +..||||.+..... .....+..|+.+ ++.++||||+++++++.. ..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46899999999999999999984 56799999876542 233456667765 566799999999999843 4589999
Q ss_pred ecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 468 YMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 468 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|++ |+|.+++... .....+++..+..++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888777542 3345789999999999999999999987 7 99999999999999999999999999986532
Q ss_pred CCCcccccccccccccCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHH--HHcCcccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQT----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQA--IRNGTFSELL 618 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~--i~~~~~~~~l 618 (701)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+.. +..+..
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 225 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---- 225 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC----
Confidence 11 1133468899999998754 4568899999999999999999999964221 1111 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+.... ...+..+.+++.+||..+|.+||++.+++.|+|++...
T Consensus 226 -~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 -PQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -CCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 11110 12345689999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=310.98 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=199.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--C--------hHHHHHHHHHHHhCCCCcEEEEeceecC--
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--G--------PRQFKQEVEILGSMRHTNMVILLGACPE-- 460 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~--------~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 460 (701)
+|.+.+.||.|+||.||+|.. .+..||+|.+...... . .+.+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999987 4567999987643211 1 2357889999999999999999999844
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 458999999999999988543 46889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcccccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~l 618 (701)
+...... .........|+..|+|||.+.... ++.++|+||||+++|+|++|.+||............... ..
T Consensus 156 ~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~ 229 (272)
T cd06629 156 KKSDDIY----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RS 229 (272)
T ss_pred ccccccc----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--cc
Confidence 7653211 111223456889999999887655 889999999999999999999999765544333321111 00
Q ss_pred CccC-CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 619 DPTV-TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 619 d~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+.. .......+..+.+++.+||..+|.+||++.+++.|+|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0111 11112334578999999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=310.68 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=197.2
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+.+ ..|+||....... ...+.+.+|+.+++.++||||++++++|.+ ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv 84 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV 84 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence 3468889999999999999998743 2589998876542 334568999999999999999999998854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999985432 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQ--AIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~--~i~~~~~~~~ld~~~ 622 (701)
.. .+......++..|+|||.+....++.++|||||||++|+|++ |++||........ .+..+...
T Consensus 160 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------- 227 (270)
T cd05056 160 ES-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------- 227 (270)
T ss_pred cc-----ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-------
Confidence 21 111223345578999999988889999999999999999996 9999976543322 22222211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+...+..+.+++.+|+..+|.+||++.+++.
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112334456999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.10 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=196.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++++|.+.+.||+|+||.||+|.. .+..|++|++....... ...+.+|+.+++.++|+||+++++++.+ ..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999987 46679999987654332 3467899999999999999999999854 358999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 67777664332 35778888899999999999999999 999999999999999999999999998754221
Q ss_pred CCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc-----Cc-------
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN-----GT------- 613 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~-----~~------- 613 (701)
. .......+++.|+|||++.+. .++.++|||||||++|+|+||++||.........+.+ +.
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 S------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 1 112344678999999988654 5789999999999999999999999755433222111 00
Q ss_pred ----cccccCccCCC---------CC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 ----FSELLDPTVTG---------WP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 ----~~~~ld~~~~~---------~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+.......... |. ......+.+++.+|+..+|.+||++.+++.|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000000 00 0113468899999999999999999999999884
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.00 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=201.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
+|+..+.||+|+||.||+|.. .+..||+|++...... ....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999987 4567999998754321 13468899999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeecccccc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLV 543 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~ 543 (701)
||||+++++|.+++... .++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999988543 36889999999999999999999999 99999999999998765 6999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~~~~~~~~ld~ 620 (701)
...... .........|+..|+|||++.+..++.++||||||+++|+|++|++||..... .......... .
T Consensus 155 ~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~--- 227 (268)
T cd06630 155 AAKGTG--AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--T--- 227 (268)
T ss_pred cccccc--CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc--C---
Confidence 433111 01112345689999999999888899999999999999999999999964331 1111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....|......+.+++.+||..+|.+||++.+++.|+|++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 11233445556799999999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.00 Aligned_cols=275 Identities=25% Similarity=0.402 Sum_probs=207.3
Q ss_pred cCceeeeeeeecCceeEEEEEEC--Cc----eEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HT----SVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~----~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
++|+..+.||+|+||.||+|.+. +. .||+|.+....... ...+.+|+.+++.++||||++++|+|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45788899999999999999873 32 37889886553222 2368899999999999999999999844 45799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999885432 35788999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--hHHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS--HQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~--~~~~~~i~~~~~~~~ld~~~ 622 (701)
... ........++..|++||++.+..++.++|||||||++|||++ |..||... ......+..+... +
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~-- 231 (303)
T cd05110 162 DEK----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL----P-- 231 (303)
T ss_pred ccc----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC----C--
Confidence 221 112233456788999999998999999999999999999997 88888653 2333334333211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCCcccCCCCCCC
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVVTPGPYNS 686 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 686 (701)
.+..++..+.+++..||..+|.+||++.+++. .+..+..-.........+.....|+|..+
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (303)
T cd05110 232 --QPPICTIDVYMVMVKCWMIDADSRPKFKELAA-EFSRMARDPQRYLVIQGDDRMKLPSPNDS 292 (303)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHHhchhhheeeccCCcCCCCCCchh
Confidence 11223346899999999999999999999865 55554333333333333444444555433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.15 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=201.2
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCC---CCcEEEEeceecC--CCceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMR---HTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~--~~~lV~ 466 (701)
.|++.+.||.|+||.||+|.+ .+..|++|.+..... .....+.+|+.+++.++ |||+++++++|.+ ..|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999998 456799999876532 33456889999999997 9999999998854 348999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998743 26889999999999999999999999 999999999999999999999999999876433
Q ss_pred CCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
. .......|+..|+|||++.++ .++.++|+|||||++|+|++|.+||............. ....+.+..
T Consensus 155 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~~~- 224 (277)
T cd06917 155 S------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSKPPRLED- 224 (277)
T ss_pred c------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cCCCCCCCc-
Confidence 2 112345789999999988654 46899999999999999999999997665433221111 111111111
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 225 -~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 225 -NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred -ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 013456899999999999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=307.80 Aligned_cols=240 Identities=26% Similarity=0.408 Sum_probs=196.9
Q ss_pred cCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec-CCCceEEeecCCC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP-EYGCLVYEYMENG 472 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~lV~Ey~~~g 472 (701)
+.|.+.+.||+|+||.||+|...+..||+|.+.... ....+.+|+.+++.++|||++++++++. +..++||||+.+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 458899999999999999999988899999986542 3467899999999999999999999884 3458999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999986543 345889999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.....+..|+|||++.++.++.++|+|||||++|+|++ |++||..... ....+..+... ..+...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------EPPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------CCCCcC
Confidence 12234567999999998899999999999999999998 9999965543 22333332111 112233
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+..+.+++.+||+.+|..||++.+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=314.30 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|++++++++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999984 56799999865432 234568899999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999988544 46889999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
.....|++.|+|||.+.+..++.++||||||+++|+|++|++||...... ...+..+.. .
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~ 216 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---------R 216 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------c
Confidence 23456899999999998888999999999999999999999999765432 122222221 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRD 664 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~ 664 (701)
.|...+..+.+++.+||..+|.+|| ++.+++.|+|++-.+
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 2222345689999999999999999 899999999986544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=329.11 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=201.1
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCC-CCcEEEEeceec
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMR-HTNMVILLGACP 459 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 459 (701)
+....++|.+.+.||+|+||.||+|++.+ ..||+|++....... ...+.+|+.+|.++. ||||+.++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34455678899999999999999998643 359999997654333 346889999999997 999999999985
Q ss_pred C--CCceEEeecCCCChhhHhcccC-------------------------------------------------------
Q 005343 460 E--YGCLVYEYMENGSLEDRLFQKD------------------------------------------------------- 482 (701)
Q Consensus 460 ~--~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 482 (701)
. ..++||||+.+|+|.+++.+..
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4 4589999999999999986432
Q ss_pred ----------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 005343 483 ----------------------------------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPA 522 (701)
Q Consensus 483 ----------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~ 522 (701)
....+++..+..|+.||+.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1134678888999999999999999998 999999999
Q ss_pred CeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005343 523 NILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGL 601 (701)
Q Consensus 523 NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 601 (701)
|||++.++.+||+|||+++.+..... ........++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986532111 011233467889999999998889999999999999999998 8889865
Q ss_pred chHHH---HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 602 SHQVE---QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 602 ~~~~~---~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....+ ..+..+.. ...|...+..+.+++.+||..+|..||++.+|+.. |.+
T Consensus 345 ~~~~~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~-L~~ 398 (401)
T cd05107 345 LPMNEQFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL-VGD 398 (401)
T ss_pred CCchHHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH-HHH
Confidence 43222 22222211 01222334569999999999999999999999743 443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.95 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=202.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|+..+.||.|+||.||++.+. +..|++|.+..... .....+.+|+++++.++||||+++++.|.. ..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999985 56799998876543 234568999999999999999999998844 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885433 568889999999999999999999 88 9999999999999999999999999987653211
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHcCccccccCccCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----QVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----~~~~~i~~~~~~~~ld~~~~ 623 (701)
.....++..|+|||++.+..++.++||||||+++|+|++|++||.... .....+.. +......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPP 222 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCC
Confidence 112678899999999999899999999999999999999999986542 11111111 0001111
Q ss_pred CCCHH-HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVE-AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~-~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+.. .+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 12222 4556899999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.07 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=199.6
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||+|+||.||++.. .+..+++|.+..... .....+.+|+.+++.++|||++++++.+.. ..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488999999999999999987 455699998865432 234568999999999999999999998743 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~~ 547 (701)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||+|+||+++. ++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986533 345889999999999999999999999 999999999999985 4568999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~~~ 625 (701)
......|+..|+|||.+....++.++||||||+++|+|++|+.||...+....... .+... ..
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 221 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--------PI 221 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--------CC
Confidence 11235688999999999988899999999999999999999999976543222211 11111 12
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 22334568999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.54 Aligned_cols=248 Identities=28% Similarity=0.468 Sum_probs=195.5
Q ss_pred hcCceeeeeeeecCceeEEEEEECC--c---eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH--T---SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~--~---~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|...+.||+|+||.||+|.... . .+++|.+...... ....+.+|+++++.++|||++++++++.+ ..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578889999999999999998742 2 5899988655322 24568999999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999885432 46899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
...... ........++.|+|||++....++.++|||||||++|+|+| |+.||..... ....+..+. ..+
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~----~~~- 230 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF----RLP- 230 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC----CCC-
Confidence 321111 11112233567999999988889999999999999999998 9999864432 222333221 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12233456899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.04 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=196.4
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
|++.+.||.|++|.||+|.+ .++.|++|++...... ....+.+|+++++.++|||++++++++.+ ..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999987 5677999998765422 23568899999999999999999999854 448999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.+....
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 -DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred -CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 4689888754332 36899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---c-Cc-----------
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---N-GT----------- 613 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---~-~~----------- 613 (701)
.......+++.|+|||++.+. .++.++||||||+++|+|+||++||........... . +.
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 112334678899999987654 578999999999999999999999976554322211 0 00
Q ss_pred -------cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 -------FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 -------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+...............+..+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00000001111112223468899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.82 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=207.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~E 467 (701)
.+++|.....||.|+||.||+|.+. +..|++|++..... ....+.+|+++++.++|||++++++.|. +..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 5667888999999999999999985 67799999876543 4567899999999999999999999874 44589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986543 36899999999999999999999999 9999999999999999999999999987553221
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~~~ 625 (701)
. ......++..|++||++.+..++.++|+|||||++|+|++|+.||...+....... ....... ..
T Consensus 171 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~ 238 (286)
T cd06614 171 S------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL------KN 238 (286)
T ss_pred h------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------cc
Confidence 1 11334578899999999888899999999999999999999999986654332222 1111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+...+..+.+++.+||+.+|..||++.+++.|.|++-
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 1123456899999999999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.19 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=202.7
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecCCC--ceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPEYG--CLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV~ 466 (701)
++|.+.+.||+|+||.||++.+.. ..|++|.+..... .....+.+|+++++.++||||+++++.+.+.. ++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468999999999999999999854 5699998876532 22346789999999999999999999985544 8999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||++||+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998443 35889999999999999999999999 999999999999999999999999998742111
Q ss_pred CCc---------ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccc
Q 005343 547 AAD---------TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFS 615 (701)
Q Consensus 547 ~~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~ 615 (701)
... ...........|+..|+|||++....++.++|+|||||++|+|++|..||..... +...+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~- 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence 100 0011112235678899999999888999999999999999999999999965432 1222222211
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHHHhcc
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRLRDLG 666 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l~~~~ 666 (701)
..+.. +...+..+.+++.+||+.+|.+||+ +.+++.|+|+.-.+..
T Consensus 234 --~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 234 --EWPEG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred --CCCCc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 11111 1123445899999999999999998 6888999998654443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.00 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=200.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC---------CceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
..++|.+.+.||+|+||.||+|++. ...||+|.+..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467899999999999999999752 22599998875432 2345689999999999 89999999999854
Q ss_pred --CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 34899999999999999865321 235788899999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++.+..... ........++..|+|||++.+..++.++||||||+++|+|++ |.+||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccc----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999987643211 111223456678999999998899999999999999999998 7888865432
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
....+..+.. ...+..++..+.+++.+||..+|.+||++.+++. .+.++..
T Consensus 246 ~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~-~l~~~~~ 298 (304)
T cd05101 246 EELFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE-DLDRILT 298 (304)
T ss_pred HHHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH-HHHHHHH
Confidence 2222322211 1122334456899999999999999999999974 4555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.15 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=192.6
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||+|+||.||+|.+ .+..|++|.+...... ....+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999998 4567999998654322 23457889999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 96 5787776443 245899999999999999999999999 9999999999999999999999999998653221
Q ss_pred cccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCC-CCchHHHH---HHHc-Cc--------c
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAM-GLSHQVEQ---AIRN-GT--------F 614 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~---~i~~-~~--------~ 614 (701)
.......+++.|+|||++.+. .++.++|||||||++|+|+||..|+ ...+.... .... +. .
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 112345678999999987664 4799999999999999999998775 33221111 1000 00 0
Q ss_pred ccccC-ccCCCC---------CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 615 SELLD-PTVTGW---------PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 615 ~~~ld-~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
....+ .....+ .......+.+++.+||..+|.+|||+.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00000 000000 01223468899999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.76 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=200.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-----ce-EEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceec--C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-----TS-VAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACP--E 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~-vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~ 460 (701)
.-++-.+.++||+|+||.||+|.+.- .. ||+|..+... ......|.+|.++|+.++|||||++||++- +
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455566899999999999999732 13 8999988633 223456999999999999999999999983 4
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..++|||+|+||+|.++|.+... .++..++..++.+.|.||+|||+.+ +|||||-..|+|++.++.+||+||||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 45899999999999999966543 5899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHH-HcCcccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAI-RNGTFSE 616 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i-~~~~~~~ 616 (701)
+.-..- .......--...|+|||.+.++.|+.++|||||||++||+++ |..||.+.. ++...+ .++...
T Consensus 310 ~~~~~~------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~- 382 (474)
T KOG0194|consen 310 RAGSQY------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM- 382 (474)
T ss_pred cCCcce------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-
Confidence 753210 001111134578999999999999999999999999999999 788887554 344444 333211
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
..|...+..+..++.+||..+|.+||++.++. ..+..+...
T Consensus 383 -------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~-~~l~~~~~~ 423 (474)
T KOG0194|consen 383 -------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK-KKLEALEKK 423 (474)
T ss_pred -------CCCCCCHHHHHHHHHHhccCChhhccCHHHHH-HHHHHHHhc
Confidence 22334555689999999999999999999986 344444443
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.79 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=194.3
Q ss_pred hcCceeeeeeeecCceeEEEEEECC------------------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH------------------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~------------------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~ 453 (701)
.++|++.+.||+|+||.||++.+.+ ..||+|++...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3569999999999999999986432 24899998765322 3456899999999999999999
Q ss_pred Eeceec--CCCceEEeecCCCChhhHhcccCC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 005343 454 LLGACP--EYGCLVYEYMENGSLEDRLFQKDN--------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523 (701)
Q Consensus 454 l~g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~N 523 (701)
+++++. +..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999984 445899999999999998865321 124778889999999999999999999 9999999999
Q ss_pred eeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 005343 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL 601 (701)
Q Consensus 524 ILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~pf~~ 601 (701)
||++.++.+||+|||+++.+..... ........+++.|++||....+.++.++|||||||++|||+| |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999986533211 111123345678999999888899999999999999999998 6688864
Q ss_pred chHHHHHHHcCcc-ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 602 SHQVEQAIRNGTF-SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 602 ~~~~~~~i~~~~~-~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
....+.....+.+ ...........+..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4322111110000 000000001112233456899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.24 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=204.1
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
.|...+.||.|+||.||++.+. +..+++|++..........+.+|+++++.++|||++.+++.+.. ..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3788899999999999999985 66799999987665456789999999999999999999998843 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+++|.+++.... ..+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885543 46899999999999999999999998 99999999999999999999999999987644321
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAA 630 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~ 630 (701)
.....|+..|++||++....++.++||||||+++|+|++|++||................ -+.. ..+...+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~ 224 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG---PPGL-RNPEKWS 224 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC---CCCc-CcccccC
Confidence 234568899999999988889999999999999999999999997664333222211100 0111 1111124
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
..+.+++.+||..+|.+||++.+++.|+|
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 56899999999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.62 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=201.1
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~~ 471 (701)
|...+.||+|+||.||++.. .+..+++|++........+.+.+|+.+++.++||||+++++++. +..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44557899999999999987 45669999886554445566899999999999999999999873 456899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998854 35888999999999999999999999 99999999999999999999999999876532211
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
......|++.|+|||.+.+..++.++|||||||++|+|++|++||...+.... .+..+.. +.. ..+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-----PKL-KNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-----CCC-cccccC
Confidence 12345689999999999888899999999999999999999999865543222 1222211 111 112223
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+..+.+++.+||..+|.+||++.+++.|+|++.
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 456999999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.96 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=196.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999873 356999998765322 23568899999999999999999999854 45
Q ss_pred ceEEeecCCCChhhHhcccC-------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 005343 463 CLVYEYMENGSLEDRLFQKD-------------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~N 523 (701)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986421 1235788899999999999999999999 9999999999
Q ss_pred eeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005343 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS 602 (701)
Q Consensus 524 ILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 602 (701)
||++.++.+||+|||++..+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999876532211 001122345677999999988899999999999999999998 88787533
Q ss_pred h--HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 603 H--QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 603 ~--~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
. .....+..+... ..+...+..+.+++.+||+.+|.+||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 237 AHEEVIYYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 2 222333333321 12333445699999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.01 Aligned_cols=247 Identities=29% Similarity=0.459 Sum_probs=195.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
++|.+.+.||+|+||.||+|.+. ...+|+|.+...... ....+.+|+.++..++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46889999999999999999873 225999988654322 23568999999999999999999999843 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986543 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
.... ........++..|++||++.+..++.++|+|||||++|+|++ |..||..... ....+.++.. .+
T Consensus 159 ~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----~~-- 229 (267)
T cd05066 159 DPEA---AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----LP-- 229 (267)
T ss_pred ccce---eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----CC--
Confidence 2211 111122334568999999998899999999999999999886 9999864432 2222332211 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+...+..+.+++.+|++.+|.+||++.+++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 --APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 12233456899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.65 Aligned_cols=242 Identities=27% Similarity=0.376 Sum_probs=186.0
Q ss_pred eeeeecCceeEEEEEEC-----CceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceec--C-CCceEEeecC
Q 005343 400 RKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACP--E-YGCLVYEYME 470 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~-~~~lV~Ey~~ 470 (701)
+.||+|+||.||+|.+. ...||+|.+.... ......+.+|+.+++.++||||++++++|. + ..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999863 2359999875432 123456889999999999999999999873 2 3589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence 999999985432 34577778889999999999999999 999999999999999999999999999765322110
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.........++..|+|||++....++.++|||||||++|||++ |.+||...+... ..+..+.. ...+.
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 225 (262)
T cd05058 155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--------LLQPE 225 (262)
T ss_pred -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------CCCCC
Confidence 1111223456778999999988899999999999999999999 567776543321 12222211 11122
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23446899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.88 Aligned_cols=246 Identities=30% Similarity=0.494 Sum_probs=198.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+++ ..|+||.+.... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45689999999999999999998854 569999987654 445779999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 99999999885532 346899999999999999999999999 9999999999999999999999999998664311
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 625 (701)
........++..|+|||.+.+..++.++|||||||++|+|+| |+.||..... ....+..+.. ...
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 225 (261)
T cd05034 158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--------MPR 225 (261)
T ss_pred ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence 111122335678999999998899999999999999999999 9999965432 2222222110 011
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 222345689999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.87 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=196.5
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|.+.+.||.|+||.||+|.. .+..++||.+...... ....+.+|+.+++.++||||++++++|.+ ..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999997 5667999987653322 23468899999999999999999998844 458999
Q ss_pred eecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 22356899999999999999999999999 99999999999999999999999999886643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~i~~~~~~~~ld~~~~~ 624 (701)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ...... .+.....+..
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~-- 228 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYPPL-- 228 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--hhhcCCCCCC--
Confidence 211 11345688999999999888899999999999999999999999854321 111111 0101111111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+...+..+.+++.+||..+|.+|||+.+|+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVY 259 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence 1123455699999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.35 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=195.9
Q ss_pred CceeeeeeeecCceeEEEEEEC----CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC----Cc
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD----HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY----GC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~ 463 (701)
.|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999984 4679999998743 33345688999999999999999999998544 58
Q ss_pred eEEeecCCCChhhHhcccC--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC----CCcEEEEee
Q 005343 464 LVYEYMENGSLEDRLFQKD--NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ----NYVSKISDV 537 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~----~~~~KL~DF 537 (701)
+||||+++ +|.+.+.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 6766664322 2246889999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----------
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV----------- 605 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~----------- 605 (701)
|++..+...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||......
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999876432211 112234578999999998766 45899999999999999999999999643321
Q ss_pred -HHHHH---------------cCcccccc-CccCCCCC-----H------HHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 606 -EQAIR---------------NGTFSELL-DPTVTGWP-----V------EAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 606 -~~~i~---------------~~~~~~~l-d~~~~~~p-----~------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...+. ...+.... ......++ . .....+.+++.+||+.+|++||++.+++.|
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 00000000 00000111 0 223458899999999999999999999999
Q ss_pred HHH
Q 005343 658 ELI 660 (701)
Q Consensus 658 ~~~ 660 (701)
+|+
T Consensus 314 ~~f 316 (316)
T cd07842 314 PYF 316 (316)
T ss_pred CCC
Confidence 885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.03 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=196.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-------CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-------~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|++.+.||+|+||.||+|.+ .++.||||+++..... ....+.+|+.++..+ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999974 2456999999765422 234588999999999 68999999998843
Q ss_pred -CCceEEeecCCCChhhHhcccCC--------------------------------------------------------
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN-------------------------------------------------------- 483 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 483 (701)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 34799999999999998854321
Q ss_pred --------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccc
Q 005343 484 --------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555 (701)
Q Consensus 484 --------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~ 555 (701)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~ 237 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVR 237 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhh
Confidence 124688888999999999999999999 99999999999999999999999999986532211 111
Q ss_pred ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---HHHHHHHcCccccccCccCCCCCHHHHH
Q 005343 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH---QVEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 556 ~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.... .....+..+.... . |...+.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~ 309 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----A---PDYTTP 309 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-----C---CCCCCH
Confidence 223345678999999988899999999999999999997 899986532 2233333332111 1 111234
Q ss_pred HHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 632 SIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+.+++..||+.+|.+||++.+|+.|
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 58999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.55 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=194.5
Q ss_pred cCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..|.+.+.||+|+||.||+|.+.. ..|+||++..... .....|..|+.+++.++||||+++++++.+. .++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 358899999999999999999742 2499999876432 2345799999999999999999999998543 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999885432 45899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
..... ..........+..|+|||++....++.++|||||||++|||++ |.+||...+. ....+.... .
T Consensus 159 ~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--------~ 229 (269)
T cd05065 159 DTSDP-TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--------R 229 (269)
T ss_pred Ccccc-ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------c
Confidence 22111 0000111122457999999999999999999999999999986 9999865432 222222111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112334456899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.36 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=197.4
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC-------CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE-------YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~~ 462 (701)
.++|.+.+.||+|+||.||+|.+ .++.||+|++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999987 45679999986432 2234568889999999999999999987632 24
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+. ++|...+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 79999995 578776632 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H---cC---
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R---NG--- 612 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~---~~--- 612 (701)
...... .........||..|+|||.+.+ ..++.++|||||||++|+|++|++||...+...... . ..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred cccccc---ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 543211 1112234578999999997654 568999999999999999999999997543221110 0 00
Q ss_pred ccccccC----------ccCC--CC---CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 613 TFSELLD----------PTVT--GW---PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 613 ~~~~~ld----------~~~~--~~---p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..+.+ +... .+ .......+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 0000000 0000 00 0112345889999999999999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=349.90 Aligned_cols=261 Identities=26% Similarity=0.302 Sum_probs=209.7
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE-- 460 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 460 (701)
++....++|.+++.||+|+||.|..++++++. ||+|++++-. .....-|..|-.||..-+.+.|+.|.-+|.|
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33445678999999999999999999997665 9999998732 2334568999999999999999999999965
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
+.|+|||||+||+|..++.+.. ++++.....++.+|..||.-||+.| +|||||||+|||||..|++||+|||.|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 4589999999999999885544 6888888899999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFS 615 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~ 615 (701)
-.+..++. ......+|||.|++||+++. +.|++.+||||+||++||||.|..||..+..++..-.--+..
T Consensus 223 lkm~~dG~-----V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 223 LKMDADGT-----VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred HhcCCCCc-----EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 87754321 23467899999999998753 569999999999999999999999998776665432211111
Q ss_pred cccCccCCCCC--HHHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHHHhc
Q 005343 616 ELLDPTVTGWP--VEAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRLRDL 665 (701)
Q Consensus 616 ~~ld~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l~~~ 665 (701)
..-.+| .+.+.+..+||.+.+. +|..|.. +.++-.|+||.=-+|
T Consensus 298 -----~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 298 -----ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred -----hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 112344 3455668888888776 6777777 999999977764333
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.65 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=198.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC---------CceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
..++|.+.+.||+|+||.||+|... ...||+|.+..... .....+.+|+.+++.+ +||||++++++|.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3457899999999999999999752 23489998875432 2245688999999999 69999999999854
Q ss_pred --CCceEEeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 3489999999999999986532 1245889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EcCCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999866322110 01122234568999999988899999999999999999999 8899865432
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
....+..+.. ...+..++..+.+++.+||..+|.+||++.+++. .+.++
T Consensus 243 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~-~l~~~ 293 (314)
T cd05099 243 EELFKLLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE-ALDKV 293 (314)
T ss_pred HHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH-HHHHH
Confidence 2233333221 1122334456889999999999999999999874 33333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.97 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=199.9
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
+|.+.+.||.|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++.+.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999984 56699999865421 2345688999999999999999999998544 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~~~~~ 547 (701)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886533 345799999999999999999999999 99999999999998875 56999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCH
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
. ......|++.|+|||++....++.++|+||||+++|+|++|.+||............ ......+. +.
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~----~~ 224 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYFAPI----SP 224 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccCCCC----CC
Confidence 1 112346889999999998888999999999999999999999999765433222211 11111111 12
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 223468999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.71 Aligned_cols=247 Identities=25% Similarity=0.279 Sum_probs=202.5
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
+|.+.+.||.|+||.||+|.+. +..|++|++..... ...+.+.+|++++++++||||+++++.+.+ ..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999985 56799999876432 234678999999999999999999998844 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+.+++|.+++... .++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988543 46889999999999999999999999 9999999999999999999999999988764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 625 (701)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... .......... .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccccC
Confidence 12345688899999999988899999999999999999999999975542 2222221110 11122
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCCh--hhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDL--VSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~--~~vl~~~~~ 660 (701)
|...+..+.+++.+||..+|.+||++ .+++.|+|+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 33344668999999999999999999 999988874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.12 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=198.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||+|.. .++.||||++..... .....+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999998 456799999865432 223467789999999999999999998732
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..|+||||+. ++|.+.+.. .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2489999995 588877732 2788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HH-cCc--
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IR-NGT-- 613 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~-~~~-- 613 (701)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... +. .+.
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98653321 123446889999999999999999999999999999999999999755422111 00 000
Q ss_pred -------------------------cccccC----ccCCC-CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 -------------------------FSELLD----PTVTG-WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 -------------------------~~~~ld----~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+..+.. +.... .+...+..+.+++.+||..+|++||++.++|.|+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000000 00000 0112345688999999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.31 Aligned_cols=255 Identities=24% Similarity=0.289 Sum_probs=195.3
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|...+.||+|+||.||++.+. ++.||+|.+...... ....+.+|+.++.++. ||||++++|++.+ ..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999984 566999998765432 3446889999999996 9999999998743 44799999
Q ss_pred cCCCChhhHhcc--cCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 469 MENGSLEDRLFQ--KDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 469 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
+. ++|.++... ......+++.....++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 465553321 12235689999999999999999999975 7 99999999999999999999999999976532
Q ss_pred CCCcccccccccccccCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTG---MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
.. ......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.........+..... ...+.+
T Consensus 161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 231 (288)
T cd06616 161 SI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPIL 231 (288)
T ss_pred CC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC--CCCCcC
Confidence 21 11334688999999988776 6899999999999999999999999755432222221110 001111
Q ss_pred C-CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 T-GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~-~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
. ..+...+..+.+|+.+||..+|.+||++.+|+.|+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 1 111234557999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.50 Aligned_cols=239 Identities=25% Similarity=0.391 Sum_probs=189.9
Q ss_pred eeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCChh
Q 005343 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLE 475 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~ 475 (701)
++||+|+||.||+|.. +++.||+|++....... ...+.+|+++++.++||||++++++|.. ..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999987 45569999987654322 3358899999999999999999999854 458999999999999
Q ss_pred hHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccc
Q 005343 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555 (701)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~ 555 (701)
+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~ 150 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-----SS 150 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-----cc
Confidence 9885432 35789999999999999999999999 99999999999999999999999999876432211 01
Q ss_pred ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCCHHHHHH
Q 005343 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 556 ~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
.....+++.|+|||++.++.++.++||||||+++|+|++ |..||...... ...+..+... ..+...+..
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 222 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM--------SCPQKCPDD 222 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC--------CCCCCCCHH
Confidence 122244677999999999999999999999999999998 99999655432 2222222111 112233456
Q ss_pred HHHHHHHhhccCcCCCCChhhhhh
Q 005343 633 IAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.89 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=195.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|.+.+.||+|+||.||+|.+. ++.|++|.+..... .....+.+|+++++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999974 56799998865432 223568899999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~ 546 (701)
|++ ++|.+.+.... ...+++.....++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 57877764332 234678888899999999999999999 999999999999985 567999999999765322
Q ss_pred CCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cc-ccccc--
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GT-FSELL-- 618 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~-~~~~l-- 618 (701)
. .......+++.|+|||++.+ ..++.++|||||||++|+|+||++||............ +. .....
T Consensus 157 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 V------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred c------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 1 11234467899999998765 45789999999999999999999999765433222110 00 00000
Q ss_pred -----C--ccCCCC--------CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 -----D--PTVTGW--------PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 -----d--~~~~~~--------p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+ .....| ....+..+.+++.+|++.+|.+||++.+++.|+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 0 000000 112234588999999999999999999999999987
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=300.62 Aligned_cols=244 Identities=26% Similarity=0.454 Sum_probs=196.0
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
+.|.+.+.||+|+||.||+|.+. +..+++|.+.... .....+.+|+++++.++|||++++++++.+ ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888999999999999999885 6679999886543 345679999999999999999999999844 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 999999885432 35789999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......++..|+|||++.++.++.++||||||+++|+|++ |++||..... ....+..+. ....+.
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~------ 224 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYKPR------ 224 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCCCC------
Confidence 01122345678999999998899999999999999999998 9999975542 222222221 111111
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 12346899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.52 Aligned_cols=231 Identities=26% Similarity=0.457 Sum_probs=184.7
Q ss_pred eeeeecCceeEEEEEECCce------------EEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec-CCCceEE
Q 005343 400 RKIGEGGYGPVYKAQLDHTS------------VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP-EYGCLVY 466 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~------------vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~lV~ 466 (701)
+.||+|+||.||+|.+.++. |++|++...... ...+.+|+.+++.++||||++++|+|. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 36999999999999985443 788877655433 677999999999999999999999875 3458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-------cEEEEeecc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-------VSKISDVGL 539 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-------~~KL~DFGl 539 (701)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999998865432 6889999999999999999999999 99999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG--MLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~ 614 (701)
+..... .....++..|+|||++... .++.++|||||||++|+|++ |..||....... ..+....
T Consensus 155 a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~- 223 (259)
T cd05037 155 PITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH- 223 (259)
T ss_pred cccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-
Confidence 876532 1234567789999998876 78999999999999999999 577775543211 1111110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
. ++......+.+++.+||..+|.+||++.+++.
T Consensus 224 -------~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 -------R--LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------C--CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 11111156899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.20 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=198.1
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
...|.+.+.||+|+||.||+|.. .+..|++|.+....... ...+.+|+.+++.++||||++++++|.+ ..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 34588899999999999999997 46679999886543322 2458899999999999999999999844 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++....+
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 67777664332 35899999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
. ....|+..|+|||++. .+.++.++||||||+++|+|+||++||...+.......... ...+..
T Consensus 168 ~----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~ 234 (307)
T cd06607 168 A----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTL 234 (307)
T ss_pred C----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCCC
Confidence 2 2346788999999874 45688999999999999999999999976554332221110 000111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+...+..+.+++.+||..+|.+||++.+++.|+|+..
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 11233456899999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.09 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=201.3
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||+|+||.||+|.. .+..|++|++...... ....+..|+.+++.++||||+++++.+.+ ..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488899999999999999987 4567999998776543 45678999999999999999999998744 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++... ..+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999988543 34788899999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccccccccCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHcCccccccCccCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGM---LGVKSDLYSLGVVLLQLITARPAMGLSH-QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~-~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.. ........++..|++||++.... ++.++||||||+++|+|++|++||.... .......... ...+....
T Consensus 155 ~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 155 TM--GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred cc--cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 11 11022456889999999988766 8899999999999999999999996442 2221111111 11111111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+ ......+.+++.+||+.+|.+||++.+++.|+|.
T Consensus 230 ~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 S-LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred c-cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1 1224568899999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.50 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=197.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec----CCCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP----EYGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~lV 465 (701)
++|.+.+.||.|+||.||+|.+. ++.+++|.+...... ....+.+|+.++.+++||||+++++++. ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999985 566999988755322 2335778999999999999999999873 456899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 58988875433 36899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--c-----------
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--N----------- 611 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~----------- 611 (701)
.. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.........-. .
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PL------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Cc------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 21 112345678899999987654 468999999999999999999999975543211100 0
Q ss_pred ----------CccccccCcc-CCCCCHH-HHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 612 ----------GTFSELLDPT-VTGWPVE-AALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 612 ----------~~~~~~ld~~-~~~~p~~-~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..+....... ...++.. ....+.+++.+||+.+|++||++.+++.|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000000000 0111211 34568899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.67 Aligned_cols=246 Identities=27% Similarity=0.467 Sum_probs=197.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeec
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYM 469 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~ 469 (701)
..+.|.+.++||+|+||.||+|.+. +..+++|.+.... .....+.+|+.+++.++|+||+++++.+.+ ..+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence 3467999999999999999999874 4569999887542 335678999999999999999999998755 347999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 9999999986532 346788999999999999999999998 99999999999999999999999999976543211
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.......++..|+|||++..+.++.++|+|||||++|+|+| |++||..... ....+..+... + .+
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----~----~~ 225 (260)
T cd05073 158 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----P----RP 225 (260)
T ss_pred ----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----C----Cc
Confidence 11123345678999999998889999999999999999999 9999975443 23333332111 1 11
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
...+..+.+++.+||..+|++||++.+++
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 23344689999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.81 Aligned_cols=246 Identities=25% Similarity=0.413 Sum_probs=193.1
Q ss_pred CceeeeeeeecCceeEEEEEEC------CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC----CCc
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE----YGC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~------~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~ 463 (701)
.|.+++.||+|+||.||++.+. +..||+|.+..... .....+.+|+.+++.++|||++++++++.+ ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4788999999999999999852 44599999875532 234568999999999999999999998854 347
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999885432 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----------------HH
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-----------------VE 606 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-----------------~~ 606 (701)
...... ........++..|+|||++.+..++.++|||||||++|+|+|+..|+..... ..
T Consensus 160 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 160 ETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 432211 0111245577889999999888899999999999999999998866432111 00
Q ss_pred HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 607 ~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+..+.. ...+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 237 RVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11111111 1112234456999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.63 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=207.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCCh-HHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGP-RQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~E 467 (701)
..+...+.++||+|-||.|.++...+ ..||+|+++.+..... ..|.+|+++|.+|+|||||.|+|+| .+..|+|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 45567888999999999999999977 7899999999886665 6799999999999999999999999 556699999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||++|+|..+|..+... .+.-....+|+.||+.|++||.+.+ +|||||-+.|+|++.++++||+|||+++-+-...
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999776432 2444556779999999999999999 9999999999999999999999999998542221
Q ss_pred Cccccccc-ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCchHHHHHHH-cCc-cccccCccC
Q 005343 548 ADTITQYH-MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSHQVEQAIR-NGT-FSELLDPTV 622 (701)
Q Consensus 548 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~~~~~~~i~-~~~-~~~~ld~~~ 622 (701)
.|+ -...+-.+.|||||.+..++++.++|||+||+++||+++ ...||+...+ ++.++ .+. +..-.....
T Consensus 692 -----yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 692 -----YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred -----ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCccee
Confidence 111 123455689999999999999999999999999999876 5578864332 22222 111 111122223
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
...|.-++..+.+++.+||..+-.+||++.++.++..
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 4567778888999999999999999999999976543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.60 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=197.5
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC-
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE- 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 460 (701)
...++|.+.+.||+|+||.||+|... ...||+|++...... ....+.+|+.+++++ +||||++++++|..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34567999999999999999999752 225999988765322 234689999999999 79999999999854
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+.+|+|.+++.... ...+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 4589999999999999885433 234899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH---HHHHHHcCccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ---VEQAIRNGTFS 615 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~---~~~~i~~~~~~ 615 (701)
++.+..... ........++..|+|||.+....++.++|||||||++|+|+| |++||..... ....+..+...
T Consensus 188 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 188 ARDIMNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred cccccCCCc----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 986533211 011123456788999999999999999999999999999998 9999865432 22223322110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+...+..+.+++.+||..+|++||++.+++.
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111223446899999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.82 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=205.6
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecCC----CceEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPEY----GCLVY 466 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~lV~ 466 (701)
+|...+.||+|+||.||+|... ++.|++|++..... .....+.+|+.++++++||||+++++.+.+. .++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999985 66799999876543 2356789999999999999999999998554 47999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985433 7899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHcCccccccCccCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~i~~~~~~~~ld~~~~~~ 625 (701)
... .......++..|++||.+....++.++||||||+++|+|++|..||..... ......... .......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCcCC
Confidence 210 012345788999999999988899999999999999999999999976552 222222111 0111223
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
|...+..+.+++.+|+..+|.+||++.+++.|+|+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 34445679999999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.68 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=197.6
Q ss_pred ceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChH---HHHHHHHHHHhCCCCcEEEEecee--cCCCceEEee
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPR---QFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEY 468 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey 468 (701)
|.-++.||-|+||-||-|++.. ..||||.+.....+..+ .+..|+..|.+++|||++.+-|.| ....+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6667889999999999999843 45999998877665543 488999999999999999999988 3345899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
| -||-.|++.-.. .++.+..+..|+.+.+.||.|||+.+ .||||||..||||+..|.|||+|||.|..+.|.
T Consensus 108 C-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred H-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 9 567777774333 46888899999999999999999999 999999999999999999999999999877553
Q ss_pred cccccccccccccCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQ---QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.+++|||+|||||++ ..|.|+-++|||||||+..||.-.+||+=.-+-+...+. +.+.-.|.+.
T Consensus 180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQNesPtLq-- 246 (948)
T KOG0577|consen 180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNESPTLQ-- 246 (948)
T ss_pred --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHhcCCCCCC--
Confidence 568999999999975 467899999999999999999999998644443322221 1111223332
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..+.+..|.+|+..||+.-|.+|||..+++.|.|.
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 12345569999999999999999999999977653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.47 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=186.5
Q ss_pred eeeeecCceeEEEEEECCc----eEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQLDHT----SVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~----~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~Ey~~~ 471 (701)
+.||+|+||.||+|.+.++ .+++|.+..... .....+.+|++++.++ +||||++++++|... .++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999998543 368888765432 2345688999999999 899999999998543 4899999999
Q ss_pred CChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 472 GSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 472 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1235889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFS 615 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~ 615 (701)
++...... ........+..|+|||++....++.++|||||||++|+|++ |.+||...... ...+..+..
T Consensus 158 l~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~- 229 (270)
T cd05047 158 LSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 229 (270)
T ss_pred Cccccchh-------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-
Confidence 98632111 01112234667999999988899999999999999999997 99999644321 122222111
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 -------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0112233446899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.55 Aligned_cols=232 Identities=22% Similarity=0.379 Sum_probs=180.8
Q ss_pred eeeecCceeEEEEEEC--------------------------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEE
Q 005343 401 KIGEGGYGPVYKAQLD--------------------------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~--------------------------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 454 (701)
+||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999741 12388998866543334568899999999999999999
Q ss_pred eceecC--CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC--
Q 005343 455 LGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-- 530 (701)
Q Consensus 455 ~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-- 530 (701)
+|+|.+ ..++||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999854 458999999999999888543 245788999999999999999999998 99999999999997643
Q ss_pred -----cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHH-HhCCCCCCCch
Q 005343 531 -----VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQL-ITARPAMGLSH 603 (701)
Q Consensus 531 -----~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~el-ltG~~pf~~~~ 603 (701)
.+||+|||++..... .....++..|+|||++.+ ..++.++|||||||++||| ++|++||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCcccccccc----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 479999998764321 122357888999998865 5689999999999999999 47999986543
Q ss_pred HH--HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 604 QV--EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 604 ~~--~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.. ...+.... ..|......+.+++.+||+.+|.+||++.+|+.+
T Consensus 227 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFYEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 11111110 0111112358999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.11 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=199.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC---------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
...+|.+.+.||+|+||.||+|++.+ ..||+|++...... ....+.+|+.++.++ +||||++++++|.+
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34568999999999999999997521 25899988754322 345789999999999 89999999999854
Q ss_pred C--CceEEeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 Y--GCLVYEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 ~--~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
. .+++|||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 3 489999999999999986532 1235788999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++.+..... ........++..|+|||.+....++.++|||||||++|||++ |.+||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EcCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999986532211 011122344578999999999999999999999999999998 8899865432
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
....+..+.. ...+...+..+.+++.+||..+|.+||++.+++.+ +.++.
T Consensus 243 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~-l~~~~ 294 (334)
T cd05100 243 EELFKLLKEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED-LDRVL 294 (334)
T ss_pred HHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH-HHHHh
Confidence 2222222211 11222334568999999999999999999999854 44443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.44 Aligned_cols=258 Identities=27% Similarity=0.312 Sum_probs=198.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC----CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE----YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++....... ...+.+|+.++++++||||+++++++.+ ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999984 5679999986543222 2346789999999999999999998743 3489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58888775432 46899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--Hc--Cccccc--
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--RN--GTFSEL-- 617 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~~--~~~~~~-- 617 (701)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.........- .. +.....
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPA------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred Ccc------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 321 11233456888999998765 558999999999999999999999997655432211 10 000000
Q ss_pred -------------cC-ccCCCCC---HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 -------------LD-PTVTGWP---VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 -------------ld-~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+. .....+. ......+.+++.+||..||++||++.+++.|+|++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 0000000 012456789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.53 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=198.8
Q ss_pred cCceeeeeeeecCceeEEEEEECC------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
++|.+.+.||+|+||.||+|.+.. ..|++|.+...... ....+.+|+.+++.++||||++++++|.. ..++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 468899999999999999998732 24899988765432 23568899999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999985432 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
... ........++..|++||.+....++.++|||||||++|||+| |++||.... .+...+..+..
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------- 229 (279)
T cd05057 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-------- 229 (279)
T ss_pred ccc----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC--------
Confidence 221 111122334678999999988899999999999999999999 999997644 23333333221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...|..++..+.+++.+||..+|..||++.+++ ..+..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~-~~l~~~ 268 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELI-NEFSKM 268 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHH
Confidence 111222334688999999999999999999975 445444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.06 Aligned_cols=260 Identities=27% Similarity=0.362 Sum_probs=195.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|.+.++||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999984 566999988654322 23356789999999999999999998732
Q ss_pred --CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
..++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 2289999995 58887774332 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHc--Cc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRN--GT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~--~~ 613 (701)
++..+....... ........++..|+|||++.+. .++.++||||||+++|+|+||++||...+.... .+.. +.
T Consensus 165 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 998764322111 1122345678999999987654 478999999999999999999999976543211 1110 11
Q ss_pred cccccCccC-----------CC----------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 FSELLDPTV-----------TG----------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 ~~~~ld~~~-----------~~----------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+.....+.. .. ++......+.+++.+||..+|.+||++.+++.|+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 100000000 00 000112346799999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.05 Aligned_cols=244 Identities=27% Similarity=0.348 Sum_probs=182.4
Q ss_pred eeeecCceeEEEEEEC----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCC
Q 005343 401 KIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGS 473 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gs 473 (701)
.||+|+||.||+|... ...+++|.+...... ....+.+|+.+++.++||||++++|.|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999752 234888877644322 23468899999999999999999999854 4589999999999
Q ss_pred hhhHhcccCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 474 LEDRLFQKDN--SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 474 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|.+++..... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999865432 233567788899999999999999999 99999999999999999999999999875432210
Q ss_pred ccccccccccCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH---HHHHHcCccccccCc
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQ-------TGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV---EQAIRNGTFSELLDP 620 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~---~~~i~~~~~~~~ld~ 620 (701)
........+++.|+|||++. ...++.++|||||||++|||++ |.+||...... ...+..+. ..+..+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (269)
T cd05042 156 -YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKP 233 (269)
T ss_pred -eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCC
Confidence 00113345677899999864 3457889999999999999999 78888654332 22222221 111122
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.++...+..+.+++..|+ .+|.+||++.+|+.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 ---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 122233445778888888 59999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.91 Aligned_cols=246 Identities=25% Similarity=0.310 Sum_probs=184.8
Q ss_pred eeeeecCceeEEEEEECC----ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLDH----TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~----~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 472 (701)
+.||+|+||.||+|.+.+ ..+++|.+...... ....+.+|+.+++.++||||++++|.|.+ ..++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 34899988765432 23468899999999999999999999854 458999999999
Q ss_pred ChhhHhcccC--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 473 SLEDRLFQKD--NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 473 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999986532 2234667788889999999999999999 99999999999999999999999999875432111
Q ss_pred cccccccccccCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH--HHcCccccccCc
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTG-------MLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQA--IRNGTFSELLDP 620 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~--i~~~~~~~~ld~ 620 (701)
........|+..|+|||++... .++.++|||||||++|||++ |++||......+.. ...+......++
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 0111234678889999987542 35789999999999999996 99999754432211 111111112222
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
... ......+.+++.+|+ .+|.+||++.+|+.
T Consensus 234 ~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 211 122345788999998 68999999999973
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.35 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=214.8
Q ss_pred cccccCHHHHHHh-hcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEE
Q 005343 380 RYRKYTIEEIEAA-TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 380 ~~~~~~~~ei~~~-~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~ 453 (701)
+|..+.+-|.... .+.|+.-+.||+||||.||-++...| .+|+|.+.+.- ........+|-.||.+++.|.||.
T Consensus 170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred HHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence 3334444444333 35789999999999999999987555 48998775432 123344688999999999999999
Q ss_pred Eecee--cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 454 LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 454 l~g~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
+--+| .+..||||..|+||+|.-.|+..+. +.|++.....++.+|+.||.+||+.+ ||+|||||+|||||+.|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGH 325 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCC
Confidence 98777 5677999999999999988877654 78999999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QV 605 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~ 605 (701)
++|+|+|||.-++... .....+||.+|||||+++++.|+...|+|||||+||||+.|+.||.... ++
T Consensus 326 vRISDLGLAvei~~g~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGK-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred eEeeccceEEecCCCC-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 9999999998875443 2355699999999999999999999999999999999999999996432 23
Q ss_pred HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHhc
Q 005343 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRDL 665 (701)
Q Consensus 606 ~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~~ 665 (701)
++.+.+. -..+|...+.+...+....|+.||.+|.. ..+|-.|++|+--++
T Consensus 399 drr~~~~---------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 399 DRRTLED---------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHhcc---------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 3333221 12345566667899999999999999875 568899999986443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=303.40 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=197.6
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||.|+||.||+|... ++.|++|++...... ....+.+|+.+++.++||||+++++.+.+ ..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999996 677999998764422 34568999999999999999999998844 45899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 9998543 34889999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
......|+..|++||.+....++.++|+||||+++|+|++|.+||.... ... ...... . .......|...+..
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~-~---~~~~~~~~~~~~~~ 222 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IYNDIL-K---GNGKLEFPNYIDKA 222 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HHHHHh-c---cCCCCCCCcccCHH
Confidence 1234578899999999988889999999999999999999999997655 211 111100 0 01112233333567
Q ss_pred HHHHHHHhhccCcCCCCC-----hhhhhhHHHHH
Q 005343 633 IAKLALQCCELRKRDRPD-----LVSVVLPELIR 661 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~ 661 (701)
+.+++.+||..+|.+||+ +.+++.|+|++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 999999999999999999 99999999987
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.29 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=200.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-----CChHHHHHHHHHHHhCCCCcEEEEeceecCC----C
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-----QGPRQFKQEVEILGSMRHTNMVILLGACPEY----G 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~ 462 (701)
.+|.+.+.||+|+||.||+|.+. +..|++|.+..... .....+.+|+++++.++||||+++++.+.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999974 56699998754321 1234688999999999999999999987442 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 7899999999999988543 34788889999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~ 622 (701)
...... .........|+..|+|||++.+..++.++|+|||||++|+|++|++||.............. .+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~ 227 (264)
T cd06653 156 IQTICM---SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTK 227 (264)
T ss_pred cccccc---cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-----CCCC
Confidence 532110 11112345689999999999888899999999999999999999999986654443332211 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
...|......+.+++.+||. +|..||+..+++.|+|
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 22344555679999999999 6899999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.76 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=201.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC------CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE------YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 462 (701)
.++|.+.+.||.|+||.||+|... +..|++|++..... .....+.+|+.+|+.++||||++++++|.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999974 56699999876432 234567889999999999999999987732 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 79999995 688888743 234899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H-cCc----
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R-NGT---- 613 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~-~~~---- 613 (701)
+...... .........|+..|+|||++.. ..++.++|||||||++|+|++|++||.......... . .|.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 5332211 1112245578999999998765 458999999999999999999999996554321110 0 000
Q ss_pred ---------cccccC--ccCCC--C---CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 614 ---------FSELLD--PTVTG--W---PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 614 ---------~~~~ld--~~~~~--~---p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+....+ +.... | ....+..+.+++.+||+.+|.+||++.+++.|+|+.-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 000000 00001 1 112345689999999999999999999999999997433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.91 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=199.6
Q ss_pred ceeeeeeeecCceeEEEEEECCceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
|.+.+.+|.|+++.||++...++.||+|++.... ......+.+|+.+++.++||||+++++.+.+ ..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3345556667777777777778889999987652 2334579999999999999999999998844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc-c
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD-T 550 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~-~ 550 (701)
|+|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... .
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999886542 235888899999999999999999999 999999999999999999999999998755322110 0
Q ss_pred cccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc--CccccccC-------
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN--GTFSELLD------- 619 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~--~~~~~~ld------- 619 (701)
..........++..|+|||++.. ..++.++|||||||++|+|++|++||.........+.. +.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 01111234567889999998866 35889999999999999999999999765443332221 11111110
Q ss_pred -------------ccC-----CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 620 -------------PTV-----TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 620 -------------~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+.. ...+......+.+++.+||..+|.+||++.+++.|+|++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 011123345688999999999999999999999999988543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.20 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=198.0
Q ss_pred cCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
++|.+...||+|+||.||+|+.. ...|++|.+...... ....+.+|+.++.+++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56889999999999999999963 245999988654333 24568999999999999999999999855 458
Q ss_pred eEEeecCCCChhhHhcccCCC------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 464 LVYEYMENGSLEDRLFQKDNS------PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 26899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCcc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTF 614 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~ 614 (701)
|++...... .........++..|++||.+.+..++.++||||||+++|+|++ |..||..... ....+..+.+
T Consensus 162 ~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNS-----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcc-----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 998754321 1112334466788999999988889999999999999999999 7888864332 2222222222
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.. + .+...+..+.+++.+||..+|.+||++.+++..
T Consensus 237 ~~---~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 EL---P----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC---C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11 1 112233468999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.96 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCceeeeeeeecCceeEEEEEECC----c--eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCCC-ceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH----T--SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEYG-CLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~----~--~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~lV 465 (701)
+...+.++||+|-||.||+|.+.. . .||||..+.+.. ++.+.|.+|.-+|+.++|||||+|+|+|.+.. ++|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wiv 468 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIV 468 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEE
Confidence 344566789999999999998722 2 399999988653 44667999999999999999999999997765 899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+++-|.|..+|..+. ..|+......++.||+.||.|||+.+ +|||||-..|||+.....+||+||||++++..
T Consensus 469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999997654 45788888899999999999999999 99999999999999999999999999999865
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
+. .|+.+...-..-|||||-+.-..++.++|||-|||++||+|. |..||.+-. ++--.+++| ..
T Consensus 544 ~~-----yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG--------eR 610 (974)
T KOG4257|consen 544 DA-----YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG--------ER 610 (974)
T ss_pred cc-----hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC--------CC
Confidence 42 334444445678999999999999999999999999999986 888886432 222223333 23
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...|..|+..|..|..+||+.+|.+||.+.++...
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 45678888899999999999999999999888643
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=306.56 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=192.1
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCC-CCcEEEEeceecCC----CceEEe
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMR-HTNMVILLGACPEY----GCLVYE 467 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~----~~lV~E 467 (701)
|.+.+.||+|+||.||+|.. .++.||+|.+...... ......+|+.++.++. |||++++++++.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999998 4567999998765322 2234567999999885 99999999998543 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 57877774432 46899999999999999999999999 999999999999999 999999999998764321
Q ss_pred CcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cc---------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GT--------- 613 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~--------- 613 (701)
......++..|+|||++. .+.++.++|||||||++|+|++|++||...+..+..... +.
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 112346789999999764 456789999999999999999999999765432211100 00
Q ss_pred ----cccccCccCC-----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 614 ----FSELLDPTVT-----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 614 ----~~~~ld~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
......+... ......+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000000000 0011335679999999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.85 Aligned_cols=233 Identities=23% Similarity=0.385 Sum_probs=183.5
Q ss_pred eeeeecCceeEEEEEECC---------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 400 RKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
+.||.|+||.||+|.... ..|++|.+........+.+..|+.+++.++||||+++++++. +..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998732 238888876544344567889999999999999999999984 456899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc--------EEEEeeccc
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV--------SKISDVGLA 540 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--------~KL~DFGla 540 (701)
+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986543 35889999999999999999999999 999999999999987664 699999988
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCCchHHHHH-HHcCccccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQVEQA-IRNGTFSEL 617 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~-~pf~~~~~~~~~-i~~~~~~~~ 617 (701)
....+ .....+++.|+|||++.+ ..++.++|||||||++|+|++|. +||......... +....
T Consensus 156 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~---- 221 (258)
T cd05078 156 ITVLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR---- 221 (258)
T ss_pred cccCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc----
Confidence 65422 123467889999998876 45899999999999999999995 676544332211 11111
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...|......+.+++.+||+.+|.+||++.+++.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 222 -----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred -----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122222346899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.26 Aligned_cols=242 Identities=26% Similarity=0.415 Sum_probs=190.7
Q ss_pred eeeeecCceeEEEEEECC--------ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 400 RKIGEGGYGPVYKAQLDH--------TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--------~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+.||+|+||.||+|.+.+ ..+++|.+..... .....+.+|+.+++.++||||++++++|.+ ..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998743 3589998765432 335678999999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccC----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-----cEEEEeecc
Q 005343 469 MENGSLEDRLFQKD----NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-----VSKISDVGL 539 (701)
Q Consensus 469 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-----~~KL~DFGl 539 (701)
+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2345789999999999999999999999 99999999999999877 899999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCcccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSE 616 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~ 616 (701)
++.+..... ........++..|+|||++.++.++.++|||||||++|+|+| |+.||....... ..+..+.
T Consensus 158 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--- 230 (269)
T cd05044 158 ARDIYKSDY----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--- 230 (269)
T ss_pred ccccccccc----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---
Confidence 976532211 011123355788999999999999999999999999999998 999986544322 1222111
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
....+...+..+.+++.+||..+|.+||++.+++.
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11122334567899999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=299.46 Aligned_cols=244 Identities=32% Similarity=0.501 Sum_probs=196.7
Q ss_pred ceeeeeeeecCceeEEEEEECC------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH------TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
|.+.+.||.|+||.||++.+.. ..||+|++...... ....+..|+.++..++||||+++++.+.+ ..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999854 66999999766543 45679999999999999999999999855 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998854332 12899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
.. +......+++.|+|||.+.+..++.++||||||+++|+|++ |++||..... ....+..+...
T Consensus 157 ~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (258)
T smart00219 157 DY-----YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-------- 223 (258)
T ss_pred cc-----cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence 11 11112337789999999988889999999999999999998 8899875432 22233333211
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 112224556899999999999999999999873
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.51 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=196.7
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~~gsL 474 (701)
||+|+||.||+|... +..|++|++..... .....+..|+++++.++||||+++++.+. +..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999874 56799998865421 22345678999999999999999998874 345899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..+....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 998865432 46899999999999999999999999 9999999999999999999999999987653311
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
......++..|++||++.++.++.++|||||||++|+|++|+.||..... ....+...... .....+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----MAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----ccccCCccCCHH
Confidence 12345678899999999888899999999999999999999999965432 11112222111 111222334556
Q ss_pred HHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHh
Q 005343 633 IAKLALQCCELRKRDRP-----DLVSVVLPELIRLRD 664 (701)
Q Consensus 633 l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~ 664 (701)
+.+++.+||+.+|.+|| ++.+++.|+|+.-.+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 89999999999999999 777899999997433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=315.50 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=200.1
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-----
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE----- 460 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----- 460 (701)
....++|.+.+.||+|+||.||+|.. .+..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34577899999999999999999987 4567999998654322 23458899999999999999999998743
Q ss_pred ---CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 461 ---YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 461 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 237999999 7899887732 35889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---c-C
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---N-G 612 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---~-~ 612 (701)
|++...... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|++||........... . +
T Consensus 163 g~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 163 GLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999865321 123467899999998766 4588999999999999999999999976543222111 0 0
Q ss_pred cc--------------------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 613 TF--------------------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 613 ~~--------------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.. ..........+.......+.+++.+|+..+|.+||++.+++.|+|++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 0000000001111233458899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=315.74 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=202.1
Q ss_pred cccCHHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEece
Q 005343 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGA 457 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~ 457 (701)
+.+...++...+++|.+.+.||+|+||.||+|.. .+..||+|++...... ....+.+|+.++.+++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3444566777889999999999999999999987 4566999998754322 23567889999999999999999988
Q ss_pred ecC--------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 458 CPE--------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 458 ~~~--------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
+.. ..+++++++ +++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 732 236788877 8899887732 24889999999999999999999999 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--
Q 005343 530 YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE-- 606 (701)
Q Consensus 530 ~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~-- 606 (701)
+.+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+...
T Consensus 157 ~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 157 CELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred CCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999998764221 234568899999998766 568899999999999999999999996543221
Q ss_pred -HHHH-cCcc--------------------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 607 -QAIR-NGTF--------------------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 607 -~~i~-~~~~--------------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.... .+.. ..................+.+++.+||..+|.+||++.+++.|+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 1111 0000 00000000000011234578999999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.25 Aligned_cols=257 Identities=23% Similarity=0.292 Sum_probs=199.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC-------C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE-------Y 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~ 461 (701)
.+.|.+.+.||+|+||.||+|... ++.||||.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999984 5679999887542 2234567889999999999999999998742 2
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 489999995 788887743 246899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HH-------
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IR------- 610 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~------- 610 (701)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|++||...+..... ..
T Consensus 157 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 764321 11234567899999998765 56899999999999999999999999755321110 00
Q ss_pred -------cCccc-------cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 -------NGTFS-------ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 -------~~~~~-------~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+... ....+.........+..+.+++.+||+.+|.+||++.+++.|+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000 00000001111233456899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.15 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=188.9
Q ss_pred hhcCceeeeee--eecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceec--CCCce
Q 005343 392 ATDYFSISRKI--GEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACP--EYGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~I--G~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~--~~~~l 464 (701)
..++|.+.+.+ |.|+||.||++... +..+++|++....... .|+.....+ +||||+++++.|. +..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666666 99999999999974 4569999886543221 122222222 7999999999883 45589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeecccccc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLV 543 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~ 543 (701)
||||+++|+|.+++... .++++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999988543 27899999999999999999999999 99999999999999988 9999999998765
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHHcCccccccC
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV----EQAIRNGTFSELLD 619 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~----~~~i~~~~~~~~ld 619 (701)
... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ....... .
T Consensus 161 ~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---- 224 (267)
T PHA03390 161 GTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q---- 224 (267)
T ss_pred CCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c----
Confidence 322 2346889999999999989999999999999999999999999744221 1111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-hhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPD-LVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-~~~vl~~~~~~ 661 (701)
.. ...+...+..+.+++.+||+.+|.+||+ +.+++.|+|++
T Consensus 225 ~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 KK-LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred cc-CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 11 1122244556899999999999999996 69999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=299.63 Aligned_cols=260 Identities=25% Similarity=0.314 Sum_probs=201.2
Q ss_pred cCceeeeeeeecCceeEEEEEECC------ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC---CC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH------TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE---YG 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~------~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~ 462 (701)
..|+.+..||+|.||.||+|...+ ..+|||.++..... -.....+|+.+++.++|||++.|..+|-. ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 358889999999999999996522 25899998766422 23457899999999999999999988744 33
Q ss_pred ceEEeecCCCChhhHhccc--CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC----CcEEEEe
Q 005343 463 CLVYEYMENGSLEDRLFQK--DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN----YVSKISD 536 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~----~~~KL~D 536 (701)
+|++||.+. +|+..+.-+ .....++......|+.||+.|+.|||++. |+||||||+|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 799999975 888877432 33457899999999999999999999999 9999999999999877 9999999
Q ss_pred eccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCch------------
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSH------------ 603 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~------------ 603 (701)
||+++++..... ..+.....+.|+||+|||++.+ ..|++++|||++|||+.||||-.|.|.+..
T Consensus 180 lGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 180 LGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999854321 2223456788999999998766 569999999999999999999998886432
Q ss_pred HHHHHHHcCccccccCccCCCCCH------H--------------------------HHHHHHHHHHHhhccCcCCCCCh
Q 005343 604 QVEQAIRNGTFSELLDPTVTGWPV------E--------------------------AALSIAKLALQCCELRKRDRPDL 651 (701)
Q Consensus 604 ~~~~~i~~~~~~~~ld~~~~~~p~------~--------------------------~~~~l~~li~~cl~~~P~~RPt~ 651 (701)
++.++++ -+..|....||. - .+....+|+..+|+.||..|.|.
T Consensus 257 Ql~rIf~-----vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 257 QLDRIFE-----VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred HHHHHHH-----HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 1222221 122222222321 0 01235689999999999999999
Q ss_pred hhhhhHHHHHHHhc
Q 005343 652 VSVVLPELIRLRDL 665 (701)
Q Consensus 652 ~~vl~~~~~~l~~~ 665 (701)
.+.++|.+|..-.+
T Consensus 332 ~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 332 EQALEHPYFTEDPL 345 (438)
T ss_pred HHHhcccccccCCC
Confidence 99999999986443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.39 Aligned_cols=268 Identities=24% Similarity=0.304 Sum_probs=202.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhC-CCCcEEEEeceecC----CC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSM-RHTNMVILLGACPE----YG 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~ 462 (701)
..++|.+.+.||+|+||.||+|.+. ++.+++|.+.... ......+.+|+.++.++ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567889999999999999999984 5679999886432 22334577899999999 99999999998743 24
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+. ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999996 5898877432 6788999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---Hc-Cc----
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RN-GT---- 613 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~-~~---- 613 (701)
+...... ..........||..|+|||++.. ..++.++|||||||++|+|+||++||.........- .. +.
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEEN-PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccc-ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6432211 01112334578999999997754 557899999999999999999999997544322110 00 00
Q ss_pred ---------cccccC----cc---CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccc
Q 005343 614 ---------FSELLD----PT---VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFE 668 (701)
Q Consensus 614 ---------~~~~ld----~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~ 668 (701)
...+++ .. ........+..+.+++.+||+.+|.+||++.+++.|+|++......+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~ 306 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence 000000 00 00111113456899999999999999999999999999987554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.40 Aligned_cols=262 Identities=26% Similarity=0.323 Sum_probs=196.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|.+.+.||+|+||.||+|.+. ++.|++|++...... ....+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999984 566999988654322 23457899999999999999999987632
Q ss_pred --CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
..++||||+. ++|...+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 2379999996 4676666432 346899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccc-----ccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HH
Q 005343 539 LARLVPPSAADTI-----TQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AI 609 (701)
Q Consensus 539 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i 609 (701)
+++.......... .....+...|++.|+|||++.+ ..++.++|||||||++|+|++|++||...+.... .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9986643221111 1112244577899999997755 4589999999999999999999999976543321 11
Q ss_pred Hc-Cc-----------cccccC-ccCCCCCH-------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 610 RN-GT-----------FSELLD-PTVTGWPV-------EAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 610 ~~-~~-----------~~~~ld-~~~~~~p~-------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.. +. .....+ ......+. .....+.+++.+||..+|.+||++.+++.|+|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 10 00 000000 00000110 112458899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=324.41 Aligned_cols=244 Identities=21% Similarity=0.361 Sum_probs=195.2
Q ss_pred eeeeeecCceeEEEEEECCceEEEE-----EeCCC-CCCChHHHHHHHHHHHhCCCCcEEEEeceecCC----CceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIK-----VLGPD-ISQGPRQFKQEVEILGSMRHTNMVILLGACPEY----GCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK-----~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~lV~Ey 468 (701)
...||+|+|-+||+|.+..+++.|- +-... .....+.|..|+.+|+.|+|||||++|.+|.+. ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3569999999999999977764442 11111 112346799999999999999999999998442 3589999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~~ 547 (701)
|..|+|..|+.+.. .+....+..|+.||+.||.|||++.| ||||||||.+||+|+. .|.|||+|+|||.....+.
T Consensus 125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999996654 46778999999999999999999885 8999999999999975 5999999999999875432
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~ 624 (701)
....+|||.|||||+.. ..|+..+||||||++++||+|+..||.-=. ++...+-.|....-+...
T Consensus 201 --------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 201 --------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--- 268 (632)
T ss_pred --------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc---
Confidence 34579999999999877 789999999999999999999999995222 333333444432222111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+++.+||.+|+.. ..+||++.++|.|+|+...
T Consensus 269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 ----KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 123589999999999 9999999999999999874
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.41 Aligned_cols=240 Identities=28% Similarity=0.403 Sum_probs=191.1
Q ss_pred eeeeecCceeEEEEEEC-CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCChh
Q 005343 400 RKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLE 475 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~ 475 (701)
++||.|+||.||++.+. ++.|++|.+...... ....+.+|+++++.++||||+.+++++.+ ..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999985 677999988765433 34578999999999999999999999854 348999999999999
Q ss_pred hHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccc
Q 005343 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555 (701)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~ 555 (701)
+++.... ..+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~ 151 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY----TVS 151 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc----eec
Confidence 9885432 35788999999999999999999999 99999999999999999999999999976532110 000
Q ss_pred ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCHHHHHH
Q 005343 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 556 ~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
.....++..|+|||.+.++.++.++|||||||++|+|+| |.+||..... ....+..+. . ...|...+..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~ 223 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--R------MPAPQLCPEE 223 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--C------CCCCccCCHH
Confidence 112234567999999998899999999999999999999 8899865442 222222211 0 0112334456
Q ss_pred HHHHHHHhhccCcCCCCChhhhhh
Q 005343 633 IAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=307.68 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=197.9
Q ss_pred eeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEeecCCCCh
Q 005343 399 SRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSL 474 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey~~~gsL 474 (701)
..+||+|+||.||++.. .+..||||.+..........+.+|+.+++.++|||++++++.+ .+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999988 4566999988655444455689999999999999999999987 4456899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++.. ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..+.... .
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~ 171 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------P 171 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc------c
Confidence 987732 35789999999999999999999999 9999999999999999999999999987653221 1
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
......|++.|++||++.+..++.++|+||||+++|+|++|.+||....... ..+..+. .+.... ....+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~ 245 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPKLKN-LHKVSPS 245 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-----CcccCC-cccCCHH
Confidence 1234568899999999988889999999999999999999999997654332 2222111 111111 1123345
Q ss_pred HHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 633 IAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence 889999999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.39 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=189.1
Q ss_pred eeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHH---hCCCCcEEEEeceecC--CCceEEeecC
Q 005343 401 KIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILG---SMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~---~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
.||+|+||.||++... ++.||+|.+...... ....+.+|..++. ..+||||+.+++.+.. ..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999984 567999988654322 1223445544443 3479999999988743 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 35899999999999999999999999 9999999999999999999999999987553211
Q ss_pred cccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHcCccccccCccCCCCCHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV-EQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...+...... .. ...|..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~---~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VN---VELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CC---cCCccc
Confidence 123468999999998764 55899999999999999999999999643211 1111111110 11 112334
Q ss_pred HHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHhcc
Q 005343 629 AALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRDLG 666 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~~~ 666 (701)
.+..+.+++.+||..+|.+|| ++.+++.|+|++=.++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 455789999999999999999 69999999999754443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.08 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=203.6
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||+|+||.||++... +..|++|.+..... .....+.+|++++.+++|||++++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999884 56799999877653 234568999999999999999999998854 34799999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 46899999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHH
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
......++..|++||...+..++.++||||||+++|+|++|++||.........+.... ......+..
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLPEG 222 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCCCC
Confidence 12345688999999998888899999999999999999999999976554333332111 011122333
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+..+.+++.+||..+|++||++.+++.|+|+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 45568999999999999999999999988774
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.58 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=205.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHH---HHHHHHHHHhCCCCcEEEEecee--cCCCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNMVILLGAC--PEYGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~---~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~ 466 (701)
++|..++.||+|.||.|.+++-+ ++.+|||+++++..-...+ -..|-.+|...+||.+..|--.| .+..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56888999999999999999885 4459999999876544433 46788999999999998887666 44569999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||..||.|.-.|.+ ...|++.....+..+|+.||.|||+.+ ||.||||.+|+|||.+|++||+|||||+--
T Consensus 248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc---
Confidence 99999999877743 446788877789999999999999999 999999999999999999999999999742
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
........+.|||+.|+|||++....|+..+|+|.+||++|||++|+.||...+. + .+.+++-..-..+|
T Consensus 319 ---I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~------kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 319 ---IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-E------KLFELILMEDLKFP 388 (516)
T ss_pred ---ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-h------HHHHHHHhhhccCC
Confidence 1222345789999999999999999999999999999999999999999965432 1 11112112222456
Q ss_pred HHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHhc
Q 005343 627 VEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRDL 665 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~~ 665 (701)
.....+...|+...|..+|++|. ++.+|..|.|+.--++
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 66666788999999999999996 4788999988876544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.06 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=195.6
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|.+...||+|+||.||+|.+ .+..||+|++..... .....+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999997 456799999875432 223468899999999999999999998743
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..++|+||+. ++|...+ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 2379999995 4776654 135889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcC----
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNG---- 612 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~---- 612 (701)
+..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..... +...
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 764321 134467889999998766 46899999999999999999999999765432211 1100
Q ss_pred -------------cc----ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 613 -------------TF----SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 613 -------------~~----~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+ .......+..+.......+.+++.+||+.+|.+||++.+++.|+|++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 0000000000001123458899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.67 Aligned_cols=284 Identities=21% Similarity=0.270 Sum_probs=205.8
Q ss_pred CceeeeeeeecCceeEEEEEEC----CceEEEEEeCCCCCC--ChHHHHHHHHHHHhC-CCCcEEEEeceec------CC
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQ--GPRQFKQEVEILGSM-RHTNMVILLGACP------EY 461 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~g~~~------~~ 461 (701)
+|.+.+.||+|+||.||++.+. +..||+|.+...... ....+.+|+.++.++ .||||+++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4888999999999999999985 446999988654322 245678899999999 5999999998642 22
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.+++++|+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 467888884 789888743 346889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHH-cCc---
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE---QAIR-NGT--- 613 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~---~~i~-~~~--- 613 (701)
.+...... .........||..|+|||++.+ ..++.++|||||||++|+|++|++||...+... ..+. .+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 76432211 1112244578999999998765 468999999999999999999999997544211 0000 000
Q ss_pred -----------------cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCC
Q 005343 614 -----------------FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDN 676 (701)
Q Consensus 614 -----------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~ 676 (701)
+.......+..........+.+++.+||+.+|.+||++.+++.|+|.+....... ...-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~----~~~~ 307 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD----EPVC 307 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc----cccc
Confidence 0000000000000112346899999999999999999999999999864322111 1112
Q ss_pred cccCCCCCCChhhhh
Q 005343 677 IVVTPGPYNSVSEMK 691 (701)
Q Consensus 677 ~~~~~~~~~~~~~~~ 691 (701)
..+.+.+|++.+.|.
T Consensus 308 ~~~~~~~~~~~~~~~ 322 (332)
T cd07857 308 QKPFDFSFESEDSME 322 (332)
T ss_pred cccccCCccccccHH
Confidence 344555577666554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=304.09 Aligned_cols=254 Identities=27% Similarity=0.365 Sum_probs=196.3
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC----CceEEe
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY----GCLVYE 467 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----~~lV~E 467 (701)
|.+.+.||.|+||.||+|... ++.+++|.+.... ......+.+|+.+++.++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999985 4679999998764 22345688999999999999999999998544 589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 58888775432 46899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-C-----ccccc
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-G-----TFSEL 617 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~-----~~~~~ 617 (701)
. .......++..|+|||.+.+ ..++.++||||||+++|+|+||++||......... ... + .+...
T Consensus 155 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 S-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred c-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 1 11234467889999997654 45799999999999999999999999765432211 110 0 00000
Q ss_pred --------cCccC------CCCCHH-HHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 618 --------LDPTV------TGWPVE-AALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 618 --------ld~~~------~~~p~~-~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..+.. ...... ++..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000 000001 14568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.82 Aligned_cols=259 Identities=26% Similarity=0.322 Sum_probs=198.2
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC------
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE------ 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------ 460 (701)
...++|.+.+.||+|+||.||+|.+. ++.|++|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999984 56799999876532 223467889999999999999999998743
Q ss_pred ------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 461 ------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
..++|+||+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 34799999975 677766443 346899999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--c
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--N 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~ 611 (701)
+|||++..+..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||........... .
T Consensus 158 ~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999987643221 01123456788999997754 4578999999999999999999999976554322211 0
Q ss_pred ---Cc----cccc--------cCc------cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 612 ---GT----FSEL--------LDP------TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 612 ---~~----~~~~--------ld~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+. +..+ .++ .........+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00 0000 000 0000011124568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=336.14 Aligned_cols=262 Identities=18% Similarity=0.240 Sum_probs=186.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce---EEEEE--------------eCC---CCCCChHHHHHHHHHHHhCCCCcE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS---VAIKV--------------LGP---DISQGPRQFKQEVEILGSMRHTNM 451 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~---vAiK~--------------l~~---~~~~~~~~~~~Ei~il~~l~HpnI 451 (701)
..++|.+++.||+|+||.||+|.+.... +++|. +.+ ........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998763211 22121 000 011123457899999999999999
Q ss_pred EEEeceec--CCCceEEeecCCCChhhHhcccCC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc
Q 005343 452 VILLGACP--EYGCLVYEYMENGSLEDRLFQKDN--SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD 527 (701)
Q Consensus 452 v~l~g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~ 527 (701)
+++++++. +..++|++++ +++|.+++..... ...........|+.||+.||.|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999984 3458999998 4677777644321 122345567789999999999999999 99999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCc--h-
Q 005343 528 QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLS--H- 603 (701)
Q Consensus 528 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~--~- 603 (701)
.++.+||+|||+++.+..... ......+||..|+|||++.+..++.++|||||||+||||++|. +|++.. .
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 999999999999987643211 1123467999999999999999999999999999999999987 455322 1
Q ss_pred --HHHHHHHcCcc--ccccCc-----------cC----CCCCH-----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 604 --QVEQAIRNGTF--SELLDP-----------TV----TGWPV-----EAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 604 --~~~~~i~~~~~--~~~ld~-----------~~----~~~p~-----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.....+..... ..+.+. .. ...+. ..+..+.+++.+||+.||.+||++.++|.|+|
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 11111110000 000000 00 00000 11234678899999999999999999999999
Q ss_pred HHH
Q 005343 660 IRL 662 (701)
Q Consensus 660 ~~l 662 (701)
+.-
T Consensus 457 f~~ 459 (501)
T PHA03210 457 FSA 459 (501)
T ss_pred hhc
Confidence 975
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.28 Aligned_cols=247 Identities=27% Similarity=0.456 Sum_probs=195.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC----CC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE----YG 462 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~ 462 (701)
..|.+.+.||+|+||.||+|.+. +..||+|++...... ....|.+|+++++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999874 356999999766543 35679999999999999999999998854 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 89999999999999985433 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----------------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV----------------- 605 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~----------------- 605 (701)
+...... ........++..|++||++.+..++.++||||||+++|+|+||+.|+......
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcc---eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 6532111 00111234566799999998889999999999999999999999887543211
Q ss_pred HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 606 ~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+..+. . ...+..++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 0 0112233456999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.13 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=204.1
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|.+.+.||.|+||.||++.+. +..|++|++..... .....+.+|+++++.++|||++++++.+.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999985 66799999876543 345568999999999999999999988744 44799999
Q ss_pred cCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2367899999999999999999999999 9999999999999999999999999998664321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
.......|++.|+|||.+....++.++|+||||+++|+|++|++||....... ..+..+.. ...
T Consensus 158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 223 (258)
T cd08215 158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY--------PPI 223 (258)
T ss_pred ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC--------CCC
Confidence 12234578899999999988889999999999999999999999997654221 11112211 112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
|...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 22334568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=303.74 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=198.7
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
|.+.+.||.|++|.||+|.. .+..+++|.+...... ....+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999998 4666999998765433 34568899999999999999999998844 448999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
. ++|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred C-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 6 48888775533 46899999999999999999999999 9999999999999999999999999998764432
Q ss_pred ccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cc-----cccccC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GT-----FSELLD 619 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~-----~~~~ld 619 (701)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||++||...+..+..... +. +..+.+
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 112335688899999988776 7899999999999999999999999766543322110 00 000000
Q ss_pred --------------ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 620 --------------PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 620 --------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..........+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00000112345678999999999999999999999999884
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.11 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=197.3
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCC--ChHHHHHHHHHHHhC-CCCcEEEEecee--cCCCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQ--GPRQFKQEVEILGSM-RHTNMVILLGAC--PEYGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~g~~--~~~~~lV~E 467 (701)
..|+++++||+||.+.||++... .+.||+|.+.....+ ...-|.+|+..|.+| .|.+||.|++|- ....|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35888999999999999999984 455888766544433 345699999999999 589999999985 445589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|- ..+|...|.++.... ..| .+..+..||+.|+.++|+.| |||.||||.|+|+-. |.+||+|||+|.-+.++.
T Consensus 441 ~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 97 569999887655433 334 55678999999999999999 999999999999976 479999999999887654
Q ss_pred CcccccccccccccCCCccCcccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcccc
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTG-----------MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSE 616 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~ 616 (701)
+.......+||+.||+||.+... +.++++||||||||||+|+.|++||+.-..... ++..
T Consensus 514 ----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----Kl~a 584 (677)
T KOG0596|consen 514 ----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----KLHA 584 (677)
T ss_pred ----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----HHHh
Confidence 33344677999999999965432 267899999999999999999999975543222 3333
Q ss_pred ccCccC-CCCCHHH-HHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 617 LLDPTV-TGWPVEA-ALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 617 ~ld~~~-~~~p~~~-~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.+|.. ..+|.-- ..++.+++..||..||++||++.++|.|+|..+
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 455522 2222111 112899999999999999999999999999877
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.11 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=201.8
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC-------CCc
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE-------YGC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~~~ 463 (701)
+|.+.+.||.|+||.||+|... +..|+||.+.... ....+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999984 5679999987654 2344678999999999999999999998844 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+. ++|.+++... .++++..+..++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 5888877432 37899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-Ccccc--
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-GTFSE-- 616 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~~~~~-- 616 (701)
...... ........++..|+|||++.+. .++.++|+||||+++|+|++|++||......... ... +....
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 443210 1123445789999999998887 7899999999999999999999999765532211 110 00000
Q ss_pred -----------ccC-------ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 617 -----------LLD-------PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 617 -----------~ld-------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+. ..+.......+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000 0000001113456889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.36 Aligned_cols=251 Identities=26% Similarity=0.430 Sum_probs=208.0
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
++|+.-..+.....+||-|-||.||.|.|+.- .||||.++.+. ...++|..|..+|+.++|||+|+|+|+|.. .+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34444455667788999999999999999654 49999998765 556889999999999999999999999954 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|||.|||..|+|.+||.+.++ ..++.-..+.++.||..|+.||...+ +|||||-..|+|+..+..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 899999999999999966543 45777888999999999999999999 99999999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLD 619 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld 619 (701)
+..+.. + .....--.+-|.|||-+....++.++|||+|||+|||+.| |..||.+-+ ++...+++|-.
T Consensus 415 MtgDTY---T--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR----- 484 (1157)
T KOG4278|consen 415 MTGDTY---T--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR----- 484 (1157)
T ss_pred hcCCce---e--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc-----
Confidence 854321 1 1122223567999999999999999999999999999988 778886554 45556665531
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+.|..|+....+|+..||+++|.+||++.+|-
T Consensus 485 ---M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 ---MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ---ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 244667777899999999999999999999884
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.57 Aligned_cols=246 Identities=24% Similarity=0.428 Sum_probs=194.6
Q ss_pred CceeeeeeeecCceeEEEEEECC---ceEEEEEeCCCCC----------CChHHHHHHHHHHHh-CCCCcEEEEeceecC
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH---TSVAIKVLGPDIS----------QGPRQFKQEVEILGS-MRHTNMVILLGACPE 460 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~---~~vAiK~l~~~~~----------~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 460 (701)
+|.+.+.||+|+||.||+|.+.. ..+|+|.+..... .....+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999854 5699998754321 123457789988865 799999999999854
Q ss_pred --CCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 461 --YGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
..++||||+++++|.+++... .....+++..+..++.|++.||.|||+ .+ ++|+||+|.|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 448999999999999887442 334568999999999999999999996 56 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcc
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTF 614 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~ 614 (701)
||++....... ......|+..|++||++.+..++.++||||||+++|+|++|++||....... ..+..+.+
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence 99998654321 2345578999999999998889999999999999999999999997654332 22222222
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
... .. ...+..+.+++.+||+.+|.+||++.++...
T Consensus 231 ~~~----~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 231 EPL----PE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcC----Cc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 111 11 1223468999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.06 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=197.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC----------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---------- 460 (701)
.++|.+.+.||.|+||.||+|... +..|++|.+........+.+.+|+++++.++||||+++++.+..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999984 55699999876655556778999999999999999999987633
Q ss_pred ------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEE
Q 005343 461 ------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSK 533 (701)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~K 533 (701)
..|+||||+. ++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2479999996 588877732 35889999999999999999999999 99999999999997 566889
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR-- 610 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~-- 610 (701)
|+|||+++.+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|++||...+.......
T Consensus 156 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999865332110 011133467899999997644 5688999999999999999999999975543322111
Q ss_pred -cCcc-------------cc-cc-CccCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 -NGTF-------------SE-LL-DPTVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 -~~~~-------------~~-~l-d~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.... .. .. .......+ ......+.+++.+||..+|.+||++.+++.|+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0000 00 00 00000111 122345889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.73 Aligned_cols=262 Identities=19% Similarity=0.251 Sum_probs=194.9
Q ss_pred eeeeec--CceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEG--GYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G--~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
..||+| +||.||++.+ .++.||+|++...... ..+.+.+|+.+++.++||||++++++|.. ..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999998 5677999998765422 23568899999999999999999999844 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc-c
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD-T 550 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~-~ 550 (701)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.+......... .
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886543 235889999999999999999999999 999999999999999999999999866433221110 0
Q ss_pred cccccccccccCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc--Ccc-c----------
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTG--MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN--GTF-S---------- 615 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~--~~~-~---------- 615 (701)
..........++..|++||++.+. .++.++|||||||++|+|++|++||............ +.. .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 000001122456779999998764 4789999999999999999999999755432222111 000 0
Q ss_pred --------------------------cccCccC-CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 616 --------------------------ELLDPTV-TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 616 --------------------------~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
...+..+ ...+......+.+|+.+||..+|.+|||+.+++.|+|++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000 0111234567899999999999999999999999999986444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.36 Aligned_cols=246 Identities=21% Similarity=0.370 Sum_probs=192.5
Q ss_pred ceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC-------
Q 005343 396 FSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY------- 461 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 461 (701)
|.+.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999862 356999998765432 245688999999999999999999987321
Q ss_pred -CceEEeecCCCChhhHhccc---CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 462 -GCLVYEYMENGSLEDRLFQK---DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
.+++++|+.+|+|.+++... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 25889999999998887532 12235788899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCcc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTF 614 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~ 614 (701)
|+++.+..... ........+++.|++||.+....++.++|||||||++|+|++ |++||...... ...+..+..
T Consensus 158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99986533211 111223345678999999998889999999999999999999 89999755432 222222211
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
. ..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 234 L--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 112233456999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.74 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=197.0
Q ss_pred hcCcee-eeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--------------hHHHHHHHHHHHhCCCCcEEEEe
Q 005343 393 TDYFSI-SRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--------------PRQFKQEVEILGSMRHTNMVILL 455 (701)
Q Consensus 393 ~~~f~~-~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~l~ 455 (701)
.++|.. .+.||.|+||.||+|.+ .++.||||++....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 46799999999999987 45679999886543222 12477899999999999999999
Q ss_pred ceec--CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEE
Q 005343 456 GACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 456 g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
+++. +..|+||||+. |+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9974 44589999996 689888843 345889999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcc--------cccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 005343 534 ISDVGLARLVPPSAADT--------ITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQ 604 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~ 604 (701)
|+|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|+||++||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998764211000 001122344678899999988764 479999999999999999999999986654
Q ss_pred HHHHHH------cCc---ccccc------------CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 605 VEQAIR------NGT---FSELL------------DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 605 ~~~~i~------~~~---~~~~l------------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+.... ... +.... .+.........+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 332211 000 00000 00000001122446889999999999999999999999999974
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.88 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=197.7
Q ss_pred CceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCC-----CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDIS-----QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
+|.+.+.||+|+||.||++.+..+ .+++|+++.... .....+..|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 478899999999999999988543 466666654221 223457789999999999999999998844 45899
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++..+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 33457899999999999999999999999 999999999999986 569999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.... ......|++.|+|||++....++.++|+||||+++|+|++|..||............ .......
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~ 224 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEGPTPS 224 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCCCCC
Confidence 3211 123456788999999998888999999999999999999999999755443222111 0111122
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+...+..+.+++.+||..+|.+||++.+++.|+|+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 344555678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.97 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=204.1
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC---CChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS---QGPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV 465 (701)
++|.+.+.||.|+||.||+|.. .+..|++|++..... .....+.+|+.++.+++ ||||+++++.+.+ ..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4689999999999999999998 466799999876432 22346889999999998 9999999998854 44899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++... ..+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999988543 36999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcc--------------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc
Q 005343 546 SAADT--------------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN 611 (701)
Q Consensus 546 ~~~~~--------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~ 611 (701)
..... ..........|+..|++||.+....++.++|+||||+++++|++|++||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 22110 0012234556889999999998888999999999999999999999999866532221110
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCCh----hhhhhHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDL----VSVVLPELI 660 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~----~~vl~~~~~ 660 (701)
. .....+|...+..+.+++.+||+.+|.+||++ .+++.|+|+
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 0 00112233335568999999999999999999 999999874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.71 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=204.3
Q ss_pred hcCceee-eeeeecCceeEEEEEECCce--EEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCCC------
Q 005343 393 TDYFSIS-RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEYG------ 462 (701)
Q Consensus 393 ~~~f~~~-~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~------ 462 (701)
+++|.+. .+||-|-.|.|..+.++.+. +|+|++.. .....+|+++.-.. .|||||.++++|.+..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455554 57999999999999886554 99999853 34568899886555 6999999999985432
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeecc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGL 539 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGl 539 (701)
.+|||.|+||.|...+..++ ...|++.+...|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 47999999999999986643 467999999999999999999999999 99999999999996 466889999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGT 613 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~ 613 (701)
|+.-. ......+.|-|++|.|||++...+|+..+|+||+|||+|-||.|+|||...+ .+...|+.|.
T Consensus 211 AK~t~-------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQ-------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccC-------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 98542 2344678899999999999999999999999999999999999999996443 4566677665
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+. +-++ .| ...+....++|..+|..+|.+|.|+.+++.|+|..-
T Consensus 284 y~-FP~p---EW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 284 YE-FPEP---EW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cc-CCCh---hH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 42 1112 23 244566889999999999999999999999999863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.22 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=206.8
Q ss_pred cCceeeeeeeecCceeEEEEEEC--C---ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--H---TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~---~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
+.-.+.+.||.|.||+||+|+++ + ..||||.|+...... ...|..|..||.+++||||+.|-|+.... ..||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999999983 2 349999998765443 45699999999999999999999998543 3689
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
.|||++|+|+.+|..++ ..|++.+...++..|+.|+.||-+.+ +|||||-..|||++.|.++|++||||+|.+..
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997766 45999999999999999999999999 99999999999999999999999999998855
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--hHHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS--HQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~--~~~~~~i~~~~~~~~ld~~~ 622 (701)
+.. ..|.....--...|.|||.+...+++.++|||||||++||.++ |..|+-.- +++-..+++|-- +
T Consensus 784 d~~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-------L 853 (996)
T KOG0196|consen 784 DPE---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-------L 853 (996)
T ss_pred CCC---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-------C
Confidence 431 1111122222468999999999999999999999999999876 88887533 456677776631 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
.-|.+++..|..|++.||+++..+||.+.+|+.+.
T Consensus 854 -PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 854 -PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred -CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 23567888899999999999999999999998643
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.29 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=195.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||.+...... ....+..|+.++.... ||||++++++|.+ ..++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 467899999999999999999996 677999998764322 3345677887776664 9999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+ +++|.+.+.... .++++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~-~~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELM-STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ecc-CcCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 998 457777664432 368999999999999999999997 47 99999999999999999999999999876532
Q ss_pred CCCcccccccccccccCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---HcCcccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGM----LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RNGTFSELL 618 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~~~~~~~l 618 (701)
... .....++..|+|||++.+.. ++.++||||||+++|+|++|++||.........+ ..+...
T Consensus 168 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 237 (296)
T cd06618 168 SKA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--- 237 (296)
T ss_pred CCc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC---
Confidence 211 12335788999999887554 7889999999999999999999997533211111 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.. .+....+..+.+++.+||..+|.+||++.+++.|+|+..
T Consensus 238 --~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 238 --SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 11 111123456899999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.59 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=195.3
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhC---CCCcEEEEeceecC--C-----
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSM---RHTNMVILLGACPE--Y----- 461 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l---~HpnIv~l~g~~~~--~----- 461 (701)
|++.+.||.|+||.||+|.+. ++.||+|.+....... ...+.+|+.++..+ +|||+++++++|.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999984 5679999997554322 34567788887666 59999999999842 3
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 579999996 58888775432 235899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcCcc----
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNGTF---- 614 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~~~---- 614 (701)
.+.... ......++..|+|||++.+..++.++|||||||++|+|++|++||......+.. +..-..
T Consensus 156 ~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEM-------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCc-------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 763321 112345788999999999989999999999999999999999999766543221 110000
Q ss_pred -------------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 615 -------------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 615 -------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
..................+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000000000111234567899999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.04 Aligned_cols=255 Identities=18% Similarity=0.204 Sum_probs=180.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc-----eEEEEEeCCCCCCChH-----------HHHHHHHHHHhCCCCcEEEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT-----SVAIKVLGPDISQGPR-----------QFKQEVEILGSMRHTNMVILL 455 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~-----~vAiK~l~~~~~~~~~-----------~~~~Ei~il~~l~HpnIv~l~ 455 (701)
..+.|.+.++||+|+||.||+|.+.++ .+++|+.......... ....++..+..+.|+|++.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999998544 4677764433221111 112333445667899999999
Q ss_pred ceecCC------CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 456 GACPEY------GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 456 g~~~~~------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
+.+... .+++++++ ..++.+.+.. ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 875322 25677776 3466665532 223577888999999999999999999 9999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcc-cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 005343 530 YVSKISDVGLARLVPPSAADT-ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA 608 (701)
Q Consensus 530 ~~~KL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~ 608 (701)
+.+||+|||+|+.+....... ..........||+.|+|||++.+..++.++|||||||+||||++|++||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999998764321110 0111123457999999999999999999999999999999999999999755211111
Q ss_pred HH---cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 609 IR---NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 609 i~---~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+. .+-+..+..... .+..++..+.+++..|+..+|.+||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 10 000111111111 0112345689999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=304.40 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=194.5
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
|...+.||+|+||.||+|.+ .+..||+|.+....... ...+.+|+.+++.++|||+++++++|.+ ..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999997 45669999987543222 3468889999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. |+|.+.+... ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 5777766443 345899999999999999999999999 999999999999999999999999998754321
Q ss_pred cccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVT 623 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~ 623 (701)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||........ .+..+.... .
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~- 244 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-----L- 244 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-----C-
Confidence 2346888999999863 45689999999999999999999999865433221 111111110 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+...+..+.+++.+||+.+|.+||++.+++.|.|+..
T Consensus 245 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 -QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01123345899999999999999999999999998865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.75 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=199.3
Q ss_pred CceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCCC----CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--C
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS----QGPRQFKQEVEILGSM-RHTNMVILLGACPEY--G 462 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~ 462 (701)
+|++.+.||.|+||.||++.. ++..||+|++..... ...+.+.+|+.++..+ +||||+.+++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999986 456799999875422 2235688999999999 599999999888543 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++++|.+++... .++++.....++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 7999999999999998543 35788899999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHcCccccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTG--MLGVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIRNGTFSEL 617 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~~~~~~~~ 617 (701)
+..... .......|+..|+|||++... .++.++||||||+++|+|+||.+||..... ...... ..
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~---- 224 (290)
T cd05613 155 FHEDEV-----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-RI---- 224 (290)
T ss_pred cccccc-----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-Hh----
Confidence 533211 112345689999999987653 478899999999999999999999964321 111111 00
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHh
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRD 664 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~ 664 (701)
......+|......+.+++.+||..+|.+|| ++.+++.|+|+.-..
T Consensus 225 -~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 225 -LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0011123344455689999999999999997 889999999987644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.40 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=201.8
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
+|++.+.||+|+||.||++... +..+++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4889999999999999999874 45699999875432 223457889999999999999999988744 44899999
Q ss_pred cCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988553 22356899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
.....++..|++||.+.+..++.++|+||||+++|+|++|++||...... ...+..+.+. ..
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------PI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------CC
Confidence 12346888999999999999999999999999999999999999766532 2223333222 22
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
+......+.+++.+||..+|.+||++.+++.|++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 2344556999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.64 Aligned_cols=245 Identities=26% Similarity=0.287 Sum_probs=188.7
Q ss_pred eeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHH---HHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 401 KIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVE---ILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~---il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
.||+|+||.||+|... ++.||+|.+....... ...+..|.. +++...||||+.+++.+.+ ..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 5679999886543221 122344443 4445689999999988744 4589999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
||+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988843 246899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHHcCccccccCccCCCCCHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVE-QAIRNGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~-~~i~~~~~~~~ld~~~~~~p~~ 628 (701)
.....|+..|+|||++.++ .++.++|||||||++|+|++|++||....... ..+..... .. ...+|..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TM---AVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--cc---CCCCCCc
Confidence 1234789999999998754 58999999999999999999999997542110 01111110 00 1123333
Q ss_pred HHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHh
Q 005343 629 AALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRD 664 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~ 664 (701)
.+..+.+++.+||..+|.+|| ++.+++.|+|++--+
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 456799999999999999999 999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.25 Aligned_cols=245 Identities=27% Similarity=0.323 Sum_probs=196.7
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||.|+||.||++.+. +..+++|++..... .....+.+|++++++++||||+++++.+.. ..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 66799999876543 234568999999999999999999988744 34899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc--cc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT--IT 552 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~--~~ 552 (701)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99885433 6899999999999999999999999 9999999999999999999999999987643221100 00
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCCCCHHH-
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGWPVEA- 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~p~~~- 629 (701)
........++..|++||.+....++.++||||||+++|+|++|++||........ .+..+.+ .+|...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI---------EWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------CCCcccc
Confidence 1122345688899999999888899999999999999999999999975543221 1222211 122222
Q ss_pred -HHHHHHHHHHhhccCcCCCCCh---hhhhhHHHHH
Q 005343 630 -ALSIAKLALQCCELRKRDRPDL---VSVVLPELIR 661 (701)
Q Consensus 630 -~~~l~~li~~cl~~~P~~RPt~---~~vl~~~~~~ 661 (701)
+..+.+++.+||+.+|.+||++ .+++.|+|++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 4568999999999999999999 9999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.21 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=197.4
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC---CC
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE---YG 462 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~ 462 (701)
...+++|.+.+.||.|+||.||+|... +..||+|.+..... .....+.+|+.++..++||||++++++|.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999874 55699998865432 234568899999999999999999998732 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+ +++|..++.. .++++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 6788887732 35788888899999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HH---------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IR--------- 610 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~--------- 610 (701)
.... .....++..|+|||++.+ ..++.++|||||||++|+|+||++||......... +.
T Consensus 158 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 158 QDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred cCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 4221 133467889999998765 56899999999999999999999999654321110 00
Q ss_pred ------cCccccccCc--cCCCCCH-----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 611 ------NGTFSELLDP--TVTGWPV-----EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 611 ------~~~~~~~ld~--~~~~~p~-----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+....+... .....|. ..+..+.+++.+||+.+|.+||++.+++.|+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 0000000000 0000111 1235689999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.32 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=198.2
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
|+..+.||+|+||.||+|... ++.|++|++.... ......+..|+.+++.++|||++++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999984 5679999988754 2234568899999999999999999999854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 68999886542 46899999999999999999999999 99999999999999999999999999986643211
Q ss_pred ccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCc---------c---cc
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGT---------F---SE 616 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~---------~---~~ 616 (701)
......++..|+|||++.+. .++.++|||||||++|+|++|++||.............. + ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12334567889999988776 789999999999999999999999977654322111000 0 00
Q ss_pred c--cCccCCCCC--------HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 617 L--LDPTVTGWP--------VEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 617 ~--ld~~~~~~p--------~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
+ .+.....++ ......+.+++.+||..+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 000011110 0124569999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.65 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=195.0
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
|.+.+.||.|+||.||+|... +..|+||.+...... ......+|+..+.+++ |||++.+++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999984 456999988765432 2234567999999999 9999999999844 448999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889998885543 346899999999999999999999999 9999999999999999999999999998653321
Q ss_pred ccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcC----------------
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNG---------------- 612 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~---------------- 612 (701)
......++..|+|||++. ...++.++|+||||+++|+|++|++||.............
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 123356889999999774 4557999999999999999999999997654332221100
Q ss_pred ---ccccccCcc----CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 613 ---TFSELLDPT----VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 613 ---~~~~~ld~~----~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+...+... +.......+..+.+++.+||+.+|.+||++.+++.|+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000000 000001113568999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.72 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=181.9
Q ss_pred eeeecCceeEEEEEEC-Cc---eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCC
Q 005343 401 KIGEGGYGPVYKAQLD-HT---SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGS 473 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~-~~---~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gs 473 (701)
.||+|+||.||+|... +. .+++|.+..... .....+.+|+.+++.++||||+++++.|.+ ..|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999752 22 366777665432 234579999999999999999999999854 4589999999999
Q ss_pred hhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 474 LEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 474 L~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
|.+++.+.. ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----~ 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----Y 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch----h
Confidence 999986542 2345677778899999999999999999 9999999999999999999999999986432110 0
Q ss_pred cccccccccCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH---HHHHHcCccccccCcc
Q 005343 553 QYHMTTAAGTFCYIDPEYQQT-------GMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV---EQAIRNGTFSELLDPT 621 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~---~~~i~~~~~~~~ld~~ 621 (701)
........|+..|+|||++.. ..++.++|||||||++|||++ |.+||...... ...+..+ ...+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ-QVKLFKPQ 233 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc-ccccCCCc
Confidence 011234568899999998743 235789999999999999997 56788644332 2222222 22233333
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.. ......+.+++..|| .+|.+||++.+|+
T Consensus 234 ~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 234 LE---LPYSERWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred cC---CCCcHHHHHHHHHHh-hCcccCCCHHHHH
Confidence 22 123345788999999 6899999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=295.57 Aligned_cols=242 Identities=23% Similarity=0.239 Sum_probs=188.8
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHH-HHhCCCCcEEEEeceecC--CCceEEeecCC
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEI-LGSMRHTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+.||.|+||.||+|.. .++.||+|++....... ...+..|..+ ....+|||++++++.+.+ ..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999998 45679999986543211 2234455544 445689999999999854 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999988443 35788999999999999999999999 99999999999999999999999999875421
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCCHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
.....|+..|++||.+.+..++.++||||||+++|+|+||.+||....... ..+..+... ... ..+...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPE---EVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCC---cccccC
Confidence 134468889999999988889999999999999999999999997554321 112222111 000 111123
Q ss_pred HHHHHHHHHHhhccCcCCCC---ChhhhhhHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRP---DLVSVVLPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RP---t~~~vl~~~~~~l 662 (701)
+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 45689999999999999999 5579999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.36 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=209.0
Q ss_pred HhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEecee--cCCCce
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGAC--PEYGCL 464 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~l 464 (701)
...+.|.+...||+|.|+.|.+|++ .++.||||++.+..-.. ...+.+|+++|+.++|||||+++.+. ....|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3467899999999999999999998 45669999998765332 34589999999999999999999987 456699
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+.+|.+.++|.+++. ........++.|+..|++|||+.+ |||||||..||||+.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999977654 344677789999999999999999 9999999999999999999999999998875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
... ...+.||++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+.... ....-.|++
T Consensus 207 ~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------- 272 (596)
T KOG0586|consen 207 YGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------- 272 (596)
T ss_pred ccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-------
Confidence 332 3467899999999999998876 78999999999999999999999765421 111112221
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|.....+..+++.++|-++|..|+++.+|..|.|.-+
T Consensus 273 --rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 273 --RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred --cccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 123344446789999999999999999999999999775
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.81 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=206.1
Q ss_pred ceeeeeeeecCceeEEEEEECC---c--eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCCC-ceEEee
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH---T--SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEYG-CLVYEY 468 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~---~--~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~lV~Ey 468 (701)
..+.++||+|.||.|++|.|.. + .||||.++.+... ....|.+|+.+|.+|+|||++.|||+.-+.. .||||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 4556889999999999999943 2 4999999887644 5678999999999999999999999997644 699999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++.|||.++|.+ .....|.......++.|||.|+.||.+++ +|||||-..|+||.....+||+||||.+-+.....
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999977 55567888889999999999999999999 99999999999999999999999999998754322
Q ss_pred cccccccc-cccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCC
Q 005343 549 DTITQYHM-TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 549 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.|.+ ....-.+.|+|||.+...+++.++|||+|||+||||+| |..||.+-. ++...++.+ ....
T Consensus 268 ----~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------erLp 335 (1039)
T KOG0199|consen 268 ----MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------ERLP 335 (1039)
T ss_pred ----ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------ccCC
Confidence 1222 22334678999999999999999999999999999998 557775443 233333322 2234
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.|..|+..+.+++..||..+|.+||++..|.+..+..
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 5778888999999999999999999999997554443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.92 Aligned_cols=255 Identities=25% Similarity=0.287 Sum_probs=198.2
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--C---
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--Y--- 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~--- 461 (701)
...++|.+...||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++|||++++++++.. .
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999984 56699998865422 223457789999999999999999887632 2
Q ss_pred ---CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 462 ---GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 462 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 57999998 7799888743 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---Hc-Cc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RN-GT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~-~~ 613 (701)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|+||++||.........- .. +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99765321 234467899999998765 467899999999999999999999997554322111 10 00
Q ss_pred ccc-c---------------c----CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 FSE-L---------------L----DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ~~~-~---------------l----d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
... + + .+.........+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000 0 0 00000000112456899999999999999999999999999973
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.77 Aligned_cols=248 Identities=26% Similarity=0.356 Sum_probs=194.8
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
|...+.||+|+||.||+|.. .+..|++|++....... ...+.+|+++++.++|||++++++++.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999987 45669999986543322 2457889999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+. |+|.+.+... ..++++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 6777777443 245889999999999999999999999 99999999999999999999999999864311
Q ss_pred cccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||...+........... ..+...
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~-- 241 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTLQ-- 241 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCC--
Confidence 23456889999999874 456889999999999999999999998765433222211110 001111
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
....+..+.+++.+||+.+|.+||++.+++.|+|++...
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 011233589999999999999999999999999987533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.05 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred cCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceec-----C----
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACP-----E---- 460 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-----~---- 460 (701)
+.|.-..+||+|.||+||+|+..++ .||+|+.-.+. ..-.....+|+.+|..++|+|++.++..|. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4567778999999999999998654 48887543322 233456789999999999999999998872 1
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||.+|+. +|..+|.. ....++..++.+++.++..||.|+|.+. |+|||+||.|+|++.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 13799999964 77776632 2356899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HH--cCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IR--NGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~--~~~~ 614 (701)
++.+..+. .....+.+..+.|++|++||.+.+ ..|+++.|||..|||+.||+||.|.|.+..+..+. |. -|++
T Consensus 171 ar~fs~~~--n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSK--NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccceeccc--ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 98775443 233344677888999999997665 45999999999999999999999999877544332 21 1222
Q ss_pred ccccCccCCCCCH------------------------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 615 SELLDPTVTGWPV------------------------EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 615 ~~~ld~~~~~~p~------------------------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
..-..|.....|. .......+|+.+++.+||.+||+..+++.|.||.--.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 2222222211111 11125679999999999999999999999999985333
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=327.50 Aligned_cols=144 Identities=28% Similarity=0.404 Sum_probs=126.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceec--CCCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACP--EYGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV 465 (701)
.++|.+.++||+|+||.||+|.+. ++.||||++....... ...+..|+.++..++||||+++++.+. +..|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999996 6779999987643222 356889999999999999999998874 455899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|||+.+|+|.+++... ..+++...+.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999988543 35788899999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.66 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=202.2
Q ss_pred hcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCC---CChHHHHHHHHHHHhC-CCCcEEEEecee--cCCCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS---QGPRQFKQEVEILGSM-RHTNMVILLGAC--PEYGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~--~~~~~l 464 (701)
..+|..+..||+|+||.|-+|..+++. +|||+++++.. ++.+--..|-++|... +-|.++.|...| .+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999998876 99999988752 2222234566666655 456677776665 456799
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+.||+|.-.+.+-+ .+.+.....++.+|+-||-|||+.+ ||+||||.+||+||.+|++||+|||+++--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-
Confidence 999999999988775543 4677788889999999999999999 999999999999999999999999999742
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
........+.|||+.|+|||++...+|+..+|||||||+|||||.|.|||.+.++ +-+.|.+.+
T Consensus 501 -----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--------- 566 (683)
T KOG0696|consen 501 -----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--------- 566 (683)
T ss_pred -----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------
Confidence 1222234678999999999999999999999999999999999999999988764 333333322
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHhc
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRDL 665 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~~ 665 (701)
..+|...+.+...+....|...|.+|.. -.+|-+|++++--++
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 2466677777889999999999999864 467778877776554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.14 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=194.6
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|...+.||+|+||.||+|+. .+..|++|.+...... ....+.+|+++++.++|||++++++++.+ ..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366778899999999999998 4556999988653222 23457889999999999999999998743 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+. |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 68877664332 45889999999999999999999999 999999999999999999999999998765321
Q ss_pred CcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTV 622 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~ 622 (701)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||........ .+..+.. +..
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~ 234 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PAL 234 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----CCc
Confidence 2346888999999864 35688899999999999999999999865443222 1222211 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
. +...+..+.+++.+||..+|.+||++.+++.|+|+...
T Consensus 235 ~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 235 Q--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred C--cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 12334568999999999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.23 Aligned_cols=196 Identities=31% Similarity=0.481 Sum_probs=170.4
Q ss_pred CceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--------CCc
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--------YGC 463 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~~~ 463 (701)
.|...+.||+||||.||+|+++.+ .||||.++...... .+...+|+++|++++|||||+++++-.+ ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 456667899999999999998544 59999998865433 4557899999999999999999987432 337
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC----CcEEEEeecc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN----YVSKISDVGL 539 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~----~~~KL~DFGl 539 (701)
+|||||.||||+.+|.+-.+...|++...+.++.+++.||.|||.++ |+||||||.||++-.+ -..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888889999999999999999999999999 9999999999999432 2459999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~ 600 (701)
|+-++.+. .+.+.+||..|++||++. ...|+..+|.|||||++|++.||..||-
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 99875432 468899999999999988 4889999999999999999999998884
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=298.74 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred CceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCCC----CChHHHHHHHHHHHhC-CCCcEEEEeceecC--CC
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS----QGPRQFKQEVEILGSM-RHTNMVILLGACPE--YG 462 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~ 462 (701)
+|.+.+.||+|+||.||++.. +++.||||++..... .....+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999985 346699999875321 2234588999999999 59999999988744 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+.+|+|.+.+... ..+++.....++.|++.||.|||+.+ ++||||+|.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 7999999999999988543 35888999999999999999999998 99999999999999999999999999887
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCcccccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELL 618 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~l 618 (701)
+..... .......|+..|++||.+.+.. .+.++||||||+++|+|+||..||...... ...+......
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 155 FLAEEE-----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred cccccc-----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 543211 1123356899999999887665 788999999999999999999999643211 1111111100
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCCh---hhhhhHHHHHHHhc
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDL---VSVVLPELIRLRDL 665 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~---~~vl~~~~~~l~~~ 665 (701)
.....|...+..+.+++.+||+.+|.+||++ .+++.|+|++-.++
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 227 --SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 0112223344568999999999999999985 56689988765444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.61 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=197.0
Q ss_pred hcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.+-|..++.||-|+||+|.+++-.+|. ||+|.|++...... ...+.|..||...+.+.||+||-.|.+ ..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 356899999999999999999876654 99999877543222 347889999999999999999999955 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|+|++||++..+|.+.+ -|++.....++.++.+|+++.|..| +|||||||+|||||.+|++||+|||||.-+..
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999997654 4788888889999999999999999 99999999999999999999999999953311
Q ss_pred CC-------Cccccc-----------------------------ccccccccCCCccCcccccCCCCCchhhHHHHHHHH
Q 005343 546 SA-------ADTITQ-----------------------------YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589 (701)
Q Consensus 546 ~~-------~~~~~~-----------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil 589 (701)
.. .+...+ ......+||..|+|||++....|+..+||||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 000000 001257899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCchHHHHHHHcCccccccCccC-CCCCHHHHHHHHHHH-HHhhccCcCC-CCChhhhhhHHHHHHHhcc
Q 005343 590 LQLITARPAMGLSHQVEQAIRNGTFSELLDPTV-TGWPVEAALSIAKLA-LQCCELRKRD-RPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 590 ~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~-~~~p~~~~~~l~~li-~~cl~~~P~~-RPt~~~vl~~~~~~l~~~~ 666 (701)
|||+.|++||-.....+...+--++...|+-.. .....+ ..++| ..|+.-+-+- +=-..+|-.|+||+--|+.
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e----~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKE----ALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHH----HHHHHHHHhcChhhhhcccchhhhhcCccccccchH
Confidence 999999999965443333222223333333221 222333 33444 4455433322 2225568899999876654
Q ss_pred c
Q 005343 667 F 667 (701)
Q Consensus 667 ~ 667 (701)
.
T Consensus 938 s 938 (1034)
T KOG0608|consen 938 S 938 (1034)
T ss_pred h
Confidence 3
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=328.98 Aligned_cols=257 Identities=28% Similarity=0.383 Sum_probs=194.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec---------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP--------- 459 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~--------- 459 (701)
..++|+.+..||+||||.||+++. +++.||||.+...... ....+.+|+..|++|+|||||.+|.+|-
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456788999999999999999987 8999999998776422 2345889999999999999998864210
Q ss_pred --------------------------------------------------------------------------------
Q 005343 460 -------------------------------------------------------------------------------- 459 (701)
Q Consensus 460 -------------------------------------------------------------------------------- 459 (701)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C---------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh
Q 005343 460 -----------------------E---------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507 (701)
Q Consensus 460 -----------------------~---------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 507 (701)
+ ..||-||||+...|.+++..+.... .....++++.+|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 0 0145678887777777664433211 24556889999999999999
Q ss_pred hcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC-----------CCC-CcccccccccccccCCCccCcccccCCC
Q 005343 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP-----------PSA-ADTITQYHMTTAAGTFCYIDPEYQQTGM 575 (701)
Q Consensus 508 ~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~-----------~~~-~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 575 (701)
+.| ||||||||.||+|+.++.|||+|||+|.... +.. .........++.+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 000 0111222457889999999999987655
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCC
Q 005343 576 ---LGVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649 (701)
Q Consensus 576 ---~~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP 649 (701)
|+.|+|+|||||||+||+. ||+..-+- -..++.|.+..- .++.......=+.+|.++++.||.+||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999999999986 47655433 233344444322 233334444468999999999999999
Q ss_pred ChhhhhhHHHHH
Q 005343 650 DLVSVVLPELIR 661 (701)
Q Consensus 650 t~~~vl~~~~~~ 661 (701)
|+.++|.+.|+.
T Consensus 864 tA~eLL~s~llp 875 (1351)
T KOG1035|consen 864 TATELLNSELLP 875 (1351)
T ss_pred CHHHHhhccCCC
Confidence 999999887776
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.91 Aligned_cols=238 Identities=27% Similarity=0.302 Sum_probs=195.1
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
||.|+||.||++... ++.+++|++...... ....+..|+.+++.++||||+++++.+.. ..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999984 567999998765432 34468999999999999999999998854 34899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~ 554 (701)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~ 148 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------S 148 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC------C
Confidence 9998543 35889999999999999999999999 9999999999999999999999999987653321 1
Q ss_pred cccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCCCCHHHHHH
Q 005343 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEAALS 632 (701)
Q Consensus 555 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~~~~ 632 (701)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...... ...+..+. ..+|...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP---------LRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCHH
Confidence 234557888999999998888999999999999999999999999765531 11222111 1223333556
Q ss_pred HHHHHHHhhccCcCCCCCh---hhhhhHHHH
Q 005343 633 IAKLALQCCELRKRDRPDL---VSVVLPELI 660 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~---~~vl~~~~~ 660 (701)
+.+++.+||..+|.+||++ .+++.|+|+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 8999999999999999999 889888874
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.30 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=217.2
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEecee-------c
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGAC-------P 459 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~-------~ 459 (701)
-..++-|.+.+.||.|.||.||+++. .++.+|+|++..+. +..+++..|.+||+.+ .|||++.+||+| +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34567899999999999999999986 56779999998775 4456788899999887 799999999997 4
Q ss_pred CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 460 EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
+..+||||||.+||..|+..... ...+.|..+..|+..++.||.+||.+. +||||||=.||||+.++.|||.|||+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 55699999999999999886655 678999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-----MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~ 614 (701)
+..+. .+..+..+.+||++|||||++... .|+.++|+||||++..||--|.||+-..+.+...+.-..-
T Consensus 170 SaQld------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 170 SAQLD------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeeee------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 98763 344456788999999999976543 3888999999999999999999999888877666543321
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
-.|.+. -|..-..+|.++|..||..+-..||++.++|.|+|.+
T Consensus 244 ---PPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 244 ---PPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ---CCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 112221 2445566799999999999999999999999998865
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=335.17 Aligned_cols=254 Identities=25% Similarity=0.307 Sum_probs=201.2
Q ss_pred CceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey 468 (701)
+|.-...||.|.||.||.|...+++ .|+|-++..... ......+|+.+|..++|||+|.+||+= .+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 4666778999999999999986655 788876554432 334578999999999999999999984 5566899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|++|+|.+.+.. +.-.++.....+..|++.||.|||++| ||||||||.||||+.+|.+|++|||.|..+.+...
T Consensus 1316 C~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred hccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999998833 233556666778899999999999999 99999999999999999999999999998866531
Q ss_pred cccccccccccccCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHcCccccccCccCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGM---LGVKSDLYSLGVVLLQLITARPAMGL-SHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~pf~~-~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
. .........||+.|||||++.+.. .+.+.||||+||+.+||+||+.||.. ++...-+..-+. ...+.
T Consensus 1390 ~--~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------gh~Pq 1461 (1509)
T KOG4645|consen 1390 T--MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------GHKPQ 1461 (1509)
T ss_pred c--CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------cCCCC
Confidence 1 123345789999999999886544 56789999999999999999999853 333322222221 11234
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.|...+.+-.+|+..||..||+.|=++.++++|.|-+-
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 45556667889999999999999999989998877664
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=285.40 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=204.1
Q ss_pred eeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEeecCCCCh
Q 005343 400 RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYEYMENGSL 474 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL 474 (701)
+.||+|+|+.|-.+.. .+..+|||++.+........+.+|++++..+ .|+||+.|+.+|.+ .+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5799999999998876 5667999999988767778899999999998 59999999999965 45899999999999
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEEeeccccccCCCC-Ccc
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---VSKISDVGLARLVPPSA-ADT 550 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~DFGla~~~~~~~-~~~ 550 (701)
...+.++. -|++.+..++..+|+.||.|||..| |.||||||+|||..... -+|||||.|..-+.... ...
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99886654 4888899999999999999999999 99999999999996543 46999999876542111 112
Q ss_pred cccccccccccCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----------------HHHHH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQ-----QTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----------------QVEQA 608 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----------------~~~~~ 608 (701)
.......+.+|+..|||||+. ....|+.++|.||||||||-||.|++||.+.. .+-..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 334456788999999999953 23469999999999999999999999996432 22334
Q ss_pred HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 609 i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
|.+|.+. +-|. +| ...+.+..+++...+-.++.+|-++.+++.|+|.+.+.
T Consensus 318 IQEGkYe-FPdk---dW-ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 318 IQEGKYE-FPDK---DW-AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HhccCCc-CChh---hh-HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 5556542 1111 22 23345578899999999999999999999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.62 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=211.0
Q ss_pred CceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
++..+..||-||||.|=++..++.. +|+|++++...-+ .+.+..|-.||..++.|.||+||..|.+. .|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455678999999999999987665 8888887654332 34588899999999999999999999664 478999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
-|-||.|+..|..++ .|...+...++..+++|+.|||+++ ||+|||||+|++|+.+|-+||.|||+|+.+..+
T Consensus 501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 999999999995543 4777778889999999999999999 999999999999999999999999999987543
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
.+.+++|||+.|.|||++.+...+..+|.||||+++||||||.|||...+.+. +.|-.|. ....|
T Consensus 574 ------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------d~i~~ 640 (732)
T KOG0614|consen 574 ------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------DKIEF 640 (732)
T ss_pred ------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------hhhhc
Confidence 24578999999999999999999999999999999999999999999887653 3344442 11357
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRD 664 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~ 664 (701)
|...+....+++.+.|..+|.+|.. +.+|=.|.|+.=-+
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 7777778899999999999999987 88999998887433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.37 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=193.3
Q ss_pred eeeeeeecCceeEEEEEECC--ceEEEEEeCCCCC-CChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEEeecCC
Q 005343 398 ISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDIS-QGPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
.+..||.|..|.||++++.. +-.|||.+..... ...+.+...+.++...+ .|+||+.+|+|-. ..++-||.| +
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 45679999999999999966 5589998876542 33456778888876664 8999999999843 347888888 3
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
.-++.+|.+ ...++++...-++..-++.||.||.... .|||||+||+|||+|..|.+||||||++..+-.+.
T Consensus 175 ~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---- 246 (391)
T KOG0983|consen 175 TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---- 246 (391)
T ss_pred HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc----
Confidence 334444432 2346899999999999999999999765 39999999999999999999999999997764433
Q ss_pred ccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccCCCC
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
..+..+|-+.|||||.+.. ..|+.++||||||+.|+||.||..||.+-+ ++-..+.+. ....++...
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-ePP~L~~~~--- 319 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EPPLLPGHM--- 319 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CCCCCCccc---
Confidence 2356689999999997754 469999999999999999999999997633 222223221 112222211
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
..+..|.+|+..||+.|+++||...++|.|+|.+..+.+
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 145569999999999999999999999999998876644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=336.73 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=192.1
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
..|.....||+|+||.||+|.+ .+..||||.+..... ....|++++++++|||||+++|+|.+ ..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999997 566799998864432 12456899999999999999999944 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++. .++|..+.+|+.|++.||.|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999983 37899999999999999999996544459999999999999999988876 666543311
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----H----HHHHHHcCccccccCcc
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----Q----VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----~----~~~~i~~~~~~~~ld~~ 621 (701)
.....||+.|+|||++.+..++.++|||||||++|||+||++||.... . ..............++.
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 123368899999999999999999999999999999999999985321 1 11111122233344444
Q ss_pred CCC---CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTG---WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
... .+......+.+++.+||+.+|.+||++.+++.. +.++
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~-L~~~ 951 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT-LESA 951 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH-HHHh
Confidence 422 234555678899999999999999999999753 4443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=283.80 Aligned_cols=225 Identities=23% Similarity=0.180 Sum_probs=179.2
Q ss_pred cCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCChhhHhcc
Q 005343 405 GGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQ 480 (701)
Q Consensus 405 G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~l~~ 480 (701)
|.||.||++.+ .++.||+|.+.... .+.+|...+....||||+++++++.+ ..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999998 45569999987643 23455566666789999999998744 45899999999999998854
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccc
Q 005343 481 KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560 (701)
Q Consensus 481 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 560 (701)
. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+... .....
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~ 143 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEA 143 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCC
Confidence 3 34899999999999999999999999 999999999999999999999999988655321 12335
Q ss_pred cCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHh
Q 005343 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQC 640 (701)
Q Consensus 561 gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~c 640 (701)
++..|+|||......++.++||||+||++|+|++|++|+...... +.. . .....|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~~--~------~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---INT--H------TTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---ccc--c------cccCCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999887533211 000 0 00112333445689999999
Q ss_pred hccCcCCCCCh-----hhhhhHHHH
Q 005343 641 CELRKRDRPDL-----VSVVLPELI 660 (701)
Q Consensus 641 l~~~P~~RPt~-----~~vl~~~~~ 660 (701)
|+.+|.+||++ .+++.|+|+
T Consensus 213 l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 213 LQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999996 777877763
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=260.65 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=193.9
Q ss_pred CceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEee
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEY 468 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey 468 (701)
.|.-.++||+|.||+||+|+..++. ||+|..+.+..+ .+....+||-+|+.++|.|||.+++... ...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3556688999999999999986654 999988776533 3567899999999999999999999863 334699999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|. .+|..++..- +..+..+....++.|++.||.|+|+++ ++||||||.|+|++.||.+||+|||+++-+.-..
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 94 5777766433 346888999999999999999999999 9999999999999999999999999999764322
Q ss_pred cccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHH----cCccccccCccC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQAIR----NGTFSELLDPTV 622 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~i~----~~~~~~~ld~~~ 622 (701)
.-.+..+.|.||++|.++-+. -|++..|+||.|||+.|+.. |+|.|.+.+-.++..+ -|...+-..|+.
T Consensus 156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 123556889999999976655 48999999999999999976 7788876653333222 122211111111
Q ss_pred CC---------CCH-----HHH----HHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 623 TG---------WPV-----EAA----LSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 623 ~~---------~p~-----~~~----~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.. +|. ..- ..=.+++...+.-+|..|.++...+.|+.+.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 11 111 000 1135788888999999999999999887764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=303.54 Aligned_cols=237 Identities=25% Similarity=0.318 Sum_probs=196.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCCC--ceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEYG--CLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~--~lV~E 467 (701)
++.|.+...+|.|+||.|-.+.+ .++..++|++.... .+..+|+.++... .||||+++.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56788889999999999999988 45569999987662 2346677666555 7999999999996654 89999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE-cCCCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL-DQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl-~~~~~~KL~DFGla~~~~~~ 546 (701)
++.||-|.+.+.... .+. ..+..|+.+|+.|+.|||..| +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999888775433 233 677789999999999999999 9999999999999 68999999999999877543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~~ 623 (701)
+.+.+-|..|.|||++....|+..+||||||++||+||+|+.||.... +....+..+.+.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-------- 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--------
Confidence 345577899999999999999999999999999999999999996432 233334444332
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
...+....+|+.+||+.+|.+||++.++..|+|+
T Consensus 533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2344568999999999999999999999999999
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.88 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=206.2
Q ss_pred eeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEeecCCC
Q 005343 399 SRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENG 472 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~Ey~~~g 472 (701)
.+.||.|-||+||-|.++ ++.||||++.+... ....++.+|+.||..++||.||.|--.| ++..+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 368999999999999985 55699999876542 2346799999999999999999998887 45668999999 56
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEeeccccccCCCCCc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DFGla~~~~~~~~~ 549 (701)
+..+++..... ..|++.....++.||+.||.|||..+ |+|.||||+||||... -.+||||||+|+.+....
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 77676655433 45888888889999999999999999 9999999999999643 478999999999985432
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHH
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
...+.+||+.|+|||++.+..|+..-|+||.|||+|--|+|.-||+-+.++...|.+..|..-- ..| .+.
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp----~PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPP----NPW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCC----Cch-hhc
Confidence 2467899999999999999999999999999999999999999999988888888877653221 123 344
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....+||...|+..-+.|.+....+-|.|.+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 55688999999999999999999999998765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-34 Score=281.87 Aligned_cols=258 Identities=24% Similarity=0.287 Sum_probs=199.6
Q ss_pred eeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC-C-CceEEeecCC
Q 005343 398 ISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE-Y-GCLVYEYMEN 471 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-~-~~lV~Ey~~~ 471 (701)
-+..||.|+||+|+|-.++ ++..|||.++.... ....++..|.+...+- +.||||++||++.. . .++-||+| .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 3567999999999999985 45599999987664 3445688888876554 79999999999743 3 36899999 4
Q ss_pred CChhhHhccc---CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 472 GSLEDRLFQK---DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 472 gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
.||+.+. +. -....+++...-.|......||.||...- .|||||+||+||||+..|.+||||||++..+..+.
T Consensus 147 ~SlDklY-k~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 147 ISLDKLY-KRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhHHHHH-HHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 5665433 21 22346888888899999999999998642 29999999999999999999999999998764443
Q ss_pred cccccccccccccCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcCccccccCccCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG--MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNGTFSELLDPTVT 623 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~~~~~~ld~~~~ 623 (701)
..+.-+|-..|||||.+... .|+.++||||||++|||+.||+.|+...+.+-.. +-.|....++.+.-
T Consensus 223 ------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~- 295 (361)
T KOG1006|consen 223 ------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE- 295 (361)
T ss_pred ------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc-
Confidence 23556888999999976543 4899999999999999999999999876654332 33454443332211
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhccccc
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFEN 669 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~ 669 (701)
.......+..++..||..+..+||...++..+.|.++.......
T Consensus 296 --~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 296 --CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred --ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 12356679999999999999999999999999999987765444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=287.82 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=198.5
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChHHHHHHHHHHHhCCC--C----cEEEEeceec--C
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRH--T----NMVILLGACP--E 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~g~~~--~ 460 (701)
..+++|.+..++|+|.||.|-.+.+..+ .||||+++.- ....+...-|+++|.++.+ | -+|++.++|. .
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3478999999999999999999988544 5999988643 2344557789999999942 3 2677777764 3
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ------------ 528 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~------------ 528 (701)
+.|+|+|.+ |-|+.++|.. ++..+++...+..|+.|++.++.|||+.+ ++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 458999999 7799999844 45678999999999999999999999999 999999999999921
Q ss_pred --------CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005343 529 --------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 529 --------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 600 (701)
+..+||+|||.|++-.. ..+..+.|..|+|||++.+-.++.++||||+||||+||.||...|.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e---------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE---------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc---------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 34679999999976422 2367789999999999999999999999999999999999998887
Q ss_pred CchHHH------HHH-----------------HcCccc-----------cccCccCC-----CCCHHHHHHHHHHHHHhh
Q 005343 601 LSHQVE------QAI-----------------RNGTFS-----------ELLDPTVT-----GWPVEAALSIAKLALQCC 641 (701)
Q Consensus 601 ~~~~~~------~~i-----------------~~~~~~-----------~~ld~~~~-----~~p~~~~~~l~~li~~cl 641 (701)
..+..+ .++ ..|.+. ...++..+ .....+...|.+|+.+||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 544211 110 111000 00000000 001234557999999999
Q ss_pred ccCcCCCCChhhhhhHHHHHH
Q 005343 642 ELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 642 ~~~P~~RPt~~~vl~~~~~~l 662 (701)
..||.+|+|+.++|.|+||..
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFAR 411 (415)
T ss_pred ccCccccccHHHHhcCHHhhc
Confidence 999999999999999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=286.59 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=191.4
Q ss_pred cCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHh--CCCCcEEEEeceec--C----CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS--MRHTNMVILLGACP--E----YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~--~----~~~lV 465 (701)
....+.++||+|.||.||||.+.++.||||++.. .....|+.|-+|.+. ++|+||+.++++-. + ..+||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3455677899999999999999999999999875 445678888888776 48999999998852 1 34799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCC------CCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP------EPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
++|.+.|+|.++|.. ..++|....+|+..++.||+|||.--| .+|+|||||+.||||.+++++.|+||||
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999944 458999999999999999999997544 3699999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCC--------CCCc---
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM------LGVKSDLYSLGVVLLQLITARPA--------MGLS--- 602 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDvwSlGvil~elltG~~p--------f~~~--- 602 (701)
|..+++..... ..-..+||..|||||++.+-. --.++||||+|.|||||++.-.. |...
T Consensus 363 Al~~~p~~~~~----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 363 ALRLEPGKPQG----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred eEEecCCCCCc----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99987654332 234489999999999876533 22479999999999999985422 2211
Q ss_pred --------hHHHHH-HHcCccccccCccCC-CCCH-HHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 603 --------HQVEQA-IRNGTFSELLDPTVT-GWPV-EAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 603 --------~~~~~~-i~~~~~~~~ld~~~~-~~p~-~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.++... +++... |.+. .|.. .....+.+.+..||..||+.|.|+.-+-+..+
T Consensus 439 evG~hPt~e~mq~~VV~kK~R-----P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQR-----PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccC-----CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 112221 122111 1111 1221 23345899999999999999999987754433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=269.80 Aligned_cols=236 Identities=29% Similarity=0.380 Sum_probs=192.4
Q ss_pred CceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCChhhHhcc
Q 005343 406 GYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQ 480 (701)
Q Consensus 406 ~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~l~~ 480 (701)
+||.||+|... +..+++|++....... ...+.+|++.+++++|+|++++++.+.. ..+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999985 4779999998765544 6789999999999999999999999853 45899999999999998854
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccc
Q 005343 481 KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560 (701)
Q Consensus 481 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 560 (701)
.. .+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 32 2889999999999999999999999 9999999999999999999999999998764321 234556
Q ss_pred cCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---HcCccccccCccCCCCCHHHHHHHHHHH
Q 005343 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RNGTFSELLDPTVTGWPVEAALSIAKLA 637 (701)
Q Consensus 561 gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~~~~~~~ld~~~~~~p~~~~~~l~~li 637 (701)
++..|++||.+....++.++||||||+++|+|++|.+||.......... ..+... ..... ...+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----FPPPE--WKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----Ccccc--ccCCHHHHHHH
Confidence 8889999999988889999999999999999999999997632222222 222111 00000 00345689999
Q ss_pred HHhhccCcCCCCChhhhhhHHHH
Q 005343 638 LQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 638 ~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+|+..+|.+||++.+++.|+|+
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHccCCchhccCHHHHhhCCCC
Confidence 99999999999999999998874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=297.16 Aligned_cols=279 Identities=25% Similarity=0.364 Sum_probs=221.8
Q ss_pred eeeeeeeecCceeEEEEEE--CC----ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC-CceEEee
Q 005343 397 SISRKIGEGGYGPVYKAQL--DH----TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY-GCLVYEY 468 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~--~~----~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~lV~Ey 468 (701)
+..+.||.|+||+||+|.+ ++ -+||||++...... ...++..|+-+|.+++|||+++|+|+|... .-||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 3457899999999999998 32 35999998766433 356799999999999999999999999654 4689999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|+.|.|.|++..+. ..+..+..+.|..||++||.|||... +|||||-..|||+..-.++||.|||+++++.+..
T Consensus 779 mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~- 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE- 852 (1177)
T ss_pred cccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc-
Confidence 99999999996643 45778888999999999999999999 9999999999999999999999999999987653
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--hHHHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS--HQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~--~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
..|......-.+-|||-|.+....|+.++|||||||++||++| |..|+.+. .++...++.|.. ...
T Consensus 853 ---~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------Lsq 921 (1177)
T KOG1025|consen 853 ---KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------LSQ 921 (1177)
T ss_pred ---ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------CCC
Confidence 3344444455678999999999999999999999999999998 77777543 345556665532 356
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH-HhcccccccCCCCCcccCCCCCCChhhhhhccc
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL-RDLGFENAENKNDNIVVTPGPYNSVSEMKQVSG 695 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (701)
|..++..+.-++.+||..|+..||++.++.. +|.++ ++.. . ....++.....|+|.++..+..+..-
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~-~fs~~ardpq-r-yl~i~~~~~~~~s~~~~~~~~~~~~~ 989 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAE-EFSRMARDPQ-R-YLVIQDERMILPSPESSLFYRELLEE 989 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHH-HHHHHhcCcc-e-EeeehhhcCCCCCCCcchHHHHhhHH
Confidence 7788888999999999999999999998754 45444 3321 1 11222445667888777776655443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.28 Aligned_cols=273 Identities=23% Similarity=0.327 Sum_probs=205.7
Q ss_pred HhhhcccccccCHHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC----
Q 005343 374 MAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR---- 447 (701)
Q Consensus 374 ~~~~~~~~~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~---- 447 (701)
..|....|....+-|.. ..++|.+.++||+|.|++||++.+ ..+.||+|+.+.. ....+....||.+|++++
T Consensus 59 ~dY~kGGYHpV~IGD~F-~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVF-NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhhhcCCCceeeccccc-cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCC
Confidence 34666788877776642 237899999999999999999988 5567999998643 244566788999999984
Q ss_pred -C---CcEEEEeceecC------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 005343 448 -H---TNMVILLGACPE------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517 (701)
Q Consensus 448 -H---pnIv~l~g~~~~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 517 (701)
| .+||+|++.|.. +.|||+|++ |-+|..++.. .....++...+..|+.||+.||.|||... +|||.
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHT 212 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHT 212 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--Ccccc
Confidence 3 369999999833 449999999 8888887744 45567999999999999999999999865 39999
Q ss_pred CCCCCCeeEcCC-----------C--------------------------------------------------------
Q 005343 518 DLKPANILLDQN-----------Y-------------------------------------------------------- 530 (701)
Q Consensus 518 DLKp~NILl~~~-----------~-------------------------------------------------------- 530 (701)
||||+||||..+ +
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 999999998211 0
Q ss_pred --------------------------------------------------------------------------------
Q 005343 531 -------------------------------------------------------------------------------- 530 (701)
Q Consensus 531 -------------------------------------------------------------------------------- 530 (701)
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence
Q ss_pred -------------------cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHH
Q 005343 531 -------------------VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQ 591 (701)
Q Consensus 531 -------------------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~e 591 (701)
.+||+|||-|+|+. ..++.-+.|..|+|||++.+..|++.+||||++|++||
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~---------khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FE 443 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWVH---------KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFE 443 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhhh---------hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHH
Confidence 12344444443321 12345567889999999999999999999999999999
Q ss_pred HHhCCCCCCCc---------hHH-----------HHHHHcCc-----------cccc--cCcc--------CCCCCHHHH
Q 005343 592 LITARPAMGLS---------HQV-----------EQAIRNGT-----------FSEL--LDPT--------VTGWPVEAA 630 (701)
Q Consensus 592 lltG~~pf~~~---------~~~-----------~~~i~~~~-----------~~~~--ld~~--------~~~~p~~~~ 630 (701)
|+||...|.-. +.+ ..+...|+ +..+ |.+. ...|+.+.+
T Consensus 444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A 523 (590)
T KOG1290|consen 444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDA 523 (590)
T ss_pred hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHH
Confidence 99999777411 111 11122222 2211 1110 135778888
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+|.+|+.-||+.+|+.|||+.+.|.|+|+.
T Consensus 524 ~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 524 QQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred HHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 9999999999999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=296.12 Aligned_cols=261 Identities=19% Similarity=0.201 Sum_probs=183.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEE------------------CCceEEEEEeCCCCCCChHH--------------HHHH
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL------------------DHTSVAIKVLGPDISQGPRQ--------------FKQE 439 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~------------------~~~~vAiK~l~~~~~~~~~~--------------~~~E 439 (701)
..++|.+.++||+|+||.||+|.+ .++.||||.+.......... +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 23459999987543322222 3447
Q ss_pred HHHHHhCCCCcE-----EEEeceec----------CCCceEEeecCCCChhhHhcccCC---------------------
Q 005343 440 VEILGSMRHTNM-----VILLGACP----------EYGCLVYEYMENGSLEDRLFQKDN--------------------- 483 (701)
Q Consensus 440 i~il~~l~HpnI-----v~l~g~~~----------~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 483 (701)
+.++.+++|.++ +.++|+|. ...+|||||+.+|+|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 56677763 234899999999999998864211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCC
Q 005343 484 SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563 (701)
Q Consensus 484 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 563 (701)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-----FNPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----cCccccCCCc
Confidence 123567788999999999999999999 99999999999999999999999999976532211 1112234578
Q ss_pred CccCcccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCchHHHHHHHcC--c---cc
Q 005343 564 CYIDPEYQQTGM--------------------L--GVKSDLYSLGVVLLQLITARP-AMGLSHQVEQAIRNG--T---FS 615 (701)
Q Consensus 564 ~Y~aPE~~~~~~--------------------~--~~~sDvwSlGvil~elltG~~-pf~~~~~~~~~i~~~--~---~~ 615 (701)
.|+|||.+.... | ..+.||||+|||||+|++|.. ||.........+... . +.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999765432 1 124799999999999999984 775332221111110 0 00
Q ss_pred cc--cCccCCCCCHHHHHHHHHHHHHhhccCc---CCCCChhhhhhHHHHH
Q 005343 616 EL--LDPTVTGWPVEAALSIAKLALQCCELRK---RDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~--ld~~~~~~p~~~~~~l~~li~~cl~~~P---~~RPt~~~vl~~~~~~ 661 (701)
.. .......| ........+|+.+||..+| .+|+++.++|.|+|+.
T Consensus 455 ~~~~~~~~~~~~-d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 455 MYKGQKYDFSLL-DRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hhcccCCCcccc-cccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 00 00011111 1234458899999999876 6899999999999983
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=304.36 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=204.4
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEece
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGA 457 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~ 457 (701)
++...++..+.+.||+|.||.|++|... ...||||.++..... ..+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344455566779999999999999852 235999999877644 345699999999998 69999999999
Q ss_pred ecC--CCceEEeecCCCChhhHhcccC------CC-------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 005343 458 CPE--YGCLVYEYMENGSLEDRLFQKD------NS-------PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPA 522 (701)
Q Consensus 458 ~~~--~~~lV~Ey~~~gsL~~~l~~~~------~~-------~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~ 522 (701)
|.. ..++|+||+..|+|.++|.... .. ..++....+.++.|||.|+.||++.. +|||||-..
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 965 4489999999999999997654 00 23888999999999999999999998 999999999
Q ss_pred CeeEcCCCcEEEEeeccccccCCCCCccccccccccccc--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005343 523 NILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG--TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAM 599 (701)
Q Consensus 523 NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 599 (701)
|||+..+..+||+|||+|+...... .|......| ...|||||.+....|+.++|||||||+||||+| |..|+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~-----~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKD-----YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCC-----ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999764332 122222233 345999999999999999999999999999999 66898
Q ss_pred CC---chHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 600 GL---SHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 600 ~~---~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+ ...+-..++.|.. ...|..+..++.+++..||+.+|.+||++.+++..
T Consensus 523 p~~~~~~~l~~~l~~G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CCCCcHHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 75 3344445666642 24466677789999999999999999999999843
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=277.24 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=195.8
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHh--CCCCcEEEEecee------cCCC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS--MRHTNMVILLGAC------PEYG 462 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~------~~~~ 462 (701)
....+..+.+.||+|.||+||+|.|.|..||||++.. .+...+.+|.+|... |+|+||+.++++- ....
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456788899999999999999999999999999864 345668899999876 4999999998874 2234
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-----NKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
+||.+|.+.|||.|+|.+ ..++....++++..+|+||++||. .|...|-|||||+.|||+.+|+.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 799999999999999954 468889999999999999999993 34345999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCC----C--CchhhHHHHHHHHHHHHhC----------CCCCCC
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM----L--GVKSDLYSLGVVLLQLITA----------RPAMGL 601 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~--~~~sDvwSlGvil~elltG----------~~pf~~ 601 (701)
|||...+... ..-.......+||..|||||++.... + -..+||||||.|+||+... ++||..
T Consensus 361 GLAv~h~~~t--~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 361 GLAVRHDSDT--DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eeeEEecccC--CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9997764432 11223346779999999999876543 1 2368999999999999852 366642
Q ss_pred ch----HHHHHHHcCccccccCccCC-CCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 602 SH----QVEQAIRNGTFSELLDPTVT-GWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 602 ~~----~~~~~i~~~~~~~~ld~~~~-~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
-. ..+++.. ---.+.+-|..+ -|. ......+.+++..||..+|.-|-++--| ...+.++
T Consensus 439 ~Vp~DPs~eeMrk-VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri-KKtl~~l 503 (513)
T KOG2052|consen 439 VVPSDPSFEEMRK-VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI-KKTLAKL 503 (513)
T ss_pred CCCCCCCHHHHhc-ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH-HHHHHHH
Confidence 21 1222211 111112223322 233 3445569999999999999999997654 3444444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=305.23 Aligned_cols=261 Identities=22% Similarity=0.244 Sum_probs=171.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEece--------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA-------- 457 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~-------- 457 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|.+..... .+.+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999984 45699998764321 1111111 1112222222222211
Q ss_pred ecCCCceEEeecCCCChhhHhcccCCC-----------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 005343 458 CPEYGCLVYEYMENGSLEDRLFQKDNS-----------------PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520 (701)
Q Consensus 458 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLK 520 (701)
.....++||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 133458999999999999988543210 11123345679999999999999999 9999999
Q ss_pred CCCeeEcC-CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC----------------------CCC
Q 005343 521 PANILLDQ-NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG----------------------MLG 577 (701)
Q Consensus 521 p~NILl~~-~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~ 577 (701)
|+|||++. ++.+||+|||+|+.+.... .+.....+||+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 6899999999998653321 1223456889999999954322 234
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHcCcc-----ccccCccCC-C----C--CHHHHHHHHHHHHHhhccC
Q 005343 578 VKSDLYSLGVVLLQLITARPAMGLSH-QVEQAIRNGTF-----SELLDPTVT-G----W--PVEAALSIAKLALQCCELR 644 (701)
Q Consensus 578 ~~sDvwSlGvil~elltG~~pf~~~~-~~~~~i~~~~~-----~~~ld~~~~-~----~--p~~~~~~l~~li~~cl~~~ 644 (701)
.++|||||||+||||+++..|++... .....+..... .....+... . + .........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 56799999999999999776654321 11111221111 001111100 0 0 0001123458999999999
Q ss_pred cCCCCChhhhhhHHHHHHHh
Q 005343 645 KRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 645 P~~RPt~~~vl~~~~~~l~~ 664 (701)
|++||++.+++.|+|+.-.+
T Consensus 438 P~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cccCCCHHHHhCCcCcCCCC
Confidence 99999999999999996433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=300.82 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=198.6
Q ss_pred ceeeeeeeecCce-eEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEEeecCC
Q 005343 396 FSISRKIGEGGYG-PVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg-~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~Ey~~~ 471 (701)
|...+.+|.|+-| .||+|.+.++.||||.+-.. .....++||..|..- +|||||.+|+.-.+. .|+..|.| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 5556679999876 68999999999999987543 234578999999888 699999999876443 37999999 5
Q ss_pred CChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-----CCcEEEEeeccccccCC
Q 005343 472 GSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-----NYVSKISDVGLARLVPP 545 (701)
Q Consensus 472 gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~~KL~DFGla~~~~~ 545 (701)
.+|.+++... .......-.....+..|++.||++||+.+ ||||||||.||||+. ...++|+|||+|+.++.
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 7999999663 11111111234568899999999999999 999999999999965 25789999999999876
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
+.. ...+..+..||.+|+|||++....-+..+|||||||++|+.++| ..|||....-+..|-.|.+.-..-....+
T Consensus 664 ~~s---S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKS---SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred Ccc---hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCch
Confidence 542 22236788999999999999999888899999999999999997 79999888777777777654432222222
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
| ...+||.+|+..+|..||++.+||.|+||
T Consensus 741 ~------eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 741 C------EAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred H------HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 2 57899999999999999999999999765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=270.74 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCCCCC---hHHHHHHHHHHHhC-CCCcEEEEeceecC--CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG---PRQFKQEVEILGSM-RHTNMVILLGACPE--YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~~~~---~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~ 463 (701)
...+|.+++.||+|+|..|..+++..+. +|+|++++....+ ..=.+.|-.+..+. +||.+|-|...|.. ..+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3567999999999999999999996554 9999988764332 33356677777665 79999999877744 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+|.||++||+|.-.+ +....++++....+..+|+.||.|||+.| ||.||||.+|+|+|..|++||+|+|+++--
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996555 44456899999999999999999999999 999999999999999999999999999743
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
-. .....++.|||+.|+|||++.+..|+..+|||+|||+++||+.|+.||+.-. ..+...+.-.|+-++...
T Consensus 402 l~------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 402 LG------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred CC------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 11 1223478899999999999999999999999999999999999999996211 000000000011111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCC------hhhhhhHHHHHHHhc
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPD------LVSVVLPELIRLRDL 665 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt------~~~vl~~~~~~l~~~ 665 (701)
...|...+.....++...|..||++|.. +.++-.|.|++.-++
T Consensus 476 -iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 476 -IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred -ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 1223334445678888999999999853 788889999987665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=255.16 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=198.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecCC----Cce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPEY----GCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~----~~l 464 (701)
..++|++.+++|+|.|++||.|.. ++..++||++++- ..+.+.+|+.||..|. ||||++|++...+. ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 567899999999999999999985 6677999999764 3567899999999997 99999999998543 379
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeecccccc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLV 543 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~ 543 (701)
|+||+++.+...+. +.|+.-.+..++.+++.||.|+|+.| |+|||+||.|+++|. ...++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876644 45777788889999999999999999 999999999999985 567899999999998
Q ss_pred CCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHHHc----------
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAM-GLSHQVEQAIRN---------- 611 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~~i~~---------- 611 (701)
.+...- .-.+.+..|--||++-. ..|+..-|+|||||+|..|+..+.|| .+.+..++.++-
T Consensus 184 Hp~~eY-------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 184 HPGKEY-------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred CCCcee-------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 765422 33466778899997654 56899999999999999999999776 322222222210
Q ss_pred ---CccccccCccCCC---------CCH--------HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 612 ---GTFSELLDPTVTG---------WPV--------EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 612 ---~~~~~~ld~~~~~---------~p~--------~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+++.--+||...+ |.. -..++..+|+.+.|..|-++|||+.+.+.|++|.-..
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0111123333221 211 1235678999999999999999999999999998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.61 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=208.1
Q ss_pred cccccCHHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC------CCcE
Q 005343 380 RYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR------HTNM 451 (701)
Q Consensus 380 ~~~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~------HpnI 451 (701)
.|..|.+-| ...++|.+....|+|-||+|..|.+ .+..||||++..+. ...+.-+.|++||++|+ --|+
T Consensus 420 GYYrv~igE--~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGE--LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhh--hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 344555544 4677899999999999999999998 45679999997653 22344578999999995 2367
Q ss_pred EEEecee--cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 452 VILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 452 v~l~g~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
+.|+..| ..+.|||+|-+ ..+|.++|.+.+..-.|....+..++.|++.||..|-..+ |+|.||||+|||++.+
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 7777766 45679999998 6799999999888888999999999999999999999999 9999999999999865
Q ss_pred -CcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HH-
Q 005343 530 -YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QV- 605 (701)
Q Consensus 530 -~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~- 605 (701)
..+||||||.|..+.... + +-...+..|.|||++.+-.|+...|+||.||+||||.||+..|.+.. ++
T Consensus 573 k~iLKLCDfGSA~~~~ene---i-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---I-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred cceeeeccCcccccccccc---c-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 577999999998764332 2 23345678999999999999999999999999999999998886532 11
Q ss_pred -----------HHHHHcCcccc---------------------------ccCc------------cCCCCCHHHHHHHHH
Q 005343 606 -----------EQAIRNGTFSE---------------------------LLDP------------TVTGWPVEAALSIAK 635 (701)
Q Consensus 606 -----------~~~i~~~~~~~---------------------------~ld~------------~~~~~p~~~~~~l~~ 635 (701)
..+++.|-|.+ .+.| .+++-.......|.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 12233332211 1111 011111233446899
Q ss_pred HHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 636 LALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 636 li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
|+..||.+||..|.+..+.|.|+|+.
T Consensus 725 LLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcCCccc
Confidence 99999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.07 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=196.8
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
..+|.-+..+|.|.- .|..+-+ .+.+||+|.+.... ....+...+|..++..+.|+||+.++.+|..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999988 5655554 67889999775542 2344668999999999999999999999822
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..|+||||| .++|...+. ..+.-.+...|+.|+++|+.|||+.+ |+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 338999999 568888775 23566788899999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc---------
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN--------- 611 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~--------- 611 (701)
+.-... ..++..+.|..|.|||++.+..|...+||||+|||+.||++|+-.|.+.+..++....
T Consensus 166 r~e~~~-------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc-------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 864332 3467789999999999998888999999999999999999999888765433322210
Q ss_pred --------------------------CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 --------------------------GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 --------------------------~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|.+.+-+.....+.-....+.+++.+||-.+|++|-+++++|.|+.+++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 011111111111112122334789999999999999999999999998873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=278.78 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=211.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee--cCCCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~~lV~E 467 (701)
..++|.++..+|.|.||.|||+++. +...|+|+++.....+..-+++|+-+++..+|||||.++|.+ .+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999984 455999999999888888899999999999999999999998 456699999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||.+|+|.+.- ....++++.++...+.+.+.||.|||+.+ -+|||||=.|||++..|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999865 34567999999999999999999999999 99999999999999999999999999876632
Q ss_pred CcccccccccccccCCCccCccc---ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEY---QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~---~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
+--+...+.||++|||||+ -..+.|+..+|||++|+...|+---.||.-..+..+...-.. -.....|.+.
T Consensus 165 ----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-kS~~qpp~lk- 238 (829)
T KOG0576|consen 165 ----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-KSGFQPPTLK- 238 (829)
T ss_pred ----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-ccCCCCCccc-
Confidence 2334578899999999995 456789999999999999999988888876555544433211 1112222222
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+......|.+|+..|+..+|+.||+...+|.|+|...
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 12233445899999999999999999999998877543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=239.42 Aligned_cols=201 Identities=28% Similarity=0.370 Sum_probs=160.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV 465 (701)
..+....+..||+|+||.|=+.++ .++-.|+|.+..... +...++.+|+++..+. ..|.+|.+||...+. .++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555667899999999988877 667799998876653 2344578888886554 799999999987543 3899
Q ss_pred EeecCCCChhhHhcc-cCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||.| ..||..+-.+ ......+++..+-+|+..+..||.|||+.- .+||||+||+|||++..|++||||||.+.++.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 4677654422 145567899999999999999999999864 29999999999999999999999999998876
Q ss_pred CCCCcccccccccccccCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQT----GMLGVKSDLYSLGVVLLQLITARPAMGLS 602 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDvwSlGvil~elltG~~pf~~~ 602 (701)
.+.+. +...|-..|||||.+.. ..|+.++||||||+.+.||.+++.|+...
T Consensus 201 dSiAk-------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 DSIAK-------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhHH-------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 55432 33578888999997543 36999999999999999999999998643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=254.39 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=190.9
Q ss_pred ceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceec-------CCCce
Q 005343 396 FSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACP-------EYGCL 464 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-------~~~~l 464 (701)
....+.||-|+||.||-+++ +++.|++|.+..-.. ...+.+.+|+.+|.-++|.|++..+++.. +..|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999998 677899997743221 22456889999999999999999888752 23378
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
+.|+| ..+|...+. ...+++...+.-+..||+.||.|||+.+ |+||||||.|+|++.|..+||||||+++.-.
T Consensus 135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88988 457777663 3446888888889999999999999999 9999999999999999999999999999764
Q ss_pred CCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HH-----------
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IR----------- 610 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~----------- 610 (701)
... ...++..+.|.+|+|||++++. .|+..+||||.|||+.|||..+..|...+.+++. |-
T Consensus 208 ~d~-----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRD-----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhh-----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 433 2345677889999999988775 5999999999999999999999888654432221 10
Q ss_pred ----cCcccccc-----Ccc---CCC--CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 611 ----NGTFSELL-----DPT---VTG--WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 611 ----~~~~~~~l-----d~~---~~~--~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+|.-..++ .|+ +.. -+....-+...+..+++..+|+.|.+..+.+.|....
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11111111 011 111 1122233467788899999999999999998876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=233.72 Aligned_cols=207 Identities=35% Similarity=0.538 Sum_probs=179.4
Q ss_pred eeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecCCCChhh
Q 005343 402 IGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYMENGSLED 476 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~ 476 (701)
||+|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++++++++++.. ..+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999996 778999998766432 24679999999999999999999999865 5689999999999999
Q ss_pred HhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCCCCccccccc
Q 005343 477 RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPSAADTITQYH 555 (701)
Q Consensus 477 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~~~~~~~~~~ 555 (701)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||++........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 885432 45889999999999999999999999 999999999999999 89999999999987643211 1
Q ss_pred ccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHH
Q 005343 556 MTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIA 634 (701)
Q Consensus 556 ~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~ 634 (701)
.....+...|++||.+... .++.+.|+|++|+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2345678899999998887 889999999999999999 3589
Q ss_pred HHHHHhhccCcCCCCChhhhhhH
Q 005343 635 KLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 635 ~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
+++..|+..+|.+||++.+++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhC
Confidence 99999999999999999998854
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=252.88 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=202.2
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE-- 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 460 (701)
...++++...++-+|.||.||.|.|.. +.|.+|.++....+- ...+.+|--.+..+.|||+..+.|++-+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 344557777789999999999997632 237788777665432 3457889999999999999999999833
Q ss_pred -CCceEEeecCCCChhhHhc-----ccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 461 -YGCLVYEYMENGSLEDRLF-----QKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
..+.+|.++.-|+|..+|. .-.....++-.+...++.|++.|+.|||+++ +||.||-..|+++|+...+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEe
Confidence 4478999999999999997 2334456777788899999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHc
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRN 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~ 611 (701)
+|-.|+|.+.|..... .....-....||+||.+.+..|+..+|||||||+||||+| |+.|+..-+ +++..+.+
T Consensus 438 tDsaLSRDLFP~DYhc----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHC----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred ccchhccccCcccccc----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999999887654211 1122345678999999999999999999999999999998 888886443 45555665
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
|. ....|.+|+.+|..++..||...|++||++.+++
T Consensus 514 Gy--------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 514 GY--------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred cc--------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 53 2245778888999999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=231.65 Aligned_cols=196 Identities=36% Similarity=0.519 Sum_probs=167.8
Q ss_pred ceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecC
Q 005343 396 FSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYME 470 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 470 (701)
|.+.+.||.|+||.||++... +..+++|.+...... ....+.+|++.+..++|+|++++++++. +..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999995 477999999876544 5677999999999999999999999885 45689999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+++|.+++..... .+++.....++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854322 1788999999999999999999998 999999999999999999999999999876433200
Q ss_pred cccccccccccCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQ-QTGMLGVKSDLYSLGVVLLQLITARPAMGL 601 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDvwSlGvil~elltG~~pf~~ 601 (701)
......++..|++||.+ ....++.++|+|+||+++++|++|++||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345678899999988 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=258.97 Aligned_cols=193 Identities=25% Similarity=0.351 Sum_probs=164.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--------CChHHHHHHHHHHHhCC---CCcEEEEeceecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--------QGPRQFKQEVEILGSMR---HTNMVILLGACPE 460 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--------~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~ 460 (701)
..|..+..+|+|+||.|+.|.++ +..|+||.+.+... .....+-.||.||..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999994 44599998766531 11223677999999998 9999999999966
Q ss_pred C--CceEEeec-CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 461 Y--GCLVYEYM-ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 461 ~--~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
+ .||+||-. +|-+|.+++ ...+.+++....-|+.||+.|+++||+.+ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 4 46888865 456888888 44466888999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~ 600 (701)
|.|.+...+ .+..++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksg--------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG--------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC--------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876433 2456789999999999999887 788999999999999999998874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=249.15 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=196.7
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEecee--cCCC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGAC--PEYG 462 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~--~~~~ 462 (701)
...+.|..+++||+|.|+.||++.+.. ..||+|.+... ..+..+..|+++|..+ -+-||+++.+.+ .+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 345678999999999999999998743 35999987654 5567799999999999 588999999987 4566
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeecccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLAR 541 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~ 541 (701)
++|+||++.....+++. .++...+..++..++.||.++|.+| ||||||||+|+|.+. .+.-.|.|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 99999999999988773 3567788899999999999999999 999999999999974 5677899999997
Q ss_pred ccCCCC------C-------c-------------------------ccccccccccccCCCccCcccc-cCCCCCchhhH
Q 005343 542 LVPPSA------A-------D-------------------------TITQYHMTTAAGTFCYIDPEYQ-QTGMLGVKSDL 582 (701)
Q Consensus 542 ~~~~~~------~-------~-------------------------~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDv 582 (701)
..+... . . ..........+||++|+|||++ ..+..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321110 0 0 0000112357899999999964 56678999999
Q ss_pred HHHHHHHHHHHhCCCCCCC-chH---------------HHH-HHHcCc--ccc----------------c----cCc---
Q 005343 583 YSLGVVLLQLITARPAMGL-SHQ---------------VEQ-AIRNGT--FSE----------------L----LDP--- 620 (701)
Q Consensus 583 wSlGvil~elltG~~pf~~-~~~---------------~~~-~i~~~~--~~~----------------~----ld~--- 620 (701)
||.|||++-+++++.||-. .++ ++. +.-.|. +.+ + +.+
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999988731 111 111 111122 111 0 000
Q ss_pred ---cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 621 ---TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 621 ---~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
....|....+..+.+|+.+|++.+|.+|.++.+.|.|+|+.=.+
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 11122223344689999999999999999999999999987433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=281.46 Aligned_cols=204 Identities=19% Similarity=0.214 Sum_probs=145.0
Q ss_pred hCCC-CcEEEEecee-------c--CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 005343 445 SMRH-TNMVILLGAC-------P--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514 (701)
Q Consensus 445 ~l~H-pnIv~l~g~~-------~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 514 (701)
.++| +||+.++++| . +..++++||+ +++|.++|... ..++++..+..|+.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5788888876 1 1235678887 67999998532 346899999999999999999999999 9
Q ss_pred eecCCCCCCeeEcCCCc-------------------EEEEeeccccccCCCCCc---c-------cccccccccccCCCc
Q 005343 515 VHRDLKPANILLDQNYV-------------------SKISDVGLARLVPPSAAD---T-------ITQYHMTTAAGTFCY 565 (701)
Q Consensus 515 iHrDLKp~NILl~~~~~-------------------~KL~DFGla~~~~~~~~~---~-------~~~~~~~~~~gt~~Y 565 (701)
|||||||+||||+..+. +||+|||+++........ . .........+||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 455555555432110000 0 000111235689999
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCc
Q 005343 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRK 645 (701)
Q Consensus 566 ~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P 645 (701)
+|||++.+..|+.++|||||||+||||++|.+|+.........+.... +.+.. .........++.+||..+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQI----LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChhh----hhcCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999999764332222222211 11111 1112335688899999999
Q ss_pred CCCCChhhhhhHHHHHH
Q 005343 646 RDRPDLVSVVLPELIRL 662 (701)
Q Consensus 646 ~~RPt~~~vl~~~~~~l 662 (701)
.+||++.+++.|+|+.-
T Consensus 254 ~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 254 SCRPSMSELLQSEFINE 270 (793)
T ss_pred hhCcChHHHhhchhhhh
Confidence 99999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=227.88 Aligned_cols=240 Identities=21% Similarity=0.300 Sum_probs=174.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEece-e--cCCCceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGA-C--PEYGCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~-~--~~~~~lV 465 (701)
..+.|.+.+.||+|-||.+-++++++ +.+++|.+.... .....|.+|..---.| .|.||+.-|.. | .+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34679999999999999999999954 569999887654 4567899998765445 58999987765 3 3445789
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc--CCCcEEEEeecccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD--QNYVSKISDVGLARLV 543 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~~KL~DFGla~~~ 543 (701)
+||++.|+|...+.. ..+.+....+++.|+++||.|+|+.+ +||||||.+|||+- +...+||||||+.+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999987733 45778888999999999999999999 99999999999993 4468999999998764
Q ss_pred CCCCCcccccccccccccCCCccCcccccC---CC--CCchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHcC
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQT---GM--LGVKSDLYSLGVVLLQLITARPAMGLSHQV------EQAIRNG 612 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~------~~~i~~~ 612 (701)
.... ...--+..|.+||.... +. ..+.+|+|.||+|+|.+|||.+|++..... -..+..+
T Consensus 174 g~tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 174 GTTV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred Ccee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 3211 11123456899996443 22 578899999999999999999999733211 1122222
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVS 653 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~ 653 (701)
. .+.++..-......+..+..+-|..+|++|-.+.+
T Consensus 245 k-----~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 245 K-----NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred c-----CccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 2 22222111111234667777888888988844433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=214.96 Aligned_cols=166 Identities=21% Similarity=0.227 Sum_probs=129.1
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|.+++... ..++++..+..|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 7899988543 346999999999999999999999876 999999999999999 9999875331
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---cCccccccCccCCCCCHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---NGTFSELLDPTVTGWPVE 628 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---~~~~~~~ld~~~~~~p~~ 628 (701)
...||+.|+|||++.+..++.++|||||||++|||+||++||.........+. .+... .++.....+..
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 134 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA--DDPRDRSNLES 134 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc--CCccccccHHH
Confidence 12689999999999999999999999999999999999999975543222111 11110 11111111222
Q ss_pred HHH--HHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 629 AAL--SIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 629 ~~~--~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
... .+.+++.+||..+|.+||++.+++.|.+....
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 222 59999999999999999999999999988753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=206.23 Aligned_cols=135 Identities=41% Similarity=0.682 Sum_probs=116.8
Q ss_pred EEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCC-----------ChHHHHHHHHHHHHHHhhcCCe
Q 005343 23 ITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPA-----------TNDELQKLFLPYRGLFARKRIL 91 (701)
Q Consensus 23 ~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~v~ 91 (701)
+||||+|+|+.|.+||+||++++...|++|++|||.+++........ ..+..+++++.+...|...++.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 59999999999999999999999999999999999986422111100 0156677888898899889999
Q ss_pred eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEecCC
Q 005343 92 AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIISSKG 158 (701)
Q Consensus 92 ~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~~kg 158 (701)
++..++.+++|+++|+++|+++++|+||||+||++++.|.|+.|||+.+|++++|++|||+||+ +|
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~-~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVS-KG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEe-Cc
Confidence 9999999779999999999999999999999999999997762379999999999999999999 87
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-22 Score=211.14 Aligned_cols=266 Identities=33% Similarity=0.468 Sum_probs=203.2
Q ss_pred ceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCC-cEEEEeceecCCC--ceEEeec
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHT-NMVILLGACPEYG--CLVYEYM 469 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~--~lV~Ey~ 469 (701)
|.+...||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +++.+++.+.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678899999999999999988 779999988776543 56799999999999988 7999999885443 7999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccccCCCCC
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVPPSAA 548 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~~~~~~ 548 (701)
.++++.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966633221126888899999999999999999999 99999999999999988 799999999986543321
Q ss_pred cccccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCccccccC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGTFSELLD 619 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~~~~~ld 619 (701)
............||..|++||.+.. ..++...|+||+|++++++++|..||.... .....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1100013467789999999998887 578999999999999999999999987654 2222222222110000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
+.....+......+.+++..|+..+|..|.+......+.+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 1111111112245889999999999999999999998866665443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=228.34 Aligned_cols=170 Identities=18% Similarity=0.143 Sum_probs=130.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCC-----CChHHHHHHHHHHHhCCCCcEEE-EeceecCC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDIS-----QGPRQFKQEVEILGSMRHTNMVI-LLGACPEY 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~ 461 (701)
...+.|.+.+.||+|+||.||+|++. ++.||||++..... .....|.+|+++|+.++|+|++. +++. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--GK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--CC
Confidence 45678999999999999999999873 45589998753311 12345899999999999999985 5442 45
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCeeEcCCCcEEEEeeccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDL-KPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDL-Kp~NILl~~~~~~KL~DFGla 540 (701)
.++||||++|++|.. + . . .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~-~-~-~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-A-R-P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHH-h-C-c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 699999999999963 2 1 1 11 1357889999999999999 999999 999999999999999999999
Q ss_pred cccCCCCCccc--ccccccccccCCCccCcccccCCC
Q 005343 541 RLVPPSAADTI--TQYHMTTAAGTFCYIDPEYQQTGM 575 (701)
Q Consensus 541 ~~~~~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~ 575 (701)
+.+........ .....+...+++.|++||++....
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 98755432111 111225778999999999876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=219.21 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=189.7
Q ss_pred CceeeeeeeecCceeEEEEEECCc---eEEEEEeCCCCCCChHHHHHHHHHHHhCCC----CcEEEEecee---cCCCce
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHT---SVAIKVLGPDISQGPRQFKQEVEILGSMRH----TNMVILLGAC---PEYGCL 464 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~---~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~g~~---~~~~~l 464 (701)
.|.+.++||+|+||.||+|..... .+|+|+...........+..|+.++..+.. +++..+++.. ....++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998554 599998876644433478899999999873 4666776665 234589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-----CcEEEEeecc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-----YVSKISDVGL 539 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-----~~~KL~DFGl 539 (701)
||+.+ |.+|.++..... ...|+..+.++|+.|++.+|.+||+.| +|||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 899999664444 567999999999999999999999999 9999999999999764 4689999999
Q ss_pred ccccC--CCCCccccccc--ccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCc
Q 005343 540 ARLVP--PSAADTITQYH--MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGT 613 (701)
Q Consensus 540 a~~~~--~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~ 613 (701)
++.+. ..........+ .....||..|.++....+...+.+.|+||++.++.+|+.|..|+..... ....+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98332 22111111111 2346699999999999999999999999999999999999988854331 111111111
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
....... .....+..+..+...+-..+..++|+...+...
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111111 112223457788888888999999999888754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=202.44 Aligned_cols=272 Identities=19% Similarity=0.217 Sum_probs=198.6
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEE--eceecCCCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVIL--LGACPEYGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l--~g~~~~~~~lV~Ey~ 469 (701)
+|++.++||+|.||.++.|.. ++.+||||.-... ...-++..|....+.|. .+.|-.. +|-|.-+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 699999999999999999986 7889999975332 34457888888888884 5666544 455666678999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-----CCcEEEEeeccccccC
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-----NYVSKISDVGLARLVP 544 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~~KL~DFGla~~~~ 544 (701)
|.||+|++.-. ...|+..+...||.|++.-++|+|++. +|.|||||+|+||.. ...+.|.|||+|+.+.
T Consensus 107 -GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999977433 346999999999999999999999999 999999999999964 3467899999999875
Q ss_pred CCCCc-ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAAD-TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
...+. .+......+..||..||+-....+...+.+.|+-|||-+|+.+|-|..||.+..- ..+. +..+.+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-----YeKIGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-----YEKIGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-----HHHhcccc
Confidence 44332 3333345778899999999999999999999999999999999999999975431 1111 11111111
Q ss_pred CC----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCCccc
Q 005343 622 VT----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVV 679 (701)
Q Consensus 622 ~~----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~~~~ 679 (701)
.. ......+.+|...+.-.-.++-.+-|+..-+-.-...-|.+.++.......|.+..
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 10 11122344677888888888999999976543222222334444444444444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=192.95 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=188.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC-cEEEEecee--cCCCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT-NMVILLGAC--PEYGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~--~~~~~lV~ 466 (701)
..+.|.++++||.|+||.+|.|.. .+..||||+-.... ...++..|..+...|++- .|..+..+. .++..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 346899999999999999999987 67789999875543 334678899999988763 343344343 44568999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DFGla~~~ 543 (701)
+.+ |.||++++.- ....|+..+.+-++-|++.-++|+|..+ +|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 9999997743 2345889999999999999999999999 9999999999999754 45689999999877
Q ss_pred CCCCCc-ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHHHHcCccccc
Q 005343 544 PPSAAD-TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV-----EQAIRNGTFSEL 617 (701)
Q Consensus 544 ~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-----~~~i~~~~~~~~ 617 (701)
-..... .+.........||..|.+-..+.+...+.+.|+-|+|.+|..+.-|..||.+-... ...|.+.+..-.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 443322 22333456788999999988888888899999999999999999999999754321 112222222222
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhh
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVS 653 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~ 653 (701)
+.....++|. ++.-.+.-|-.+.-.+-|+..-
T Consensus 245 ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 245 IEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred HHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHH
Confidence 2222234554 4788889999999999999643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=195.97 Aligned_cols=170 Identities=19% Similarity=0.219 Sum_probs=134.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHH---------HHHHHHHHHhCCCCcEEEEeceec---
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ---------FKQEVEILGSMRHTNMVILLGACP--- 459 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~---------~~~Ei~il~~l~HpnIv~l~g~~~--- 459 (701)
..++|++.+.||.|+||.||....++..+|||++.......... +.+|+..+.++.||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 56899999999999999999987777789999998765444333 678999999999999988877642
Q ss_pred -------CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 460 -------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 460 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
...+|||||++|.+|.+.. .++. ....+++.+|..||..| ++|||+||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 2357999999999998763 1222 24669999999999999 99999999999999988 9
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt 594 (701)
+|+|||.......... ...+.....|+.++|+||||++|..+..
T Consensus 174 ~liDfg~~~~~~e~~a------------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA------------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhh------------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 9999998765421110 0114555567789999999999876543
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=178.16 Aligned_cols=129 Identities=16% Similarity=0.103 Sum_probs=101.5
Q ss_pred CCEEEEEeCCCc--chHHHHHHHHHhccCCCCeEEEEEEecCCCCCC--CCCC--C------hHHHHHHHHHHHHHHhhc
Q 005343 21 NAITAVAIDADK--SSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR--GRPA--T------NDELQKLFLPYRGLFARK 88 (701)
Q Consensus 21 ~~~IlVavD~s~--~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~--~~~~--~------~~~~~~~l~~~~~~~~~~ 88 (701)
.++||||||||+ .|.+|++||+.++.. +++|++|||.++..... .... . .+..++.++.+...+...
T Consensus 2 ~~~ILv~vD~S~~~~s~~al~~A~~la~~-~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 80 (142)
T PRK15456 2 YKTIIMPVDVFEMELSDKAVRHAEFLAQD-DGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTID 80 (142)
T ss_pred CccEEEeccCCchhHHHHHHHHHHHHHhc-CCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCC
Confidence 479999999994 899999999998876 46999999998742111 1011 0 133445566665555445
Q ss_pred CCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 89 RILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 89 ~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+++++.++.. |+|++.|+++|+++++|+||||+||++ +.+.|+ |||+++|+++++ |||+||.
T Consensus 81 ~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~ll-GS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 81 PSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-ISTHLL-GSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred CcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-ccceec-CccHHHHHHcCC--CCEEEeC
Confidence 7788888877 799999999999999999999999986 777555 999999999998 9999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=223.96 Aligned_cols=262 Identities=20% Similarity=0.224 Sum_probs=188.1
Q ss_pred eeeeeeeecCceeEEEEEE--CCceEEEEEeCCC--CCCChH----HHHHHHHHHHhCCCCcEEEEeceecCCC--ceEE
Q 005343 397 SISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPD--ISQGPR----QFKQEVEILGSMRHTNMVILLGACPEYG--CLVY 466 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~--~~~~~~----~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV~ 466 (701)
.....+|.|+||.|+.... ....++.|..... ...... .+..|+.+-..+.|||++..+..+.+.. .-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998887765 2222444433211 111111 2566788888899999987776653322 3349
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|||++ +|..++... ..++...+-.++.|++.|+.|||..| |.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988543 34677788889999999999999999 999999999999999999999999999776433
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGV-KSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
... ........+|+..|+|||.+....|++ ..||||.|+++..|++|+.||.....-++.........-.......+
T Consensus 474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 211 112346789999999999999999976 68999999999999999999865543222110000000000000111
Q ss_pred C--HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhccc
Q 005343 626 P--VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGF 667 (701)
Q Consensus 626 p--~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~ 667 (701)
+ ...+.....++-+||+++|..|-++.+|+..+|++--+.|.
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 1 23344578999999999999999999999999999766554
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=175.07 Aligned_cols=130 Identities=15% Similarity=0.123 Sum_probs=102.4
Q ss_pred CCEEEEEeCCCcc--hHHHHHHHHHhccCCCCeEEEEEEecCCCCCC--CC--CC--C--h---HHHHHHHHHHHHHHhh
Q 005343 21 NAITAVAIDADKS--SQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR--GR--PA--T--N---DELQKLFLPYRGLFAR 87 (701)
Q Consensus 21 ~~~IlVavD~s~~--S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~--~~--~~--~--~---~~~~~~l~~~~~~~~~ 87 (701)
.++||||+|||+. |.+|++||++++...|++|+++||+++.+... +. .. . . +..++.++.+...+..
T Consensus 2 ~~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (144)
T PRK15005 2 NRTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKL 81 (144)
T ss_pred CccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCC
Confidence 4789999999988 58999999999999999999999998642111 11 00 0 1 2333445555544455
Q ss_pred cCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 88 KRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 88 ~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++.++.++.. |+|++.|+++|+++++|+||||+| ++++.+.++ ||++++|++++| |||++|.
T Consensus 82 ~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~ll-GS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 82 PTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASH-RPDITTYLL-GSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCC-CCCchheee-cchHHHHHHhCC--CCEEEeC
Confidence 56778888877 799999999999999999999999 467888666 999999999999 9999983
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=189.31 Aligned_cols=247 Identities=22% Similarity=0.366 Sum_probs=186.6
Q ss_pred ceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecCC
Q 005343 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYMEN 471 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~~ 471 (701)
..++-+|.+...|+.|+|++.+..++.|++...... ..+.|..|.-.|+-+.||||+.++|+|. .+..++..||+.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 344567899999999999999999999988765422 2356999999999999999999999994 455788999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeec-CCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR-DLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr-DLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
|||...|+... .-...-.+..+++.+++.|+.|||+..| +|-| -|.+..+++|.+.+.+|+ .+-+++
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltaris-mad~kf-------- 339 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARIS-MADTKF-------- 339 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhhee-ccccee--------
Confidence 99999996543 2345667788899999999999999874 5544 588999999999888774 111111
Q ss_pred cccccccccccCCCccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGML---GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
........-.+.|++||.++..+- -..+|+|||+++||||.|...||......+--..- .+.......|.
T Consensus 340 --sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----aleglrv~ipp 412 (448)
T KOG0195|consen 340 --SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----ALEGLRVHIPP 412 (448)
T ss_pred --eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----hhccccccCCC
Confidence 011223345788999998877653 34789999999999999999999766554332221 01111223466
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+..+.+|+.-|+..||.+||.+..|+ +-+.++
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmiv-pilekm 446 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIV-PILEKM 446 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceeh-hhHHHh
Confidence 6777899999999999999999998775 556554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=186.21 Aligned_cols=138 Identities=20% Similarity=0.173 Sum_probs=106.6
Q ss_pred eeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC---------hH-----------------HHHHHHHHHHhCCCCcE
Q 005343 399 SRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG---------PR-----------------QFKQEVEILGSMRHTNM 451 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~---------~~-----------------~~~~Ei~il~~l~HpnI 451 (701)
...||+|+||.||+|.. ++..||||+++...... .. ...+|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998 57789999997653211 01 12459999999987665
Q ss_pred EEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCCeeEcCCC
Q 005343 452 VILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL-HQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 452 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
.....+.....+|||||++|++|...... ..++++.....++.|++.+|.|| |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 33222223345899999998877654322 23688899999999999999999 6888 99999999999998 47
Q ss_pred cEEEEeecccccc
Q 005343 531 VSKISDVGLARLV 543 (701)
Q Consensus 531 ~~KL~DFGla~~~ 543 (701)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=181.99 Aligned_cols=189 Identities=15% Similarity=0.101 Sum_probs=140.6
Q ss_pred eeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCCh----HHHHHHHHHHHhCC-CCcEEEEeceecCCCceEEeecCC
Q 005343 397 SISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGP----RQFKQEVEILGSMR-HTNMVILLGACPEYGCLVYEYMEN 471 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~----~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~lV~Ey~~~ 471 (701)
.+...|++|+||+||.+...+..++.+.+........ ..+.+|+++|++|. |+++..++++ +..+++|||+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 4567899999999998888888888887765543111 14789999999995 5778888876 346899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCeeEcCCCcEEEEeeccccccCCCCCc-
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDL-KPANILLDQNYVSKISDVGLARLVPPSAAD- 549 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDL-Kp~NILl~~~~~~KL~DFGla~~~~~~~~~- 549 (701)
.+|...+.. ....++.|++.+|.++|..| |+|||| ||+|||++.++.++|+|||+|....+...-
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 988654311 11347789999999999999 999999 799999999999999999999865433210
Q ss_pred ------ccccccccccccCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005343 550 ------TITQYHMTTAAGTFCYIDPEYQQ--TGMLGVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 550 ------~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDvwSlGvil~elltG~~pf~ 600 (701)
............++.|++|+... ...--...++++-|+-+|.++|+..|+-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00000011233678889997432 2222357799999999999999997753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=180.98 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=109.7
Q ss_pred eeeeeecCceeEEEEEEC-CceEEEEEeCCCCCC---------------------C-----hHHHHHHHHHHHhCCCCcE
Q 005343 399 SRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQ---------------------G-----PRQFKQEVEILGSMRHTNM 451 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~---------------------~-----~~~~~~Ei~il~~l~HpnI 451 (701)
...||+|+||.||+|.+. ++.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999984 788999999876321 0 1123678999999999887
Q ss_pred EEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCC
Q 005343 452 VILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 452 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~ 530 (701)
.....+.....+|||||++|+++...... ...++......++.|++.+|.+||+ .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 54333333446899999988865443222 1346778889999999999999999 88 99999999999999 88
Q ss_pred cEEEEeeccccccC
Q 005343 531 VSKISDVGLARLVP 544 (701)
Q Consensus 531 ~~KL~DFGla~~~~ 544 (701)
.++|+|||++..++
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-20 Score=211.09 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=179.6
Q ss_pred CceeeeeeeecCceeEEEEEECCceEEEEEeCCCC-CCChHHHHHHHHH--HHhCCCCcEEEEecee--cCCCceEEeec
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDI-SQGPRQFKQEVEI--LGSMRHTNMVILLGAC--PEYGCLVYEYM 469 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~-~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 469 (701)
+|...+.||.+.|=+|.+|.+++..|+||++-+.. .-..+.|.++++- ...++|||++++.-.- ....|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 57788899999999999999988889999986654 3445555554443 4456899999886553 33458888998
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc--CCCC
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV--PPSA 547 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~--~~~~ 547 (701)
. -+|.|+| ...+-+..-+..-|+.|++.||.-+|..| |+|||||.+|||++.-.=+.|+||..-+.. +.+.
T Consensus 104 k-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 4888888 33345677788889999999999999999 999999999999998878899999765422 2221
Q ss_pred CcccccccccccccCCCccCcccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHcCccc
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTG----------M-LGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQAIRNGTFS 615 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~i~~~~~~ 615 (701)
.... .+.+.+...-.+|+|||.|... . .++++||||+||+++||++ |+|||.+.+.... +.|. .
T Consensus 177 Padf-~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY--r~~~-~ 252 (1431)
T KOG1240|consen 177 PADF-TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY--RSGN-A 252 (1431)
T ss_pred cccc-eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH--hccC-c
Confidence 1111 1222233344689999965442 1 6789999999999999987 7999976655422 2221 1
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
......+...+. ..+.+++..|++.+|..|-++.+.|..
T Consensus 253 ~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111111 148899999999999999999998854
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=169.85 Aligned_cols=129 Identities=16% Similarity=0.163 Sum_probs=97.7
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC-CCC--CCCh----HHHHHHHHHHHHHHhhcCCeee
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP-RGR--PATN----DELQKLFLPYRGLFARKRILAR 93 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~-~~~--~~~~----~~~~~~l~~~~~~~~~~~v~~~ 93 (701)
.++||||+|+|+.|..||+||+.++...|++|++|||..+.... .+. .... ...++....+..++...|+.+.
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 47999999999999999999999999899999999995432111 110 0001 1122233344555566788876
Q ss_pred EEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 94 EVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 94 ~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
..++..|+|+++|+++|+++++|+||||+|| +++.+ + ||||++|+++|+ |||++|.
T Consensus 83 ~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~--l-gSva~~v~~~a~--~pVLvv~ 138 (144)
T PRK15118 83 ETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFWSK--L-MSSARQLINTVH--VDMLIVP 138 (144)
T ss_pred EEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHHHH--H-HHHHHHHHhhCC--CCEEEec
Confidence 5555458999999999999999999999997 44443 4 899999999998 9999997
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-19 Score=162.55 Aligned_cols=123 Identities=20% Similarity=0.214 Sum_probs=106.3
Q ss_pred EEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcCCh
Q 005343 23 ITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQDIDV 102 (701)
Q Consensus 23 ~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~~~ 102 (701)
+||||||+|+.+++|++||+.++...++.|++|||.++... ...++.++.++.+...+...++. ..++.+++|
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~-----~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~ 73 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN-----RLSEAERRRLAEALRLAEELGAE--VVTLPGDDV 73 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc-----cCCHHHHHHHHHHHHHHHHcCCE--EEEEeCCcH
Confidence 59999999999999999999999999999999999986321 12356677888888888877765 345566899
Q ss_pred hHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 103 SSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 103 ~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
+++|+++|+++++|+||||+||++++.+.|+ ||++++|+++| ..|+|+||
T Consensus 74 ~~~I~~~~~~~~~dllviG~~~~~~~~~~~~-Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 74 AEAIVEFAREHNVTQIVVGKSRRSRWRELFR-GSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHHHHHHHcCCCEEEeCCCCCchHHHHhc-ccHHHHHHHhC-CCCeEEEe
Confidence 9999999999999999999999999999766 99999999999 24999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=204.08 Aligned_cols=231 Identities=25% Similarity=0.269 Sum_probs=179.7
Q ss_pred eeecCceeEEEEEE-----CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEEeecCC
Q 005343 402 IGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVYEYMEN 471 (701)
Q Consensus 402 IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~Ey~~~ 471 (701)
+|.|.||.|++++- .+..+|+|++++..... ......|..++..++ ||.+|.+.-.+.. ..+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999997653 45568999886653211 124567888888887 9999999877643 45899999999
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~ 551 (701)
|.|...+.. ...+.......+...++.++.++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..
T Consensus 82 g~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~----- 150 (612)
T KOG0603|consen 82 GDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE----- 150 (612)
T ss_pred chhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh-----
Confidence 999887743 334666777778889999999999999 999999999999999999999999999865221
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAAL 631 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~ 631 (701)
...|||..|||||++. .....+|+||||++.+||+||-.||+. .....+.. . -...|.+...
T Consensus 151 -----~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~Il~-~---------~~~~p~~l~~ 212 (612)
T KOG0603|consen 151 -----KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRILK-A---------ELEMPRELSA 212 (612)
T ss_pred -----hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHHhh-h---------ccCCchhhhH
Confidence 1129999999999988 567789999999999999999999987 22222221 1 1245667777
Q ss_pred HHHHHHHHhhccCcCCCCCh-----hhhhhHHHHH
Q 005343 632 SIAKLALQCCELRKRDRPDL-----VSVVLPELIR 661 (701)
Q Consensus 632 ~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~ 661 (701)
....++..++..+|.+|--. .++..|.++.
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~ 247 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ 247 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe
Confidence 78999999999999998765 4555555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-20 Score=208.98 Aligned_cols=223 Identities=24% Similarity=0.332 Sum_probs=158.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCCCceEEeecC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYME 470 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~lV~Ey~~ 470 (701)
.++|..+++|-.|+||.||.++++ .+++|+|+ +++. .+.+ .|+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilR--nilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILR--NILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhh--ccccccCCccee------------------
Confidence 467999999999999999999987 55688853 3221 0110 033333344333
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc-
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD- 549 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~- 549 (701)
|+-.+.+ .+.++++. +++.+++|||+.+ |+|||+||+|.|++.-|++|++|||+.+..-.....
T Consensus 136 -gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4444444 22234443 3488999999999 999999999999999999999999998754222111
Q ss_pred --------ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCcccccc
Q 005343 550 --------TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELL 618 (701)
Q Consensus 550 --------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~l 618 (701)
...+......+||+.|+|||++....|+..+|||++|+|+||++.|..||.++. .+.+.+....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-----
Confidence 111223356799999999999999999999999999999999999998886652 2333333221
Q ss_pred CccCCCCCH---HHHHHHHHHHHHhhccCcCCCCC---hhhhhhHHHHHHHhcc
Q 005343 619 DPTVTGWPV---EAALSIAKLALQCCELRKRDRPD---LVSVVLPELIRLRDLG 666 (701)
Q Consensus 619 d~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPt---~~~vl~~~~~~l~~~~ 666 (701)
.||. ..+.+.++++.+.|..+|..|-- ..+|-.|.+++..|+.
T Consensus 276 -----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 -----EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -----cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1221 12335899999999999999954 5667788888877765
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=168.61 Aligned_cols=126 Identities=13% Similarity=0.206 Sum_probs=97.4
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC-CC--CCCCh-------HHHHHHHHHHHHHHhhcCC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP-RG--RPATN-------DELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~-~~--~~~~~-------~~~~~~l~~~~~~~~~~~v 90 (701)
.++||||||+|+.|.+|+++|+.++...+++|+++||.++.... .. ..... +..++.+..+...+. ..
T Consensus 3 ~k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~ 80 (142)
T PRK09982 3 YKHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WP 80 (142)
T ss_pred ceEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CC
Confidence 47999999999999999999999999999999999999764211 11 11111 223334444443332 23
Q ss_pred eeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 LAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 ~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++..+.. |+|++.|+++|++.++|+||||+| ++++.+.| | ||++|+++++ |||++|.
T Consensus 81 ~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~--~-va~~V~~~s~--~pVLvv~ 138 (142)
T PRK09982 81 KTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM--P-AYRGMINKMS--ADLLIVP 138 (142)
T ss_pred cceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH--H-HHHHHHhcCC--CCEEEec
Confidence 45556666 899999999999999999999987 88998844 5 9999999998 9999996
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.11 Aligned_cols=130 Identities=15% Similarity=0.205 Sum_probs=112.5
Q ss_pred EEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCC--CCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcC
Q 005343 23 ITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR--GRPATNDELQKLFLPYRGLFARKRILAREVVLQDI 100 (701)
Q Consensus 23 ~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~ 100 (701)
+||||+|+++.+..||++|..++...++.|+++||.+++.... ......+..++.++.+..++...|+.++..+..+|
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 80 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSPSQLEVNVQRARKLLRQAERIAASLGVPVHTIIRIDH 80 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCcchhHHHHHHHHHHHHHHHHHhhhcCCceEEEEEecC
Confidence 5999999999999999999999999999999999998642211 11112356678889999999999999998888778
Q ss_pred ChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 101 DVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 101 ~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+|.++|+++|+++++|+||||+++++++.+.++ ||++++|+++++ |||++|.
T Consensus 81 ~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~l-Gs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 81 DIASGILRTAKERQADLIIMGWHGSTSLRDRLF-GGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred CHHHHHHHHHHhcCCCEEEEecCCCCCccceec-CchHHHHHhcCC--CCEEEeC
Confidence 999999999999999999999999999977666 999999999998 9999983
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-18 Score=175.74 Aligned_cols=230 Identities=21% Similarity=0.286 Sum_probs=148.6
Q ss_pred CceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCC---C-------c------EEE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQ---GPRQFKQEVEILGSMRH---T-------N------MVI 453 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~H---p-------n------Iv~ 453 (701)
.+.....||.|+|+.||.+++.. ..+|+|++...... ..+++.+|.-....+.+ | . ++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35667899999999999999965 66999987655422 23456666655544332 1 1 222
Q ss_pred Eece---e----------cCCCceEEeecCCCChhhHhc---ccCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 005343 454 LLGA---C----------PEYGCLVYEYMENGSLEDRLF---QKDN-SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516 (701)
Q Consensus 454 l~g~---~----------~~~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 516 (701)
+-+- + --+.+++|+-+ .++|.+++. .... ...+....+..+..|++..+++||..| +||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 2110 0 11235677777 578877653 2222 233555667788899999999999999 999
Q ss_pred cCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC--------CCCCchhhHHHHHHH
Q 005343 517 RDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--------GMLGVKSDLYSLGVV 588 (701)
Q Consensus 517 rDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDvwSlGvi 588 (701)
+||+|+|+|++.+|.++|+||+....... .+ .....+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~-------~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT-------RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE-------EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc-------ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999988765321 11 11344577999996533 247889999999999
Q ss_pred HHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCC
Q 005343 589 LLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDR 648 (701)
Q Consensus 589 l~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R 648 (701)
+|.|++|..||+..... .. .+.....+. +.+..+..||..+|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~------~~----~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPE------AD----PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGG------ST----SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCcc------cc----ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999865421 00 001334455 777789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=170.87 Aligned_cols=132 Identities=17% Similarity=0.275 Sum_probs=103.8
Q ss_pred eeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhC-----CCCcEEEEeceecCCC---c---eEE
Q 005343 399 SRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSM-----RHTNMVILLGACPEYG---C---LVY 466 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~---lV~ 466 (701)
...||+|+||.||. +. ....+||++........+.+.+|+.+++.+ .||||+.++|++.+.. + +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 42 223579988776555667899999999999 6799999999996642 3 689
Q ss_pred ee--cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCeeEcC----CCcEEEEe-ec
Q 005343 467 EY--MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL-LFLHQNKPEPLVHRDLKPANILLDQ----NYVSKISD-VG 538 (701)
Q Consensus 467 Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~iiHrDLKp~NILl~~----~~~~KL~D-FG 538 (701)
|| +.+|+|.+++.+. .+++. ..++.+++.++ .|||+++ ||||||||+|||++. ++.++|+| ||
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5579999999442 25544 35678888887 8999999 999999999999974 34899999 55
Q ss_pred ccc
Q 005343 539 LAR 541 (701)
Q Consensus 539 la~ 541 (701)
...
T Consensus 156 ~~~ 158 (210)
T PRK10345 156 EST 158 (210)
T ss_pred Ccc
Confidence 443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.5e-19 Score=188.92 Aligned_cols=184 Identities=27% Similarity=0.388 Sum_probs=141.4
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
+.++.|++|.-.+|.+.|.++......++.....++.|++.|+.| ++ .+|||+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 457999999999999999877777788899999999999999999 67 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHHcCccccccC
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAIRNGTFSELLD 619 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~i~~~~~~~~ld 619 (701)
...............++..+||.+||+||.+.+..|+.++||||||+||+||++- ..+|.. ......++.|.+...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-~~t~~d~r~g~ip~~-- 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-IATLTDIRDGIIPPE-- 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-HHhhhhhhcCCCChH--
Confidence 7764433222223356788999999999999999999999999999999999982 222211 111223344433210
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.+.++|. =..|+.+++...|.+||+....-.|.|
T Consensus 481 -~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 481 -FLQDYPE-----EYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred -HhhcCcH-----HHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 1223333 358999999999999996665555544
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-18 Score=157.97 Aligned_cols=132 Identities=24% Similarity=0.300 Sum_probs=101.0
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCCh-------HHHHHHHHHHHHHHhhcCCeee
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATN-------DELQKLFLPYRGLFARKRILAR 93 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~v~~~ 93 (701)
.++||||+|+++.+..|++||+.++...+++|++|||.++........... .............+...+....
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVI 81 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEE
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhcccee
Confidence 489999999999999999999999999999999999998741110000000 0000001111133445566666
Q ss_pred EEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 94 EVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 94 ~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
...+..+++.++|+++++++++|+||||+++++++.+.++ ||++++|++++| |||++|.
T Consensus 82 ~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~-gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 82 EVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLF-GSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSS-HHHHHHHHHHTS--SEEEEEE
T ss_pred EEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCc-CCHHHHHHHcCC--CCEEEeC
Confidence 6666669999999999999999999999999999999665 999999999999 9999983
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=156.00 Aligned_cols=130 Identities=11% Similarity=0.105 Sum_probs=101.0
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCC--h---HHH-HHHHHHHHHHHhhcCCeeeE
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPAT--N---DEL-QKLFLPYRGLFARKRILARE 94 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~--~---~~~-~~~l~~~~~~~~~~~v~~~~ 94 (701)
.++||||+|+|+.+..||++|+.++...|++|+++||.+++......... . +.. ++....+..++.+.|+..+.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 48999999999999999999999999999999999998764221111110 1 111 11122334445566777665
Q ss_pred EEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 95 VVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 95 ~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++..|++.+.|+++|++.++|+||||+||++++.+. +||+++|+++++ ||||+|.
T Consensus 83 ~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~---~s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 83 TFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRA---SCSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred EEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHH---HHHHHHHHhcCC--CCEEEEe
Confidence 5555699999999999999999999999999999983 489999999998 9999997
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=193.50 Aligned_cols=196 Identities=22% Similarity=0.292 Sum_probs=155.7
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEE----Eec--eecC
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI----LLG--ACPE 460 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~----l~g--~~~~ 460 (701)
+.+.....|.+...||+|+||.||+|.. ++..||+|+-++... .+|.--.+++.+|+ |-+.. +.. .|.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLK-PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhc-hhhhcchHHHHHHHccCC
Confidence 3344556799999999999999999998 556699999776543 33444455666666 33332 222 2366
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-------CCCcEE
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-------QNYVSK 533 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-------~~~~~K 533 (701)
..+||+||.+.|+|.+++. ....++|.....++.|++.-+..||..+ |||+||||+|+||. .+.-++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 6789999999999999984 5567899999999999999999999999 99999999999993 345689
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~ 597 (701)
|+|||.+-.+..-. ...++...++|-.+-.+|+..+..++..+|.|.|+-+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFP----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcC----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986542111 1234567788999999999999999999999999999999999973
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=163.78 Aligned_cols=129 Identities=22% Similarity=0.356 Sum_probs=106.0
Q ss_pred eeeecCceeEEEEEECCceEEEEEeCCCCCCC--------hHHHHHHHHHHHhCCCCcE--EEEeceecCCCceEEeecC
Q 005343 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--------PRQFKQEVEILGSMRHTNM--VILLGACPEYGCLVYEYME 470 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--------~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~~~lV~Ey~~ 470 (701)
.||+|+||.||+|.+.+..|++|+........ ...+.+|++++..+.|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999876543211 2457789999999988764 3455555666799999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
|++|.+.+..... .++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999987733210 68999999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=165.49 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=109.7
Q ss_pred eeeeecCceeEEEEEECCceEEEEEeCCCCCCC--------hHHHHHHHHHHHhCCCCcEEEEece--ecCCCceEEeec
Q 005343 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--------PRQFKQEVEILGSMRHTNMVILLGA--CPEYGCLVYEYM 469 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~g~--~~~~~~lV~Ey~ 469 (701)
+.||+|++|.||+|.+.+..|++|+........ ...+.+|+.++..+.|+++.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999999988999999876543221 1347889999999999887654433 456678999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+|++|.+.+... .+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988432 12 77889999999999999999 99999999999999 78899999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-17 Score=182.25 Aligned_cols=202 Identities=23% Similarity=0.418 Sum_probs=150.1
Q ss_pred HHhCCCCcEEEEeceecC--CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCe-eecCC
Q 005343 443 LGSMRHTNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL-VHRDL 519 (701)
Q Consensus 443 l~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-iHrDL 519 (701)
|+.+.|.|+.+++|.+-+ ..+.|.+||..|+|.|.+.. ....++|.-...++.+|+.||.|||+.. | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 457899999999999854 34789999999999999965 3356889999999999999999999865 5 99999
Q ss_pred CCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCC-------CCchhhHHHHHHHHHHH
Q 005343 520 KPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM-------LGVKSDLYSLGVVLLQL 592 (701)
Q Consensus 520 Kp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~~~~sDvwSlGvil~el 592 (701)
++.|+++|....+||+|||+........ .........-..-|.|||.+.... .+.+.||||||++++|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~----~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA----EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc----cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999987763200 000111222445699999876642 46679999999999999
Q ss_pred HhCCCCCCCchH------HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 593 ITARPAMGLSHQ------VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 593 ltG~~pf~~~~~------~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
++.+.||+.... +-..+..+ ....+-|.+.... +....+..++..||..+|..||++.+|-
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999999975332 11122220 1111222221111 3333689999999999999999999885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-17 Score=167.56 Aligned_cols=141 Identities=20% Similarity=0.196 Sum_probs=109.1
Q ss_pred CceeeeeeeecCceeEEEEE-E--CCceEEEEEeCCCCCC-------------------C-----hHHHHHHHHHHHhCC
Q 005343 395 YFSISRKIGEGGYGPVYKAQ-L--DHTSVAIKVLGPDISQ-------------------G-----PRQFKQEVEILGSMR 447 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~-~--~~~~vAiK~l~~~~~~-------------------~-----~~~~~~Ei~il~~l~ 447 (701)
.|.+.+.||+|+||.||+|. . .++.||+|++...... . ...+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999998 3 6778999998754311 0 122568999999997
Q ss_pred CCc--EEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 448 HTN--MVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 448 Hpn--Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
+.+ +..+++. ...++||||+.|++|...+.. ...+.......++.|++.+|.+||+.+ .|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 533 3344443 345899999999888665422 224555666789999999999999987 3999999999999
Q ss_pred EcCCCcEEEEeecccccc
Q 005343 526 LDQNYVSKISDVGLARLV 543 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~ 543 (701)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=188.24 Aligned_cols=136 Identities=21% Similarity=0.250 Sum_probs=110.6
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCC--------ChHHHHHHHHHHHhCCCCcEEEEecee--cCCC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQ--------GPRQFKQEVEILGSMRHTNMVILLGAC--PEYG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~~~ 462 (701)
...|...++||+|+||.||+|.+.+..+++|+....... ....+.+|++++..++|++++....++ .+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345667899999999999999997777766654322111 124578999999999999987655544 4467
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 89999999999998873 34678999999999999999 9999999999999 577899999999975
Q ss_pred c
Q 005343 543 V 543 (701)
Q Consensus 543 ~ 543 (701)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=165.93 Aligned_cols=192 Identities=19% Similarity=0.229 Sum_probs=134.5
Q ss_pred CCCcEEEEeceecCC-----------------------------CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHH
Q 005343 447 RHTNMVILLGACPEY-----------------------------GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497 (701)
Q Consensus 447 ~HpnIv~l~g~~~~~-----------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 497 (701)
+|||||.+.++|-+. .|+||.-.+ -+|..++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 599999998876211 157777663 4788887433 355667778999
Q ss_pred HHHHHHHHHhhcCCCCeeecCCCCCCeeE--cCCC--cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC
Q 005343 498 EIATALLFLHQNKPEPLVHRDLKPANILL--DQNY--VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573 (701)
Q Consensus 498 qia~aL~~LH~~~~~~iiHrDLKp~NILl--~~~~--~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 573 (701)
|+++|+.|||++| |.|||+|++|||+ |+++ .+.|+|||+|---....-........-..-|.-..||||++..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4444 4579999987421111111111122344567888999998765
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCC
Q 005343 574 GM------LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRD 647 (701)
Q Consensus 574 ~~------~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~ 647 (701)
.+ --.++|.|+.|.+.||+++...||...-+. .+...++++ ..++..|..++..+.+++...|+.+|.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~r~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDTRTYQE---SQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eechhhhhh---hhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 43 124899999999999999999999653221 111112222 2234455666777899999999999999
Q ss_pred CCCh
Q 005343 648 RPDL 651 (701)
Q Consensus 648 RPt~ 651 (701)
||+.
T Consensus 501 Rvsp 504 (598)
T KOG4158|consen 501 RVSP 504 (598)
T ss_pred cCCc
Confidence 9984
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=158.24 Aligned_cols=135 Identities=21% Similarity=0.174 Sum_probs=107.0
Q ss_pred CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC----------------------ChHHHHHHHHHHHhCCCCc-
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ----------------------GPRQFKQEVEILGSMRHTN- 450 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~----------------------~~~~~~~Ei~il~~l~Hpn- 450 (701)
.|.+.+.||+|+||.||++.. .++.||||++...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 478889999999999999988 5778999987654310 0113678899999998874
Q ss_pred -EEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 451 -MVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 451 -Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
+...++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+||||||+||+++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4444443 345899999999998765421 234568899999999999998 9999999999999999
Q ss_pred CcEEEEeecccccc
Q 005343 530 YVSKISDVGLARLV 543 (701)
Q Consensus 530 ~~~KL~DFGla~~~ 543 (701)
+.++|+|||++...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=167.40 Aligned_cols=132 Identities=15% Similarity=0.054 Sum_probs=108.7
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCC-C-CCCC---------hHHHHHHHHHHHHHHhhcC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR-G-RPAT---------NDELQKLFLPYRGLFARKR 89 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~-~-~~~~---------~~~~~~~l~~~~~~~~~~~ 89 (701)
.++||||+|+|+.|..|++||+.++...++.|+++||+++..... + .... .+..++.++.+...+...|
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 478999999999999999999999999999999999986532110 1 0000 0223445666666667778
Q ss_pred CeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 90 ILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 90 v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
++++..+...|++.++|+++|+++++|+||||++|.+++.+.++ ||++.++++++| |||++|.
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~-gs~~~~l~~~~~--~pvlvv~ 145 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIF-TPTDWHLLRKCP--CPVLMVK 145 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhcc-ChhHHHHHhcCC--CCEEEec
Confidence 99998887668999999999999999999999999999999767 999999999998 9999998
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=161.98 Aligned_cols=133 Identities=13% Similarity=0.131 Sum_probs=101.4
Q ss_pred CCCEEEEEeCCCcch-------HHHHHHHHHhccCC-CCeEEEEEEecCCCCCC--CCC--CCh---HHH-HHHHHHHHH
Q 005343 20 ANAITAVAIDADKSS-------QYAVKWAVDNLLNE-TSQYVLLHVRNHSSNPR--GRP--ATN---DEL-QKLFLPYRG 83 (701)
Q Consensus 20 ~~~~IlVavD~s~~S-------~~Al~wA~~~~~~~-g~~v~llHV~~~~~~~~--~~~--~~~---~~~-~~~l~~~~~ 83 (701)
..++||||+|+|+.+ ..||++|+.++... ++.|++|||.+...... ..+ ... +.. ++..+.+..
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKA 230 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHH
Confidence 358999999999653 68999999999887 99999999987532111 000 011 111 123334455
Q ss_pred HHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 84 LFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 84 ~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
++...++..+..++..|+|.++|+++|++.++|+||||++|++++.+.|+ ||++++|++++| |||++|.
T Consensus 231 ~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~ll-GS~a~~v~~~~~--~pVLvv~ 299 (305)
T PRK11175 231 LRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFL-GNTAEHVIDHLN--CDLLAIK 299 (305)
T ss_pred HHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceee-cchHHHHHhcCC--CCEEEEc
Confidence 55666777654444448999999999999999999999999999999766 999999999999 9999996
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=149.48 Aligned_cols=135 Identities=21% Similarity=0.208 Sum_probs=96.1
Q ss_pred eeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCCh--HH----------------------HHHHHHHHHhCCCCc--E
Q 005343 399 SRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGP--RQ----------------------FKQEVEILGSMRHTN--M 451 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~--~~----------------------~~~Ei~il~~l~Hpn--I 451 (701)
.+.||+|+||.||+|.+. +..||||++........ .. ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999985 77899999876432111 11 134566666654432 2
Q ss_pred EEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCC
Q 005343 452 VILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 452 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~ 530 (701)
...++. ...++||||++++.+......... .. .....++.+++.++.+||. .+ |+||||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 333332 345899999998554322111110 11 4567899999999999999 88 99999999999999 89
Q ss_pred cEEEEeecccccc
Q 005343 531 VSKISDVGLARLV 543 (701)
Q Consensus 531 ~~KL~DFGla~~~ 543 (701)
.++|+|||++...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-15 Score=139.07 Aligned_cols=134 Identities=24% Similarity=0.256 Sum_probs=111.6
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCC--CcEEEEeceecC--CCceEEeecCCCC
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRH--TNMVILLGACPE--YGCLVYEYMENGS 473 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~--~~~lV~Ey~~~gs 473 (701)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.++..+.| +++..+++++.. ..+++|||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 457899999999999999888899999866543 5678999999999976 478888877644 5689999998877
Q ss_pred hhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 474 LEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+..+ +......++.+++.+|.+||.....+++|+||+|.||+++.++.+++.|||++...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7543 44566778999999999999864334999999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=135.58 Aligned_cols=128 Identities=25% Similarity=0.360 Sum_probs=108.9
Q ss_pred EEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCC--CCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcC
Q 005343 23 ITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRG--RPATNDELQKLFLPYRGLFARKRILAREVVLQDI 100 (701)
Q Consensus 23 ~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~ 100 (701)
+||||+|++..+..+++||..++...++.|+++||.++...... ......+.++.++.+...|...|+.+...+.. |
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~ 79 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLE-G 79 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcchhHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEec-C
Confidence 58999999999999999999999999999999999876321110 01123566788888888888889999888887 6
Q ss_pred ChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 101 DVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 101 ~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
++.++|++++++.++|+||||+++++.+.+.++ ||++.+++++++ |||++|
T Consensus 80 ~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~-~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 80 DPAEAILEAAEELGADLIVMGSRGRSGLRRLLL-GSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred CCHHHHHHHHHHcCCCEEEEcCCCCCccceeee-ccHHHHHHhCCC--CCEEeC
Confidence 779999999999999999999999999888666 999999999987 999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.4e-14 Score=134.40 Aligned_cols=132 Identities=19% Similarity=0.239 Sum_probs=110.6
Q ss_pred CCCEEEEEeC-CCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCC-CC----CC--------ChHHHHHHHHHHHHHH
Q 005343 20 ANAITAVAID-ADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR-GR----PA--------TNDELQKLFLPYRGLF 85 (701)
Q Consensus 20 ~~~~IlVavD-~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~-~~----~~--------~~~~~~~~l~~~~~~~ 85 (701)
..++|++++| +++.+..|+.+|+..+...+..+.++||.+...... .. .. ......+.++.+....
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 4589999999 999999999999999999999999999997742111 00 01 1245577888888888
Q ss_pred hhcCCee-eEEEEEcCCh-hHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 86 ARKRILA-REVVLQDIDV-SSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 86 ~~~~v~~-~~~v~~~~~~-~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
...++.. +..+.. |+| .+.|+++|.++++|+||||++|++++.+ +++|||+++|+++++ |||++|.
T Consensus 84 ~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~-~llGsvs~~v~~~~~--~pVlvv~ 151 (154)
T COG0589 84 EAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRSGLSR-LLLGSVAEKVLRHAP--CPVLVVR 151 (154)
T ss_pred HHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCccccc-eeeehhHHHHHhcCC--CCEEEEc
Confidence 8889885 777777 666 7999999999999999999999999999 445999999999998 9999996
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-14 Score=145.44 Aligned_cols=132 Identities=19% Similarity=0.193 Sum_probs=103.2
Q ss_pred eeee-ecCceeEEEEEECCceEEEEEeCCCC-------------CCChHHHHHHHHHHHhCCCCcE--EEEeceecC---
Q 005343 400 RKIG-EGGYGPVYKAQLDHTSVAIKVLGPDI-------------SQGPRQFKQEVEILGSMRHTNM--VILLGACPE--- 460 (701)
Q Consensus 400 ~~IG-~G~fg~Vyk~~~~~~~vAiK~l~~~~-------------~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~--- 460 (701)
..|| .||.|+||.+...+..++||.+.... ......+.+|++++..|.|+++ ...++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999999988899999774321 0123457889999999998775 555555321
Q ss_pred ---CCceEEeecCC-CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 461 ---YGCLVYEYMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 461 ---~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
..++||||++| .+|.+++.. .+++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 12599999997 689887733 234443 3678999999999999 99999999999999999999999
Q ss_pred eccccc
Q 005343 537 VGLARL 542 (701)
Q Consensus 537 FGla~~ 542 (701)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-16 Score=178.02 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=190.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE-CCce--EEEEEeCCCC--CCChHHHHHHHHHHHhCC-CCcEEEEecee--cCCCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-DHTS--VAIKVLGPDI--SQGPRQFKQEVEILGSMR-HTNMVILLGAC--PEYGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-~~~~--vAiK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~--~~~~~l 464 (701)
...|.+.+.||+|+|+.|-.... .+.. +|+|.+.... .........|..+-..+. |+|++.+++.. ++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45688888899999999988876 2333 5556554432 222344566888888887 99999999987 445689
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH-QNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARL 542 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~ 542 (701)
+++|..||++.+.+... .....+....-.++.|+..+|.|+| ..+ +.||||||+|.+++.++ .+|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998877321 1113344455578999999999999 888 99999999999999999 999999999988
Q ss_pred cCC-CCCccccccccccccc-CCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccC
Q 005343 543 VPP-SAADTITQYHMTTAAG-TFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLD 619 (701)
Q Consensus 543 ~~~-~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld 619 (701)
+.. .. ........+| ++.|+|||.+.+ ...++..|+||.|+++.-+++|..|+....... +.+.....
T Consensus 175 ~~~~~g----~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~ 245 (601)
T KOG0590|consen 175 YRNKNG----AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKS 245 (601)
T ss_pred ccccCC----cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecc
Confidence 755 22 2223455677 999999998877 456889999999999999999998886554322 12111111
Q ss_pred cc----CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 620 PT----VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 620 ~~----~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.. ...| ........+++..++..+|..|.+..++-.+.|...
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPW-NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCcc-ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 11 1122 122334678889999999999999999999999887
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-13 Score=141.36 Aligned_cols=207 Identities=23% Similarity=0.310 Sum_probs=146.4
Q ss_pred HHHHHHHhCCCCcEEEEeceecCCC-------ceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhc
Q 005343 438 QEVEILGSMRHTNMVILLGACPEYG-------CLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQN 509 (701)
Q Consensus 438 ~Ei~il~~l~HpnIv~l~g~~~~~~-------~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~ 509 (701)
.-..-|-.+.|-|||++..|+.+.. .++.|||..|+|..+|.+. .....+......+++-||+.||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 3344556678999999988885433 5899999999999999764 3344577777789999999999999998
Q ss_pred CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHH
Q 005343 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589 (701)
Q Consensus 510 ~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil 589 (701)
. .||+|+++..+-|++..+|.+||+--.-.. +.++.. ........-..+-++|.+||+-.....+..+|||+||+..
T Consensus 196 ~-PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~-~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVN-STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred C-CccccCCcchhheeecCCceEEecccCccc-cchhhh-hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 7 579999999999999999999986322111 111110 0011112233467889999998888888899999999999
Q ss_pred HHHHhCCC-CCCCchH--HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 590 LQLITARP-AMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 590 ~elltG~~-pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
++|..|.. |-..... ++..+..-.+ .+- ++ . =..++..|++-.|..||+++.++-|++
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~~i~-~le----n~--l-----qr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIANVII-GLE----NG--L-----QRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhhhee-ecc----Cc--c-----ccCcCcccccCCCCCCcchhhhhcCce
Confidence 99998873 3333332 2222222111 010 11 1 247889999999999999999997754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-12 Score=144.68 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=98.2
Q ss_pred eeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChH----------------------------------------HHHH
Q 005343 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPR----------------------------------------QFKQ 438 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~----------------------------------------~~~~ 438 (701)
+.||.|++|.||+|++ +++.||||+.++....... .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999998 6888999998775311100 1344
Q ss_pred HHHHHHhCC-----CCcEE--EEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHH-HHHHHhhcC
Q 005343 439 EVEILGSMR-----HTNMV--ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT-ALLFLHQNK 510 (701)
Q Consensus 439 Ei~il~~l~-----HpnIv--~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 510 (701)
|...+.+++ ++++. .++..+....+|||||++|++|.+.+..... .+ .+..++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 555555542 33332 2232223456899999999999887643211 11 23456777766 477899988
Q ss_pred CCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 511 ~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
++|+|++|.||+++.++.++|+|||++..+++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=138.71 Aligned_cols=104 Identities=13% Similarity=0.133 Sum_probs=84.8
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCC--CCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhh------cCCe
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNE--TSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFAR------KRIL 91 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~--g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~------~~v~ 91 (701)
..+|||||||||+.|++|+++|++++... +++|++|||.+...............+++++.++..+.. .||+
T Consensus 4 ~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~~~~~~~~~eelle~~~~~~~~~l~~~~~gV~ 83 (357)
T PRK12652 4 AANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPEGQDELAAAEELLERVEVWATEDLGDDASSVT 83 (357)
T ss_pred ccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccchhHHHHHHHHHHHHHHHHHHHhhhcccCCCc
Confidence 45899999999999999999999999874 599999999986422111112225566778888877765 5999
Q ss_pred eeEEEEEc-------CChhHHHHHHHHHcCCCEEEEccC
Q 005343 92 AREVVLQD-------IDVSSALIYYVKNNSVGNIVAGGS 123 (701)
Q Consensus 92 ~~~~v~~~-------~~~~~~Iv~~a~~~~~d~IV~Gs~ 123 (701)
+++.++.+ |+|+++|++||+++++|+||||-.
T Consensus 84 ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 84 IETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred eEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 99988874 799999999999999999999965
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.7e-12 Score=125.37 Aligned_cols=131 Identities=21% Similarity=0.197 Sum_probs=100.6
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEE-EEeceecCCCceEEeecCCCChhhH
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV-ILLGACPEYGCLVYEYMENGSLEDR 477 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~lV~Ey~~~gsL~~~ 477 (701)
.+.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.+++ .+++...+..++||||++|.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 35789999999999999988999998765432 223468899999988655443 4555555567899999999887542
Q ss_pred hcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 478 LFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK--PEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 478 l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
. .. ...++.+++.+|..||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 11 1235779999999999987 23369999999999999 66799999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.6e-12 Score=147.18 Aligned_cols=265 Identities=21% Similarity=0.227 Sum_probs=183.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce--EEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEece--ecCCCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGA--CPEYGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~--vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~--~~~~~~l 464 (701)
..+.|.+.+-+-.|.||.++.+.-.++. .++|+..... ....+....+-.++-..++|.++...-. |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4577888889999999999987654333 3444433221 1122333444444444566777765544 4566689
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|++|+.+++|...|+.-. ..+.+-.......+..+++|||... ++|||++|.|+|...+++.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999998885433 3444444556778899999999988 9999999999999999999999998543321
Q ss_pred ---CCCCc----c---------------c---ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005343 545 ---PSAAD----T---------------I---TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599 (701)
Q Consensus 545 ---~~~~~----~---------------~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf 599 (701)
+.... . . .........||+.|++||...+...+..+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00000 0 0 001234578999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChh---hhhhHHHHHHHhcc
Q 005343 600 GLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLV---SVVLPELIRLRDLG 666 (701)
Q Consensus 600 ~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~---~vl~~~~~~l~~~~ 666 (701)
...... +.+++ .. ..+..+..-|........+++...+..+|..|-.+. ++=-|.|++--++.
T Consensus 1036 na~tpq-~~f~n-i~--~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1036 NAETPQ-QIFEN-IL--NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCcchh-hhhhc-cc--cCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 755432 22211 10 011222233445566789999999999999999887 66667777655544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.8e-12 Score=138.61 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=175.6
Q ss_pred Cceeeeeeee--cCceeEEEEEE--C--CceEEEEEeCCCCC--CChHHHHHHHHHHHhC-CCCcEEEEeceecCCC--c
Q 005343 395 YFSISRKIGE--GGYGPVYKAQL--D--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSM-RHTNMVILLGACPEYG--C 463 (701)
Q Consensus 395 ~f~~~~~IG~--G~fg~Vyk~~~--~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~--~ 463 (701)
.|-+...+|. |.+|.||.+.. . ...+|+|.-+.... .....=.+|+...+++ .|+|.+..+..+.+.. +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3666788999 99999999987 3 34488886433332 2223335677777777 4999999888875543 6
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeec
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT----ALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVG 538 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFG 538 (701)
+-+|++ +.+|..+..... ..++....+.+..+... ||.++|+.+ ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 667777 577877664432 33566667777888888 999999999 9999999999999998 889999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHHHcCccccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM-GLSHQVEQAIRNGTFSEL 617 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~~i~~~~~~~~ 617 (701)
+...+............ ....|...|++||.. .+.++...|+|++|.++.+-.+|-.++ .+.+.....++.+.+.
T Consensus 269 ~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-- 344 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVS-KRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-- 344 (524)
T ss_pred eeEEccCCccccceeee-ecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--
Confidence 99888655422222211 333577789999954 557788999999999999998887443 2211111111111110
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+ .+-......+...+.+|++.+|..|++.+.+..+.+...
T Consensus 345 -~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 -L----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -h----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0 011112234666999999999999999999987766553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.4e-11 Score=136.13 Aligned_cols=144 Identities=20% Similarity=0.266 Sum_probs=92.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--------------------------Ch--------H--
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--------------------------GP--------R-- 434 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--------------------------~~--------~-- 434 (701)
...|+. +.||.|++|.||+|++. ++.||||+.++.... .. +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 78999999999999984 678999999876311 00 1
Q ss_pred ----HHHHHHHHHHhCC----CCcEEEEecee---cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHH-
Q 005343 435 ----QFKQEVEILGSMR----HTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA- 502 (701)
Q Consensus 435 ----~~~~Ei~il~~l~----HpnIv~l~g~~---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a- 502 (701)
.|.+|...+.+++ +.+.+.+-..+ ....+|||||++|+.+.+...-.... ... ..++...+..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~---~~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDM---KLLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCH---HHHHHHHHHHH
Confidence 1344554444442 33334333333 34558999999999997742111111 111 1122222222
Q ss_pred HHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEeeccccccCC
Q 005343 503 LLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDVGLARLVPP 545 (701)
Q Consensus 503 L~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DFGla~~~~~ 545 (701)
+.-+...| ++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22234567 99999999999999887 999999999987754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=113.54 Aligned_cols=140 Identities=24% Similarity=0.322 Sum_probs=108.3
Q ss_pred eeeeecCceeEEEEEECC-ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCC--cEEEEeceecC-----CCceEEeecC
Q 005343 400 RKIGEGGYGPVYKAQLDH-TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHT--NMVILLGACPE-----YGCLVYEYME 470 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~-----~~~lV~Ey~~ 470 (701)
+.||.|.++.||++...+ ..+++|+...... .....+.+|++++..+.+. ++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999876 7899998765432 1345789999999999753 34556666644 4489999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK---------------------------------------- 510 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 510 (701)
|.++.+.+.. ..++...+..++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888775521 34677778888999999999998531
Q ss_pred -------------CCCeeecCCCCCCeeEcC--CCcEEEEeecccccc
Q 005343 511 -------------PEPLVHRDLKPANILLDQ--NYVSKISDVGLARLV 543 (701)
Q Consensus 511 -------------~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~ 543 (701)
+..++|+|+.|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 234799999999999998 677899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.2e-10 Score=110.66 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=95.8
Q ss_pred eeeeeecCceeEEEEEEC--------CceEEEEEeCCCCC---------------------CC-hHHH----HHHHHHHH
Q 005343 399 SRKIGEGGYGPVYKAQLD--------HTSVAIKVLGPDIS---------------------QG-PRQF----KQEVEILG 444 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~--------~~~vAiK~l~~~~~---------------------~~-~~~~----~~Ei~il~ 444 (701)
...||.|.=+.||.|... +..+|||+.+.... .+ ...+ .+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357999999999999764 26799998754210 11 1123 37999998
Q ss_pred hCCC--CcEEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCC
Q 005343 445 SMRH--TNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL-HQNKPEPLVHRDLKP 521 (701)
Q Consensus 445 ~l~H--pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiHrDLKp 521 (701)
++.. -++-..+++ ...+|||||+.++.+..-..+ ...++......+..+++.+|..| |..+ |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 8843 233344433 567899999976544221111 11244455667889999999998 8889 99999999
Q ss_pred CCeeEcCCCcEEEEeecccccc
Q 005343 522 ANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 522 ~NILl~~~~~~KL~DFGla~~~ 543 (701)
.|||++. +.+.|+|||.+...
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeC
Confidence 9999974 67899999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.7e-11 Score=129.60 Aligned_cols=243 Identities=26% Similarity=0.289 Sum_probs=169.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCCCChHH--HHHHHHHHHhC-CCCcEEEEecee--cCCCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDISQGPRQ--FKQEVEILGSM-RHTNMVILLGAC--PEYGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~~~~~~--~~~Ei~il~~l-~HpnIv~l~g~~--~~~~~ 463 (701)
.+.+|..+..||.|.|+.|+....+ +..|++|-+.........+ -..|+-+...+ -|.+++.++..| .++.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567999999999999999998753 4458888766554333222 24455555554 477777766555 34557
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeeccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARL 542 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFGla~~ 542 (701)
+=.||++++++...+. -..-+....++++..|++.++.++|+.. ++|+|+||+||++.++ +..+++|||....
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 8889999999877662 2233566678889999999999999999 9999999999999875 7889999998763
Q ss_pred cCCCCCcccccccccccccCCCc-cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCcc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCY-IDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~ 621 (701)
+... .....-++..| .+|.......+..+.|+||||.-+.+.++|.+.-...... ..+..|.. +.
T Consensus 417 ~~~~--------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-~~i~~~~~-----p~ 482 (524)
T KOG0601|consen 417 LAFS--------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-LTIRSGDT-----PN 482 (524)
T ss_pred ccee--------cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-eeeecccc-----cC
Confidence 3211 11122223334 3566666777899999999999999999998543221111 11112211 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
.+..- ..+..+...+...++..||.+.+...|.
T Consensus 483 ---~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 483 ---LPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ---CCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 12222 5688999999999999999998887654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-09 Score=103.26 Aligned_cols=128 Identities=26% Similarity=0.367 Sum_probs=99.9
Q ss_pred eeeecCceeEEEEEECCceEEEEEeCCCCCCC--------hHHHHHHHHHHHhCCCC--cEEEEeceecCCCceEEeecC
Q 005343 401 KIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--------PRQFKQEVEILGSMRHT--NMVILLGACPEYGCLVYEYME 470 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--------~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~~~lV~Ey~~ 470 (701)
.|++|+=+.+|.+.+.+.++++|.-.+..-.. ...-.+|..++.+++-- +...++++.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999999888788888643332111 12357799999887533 444567777888899999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|..|.+.+... +..++..+-.-+.-||..+ |||+||.++||.+..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888433 2457778888888999999 99999999999998776 89999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=121.50 Aligned_cols=162 Identities=22% Similarity=0.219 Sum_probs=119.9
Q ss_pred CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCCC--ceEEeecCCCChhhHhcccCCCCCCChHHHH
Q 005343 416 DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRF 493 (701)
Q Consensus 416 ~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~ 493 (701)
.+.+|.|.+.............+-+.-|+.++||||+.++..+.... |||+|-+. .|..++.+. ......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHHH
Confidence 45568887776654433455788899999999999999999986655 89999874 566666332 244555
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC
Q 005343 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573 (701)
Q Consensus 494 ~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 573 (701)
-.+.||+.||.|||..+. ++|++|.-+.|+++..|..||++|.++...+.... ......--..|..|+.+..
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCc
Confidence 678999999999985442 99999999999999999999999999875532211 0111122234677776554
Q ss_pred CCCCchhhHHHHHHHHHHHHhC
Q 005343 574 GMLGVKSDLYSLGVVLLQLITA 595 (701)
Q Consensus 574 ~~~~~~sDvwSlGvil~elltG 595 (701)
.. ...|.|-|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 44 346999999999999999
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=129.62 Aligned_cols=126 Identities=15% Similarity=0.188 Sum_probs=103.6
Q ss_pred CCCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEE
Q 005343 19 TANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQ 98 (701)
Q Consensus 19 ~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~ 98 (701)
...++|||+|++++.+.+++++|..++.+.++.+++|||..+.. .....+..+. +.....+|.+.|.+ .+++.
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~----~~~~~~~~~~-l~~~~~lA~~lGa~--~~~~~ 320 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRL----HRLPEKKRRA-ILSALRLAQELGAE--TATLS 320 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCc----CcCCHHHHHH-HHHHHHHHHHcCCE--EEEEe
Confidence 45688999999999999999999999999999999999987521 0112233333 44444588888877 55677
Q ss_pred cCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 99 DIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 99 ~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
|+|++++|++||++++++.||||.++++++ |+.||+++++++.++ ...|+||.
T Consensus 321 ~~dva~~i~~~A~~~~vt~IViG~s~~~~~---~~~~s~~~~l~r~~~-~idi~iv~ 373 (895)
T PRK10490 321 DPAEEKAVLRYAREHNLGKIIIGRRASRRW---WRRESFADRLARLGP-DLDLVIVA 373 (895)
T ss_pred CCCHHHHHHHHHHHhCCCEEEECCCCCCCC---ccCCCHHHHHHHhCC-CCCEEEEe
Confidence 899999999999999999999999999875 444899999999998 89999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-08 Score=107.23 Aligned_cols=211 Identities=20% Similarity=0.253 Sum_probs=147.5
Q ss_pred eeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec-----C-CCceEEeecCC-CChhhHh
Q 005343 408 GPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP-----E-YGCLVYEYMEN-GSLEDRL 478 (701)
Q Consensus 408 g~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-----~-~~~lV~Ey~~~-gsL~~~l 478 (701)
.+.|++.. +|..|++|.++.+..........-+++++++.|+|+|++..+|. + ..+|||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899986 67779999997665555545556688999999999999988764 2 23799999986 6787766
Q ss_pred cccC------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 479 FQKD------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 479 ~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
+... .+...++..++.++.|+..||.++|+.| +--+=|.|.+||++.+..++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 2335778999999999999999999999 888999999999999989999988877665432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHcCccccccCccCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-QVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.. +| +.. -.+-|.=-||.+++-|.||..--...+ .....++ ..
T Consensus 447 ~~------------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------------~I 490 (655)
T KOG3741|consen 447 PT------------------EP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------------RI 490 (655)
T ss_pred CC------------------cc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH-------------Hh
Confidence 10 11 111 124689999999999999963311111 1111011 01
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
-.....++.+++.-....++++ -++.+++-+-
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1233445667777777777776 5666665443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=96.01 Aligned_cols=141 Identities=21% Similarity=0.238 Sum_probs=101.4
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeCCCC--------CCChHHHHHHHHHHHhCCCCcEE--EEeceecCCCceEEe
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDI--------SQGPRQFKQEVEILGSMRHTNMV--ILLGACPEYGCLVYE 467 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv--~l~g~~~~~~~lV~E 467 (701)
.+..|-+|+-+.|+++.+.+..+.||.--... .-......+|+.+|.+++--.|. .++-.-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 56789999999999999999998888432111 01123478899999888633332 222222445689999
Q ss_pred ecCC-CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEEeeccccc
Q 005343 468 YMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---VSKISDVGLARL 542 (701)
Q Consensus 468 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~DFGla~~ 542 (701)
|++| .++.+++........ .......++..|-+.|.-||.++ |||+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 477777765543332 23333678889999999999999 99999999999996443 458999999753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.4e-08 Score=102.80 Aligned_cols=253 Identities=18% Similarity=0.222 Sum_probs=163.9
Q ss_pred eeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEE--------EeceecCC-CceEE
Q 005343 397 SISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVI--------LLGACPEY-GCLVY 466 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~--------l~g~~~~~-~~lV~ 466 (701)
...+.||+|+-+.+|-.--- ...+-|+.+....... .+-+..|... .||-+-. |+|.-... ..+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34678999999999954221 2234566665432222 2223333333 5553322 22222111 24667
Q ss_pred eecCCCChhhHh----cccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 467 EYMENGSLEDRL----FQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 467 Ey~~~gsL~~~l----~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
..+.+.---..+ .++...+...|.-.++.+..++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 766554222222 23456677899999999999999999999999 99999999999999999999887432211
Q ss_pred cCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCc-------hHHHHHH
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITA-RPAMGLS-------HQVEQAI 609 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG-~~pf~~~-------~~~~~~i 609 (701)
..........+|...|.+||... +-.-+...|.|.||+++++||.| +.||.+- ...+..|
T Consensus 167 -------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 167 -------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred -------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 11222346778999999999654 33356789999999999999987 8898643 2345667
Q ss_pred HcCccccccCcc------CCCCCHHH-HHHHHHHHHHhhccC--cCCCCChhhhhhHHHHHHHh
Q 005343 610 RNGTFSELLDPT------VTGWPVEA-ALSIAKLALQCCELR--KRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 610 ~~~~~~~~ld~~------~~~~p~~~-~~~l~~li~~cl~~~--P~~RPt~~~vl~~~~~~l~~ 664 (701)
..|.|..--+.. -..||... +..+..+..+|+... +.-||+...=+ -.+..+++
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~-aAl~al~~ 302 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV-AALDALRQ 302 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHHHHH
Confidence 777765543322 23566554 445888889999853 67899986433 34444433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=7e-08 Score=100.61 Aligned_cols=139 Identities=16% Similarity=0.069 Sum_probs=98.4
Q ss_pred eeeeecCceeEEEEEECCceEEEEEeCCCCCC-----------ChHHHHHHHHHHHhCC-----CCcEEEEece--e--c
Q 005343 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQ-----------GPRQFKQEVEILGSMR-----HTNMVILLGA--C--P 459 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~-----------~~~~~~~Ei~il~~l~-----HpnIv~l~g~--~--~ 459 (701)
+.+-......|+++.+.++.|.||........ ....+.+|...+..|. -|.+|-+... . .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 34444455567788888899999976433211 1114788999887774 3444333211 1 1
Q ss_pred CCCceEEeecCCC-ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-------CCc
Q 005343 460 EYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-------NYV 531 (701)
Q Consensus 460 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-------~~~ 531 (701)
...+||+|++++. +|.+++.... ..+.+...+..++.+++..+.-||..| |+|+|+++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2357999999876 7888874322 234456677789999999999999999 999999999999975 578
Q ss_pred EEEEeeccccc
Q 005343 532 SKISDVGLARL 542 (701)
Q Consensus 532 ~KL~DFGla~~ 542 (701)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=108.06 Aligned_cols=129 Identities=21% Similarity=0.218 Sum_probs=109.1
Q ss_pred cCCCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEE
Q 005343 18 ITANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVL 97 (701)
Q Consensus 18 ~~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~ 97 (701)
+....+|||+|+++..|.+.++||..++.+.++..++|||-.+. . ....+..+..+.....+|.+.| .+.+++
T Consensus 245 ~~~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~-~----~~~~~~~~~~l~~~~~Lae~lG--ae~~~l 317 (890)
T COG2205 245 WAARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPE-L----HRLSEKEARRLHENLRLAEELG--AEIVTL 317 (890)
T ss_pred ccccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccc-c----ccccHHHHHHHHHHHHHHHHhC--CeEEEE
Confidence 34458999999999999999999999999999999999998862 1 1122344556667777777665 456678
Q ss_pred EcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 98 QDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 98 ~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.|++++++|++||..+++..||||.+.++.+.+.|. ||.+.++++.++ ...|++|.
T Consensus 318 ~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~-~~l~~~L~~~~~-~idv~ii~ 373 (890)
T COG2205 318 YGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFK-GSLADRLAREAP-GIDVHIVA 373 (890)
T ss_pred eCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhc-ccHHHHHHhcCC-CceEEEee
Confidence 889999999999999999999999999998888667 999999999998 89999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-07 Score=94.04 Aligned_cols=124 Identities=26% Similarity=0.258 Sum_probs=79.8
Q ss_pred eEEEEEE-CCceEEEEEeCCCCCC----------------------C----hHHHHHHHHHHHhCCCCc--EEEEeceec
Q 005343 409 PVYKAQL-DHTSVAIKVLGPDISQ----------------------G----PRQFKQEVEILGSMRHTN--MVILLGACP 459 (701)
Q Consensus 409 ~Vyk~~~-~~~~vAiK~l~~~~~~----------------------~----~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~ 459 (701)
.||.|.. ++..+|+|+.+..... . .....+|.+.|.++..-+ +-..+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899987 6778999997653110 0 012578999999997653 3444433
Q ss_pred CCCceEEeecC--CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 460 EYGCLVYEYME--NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF-LHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 460 ~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
...+|||||++ |..+.. |.... ++......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 544433 32211 1133455678888886655 57888 9999999999999988 899999
Q ss_pred ecccccc
Q 005343 537 VGLARLV 543 (701)
Q Consensus 537 FGla~~~ 543 (701)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-08 Score=114.08 Aligned_cols=159 Identities=17% Similarity=0.279 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccc---cccccCCCccCccccc
Q 005343 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM---TTAAGTFCYIDPEYQQ 572 (701)
Q Consensus 496 ~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~---~~~~gt~~Y~aPE~~~ 572 (701)
+.+++.||.|+|..- .+||++|.|++|.++.++.+||+.|+++.-..+...-....|.. ........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999764 29999999999999999999999999987654432211111111 1233456899999999
Q ss_pred CCCCCchhhHHHHHHHHHHHH-hCCCCCCCchH-HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC
Q 005343 573 TGMLGVKSDLYSLGVVLLQLI-TARPAMGLSHQ-VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650 (701)
Q Consensus 573 ~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~-~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt 650 (701)
....+.++|+||+||++|.+. .|++-+..... .......+ .++...-..+...+.++.+=+.+++..++.-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 988999999999999999999 56655533211 11111111 1112222333455567889999999999999998
Q ss_pred hhhhhhHHHH
Q 005343 651 LVSVVLPELI 660 (701)
Q Consensus 651 ~~~vl~~~~~ 660 (701)
+..+..-+++
T Consensus 259 ~~~l~~~~ff 268 (700)
T KOG2137|consen 259 LDLLLSIPFF 268 (700)
T ss_pred hhhhhccccc
Confidence 8777644443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.5e-07 Score=88.74 Aligned_cols=105 Identities=25% Similarity=0.252 Sum_probs=78.5
Q ss_pred hHHHHHHHHHHHhCCC-----CcEEEEecee---cCCCceEEeecCCC-ChhhHhcccCCCCCCChHHHHHHHHHHHHHH
Q 005343 433 PRQFKQEVEILGSMRH-----TNMVILLGAC---PEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503 (701)
Q Consensus 433 ~~~~~~Ei~il~~l~H-----pnIv~l~g~~---~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 503 (701)
.....+|...+..|.. |..+-+...- ....+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3457888888877743 3333332110 12237999999884 78888854222 45566778999999999
Q ss_pred HHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEEeecccccc
Q 005343 504 LFLHQNKPEPLVHRDLKPANILLDQNY---VSKISDVGLARLV 543 (701)
Q Consensus 504 ~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~DFGla~~~ 543 (701)
.-||..| |+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998876 8899999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.5e-06 Score=83.93 Aligned_cols=136 Identities=16% Similarity=0.143 Sum_probs=101.3
Q ss_pred eeecCceeEEEEEECCceEEEEEeCCCC------CCChHHHHHHHHHHHhCCCCc--EEEEeceec---C----CCceEE
Q 005343 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDI------SQGPRQFKQEVEILGSMRHTN--MVILLGACP---E----YGCLVY 466 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~~~~vAiK~l~~~~------~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~---~----~~~lV~ 466 (701)
-|+||-+-|+...+.+..+-+|.-.... ......|.+|+..|..|..-+ +.... ++. . ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 5779999999999888888888654221 124467999999999885322 22222 221 1 237999
Q ss_pred eecCC-CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc--EEEEeeccccc
Q 005343 467 EYMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV--SKISDVGLARL 542 (701)
Q Consensus 467 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--~KL~DFGla~~ 542 (701)
|-+.| -+|.+++... ...+.+...+..++.+|+..|.-||..| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98754 5788877443 2335677778899999999999999999 999999999999986666 89999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.1e-06 Score=89.61 Aligned_cols=135 Identities=22% Similarity=0.146 Sum_probs=93.4
Q ss_pred CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC----------------------ChHHHHHHHHHHHhCCCC--
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ----------------------GPRQFKQEVEILGSMRHT-- 449 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~----------------------~~~~~~~Ei~il~~l~Hp-- 449 (701)
-+.+..+||-|.=|.||.|.. ++.++|||..+..... .....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356778999999999999998 5888999986432110 112367899999888543
Q ss_pred cEEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 450 NMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 450 nIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
.+..-++ .+..++||||++|-.|...- +..+..-.|+..|++-+.-+-..| |||+|+++-|||++.+
T Consensus 172 ~VP~P~~--~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIA--WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCccc--cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 2222222 23447999999886554321 112223345555665555555778 9999999999999999
Q ss_pred CcEEEEeeccccc
Q 005343 530 YVSKISDVGLARL 542 (701)
Q Consensus 530 ~~~KL~DFGla~~ 542 (701)
|.+.++||-.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-05 Score=78.34 Aligned_cols=105 Identities=23% Similarity=0.234 Sum_probs=85.0
Q ss_pred HHHHHHHHhCCC-CcEEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCee
Q 005343 437 KQEVEILGSMRH-TNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515 (701)
Q Consensus 437 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ii 515 (701)
..|.-+|..+.+ +++.+++|+|++ .+|.||...+++...-..-......+|..|.+||.+++..+.+|+.....++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 458888888876 699999999954 68999998777653211111223468999999999999999999987666799
Q ss_pred ecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 516 HRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 516 HrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
-.|++|+|+-++++|.+|+.|...+-..
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 9999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.2e-06 Score=83.03 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=93.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHH---------HHHHHHHHHhCCCC---cEEEEece--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQ---------FKQEVEILGSMRHT---NMVILLGA-- 457 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~---------~~~Ei~il~~l~Hp---nIv~l~g~-- 457 (701)
..++|.+.+.+-......|.+-..+++.+.+|..+.......+. ..+.+..+.+++.. ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46789999999988899999999999999999876654222222 23344433333221 11111111
Q ss_pred -----ecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 458 -----CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 458 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
+....+|+|||++|..|.+... ++. .++..+..++.-||..| ++|+|..|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1233468999999988876531 222 25567888899999999 99999999999999766 8
Q ss_pred EEEeecccc
Q 005343 533 KISDVGLAR 541 (701)
Q Consensus 533 KL~DFGla~ 541 (701)
++.||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=81.83 Aligned_cols=152 Identities=23% Similarity=0.244 Sum_probs=95.4
Q ss_pred ccCHHHHHHhhcCceeeeeee---ecCceeEEEEEE-CCceEEEEEeCCCCCCCh-------------------HH----
Q 005343 383 KYTIEEIEAATDYFSISRKIG---EGGYGPVYKAQL-DHTSVAIKVLGPDISQGP-------------------RQ---- 435 (701)
Q Consensus 383 ~~~~~ei~~~~~~f~~~~~IG---~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~-------------------~~---- 435 (701)
..+.+.+....+...+....| .|.-..||+|.. ++..+|+|+++....... ++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 344555555666666655555 566678999886 577899999875432211 11
Q ss_pred -HHHHHHHHHhCCCCcE--EEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCC
Q 005343 436 -FKQEVEILGSMRHTNM--VILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKP 511 (701)
Q Consensus 436 -~~~Ei~il~~l~HpnI--v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~ 511 (701)
..+|+.-|+++..-.| -.-++ .....|||||+....+ -...-...++.......+..+++..+.-|-. .+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~--~~~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIA--FRNNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcee--ecCCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 2456666666532211 11111 1245799999943210 1111111223333566778888888888776 77
Q ss_pred CCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 512 ~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||+||+.-|||+. ++.+.|+|||.|...
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 788999999988654
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.1e-06 Score=71.59 Aligned_cols=84 Identities=17% Similarity=0.126 Sum_probs=72.8
Q ss_pred EEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcCChh
Q 005343 24 TAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQDIDVS 103 (701)
Q Consensus 24 IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~~~~ 103 (701)
|+||++|+..|..++.||.... ..+..++++|+. ...
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~------------------------------------------~~~ 37 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV------------------------------------------AFV 37 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH------------------------------------------HHH
Confidence 6899999999999999999976 446678888876 456
Q ss_pred HHHHHHHHHcCCCEEEEccCCCCcccccccCC-CcchhhcccCCCceeEEE
Q 005343 104 SALIYYVKNNSVGNIVAGGSSRNLLTRKFRNL-DLPSSLLKSAPESCAVYI 153 (701)
Q Consensus 104 ~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~g-Sva~~v~~~ap~~c~V~v 153 (701)
+.+.++|++.++|+||+|+++.....+.+. | +++.++++.++ |||+.
T Consensus 38 ~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~-~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 38 RILKRLAAEEGADVIILGHNADDVAGRRLG-ASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred HHHHHHHHHcCCCEEEEcCCchhhhhhccC-chhhhhhcccccC--CceeC
Confidence 778899999999999999999998888555 7 99999999998 99874
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.8e-05 Score=80.77 Aligned_cols=138 Identities=16% Similarity=0.210 Sum_probs=79.2
Q ss_pred eeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE--EEEecee--cCCCceEEeecCCCC-h
Q 005343 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM--VILLGAC--PEYGCLVYEYMENGS-L 474 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~--~~~~~lV~Ey~~~gs-L 474 (701)
..||.|..+.||+. .+..+++|..... .......+|.+++..+..-.+ ...++++ .+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57999999999984 3456788887653 344567899999988753222 3334443 333478999998863 2
Q ss_pred hhHh--------------cc-----cCC-CCCCChHHH-HHHHH----------HHHH-HHHHHhhc-CCCCeeecCCCC
Q 005343 475 EDRL--------------FQ-----KDN-SPPIHWSIR-FKIAA----------EIAT-ALLFLHQN-KPEPLVHRDLKP 521 (701)
Q Consensus 475 ~~~l--------------~~-----~~~-~~~l~~~~~-~~i~~----------qia~-aL~~LH~~-~~~~iiHrDLKp 521 (701)
...+ .. +.. ....+.... ..+.. .+.. ...+|... .+..++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00 000 001111110 00100 0111 12222211 122478999999
Q ss_pred CCeeEcCCCcEEEEeeccccc
Q 005343 522 ANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 522 ~NILl~~~~~~KL~DFGla~~ 542 (701)
.||+++.++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1e-05 Score=81.64 Aligned_cols=142 Identities=24% Similarity=0.291 Sum_probs=83.6
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC--cEEEEecee---c--CCCceEEeecCC
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT--NMVILLGAC---P--EYGCLVYEYMEN 471 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~---~--~~~~lV~Ey~~~ 471 (701)
++.|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+..++..+ . ...+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 467999999999999998888999997654 3456688899998887432 233444422 1 123789999999
Q ss_pred CChhh----------------Hhc---cc-CCCCCCChHHH---------HHH------------HHHHHH-HHHHHhhc
Q 005343 472 GSLED----------------RLF---QK-DNSPPIHWSIR---------FKI------------AAEIAT-ALLFLHQN 509 (701)
Q Consensus 472 gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~~LH~~ 509 (701)
..+.. .+. .. ....++.+... ... ...+.. .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 111 11 01111111110 000 111222 33344432
Q ss_pred ----CCCCeeecCCCCCCeeEc-CCCcEEEEeeccccc
Q 005343 510 ----KPEPLVHRDLKPANILLD-QNYVSKISDVGLARL 542 (701)
Q Consensus 510 ----~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~ 542 (701)
.+..++|+|+.|.|||++ .++.+-|.||+.+.+
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 334599999999999999 666668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-05 Score=90.53 Aligned_cols=138 Identities=21% Similarity=0.281 Sum_probs=91.1
Q ss_pred eeeeecCceeEEEEEEC-CceEEEEEeCCCCCCCh--------------------------H----H----------HHH
Q 005343 400 RKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGP--------------------------R----Q----------FKQ 438 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~--------------------------~----~----------~~~ 438 (701)
..|+.++-|.||+|++. |..||||+.+++..... . + +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999996 78899999887632211 0 0 233
Q ss_pred HHHHHHhCC-----CCcEE--EEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHH-HHHhhcC
Q 005343 439 EVEILGSMR-----HTNMV--ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL-LFLHQNK 510 (701)
Q Consensus 439 Ei~il~~l~-----HpnIv--~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~ 510 (701)
|..-+.+++ .|++. +++--+.....|+|||++|-.+.+....+. ..++. ..|+..++.+. .-+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence 444443332 23332 222222345589999999998888753322 22332 23444444442 2222356
Q ss_pred CCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 511 ~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
++|.|..|.||+++.+|.+-+.|||+...+++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3e-05 Score=79.76 Aligned_cols=139 Identities=15% Similarity=0.136 Sum_probs=81.9
Q ss_pred eeeecCc-eeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecC--CCceEEeecCCCChhh
Q 005343 401 KIGEGGY-GPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPE--YGCLVYEYMENGSLED 476 (701)
Q Consensus 401 ~IG~G~f-g~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~ 476 (701)
.|-.|.+ ..||+....+..+.+|+..... ...+.+|++++..+. +--+.++++++.. ..++|||+++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3445555 7899998877778888875432 345778999988874 2223355555543 4689999999887764
Q ss_pred Hhc-------------------ccCC-CCCCChH--HHHHHHH--------------------HHHHHHHHHhhc----C
Q 005343 477 RLF-------------------QKDN-SPPIHWS--IRFKIAA--------------------EIATALLFLHQN----K 510 (701)
Q Consensus 477 ~l~-------------------~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~~LH~~----~ 510 (701)
... .... ..++... .+..... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0000 0011100 0000000 011112222111 1
Q ss_pred CCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 511 ~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.8e-05 Score=74.68 Aligned_cols=128 Identities=18% Similarity=0.200 Sum_probs=91.5
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEE-EeceecCCCceEEeecCCCChhh
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI-LLGACPEYGCLVYEYMENGSLED 476 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~~~lV~Ey~~~gsL~~ 476 (701)
..+.||+|.+|.||+|.+.+..+|+|+-..+ .....+..|.++|..+.--++.+ +|.+ +..++.|||+.|-.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCcchhh
Confidence 3567999999999999999999999998765 34567899999998887665543 3322 22356699999888876
Q ss_pred HhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC-CCCeeEcCCCcEEEEeeccccc
Q 005343 477 RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK-PANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 477 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLK-p~NILl~~~~~~KL~DFGla~~ 542 (701)
.-... ... -...+++.-.-|...| |-|..|. |..++|.+++.+.|+||.-|..
T Consensus 102 ~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54211 122 2345566645566778 9999997 5444454555899999998863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.3e-07 Score=99.89 Aligned_cols=188 Identities=19% Similarity=0.152 Sum_probs=131.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCce-EEEEEeCCCCCCChHHHHHHHHHHHhCCCCc-EEEEecee--cCCCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS-VAIKVLGPDISQGPRQFKQEVEILGSMRHTN-MVILLGAC--PEYGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~-vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~--~~~~~lV~E 467 (701)
.+..|.....+++|+++.+||.+...+. ...+++... ....-++++|.+++||| .+..++-+ .++..++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 4445555667899999999998764433 334444332 44567899999999999 55555555 334578999
Q ss_pred ecCCC-ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 468 YMENG-SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|+.+| +..+.. ......+..-+...+...-+.+|++||+.- =+||| |||..+ +..|.+||+....+...
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 221111 011111233334455666678899999864 58999 887766 56799999988766432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGL 601 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 601 (701)
. ......+|+.+++||....+.+....|+|++|+--.+|--|-+|-..
T Consensus 385 ~-------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 M-------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c-------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 1 34677899999999999999999999999999877788878777543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.2e-05 Score=89.61 Aligned_cols=147 Identities=20% Similarity=0.331 Sum_probs=91.3
Q ss_pred eeeeeecCceeEEEEEECC----ceEEEEEeCCCCC-CChHHHHHHHHHHHhCC-CCcE--EEEeceecC-----CCceE
Q 005343 399 SRKIGEGGYGPVYKAQLDH----TSVAIKVLGPDIS-QGPRQFKQEVEILGSMR-HTNM--VILLGACPE-----YGCLV 465 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~----~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~-----~~~lV 465 (701)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |+++ ..++++|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5678999999999988754 3577776544321 23456899999999995 6654 667777754 35899
Q ss_pred EeecCCCChhh--------------------Hh---cccCC--------CCCCCh--HHHHHHH---------------H
Q 005343 466 YEYMENGSLED--------------------RL---FQKDN--------SPPIHW--SIRFKIA---------------A 497 (701)
Q Consensus 466 ~Ey~~~gsL~~--------------------~l---~~~~~--------~~~l~~--~~~~~i~---------------~ 497 (701)
|||++|..+.+ .| +.-.. ..+..+ .+..++. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764322 11 11000 001111 1111111 1
Q ss_pred HHHHHHHHHhhcCCC--------CeeecCCCCCCeeEcC--CCcEEEEeeccccccCC
Q 005343 498 EIATALLFLHQNKPE--------PLVHRDLKPANILLDQ--NYVSKISDVGLARLVPP 545 (701)
Q Consensus 498 qia~aL~~LH~~~~~--------~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~ 545 (701)
.+...+.+|..+-|. .+||+|+++.|||++. ...+-|.||+++.+-++
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 123345677554442 3999999999999975 33457999999876443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=5.7e-05 Score=85.26 Aligned_cols=138 Identities=20% Similarity=0.262 Sum_probs=89.9
Q ss_pred eeeeecCceeEEEEEE-CCceEEEEEeCCCCCCCh-------------------------------H------HHHHHHH
Q 005343 400 RKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGP-------------------------------R------QFKQEVE 441 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~-------------------------------~------~~~~Ei~ 441 (701)
+.||.-+.|.||+|+. ++..||||+-++...... + .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999998 556699999877543220 0 1334443
Q ss_pred HHHh----CCCCc------EEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHH-HhhcC
Q 005343 442 ILGS----MRHTN------MVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF-LHQNK 510 (701)
Q Consensus 442 il~~----l~Hpn------Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~ 510 (701)
-..+ +.|-+ |-++|-.+.....|+||||+|..+.|...-... .++.. .|+..+.++... |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence 3322 23444 333444444556899999999888776433222 23434 344445444222 22345
Q ss_pred CCCeeecCCCCCCeeEc----CCCcEEEEeeccccccCC
Q 005343 511 PEPLVHRDLKPANILLD----QNYVSKISDVGLARLVPP 545 (701)
Q Consensus 511 ~~~iiHrDLKp~NILl~----~~~~~KL~DFGla~~~~~ 545 (701)
++|.|-.|.|||+. .++.+.+-|||+...++.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 378899999999887643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.8e-05 Score=75.61 Aligned_cols=72 Identities=15% Similarity=0.268 Sum_probs=44.6
Q ss_pred eeeeeecCce-eEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC---cEEEEecee--cC---CCceEEeec
Q 005343 399 SRKIGEGGYG-PVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT---NMVILLGAC--PE---YGCLVYEYM 469 (701)
Q Consensus 399 ~~~IG~G~fg-~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~--~~---~~~lV~Ey~ 469 (701)
++.|+.||.. .||+. +..+++|+.... .....+.+|.++|..+... .+-..++.. .+ ..+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567877776 59975 345777875432 2345789999999777421 122233322 22 237899999
Q ss_pred CCCChh
Q 005343 470 ENGSLE 475 (701)
Q Consensus 470 ~~gsL~ 475 (701)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00022 Score=72.71 Aligned_cols=141 Identities=18% Similarity=0.278 Sum_probs=81.5
Q ss_pred eeeeeecCceeEEEEEEC---CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEeecCCCCh
Q 005343 399 SRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEYMENGSL 474 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL 474 (701)
++.|..|-...+|+.... +..|++|+..... ...-...+|+.++..+...++ .++++.+. ..++|||++|.++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l 79 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTL 79 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcC
Confidence 356777888899999875 4678999775432 111233578888888853333 34444443 3589999998765
Q ss_pred hhH----------h-------cccCCC--------CCC-ChHHHHHHHH----------------------HHHHHHHH-
Q 005343 475 EDR----------L-------FQKDNS--------PPI-HWSIRFKIAA----------------------EIATALLF- 505 (701)
Q Consensus 475 ~~~----------l-------~~~~~~--------~~l-~~~~~~~i~~----------------------qia~aL~~- 505 (701)
... + +..... ... .+..+..+.. .+...+..
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 1 111111 011 1222112211 11111112
Q ss_pred ---Hhhc-CCCCeeecCCCCCCeeEcC-CCcEEEEeeccccc
Q 005343 506 ---LHQN-KPEPLVHRDLKPANILLDQ-NYVSKISDVGLARL 542 (701)
Q Consensus 506 ---LH~~-~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~ 542 (701)
+-.. .+..++|+|+.|.|||++. ++.+.|+||..|.+
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2211 2334899999999999998 57899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00013 Score=75.82 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=78.9
Q ss_pred eeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEE-EEeceecCCCceEEeecCCCChhhH---
Q 005343 402 IGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV-ILLGACPEYGCLVYEYMENGSLEDR--- 477 (701)
Q Consensus 402 IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~lV~Ey~~~gsL~~~--- 477 (701)
+..|-.+.+|+....+..+++|+.......-.-...+|..+++.+....++ .+++.+ ..++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCccccccccc
Confidence 456778899999887778999876543222112357899999888543222 233333 35799999998665321
Q ss_pred --------------hcccC-CCCCCChHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeeecCCCCCCeeEc
Q 005343 478 --------------LFQKD-NSPPIHWSIR-FKIAAEI---------ATALLFLHQN-----KPEPLVHRDLKPANILLD 527 (701)
Q Consensus 478 --------------l~~~~-~~~~l~~~~~-~~i~~qi---------a~aL~~LH~~-----~~~~iiHrDLKp~NILl~ 527 (701)
|+... ...+++...+ ..+..++ ...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 0111222111 1111111 1112222111 122489999999999999
Q ss_pred CCCcEEEEeeccccc
Q 005343 528 QNYVSKISDVGLARL 542 (701)
Q Consensus 528 ~~~~~KL~DFGla~~ 542 (701)
.++ +.|+||+.|..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 887 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00012 Score=87.12 Aligned_cols=200 Identities=19% Similarity=0.166 Sum_probs=139.6
Q ss_pred HHHHHHHHHhCCCCcEEEEeceecCCC------ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc
Q 005343 436 FKQEVEILGSMRHTNMVILLGACPEYG------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509 (701)
Q Consensus 436 ~~~Ei~il~~l~HpnIv~l~g~~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 509 (701)
...|+..+..+.|+|++.++++..+.. .+..+|+..-++...+ ......+..+.+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677788889999999888763322 2345788887877766 3445678888888999999999999998
Q ss_pred CCCCeeecCCCCC---CeeEcCCCcEEEE--eeccccccCCCCCcccccccccccccCCCccCcccccCCCCCc--hhhH
Q 005343 510 KPEPLVHRDLKPA---NILLDQNYVSKIS--DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGV--KSDL 582 (701)
Q Consensus 510 ~~~~iiHrDLKp~---NILl~~~~~~KL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~--~sDv 582 (701)
. ..|.-|..+ +...+..+.+.++ ||+....++.... .....-+..|.+||......+.. ..|+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-------SFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc-------chhhcCccccccccccccccchhhhhhHH
Confidence 6 666655555 5555666777777 8888776543221 12223445577788766666544 4799
Q ss_pred HHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 583 YSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 583 wSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|.+|..+..+..|..+-.....+.. +++... ...+..+...|+.-++++|+...+++.|++.+.
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~~---------~l~~~~-------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPVS---------LLDVLS-------TSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchhh---------hhcccc-------chhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9999999999998866432222111 111111 114678899999999999999999999999886
Q ss_pred Hh
Q 005343 663 RD 664 (701)
Q Consensus 663 ~~ 664 (701)
..
T Consensus 440 ~~ 441 (1351)
T KOG1035|consen 440 PT 441 (1351)
T ss_pred cc
Confidence 43
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00068 Score=74.61 Aligned_cols=75 Identities=20% Similarity=0.197 Sum_probs=55.6
Q ss_pred eeeeeecCceeEEEEEECCc--eEEEEEeCCCC-------CCChHHHHHHHHHHHhCC---CCcEEEEeceecCCCceEE
Q 005343 399 SRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI-------SQGPRQFKQEVEILGSMR---HTNMVILLGACPEYGCLVY 466 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~-------~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~lV~ 466 (701)
.+.||.|.+..||++...+. .|+||.-.+.. ......+..|.+.|..+. -.++..++.+..+..++||
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM 110 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM 110 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence 36799999999999998653 79999854221 124566788888888763 3456778888777789999
Q ss_pred eecCCCC
Q 005343 467 EYMENGS 473 (701)
Q Consensus 467 Ey~~~gs 473 (701)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00062 Score=72.42 Aligned_cols=74 Identities=16% Similarity=0.127 Sum_probs=54.0
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCC---CcEEEEeceec-----CCCceEEeecC
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRH---TNMVILLGACP-----EYGCLVYEYME 470 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~-----~~~~lV~Ey~~ 470 (701)
.+.||.|..+.||.....+..+.+|..+. ......+..|...|+.|.- ..+.++++.|. ...+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46799999999999987655677787533 1234578999999988843 34566776653 33589999999
Q ss_pred CCCh
Q 005343 471 NGSL 474 (701)
Q Consensus 471 ~gsL 474 (701)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00064 Score=67.41 Aligned_cols=123 Identities=22% Similarity=0.366 Sum_probs=89.3
Q ss_pred cCceeeeeeeecCc-eeEEEEEECCceEEEEEeCC---CCC------------------CChHHHHHHHHHHHhCC---C
Q 005343 394 DYFSISRKIGEGGY-GPVYKAQLDHTSVAIKVLGP---DIS------------------QGPRQFKQEVEILGSMR---H 448 (701)
Q Consensus 394 ~~f~~~~~IG~G~f-g~Vyk~~~~~~~vAiK~l~~---~~~------------------~~~~~~~~Ei~il~~l~---H 448 (701)
..++.++.||.|.- |.||++...+..+|+|++.. ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 99999999999999999322 110 01123788998887774 4
Q ss_pred CcE--EEEecee--c-CC-----------------CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHH
Q 005343 449 TNM--VILLGAC--P-EY-----------------GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506 (701)
Q Consensus 449 pnI--v~l~g~~--~-~~-----------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L 506 (701)
.++ |+.+|+. . +. ..||.||.+... .+... -+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHHH
Confidence 455 7888875 1 00 036777775532 12222 356788889999
Q ss_pred hhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 507 H~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
|..| |+-+|+++.|.. + -||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc---C--CEEEecccC
Confidence 9999 999999999986 3 389999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0014 Score=70.34 Aligned_cols=139 Identities=16% Similarity=0.209 Sum_probs=77.2
Q ss_pred eeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhC-----CCCcEEEE-----eceecCCCceEEeec
Q 005343 400 RKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM-----RHTNMVIL-----LGACPEYGCLVYEYM 469 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l-----~g~~~~~~~lV~Ey~ 469 (701)
+.|+.|....+|+....+..+++|++. . .....+..|+.++..| .-|.++.- +.......+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 456677778999998777789999876 2 2234444555555554 34444431 111233457999999
Q ss_pred CCCChh-----------hHh---cccCC--------CCCCCh-HHHHH------------HHHH-HHHHHHHHhhc----
Q 005343 470 ENGSLE-----------DRL---FQKDN--------SPPIHW-SIRFK------------IAAE-IATALLFLHQN---- 509 (701)
Q Consensus 470 ~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~------------i~~q-ia~aL~~LH~~---- 509 (701)
+|..+. ..| +.... ...+.| ..... .+.+ +...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 886431 111 11000 001112 11111 1111 11122333211
Q ss_pred CCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 510 ~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
-|..+||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977767899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00056 Score=72.42 Aligned_cols=141 Identities=16% Similarity=0.190 Sum_probs=85.4
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc--EEEEece--------ecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--MVILLGA--------CPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~--------~~~~~~lV~Ey 468 (701)
.+.|..|....+|+...++..+++|+... .....+..|+.++..+.+.. +..++.. ..+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45677787889999988777899998764 33456777888887774322 3333322 12334789999
Q ss_pred cCCCChhh-----------H---hccc----CCC----CCCChHHHH----------HHHHHHHHHHHHHhh----cCCC
Q 005343 469 MENGSLED-----------R---LFQK----DNS----PPIHWSIRF----------KIAAEIATALLFLHQ----NKPE 512 (701)
Q Consensus 469 ~~~gsL~~-----------~---l~~~----~~~----~~l~~~~~~----------~i~~qia~aL~~LH~----~~~~ 512 (701)
++|..+.. . ++.. ... ....|.... .....+..++.++.. .-+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98866532 0 0100 000 011222110 011123344555543 1233
Q ss_pred CeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 513 PLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 513 ~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
.++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 499999999999999988889999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=8.3e-05 Score=90.12 Aligned_cols=175 Identities=14% Similarity=0.054 Sum_probs=125.8
Q ss_pred EEEEEeCCCCCCCh-----HHHHHHHHHHHhCCCCcEEEEeceecC----CCceEEeecCCCChhhHhccc-CCCCCCCh
Q 005343 420 VAIKVLGPDISQGP-----RQFKQEVEILGSMRHTNMVILLGACPE----YGCLVYEYMENGSLEDRLFQK-DNSPPIHW 489 (701)
Q Consensus 420 vAiK~l~~~~~~~~-----~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~ 489 (701)
+.+++.+...-+.. +....|.+.++...|++++..+.-.++ ..+.+++|+.+|.+.+.+.+. ...+++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45666544332222 223455556667789998877655432 337899999999999988764 34445555
Q ss_pred HHHHHHHHHHHHHHHHHhhc--CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccC
Q 005343 490 SIRFKIAAEIATALLFLHQN--KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567 (701)
Q Consensus 490 ~~~~~i~~qia~aL~~LH~~--~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~a 567 (701)
.-+.....+...+..-+|+. ++..-+|++||+.|.++..++.+|++++|+.+...+. .......++++.|+.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~------~sf~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV------LSFFGLELCSPIYVL 1408 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch------HhhhhhhhCCHHHHH
Confidence 55554445546666665543 3345799999999999999999999999999843221 112356678889999
Q ss_pred cccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005343 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMG 600 (701)
Q Consensus 568 PE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 600 (701)
|++...-.++.++|+|..|+-+|.+--|.++|-
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999998899999999999999999999988873
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0018 Score=64.56 Aligned_cols=132 Identities=25% Similarity=0.349 Sum_probs=89.2
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCC----------------CCChHHHHHHHHHHHhCC------CCcEEEEec
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDI----------------SQGPRQFKQEVEILGSMR------HTNMVILLG 456 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~----------------~~~~~~~~~Ei~il~~l~------HpnIv~l~g 456 (701)
...||+|+.-.||.-- .+....||+..... ....++..+|+.-...+. +.+|..++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3579999999998522 34457889987765 223456777877776666 778889999
Q ss_pred eecCCC--ceEEeecCC------CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC
Q 005343 457 ACPEYG--CLVYEYMEN------GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ 528 (701)
Q Consensus 457 ~~~~~~--~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~ 528 (701)
+...+. .+|+|.+.+ -+|.+++... .++. . +...+-.-..||-.++ |+.+||+|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 986544 688887642 3577777322 3444 2 3334445556777778 999999999999953
Q ss_pred C---C-cEEEEe-eccccc
Q 005343 529 N---Y-VSKISD-VGLARL 542 (701)
Q Consensus 529 ~---~-~~KL~D-FGla~~ 542 (701)
+ . .+.|.| ||-..+
T Consensus 154 ~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred cCCCceEEEEEeCCCCccc
Confidence 2 2 567777 565443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0037 Score=66.73 Aligned_cols=141 Identities=17% Similarity=0.227 Sum_probs=81.9
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc--EEEEecee--------cCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--MVILLGAC--------PEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~--------~~~~~lV~Ey 468 (701)
...++.|....+|+...++..+++|+.... .....+..|++++..|.... +..++... .+..+++|+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 456777777899998877667889987653 22445667777777763222 22322221 2234789999
Q ss_pred cCCCChhh-----------H---hcccCCC--C-------CCChHHHH------------HHHHHHHHHHHHHhh----c
Q 005343 469 MENGSLED-----------R---LFQKDNS--P-------PIHWSIRF------------KIAAEIATALLFLHQ----N 509 (701)
Q Consensus 469 ~~~gsL~~-----------~---l~~~~~~--~-------~l~~~~~~------------~i~~qia~aL~~LH~----~ 509 (701)
++|..+.. . ++..... . .-.|.... .....+...+.+|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98854321 1 1110000 0 01111110 001123344555543 2
Q ss_pred CCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 510 ~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
-+..++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23459999999999999998877999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=69.19 Aligned_cols=140 Identities=23% Similarity=0.303 Sum_probs=82.7
Q ss_pred eeeeecCceeEEEEEECC--------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEE-EEeceecCCCceEEeecC
Q 005343 400 RKIGEGGYGPVYKAQLDH--------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV-ILLGACPEYGCLVYEYME 470 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~--------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~lV~Ey~~ 470 (701)
+.|..|-...||+....+ ..+++|+..... .......+|..++..+....+. ++++++. ..+|+||++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 456666677999988753 578999976543 2234567888888887533332 4455553 357899998
Q ss_pred CCChhhHh-----------------cccCCCC------CCC--hHHHHH--------------------------HHHHH
Q 005343 471 NGSLEDRL-----------------FQKDNSP------PIH--WSIRFK--------------------------IAAEI 499 (701)
Q Consensus 471 ~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~qi 499 (701)
|..+.... +...... ..+ |..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 87664311 1111100 010 111111 11122
Q ss_pred HHHHHHHhh------cCCCCeeecCCCCCCeeEcCC----CcEEEEeeccccc
Q 005343 500 ATALLFLHQ------NKPEPLVHRDLKPANILLDQN----YVSKISDVGLARL 542 (701)
Q Consensus 500 a~aL~~LH~------~~~~~iiHrDLKp~NILl~~~----~~~KL~DFGla~~ 542 (701)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 223444432 134458999999999999974 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0031 Score=69.26 Aligned_cols=80 Identities=19% Similarity=0.145 Sum_probs=56.9
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCC-------CChHHHHHHHHHHHhCC---CCcEEEEeceecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS-------QGPRQFKQEVEILGSMR---HTNMVILLGACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~-------~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~lV~Ey 468 (701)
.+.||.|-...||+....+..++||.-..... ........|.+.|..+. ..++.+++.++.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 56789999999999988777799997542211 13344455677776664 246778999999999999999
Q ss_pred cCC--CChhhHh
Q 005343 469 MEN--GSLEDRL 478 (701)
Q Consensus 469 ~~~--gsL~~~l 478 (701)
+++ ..+.+.+
T Consensus 117 L~~~~~ilr~~L 128 (418)
T PLN02756 117 LEPPHIILRKGL 128 (418)
T ss_pred cCCcceehhhhh
Confidence 976 2444433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0068 Score=65.86 Aligned_cols=142 Identities=18% Similarity=0.224 Sum_probs=81.8
Q ss_pred eeeeeecCceeEEEEEEC------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEE-EEeceecCCCceEEeecCC
Q 005343 399 SRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV-ILLGACPEYGCLVYEYMEN 471 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~lV~Ey~~~ 471 (701)
...|-.|-...+|++... +..|++|+.......... -.+|..++..+..-++- ++++.+... .|++|+++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g 117 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHA 117 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCC
Confidence 345555778899998753 246899987665322222 37788888888543333 445655433 78999987
Q ss_pred CChhhH-----------------hcccCC-C-C-CCChHHHHHHHHHH-----------------HHHHHHH----hh-c
Q 005343 472 GSLEDR-----------------LFQKDN-S-P-PIHWSIRFKIAAEI-----------------ATALLFL----HQ-N 509 (701)
Q Consensus 472 gsL~~~-----------------l~~~~~-~-~-~l~~~~~~~i~~qi-----------------a~aL~~L----H~-~ 509 (701)
.+|... ++.... . . +..+.....+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665321 111110 0 0 11223332332111 1112222 21 1
Q ss_pred CCCCeeecCCCCCCeeEcC-CCcEEEEeecccccc
Q 005343 510 KPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLV 543 (701)
Q Consensus 510 ~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~ 543 (701)
.+..++|+|+++.|||+++ ++.+.|+||..|.+-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2234899999999999986 578999999988643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0083 Score=63.97 Aligned_cols=146 Identities=21% Similarity=0.287 Sum_probs=81.9
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCC--CCCCChHHHHHHHHHHHhCCC--CcEEEEeceecCCC----ceEEeecC
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGP--DISQGPRQFKQEVEILGSMRH--TNMVILLGACPEYG----CLVYEYME 470 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~--~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~----~lV~Ey~~ 470 (701)
.+.+-.|--..+|.....++.+++. ... ..........+|..+|+.+.- .-+-..++.|.+.. +.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3344333333555555556677777 321 112334457888888888743 22345577776655 89999998
Q ss_pred CCChhhHhcccCCC-----------------------CC------CChHHHHHHHHH--------------HHHHHHHHh
Q 005343 471 NGSLEDRLFQKDNS-----------------------PP------IHWSIRFKIAAE--------------IATALLFLH 507 (701)
Q Consensus 471 ~gsL~~~l~~~~~~-----------------------~~------l~~~~~~~i~~q--------------ia~aL~~LH 507 (701)
|..+.+.+...... +. ....+..++..+ ...-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84333222110000 00 000000111111 122244454
Q ss_pred hcCC-----CCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 508 QNKP-----EPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 508 ~~~~-----~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
.+.| .+++|+|+.+.||+++.++-+=|.||+++.+-+|
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4433 4589999999999999998899999999987554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0049 Score=66.63 Aligned_cols=78 Identities=14% Similarity=0.106 Sum_probs=52.5
Q ss_pred eeeecCceeEEEEEECC--ceEEEEEeCC-------CCCCChHHHHHHHHHHHhCC--CC-cEEEEeceecCCCceEEee
Q 005343 401 KIGEGGYGPVYKAQLDH--TSVAIKVLGP-------DISQGPRQFKQEVEILGSMR--HT-NMVILLGACPEYGCLVYEY 468 (701)
Q Consensus 401 ~IG~G~fg~Vyk~~~~~--~~vAiK~l~~-------~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~lV~Ey 468 (701)
.||.|-...||++...+ +.|+||.-.. +.........-|.+.|.... -| .+.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47889999999999864 4699996432 11233455667888887663 34 4556777777777899999
Q ss_pred cCCC-ChhhHh
Q 005343 469 MENG-SLEDRL 478 (701)
Q Consensus 469 ~~~g-sL~~~l 478 (701)
++.. .|.+.|
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 9543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0015 Score=68.45 Aligned_cols=150 Identities=13% Similarity=0.175 Sum_probs=100.4
Q ss_pred cccccCHHHHHHhhc---CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCC------------------CC----h
Q 005343 380 RYRKYTIEEIEAATD---YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDIS------------------QG----P 433 (701)
Q Consensus 380 ~~~~~~~~ei~~~~~---~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~------------------~~----~ 433 (701)
.|..|.+--+....+ -+.+.+.||-|.-+.||.+-+ .+++.++|+.+..-. .+ .
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 455565555555444 478899999999999999988 488888886432210 00 0
Q ss_pred HHHHHHHHHHHhCC-CCc-EEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCC
Q 005343 434 RQFKQEVEILGSMR-HTN-MVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511 (701)
Q Consensus 434 ~~~~~Ei~il~~l~-Hpn-Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 511 (701)
-...+|+..|+.|. |-. +.+.++. ...|+|||++.|-.|...-. ..... .+...+..-+.-|..+|
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC-
Confidence 12466777777774 222 2222222 23489999998877754321 11222 34555666677788889
Q ss_pred CCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 512 ~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||+|..-=||+++.++.++++||-.+...
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999766543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 701 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-38 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-97
Identities = 105/305 (34%), Positives = 160/305 (52%), Gaps = 30/305 (9%)
Query: 372 EAMAYKNVRYRKYTIEEIEAATDYFS------ISRKIGEGGYGPVYKAQLDHTSVAIKVL 425
+++ + R+ ++ E++ T+ F K+GEGG+G VYK +++T+VA+K L
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKL 62
Query: 426 G----PDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLF 479
+ +QF QE++++ +H N+V LLG + CLVY YM NGSL DRL
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 480 QKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539
D +PP+ W +R KIA A + FLH+ +HRD+K ANILLD+ + +KISD GL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 540 ARLVPPSAADTITQYHMTTA-AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA 598
AR A T MT+ GT Y+ PE G + KSD+YS GVVLL++IT PA
Sbjct: 180 ARAS-EKFAQT----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 599 MGLSHQ----VEQA----IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
+ + ++ T + +D + + ++ +A QC +K RPD
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 651 LVSVV 655
+ V
Sbjct: 294 IKKVQ 298
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 5e-97
Identities = 105/300 (35%), Positives = 158/300 (52%), Gaps = 25/300 (8%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEV 440
+ + ++E AT+ F IG G +G VYK L D VA+K P+ SQG +F+ E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 441 EILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDN-SPPIHWSIRFKIAA 497
E L RH ++V L+G C E L+Y+YMENG+L+ L+ D + + W R +I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
A L +LH ++HRD+K NILLD+N+V KI+D G+++ + Q H++
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGT-----ELDQTHLS 198
Query: 558 TA-AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--------- 607
T GT YIDPEY G L KSD+YS GVVL +++ AR A+ S E
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 608 AIRNGTFSELLDPTVTG-WPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELIRLRD 664
+ NG +++DP + E+ A++C L DRP + V+ L +RL++
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 4e-91
Identities = 101/292 (34%), Positives = 159/292 (54%), Gaps = 24/292 (8%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGP-RQFKQE 439
+++++ E++ A+D FS +G GG+G VYK +L D T VA+K L + +QG QF+ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 440 VEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLF-QKDNSPPIHWSIRFKIA 496
VE++ H N++ L G C LVY YM NGS+ L + ++ PP+ W R +IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
A L +LH + ++HRD+K ANILLD+ + + + D GLA+L+ DT H+
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DT----HV 191
Query: 557 TTA-AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--------VEQ 607
TTA GT +I PEY TG K+D++ GV+LL+LIT + A L+ ++
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 608 A---IRNGTFSELLDPTVTG-WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
++ L+D + G + E + ++AL C + +RP + VV
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-62
Identities = 70/318 (22%), Positives = 128/318 (40%), Gaps = 47/318 (14%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILG 444
E + + + G +G V+KAQL + VA+K+ Q Q + EV L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSLP 73
Query: 445 SMRHTNMVILLGAC-------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
M+H N++ +GA + L+ + E GSL D L + + W+ IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFL----KANVVSWNELCHIAE 128
Query: 498 EIATALLFLHQNKPE-------PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
+A L +LH++ P + HRD+K N+LL N + I+D GLA
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK--- 185
Query: 551 ITQYHMTTAAGTFCYIDPEYQQTGMLG-----VKSDLYSLGVVLLQLITARPAMGLSHQ- 604
+ GT Y+ PE + + ++ D+Y++G+VL +L + A
Sbjct: 186 -SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 605 -----VEQAIRNGTFSEL--------LDPTVTG-WPVEAALS-IAKLALQCCELRKRDRP 649
E+ ++ + ++ P + W A ++ + + +C + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 650 DLVSVV--LPELIRLRDL 665
V + ++ RL ++
Sbjct: 305 SAGCVGERITQMQRLTNI 322
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-60
Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 24/265 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
+ +G G +G V KA+ VAIK + + + F E+ L + H N+V L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLY 67
Query: 456 GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
GAC CLV EY E GSL + L + P + + + + +LH +P+ L+
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 516 HRDLKPANILLDQNY-VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
HRDLKP N+LL V KI D G A + Q HMT G+ ++ PE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---------QTHMTNNKGSAAWMAPEVFEGS 178
Query: 575 MLGVKSDLYSLGVVLLQLITAR-PAMGLSH---QVEQAIRNGTFSELLDPTVTGWPVEAA 630
K D++S G++L ++IT R P + ++ A+ NG P +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----TRPPL---IKNLP 230
Query: 631 LSIAKLALQCCELRKRDRPDLVSVV 655
I L +C RP + +V
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIV 255
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 20/270 (7%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPD--ISQGPRQFKQEVEILG 444
++++ +I KIG G +G V++A+ + VA+K+L ++ +F +EV I+
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 445 SMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
+RH N+V+ +GA P +V EY+ GSL L + + R +A ++A
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
+ +LH P P+VHR+LK N+L+D+ Y K+ D GL+RL T +AAGT
Sbjct: 150 MNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK------ASTFLSSKSAAGT 202
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH-QVEQAIRNGTFSELLDP 620
++ PE + KSD+YS GV+L +L T + P L+ QV A+
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----KRL 258
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPD 650
+ P +A + C RP
Sbjct: 259 EI---PRNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 21/288 (7%)
Query: 371 MEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS 430
M+ + + + ++ E ++ ++IG G +G VYK + H VA+K+L
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAP 59
Query: 431 QGP--RQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPP 486
+ FK EV +L RH N+++ +G P+ +V ++ E SL L +
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL--HASETK 116
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
IA + A + +LH ++HRDLK NI L ++ KI D GLA
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK--- 170
Query: 547 AADTITQYHMTTAAGTFCYIDPE---YQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLS 602
+ + +G+ ++ PE Q + +SD+Y+ G+VL +L+T + P ++
Sbjct: 171 -SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
Query: 603 HQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
++ I L P ++ + +L +C + ++ +RP
Sbjct: 230 NR--DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-54
Identities = 79/269 (29%), Positives = 115/269 (42%), Gaps = 35/269 (13%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGP----DISQGPRQFKQEVEILGSMRHTNMVI 453
+ IG GG+G VY+A VA+K DISQ +QE ++ ++H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 454 LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L G C CLV E+ G L L + I I A +IA + +LH
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 512 EPLVHRDLKPANILLDQ--------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
P++HRDLK +NIL+ Q N + KI+D GLAR + +AAG +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--------WHRTTKMSAAGAY 178
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH-QVEQAIRNGTFSELLDPT 621
++ PE + M SD++S GV+L +L+T P G+ V + L
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK----LALP 234
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRPD 650
+ P AKL C RP
Sbjct: 235 I---PSTCPEPFAKLMEDCWNPDPHSRPS 260
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 60/245 (24%), Positives = 89/245 (36%), Gaps = 33/245 (13%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEI--LG 444
E D + IG G YG VYK LD VA+KV + F E I +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 445 SMRHTNMVILLGAC--------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
M H N+ + EY LV EY NGSL L + W ++A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYL----SLHTSDWVSSCRLA 117
Query: 497 AEIATALLFLHQNKPE------PLVHRDLKPANILLDQNYVSKISDVGLARLVPPS--AA 548
+ L +LH P + HRDL N+L+ + ISD GL+ + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 549 DTITQYHMTTAAGTFCYIDPEY-------QQTGMLGVKSDLYSLGVVLLQLITARPAMGL 601
+ GT Y+ PE + + D+Y+LG++ ++ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 602 SHQVE 606
V
Sbjct: 238 GESVP 242
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-53
Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 33/272 (12%)
Query: 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGP-------RQFKQEVEILGSM 446
++IG+GG+G V+K +L + VAIK L S+G ++F++EV I+ ++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 447 RHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
H N+V L G +V E++ G L RL D + PI WS++ ++ +IA + ++
Sbjct: 81 NHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 507 HQNKPEPLVHRDLKPANILLDQ-----NYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
P P+VHRDL+ NI L +K++D GL++ + + ++ G
Sbjct: 139 QNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLG 188
Query: 562 TFCYIDPE--YQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQVEQAIRNGTFSELL 618
F ++ PE + K+D YS ++L ++T P S+ + N E L
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGL 247
Query: 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
PT+ P + + + C + RP
Sbjct: 248 RPTI---PEDCPPRLRNVIELCWSGDPKKRPH 276
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-52
Identities = 55/265 (20%), Positives = 107/265 (40%), Gaps = 31/265 (11%)
Query: 397 SISRKIGEGGYGPVYKAQLDHTSVAIKVLGPD--ISQGPRQFKQEVEILGSMRHTNMVIL 454
+ K+ E G ++K + + +KVL ++ R F +E L H N++ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 455 LGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LGAC + L+ +M GSL + L + + + S K A ++A + FLH +
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE- 569
P + L ++++D++ ++IS + + ++ PE
Sbjct: 132 P-LIPRHALNSRSVMIDEDMTARISMADVKFS-----------FQSPGRMYAPAWVAPEA 179
Query: 570 --YQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH-QVEQAIRNGTFSELLDPTVTGW 625
+ +D++S V+L +L+T P LS+ ++ + L PT+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG----LRPTI--- 232
Query: 626 PVEAALSIAKLALQCCELRKRDRPD 650
P + ++KL C RP
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPK 257
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-51
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 29/278 (10%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGS 445
+G+G +G K T + +K L + R F +EV+++
Sbjct: 6 IFRP--SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 446 MRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+ H N++ +G + + EY++ G+L + K WS R A +IA+ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGM 121
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP--------PSAADTITQYH 555
+LH ++HRDL N L+ +N ++D GLARL+ + +
Sbjct: 122 AYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT---ARPAMGLSHQVEQAIRNG 612
T G ++ PE K D++S G+VL ++I A P L ++ +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVR 237
Query: 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
F + P P + ++CC+L RP
Sbjct: 238 GFLDRYCP--PNCPPS----FFPITVRCCDLDPEKRPS 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGP--DISQGPRQFKQEVEILGSMRHTNMVILL 455
I IG+G +G VY + H VAI+++ D + FK+EV RH N+V+ +
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 456 GAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
GAC P + ++ + +L + +D + + +IA EI + +LH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT 573
++H+DLK N+ D V I+D GL + A + G C++ PE +
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDK-LRIQNGWLCHLAPEIIRQ 208
Query: 574 GMLGV---------KSDLYSLGVVLLQLITAR-PAMGLS-HQVEQAIRNGTFSELLDPTV 622
SD+++LG + +L P + + G + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG---MKPNLSQ 265
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665
G E I+ + L C + +RP ++ L L
Sbjct: 266 IGMGKE----ISDILLFCWAFEQEERPTFTKLM----DMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEI--LGSMRHTNMVILL 455
+ +G+G YG V++ +VA+K+ S+ + + +E E+ +RH N++ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 456 GAC-------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH- 507
+ + L+ Y E GSL D L + +I IA+ L LH
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 508 -----QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
Q KP + HRDLK NIL+ +N I+D+GLA + S GT
Sbjct: 124 EIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS--TNQLDVGNNPRVGT 180
Query: 563 FCYIDPE------YQQTGMLGVKSDLYSLGVVLLQLIT 594
Y+ PE + D+++ G+VL ++
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-46
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEI--LGSMRHTNMVILL 455
+ ++IG+G YG V+ + VA+KV + + +E EI MRH N++ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 456 GAC-------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH- 507
A + L+ +Y ENGSL D L S + K+A + L LH
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 508 -----QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
Q KP + HRDLK NIL+ +N I+D+GLA + T GT
Sbjct: 153 EIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE--VDIPPNTRVGT 209
Query: 563 FCYIDPE------YQQTGMLGVKSDLYSLGVVLLQLIT 594
Y+ PE + + +D+YS G++L ++
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEI--LGSMRHTNMVILL 455
+ IG+G +G V++ + VA+K+ S+ R + +E EI +RH N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 456 GAC-------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
A + LV +Y E+GSL D L N + K+A A+ L LH
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 509 NKPE-----PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+ HRDLK NIL+ +N I+D+GLA + GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TDTIDIAPNHRVGTK 215
Query: 564 CYIDPE-YQQTGMLGV-----KSDLYSLGVVLLQLIT 594
Y+ PE + + ++D+Y++G+V ++
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 30/249 (12%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQ---FKQEVEILGSMRHTN 450
F + +G GG+G V++A+ +D + AIK + + +EV+ L + H
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPG 64
Query: 451 MVILLGA--------------CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
+V A Y + + +L+D + + S+ I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV--PPSAADTITQY 554
+IA A+ FLH L+HRDLKP+NI + V K+ D GL + +T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 555 H----MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610
T GT Y+ PE K D++SLG++L +L+ + +R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 611 NGTFSELLD 619
N F L
Sbjct: 242 NLKFPPLFT 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 34/247 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMV 452
F +G+G +G V KA+ LD AIK + ++ EV +L S+ H +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 453 ILLGA---------------CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
A + EY ENG+L D + +N ++
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYW-RLFR 123
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY--- 554
+I AL ++H ++HRDLKP NI +D++ KI D GLA+ V S
Sbjct: 124 QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 555 -----HMTTAAGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA 608
++T+A GT Y+ E TG K D+YSLG++ ++I + +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 609 IRNGTFS 615
+R+ +
Sbjct: 241 LRSVSIE 247
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 63/266 (23%), Positives = 104/266 (39%), Gaps = 29/266 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTN 450
+ + +IG G +G V+ +L D+T VA+K + +F QE IL H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 451 MVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L+G C + +V E ++ G L + + ++ + A + +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY--I 566
+HRDL N L+ + V KISD G++R Y +
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREE------ADGVYAASGGLRQVPVKWT 282
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVT 623
PE G +SD++S G++L + + A P LS Q + + G L
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC--- 336
Query: 624 GWPVEAALSIAKLALQCCELRKRDRP 649
P ++ +L QC RP
Sbjct: 337 --PELCPDAVFRLMEQCWAYEPGQRP 360
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 29/223 (13%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTN 450
+ +S +G+G V++ + T AIKV P +E E+L + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 451 MVILL----GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
+V L + L+ E+ GSL L + N+ + S + ++ + L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 507 HQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
+N +VHR++KP NI+ D V K++D G AR + + GT
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYGT 178
Query: 563 FCYIDPEYQQTGML--------GVKSDLYSLGVVLLQLITARP 597
Y+ P+ + +L G DL+S+GV T
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 37/246 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
F IG GG+G V+KA+ +D + IK + + ++EV+ L + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVH 68
Query: 454 LLGACPEYG------------------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI 495
G + + E+ + G+LE + ++ ++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-EL 127
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
+I + ++H K L++RDLKP+NI L KI D GL +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK------- 177
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQAIRNGTF 614
T + GT Y+ PE + G + DLY+LG++L +L+ A S + +R+G
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-KFFTDLRDGII 236
Query: 615 SELLDP 620
S++ D
Sbjct: 237 SDIFDK 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS-VAIKV--LGPDISQGPRQFKQEVEILGSMRHTNMV 452
+SI ++IG GG V++ + AIK L +Q ++ E+ L ++ +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 453 I--LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
I L +Y +V E N L L +K + P W + + A+ +HQ
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKS-YWKNMLEAVHTIHQ 145
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ +VH DLKPAN L+ + K+ D G+A + P DT T + GT Y+ P
Sbjct: 146 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQP---DT-TSVVKDSQVGTVNYMPP 197
Query: 569 E-----------YQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + + KSD++SLG +L + +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+ + K+G+G +G V+ T VAIK L P + P F QE +++ +RH +V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 242
Query: 453 ILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L E +V EYM GSL D L + + + +AA+IA+ + ++ +
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMN- 300
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----TAAGTFCYID 567
VHRDL+ ANIL+ +N V K++D GLARL+ + T Q TA
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTA-------- 349
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTG 624
PE G +KSD++S G++L +L T P G+ +V + G +
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPC---- 402
Query: 625 WPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIRLRDLGFENAEN 672
P E S+ L QC +RP L + L + + ++ EN
Sbjct: 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQA-FLEDYFTSTEPQYQPGEN 451
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTN 450
+ +S +G+G V++ + T AIKV P +E E+L + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 451 MVILLGACPEYG-----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
+V L A E L+ E+ GSL L + N+ + S + ++ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 506 LHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L +N +VHR++KP NI+ D V K++D G AR + + G
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYG 177
Query: 562 TFCYIDPEYQQTGML--------GVKSDLYSLGVVLLQLITARP 597
T Y+ P+ + +L G DL+S+GV T
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS-VAIKV--LGPDISQGPRQFKQEVEILGSMRHTNMV 452
+SI ++IG GG V++ + AIK L +Q ++ E+ L ++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 453 I--LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
I L +Y +V E N L L +K + P W + + A+ +HQ
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKS-YWKNMLEAVHTIHQ 126
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ +VH DLKPAN L+ + K+ D G+A + P DT T + GT Y+ P
Sbjct: 127 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQP---DT-TSVVKDSQVGTVNYMPP 178
Query: 569 E-----------YQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + + KSD++SLG +L + +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQFKQEVE 441
E + ++G+G +G V + D VA+K L R F++E++
Sbjct: 19 IFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 442 ILGSMRHTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
IL ++ +V G G LV EY+ +G L D L + + + S ++
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+I + +L + VHRDL NIL++ KI+D GLA+L+P Y +
Sbjct: 135 QICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVR 187
Query: 558 ---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A PE + +SD++S GVVL +L T
Sbjct: 188 EPGQSPIFWYA--------PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQFKQEVE 441
+ E + +++G+G +G V + D VA+K L + R F++E+E
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 442 ILGSMRHTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
IL S++H N+V G C G L+ EY+ GSL D L + + I + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+I + +L + +HRDL NIL++ KI D GL +++P + +
Sbjct: 122 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFKVK 174
Query: 558 ---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A PE V SD++S GVVL +L T
Sbjct: 175 EPGESPIFWYA--------PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 62/291 (21%), Positives = 114/291 (39%), Gaps = 54/291 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
F + +G G +G VYK VAIK L S + E ++ S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 449 TNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
++ LLG C L+ + M G L D + + ++ + + + +IA + +
Sbjct: 77 PHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNY 132
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT-------- 557
L + LVHRDL N+L+ KI+D GLA+L+ + +
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAEGGKVPIK 184
Query: 558 -TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGT 613
A E + +SD++S GV + +L+T ++P G+ ++ + G
Sbjct: 185 WMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIR 661
E L P + + + +C + RP +L+ ++ R
Sbjct: 236 --ERLPQ-----PPICTIDVYMIMRKCWMIDADSRPKFRELII-EFSKMAR 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 398 ISRKIGEGGYGPVYKAQ---LDHTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNM 451
I K+G GG VY A+ L+ VAIK + + ++F++EV + H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 452 VILLGACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V ++ E C LV EY+E +L + + + + +I +I + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAIN--FTNQILDGIKHAHDM 130
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA-GTFCYIDP 568
+ +VHRD+KP NIL+D N KI D G+A+ + + ++TQ T GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQ---TNHVLGTVQYFSP 181
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + +D+YS+G+VL +++ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 19/241 (7%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLG-PDISQGPRQF-KQEVEILGS 445
+ + + + IG G YG K + D + K L +++ +Q EV +L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 446 MRHTNMVILLGACPEYG----CLVYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIA 500
++H N+V + +V EY E G L + + ++ ++
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 501 TALLFLHQNKPEPL--VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
AL H+ +HRDLKPAN+ LD K+ D GLAR++ + T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS------FAKT 175
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA-MGLSH-QVEQAIRNGTFSE 616
GT Y+ PE KSD++SLG +L +L P S ++ IR G F
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235
Query: 617 L 617
+
Sbjct: 236 I 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDIS-QGPRQFKQEVEILGSM 446
+ R +GEG +G V + D VA+K L P+ K+E+EIL ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 447 RHTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
H N+V G C E G L+ E++ +GSL++ L N I+ + K A +I
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----- 557
+ +L + VHRDL N+L++ + KI D GL + + Y +
Sbjct: 139 MDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDKEYYTVKDDRDS 191
Query: 558 ----TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A PE + SD++S GV L +L+T
Sbjct: 192 PVFWYA--------PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 35/291 (12%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+ + K+G+G +G V+ T VAIK L P + P F QE +++ +RH +V
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 325
Query: 453 ILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L E +V EYM GSL D L + + + +AA+IA+ + ++ +
Sbjct: 326 QLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMN- 383
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----TAAGTFCYID 567
VHRDL+ ANIL+ +N V K++D GLARL+ + T Q TA
Sbjct: 384 --YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTA-------- 432
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTG 624
PE G +KSD++S G++L +L T P G+ +V + G +
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPC---- 485
Query: 625 WPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIRLRDLGFENAEN 672
P E S+ L QC +RP L + L + + ++ EN
Sbjct: 486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQA-FLEDYFTSTEPQYQPGEN 534
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 31/266 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
++ K+G G YG VY+ +VA+K L D + +F +E ++ ++H N+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 452 VILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V LLG C ++ E+M G+L D L ++ N + + +A +I++A+ +L +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID-- 567
+HR+L N L+ +N++ K++D GL+RL+ Y T AG I
Sbjct: 338 N---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAGAKFPIKWT 386
Query: 568 -PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVT 623
PE +KSD+++ GV+L ++ T P G+ QV + + ++
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMER--- 440
Query: 624 GWPVEAALSIAKLALQCCELRKRDRP 649
P + +L C + DRP
Sbjct: 441 --PEGCPEKVYELMRACWQWNPSDRP 464
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS-VAIKV--LGPDISQGPRQFKQEVEILGSMRHTNMV 452
+SI ++IG GG V++ + AIK L +Q ++ E+ L ++ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 453 I--LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
I L +Y +V E N L L +K + P W + + A+ +HQ
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKS-YWKNMLEAVHTIHQ 173
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ +VH DLKPAN L+ + K+ D G+A + P DT T + G Y+ P
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQP---DT-TSVVKDSQVGAVNYMPP 225
Query: 569 E-----------YQQTGMLGVKSDLYSLGVVLLQLITARP 597
E + + KSD++SLG +L + +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDISQGPRQFKQEVE 441
+ E + +++G+G +G V + D VA+K L + R F++E+E
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 442 ILGSMRHTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
IL S++H N+V G C G L+ EY+ GSL D L + + I + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+I + +L + +HRDL NIL++ KI D GL +++P Y +
Sbjct: 153 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYKVK 205
Query: 558 ---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A PE V SD++S GVVL +L T
Sbjct: 206 EPGESPIFWYA--------PESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 394 DYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLG-PDISQGPRQF-KQEVEILGSMRHT 449
+ + +KIGEG +G + D IK + +S R+ ++EV +L +M+H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 450 NMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N+V + E G L V +Y E G L R+ +I AL +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
K ++HRD+K NI L ++ ++ D G+AR++ + GT Y+
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA------RACIGTPYYLS 193
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSEL 617
PE + KSD+++LG VL +L T + A I +G+F +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 53/248 (21%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 376 YKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVL---------- 425
Y N+ Y ++E + + + I R + +G + + + D+ A+K
Sbjct: 13 YSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRD 72
Query: 426 -------GPDISQGPRQFKQEVEILGSMRHTNMVILLG--ACPEYGCLVYEYMENGSLED 476
I FK E++I+ +++ + G + ++YEYMEN S+
Sbjct: 73 FTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132
Query: 477 RL-----FQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531
K+ + I + I + + ++H K + HRD+KP+NIL+D+N
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGR 190
Query: 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE--YQQTGMLGVKSDLYSLGVVL 589
K+SD G + + + + GT+ ++ PE ++ G K D++SLG+ L
Sbjct: 191 VKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
Query: 590 LQLITARP 597
+
Sbjct: 243 YVMFYNVV 250
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-33
Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 41/268 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ + IG+G +G V VA+K + D + + F E ++ +RH+N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 250
Query: 454 LLGACPEYGCLVY---EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LLG E +Y EYM GSL D L + + K + ++ A+ +L N
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT------TAAGTFC 564
VHRDL N+L+ ++ V+K+SD GL + + + TA
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----- 354
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPT 621
PE + KSD++S G++L ++ + P + V + G +D
Sbjct: 355 ---PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDA- 407
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRP 649
P ++ + C L RP
Sbjct: 408 ----PDGCPPAVYDVMKNCWHLDAATRP 431
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLD------HTSVAIKVLGPDIS-QGPRQFKQEVEILGSM 446
Y R +GEG +G V D VA+K L D Q +KQE++IL ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 447 RHTNMVILLGACPEYG----CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
H +++ G C + G LV EY+ GSL D L +S + + F A +I
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLF--AQQICEG 146
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----- 557
+ +LH +HRDL N+LLD + + KI D GLA+ VP + Y +
Sbjct: 147 MAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDS 199
Query: 558 ----TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
A PE + SD++S GV L +L+T
Sbjct: 200 PVFWYA--------PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ-FKQEVE 441
E++A SI + +G G +G V +L SVAIK L ++ R+ F E
Sbjct: 41 ELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 442 ILGSMRHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
I+G H N++ L G P +V EYMENGSL+ F + + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVM--IVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLR 154
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
IA+ + +L VHRDL NIL++ N V K+SD GL R++ D + T
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL----EDDPEAAYTT 207
Query: 558 ---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQV 605
T+ PE SD++S G+VL ++++ RP +S V
Sbjct: 208 RGGKIPIRWTS--------PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIR 661
+A+ G L P P++ ++ +L L C + + +RP +VS +L +LIR
Sbjct: 260 IKAVDEG---YRLPP-----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS-ILDKLIR 309
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 74/276 (26%), Positives = 113/276 (40%), Gaps = 47/276 (17%)
Query: 396 FSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ---FKQEVEILGSMR 447
+ K+G+G +G V + + SVA+K L PD+ P F +EV + S+
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 448 HTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
H N++ L G +V E GSL DRL + + R+ A ++A + +L
Sbjct: 80 HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYL 137
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT--------- 557
+ +HRDL N+LL + KI D GL R +P + Y M
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHYVMQEHRKVPFAW 190
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAI-RNGT 613
A PE +T SD + GV L ++ T P +GL+ Q+ I + G
Sbjct: 191 CA--------PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG- 241
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
E L P + I + +QC + DRP
Sbjct: 242 --ERLPR-----PEDCPQDIYNVMVQCWAHKPEDRP 270
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ + IG+G +G V VA+K + D + + F E ++ +RH+N+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 78
Query: 454 LLGACPEYGCLVY---EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LLG E +Y EYM GSL D L + + K + ++ A+ +L N
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT------TAAGTFC 564
VHRDL N+L+ ++ V+K+SD GL + + + TA
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----- 182
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
PE + KSD++S G++L ++ + P + V + G
Sbjct: 183 ---PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/283 (20%), Positives = 108/283 (38%), Gaps = 52/283 (18%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ-FKQEVE 441
I + ++R +GEG +G VY+ + +VA+K D + ++ F E
Sbjct: 8 GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 442 ILGSMRHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
I+ ++ H ++V L+G P + ++ E G L L + NS + + + + +
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQ 121
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT- 557
I A+ +L VHRD+ NIL+ K+ D GL+R + D Y+
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI----ED--EDYYKAS 172
Query: 558 --------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVE 606
+ PE SD++ V + ++++ +P L V
Sbjct: 173 VTRLPIKWMS--------PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
Query: 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ G + L P + L +C + DRP
Sbjct: 225 GVLEKG---DRLPK-----PDLCPPVLYTLMTRCWDYDPSDRP 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 58/271 (21%), Positives = 115/271 (42%), Gaps = 33/271 (12%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSM 446
EI+ + +++G G +G V + VAIK++ +F +E +++ ++
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNL 76
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
H +V L G C + ++ EYM NG L + + ++ ++ ++ A+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+L + +HRDL N L++ V K+SD GL+R V +Y T++ G+
Sbjct: 135 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------DEY--TSSVGSKF 183
Query: 565 YID---PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELL 618
+ PE KSD+++ GV++ ++ + P + + + I G L
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRL 240
Query: 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
P A+ + + C + +RP
Sbjct: 241 YR-----PHLASEKVYTIMYSCWHEKADERP 266
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 60/279 (21%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSM 446
E++ + ++ +++G G +G V + VA+K++ S +F QE + + +
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKL 60
Query: 447 RHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
H +V G C P Y +V EY+ NG L + L + + + S ++ ++
Sbjct: 61 SHPKLVKFYGVCSKEYPIY--IVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEG 116
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----- 557
+ FL ++ +HRDL N L+D++ K+SD G+ R V QY +
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV------LDDQYVSSVGTKF 167
Query: 558 ----TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIR 610
+A PE KSD+++ G+++ ++ + P + +V +
Sbjct: 168 PVKWSA--------PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
Query: 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
G L P A+ +I ++ C RP
Sbjct: 220 QG---HRLYR-----PHLASDTIYQIMYSCWHELPEKRP 250
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 21/238 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ +K+GEGG+ V + D A+K + Q + ++E ++ H N++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 454 LLGACPEYG------CLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFL 506
L+ C L+ + + G+L + + + KD + + I L +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV---PPSAADTITQYHMTTAAGTF 563
H HRDLKP NILL + D+G + +T T
Sbjct: 151 HAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 564 CYIDPE---YQQTGMLGVKSDLYSLGVVLLQLITARP---AMGLSHQVEQAIRNGTFS 615
Y PE Q ++ ++D++SLG VL ++ + S
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 398 ISRKIGEGGYGPVYKAQLDHT---SVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNM 451
+ R +G GG G VY+A+ D VA+K++ +S P + ++E G ++ ++
Sbjct: 38 LRRLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 452 VIL--LGACPEYGCLVY---EYMENGSLEDRLFQKDNSP-PIHWSIRFKIAAEIATALLF 505
V + G E +Y + L L + P ++ I +I +AL
Sbjct: 97 VPIHDFG---EIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDA 149
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
H HRD+KP NIL+ + + + D G+A + +TQ T GT Y
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKLTQLGNTV--GTLYY 201
Query: 566 IDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ PE ++D+Y+L VL + +T P
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 398 ISRKIGEGGYGPVYKAQLDHT---SVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNM 451
+ +G GG V+ A+ D VA+KVL D+++ P +F++E + ++ H +
Sbjct: 16 LGEILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 452 VILL------GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
V + +V EY++ +L D + + +I + A+ AL F
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIE--VIADACQALNF 131
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA--GTF 563
HQN ++HRD+KPANI++ K+ D G+AR + S ++TQ TAA GT
Sbjct: 132 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQ----TAAVIGTA 183
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
Y+ PE + + +SD+YSLG VL +++T P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 33/271 (12%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSM 446
I+ + ++IG G +G V+ + VAIK + + F +E E++ +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKL 60
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
H +V L G C E CLV E+ME+G L D + + + ++ +
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+L + ++HRDL N L+ +N V K+SD G+ R V QY T++ GT
Sbjct: 119 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QY--TSSTGTKF 167
Query: 565 YID---PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELL 618
+ PE KSD++S GV++ ++ + P S +V + I G L
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRL 224
Query: 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
P A+ + ++ C R DRP
Sbjct: 225 YK-----PRLASTHVYQIMNHCWRERPEDRP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 25/229 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+ + ++G G +G V+ HT VA+K L P F E ++ ++H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 453 ILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
L P Y ++ EYMENGSL D L + + + + +AA+IA + F+ +
Sbjct: 72 RLYAVVTQEPIY--IITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID-- 567
+HRDL+ ANIL+ KI+D GLARL+ +Y T G I
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLI------EDNEY--TAREGAKFPIKWT 177
Query: 568 -PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
PE G +KSD++S G++L +++T P G++ +V Q + G
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 75/284 (26%), Positives = 113/284 (39%), Gaps = 51/284 (17%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ-FKQEVE 441
EIEA I + IG G G V +L VAIK L ++ R+ F E
Sbjct: 45 EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 442 ILGSMRHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
I+G H N++ L G +V EYMENGSL+ F + + +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAM--IVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLR 158
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+ + +L VHRDL N+L+D N V K+SD GL+R++ D + T
Sbjct: 159 GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL----EDDPDAAYTT 211
Query: 558 ---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQV 605
TA PE SD++S GVV+ +++ RP ++ V
Sbjct: 212 TGGKIPIRWTA--------PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263
Query: 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
++ G L P+ ++ +L L C + RP
Sbjct: 264 ISSVEEG---YRLPA-----PMGCPHALHQLMLDCWHKDRAQRP 299
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 21/215 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGP-----RQFKQEVEILGSM 446
F I +KIG G + VY+A LD VA+K + I +E+++L +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89
Query: 447 RHTNMVILLGACPEYGCL--VYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIATAL 503
H N++ + E L V E + G L + K I +K ++ +AL
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+H + ++HRD+KPAN+ + V K+ D+GL R + + GT
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGTP 200
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA 598
Y+ PE KSD++SLG +L ++ +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 71/331 (21%), Positives = 126/331 (38%), Gaps = 56/331 (16%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSM 446
+ +G G +G V+K V IKV+ Q + + +GS+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 447 RHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
H ++V LLG C LV +Y+ GSL D + Q + + + +IA +
Sbjct: 73 DHAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHVRQHRGALGPQLLLNW--GVQIAKGM 128
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT------ 557
+L ++ +VHR+L N+LL +++D G+A L+PP + +
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-----DKQLLYSEAKTP 180
Query: 558 ---TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRN 611
A E G +SD++S GV + +L+T A P GL +V +
Sbjct: 181 IKWMA--------LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
Query: 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP---DLVSVVLPELIRLRDLGFE 668
G E L P + + + ++C + + RP +L + + RD
Sbjct: 233 G---ERLAQ-----PQICTIDVYMVMVKCWMIDENIRPTFKELAN-EFTRM--ARDPPRY 281
Query: 669 NAENKNDNIVVTPGPYNSVSEMKQVSGNNMR 699
+ + PGP K++ +
Sbjct: 282 LVIKRESGPGIAPGPEPHGLTNKKLEEVELE 312
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 52/283 (18%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ-FKQEVE 441
EI+ + + R IGEG +G V++ +VAIK S R+ F QE
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 442 ILGSMRHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
+ H ++V L+G P + ++ E G L L + + + A +
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQ 124
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT- 557
++TAL +L + VHRD+ N+L+ N K+ D GL+R + D + Y+
Sbjct: 125 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM----ED--STYYKAS 175
Query: 558 --------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVE 606
A PE SD++ GV + +++ +P G+ + V
Sbjct: 176 KGKLPIKWMA--------PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227
Query: 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
I NG E L P ++ L +C RP
Sbjct: 228 GRIENG---ERLPM-----PPNCPPTLYSLMTKCWAYDPSRRP 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 29/265 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
++ K+G G YG VY+ +VA+K L D + +F +E ++ ++H N+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 452 VILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V LLG C ++ E+M G+L D L ++ N + + +A +I++A+ +L +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY--ID 567
+HRDL N L+ +N++ K++D GL+RL+ + A F
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKFPIKWTA 180
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELLDPTVTG 624
PE +KSD+++ GV+L ++ T P G+ QV + + ++
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMER---- 233
Query: 625 WPVEAALSIAKLALQCCELRKRDRP 649
P + +L C + DRP
Sbjct: 234 -PEGCPEKVYELMRACWQWNPSDRP 257
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 59/272 (21%), Positives = 101/272 (37%), Gaps = 47/272 (17%)
Query: 398 ISRKIGEGGYGPVYKAQL----DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMV 452
++G G +G V + VAIKVL + +E +I+ + + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 453 ILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
L+G C LV E G L L I S ++ +++ + +L +
Sbjct: 74 RLIGVCQAEALM--LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT---------TAA 560
VHRDL N+LL + +KISD GL++ + + Y A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYA- 181
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSEL 617
PE +SD++S GV + + ++ +P + +V I G +
Sbjct: 182 -------PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KR 231
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
++ P E + L C + DRP
Sbjct: 232 MEC-----PPECPPELYALMSDCWIYKWEDRP 258
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 50/279 (17%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM 446
+ + IG G +G VYK L VAIK L ++ R F E I+G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 447 RHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
H N++ L G P ++ EYMENG+L+ F ++ + IA
Sbjct: 104 SHHNIIRLEGVISKYKPMM--IITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAG 159
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT----- 557
+ +L VHRDL NIL++ N V K+SD GL+R++ D + T
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL----EDDPEATYTTSGGKI 212
Query: 558 ----TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIR 610
TA PE SD++S G+V+ +++T RP LS H+V +AI
Sbjct: 213 PIRWTA--------PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
Query: 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+G L P++ +I +L +QC + + RP
Sbjct: 265 DG---FRLPT-----PMDCPSAIYQLMMQCWQQERARRP 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 44/231 (19%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR----- 434
R++ +E+ F I R +G+G +G VY A+ + +A+KVL +Q +
Sbjct: 4 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEH 54
Query: 435 QFKQEVEILGSMRHTNMVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR 492
Q ++EVEI +RH N++ L G L+ EY G++ L + +
Sbjct: 55 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---------K 105
Query: 493 F------KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
F E+A AL + H + ++HRD+KP N+LL KI+D G + P S
Sbjct: 106 FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ GT Y+ PE + M K DL+SLGV+ + + +P
Sbjct: 163 RRTDL--------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQG-PRQFKQEVE 441
I ++ + IG G +G VY L A+K L G QF E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 442 ILGSMRHTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
I+ H N++ LLG C +V YM++G L + F ++ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQ 136
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT- 557
+A + +L K VHRDL N +LD+ + K++D GLAR + + + ++ T
Sbjct: 137 VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTG 191
Query: 558 -------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQ 607
A E QT KSD++S GV+L +L+T A P ++ +
Sbjct: 192 AKLPVKWMA--------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243
Query: 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ G L P + ++ L+C + RP
Sbjct: 244 YLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRP 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMRHT 449
+ + ++G GG+G V + T VAIK ++S R+ + E++I+ + H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 450 NMVILL--------GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
N+V A + L EY E G L L Q +N + + ++I++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLVPPSAADTITQYHMTT 558
AL +LH+N+ ++HRDLKP NI+L Q + KI D+G A+ + T
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------LCTE 182
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT Y+ PE + V D +S G + + IT
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 54/213 (25%), Positives = 82/213 (38%), Gaps = 35/213 (16%)
Query: 398 ISRKIGEGGYGPVYKA---QLDHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTNMV- 452
+ I GG G +Y A ++ V +K L + E + L + H ++V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 453 --------ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
G Y +V EY+ SL+ QK P+ +I EI AL
Sbjct: 144 IFNFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIA--YLLEILPALS 196
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+LH LV+ DLKP NI+L + + K+ D+G I + GT
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEEQL-KLIDLGAVS--------RINSFGY--LYGTPG 242
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ PE V +D+Y++G L L P
Sbjct: 243 FQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 50/276 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
F + +G G +G VYK VAIK L S + E ++ S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 449 TNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
++ LLG C L+ + M G L D + + ++ + + + +IA + +
Sbjct: 77 PHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNY 132
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT-------- 557
L + LVHRDL N+L+ KI+D GLA+L+ + +
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAEGGKVPIK 184
Query: 558 -TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGT 613
A E + +SD++S GV + +L+T ++P G+ ++ + G
Sbjct: 185 WMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
E L P + + + ++C + RP
Sbjct: 236 --ERLPQ-----PPICTIDVYMIMVKCWMIDADSRP 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-31
Identities = 67/227 (29%), Positives = 112/227 (49%), Gaps = 21/227 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV 452
+ + +K+G G +G V+ A HT VA+K + P S F E ++ +++H +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLV 246
Query: 453 ILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
L + ++ E+M GSL D L + D +A+IA + F+ Q
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN- 304
Query: 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID---P 568
+HRDL+ ANIL+ + V KI+D GLAR++ + +Y T G I P
Sbjct: 305 --YIHRDLRAANILVSASLVCKIADFGLARVIEDN------EY--TAREGAKFPIKWTAP 354
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
E G +KSD++S G++L++++T P G+S +V +A+ G
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 35/235 (14%), Positives = 73/235 (31%), Gaps = 29/235 (12%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS-------VAIKVLGPDISQGPRQFK 437
E + + + +GEG + VY+A + +KV P
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 438 QEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRL--FQKDNSPPIHWSIRF 493
Q +E L + A LV E G+L + + ++ + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS-----------KISDVGLARL 542
A + + +H + ++H D+KP N +L ++ + D+G +
Sbjct: 176 SFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ TI T T + E + D + + + ++
Sbjct: 233 MKLFPKGTI----FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 49/271 (18%)
Query: 400 RKIGEGGYGPVYKAQL----DHTSVAIKVLGPDISQGPRQ--FKQEVEILGSMRHTNMVI 453
+++G G +G V K +VA+K+L + + + E ++ + + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 454 LLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
++G C LV E E G L L Q + + ++ +++ + +L ++
Sbjct: 83 MIGICEAESWM--LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEESN 137
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT---------TAAG 561
VHRDL N+LL + +KISD GL++ + Y A
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYA-- 188
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSELL 618
PE KSD++S GV++ + + +P G+ +V + G E +
Sbjct: 189 ------PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERM 239
Query: 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
P + L C +RP
Sbjct: 240 GC-----PAGCPREMYDLMNLCWTYDVENRP 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 33/277 (11%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQG-PRQFKQEVE 441
I R IG+G +G VY + + AIK L F +E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 442 ILGSMRHTNMVILLGACPEYGCLVY---EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
++ + H N++ L+G L + YM +G L + +P + I F +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQ 132
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
+A + +L + K VHRDL N +LD+++ K++D GLAR + Y +
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI-----LDREYYSVQQ 184
Query: 559 AAGTFCYID---PEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNG 612
+ E QT KSD++S GV+L +L+T A P + + + G
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
Query: 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
L P S+ ++ QC E RP
Sbjct: 245 ---RRLPQ-----PEYCPDSLYQVMQQCWEADPAVRP 273
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQGPRQ 435
Y + + E + + R IGEG +G V++ +VAIK S R+
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 436 -FKQEVEILGSMRHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSI 491
F QE + H ++V L+G P + ++ E G L L + S + I
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
+ A +++TAL +L + VHRD+ N+L+ N K+ D GL+R + +
Sbjct: 495 LY--AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDS 544
Query: 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQA 608
T Y + ++ PE SD++ GV + +++ +P G+ + V
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
I NG E L P ++ L +C RP
Sbjct: 605 IENG---ERLPM-----PPNCPPTLYSLMTKCWAYDPSRRP 637
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 68/282 (24%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDISQG-PRQFKQEVE 441
I ++ + IG G +G VY L A+K L G QF E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 442 ILGSMRHTNMVILLGACPEYGCLVY---EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
I+ H N++ LLG C YM++G L + F ++ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQ 200
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT- 557
+A + FL K VHRDL N +LD+ + K++D GLAR + + + ++ T
Sbjct: 201 VAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTG 255
Query: 558 -------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQ 607
A E QT KSD++S GV+L +L+T A P ++ +
Sbjct: 256 AKLPVKWMA--------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
Query: 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ G L P + ++ L+C + RP
Sbjct: 308 YLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRP 341
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 74/290 (25%), Positives = 116/290 (40%), Gaps = 63/290 (21%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
++GE +G VYK L +VAIK L R+ F+ E + ++H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 449 TNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIR-------------- 492
N+V LLG + +++ Y +G L + F SP
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHE--FLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 493 -FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
+ A+IA + +L + +VH+DL N+L+ KISD+GL R V AAD
Sbjct: 130 FVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADY- 183
Query: 552 TQYHMT---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMG 600
Y + A PE G + SD++S GVVL ++ + +P G
Sbjct: 184 --YKLLGNSLLPIRWMA--------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 601 LSHQ-VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
S+Q V + IRN ++L P + + L ++C RP
Sbjct: 234 YSNQDVVEMIRNR---QVLPC-----PDDCPAWVYALMIECWNEFPSRRP 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 55/262 (20%), Positives = 96/262 (36%), Gaps = 39/262 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKA-QLDHTSVAIKVLGPDISQGPRQFKQEVEILG-SMRHTNM 451
+ + +G G G V VA+K + D E+++L S H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71
Query: 452 VILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE----IATALLF 505
+ + + + E +L+D + K+ S + IA+ +
Sbjct: 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 506 LHQNKPEPLVHRDLKPANILLD-------------QNYVSKISDVGLARLVPPSAADTIT 552
LH K ++HRDLKP NIL+ +N ISD GL + + +
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--QSSF 185
Query: 553 QYHMTTAAGTFCYIDPE-------YQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQ 604
+ ++ +GT + PE Q L D++S+G V +++ + G +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 605 VEQAIRNGTFSELLDPTVTGWP 626
E I G FS L +
Sbjct: 246 RESNIIRGIFS-LDEMKCLHDR 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR---QFKQEVEILGSMRHTN 450
+ R +G+GG+ ++ T A K++ + P + E+ I S+ H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 451 MVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF------KIAAEIATA 502
+V G ++ +V E SL + ++ +I
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLG 127
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
+LH+N+ ++HRDLK N+ L+++ KI D GLA V + + GT
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGT 178
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
YI PE + D++S+G ++ L+ +P
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 70/260 (26%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT 449
+ R++GEG +G V+ A+ D VA+K L + F++E E+L +++H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIR--------------- 492
++V G C + +V+EYM++G L F + + P +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
IA++IA+ +++L VHRDL N L+ N + KI D G++R V
Sbjct: 136 LHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV--------- 183
Query: 553 QYHMTTAAGTFCYIDPEY--QQTGMLGVK---------------SDLYSLGVVLLQLIT- 594
Y Y ML ++ SD++S GV+L ++ T
Sbjct: 184 ------------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 595 -ARPAMGLSH-QVEQAIRNG 612
+P LS+ +V + I G
Sbjct: 232 GKQPWFQLSNTEVIECITQG 251
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR-----QFKQEVEILGSMRH 448
F I R +G+G +G VY A+ +A+KVL SQ + Q ++E+EI +RH
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVL--FKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 449 TNMVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF------KIAAEIA 500
N++ + + L+ E+ G L L + RF E+A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELA 124
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
AL + H+ K ++HRD+KP N+L+ KI+D G + P T
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMC 173
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT Y+ PE + K DL+ GV+ + + P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 31/254 (12%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGP 433
Y +E E A + ++SR++G+G +G VY+ T VAIK + S
Sbjct: 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 71
Query: 434 RQ-FKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLED-------RLFQKDN 483
R F E ++ ++V LLG + ++ E M G L+ +
Sbjct: 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 484 SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543
P S ++A EIA + +L+ NK VHRDL N ++ +++ KI D G+ R +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 544 PPSAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAM 599
T Y+ G ++ PE + G+ SD++S GVVL ++ T +P
Sbjct: 189 YE------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 600 GLS-HQVEQAIRNG 612
GLS QV + + G
Sbjct: 243 GLSNEQVLRFVMEG 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 52/254 (20%), Positives = 97/254 (38%), Gaps = 52/254 (20%)
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDISQGPRQFKQ 438
+I + + +G+G + ++K T V +KVL F +
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 439 EVEILGSMRHTNMVILLGAC----PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK 494
++ + H ++V+ G C LV E+++ GSL+ L + N I W + +
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENI--LVQEFVKFGSLDTYLKKNKNCINILWKL--E 117
Query: 495 IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--------NYVSKISDVGLARLVPPS 546
+A ++A A+ FL +N L+H ++ NILL + K+SD G++ V P
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 547 AADTITQYHMT----TAAGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLIT--ARPAM 599
PE + L + +D +S G L ++ + +P
Sbjct: 175 ------DILQERIPWVP--------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220
Query: 600 GLS-HQVEQAIRNG 612
L + Q +
Sbjct: 221 ALDSQRKLQFYEDR 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 395 YFSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPR----QFKQEVEILGSMR 447
+ +IG G + VYK LD + VA L + + +FK+E E+L ++
Sbjct: 27 FLKFDIEIGRGSFKTVYKG-LDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 448 HTNMVILLGACPEYG------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
H N+V + LV E M +G+L+ L + + +I
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILK 140
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
L FLH P P++HRDLK NI + KI D+GLA L
Sbjct: 141 GLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------KRASFAKAVI 191
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT ++ PE + D+Y+ G+ +L++ T+
Sbjct: 192 GTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/255 (21%), Positives = 107/255 (41%), Gaps = 36/255 (14%)
Query: 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS--QGPRQ 435
K +E++ F++ R +G+G +G V +AQL VA+K+L DI +
Sbjct: 12 KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 436 FKQEVEILGSMRHTNMVILLGACPEYG--------CLVYEYMENGSLED-----RLFQKD 482
F +E + H ++ L+G ++ +M++G L R+ +
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 483 NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
+ P+ +RF +IA + +L +HRDL N +L ++ ++D GL+R
Sbjct: 132 FNLPLQTLVRF--MVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 543 VPPSAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPA 598
+ Y+ A ++ E + V SD+++ GV + +++T P
Sbjct: 187 IYSG------DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 599 MGLS-HQVEQAIRNG 612
G+ ++ + G
Sbjct: 241 AGIENAEIYNYLIGG 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR---QFKQEVEILGSMRHTN 450
+ R +G+GG+ ++ T A K++ + P + E+ I S+ H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 451 MVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF------KIAAEIATA 502
+V G ++ +V E SL + ++ +I
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLG 153
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
+LH+N+ ++HRDLK N+ L+++ KI D GLA V + + GT
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGT 204
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
YI PE + D++S+G ++ L+ +P
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPR---QFKQEVEILGSMRHTN 450
F + +G+G + VY+A+ HT VAIK++ + + EV+I ++H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 451 MVILLGACPEYGC--------LVYEYMENGSLEDRLFQKDNSPPIHWSIRF------KIA 496
++ L Y LV E NG + L + F
Sbjct: 73 ILEL------YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFM 118
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
+I T +L+LH + ++HRDL +N+LL +N KI+D GLA + + H
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----HEKHY 170
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T GT YI PE G++SD++SLG + L+ RP
Sbjct: 171 TL-CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 57/286 (19%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT 449
+ ++GEG +G V+ A+ D VA+K L + F++E E+L ++H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLEDRL------------FQKDNSPPIHWSIRFKI 495
++V G C E +V+EYM +G L L + P+ +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
A+++A +++L VHRDL N L+ Q V KI D G++R + + D Y
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDY---YR 215
Query: 556 MT---------TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH- 603
+ PE +SD++S GVVL ++ T +P LS+
Sbjct: 216 VGGRTMLPIRWMP--------PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ I G L+ P + + C + + R
Sbjct: 268 EAIDCITQG---RELER-----PRACPPEVYAIMRGCWQREPQQRH 305
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 31/259 (11%)
Query: 376 YKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPD 428
Y + E ++ R +G G +G VY+ Q+ VA+K L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 429 ISQGPRQ-FKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLED----RLFQK 481
S+ F E I+ H N+V +G + ++ E M G L+ +
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 482 DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVG 538
+ +A +IA +L +N +HRD+ N LL V+KI D G
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 539 LARLVPPSAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-- 594
+AR + Y+ ++ PE G+ K+D +S GV+L ++ +
Sbjct: 189 MARDIYR------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 242
Query: 595 ARPAMGLSH-QVEQAIRNG 612
P S+ +V + + +G
Sbjct: 243 YMPYPSKSNQEVLEFVTSG 261
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 52/252 (20%), Positives = 101/252 (40%), Gaps = 31/252 (12%)
Query: 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS--QGPRQ 435
+ +E++ + + + +GEG +G V + L VA+K + D S + +
Sbjct: 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE 82
Query: 436 FKQEVEILGSMRHTNMVILLGAC----PEYGCLVY---EYMENGSLEDRLFQ-KDNSPPI 487
F E + H N++ LLG C + +M+ G L L + + P
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 488 HWSIR--FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545
H ++ K +IA + +L +HRDL N +L + ++D GL++ +
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
Query: 546 SAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGL 601
Y+ +I E + KSD+++ GV + ++ T P G+
Sbjct: 200 ------GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
Query: 602 S-HQVEQAIRNG 612
H++ + +G
Sbjct: 254 QNHEMYDYLLHG 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 8e-29
Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 47/273 (17%)
Query: 398 ISRKIGEGGYGPVYKAQL----DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMV 452
++G G +G V + VAIKVL + +E +I+ + + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 453 ILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
L+G C LV E G L L I S ++ +++ + +L +
Sbjct: 400 RLIGVCQAEALM--LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT---------TAA 560
VHR+L N+LL + +KISD GL++ + + Y A
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYA- 507
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQAIRNGTFSEL 617
PE +SD++S GV + + ++ +P + +V I G +
Sbjct: 508 -------PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KR 557
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
++ P E + L C + DRPD
Sbjct: 558 MEC-----PPECPPELYALMSDCWIYKWEDRPD 585
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 57/236 (24%), Positives = 85/236 (36%), Gaps = 24/236 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDI--SQGPRQFKQEVEILGSM-RHTN 450
F ++G G YG V+K + D A+K + + EV + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 451 MVILLGACPEYGCLVYEYME--NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
V L A E G L Y E SL+ + + + + AL LH
Sbjct: 119 CVRLEQAWEEGGIL-YLQTELCGPSLQQHC-EAWGASLPEAQVWG-YLRDTLLALAHLHS 175
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLAR-LVPPSAADTITQYHMTTAAGTFCYID 567
LVH D+KPANI L K+ D GL L A + G Y+
Sbjct: 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--------GDPRYMA 224
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT 623
PE Q G +D++SLG+ +L++ Q +R G ++
Sbjct: 225 PELLQGS-YGTAADVFSLGLTILEVACNMELPHGGEGW-QQLRQGYLPPEFTAGLS 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 22/240 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKV--LGPDISQGPRQFKQEVEILGSM-RHTN 450
F KIG G +G V+K LD AIK S + +EV + +H++
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSP-PIHWSIRFKIAAEIATALLFLH 507
+V A E + EY GSL D + + + + ++ L ++H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI--------TQY-HMTT 558
LVH D+KP+NI + + + + S T+
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 559 AAGTFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617
G ++ E Q+ K+D+++L + ++ A P Q IR G +
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-HEIRQGRLPRI 248
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 25/233 (10%)
Query: 396 FSISRKIGEGGYGPVYKA-QLDHTSVAIKVLGPDISQGPRQFKQEVEIL-GSMRHTNMVI 453
F +G G G + D+ VA+K + P+ + EV++L S H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82
Query: 454 LLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
++ + E +L++ + QKD + + + + L LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLHSLN- 138
Query: 512 EPLVHRDLKPANILL-----DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+VHRDLKP NIL+ + ISD GL + + + + GT +I
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV---GRHSFSRRSGVPGTEGWI 193
Query: 567 DPEY---QQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAIRNGTFS 615
PE D++S G V +I+ G S Q + I G S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 57/283 (20%), Positives = 99/283 (34%), Gaps = 23/283 (8%)
Query: 367 KKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLG 426
K+I + + + + A ++ I R P K Q + + +K
Sbjct: 37 KRIRLPNRELAREKVMREV--KALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 427 PDIS----QGPRQFKQEVEILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQ 480
D ++ + N V L L + +L+D + +
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 481 KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540
+ + + I +IA A+ FLH L+HRDLKP+NI + V K+ D GL
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 541 RLV------PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
+ T GT Y+ PE K D++SLG++L +L+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
Query: 595 A-RPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKL 636
+ M + +RN F L +P E + + +
Sbjct: 272 SFSTQMERVRIITD-VRNLKFPLLFTQK---YPQEHMM-VQDM 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 31/259 (11%)
Query: 376 YKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPD 428
Y + E ++ R +G G +G VY+ Q+ VA+K L
Sbjct: 53 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112
Query: 429 ISQGPRQ-FKQEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLED--RLFQKDN 483
S+ F E I+ H N+V +G + ++ E M G L+ R +
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 484 SPPIHWSIR--FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVG 538
S P ++ +A +IA +L +N +HRD+ N LL V+KI D G
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 539 LARLVPPSAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-- 594
+AR + Y+ ++ PE G+ K+D +S GV+L ++ +
Sbjct: 230 MARDIYR------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283
Query: 595 ARPAMGLS-HQVEQAIRNG 612
P S +V + + +G
Sbjct: 284 YMPYPSKSNQEVLEFVTSG 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/262 (22%), Positives = 104/262 (39%), Gaps = 70/262 (26%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM-R 447
+ + +G G +G V +A +VA+K+L + + E++IL +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 448 HTNMVILLGACPEYG---CLVYEYMENGSL-----------EDRLFQKDNSPPIHWSIR- 492
H N+V LLGAC + G ++ E+ + G+L ++ ++
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 493 -FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
+ ++A + FL K +HRDL NILL + V KI D GLAR +
Sbjct: 150 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI-------- 198
Query: 552 TQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLLQLIT 594
Y DP+Y + L +K SD++S GV+L ++ +
Sbjct: 199 -------------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 595 -AR---PAMGLSHQVEQAIRNG 612
P + + + + ++ G
Sbjct: 246 LGASPYPGVKIDEEFCRRLKEG 267
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 68/318 (21%), Positives = 120/318 (37%), Gaps = 32/318 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMV 452
+ R + EGG+ VY+AQ A+K L + + R QEV + + H N+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 453 ILLGAC---------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
A + L+ + G L + L + ++ P+ KI + A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAG 561
+H+ KP P++HRDLK N+LL K+ D G A P + + + +
Sbjct: 150 QHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 562 TFC----YIDPE---YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTF 614
T Y PE +G K D+++LG +L L + ++ I NG +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--RIVNGKY 266
Query: 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKN 674
S T L ++ +R + V+ +L + N ++
Sbjct: 267 SIPPHDTQYT-------VFHSLIRAMLQVNPEERLSIAE-VVHQLQEIAAARNVNPKSPI 318
Query: 675 DNIVVTPGPYNSVSEMKQ 692
++ G Y S + +
Sbjct: 319 TELLEQNGGYGSATLSRG 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 75/266 (28%)
Query: 398 ISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSMRHT 449
+ + +GEG +G V KA +T+VA+K+L + S + E +L + H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLEDRL---------------------FQKDNSPP 486
+++ L GAC + G L+ EY + GSL L +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
+ A +I+ + +L + K LVHRDL NIL+ + KISD GL+R V
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDV--- 200
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVL 589
Y + Y + G + VK SD++S GV+L
Sbjct: 201 ------------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 590 LQLIT--ARPAMGLS-HQVEQAIRNG 612
+++T P G+ ++ ++ G
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/265 (22%), Positives = 111/265 (41%), Gaps = 70/265 (26%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDISQGPRQ-FKQEVEIL 443
D ++ + +GEG +G V A+ + +VA+K+L D ++ E+E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 444 GSM-RHTNMVILLGACPEYG--CLVYEYMENGSLEDRL-------------FQKDNSPPI 487
+ +H N++ LLGAC + G ++ EY G+L + L + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 488 HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547
+ ++A + +L K +HRDL N+L+ +N V KI+D GLAR +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI---- 207
Query: 548 ADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLL 590
Y++T G L VK SD++S GV++
Sbjct: 208 -----------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250
Query: 591 QLIT--ARPAMGLS-HQVEQAIRNG 612
++ T P G+ ++ + ++ G
Sbjct: 251 EIFTLGGSPYPGIPVEELFKLLKEG 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/263 (23%), Positives = 98/263 (37%), Gaps = 71/263 (26%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM-R 447
S + +G G +G V +A +VA+K+L P R+ E+++L +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 448 HTNMVILLGACPEYG--CLVYEYMENGSLEDRL---------------FQKDNSPPIHWS 490
H N+V LLGAC G ++ EY G L + L +D+ +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
+ ++A + FL +HRDL NILL ++KI D GLAR +
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI------- 195
Query: 551 ITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLLQLI 593
D Y L VK SD++S G+ L +L
Sbjct: 196 --------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 594 T-AR---PAMGLSHQVEQAIRNG 612
+ P M + + + I+ G
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEG 264
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 58/246 (23%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 357 ELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD 416
+L+ ++ +E+++ +EA + + + ++ E ++G G G V+K
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSHK 55
Query: 417 HTS--VAIKVLGPDISQGPR-QFKQEVEILGSMRHTNMVILLGACPEYGCLVY--EYMEN 471
+ +A K++ +I R Q +E+++L +V GA G + E+M+
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531
GSL+ L + I I K++ + L +L + ++HRD+KP+NIL++
Sbjct: 116 GSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGE 170
Query: 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQ 591
K+ D G++ + S A++ GT Y+ PE Q V+SD++S+G+ L++
Sbjct: 171 IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 592 LITARP 597
+ R
Sbjct: 223 MAVGRY 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMRHT 449
D F RK+G G +G V+ + + IK + D SQ P + + E+E+L S+ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IAT 501
N++ + +V E E G L +R+ AE +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMN 135
Query: 502 ALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
AL + H +VH+DLKP NIL + KI D GLA L H T
Sbjct: 136 ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-------HSTN 185
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
AAGT Y+ PE + + K D++S GVV+
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 55/247 (22%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKV-----LGPDISQGPRQFKQEVEILGS 445
+ + IG+G YG V A + T AIK+ + + + K EV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 446 MRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF---------- 493
+ H N+ L +Y CLV E G L D+L + ++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 494 -----------------------KIAAE----IATALLFLHQNKPEPLVHRDLKPANILL 526
K+ + I +AL +LH + HRD+KP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201
Query: 527 --DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE--YQQTGMLGVKSDL 582
++++ K+ D GL++ + Y MTT AGT ++ PE G K D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKL--NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 583 YSLGVVL 589
+S GV+L
Sbjct: 260 WSAGVLL 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 38/245 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQGPRQ-FKQEVEILGSM-R 447
+ IGEG +G V KA++ AIK + S+ + F E+E+L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 448 HTNMVILLGACPEYG--CLVYEYMENGSLED-----RLFQKDNSPPIHWSIR-------- 492
H N++ LLGAC G L EY +G+L D R+ + D + I S
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
AA++A + +L Q + +HRDL NIL+ +NYV+KI+D GL+R
Sbjct: 145 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---------GQ 192
Query: 553 QYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLS-HQVEQ 607
+ ++ G ++ E + SD++S GV+L ++++ P G++ ++ +
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 608 AIRNG 612
+ G
Sbjct: 253 KLPQG 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 54/259 (20%), Positives = 97/259 (37%), Gaps = 67/259 (25%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM-R 447
+ +G G +G V +A VA+K+L ++ E++I+ + +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 448 HTNMVILLGACPEYG--CLVYEYMENGSL-----------EDRLFQKDNSPPIHWSIRFK 494
H N+V LLGAC G ++ EY G L E +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 495 IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554
++++A + FL +HRD+ N+LL +V+KI D GLAR +
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI----------- 214
Query: 555 HMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLLQLIT-AR 596
D Y L VK SD++S G++L ++ +
Sbjct: 215 ----------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 597 ---PAMGLSHQVEQAIRNG 612
P + ++ + + +++G
Sbjct: 265 NPYPGILVNSKFYKLVKDG 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 43/215 (20%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
Y+++ IG G +G V A T A K + + +FKQE+EI+ S+ H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IATA 502
++ L LV E G L +R+ K F AA + +A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSA 118
Query: 503 LLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ + H+ + HRDLKP N L + K+ D GLA P M T
Sbjct: 119 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-------MRTK 168
Query: 560 AGTFCYIDPE-----YQQTGMLGVKSDLYSLGVVL 589
GT Y+ P+ Y G + D +S GV++
Sbjct: 169 VGTPYYVSPQVLEGLY------GPECDEWSAGVMM 197
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 62/261 (23%), Positives = 112/261 (42%), Gaps = 70/261 (26%)
Query: 398 ISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM- 446
+ + +GEG +G V A+ + +VA+K+L D ++ E+E++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 447 RHTNMVILLGACPEYG--CLVYEYMENGSLEDRL---------FQKDNSPPIHWSIRFK- 494
+H N++ LLGAC + G ++ EY G+L + L + D + + FK
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 495 ---IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
++A + +L K +HRDL N+L+ +N V KI+D GLAR +
Sbjct: 205 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI-------- 253
Query: 552 TQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLLQLIT 594
Y++T G L VK SD++S GV++ ++ T
Sbjct: 254 -------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 595 --ARPAMGLS-HQVEQAIRNG 612
P G+ ++ + ++ G
Sbjct: 301 LGGSPYPGIPVEELFKLLKEG 321
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 75/267 (28%)
Query: 397 SISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQGPRQ-FKQEVEILGSMRH 448
R IGEG +G V++A+ T VA+K+L + S + F++E ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 449 TNMVILLGACPEYG--CLVYEYMENGSLEDRL---------------------FQKDNSP 485
N+V LLG C CL++EYM G L + L P
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 486 PIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545
P+ + + IA ++A + +L + K VHRDL N L+ +N V KI+D GL+R +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 546 SAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVV 588
Y Y+ + ++ SD+++ GVV
Sbjct: 225 -------------------YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
Query: 589 LLQLIT--ARPAMGLSH-QVEQAIRNG 612
L ++ + +P G++H +V +R+G
Sbjct: 266 LWEIFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 62/279 (22%), Positives = 114/279 (40%), Gaps = 51/279 (18%)
Query: 368 KIVMEAMAYKNVRYRKYTIEEIEAAT----DYFSISRKIGEGGYGPVYKAQLDHT--SVA 421
+I + K + T+++ D + +S+ +G G G V A T VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 422 IKVL--------GPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMEN 471
I+++ + + E+EIL + H ++ + +Y +V E ME
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEG 223
Query: 472 GSLEDRLFQKDNSPPIHWSIRF--KIAAE----IATALLFLHQNKPEPLVHRDLKPANIL 525
G L D++ R + A+ +LH+N ++HRDLKP N+L
Sbjct: 224 GELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271
Query: 526 L---DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE---YQQTGMLGVK 579
L +++ + KI+D G ++++ ++ M T GT Y+ PE T
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSL-------MRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 580 SDLYSLGVVLLQLITARP---AMGLSHQVEQAIRNGTFS 615
D +SLGV+L ++ P ++ I +G ++
Sbjct: 325 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLG----PDISQGPRQFKQEVEILGSMRHTNM 451
+ +GEG YG V + A+K+L I G K+E+++L +RH N+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 452 V----ILLGACPEYGCLVYEYMENGSLE--DRLFQKDNSPPIHWSIRFKIAA------EI 499
+ +L + +V EY G E D + +K RF + ++
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVCQAHGYFCQL 118
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
L +LH +VH+D+KP N+LL KIS +G+A + P AAD T+
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD----DTCRTS 171
Query: 560 AGTFCYIDPE--YQQTGMLGVKSDLYSLGVVLLQLIT 594
G+ + PE G K D++S GV L + T
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 60/268 (22%), Positives = 98/268 (36%), Gaps = 76/268 (28%)
Query: 397 SISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM-R 447
+ +G G +G V A VA+K+L R+ E++++ +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 448 HTNMVILLGACPEYG--CLVYEYMENGSL--------------------EDRLFQKDNSP 485
H N+V LLGAC G L++EY G L + RL ++++
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 486 PIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545
+ + A ++A + FL VHRDL N+L+ V KI D GLAR +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 546 SAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVV 588
D Y L VK SD++S G++
Sbjct: 223 -------------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 589 LLQLIT-AR---PAMGLSHQVEQAIRNG 612
L ++ + P + + + I+NG
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 402 IGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC 458
+G+G YG VY D ++ +AIK + S+ + +E+ + ++H N+V LG+
Sbjct: 30 LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 459 PEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516
E G + E + GSL L K + +I L +LH N+ +VH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 517 RDLKPANILLDQ-NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE--YQQT 573
RD+K N+L++ + V KISD G ++ + T GT Y+ PE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL------AGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 574 GMLGVKSDLYSLGVVLLQLITARP 597
G +D++SLG ++++ T +P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 33/312 (10%), Positives = 70/312 (22%), Gaps = 55/312 (17%)
Query: 395 YFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGP---RQFKQEVEILGSMRHT 449
+ + G V+ + A+KV + + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 450 NMVILLGACPEYG----------------------------CLVYEYMENGSLEDRLFQK 481
+ L+ LE
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 482 DNSPPIH----WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537
D + A++ L LVH P N+ + + + DV
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEY--QQTGMLGVKSDLYSLGVVLLQLITA 595
V ++ Y E+ T + + LG+ + ++
Sbjct: 239 SALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 596 RPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLAL--QCCELRKRDRPDLVS 653
GL + + + L L + +R R +
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 654 VVL-PELIRLRD 664
+ PE ++L++
Sbjct: 350 AMETPEFLQLQN 361
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 40/271 (14%)
Query: 362 QEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--S 419
E + + + + + +K+G G YG V + T
Sbjct: 8 SSGRENLYFQGDLQATPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 420 VAIKVL------GPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMEN 471
AIK++ S+ +EV +L + H N++ L LV E +
Sbjct: 65 RAIKIIRKTSVSTSSNSK----LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 472 GSLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLHQNKPEPLVHRDLKPANILL--- 526
G L D + + ++ I ++ + + +LH++ +VHRDLKP N+LL
Sbjct: 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESK 172
Query: 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLG 586
+++ + KI D GL+ + M GT YI PE + K D++S+G
Sbjct: 173 EKDALIKIVDFGLSAVFENQKK-------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIG 224
Query: 587 VVLLQLITARPAMGLSHQVE--QAIRNGTFS 615
V+L L+ P G E + + G ++
Sbjct: 225 VILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 33/210 (15%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
F +G G + V+ + T A+K + + + E+ +L ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 451 MVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IATA 502
+V L + LV + + G L DR+ ++ + K A+ + +A
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSA 118
Query: 503 LLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ +LH+N +VHRDLKP N+L ++N I+D GL+++ M+TA
Sbjct: 119 VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--------MSTA 167
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT Y+ PE D +S+GV+
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMVIL 454
+ + +GEG YG V A ++ +VA+K++ P K+E+ I + H N+V
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 455 LG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G L EY G L DR+ P F ++ +++LH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG-- 125
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQ 571
+ HRD+KP N+LLD+ KISD GLA + + + + GT Y+ PE +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----RLLNKMCGTLPYVAPELLK 180
Query: 572 QTGMLGVKSDLYSLGVVLLQLIT 594
+ D++S G+VL ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 30/237 (12%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVL---GPDISQGPRQFKQEVEILGSMR 447
+D + R +G+G +G V + + A+KV+ +EV++L +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 448 HTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR--FKIAAEIATAL 503
H N++ L Y LV E G L D + + +S +I ++ + +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGI 139
Query: 504 LFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
++H+NK +VHRDLKP N+LL ++ +I D GL+ S M
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-------KMKDKI 189
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ-VEQAIRNGTFS 615
GT YI PE G K D++S GV+L L++ P G + + + + G ++
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 63/262 (24%), Positives = 112/262 (42%), Gaps = 70/262 (26%)
Query: 397 SISRKIGEGGYGPVYKAQL---------DHTSVAIKVLGPDISQGPRQ-FKQEVEILGSM 446
+ + +GEG +G V A+ T VA+K+L D ++ E+E++ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 447 -RHTNMVILLGACPEYG--CLVYEYMENGSLEDRL---------FQKDNSPPIHWSIRFK 494
+H N++ LLGAC + G ++ EY G+L + L + + S + K
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 495 ----IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
A ++A + +L K +HRDL N+L+ ++ V KI+D GLAR +
Sbjct: 192 DLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI------- 241
Query: 551 ITQYHMTTAAGTFCYIDPEYQQT--GMLGVK---------------SDLYSLGVVLLQLI 593
+ Y++T G L VK SD++S GV+L ++
Sbjct: 242 --------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
Query: 594 T--ARPAMGLS-HQVEQAIRNG 612
T P G+ ++ + ++ G
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEG 309
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 375 AYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG 432
A + RK E+ F + +GEG + V A+ TS AIK+L
Sbjct: 18 AQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK 70
Query: 433 PRQFKQ---EVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSL-----EDRLFQKD 482
+ E +++ + H V L E Y +NG L + F +
Sbjct: 71 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 483 NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLAR 541
+ RF AEI +AL +LH ++HRDLKP NILL+++ ++ +I+D G A+
Sbjct: 131 CT-------RF-YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI-QITDFGTAK 178
Query: 542 LVPPSAADTITQYHMTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ P + +F Y+ PE SDL++LG ++ QL+ P
Sbjct: 179 VLSPESKQARAN--------SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 45/252 (17%), Positives = 91/252 (36%), Gaps = 29/252 (11%)
Query: 353 REIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYK 412
++ L E+ E ++ E + + YR+ + + ++G G +G V++
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYRE--------EVHWMTHQPRVGRGSFGEVHR 76
Query: 413 AQLDHTS---VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCL--VYE 467
D + A+K + + +E+ + +V L GA E + E
Sbjct: 77 M-KDKQTGFQCAVKKV--RLEVFR---VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD 527
+E GSL + + + L +LH + ++H D+K N+LL
Sbjct: 131 LLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLS 184
Query: 528 QNYVS-KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQQTGMLGVKSDLYSL 585
+ + D G A + P + GT ++ PE K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGK-SLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 242
Query: 586 GVVLLQLITARP 597
++L ++
Sbjct: 243 CCMMLHMLNGCH 254
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 47/250 (18%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL--------GPDISQGPRQFKQEVEI 442
D + +S+ +G G G V A T VAIK++ + + E+EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 443 LGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE 498
L + H ++ + +Y +V E ME G L D++ R
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---------RLKEATCKL 118
Query: 499 ----IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTI 551
+ A+ +LH+N ++HRDLKP N+LL +++ + KI+D G ++++ ++
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 172
Query: 552 TQYHMTTAAGTFCYIDPE---YQQTGMLGVKSDLYSLGVVLLQLITARP---AMGLSHQV 605
M T GT Y+ PE T D +SLGV+L ++ P +
Sbjct: 173 ----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 606 EQAIRNGTFS 615
+ I +G ++
Sbjct: 229 KDQITSGKYN 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 53/221 (23%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
+ ++I +G+G +G V K + T A+KV+ D S +EVE+L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----ILREVELLK 76
Query: 445 SMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE-- 498
+ H N++ L +V E G L D + ++ RF AA
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARII 127
Query: 499 --IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQ 553
+ + + ++H++ +VHRDLKP NILL +++ KI D GL+ +
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----- 179
Query: 554 YHMTTAAGTFCYIDPE-----YQQTGMLGVKSDLYSLGVVL 589
M GT YI PE Y K D++S GV+L
Sbjct: 180 --MKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 50/242 (20%), Positives = 94/242 (38%), Gaps = 33/242 (13%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKV-----LGPDISQGPRQFKQEVEILGS 445
D + + IG+G + V + T A+K+ K+E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 446 MRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE--- 498
++H ++V LL +V+E+M+ L + ++ + +A+
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA-----DAGFVYSEAVASHYMR 137
Query: 499 -IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQY 554
I AL + H N ++HRD+KP +LL + + K+ G+A + S
Sbjct: 138 QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES------GL 188
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQAIRNGT 613
GT ++ PE + G D++ GV+L L++ P G ++ + I G
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK 248
Query: 614 FS 615
+
Sbjct: 249 YK 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 43/278 (15%)
Query: 362 QEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--S 419
+ + + +A Y + +I + + RK+G G YG V + +
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 420 VAIKVL-------------GPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCL 464
AIKV+ +I + + E+ +L S+ H N++ L +Y L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 465 VYEYMENGSLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLHQNKPEPLVHRDLKPA 522
V E+ E G L +++ + + I +I + + +LH++ +VHRD+KP
Sbjct: 124 VTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE 175
Query: 523 NILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK 579
NILL + KI D GL+ Y + GT YI PE + K
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKD-------YKLRDRLGTAYYIAPEVLK-KKYNEK 227
Query: 580 SDLYSLGVVLLQLIT-ARPAMGLSHQ-VEQAIRNGTFS 615
D++S GV++ L+ P G + Q + + + G +
Sbjct: 228 CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+ F + K+GEG YG VYKA T VAIK + + ++ +E+ I+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V G+ + L V EY GS+ D + + N I I L +LH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ +HRD+K NILL+ +K++D G+ + T T T GT ++ P
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGV------AGQLTDTMAKRNTVIGTPFWMAP 194
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITARP 597
E Q +D++SLG+ +++ +P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 37/240 (15%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
+ ++I +G+G +G V K + T A+KV+ D S +EVE+L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----ILREVELLK 76
Query: 445 SMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR--FKIAAEIA 500
+ H N++ L +V E G L D + ++ +S +I ++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVF 131
Query: 501 TALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+ + ++H++ +VHRDLKP NILL +++ KI D GL+ + M
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMK 181
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ-VEQAIRNGTFS 615
GT YI PE + G K D++S GV+L L++ P G + + + + G ++
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPD-ISQGPRQFKQEVEILGSMRHTNMVIL 454
+ + +GEG YG V A ++ +VA+K++ P K+E+ I + H N+V
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 455 LG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G L EY G L DR+ P F ++ +++LH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG-- 125
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQ 571
+ HRD+KP N+LLD+ KISD GLA + + + + GT Y+ PE +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----RLLNKMCGTLPYVAPELLK 180
Query: 572 QTGMLGVKSDLYSLGVVL 589
+ D++S G+VL
Sbjct: 181 RREFHAEPVDVWSCGIVL 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 45/223 (20%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL---------GPDISQGPRQFKQEVE 441
+ + +G G V + T A+K++ ++ + +EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 442 ILGSM-RHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIA 496
IL + H N++ L + LV++ M+ G L D L +K K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKET 126
Query: 497 AE----IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552
+ + + LH+ +VHRDLKP NILLD + K++D G + + P
Sbjct: 127 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---- 179
Query: 553 QYHMTTAAGTFCYIDPE------YQQTGMLGVKSDLYSLGVVL 589
+ GT Y+ PE G + D++S GV++
Sbjct: 180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ--FKQEVEILGSMRH 448
KIGEG G V A+ H+ VA+K++ D+ + R+ EV I+ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQH 101
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V + + L + E+++ G+L D + Q + I + + AL +L
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---QIAT-VCEAVLQALAYL 157
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H ++HRD+K +ILL + K+SD G A + + GT ++
Sbjct: 158 HAQG---VIHRDIKSDSILLTLDGRVKLSDFGF------CAQISKDVPKRKSLVGTPYWM 208
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE + + D++SLG+++++++ P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ--FKQEVEILGSMRH 448
++ KIG+G G VY A T VAI+ + ++ Q P++ E+ ++ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKN 76
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA---EIATAL 503
N+V L + L V EY+ GSL D + + +IAA E AL
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQAL 129
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
FLH N+ ++HRD+K NILL + K++D G A T Q +T GT
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTP 180
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE G K D++SLG++ +++I P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 48/243 (19%), Positives = 92/243 (37%), Gaps = 36/243 (14%)
Query: 359 KAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT 418
K ++ + + + + V ++ ++ DY+ I ++G G +G V++ T
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVY------DYYDILEELGSGAFGVVHRCVEKAT 75
Query: 419 --SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSL 474
K + K E+ I+ + H ++ L A L+ E++ G L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 475 EDRLFQKDNSPPIHWSIRF--KIAAE----IATALLFLHQNKPEPLVHRDLKPANILLDQ 528
DR+ +D L +H++ +VH D+KP NI+ +
Sbjct: 136 FDRIAAEDYK--------MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184
Query: 529 NYVS--KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLG 586
S KI D GLA + P + T + PE +G +D++++G
Sbjct: 185 KKASSVKIIDFGLATKLNPDEI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 587 VVL 589
V+
Sbjct: 238 VLG 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 32/245 (13%), Positives = 63/245 (25%), Gaps = 52/245 (21%)
Query: 396 FSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGP---RQFKQEVEILGSMRH-- 448
+G+ +A Q S + V +Q K+EV L +R
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 449 --------------TNMVILLGACPEYG-------------CLVYEYMENGSLEDRLF-- 479
++V +Y M+ +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVL 198
Query: 480 --QKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537
+ R ++ ++ L LH LVH L+P +I+LDQ ++
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPE-----YQQTGMLGVKSDLYSLGVVLLQL 592
+ ++ D ++LG+ + +
Sbjct: 256 EHLV-----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
Query: 593 ITARP 597
A
Sbjct: 311 WCADL 315
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 46/212 (21%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLG--PDISQGPRQFKQEVEILGSMRH 448
+D + + ++G+G + V + T A K++ ++ ++ ++E I ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 449 TNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IA 500
N+V L + + LV++ + G L + + ++ + A+ I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQIL 115
Query: 501 TALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++ + H N +VHR+LKP N+LL + K++D GLA V
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-------SEAWH 165
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
AGT Y+ PE + D+++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR--QFKQEVEILGSMRH 448
+ + I ++G+G +G VYKA+ T A KV+ + + E+EIL + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 449 TNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
+V LLGA G L + E+ G+++ + + + I+ + ++ AL FL
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFL 133
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H + ++HRDLK N+L+ +++D G+ SA + T + GT ++
Sbjct: 134 HSKR---IIHRDLKAGNVLMTLEGDIRLADFGV------SAKNLKTLQKRDSFIGTPYWM 184
Query: 567 DPE-----YQQTGMLGVKSDLYSLGVVLLQLITARP 597
PE + K+D++SLG+ L+++ P
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 389 IEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR-QFKQEVEI-LG 444
+E D ++G G YG V K + + +A+K + ++ + + +++I +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 445 SMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRL-FQKDNSPPIHWSIRFKIAAEIAT 501
++ V GA G + E M + SL+ D I I KIA I
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL-ARLVPPSAADTITQYHMTTAA 560
AL LH ++HRD+KP+N+L++ K+ D G+ LV D + A
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV-----DDVA---KDIDA 170
Query: 561 GTFCY-----IDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
G Y I+PE Q G VKSD++SLG+ +++L R
Sbjct: 171 GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRF 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 30/246 (12%), Positives = 70/246 (28%), Gaps = 61/246 (24%)
Query: 400 RKIGEGGYGPVYKA--QLDHTSVAIKVLG----------------------------PDI 429
+G+ +A Q S + V
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 430 SQGPRQFKQEVEILGSMRHTNMVILLGACPEYG----CLVYEYME--NGSLEDRLFQK-D 482
++ +F +++ + M+ + + +Y M+ + + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 483 NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542
+ R ++ ++ L LH LVH L+P +I+LDQ ++
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 543 VPPSAADTITQYHMTTAAGTFCYIDPEY-----------QQTGMLGVKSDLYSLGVVLLQ 591
++ + + PE + ++ D ++LG+V+
Sbjct: 256 DG----------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 592 LITARP 597
+ A
Sbjct: 306 IWCADL 311
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+D+F + ++G G VY+ + T A+KVL + + + E+ +L + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IATA 502
++ L P LV E + G L DR+ +K + + AA+ I A
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEA 160
Query: 503 LLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ +LH+N +VHRDLKP N+L + KI+D GL+++V M T
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-------MKTV 210
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT Y PE + G + D++S+G++
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 32/210 (15%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPD--ISQGPRQFKQEVEILGSMRHTNMVI 453
+ + IG+G + V A L VAIK++ ++ +EV I+ + H N+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 454 LLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF------KIAAEIATALLF 505
L + L+ EY G + D L R +I +A+ +
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQY 129
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
HQ + +VHRDLK N+LLD + KI+D G + + G Y
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-------KLDAFCGAPPY 179
Query: 566 IDPE-YQQTGMLGVKSDLYSLGVVLLQLIT 594
PE +Q G + D++SLGV+L L++
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 31/279 (11%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR-QFKQEVEI- 442
+ + + +IG G YG V K + +A+K + + + + Q ++++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 443 LGSMRHTNMVILLGACPEYGCL--VYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAE 498
+ S +V GA G E M + S + + I I KI
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL-ARLVPPSAADTITQYHMT 557
AL L +N ++HRD+KP+NILLD++ K+ D G+ +LV D+I + T
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----DSIAK---T 183
Query: 558 TAAGTFCYIDPEYQQTGMLG----VKSDLYSLGVVLLQLITARP---AMGLSHQVEQAIR 610
AG Y+ PE V+SD++SLG+ L +L T R +
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
G +L + + + C + RP
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVN----LCLTKDESKRP 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 395 YFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVL--------GPDISQGPRQFKQEVEILG 444
+S +G G +G V+ A + V +K + + E+ IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 445 SMRHTNMVILLG--ACPEYGCLVYEYMENGS-LEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+ H N++ +L + LV E +G L + + S F+ ++ +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR---QLVS 141
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
A+ +L ++HRD+K NI++ +++ K+ D G A + T G
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-------LFYTFCG 191
Query: 562 TFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLIT 594
T Y PE G + +++SLGV L L+
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
D++ + ++G G + V K + T A K + + ++EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 445 SMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE-- 498
+RH N++ L L+ E + G L D L +K++ A +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---------LTEDEATQFL 114
Query: 499 --IATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTIT 552
I + +LH + + H DLKP NI+L N K+ D G+A +
Sbjct: 115 KQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---- 167
Query: 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT ++ PE LG+++D++S+GV+
Sbjct: 168 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 393 TDYFSISRK-IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMR-H 448
D + + +GEG + V TS A+K++ + +EVE+L + H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 449 TNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAEIATALL 504
N++ L+ + LV+E M GS+ + ++ H++ + ++A+AL
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALD 125
Query: 505 FLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADT-ITQYHMTTAA 560
FLH + HRDLKP NIL +Q KI D L + + + I+ + T
Sbjct: 126 FLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 561 GTFCYIDPE-----YQQTGMLGVKSDLYSLGVVL 589
G+ Y+ PE ++ + + DL+SLGV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
+D + + ++G+G + V + T A K++ D + ++E I
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICR 83
Query: 445 SMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE-- 498
++H N+V L + + LV++ + G L + + ++ + A+
Sbjct: 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCI 134
Query: 499 --IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQ 553
I ++ + H N +VHR+LKP N+LL + K++D GLA V S A
Sbjct: 135 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA----- 186
Query: 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
AGT Y+ PE + D+++ GV+L
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 57/253 (22%), Positives = 98/253 (38%), Gaps = 47/253 (18%)
Query: 362 QEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--S 419
Q + + + ++M ++ +E + IG G V + T
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFY---QKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 420 VAIKVL--------GPDISQGPRQFKQEVEILGSMR-HTNMVILLGAC--PEYGCLVYEY 468
A+K++ + + ++E IL + H +++ L+ + + LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 469 MENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IATALLFLHQNKPEPLVHRDLKPA 522
M G L D L +K K + A+ FLH N +VHRDLKP
Sbjct: 182 MRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE 229
Query: 523 NILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE------YQQTGML 576
NILLD N ++SD G + + P + GT Y+ PE +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEK-------LRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 577 GVKSDLYSLGVVL 589
G + DL++ GV+L
Sbjct: 283 GKEVDLWACGVIL 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR-QFKQEVEIL 443
+ +A + ++G G G V+K + T +A+K + ++ + +++++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 444 GSM-RHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+V G + E M + +K PI I K+ I
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KLKKRMQGPIPERILGKMTVAIV 134
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL-ARLVPPSAADTITQYHMTTA 559
AL +L + ++HRD+KP+NILLD+ K+ D G+ RLV D + +
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-----DDKAK---DRS 184
Query: 560 AGTFCY-----IDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
AG Y IDP +++D++SLG+ L++L T +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVL---------GPDISQGPR------------ 434
+ +IG+G YG V A + D+T A+KVL G PR
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 435 -----QFKQEVEILGSMRHTNMV----ILLGACPEYGCLVYEYMENGSLEDRLFQKDNSP 485
Q QE+ IL + H N+V +L ++ +V+E + G + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 486 PIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545
P+ ++ + +LH K ++HRD+KP+N+L+ ++ KI+D G++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 546 SAADTITQYHMTTAAGTFCYIDPE---YQQTGMLGVKSDLYSLGVVLLQLITAR 596
S A ++ GT ++ PE + G D++++GV L + +
Sbjct: 190 SDA------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
D++ I ++G G +G V++ T + A K + ++E++ + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFL 506
+V L A ++YE+M G L +++ + N S + ++ L +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHM 271
Query: 507 HQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
H+N VH DLKP NI+ N + K+ D GL + P + GT
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQ-------SVKVTTGTA 320
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVL 589
+ PE + +G +D++S+GV+
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 374 MAYKNVRYRKYTIEEIEA-ATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS 430
MA+ V+ ++ ++A + F+ KIG+G +G V+K + T VAIK++ + +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 431 QGPRQ-FKQEVEILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPI 487
+ + +QE+ +L + G+ + L + EY+ GS D L +
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDET 119
Query: 488 HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547
+ I EI L +LH K +HRD+K AN+LL ++ K++D G+ +
Sbjct: 120 QIAT---ILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGV------AG 167
Query: 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T TQ T GT ++ PE + K+D++SLG+ ++L P
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMRHTN 450
D + + IG G V A VAIK + + Q +E++ + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 451 MVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFK---IAA---EIATA 502
+V + L V + + GS+ D + + + H S IA E+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL-ARLVPPSAADTITQYHMTTAAG 561
L +LH+N +HRD+K NILL ++ +I+D G+ A L + D T G
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLA--TGGDITRNKVRKTFVG 188
Query: 562 TFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARP 597
T C++ PE +Q K+D++S G+ ++L T
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-23
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 41/216 (18%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
T+ + + ++G+G + V + A ++ D + ++E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK----LEREARICR 65
Query: 445 SMRHTNMVILLGACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE-- 498
++H N+V L + E G L+++ + G L + + ++ + A+
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCI 116
Query: 499 --IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQ 553
I A+L HQ +VHR+LKP N+LL + K++D GLA V Q
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE------Q 167
Query: 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
AGT Y+ PE + G DL++ GV+L
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
D++ I ++G G + V K + T A K + + ++EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 445 SMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE---- 498
+ H N++ L L+ E + G L D L QK+ S+ + A
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQ 123
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTITQY 554
I + +LH K + H DLKP NI+L K+ D GLA +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------ 174
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT ++ PE LG+++D++S+GV+
Sbjct: 175 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQF 436
T+ E DY+ ++G G + V K + T A K +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 437 KQEVEILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK 494
++EV IL ++H N++ L L+ E + G L D L +K+ +
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEE-- 114
Query: 495 IAAE----IATALLFLHQNKPEPLVHRDLKPANILL-DQNYVS---KISDVGLARLVPPS 546
A E I + +LH + + H DLKP NI+L D+N KI D GLA +
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT ++ PE LG+++D++S+GV+
Sbjct: 172 NE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 395 YFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPR---QFKQEVEILGSMRHT 449
++ + +G G +G V QL VA+K+L + + K+E++ L RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 450 NMVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+++ L + P +V EY+ G L D + + + F+ +I +A+ + H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH 128
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
++ +VHRDLKP N+LLD + +KI+D GL+ ++ + T+ G+ Y
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAA 178
Query: 568 PE-YQQTGMLGVKSDLYSLGVVLLQLIT 594
PE G + D++S GV+L L+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLC 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 29/216 (13%)
Query: 394 DYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVL------GPDISQGPRQFKQEVEILGS 445
+ + +G GG+G VY D+ VAIK + + EV +L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 446 MRHT--NMVILLG--ACPEYGCLVYEYMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+ ++ LL P+ L+ E E L D + ++ + ++
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVL 159
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVS-KISDVGLARLVPPSAADTITQYHMTTA 559
A+ H ++HRD+K NIL+D N K+ D G L+ + T
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDF 208
Query: 560 AGTFCYIDPEY-QQTGMLGVKSDLYSLGVVLLQLIT 594
GT Y PE+ + G + ++SLG++L ++
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL------GPDISQGPRQFKQEVEILG 444
D++ I ++G G + V K + T A K + + ++EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 445 SMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE---- 498
+ H N++ L L+ E + G L D L QK+ S+ + A
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQ 123
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTITQY 554
I + +LH K + H DLKP NI+L K+ D GLA +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------ 174
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
GT ++ PE LG+++D++S+GV+
Sbjct: 175 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 34/239 (14%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILG-SMRHT 449
TD + + IG G Y + T A+K+ I + R +E+EIL +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQHP 76
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAEIATALLF 505
N++ L +Y +V E M+ G L D++ ++ +S R + I + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEY 131
Query: 506 LHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
LH +VHRDLKP+NIL +I D G A+ + + T
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA------ENGLLMTPCY 182
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP---AMGLSHQVE--QAIRNGTFS 615
T ++ PE + D++SLGV+L ++T E I +G FS
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 54/301 (17%)
Query: 347 ELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGG 406
L QE + + + +K + + D+F R +G GG
Sbjct: 145 PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGE-------DWFLDFRVLGRGG 197
Query: 407 YGPVYKAQLDHTSV--AIKVLGPD-ISQGPRQFKQEVE-------ILGSMRHTNMVILLG 456
+G V+ Q+ T A K L + + ++ + IL + +V L
Sbjct: 198 FGEVFACQMKATGKLYACKKLNKKRLKK-----RKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 457 A--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI------AAEIATALLFLHQ 508
A CLV M G + ++ D P F+ A+I + L LHQ
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-----GFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 509 NKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+++RDLKP N+LLD + V +ISD+GLA + T AGT ++
Sbjct: 308 RN---IIYRDLKPENVLLDDDGNV-RISDLGLAVELKAGQTKT------KGYAGTPGFMA 357
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP------AMGLSHQVEQAIRNGT--FSELLD 619
PE D ++LGV L ++I AR + +++Q + + +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 620 P 620
P
Sbjct: 418 P 418
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/218 (22%), Positives = 78/218 (35%), Gaps = 45/218 (20%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVL-------GPDISQGPRQFKQEVEIL--- 443
+ + +G+GG+G V+ D VAIKV+ +S EV +L
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 444 -GSMRHTNMVILLG--ACPEYGCLVYEYMENGS-LEDRLFQKDNSPPIHWSIRF------ 493
H ++ LL E LV E L D + +K
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSR 142
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS-KISDVGLARLVPPSAADTIT 552
++ A+ H +VHRD+K NIL+D K+ D G L+
Sbjct: 143 CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE------ 193
Query: 553 QYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVL 589
T GT Y PE+ + + ++SLG++L
Sbjct: 194 --PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 46/246 (18%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQ-FKQEVEILGSMR-HT 449
D + +GEG + K + + A+K+ IS+ ++E+ L H
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI----ISKRMEANTQKEITALKLCEGHP 66
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----IAT 501
N+V L + LV E + G L +R+ +K + F A+ + +
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVS 117
Query: 502 ALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
A+ +H +VHRDLKP N+L + N KI D G ARL PP + T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD------NQPLKT 168
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP---------AMGLSHQVEQAI 609
T Y PE DL+SLGV+L +++ + + ++ + I
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228
Query: 610 RNGTFS 615
+ G FS
Sbjct: 229 KKGDFS 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ-FKQEVEILGSM-RH 448
F + +G G YG VYK + T AIKV+ D++ + KQE+ +L H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHH 80
Query: 449 TNMVILLGA-----CPEYGC---LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
N+ GA P LV E+ GS+ D + + I + I EI
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREIL 139
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
L LHQ+K ++HRD+K N+LL +N K+ D G+ SA T T
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV------SAQLDRTVGRRNTFI 190
Query: 561 GTFCYIDPE-----YQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT ++ PE KSDL+SLG+ +++ P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 46/246 (18%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSM-RHTN 450
DY S+ +G G G V + T A+K+ + P+ ++EVE+ + +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM----LQDCPK-ARREVELHWRASQCPH 116
Query: 451 MVILLGAC------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE---- 498
+V ++ + +V E ++ G L R+ + + F + A+E
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKS 169
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYH 555
I A+ +LH + HRD+KP N+L N + K++D G A+ +
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS------- 219
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP------AMGLSHQVEQAI 609
+TT T Y+ PE D++SLGV++ L+ P + +S ++ I
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279
Query: 610 RNGTFS 615
R G +
Sbjct: 280 RMGQYE 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 43/212 (20%), Positives = 84/212 (39%), Gaps = 37/212 (17%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVL---GPDISQGPRQFKQEVEILGSMR 447
+ + I+ +G G +G V++ + + K + G D K+E+ IL R
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIAR 59
Query: 448 HTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE----I 499
H N++ L + E +++E++ + +R+ + +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQV 111
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILL--DQNYVSKISDVGLARLVPPSAADTITQYHMT 557
AL FLH + + H D++P NI+ ++ KI + G AR + P
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-------FR 161
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
Y PE Q ++ +D++SLG ++
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 53/250 (21%), Positives = 102/250 (40%), Gaps = 28/250 (11%)
Query: 352 KREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRK--IGEGGYGP 409
++ E ++ + + ++ A + + A ++++S+ +G G +G
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 410 VYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA--CPEYGCLV 465
V+K + T +A K++ + + K E+ ++ + H N++ L A LV
Sbjct: 105 VHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164
Query: 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE----IATALLFLHQNKPEPLVHRDLKP 521
EY++ G L DR+ + + + I + +HQ ++H DLKP
Sbjct: 165 MEYVDGGELFDRIIDESYN------LTELDTILFMKQICEGIRHMHQMY---ILHLDLKP 215
Query: 522 ANILLDQNYVS--KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK 579
NIL KI D GLAR P + GT ++ PE +
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREK-------LKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 580 SDLYSLGVVL 589
+D++S+GV+
Sbjct: 269 TDMWSVGVIA 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 48/248 (19%)
Query: 393 TDYFSISRK-IGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILG-SMRH 448
TD + +S++ +G G G V + T A+K+ + P+ +QEV+ +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL----LYDSPK-ARQEVDHHWQASGG 81
Query: 449 TNMVILLGA------CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE-- 498
++V +L ++ E ME G L R+ ++ + F + AAE
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIM 134
Query: 499 --IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQ 553
I TA+ FLH + + HRD+KP N+L +++ V K++D G A+ +A
Sbjct: 135 RDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA------ 185
Query: 554 YHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP------AMGLSHQVEQ 607
+ T T Y+ PE D++SLGV++ L+ P +S +++
Sbjct: 186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
Query: 608 AIRNGTFS 615
IR G +
Sbjct: 244 RIRLGQYG 251
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 9e-22
Identities = 77/341 (22%), Positives = 131/341 (38%), Gaps = 47/341 (13%)
Query: 273 RLELKQSMEIYNSVSKEAVSTSQTAVKLQQRKKEEALKLEEARLAEEAALALVKSERQKT 332
R EL + + + V++ V+ ++K L + L+ + + RQ
Sbjct: 74 RPELSRCVAFLDGVAEYEVTP-------DDKRKACGRNLTQNFLSHTGPDLIPEVPRQLV 126
Query: 333 RAAMEAALMAQRLVELEAMKREIAE---LKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEI 389
+ + + R E + + + + +K + + T
Sbjct: 127 TNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTK--- 183
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPD-ISQGPRQFKQEVE----- 441
+ F R +G+GG+G V Q+ T A K L I + ++
Sbjct: 184 ----NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNE 234
Query: 442 --ILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
IL + +V L A + CLV M G L+ ++ + F AA
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YAA 293
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHM 556
EI L LH+ + +V+RDLKP NILLD + ++ +ISD+GLA VP TI
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHI-RISDLGLAVHVPEG--QTI----- 342
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
GT Y+ PE + D ++LG +L ++I +
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 19/218 (8%)
Query: 393 TDYFSISRKIGEG--GYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF----KQEVEILG 444
+ + IG+G V A+ T V ++ + ++ + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 445 SMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
H N+V L V +M GS +D + +I + I + A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKA 140
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG-LARLVPPSAADTITQYHMTTAAG 561
L ++H VHR +K ++IL+ + +S + ++ + +
Sbjct: 141 LDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 562 TFCYIDPEYQQTGMLG--VKSDLYSLGVVLLQLITARP 597
++ PE Q + G KSD+YS+G+ +L
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 36/299 (12%)
Query: 313 EARLAE-EAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVM 371
E RL + E + ++ ++E L + E + K + E E
Sbjct: 3 EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWA--- 59
Query: 372 EAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDI 429
V+ + E+ F I + IG G +G V +L + A+K+L
Sbjct: 60 -KPFTSKVKQMRLHRED-------FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE 111
Query: 430 SQGPRQ---FKQEVEILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNS 484
+ F++E ++L + + L A LV +Y G L L + ++
Sbjct: 112 MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR 171
Query: 485 PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLV 543
P + RF AE+ A+ +HQ VHRD+KP NIL+D N ++ +++D G +
Sbjct: 172 LPEEMA-RF-YLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHI-RLADFGSCLKL 225
Query: 544 PPSAADTITQYHMTTAAGTFCYIDPE-----YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ A GT YI PE G G + D +SLGV + +++
Sbjct: 226 MEDGTVQ-----SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 63/250 (25%), Positives = 113/250 (45%), Gaps = 31/250 (12%)
Query: 391 AATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGSMR 447
+++ F K+G G Y VYK T VA+K + D +G P +E+ ++ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 448 HTNMVILLGACPEYGC--LVYEYMEN--GSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
H N+V L LV+E+M+N D + + ++ ++ L
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAG 561
F H+NK ++HRDLKP N+L+++ K+ D GLAR +P + ++
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--------FSSEVV 170
Query: 562 TFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSE 616
T Y P+ ++G ++ D++S G +L ++IT +P ++ EQ F
Sbjct: 171 TLWYRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL--IFDI 224
Query: 617 LLDPTVTGWP 626
+ P + WP
Sbjct: 225 MGTPNESLWP 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPDISQGPRQF---KQEVEILGSMRH 448
D+F I R IG+G +G V Q + T A+K + + +E++I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 449 TNMVILLGA--CPEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+V L + E +V + + G L ++ F+++ +++ E+
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-------TVKL-FICELVM 126
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAA 560
AL +L + ++HRD+KP NILLD++ +V I+D +A ++P +T TT A
Sbjct: 127 ALDYLQNQR---IIHRDMKPDNILLDEHGHV-HITDFNIAAMLPR---ETQI----TTMA 175
Query: 561 GTFCYIDPE-YQQTGMLG----VKSDLYSLGVVLLQLITARP 597
GT Y+ PE + G V D +SLGV +L+ R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 32/208 (15%), Positives = 57/208 (27%), Gaps = 50/208 (24%)
Query: 398 ISRKIGEGGYGPVYKA---QLDHTSVAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNM 451
+ G ++A LD VA+ + P L + +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 452 VILL--GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
+L G +V E++ GSL++ D SP +IR +A A H+
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIR--AMQSLAAAADAAHRA 148
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+ P+ + +S G L +
Sbjct: 149 ---GVALSIDHPSRVR--------VSIDGDVVL------------------AYPATMPDA 179
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ D+ +G L L+ R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRW 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 395 YFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI---SQGPRQFKQEVEILGSMRHT 449
++ + +G G +G V + + T VA+K+L + ++E++ L RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 450 NMVILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+++ L + P +V EY+ G L D + + F+ +I + + + H
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCH 133
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
++ +VHRDLKP N+LLD + +KI+D GL+ ++ + T+ G+ Y
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAA 183
Query: 568 PE-YQQTGMLGVKSDLYSLGVVLLQLIT 594
PE G + D++S GV+L L+
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (228), Expect = 2e-20
Identities = 40/195 (20%), Positives = 66/195 (33%), Gaps = 47/195 (24%)
Query: 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVL---GPDISQGPRQ-----FKQEVEIL 443
T+ KIGEG +G V++ DHT VAIK++ GPD+ G Q E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 444 ---------GSMRHTNMVILL------GACPEYGCLVYEYM--ENGSLEDRL-------- 478
R + L G+ P +++ GS DR
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 479 ------------FQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526
++ + + I ++ +L + HRDL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLL 195
Query: 527 DQNYVSKISDVGLAR 541
+ + K+ +
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 56/283 (19%)
Query: 381 YRKYTIEEIEAATDYFSISR-KIGEGGYGPVYKAQLDHTS----VAIKVLGPDISQG-PR 434
++ E E D F K+G G YG VYKA+ A+K + G
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISM 63
Query: 435 QFKQEVEILGSMRHTNMVILLGACPEYG----CLVYEYMEN---GSLEDRLFQKDNSPPI 487
+E+ +L ++H N++ L + L+++Y E+ ++ K N P+
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 488 HWSIRF--KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS----KISDVGLAR 541
+ +I + +LH N ++HRDLKPANIL+ KI+D+G AR
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 542 L--VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLIT 594
L P + TF Y PE +LG + D++++G + +L+T
Sbjct: 181 LFNSPLK-----PLADLDPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLT 231
Query: 595 ARPAMGLSHQVEQAIRNGTFSELLD-----------PTVTGWP 626
+ P Q + D P W
Sbjct: 232 SEPIF----HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 270
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 30/244 (12%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGSMRHTN 450
+ + K+GEG Y VYK + T VA+K + + +G P +EV +L ++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 451 MVILLGACPEYGC--LVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+V L LV+EY++ D + + D I+ ++ L + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ K ++HRDLKP N+L+++ K++D GLAR A +I T Y
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWYRP 168
Query: 568 PEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622
P+ +LG D++ +G + ++ T RP S EQ F L PT
Sbjct: 169 PDI----LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF--IFRILGTPTE 222
Query: 623 TGWP 626
WP
Sbjct: 223 ETWP 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 41/238 (17%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVIL 454
+ IG G +G +L VA+K + + ++E+ S+RH N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRF 81
Query: 455 --LGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAA------EIATALLFL 506
+ P + ++ EY G L +R+ RF ++ + + +
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYC 132
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVS--KISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
H + + HRDLK N LLD + KI D G ++ + + GT
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-------PKSTVGTPA 182
Query: 565 YIDPE-YQQTGMLGVKSDLYSLGVVLLQLITAR-P-----AMGLSHQVEQAIRNGTFS 615
YI PE + G +D++S GV L ++ P + Q I + +S
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 398 ISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPD-ISQG--PRQFKQEVEILGSMRHTNMV 452
I +GEG +G V A VA+K + + + + ++E+ L +RH +++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 453 ILLG--ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
L P +V EY G L D + +K F+ +I A+ + H++K
Sbjct: 73 KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ---QIICAIEYCHRHK 128
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE- 569
+VHRDLKP N+LLD N KI+D GL+ ++ + T+ G+ Y PE
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-------FLKTSCGSPNYAAPEV 178
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR 596
G + D++S G+VL ++ R
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 54/265 (20%), Positives = 103/265 (38%), Gaps = 49/265 (18%)
Query: 350 AMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGP 409
A ++ +E ++++E K ++ +++ F + +G G +G
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGR 56
Query: 410 VYKAQLDHTS--VAIKVLGPDISQGPRQF---KQEVEILGSMRHTNMVILLGAC--PEYG 462
V + + A+K+L +Q E IL ++ +V L +
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 463 CLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517
+V EY+ G + F + ++ RF AA+I +LH L++R
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHA-------RF-YAAQIVLTFEYLHSLD---LIYR 165
Query: 518 DLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPEYQQ 572
DLKP N+L+DQ Y+ +++D G A+ V T C + PE
Sbjct: 166 DLKPENLLIDQQGYI-QVTDFGFAKRVK-------------GRTWTLCGTPEALAPEIIL 211
Query: 573 TGMLGVKSDLYSLGVVLLQLITARP 597
+ D ++LGV++ ++ P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ-----FKQEVEILGS 445
FS R+IG G +G VY A+ S VAIK + S +EV L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQK 110
Query: 446 MRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+RH N + G V EY GS D L + P I + L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAA-VTHGALQGL 167
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+LH + ++HRD+K NILL + + K+ D G A + + GT
Sbjct: 168 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS--------ASIMAP--ANSFVGTP 214
Query: 564 CYIDPE---YQQTGMLGVKSDLYSLGVVLLQLITARP 597
++ PE G K D++SLG+ ++L +P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK--VLGPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
KIGEG YG V+K + T VAIK + D + +E+ +L ++H N+V LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 457 ACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
LV+EY ++ ++ L + + I + A+ F H++
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 515 VHRDLKPANILLDQNYVSKISDVGLAR 541
+HRD+KP NIL+ ++ V K+ D G AR
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-20
Identities = 77/315 (24%), Positives = 118/315 (37%), Gaps = 35/315 (11%)
Query: 299 KLQQRKKEEALKLEEARLAEEAALALVKSERQKTRAAMEAALMAQRLVELEAMKREIAEL 358
KL+ ++ E L K+ + ++ V + + I E+
Sbjct: 94 KLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEI 153
Query: 359 KAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHT 418
+ + +E+ + K I + FS+ R IG GG+G VY + T
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT 213
Query: 419 SV--AIKVLGPD-ISQGPRQFKQEVE-------IL---GSMRHTNMVILLGA--CPEYGC 463
A+K L I KQ +L + +V + A P+
Sbjct: 214 GKMYAMKCLDKKRIKM-----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268
Query: 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
+ + M G L L Q +RF AAEI L +H +V+RDLKPAN
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEAD--MRF-YAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-DL 582
ILLD++ +ISD+GLA GT Y+ PE Q G+ S D
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEVLQKGVAYDSSADW 374
Query: 583 YSLGVVLLQLITARP 597
+SLG +L +L+
Sbjct: 375 FSLGCMLFKLLRGHS 389
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 34/228 (14%)
Query: 379 VRYRKYTIEEIEAATDYFSI-SRKIGEGGYGPVYKAQLDHT--SVAIKVLG-PDISQGPR 434
+ + +E +++ + S+++G G + V + T A K L Q R
Sbjct: 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 435 Q-FKQEVEILGSMRHT-NMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS 490
E+ +L + ++ L L+ EY G + +
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE------ 126
Query: 491 IRF--KIAAE----IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLAR 541
I + +LHQN +VH DLKP NILL KI D G++R
Sbjct: 127 -MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVL 589
+ + + GT Y+ PE + +D++++G++
Sbjct: 183 KIGHACE-------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 66/265 (24%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 348 LEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGY 407
L+ + EL A + ++K + + + R ++E+ D F I + IG G +
Sbjct: 18 LDLLLGVHQELGASELAQDKYVADFLQWAEPIVVR---LKEVRLQRDDFEILKVIGRGAF 74
Query: 408 GPVYKAQLDHTS--VAIKVLGPD--ISQG-PRQFKQEVEILGSMRHTNMVILLGA--CPE 460
V ++ T A+K++ + +G F++E ++L + + L A
Sbjct: 75 SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134
Query: 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520
Y LV EY G L L + P + RF AEI A+ +H+ VHRD+K
Sbjct: 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RF-YLAEIVMAIDSVHRLG---YVHRDIK 189
Query: 521 PANILLDQNYVSKISDVGLA-RLVPPSAADTITQYHMTTAAGTFCYIDPE-------YQQ 572
P NILLD+ +++D G +L + A GT Y+ PE
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRS------LVAVGTPDYLSPEILQAVGGGPG 243
Query: 573 TGMLGVKSDLYSLGVVLLQLITARP 597
TG G + D ++LGV ++ +
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIK--VLGPDISQGPRQFKQEVEILGSMRHTNMVILLG 456
+GEG YG V K + T VAIK + D + +E+++L +RH N+V LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 457 ACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
C + LV+E++++ ++ D L + + + + K +I + F H +
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHNI--- 145
Query: 515 VHRDLKPANILLDQNYVSKISDVGLAR 541
+HRD+KP NIL+ Q+ V K+ D G AR
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 68/247 (27%), Positives = 112/247 (45%), Gaps = 36/247 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ-G-PRQFKQEVEILGSMRHT 449
+ + K+GEG YG VYKA+ D VA+K + D G P +E+ +L + H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 450 NMVILLGACPEYGC--LVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V L+ C LV+E+ME D + +N + S ++ +
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAGTFC 564
HQ++ ++HRDLKP N+L++ + K++D GLAR +P + T T
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--------YTHEVVTLW 184
Query: 565 YIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLD 619
Y P+ ++G K D++S+G + ++IT +P +Q + FS L
Sbjct: 185 YRAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK--IFSILGT 238
Query: 620 PTVTGWP 626
P WP
Sbjct: 239 PNPREWP 245
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 36/247 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ-G-PRQFKQEVEILGSMRHT 449
+ + KIGEG YG VYKAQ ++ A+K + + G P +E+ IL ++H+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 450 NMVILLGACPEYG--CLVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V L LV+E+++ D + + ++ + +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAGTFC 564
H + ++HRDLKP N+L+++ KI+D GLAR +P T T
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--------YTHEIVTLW 165
Query: 565 YIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLD 619
Y P+ ++G K D++S+G + +++ P + +Q +R F L
Sbjct: 166 YRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR--IFRILGT 219
Query: 620 PTVTGWP 626
P WP
Sbjct: 220 PNSKNWP 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ-G-PRQFKQEVEILGSMRHT 449
D + K+GEG YG VYKA T+ VAIK + + + G P +EV +L ++H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 450 NMVILLGACPEYGC--LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N++ L L++EY EN L+ + D +P + + ++ + F H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 508 QNKPEPLVHRDLKPANILLDQNYVS-----KISDVGLARL--VPPSAADTITQYHMTTAA 560
+ +HRDLKP N+LL + S KI D GLAR +P T
Sbjct: 150 SRRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--------FTHEI 198
Query: 561 GTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFS 615
T Y PE +LG + D++S+ + +++ P +++Q + F
Sbjct: 199 ITLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK--IFE 252
Query: 616 ELLDPTVTGWP 626
L P T WP
Sbjct: 253 VLGLPDDTTWP 263
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 65/266 (24%), Positives = 107/266 (40%), Gaps = 36/266 (13%)
Query: 348 LEAMKREIAELKAMQEEEEKKIVMEAMAYKN----VRYRKYTIEEIEAATDYFSISRKIG 403
L+ + + +L + K I YK+ +R + E+ + + + IG
Sbjct: 26 LDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAED-------YEVVKVIG 78
Query: 404 EGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNMVILLGA- 457
G +G V + T A+K+L F +E +I+ +V L A
Sbjct: 79 RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138
Query: 458 -CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516
Y +V EYM G L + + D RF AE+ AL +H +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW---ARF-YTAEVVLALDAIHSMG---FIH 191
Query: 517 RDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE-YQQTG 574
RD+KP N+LLD++ ++ K++D G + TA GT YI PE + G
Sbjct: 192 RDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVR-----CDTAVGTPDYISPEVLKSQG 245
Query: 575 ML---GVKSDLYSLGVVLLQLITARP 597
G + D +S+GV L +++
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 38/249 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ-G-PRQFKQEVEILGSMRHT 449
+ KIGEG YG V+KA+ T VA+K + D G P +E+ +L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 450 NMVILLGACPEYGC--LVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
N+V L LV+E+ + D + + + + I ++ L F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTAAGTFC 564
H ++HRDLKP N+L+++N K+++ GLAR +P + T
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--------YSAEVVTLW 166
Query: 565 YIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAM--GLSHQVEQAIRNGTFSEL 617
Y P+ + G K D++S G + +L A + G +Q R F L
Sbjct: 167 YRPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKR--IFRLL 219
Query: 618 LDPTVTGWP 626
PT WP
Sbjct: 220 GTPTEEQWP 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 52/233 (22%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFK----QEVEILGSM 446
D F + R G+G +G V + T SVAIK + Q PR F+ Q ++ L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----KVIQDPR-FRNRELQIMQDLAVL 76
Query: 447 RHTNMV----ILLGACPE-----YGCLVYEYMENGSLED-----RLFQKDNS--PPIHWS 490
H N+V Y +V EY+ + R + + PPI
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPIL-- 130
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAAD 549
I+ ++ ++ LH + HRD+KP N+L++ + K+ D G A+ + PS +
Sbjct: 131 IKV-FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--E 186
Query: 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
Y + Y PE + G + D++S+G + +++ P
Sbjct: 187 PNVAYICSR-----YYRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 49/232 (21%)
Query: 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQF---K 437
KY++++ F I R +G G +G V+ + H A+KVL +I +Q
Sbjct: 2 KYSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN 54
Query: 438 QEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWS 490
E +L + H ++ + G + ++ +Y+E G L + + F +
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA------ 108
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAAD 549
+F AAE+ AL +LH +++RDLKP NILLD+N ++ KI+D G A+ VP
Sbjct: 109 -KF-YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHI-KITDFGFAKYVP----- 157
Query: 550 TITQYHMTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T C YI PE T D +S G+++ +++
Sbjct: 158 --------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 63/267 (23%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVL-------GPDISQGPRQFKQEVEILG 444
+ KIG+G +G V+KA+ T VA+K + G I+ R E++IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALR----EIKILQ 71
Query: 445 SMRHTNMVILLGACPEYGC----------LVYEYMEN---GSLEDRLFQKDNSPPIHWSI 491
++H N+V L+ C LV+++ E+ G L + + ++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--------NVLVKFT- 122
Query: 492 RFKIAAEIAT-------ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544
+EI L ++H+NK ++HRD+K AN+L+ ++ V K++D GLAR
Sbjct: 123 ----LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARPAM 599
+ +Y T T Y PE +LG + DL+ G ++ ++ T P M
Sbjct: 176 LAKNSQPNRY--TNRVVTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229
Query: 600 GLSHQVEQAIRNGTFSELLDPTVTGWP 626
+ + Q T WP
Sbjct: 230 QGNTEQHQLAL--ISQLCGSITPEVWP 254
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 63/266 (23%), Positives = 104/266 (39%), Gaps = 52/266 (19%)
Query: 356 AELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVY---K 412
A+ E+ A K IE F + + +G G YG V+ K
Sbjct: 23 ADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FELLKVLGTGAYGKVFLVRK 75
Query: 413 AQLDHTSV--AIKVLGPD-ISQGPRQF---KQEVEILGSMRHTNMVILLGAC---PEYGC 463
T A+KVL I Q + + E ++L +R + ++ L
Sbjct: 76 ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135
Query: 464 LVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518
L+ +Y+ G L + F + + EI AL LH+ +++RD
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEV-------QI-YVGEIVLALEHLHKLG---IIYRD 184
Query: 519 LKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPEYQQT 573
+K NILLD N +V ++D GL++ + A FC Y+ P+ +
Sbjct: 185 IKLENILLDSNGHV-VLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRG 234
Query: 574 GMLG-VKS-DLYSLGVVLLQLITARP 597
G G K+ D +SLGV++ +L+T
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 52/158 (32%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIK----VLGPDISQG-PRQFKQEVEILGSM 446
+ +GEG + VYKA+ +T+ VAIK + G R +E+++L +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 447 RHTNMVILLGACPEYGC--LVYEYMENGSLED-RLFQKDNSPPIHWSIRFKIAAEIATAL 503
H N++ LL A LV+++ME D + KDNS + S L
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+LHQ+ ++HRDLKP N+LLD+N V K++D GLA+
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 33/168 (19%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSM-RHTN 450
DY S+ +G G G V + T A+K+L D + ++EVE+ + +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDC----PKARREVELHWRASQCPH 72
Query: 451 MVILLGAC------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF--KIAAE---- 498
+V ++ + +V E ++ G L R+ + + F + A+E
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKS 125
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLV 543
I A+ +LH + HRD+KP N+L N + K++D G A+
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
++ + IG G +G V++A+L + VAIK + Q R +E++I+ ++H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 455 LGACPEYGC--------LVYEYME---NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
G LV EY+ + K P + I+ ++ +L
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL--IKL-YMYQLLRSL 154
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADT---ITQYHMTTA 559
++H + HRD+KP N+LLD V K+ D G A+++ + ++Y
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----- 206
Query: 560 AGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
Y PE + G + D++S G V+ +L+ +P
Sbjct: 207 -----YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILGS 445
F + +G+G +G V + T A+K+L + I K EV +L +
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQN 61
Query: 446 MRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI------AA 497
RH + L A + C V EY G L F + F A
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFH------LSRERVFTEERARFYGA 112
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHM 556
EI +AL +LH +V+RD+K N++LD++ ++ KI+D GL + + I+
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI-KITDFGLCK-------EGISDGAT 161
Query: 557 TTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
TFC Y+ PE + G D + LGVV+ +++ R
Sbjct: 162 MK---TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 69/291 (23%), Positives = 118/291 (40%), Gaps = 59/291 (20%)
Query: 328 ERQKTRAAMEAALMAQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIE 387
ER++ A++ L+ + ++ + ++ + + T+
Sbjct: 95 EREEWTTAIQ-----TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK-HRVTMN 148
Query: 388 EIEAATDYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPD-ISQGPRQFKQEVE--- 441
E F + +G+G +G V + T A+K+L + I K EV
Sbjct: 149 E-------FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTL 196
Query: 442 ----ILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWS 490
+L + RH + L + + C V EY G L +R+F +D +
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------ 250
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550
RF AEI +AL +LH K +V+RDLK N++LD++ KI+D GL + +
Sbjct: 251 -RF-YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EG 299
Query: 551 ITQYHMTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
I TFC Y+ PE + G D + LGVV+ +++ R
Sbjct: 300 IKDGATMK---TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 37/230 (16%)
Query: 381 YRKYTIEEIE-AATDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFK 437
Y Y +E D + + RK+G G Y V++A ++ V +K+L P + + K
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 438 QEVEILGSMR-HTNMVILL----GACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR 492
+E++IL ++R N++ L LV+E++ N + +L+Q IR
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQT--LTDYD--IR 133
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTI 551
F + EI AL + H ++HRD+KP N+++D ++ ++ D GLA P
Sbjct: 134 FYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 186
Query: 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITAR 596
+ + PE ++ + D++SLG +L +I +
Sbjct: 187 ----YNVRVASRYFKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQ-EVEILGSMRHTNMV 452
++ ++ IG G +G VY+A+L + VAIK + D ++FK E++I+ + H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 453 ILLGACPEYG--------CLVYEYME---NGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
L G LV +Y+ K P I+ ++ ++
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKL-YMYQLFR 167
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAA 560
+L ++H + HRD+KP N+LLD + V K+ D G A+ + +
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-------NVSYI 217
Query: 561 GTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
+ Y PE + G D++S G VL +L+ +P
Sbjct: 218 CSRYYRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 50/241 (20%)
Query: 378 NVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVY---KAQLDHTSV--AIKVLGPD-ISQ 431
N K E F + R +G+GGYG V+ K +T A+KVL I +
Sbjct: 8 NRGPEKIRPEC-------FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 432 GPRQF---KQEVEILGSMRHTNMVILLGA--CPEYGCLVYEYMENGSL-----EDRLFQK 481
+ K E IL ++H +V L+ A L+ EY+ G L + +F +
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 482 DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLA 540
D + F AEI+ AL LHQ +++RDLKP NI+L+ +V K++D GL
Sbjct: 121 DTA-------CF-YLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV-KLTDFGLC 168
Query: 541 RLVPPSAADTITQYHMTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596
+ +I +T TFC Y+ PE D +SLG ++ ++T
Sbjct: 169 KE-------SIHDGTVTH---TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
Query: 597 P 597
P
Sbjct: 219 P 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 47/251 (18%)
Query: 401 KIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQ-GPRQFKQ----EVEILGSMR---HTN 450
+IG G YG VYKA+ H+ VA+K + G EV +L + H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 451 MVILLGACPEYGC-------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEIAT 501
+V L+ C LV+E+++ D K P + + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL--VPPSAADTITQYHMTTA 559
L FLH N +VHRDLKP NIL+ K++D GLAR+ + +T
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---------LTPV 179
Query: 560 AGTFCYIDPEYQQTGMLGVK----SDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFS 615
T Y PE +L D++S+G + ++ +P + + +Q + F
Sbjct: 180 VVTLWYRAPEV----LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK--IFD 233
Query: 616 ELLDPTVTGWP 626
+ P WP
Sbjct: 234 LIGLPPEDDWP 244
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 58/259 (22%), Positives = 105/259 (40%), Gaps = 60/259 (23%)
Query: 363 EEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVY---KAQLDHTS 419
E K+I + + K + F + + +G+G +G V+ K
Sbjct: 2 EGSIKEI--AITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFLVKKISGSDAR 52
Query: 420 V--AIKVLGPD-ISQGPRQFKQEVE------ILGSMRHTNMVILLGA--CPEYGCLVYEY 468
A+KVL + + V IL + H +V L A L+ ++
Sbjct: 53 QLYAMKVLKKATLKV-----RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107
Query: 469 MENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
+ G L ++ +F +++ +F AE+A AL LH +++RDLKP N
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDV-------KF-YLAELALALDHLHSLG---IIYRDLKPEN 156
Query: 524 ILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPEYQQTGMLGV 578
ILLD+ ++ K++D GL++ +I +FC Y+ PE
Sbjct: 157 ILLDEEGHI-KLTDFGLSKE-------SIDHEKKAY---SFCGTVEYMAPEVVNRRGHTQ 205
Query: 579 KSDLYSLGVVLLQLITARP 597
+D +S GV++ +++T
Sbjct: 206 SADWWSFGVLMFEMLTGTL 224
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILG- 444
F + + +G+G +G V+ A+ T+ AIK L D + +VE +L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSL 73
Query: 445 SMRHTNMVILLGA--CPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATA 502
+ H + + E V EY+ G L + Q + + + F AAEI
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRA-TF-YAAEIILG 130
Query: 503 LLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L FLH +V+RDLK NILLD++ ++ KI+D G+ + + + T
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHI-KIADFGMCK-------ENMLGDAKTN--- 176
Query: 562 TFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
TFC YI PE D +S GV+L +++ +
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 49/233 (21%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGP--DISQGPRQFKQEVEILGSMRH 448
+ F + +GEG YG V A + VAIK + P R + E++IL +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 449 TNMVILLGACPEYGC-------LVYEYME--------NGSLEDRLFQKDNSPPIHWSIRF 493
N++ + ++ E M+ L D H I++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD----------DH--IQY 116
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD---- 549
+ A+ LH + ++HRDLKP+N+L++ N K+ D GLAR++ SAAD
Sbjct: 117 -FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
T Q M T Y PE ML D++S G +L +L RP
Sbjct: 173 TGQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 6e-16
Identities = 64/276 (23%), Positives = 105/276 (38%), Gaps = 59/276 (21%)
Query: 346 VELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEG 405
EL + + EEK + N + + + F+ +G+G
Sbjct: 300 EELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLGKG 352
Query: 406 GYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILGSMRHTNMVILL 455
+G V ++ T A+K+L D + Q +VE +L + L
Sbjct: 353 SFGKVMLSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 456 GAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK------IAAEIATALLFL 506
+C + V EY+ G L ++ I RFK AAEIA L FL
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDL---MYH------IQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 507 HQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC- 564
+++RDLK N++LD ++ KI+D G+ + + I T TFC
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHI-KIADFGMCK-------ENIWDGVTTK---TFCG 504
Query: 565 ---YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
YI PE G D ++ GV+L +++ +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILGS 445
F+ +G+G +G V ++ T A+K+L D + Q +VE +L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLAL 76
Query: 446 MRHTNMVILLGAC---PEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAA 497
+ L +C + V EY+ G L + F++ ++ F AA
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VF-YAA 128
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHM 556
EIA L FL +++RDLK N++LD ++ KI+D G+ + + I
Sbjct: 129 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHI-KIADFGMCK-------ENIWDGVT 177
Query: 557 TTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T TFC YI PE G D ++ GV+L +++ +
Sbjct: 178 TK---TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/253 (23%), Positives = 86/253 (33%), Gaps = 51/253 (20%)
Query: 374 MAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIK--VLGPDI 429
M K + I E+ A +++ R I G YG V +D VAIK
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSD 60
Query: 430 SQGPRQFKQ---------EVEILGSMRHTNMVILLGACPEYGC-------LVYEYMENGS 473
+ E+ +L H N++ L + LV E M
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-- 118
Query: 474 LED--RLFQKDNSP--PIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529
D ++ P H I++ I L LH+ +VHRDL P NILL N
Sbjct: 119 --DLAQVIHDQRIVISPQH--IQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADN 170
Query: 530 YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYS 584
I D LAR A + T Y PE ++ K D++S
Sbjct: 171 NDITICDFNLAREDTADA-------NKTHYVTHRWYRAPEL----VMQFKGFTKLVDMWS 219
Query: 585 LGVVLLQLITARP 597
G V+ ++ +
Sbjct: 220 AGCVMAEMFNRKA 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 55/266 (20%)
Query: 354 EIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKA 413
+ AM E++ +++ F + R IG G Y V
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLLV 71
Query: 414 QLDHTSV--AIKVLGPD-ISQGPRQFKQEVE-------ILGSMRHTNMVILLGAC---PE 460
+L T A++V+ + ++ ++++ + + ++ L +C
Sbjct: 72 RLKKTDRIYAMRVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 461 YGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLV 515
V EY+ G L R ++++ RF +AEI+ AL +LH+ ++
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RF-YSAEISLALNYLHERG---II 175
Query: 516 HRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC----YIDPEYQ 571
+RDLK N+LLD K++D G+ + + + T+ TFC YI PE
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTS---TFCGTPNYIAPEIL 225
Query: 572 QTGMLGVKSDLYSLGVVLLQLITARP 597
+ G D ++LGV++ +++ R
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGP--DISQGPRQFKQEVEILGSMRH 448
++ IGEG YG V A L+ VAIK + P + R + E++IL RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 449 TNMVILLGACPEYGC-------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAEI 499
N++ + +V + ME D +L + + H I + +I
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDH--ICY-FLYQI 137
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
L ++H ++HRDLKP+N+LL+ KI D GLAR+ P D +T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEY 191
Query: 560 AGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
T Y PE ML K D++S+G +L ++++ RP
Sbjct: 192 VATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 50/225 (22%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPD-ISQGPRQFKQEVE-------ILG- 444
F + IG+G +G V A+ V A+KVL I + K+E + +L
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-----KKEEKHIMSERNVLLK 94
Query: 445 SMRHTNMVILLGA--CPEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAA 497
+++H +V L + + V +Y+ G L +R F + + RF AA
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RF-YAA 146
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHM 556
EIA+AL +LH +V+RDLKP NILLD ++ ++D GL + + I
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHI-VLTDFGLCK-------ENIEHNST 195
Query: 557 TTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
T+ TFC Y+ PE D + LG VL +++ P
Sbjct: 196 TS---TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQG--PRQFKQEVEILGSMR- 447
+ +IGEG YG V+KA+ VA+K + + P +EV +L +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 448 --HTNMVILLGACPEYGC-------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIA 496
H N+V L C LV+E+++ D K P + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMM 126
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
++ L FLH ++ +VHRDLKP NIL+ + K++D GLAR
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 54/239 (22%), Positives = 103/239 (43%), Gaps = 57/239 (23%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSV--AIKVLGPD-ISQGPRQFKQ 438
+++ F + R IG G Y V +L T A+KV+ + ++ +
Sbjct: 4 DPLGLQD-------FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DE 51
Query: 439 EVE-------ILGSMRHTNMVILLGAC---PEYGCLVYEYMENGSL-----EDRLFQKDN 483
+++ + + ++ L +C V EY+ G L R +++
Sbjct: 52 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 484 SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARL 542
+ RF +AEI+ AL +LH+ +++RDLK N+LLD ++ K++D G+ +
Sbjct: 112 A-------RF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI-KLTDYGMCK- 158
Query: 543 VPPSAADTITQYHMTTAAGTFC----YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ + T+ TFC YI PE + G D ++LGV++ +++ R
Sbjct: 159 ------EGLRPGDTTS---TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 58/229 (25%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVE-------ILGS 445
F R +G+G +G V A++ T A+KVL D I Q +VE IL
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-----DDDVECTMTEKRILSL 79
Query: 446 MRHTNMVILLGAC---PEYGCLVYEYMENGSL-----EDRLFQKDNSPPIHWSIRFKIAA 497
R+ + L C P+ V E++ G L + R F + + RF AA
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF-YAA 131
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHM 556
EI +AL+FLH +++RDLK N+LLD + K++D G+ + + I
Sbjct: 132 EIISALMFLHDKG---IIYRDLKLDNVLLDHEGHC-KLADFGMCK-------EGICNGVT 180
Query: 557 TTAAGTFC----YIDPE---YQQTGMLGVKS-DLYSLGVVLLQLITARP 597
T TFC YI PE G + D +++GV+L +++
Sbjct: 181 TA---TFCGTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEMLCGHA 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 39/245 (15%)
Query: 371 MEAMAYKNVRYRKYTIEEIE-AATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIK-VLG 426
M + + ++ + I + + + IG G G V A +VAIK +
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 427 P--DISQGPRQFKQEVEILGSMRHTNMVILLGA-CPEYGC-------LVYEYMENGSLED 476
P + + R ++ E+ ++ + H N++ LL P+ +V E M+ +
Sbjct: 61 PFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN 115
Query: 477 RLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536
L Q H + + + ++ + LH ++HRDLKP+NI++ + KI D
Sbjct: 116 -LCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 170
Query: 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK----SDLYSLGVVLLQL 592
GLAR S + MT T Y PE +LG+ D++S+G ++ ++
Sbjct: 171 FGLARTAGTS-------FMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEM 219
Query: 593 ITARP 597
I
Sbjct: 220 IKGGV 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 55/272 (20%), Positives = 94/272 (34%), Gaps = 56/272 (20%)
Query: 377 KNVRYRKYTIEEIEAA-TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGP 433
+ R Y D + I IG G YG VY A +T +VAIK + + +
Sbjct: 8 SSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDL 66
Query: 434 RQFKQ---EVEILGSMRHTNMVILLGACPEYGC-------LVYEYME---------NGSL 474
K+ E+ IL ++ ++ L +V E + L
Sbjct: 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL 126
Query: 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534
+ H I+ I + F+H++ ++HRDLKPAN LL+Q+ K+
Sbjct: 127 TE----------EH--IKT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170
Query: 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------------MLGVKS-- 580
D GLAR + I + + Q T +L ++
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230
Query: 581 ---DLYSLGVVLLQLITARPAMGLSHQVEQAI 609
D++S G + +L+ + +
Sbjct: 231 KSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/264 (19%), Positives = 96/264 (36%), Gaps = 82/264 (31%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQ-EVEILGSM 446
E ++ +S+ + +G G +G V + + A+K + D ++K E++I+ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 447 RHTNMVILL----------------------------------GACPEYGC------LVY 466
H N++ L+ + ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 467 EYMENGSLED-----RLFQKDNS--PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDL 519
EY+ + + F + P I ++ A+ F+H + HRD+
Sbjct: 118 EYVP----DTLHKVLKSFIRSGRSIPMNL--ISI-YIYQLFRAVGFIHSLG---ICHRDI 167
Query: 520 KPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGV 578
KP N+L++ K+ D G A+ + PS + Y + Y PE MLG
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSR-----FYRAPEL----MLGA 216
Query: 579 KS-----DLYSLGVVLLQLITARP 597
DL+S+G V +LI +P
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKP 240
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 380 RYRKYTIEEIE-AATDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQF 436
+ K + + + +G G YG V A + VAIK L Q
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFA 67
Query: 437 KQ---EVEILGSMRHTNMVILLGA-CPEYGC-------LVYEYMENGSLEDRLFQKDNSP 485
K+ E+ +L M+H N++ LL P LV +M+ D L +
Sbjct: 68 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLK 122
Query: 486 PIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545
I++ + ++ L ++H +VHRDLKP N+ ++++ KI D GLAR
Sbjct: 123 FSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---- 174
Query: 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
A +T Y +T Y PE +L D++S+G ++ +++T +
Sbjct: 175 HADAEMTGYVVTRW-----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 45/232 (19%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIK-VLGPDISQGPRQFKQEVEILGSMRHT 449
+ + +G GG G V+ A VAIK ++ D + E++I+ + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 450 NMVILLGA-CPEYGC---------------LVYEYMENGSLED--RLFQKDNSPPIHWSI 491
N+V + P +V EYME D + ++ H
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEH--A 122
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADT 550
R ++ L ++H ++HRDLKPAN+ ++ ++ V KI D GLAR++ P +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
H++ T Y P +L + D+++ G + +++T +
Sbjct: 179 G---HLSEGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 60/271 (22%), Positives = 114/271 (42%), Gaps = 43/271 (15%)
Query: 349 EAMKREIAELKAMQEEEEKKIVMEA--MAYKNVRYRKYTIEEIEAA---TDYFSISRKIG 403
+ +IA + ++ + + + M+ V + Y++E ++ + + IG
Sbjct: 12 PTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIG 71
Query: 404 EGGYGPVYKAQLDHT--SVAIK-VLGP--DISQGPRQFKQEVEILGSMRHTNMVILLGA- 457
G G V A +VAIK + P + + R ++ E+ ++ + H N++ LL
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 130
Query: 458 CPEYGC-------LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
P+ LV E M+ L Q H + + + ++ + LH
Sbjct: 131 TPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG 184
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRDLKP+NI++ + KI D GLAR T + MT T Y PE
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------TSFMMTPYVVTRYYRAPEV 234
Query: 571 QQTGMLGVK----SDLYSLGVVLLQLITARP 597
+LG+ D++S+G ++ +++ +
Sbjct: 235 ----ILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 42/204 (20%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIK-VLGP--DISQGPRQFKQEVEILGSMR 447
D + I IG G YG V +A +L+ VAIK +L D+ R + E+ IL +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN 110
Query: 448 HTNMV----ILLGACPE-----YGCLVYEYME---------NGSLEDRLFQKDNSPPIHW 489
H ++V I++ E Y +V E + L + +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRTPVYLTELHIKT-------- 160
Query: 490 SIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549
+ + + ++H ++HRDLKPAN L++Q+ K+ D GLAR V
Sbjct: 161 -----LLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 550 TITQYHMTTAAGTFCYIDPEYQQT 573
P +
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNL 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGP---DISQGPRQFKQEVEILGSMR 447
+ + +G G YG V A T VA+K L I R ++ E+ +L M+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 448 HTNMVILLGA-CPEYGC-------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAA 497
H N++ LL P LV M D + + H ++F +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDH--VQF-LIY 139
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+I L ++H ++HRDLKP+N+ ++++ KI D GLAR AD +T Y T
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVAT 192
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
Y PE ML D++S+G ++ +L+T R
Sbjct: 193 RW-----YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIKVLGPDISQGPRQFKQ---EVEILGSMR 447
+ + +G G YG V A VAIK L Q K+ E+ +L MR
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMR 82
Query: 448 HTNMVILLGA-CPEYGC-------LVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAA 497
H N++ LL P+ LV +M D +L + + I+F +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDR--IQF-LVY 135
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
++ L ++H ++HRDLKP N+ ++++ KI D GLAR A +T Y +T
Sbjct: 136 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVT 188
Query: 558 TAAGTFCYIDPEYQQTGMLGVKS-----DLYSLGVVLLQLITARP 597
Y PE +L D++S+G ++ ++IT +
Sbjct: 189 RW-----YRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 51/252 (20%), Positives = 98/252 (38%), Gaps = 50/252 (19%)
Query: 376 YKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQG 432
Y+ Y E Y + RK+G G + V+ A+ D + VA+K++
Sbjct: 2 YRPGGYHPAFKGEPYKDARY-ILVRKLGWGHFSTVWLAK-DMVNNTHVAMKIVR-GDKVY 58
Query: 433 PRQFKQEVEILGSMRHT-----------NMVILL------GACPEYGCLVYEYMENGSLE 475
+ E+++L + +++ LL G + +V+E + +L
Sbjct: 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLL 117
Query: 476 DRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS--- 532
L +K I +I+ ++ L ++H+ ++H D+KP N+L++
Sbjct: 118 A-LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174
Query: 533 ---KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK----SDLYSL 585
KI+D+G A + T T Y PE +LG +D++S
Sbjct: 175 IQIKIADLGNACWYD----EHYTNSIQTRE-----YRSPEV----LLGAPWGCGADIWST 221
Query: 586 GVVLLQLITARP 597
++ +LIT
Sbjct: 222 ACLIFELITGDF 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 43/235 (18%)
Query: 393 TDYFSISRKIGEGGYGPVYKA--QLDHTSVAIK-VLGP--DISQGPRQFKQEVEILGSMR 447
+ + +K+G+G YG V+K+ + VA+K + + + R F+ E+ IL +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELS 66
Query: 448 -HTNMVILLGAC-PE-----YGCLVYEYMENGSLED--RLFQKDNSPPIHWSIRFKIAAE 498
H N+V LL + Y LV++YME D + + + P+H ++ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVY--LVFDYME----TDLHAVIRANILEPVH--KQY-VVYQ 117
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
+ + +LH L+HRD+KP+NILL+ K++D GL+R T
Sbjct: 118 LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 559 AAGTFCYIDP----EYQQT-------GMLGVKS-----DLYSLGVVLLQLITARP 597
D +Y T +LG D++SLG +L +++ +P
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 56/240 (23%), Positives = 95/240 (39%), Gaps = 61/240 (25%)
Query: 396 FSISRKIGEGGYGPVYKAQLDH----TSVAIKVLGPDISQGPRQFKQ---EVEILGSMR- 447
+ I +GEG +G V + DH VA+K+ + R + E+++L +
Sbjct: 16 YEIVDTLGEGAFGKVVECI-DHKAGGRHVAVKI----VKNVDRYCEAARSEIQVLEHLNT 70
Query: 448 ----HTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNS-PPIHWS-IRFKIAAE 498
T + + E+ C+V+E + S D F K+N P IR K+A +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYD--FIKENGFLPFRLDHIR-KMAYQ 126
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI------- 551
I ++ FLH NK L H DLKP NIL Q+ ++ + + R I
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 552 ----TQYHMTTAAGTFCYID------PEYQQTGMLGVK----SDLYSLGVVLLQLITARP 597
++H T + PE +L + D++S+G +L++
Sbjct: 184 ATYDDEHHST-------LVSTRHYRAPE----VILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 43/235 (18%)
Query: 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPRQFKQ-- 438
Y ++ E D + I IG+G +G V KA D VAIK+ I Q
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-DRVEQEWVAIKI----IKNKKAFLNQAQ 98
Query: 439 -EVEILGSMRHT------NMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNS-PPIH 488
EV +L M +V L CLV+E + +L D ++ + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYD--LLRNTNFRGVS 155
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS--KISDVGLARLVPPS 546
++ K A ++ TALLFL + ++H DLKP NILL S KI D G S
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG-------S 207
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK----SDLYSLGVVLLQLITARP 597
+ + + Y PE +LG+ D++SLG +L+++ T P
Sbjct: 208 S--CQLGQRIYQYIQSRFYRSPEV----LLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 49/240 (20%), Positives = 93/240 (38%), Gaps = 61/240 (25%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS----VAIKVLGPDISQGPRQFKQ---EVEILGSMRH 448
+ I +GEG +G V + LDH VA+K+ I + + E+ +L ++
Sbjct: 21 YEIVGNLGEGTFGKVVEC-LDHARGKSQVALKI----IRNVGKYREAARLEINVLKKIKE 75
Query: 449 -----TNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNS-PPIHWS-IRFKIAAE 498
+ +L+ + C+ +E + + + F K+N+ P +R +A +
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFE--FLKENNFQPYPLPHVR-HMAYQ 131
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI------- 551
+ AL FLH+N+ L H DLKP NIL + + + + +I
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 552 ----TQYHMTTAAGTFCYID------PEYQQTGMLGVK----SDLYSLGVVLLQLITARP 597
++H T + PE +L + D++S+G +L +
Sbjct: 189 ATFDHEHHTT-------IVATRHYRPPE----VILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 53/237 (22%), Positives = 86/237 (36%), Gaps = 51/237 (21%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPRQFKQ---EVEILGSMR-- 447
F + RK+G+G +G V Q + A+KV + + + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQ-HIDNKKYYAVKV----VRNIKKYTRSAKIEADILKKIQND 91
Query: 448 --HTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNS-PPIHWS-IRFKIAAEIA 500
+ N ++ Y CL++E + SL + N+ H I+ EI
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYE--IITRNNYNGFHIEDIK-LYCIEIL 147
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
AL +L + L H DLKP NILL + L + + I Y +
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILL----DDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 561 ------GTFCYID---PEYQQT-------GMLGVK----SDLYSLGVVLLQLITARP 597
G + T +L + SD++S G VL +L T
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 45/223 (20%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQGPRQFKQ---EVEILGSMR-- 447
+ + + IG+G +G V KA DH VA+K+ + R +Q E+ IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAY-DHKVHQHVALKM----VRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 448 ---HTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNS-PPIHWSIRFKIAAEIA 500
+T VI + + C+ +E + +L + K N + K A I
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE--LIKKNKFQGFSLPLVRKFAHSIL 210
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVS--KISDVGLARLVPPSAADTITQYHMTT 558
L LH+N+ ++H DLKP NILL Q S K+ D G + + T
Sbjct: 211 QCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYT 258
Query: 559 AAGTFCYIDPEYQQTGMLGVK----SDLYSLGVVLLQLITARP 597
+ Y PE +LG + D++SLG +L +L+T P
Sbjct: 259 YIQSRFYRAPEV----ILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 8e-12
Identities = 78/652 (11%), Positives = 182/652 (27%), Gaps = 204/652 (31%)
Query: 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQ-------YVLLHVRNHSSNPR------GR 67
+ ++ Y K+ + + E Q Y+ R ++ N R
Sbjct: 76 EEMVQKFVEEVLRINY--KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 68 PATNDELQKLFL---PYRGLF------ARKRILAREVVLQDIDVSSAL---IYYVKNNSV 115
+L++ L P + + + K +A +V V + I+++ ++
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV-CLSYKVQCKMDFKIFWL---NL 189
Query: 116 GNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIISSKGKLQSSRPAASQPQMLSG 175
N + + +L + +D + + + I S + +L+ + L
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-- 247
Query: 176 DALIPKQPPLGERPSVIQPDSPRSVEIGRS-DYSCDT-----DSHMQNSFNSESESDISD 229
L+ L + ++ + + + SC + + ++ + + IS
Sbjct: 248 --LV-----L---------LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 230 FSVPVSYQSTEISE------NIDFSSLSKSSKDHFPQSPKGLEAEIKRLRLELKQSMEIY 283
++ E+ + L + P+ + I+ +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN----W 347
Query: 284 NSVSKEAVSTS-QTAVKLQQRKKEEALKLEEARLAEEAALAL----VKSERQKTRAAMEA 338
V+ + ++T ++++ L+ E R + L++
Sbjct: 348 KHVNCDKLTTIIESSL--------NVLEPAEYRKMFDR-LSVFPPSAH------------ 386
Query: 339 ALMAQRLVEL-EAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFS 397
+ L + + + + + + K ++ K + +I I Y
Sbjct: 387 -IPTILLSLIWFDVIKSDVMV--VVNKLHKY----SLVEKQPKESTISIPSI-----YLE 434
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA 457
+ K+ + L H S
Sbjct: 435 LKVKLEN-------EYAL-HRS-------------------------------------- 448
Query: 458 CPEYGCLVYEYMENGSLEDRLFQKDNSPP-----IHWSIRFKIAAEIATALLFLHQNKPE 512
+V Y ++ D PP + I H E
Sbjct: 449 ------IVDHY----NIPKTFDSDDLIPPYLDQYFYSHIGH-------------HLKNIE 485
Query: 513 PLVHRDLKPANILLDQNYV-SKISDVGLARLVPPSAADTITQ---YHMTTAAGTFCYI-- 566
L + LD ++ KI A S +T+ Q Y YI
Sbjct: 486 HPERMTLFR-MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP--------YICD 536
Query: 567 -DPEYQQ------TGMLGVKSDLY-SLGVVLLQLITARPAMGLSHQVEQAIR 610
DP+Y++ + ++ +L S LL++ + E+A +
Sbjct: 537 NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAI---FEEAHK 585
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 46/294 (15%), Positives = 98/294 (33%), Gaps = 25/294 (8%)
Query: 363 EEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRKIGE-GGYGPVYKAQLDHTSVA 421
E + ++ E ++ + + + A T I E +G + +
Sbjct: 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 125
Query: 422 IKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQK 481
+ + + R + + + G + + + + E+
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185
Query: 482 DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+ + ++A + FL K +HRDL NILL + V KI D GLAR
Sbjct: 186 Y-KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 542 LVPPSAADTITQYHMTTAAGTF--CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR--- 596
+ ++ ++ PE + ++SD++S GV+L ++ +
Sbjct: 242 DI------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
Query: 597 -PAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
P + + + + ++ GT + P + + L C RP
Sbjct: 296 YPGVKIDEEFCRRLKEGT---RMRA-----PDYTTPEMYQTMLDCWHGEPSQRP 341
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQG-PRQFKQEVEILGS 445
D + + +G G +G V +A +VA+K+L + R E++IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 446 M-RHTNMVILLGACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWS 490
+ H N+V LLGAC + G ++ E+ + G+L L K N + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--- 450
+ + RKIG G +G +Y VAIK+ + Q E +I M+
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 451 MVILLGACPEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLH 507
+ GA +Y +V E + G SLED LF + +S++ +A ++ + + ++H
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLED-LFNFCSR---KFSLKTVLLLADQMISRIEYIH 122
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSK---ISDVGLAR 541
+HRD+KP N L+ I D GLA+
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 36/159 (22%), Positives = 65/159 (40%), Gaps = 24/159 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--- 450
+ + R+IGEG +G +++ L++ VAIK Q + E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 451 MVILLGACPEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLH 507
V G + LV + + G SLED L +S++ A ++ + +H
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSK-----ISDVGLAR 541
+ LV+RD+KP N L+ + + D G+ +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--- 450
F + +KIG G +G + + + VAIK+ + Q E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--PMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 451 MVILLGACPEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLH 507
V G C +Y +V E + G SLED LF + +S++ IA ++ + + ++H
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSK-----ISDVGLAR 541
L++RD+KP N L+ + I D LA+
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 43/230 (18%), Positives = 83/230 (36%), Gaps = 46/230 (20%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFK--------QEVEILGS 445
+ + +KIG GG+G +Y A A V+ + + F + + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 446 MRHTNMVILLGACPEYGCLVYEYMENG-----------SLEDRLFQKDNSPPIHWSIR-- 492
+ LG YG + E+ L+ + ++ +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNG----TFKKSTV 153
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI--SDVGLA-RLVPPSAAD 549
++ + L ++H+N+ VH D+K AN+LL ++ +D GL+ R P
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 550 TITQYHMTTAAGTFCY--IDPEYQQTGMLGV----KSDLYSLGVVLLQLI 593
+ GT + +D GV +SD+ LG +L+ +
Sbjct: 211 QYQENPRKGHNGTIEFTSLD------AHKGVALSRRSDVEILGYCMLRWL 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 45/232 (19%), Positives = 86/232 (37%), Gaps = 47/232 (20%)
Query: 396 FSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQFK-----QEVEIL 443
+ + IG+GG+G +Y A + +KV D + K + E +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 444 GSMRHTNMVILLGACPEYGCLVYEYMENG-----------SLEDRLFQKDNSPPIHWSIR 492
T + LG +G +++ L+ +++ + +S +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAK---RFSRK 152
Query: 493 --FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI--SDVGLA-RLVPPSA 547
+++ I L ++H+++ VH D+K +N+LL+ ++ D GLA R P
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 548 ADTITQYHMTTAAGTFCY--IDPEYQQTGMLGV----KSDLYSLGVVLLQLI 593
GT + ID GV + DL LG ++Q +
Sbjct: 210 HKAYAADPKRCHDGTIEFTSID------AHNGVAPSRRGDLEILGYCMIQWL 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 69/265 (26%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
+ + RK+G G + V+ + VA+KV+ E+ +L S+R+++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD 94
Query: 451 -------MVILL-------GACPEYGCLVYEYMENG-SLEDRLFQKDNSP-PIHWSIRFK 494
MV+ L G + C+V+E + G L + ++ + K
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLK--WIIKSNYQGLPLPCVKK 150
Query: 495 IAAEIATALLFLH-QNKPEPLVHRDLKPANILL--------------------------- 526
I ++ L +LH + + ++H D+KP NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 527 --------------DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
K ++ ++ A H T T Y E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQTRQYRSLEVLI 266
Query: 573 TGMLGVKSDLYSLGVVLLQLITARP 597
+D++S + +L T
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDY 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 32/172 (18%), Positives = 60/172 (34%), Gaps = 32/172 (18%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS----------VAIKV------LGPDISQGPRQFK-- 437
+ + G +Y+A T ++K+ L + + R K
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 438 --QEVEILGSMRHTNM--VILLGA-CPEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSI 491
+ + L S + + G +Y LV + G SL+ +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERS 160
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI--SDVGLAR 541
++A + AL FLH+N+ VH ++ NI +D S++ + G A
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--- 450
F + RKIG G +G +Y + VAIK+ ++ Q E +I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 451 MVILLGACPEYGCLVYEYMENG-SLEDRLFQKDNSPPIHWSIR--FKIAAEIATALLFLH 507
V G +Y LV + + G SLED LF + S++ +A ++ + F+H
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLED-LFNFCSR---KLSLKTVLMLADQMINRVEFVH 120
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSK---ISDVGLAR 541
+HRD+KP N L+ + I D GLA+
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 701 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.85 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.84 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.84 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.84 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.83 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.83 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.83 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.82 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.82 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.82 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.81 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.74 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.71 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.69 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.68 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.68 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.68 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.67 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.66 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.64 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.63 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.07 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 93.39 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 93.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.36 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 89.79 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 84.59 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.28 | |
| 2nz2_A | 413 | Argininosuccinate synthase; amino-acid biosynthesi | 82.5 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.13 | |
| 1kor_A | 400 | Argininosuccinate synthetase; ligase, riken struct | 80.22 | |
| 3bl5_A | 219 | Queuosine biosynthesis protein QUEC; PREQ1 biosynt | 80.03 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=456.79 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=205.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.++|.+++.||+|+||.||+|++. ++.||||++...... ..+.+.+|+.+|++|+|||||+++++|.+. .||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999984 567999999765432 245689999999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|||+||+|.++|.... ...+++.....|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999996543 346789999999999999999999999 999999999999999999999999999876321
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 624 (701)
....+..+||+.|||||++.+..|+.++|||||||+||||+||++||...+..+ ..+..+.+. .
T Consensus 179 ------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------~ 244 (350)
T 4b9d_A 179 ------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------P 244 (350)
T ss_dssp ------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------C
T ss_pred ------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------C
Confidence 112355789999999999999999999999999999999999999998765432 233344332 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+...+..+.+|+.+||+.||.+||++.+++.|+|++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 2223345689999999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=452.78 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=212.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.+.|++.++||+|+||.||+|++. ++.||||++........+.+.+|+.+|+.++|||||+++++|.+ ..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999995 55699999977666667779999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|+||+|.+++.. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999998854 24899999999999999999999999 9999999999999999999999999999774332
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p 626 (701)
....+.+||+.|||||++.+..|+.++|||||||+||||+||++||...+..+ ..+..+. .+.... +
T Consensus 225 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~~~~-~ 293 (346)
T 4fih_A 225 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPRLKN-L 293 (346)
T ss_dssp -----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-----CCCCSC-G
T ss_pred -----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----CCCCCc-c
Confidence 12356799999999999999999999999999999999999999997765433 2333321 111211 1
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+|+.+||..||.+||++.+++.|+|++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 23445689999999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=443.22 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=203.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey 468 (701)
..++|.+.++||+|+||.||+|++.+ .||||+++..... ..+.|.+|+.+|++++|||||+++|+|.+ ..||||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 45678999999999999999998765 5999998754322 23569999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|+||+|.++|.... .+++|..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999996433 46999999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~ 622 (701)
.......+||+.|||||++. .+.|+.++|||||||+||||+||++||...+ .+...+..+. ..|..
T Consensus 188 ----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~----~~p~~ 259 (307)
T 3omv_A 188 ----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY----ASPDL 259 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC----CCCCS
T ss_pred ----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCCc
Confidence 12235678999999999885 3469999999999999999999999997543 2333444432 22333
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...+..++..+.+|+.+||+.+|.+||++.+|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 44445566679999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=442.91 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=208.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
.++|.+.+.||+|+||.||+|++. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+ ..|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357999999999999999999873 45699999986654456679999999999999999999999955 458
Q ss_pred eEEeecCCCChhhHhcccC----------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEE
Q 005343 464 LVYEYMENGSLEDRLFQKD----------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
||||||++|+|.++|.... ....++|..+..|+.||+.||.|||+++ ||||||||+||||+.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996532 3457999999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHH
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIR 610 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~ 610 (701)
|+|||+|+.+..... .......+||+.|||||++.++.|+.++|||||||+||||+| |++||.... ++...+.
T Consensus 169 i~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 169 IGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp ECCCSCHHHHTGGGC----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ECCcccceecCCCCc----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987643211 112234579999999999999999999999999999999999 899997654 3334444
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+.. ...|..++..+.+|+.+||+.+|.+||++.+|+ ..|..+
T Consensus 245 ~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~-~~L~~~ 287 (299)
T 4asz_A 245 QGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH-TLLQNL 287 (299)
T ss_dssp HTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHH
T ss_pred cCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH-HHHHHH
Confidence 4432 123444556799999999999999999999984 334443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=454.15 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=213.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.+.|+++++||+|+||.||+|++. ++.||||++........+.+.+|+.+|+.++|||||+++++|.+ ..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 457999999999999999999995 55699999987766667789999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
|+||+|.+++.. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999998853 24899999999999999999999999 9999999999999999999999999999774332
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~p 626 (701)
....+.+||+.|||||++.+..|+.++|||||||+||||++|++||...+..+ ..+..+.. +.+..+
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~~~~~~- 370 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PRLKNL- 370 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCSCT-
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCccc-
Confidence 12456799999999999999999999999999999999999999997665432 23333221 112111
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+|+.+||..||.+||++.++|.|+|++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 22344689999999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=440.05 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=206.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
+.+++.++||+|+||.||+|.+. ++.||||+++..... ..+.|.+|+.+|++++|||||+++|+|.+ ..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45788999999999999999973 356999999765433 35679999999999999999999999954 458
Q ss_pred eEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC
Q 005343 464 LVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
||||||++|+|.++|..... ...++|..+..|+.||+.||.|||+.+ ||||||||+||||+.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965421 246899999999999999999999999 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHH
Q 005343 531 VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQ 607 (701)
Q Consensus 531 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~ 607 (701)
.+||+|||+|+.+.... .....+..+||+.|||||++.++.|+.++|||||||+||||+| |++||.... ++..
T Consensus 183 ~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999998764321 1122356789999999999999999999999999999999999 899997654 3344
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+..+.. ...|..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 259 ~i~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 259 MIRNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4454432 1234455567999999999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=443.84 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=202.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
.++|.+.++||+|+||.||+|++. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+ ..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356889999999999999999874 45699999986654456679999999999999999999999965 448
Q ss_pred eEEeecCCCChhhHhcccCC------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 464 LVYEYMENGSLEDRLFQKDN------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
||||||++|+|.++|..... ..+++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999965432 346999999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQA 608 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~ 608 (701)
+||+|||+|+.+..... ....+..+||+.|||||++.+..|+.++|||||||+||||+| |++||..... +...
T Consensus 197 ~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp EEECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred EEEcccccceeccCCCc----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999987643221 112345689999999999999999999999999999999999 8999976543 3333
Q ss_pred HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 609 i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+..+.. ...|..++..+.+|+.+||+.+|.+||++.+|+.+ |..+
T Consensus 273 i~~g~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~-L~~l 317 (329)
T 4aoj_A 273 ITQGRE--------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR-LQAL 317 (329)
T ss_dssp HHHTCC--------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH-HHHH
T ss_pred HHcCCC--------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH-HHHH
Confidence 444431 12344455679999999999999999999999743 4444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=439.44 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=209.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++++.||+|+||.||+|++. ++.||||++.+.. ......+.+|+++|+.++|||||+++++|.+. .||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999984 5569999997532 24456799999999999999999999999554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|||+||+|.+++.+. ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999654 35899999999999999999999999 999999999999999999999999999987543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
.. .....+.+||+.|||||++.+..|+.++|||||||+||+|+||++||...+.. ...+..+.+ .
T Consensus 186 ~~----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~ 252 (311)
T 4aw0_A 186 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---------D 252 (311)
T ss_dssp TT----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------C
T ss_pred CC----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------C
Confidence 21 22346779999999999999999999999999999999999999999766532 233333332 2
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+|...+..+.+|+.+||..||.+||++.+++.|.|.+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~ 289 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHH
Confidence 2333445689999999999999999999976555544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=435.87 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=200.8
Q ss_pred ceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC------CCceE
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------YGCLV 465 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~lV 465 (701)
|++.++||+|+||.||+|.+.. ..||+|++...... ....|.+|+.+|++++|||||+++++|.+ ..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999954 45999998654322 24569999999999999999999999843 24899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~ 544 (701)
||||+||+|.+++.+. ..+++..+..|+.||+.||.|||++++ +||||||||+||||+. +|.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999654 468999999999999999999999863 5999999999999984 8999999999998653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~~~~~~~~ld~~ 621 (701)
.. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||++||...... ...+..+.....
T Consensus 184 ~~--------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~---- 250 (290)
T 3fpq_A 184 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS---- 250 (290)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG----
T ss_pred CC--------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC----
Confidence 22 2345789999999998864 6999999999999999999999999654332 233333322111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
++...+..+.+|+.+||+.||.+|||+.+++.|+|++
T Consensus 251 ---~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 251 ---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp ---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 1112234589999999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=428.55 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=195.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
++|++.+.||+|+||.||+|++. ++.||||++.+... .....+.+|+.+|+.++|||||++++++.+ ..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999984 66799999976532 234569999999999999999999999854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+ +|+|.+++.+. ..+++.....++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 78999998654 36899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~ 623 (701)
. ...+.+||+.|+|||++.+..| +.++|||||||+||+|+||++||...+.. ...+..+.+
T Consensus 166 ~-------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------- 229 (275)
T 3hyh_A 166 N-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------- 229 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred C-------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 1 2346789999999999988876 68999999999999999999999866532 233444432
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+|...+..+.+|+.+||+.||.+|||+.+++.|+|++.
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 123334456899999999999999999999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=435.99 Aligned_cols=256 Identities=18% Similarity=0.218 Sum_probs=205.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.+.|.+.++||+|+||.||+|++. ++.||||+++.... +.+|+.+|+.++|||||+++++|.+. .||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 467999999999999999999985 55699999976532 25799999999999999999998543 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccccCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVPPSA 547 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~~~~~ 547 (701)
|+||+|.++|.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999654 35899999999999999999999999 99999999999999887 69999999999875432
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 625 (701)
... ........+||+.|||||++.+..|+.++|||||||+||||+||++||..... +...+..+.. .....
T Consensus 206 ~~~-~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------~~~~~ 278 (336)
T 4g3f_A 206 LGK-SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------PIREI 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------GGGGS
T ss_pred ccc-ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------Cchhc
Confidence 111 11123456899999999999999999999999999999999999999975432 1222222221 11123
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
|...+..+.+|+.+||+.||.+|||+.+++.|....+.+..
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 34455668999999999999999999999988777666554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=437.26 Aligned_cols=248 Identities=23% Similarity=0.277 Sum_probs=201.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
++|++++.||+|+||.||+|+.. ++.||||++..... .....+.+|+++|++++|||||+++++|.+ ..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999872 34699999876431 223468899999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||||+||+|.+++.+. ..+++.....++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999654 35899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~ 622 (701)
... ....+.+||+.|||||++.+..|+.++|||||||+||||+||++||...+.. ...+..+.+
T Consensus 178 ~~~------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------- 243 (304)
T 3ubd_A 178 DHE------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-------- 243 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred CCC------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------
Confidence 321 1235678999999999999999999999999999999999999999876543 233333332
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l 662 (701)
.+|...+..+.+|+.+||+.||.+||+ +.+++.|+|++-
T Consensus 244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 223344556899999999999999998 579999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=436.18 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=217.1
Q ss_pred cccCHHHHHHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCC-CcEE
Q 005343 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRH-TNMV 452 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~H-pnIv 452 (701)
..|...+++...++|.+.+.||+|+||.||+|.+.+ +.||||++....... .+.|.+|+.+|.+++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 356677787888999999999999999999999844 359999997764332 4569999999999965 8999
Q ss_pred EEeceecC---CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 005343 453 ILLGACPE---YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516 (701)
Q Consensus 453 ~l~g~~~~---~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 516 (701)
+++|+|.+ ..+||||||++|+|.++|..... ...+++..+..|+.||+.||.|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 99999843 35899999999999999965321 345899999999999999999999999 999
Q ss_pred cCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-C
Q 005343 517 RDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-A 595 (701)
Q Consensus 517 rDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G 595 (701)
|||||+||||+.++.+||+|||+|+.+..... .......+||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCC----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 99999999999999999999999997644321 122356789999999999999999999999999999999998 9
Q ss_pred CCCCCCc---hHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 596 RPAMGLS---HQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 596 ~~pf~~~---~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
++||... ..+...+..+... ..|..++..+.+++.+||+.+|.+|||+.+|+.|
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999653 3455555555321 2233445568999999999999999999999876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=428.97 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=194.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC---------
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY--------- 461 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------- 461 (701)
++|++++.||+|+||.||+|++. ++.||||++...... ..+.+.+|+.+|++++|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35999999999999999999985 667999998765432 235689999999999999999999987421
Q ss_pred -----CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 462 -----GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 462 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
.|+|||||++|+|.+++.........++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999976665556777888899999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcc------cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-
Q 005343 537 VGLARLVPPSAADT------ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI- 609 (701)
Q Consensus 537 FGla~~~~~~~~~~------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i- 609 (701)
||+|+.+....... ......++.+||+.|||||++.+..|+.++|||||||+||||++ ||.........+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99999875432211 11123456789999999999999999999999999999999997 676543322222
Q ss_pred --HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 610 --RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 610 --~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....+. ..+......+.+|+.+||+.||.+||++.+++.|+|++
T Consensus 239 ~~~~~~~p--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~ 284 (299)
T 4g31_A 239 DVRNLKFP--------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284 (299)
T ss_dssp HHHTTCCC--------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred HHhcCCCC--------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 222211 11123334578899999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=423.13 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=195.3
Q ss_pred cCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHH--HHHHHHHHhCCCCcEEEEeceecCC------CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQF--KQEVEILGSMRHTNMVILLGACPEY------GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~--~~Ei~il~~l~HpnIv~l~g~~~~~------~~lV 465 (701)
.+|.+.++||+|+||.||+|+++++.||||++... ....+ ..|+.++..++|||||+++|+|.+. .|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35888999999999999999999999999999653 23334 4455566788999999999998532 3899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK-----PEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
||||++|+|.++|... +++|..+.+|+.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999543 5899999999999999999999871 123999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCch-----------
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITARPAMGLSH----------- 603 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~----------- 603 (701)
+....... .........+||+.|||||++.+. .|+.++|||||||+||||+||.+||+...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 156 VRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTT--EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccCCCC--ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 87643321 111123456899999999998654 47889999999999999999988764221
Q ss_pred ------HHHHHHHcCccccccCccCCCC--CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 604 ------QVEQAIRNGTFSELLDPTVTGW--PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 604 ------~~~~~i~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.....+..+ .+.|.++.. +.+....+.+|+.+||+.||.+|||+.+|+. .|.+|.
T Consensus 234 ~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~-~L~~l~ 296 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK-TLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH-HHHHHH
T ss_pred ccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH-HHHHHH
Confidence 112222222 222333221 2355667999999999999999999999974 455553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=427.08 Aligned_cols=260 Identities=25% Similarity=0.321 Sum_probs=204.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|.+++.||+|+||.||+|++. ++.||||++...... ..+.+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999985 566999999765432 23468899999999999999999998632
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..|||||||+ |+|.+++.. ..++++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 3489999995 789998854 346999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFS 615 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~~ 615 (701)
+.+..... .......+.+||++|+|||++.+. .|+.++||||+|||||||+||++||.+.+....... .|...
T Consensus 206 ~~~~~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 87643221 122334678999999999987765 579999999999999999999999987765433211 12111
Q ss_pred cccCc---------------cCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 ELLDP---------------TVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~ld~---------------~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..... .....+ ...+..+.+|+.+||..||.+|||+.++|.|+|++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 10000 000001 01234688999999999999999999999999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=412.24 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=198.5
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YG 462 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~ 462 (701)
...+.|++.++||+|+||.||+|+++ +..||||++... .....+.+|+++|+.+ +|||||.++++|.+ +.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35678999999999999999999873 345999998654 4456789999999998 69999999999844 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeecccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLAR 541 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFGla~ 541 (701)
||||||++||+|.+++. .+++..+..++.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 89999999999999882 4889999999999999999999999 9999999999999876 899999999998
Q ss_pred ccCCCCCccc----------------------ccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCC
Q 005343 542 LVPPSAADTI----------------------TQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPA 598 (701)
Q Consensus 542 ~~~~~~~~~~----------------------~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~p 598 (701)
.......... .....+..+||++|+|||++.+. .|+.++||||+|||||||+||++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 7644321110 11123556899999999988765 589999999999999999999998
Q ss_pred CC-CchHHHHHHH----cCc---------cc------------------------cccCcc-----------CCCCCHHH
Q 005343 599 MG-LSHQVEQAIR----NGT---------FS------------------------ELLDPT-----------VTGWPVEA 629 (701)
Q Consensus 599 f~-~~~~~~~~i~----~~~---------~~------------------------~~ld~~-----------~~~~p~~~ 629 (701)
|. ..+...+... .|. +. ....+. ...| ...
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~i 325 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW-NEV 325 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C-TTC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc-ccC
Confidence 84 3322221100 000 00 000000 0001 112
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.++.+|+.+||..||.+|||+.++|.|+|++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 34578999999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=428.00 Aligned_cols=253 Identities=20% Similarity=0.345 Sum_probs=211.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.++|.+++.||+|+||.||+|++. +..||||++..........+.+|+.+|+.++|||||+++++|.+. .||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999985 556999999776544566789999999999999999999999554 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--CCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~~ 546 (701)
|+||+|.++|... ...+++..+..|+.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+|+.+.+.
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988543 246899999999999999999999999 999999999999985 489999999999987543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 624 (701)
. .....+||+.|||||++.+..|+.++|||||||+||+|++|++||...+..+ ..+..+.+. +..+....
T Consensus 311 ~-------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 382 (573)
T 3uto_A 311 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFSG 382 (573)
T ss_dssp S-------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-CCSGGGTT
T ss_pred C-------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-CCcccccC
Confidence 2 2345689999999999999999999999999999999999999998765433 333433321 11111222
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+ +..+.+|+.+||..||.+||++.++|.|+|++-
T Consensus 383 ~----s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 383 I----SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 2 345889999999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=426.40 Aligned_cols=250 Identities=26% Similarity=0.302 Sum_probs=203.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHH---HHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQ---EVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~---Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|.+++.||+|+||.||+|++. +..||||++.+.. ......+.+ ++.+++.++|||||+++++|.+ ..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999995 4569999986532 122233344 4667778899999999999954 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|||||||+||+|.++|.+. ..|++.....|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 8999999999999999654 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHcCcccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSH-----QVEQAIRNGTFSE 616 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~-----~~~~~i~~~~~~~ 616 (701)
+... ...+.+||+.|||||++.. ..|+.++||||||||||||+||++||.... .+...+....+
T Consensus 342 ~~~~--------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-- 411 (689)
T 3v5w_A 342 FSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 411 (689)
T ss_dssp CSSC--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--
T ss_pred cCCC--------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--
Confidence 6432 2346799999999999865 579999999999999999999999996432 12222222221
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHhc
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRDL 665 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~~ 665 (701)
.+|...+..+.+|+.+||..||.+|++ +.+|+.|+|++--++
T Consensus 412 -------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 412 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 233344556899999999999999998 699999999875443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=376.26 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=212.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+ .++.||||++........+.+.+|+.+++.++||||++++++|. +..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346799999999999999999987 45679999998776666778999999999999999999999984 44589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998543 4889999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---cCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---NGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---~~~~~~~ld~~~~~ 624 (701)
. .....+||+.|+|||++.+..++.++|||||||++|+|+||++||...+....... .+.. .. .
T Consensus 171 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~------~ 237 (297)
T 3fxz_A 171 S------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-EL------Q 237 (297)
T ss_dssp C------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CC------S
T ss_pred c------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CC------C
Confidence 1 23456899999999999999999999999999999999999999977654433221 1111 11 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+...+..+.+++.+||+.+|.+||++.+++.|+|++.
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 22334456899999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=379.51 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=209.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+|+.++||||+++++++.+. .++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999998 5667999998765322 235688999999999999999999998543 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998654 35889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLG-VKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|+||++||...+. ....+..+.+
T Consensus 167 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 231 (328)
T 3fe3_A 167 GG-------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------- 231 (328)
T ss_dssp SC-------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred CC-------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 21 23566899999999999888765 899999999999999999999986653 3333444432
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|...+..+.+|+.+||..+|.+|||+.+++.|+|++.
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 123334456899999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.22 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=215.1
Q ss_pred ccCHHHHHHhhc----------CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc
Q 005343 383 KYTIEEIEAATD----------YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450 (701)
Q Consensus 383 ~~~~~ei~~~~~----------~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn 450 (701)
.++.+++..+++ .|...+.||+|+||.||+|++. ++.||||++........+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 455556555554 3888899999999999999984 6779999998777667788999999999999999
Q ss_pred EEEEeceec--CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC
Q 005343 451 MVILLGACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ 528 (701)
Q Consensus 451 Iv~l~g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~ 528 (701)
|++++++|. +..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999984 345899999999999998843 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-
Q 005343 529 NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ- 607 (701)
Q Consensus 529 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~- 607 (701)
++.+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|+|+||++||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999987643221 12456899999999999999999999999999999999999999976554322
Q ss_pred -HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 608 -AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 608 -~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..... +... .+...+..+.+++.+||+.+|.+||++.+++.|+|+.-
T Consensus 251 ~~~~~~~~-----~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 251 KRLRDSPP-----PKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHHHSSC-----CCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HHHhcCCC-----CCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 2222211 1111 11223446899999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=374.93 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=207.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY-------- 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 461 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++...... ..+.+.+|+.+|+.++||||++++++|.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999984 667999999765433 346799999999999999999999987321
Q ss_pred ---------------------------------------------------CceEEeecCCCChhhHhcccCCCCCCChH
Q 005343 462 ---------------------------------------------------GCLVYEYMENGSLEDRLFQKDNSPPIHWS 490 (701)
Q Consensus 462 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 490 (701)
.++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 47999999999999999877666677888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc------cccccccccCCC
Q 005343 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT------QYHMTTAAGTFC 564 (701)
Q Consensus 491 ~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~------~~~~~~~~gt~~ 564 (701)
.+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......... .......+||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 999999999999999999999999999887543211100 122345689999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccC
Q 005343 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELR 644 (701)
Q Consensus 565 Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~ 644 (701)
|+|||++.+..++.++|||||||++|+|++|.+|+.........+..+.+.. .+......+.+++.+||+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPL--------LFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCH--------HHHHHCHHHHHHHHHHHCSS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCc--------ccccCChhHHHHHHHHccCC
Confidence 9999999999999999999999999999999888643333333333332211 11233456899999999999
Q ss_pred cCCCCChhhhhhHHHHH
Q 005343 645 KRDRPDLVSVVLPELIR 661 (701)
Q Consensus 645 P~~RPt~~~vl~~~~~~ 661 (701)
|.+||++.+++.|+|++
T Consensus 314 p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 314 PTERPEATDIIENAIFE 330 (332)
T ss_dssp GGGSCCHHHHHHSTTCC
T ss_pred CCcCCCHHHHhhchhhh
Confidence 99999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=371.05 Aligned_cols=270 Identities=36% Similarity=0.592 Sum_probs=222.3
Q ss_pred cCHHHHHHhhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--
Q 005343 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-- 460 (701)
Q Consensus 384 ~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 460 (701)
+++.++...+++|.+.+.||+|+||.||+|.+. +..||||++..........+.+|+.+++.++||||++++++|.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 444555667899999999999999999999984 67799999887765666789999999999999999999999854
Q ss_pred CCceEEeecCCCChhhHhcccCC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDN-SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 45899999999999999865432 346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---------HHHHHHH
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---------QVEQAIR 610 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---------~~~~~i~ 610 (701)
++....... ........||+.|+|||++.+..++.++|||||||++|+|+||++||.... .......
T Consensus 186 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 186 SKKGTELDQ----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CEECSSSSC----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccc----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 986532211 111244568999999999999999999999999999999999999986432 1122333
Q ss_pred cCccccccCccCC-CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 611 NGTFSELLDPTVT-GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 611 ~~~~~~~ld~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
.+.+...+++... ..+...+..+.+++.+||+.+|.+||++.+++.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 4555556665543 4567788889999999999999999999999865443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=373.58 Aligned_cols=272 Identities=36% Similarity=0.603 Sum_probs=222.8
Q ss_pred ccccccCHHHHHHhhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEec
Q 005343 379 VRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLG 456 (701)
Q Consensus 379 ~~~~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g 456 (701)
.....|++.++....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4456789999999999999999999999999999987 4677999998765432 3346899999999999999999999
Q ss_pred eecC--CCceEEeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhc---CCCCeeecCCCCCCeeEcCCC
Q 005343 457 ACPE--YGCLVYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQN---KPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 457 ~~~~--~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~---~~~~iiHrDLKp~NILl~~~~ 530 (701)
+|.+ ..++||||+++|+|.+++.... ...++++..+..|+.|++.||.|||+. + |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCC
Confidence 9854 4589999999999999997653 345699999999999999999999999 7 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------
Q 005343 531 VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ------ 604 (701)
Q Consensus 531 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~------ 604 (701)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|+||++||.....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp CEEECCCSSCEECCSSSS-----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred CEEeccCccccccCcccc-----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 999999999987643321 123445699999999999999999999999999999999999999952211
Q ss_pred -----HHHHHHcCccccccCccC-CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 605 -----VEQAIRNGTFSELLDPTV-TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 605 -----~~~~i~~~~~~~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
+...+....+..+.+... ..++......+.+++.+||+.+|.+||++.+++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111112233334444443 245677788899999999999999999999998554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=362.29 Aligned_cols=270 Identities=38% Similarity=0.640 Sum_probs=225.5
Q ss_pred ccccccCHHHHHHhhcCceee------eeeeecCceeEEEEEECCceEEEEEeCCCCC----CChHHHHHHHHHHHhCCC
Q 005343 379 VRYRKYTIEEIEAATDYFSIS------RKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS----QGPRQFKQEVEILGSMRH 448 (701)
Q Consensus 379 ~~~~~~~~~ei~~~~~~f~~~------~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~----~~~~~~~~Ei~il~~l~H 448 (701)
..+..|++.++..++++|... +.||+|+||.||+|.++++.||+|++..... .....+.+|+.+++.++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 467889999999999998887 8999999999999999999999999876432 224568999999999999
Q ss_pred CcEEEEeceecC--CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 449 TNMVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 449 pnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
|||+++++++.+ ..++||||+++|+|.+++.......++++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 999999999854 45899999999999999976555667999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--- 603 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--- 603 (701)
+.++.+||+|||+++....... ........||+.|+|||.+.+ .++.++|||||||++|+|+||++||....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cCCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 9999999999999987643221 112244679999999998764 58999999999999999999999997542
Q ss_pred ---HHHHHHHc--CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 604 ---QVEQAIRN--GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 604 ---~~~~~i~~--~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.....+.. ..+...+++.....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12222221 223444556666777888888999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.68 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=208.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecCC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPEY-- 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 461 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999985 567999998765432 246799999999999999999999998554
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEee
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDV 537 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DF 537 (701)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 4899999999999999844 346899999999999999999999999 99999999999998776 7999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFS 615 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~ 615 (701)
|+++.+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...... ...+..+.+.
T Consensus 164 G~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (361)
T 2yab_A 164 GLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236 (361)
T ss_dssp SSCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred CCceEcCCCC-------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9998764421 234568999999999999999999999999999999999999999766533 2233333221
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.++. ++...+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 237 --~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 237 --FDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp --CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred --CCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 0000 0012234589999999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.18 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=208.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCC---CCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|+.. ++.||||++.+. .......+.+|+.+|+.++||||++++++|.+ ..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999984 566999998754 23445678999999999999999999999854 44899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999988653 35889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+. ....+..+.+
T Consensus 158 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 222 (337)
T 1o6l_A 158 DG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------- 222 (337)
T ss_dssp TT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CC------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21 123567899999999999999999999999999999999999999976543 2222332221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||+.+|.+|| ++.+++.|+|++-
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 23333445689999999999999999 8999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.82 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=200.1
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
+....++|.+.+.||+|+||.||+|.+.++.||||++....... ...+.+|+.++++++||||++++++|.+ ..++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33456789999999999999999999999999999997664332 3468899999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999965443345899999999999999999999986 359999999999999999999999999998653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||............... .....
T Consensus 191 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~ 259 (309)
T 3p86_A 191 STF------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-----CKRLE 259 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS-----CCCCC
T ss_pred ccc------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----CCCCC
Confidence 221 1234567999999999999999999999999999999999999999866543222111000 00112
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.|...+..+.+++.+||+.+|.+||++.+++.
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 23344456899999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.20 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=203.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999984 56799999865432 2245689999999999999999999998654 479999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998843 345899999999999999999999999 9999999999999999999999999998663221
Q ss_pred CcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHcCccccccCccCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~~~~~~~~ld~~~~ 623 (701)
........+||+.|+|||++.+..+ +.++|||||||++|+|+||++||...... ...+..... .. +..
T Consensus 160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~-~~~- 231 (323)
T 3tki_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YL-NPW- 231 (323)
T ss_dssp ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TS-TTG-
T ss_pred ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cC-Ccc-
Confidence 1122346789999999999887775 77999999999999999999999754321 112222111 01 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 232 ---~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 232 ---KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp ---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 22334588999999999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=359.88 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--------------------------ChHHHHHHHHHHH
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--------------------------GPRQFKQEVEILG 444 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--------------------------~~~~~~~Ei~il~ 444 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999998 4567999998764311 1346899999999
Q ss_pred hCCCCcEEEEeceecC----CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 005343 445 SMRHTNMVILLGACPE----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520 (701)
Q Consensus 445 ~l~HpnIv~l~g~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLK 520 (701)
.++||||+++++++.+ ..++||||+++|+|.+++. ..++++..+..++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999854 3489999999999987652 346899999999999999999999999 9999999
Q ss_pred CCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCC
Q 005343 521 PANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM---LGVKSDLYSLGVVLLQLITARP 597 (701)
Q Consensus 521 p~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~ 597 (701)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999987643221 124568999999999987765 4789999999999999999999
Q ss_pred CCCCchHH--HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 598 AMGLSHQV--EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 598 pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
||...... ...+..+.+. .+..... +..+.+++.+||+.+|.+||++.+++.|+|+.
T Consensus 239 pf~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALE---FPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCC---CCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCccHHHHHHHHhcccCC---CCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 99765432 2223332221 1111222 34589999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=372.40 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=206.5
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++.... ......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 45679999986432 23345789999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78999988654 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~ 624 (701)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||...... .+...+......
T Consensus 161 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~ 226 (336)
T 3h4j_B 161 GN-------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCVYV 226 (336)
T ss_dssp SB-------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSCCC
T ss_pred Cc-------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCCC
Confidence 21 2345689999999999988776 78999999999999999999999654211 111111122223
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.|...+..+.+|+.+||..||.+|||+.+++.|+|++.
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 34445567899999999999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=377.39 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=203.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~ 463 (701)
..++|.+.+.||+|+||.||+|++. ++.||||++.+.. ......+.+|..+|..+ +||||++++++|.+ ..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999985 5569999987542 23445688999999988 79999999999854 448
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998654 35899999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.. ...+..+.+
T Consensus 175 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------- 241 (353)
T 3txo_A 175 ICN------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------- 241 (353)
T ss_dssp CC---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred ccC------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 221 12235678999999999999999999999999999999999999999766542 233333322
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCCh------hhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDL------VSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~------~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+||+. .+++.|+|++-
T Consensus 242 --~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 242 --VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 2233344568999999999999999998 88999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=367.61 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=206.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecCC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPEY--G 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 462 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+|+.++||||++++++|.+. .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456999999999999999999985 567999998765422 356799999999999999999999998553 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEeec
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDVG 538 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DFG 538 (701)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 899999999999999843 346899999999999999999999999 99999999999998877 89999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~ 616 (701)
+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+....+.
T Consensus 164 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 235 (326)
T 2y0a_A 164 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE- 235 (326)
T ss_dssp TCEECCTTS-------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC-
T ss_pred CCeECCCCC-------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC-
Confidence 998764322 1245679999999999999999999999999999999999999997654332 222222211
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....... ..+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 236 ~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 236 FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 0000001 2234589999999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=369.49 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=208.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC-----CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI-----SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
.+.|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999984 5679999985421 2245779999999999999999999999854 348
Q ss_pred eEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc---EEEEeecc
Q 005343 464 LVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV---SKISDVGL 539 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---~KL~DFGl 539 (701)
+||||+++|+|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998888654 23346899999999999999999999999 999999999999976554 99999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHcCcccccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQAIRNGTFSELL 618 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~i~~~~~~~~l 618 (701)
++.+.... ......+||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+..+.+...
T Consensus 180 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~- 252 (351)
T 3c0i_A 180 AIQLGESG------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN- 252 (351)
T ss_dssp CEECCTTS------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCC-
T ss_pred eeEecCCC------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCC-
Confidence 98764322 123456899999999999999999999999999999999999999976543 2223333332110
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..... ..+..+.+|+.+||..+|.+||++.+++.|+|++-.+
T Consensus 253 ~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 253 PRQWS----HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred ccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 00001 1234689999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.66 Aligned_cols=252 Identities=18% Similarity=0.284 Sum_probs=207.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+|+.+++.++||||++++++|.+ ..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999985 5569999987542 334568999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--CCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~~ 546 (701)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998543 246899999999999999999999999 999999999999987 789999999999877543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+..+.+... .....
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~- 228 (321)
T 1tki_A 158 D-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFK- 228 (321)
T ss_dssp C-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HHHHT-
T ss_pred C-------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-hhhhc-
Confidence 2 124567999999999999988999999999999999999999999765432 223333322100 00011
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 229 ---~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 229 ---EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 22346899999999999999999999999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=377.53 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=205.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhC-CCCcEEEEeceecCC--Cce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~l 464 (701)
.++|.+++.||+|+||.||+|++. ++.||+|++++.... ....+.+|..+|.++ +||||++++++|.+. .++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999985 456999999765322 234588999999887 899999999998554 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999988654 35899999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----------HHHHHHHcCc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----------QVEQAIRNGT 613 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----------~~~~~i~~~~ 613 (701)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||.... .....+..+.
T Consensus 205 ~~------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 205 RP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CT------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred cC------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 21 112356789999999999999999999999999999999999999995321 1222232222
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCCh------hhhhhHHHHHHH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDL------VSVVLPELIRLR 663 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~------~~vl~~~~~~l~ 663 (701)
+ .+|...+..+.+|+.+||+.+|.+||+. .+++.|+|++--
T Consensus 279 ~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 I---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred c---------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 1 2333445568999999999999999985 799999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=365.41 Aligned_cols=258 Identities=23% Similarity=0.293 Sum_probs=200.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|.+ .++.||+|++....... ...+.+|+.+++.++||||+++++++.+. .++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 467899999999999999999998 56679999997654322 35689999999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||++ |+|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9997 5788877543 345899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHH-cCccccccC--
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIR-NGTFSELLD-- 619 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~-~~~~~~~ld-- 619 (701)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ...... .+.......
T Consensus 173 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 V------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp C------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred c------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 1 12345678999999998876 5689999999999999999999999975432 222211 010000000
Q ss_pred ------------ccCCCC-----CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 620 ------------PTVTGW-----PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ------------~~~~~~-----p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...... .......+.+|+.+||..||.+|||+.+++.|+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 000000 111234688999999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=366.53 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=207.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|+.+++.++||||++++++|.+. .++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999984 5679999987542 23456788999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998653 35899999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~ 623 (701)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|++||...+... ..+..+.+
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------- 220 (318)
T 1fot_A 159 V---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------- 220 (318)
T ss_dssp C---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------
T ss_pred c---------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 1 245689999999999999999999999999999999999999997655322 22222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 22333345689999999999999999 8999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.19 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=208.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||++++++|.+. .++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999985 567999999765432 234688999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DFGla~~ 542 (701)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999988543 45899999999999999999999999 9999999999999754 4699999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+. ....+..+.+.. ..+
T Consensus 181 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~ 252 (362)
T 2bdw_A 181 VNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PSP 252 (362)
T ss_dssp CTTCC-------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CTT
T ss_pred ecCCc-------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-Ccc
Confidence 64321 12456899999999999999999999999999999999999999976543 333344443321 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+ ...+..+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 253 ~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11 123446899999999999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.14 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=208.4
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CC
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YG 462 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~ 462 (701)
...++|.+.+.||+|+||.||+|++. ++.||||+++... ......+..|..++..+ +||||++++++|.+ ..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35678999999999999999999985 5669999997642 23456688999999876 99999999999854 44
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 8999999999999998653 35899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~ 620 (701)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+.. ...+..+..
T Consensus 168 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------ 235 (345)
T 1xjd_A 168 NMLGD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------ 235 (345)
T ss_dssp CCCTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred cccCC------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC------
Confidence 43221 1235678999999999999999999999999999999999999999765532 223333221
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChh-hhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLV-SVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~-~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+||++. +++.|+|++-
T Consensus 236 ---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 236 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 12333445689999999999999999998 9999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.52 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=200.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCCCceEEeecCCC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEYGCLVYEYMENG 472 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~lV~Ey~~~g 472 (701)
.++|.+.+.||+|+||.||+|.+.++.||||++... .....|.+|+.++++++||||++++|++.+..++||||+++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 357999999999999999999999999999998643 345679999999999999999999999998899999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc-EEEEeeccccccCCCCCccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV-SKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-~KL~DFGla~~~~~~~~~~~ 551 (701)
+|.+++......+.+++..+..++.||+.||.|||+.++.+|+||||||+|||++.++. +||+|||++..+...
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 99999976655556889999999999999999999933223999999999999988876 799999999765321
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--H--HHHHHHcCccccccCccCCCCCH
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--Q--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||.... . ....+..+... ..+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~ 227 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--------PLIK 227 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC--------CCBT
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC--------Cccc
Confidence 234469999999999999999999999999999999999999996432 1 11222222211 1112
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..+..+.+++.+||+.+|.+||++.+++. .+..+..
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~~~~ 263 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK-IMTHLMR 263 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHGG
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHH-HHHHHHH
Confidence 23345899999999999999999999974 4455544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=370.77 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=209.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|++. +..||||++.... ......+.+|+.+|+.++||||+++++++.+. .|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999984 5679999986542 23456789999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999996543 5899999999999999999999999 99999999999999999999999999987633
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~ 623 (701)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.. ...+..+.+
T Consensus 194 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 255 (350)
T 1rdq_E 194 R---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------- 255 (350)
T ss_dssp C---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred C---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2 24568999999999999999999999999999999999999999766432 233333332
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHHh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLRD 664 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~~ 664 (701)
.+|...+..+.+++.+||+.+|.+||+ +.+++.|+|++--+
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 123334456899999999999999999 99999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.46 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=203.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++....... ...+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999984 5679999986654333 34689999999999999999999998654 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998654 36899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~ 623 (701)
.. .......+||+.|+|||.+.+..++.++|||||||++|+|+||++||........... ........ .
T Consensus 164 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~ 234 (294)
T 4eqm_A 164 TS-----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT----T 234 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH----H
T ss_pred cc-----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc----h
Confidence 21 1122456799999999999999999999999999999999999999987765443322 11111110 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+...+..+.+++.+||+.+|.+||+..+.+.+.|..+.
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1122334568999999999999999987778888887653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.55 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=206.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhC-CCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSM-RHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++....... ...+.+|+.++..+ +||||++++++|.+ ..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999985 5569999997654333 34578999999988 89999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999988654 35899999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----------hHHHHHHHcCc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS-----------HQVEQAIRNGT 613 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~-----------~~~~~~i~~~~ 613 (701)
... ......+||+.|+|||++.+..++.++|||||||++|||++|++||... ......+..+.
T Consensus 162 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 162 RPG------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp CTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred CCC------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 211 1235668999999999999999999999999999999999999999642 11222232222
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCCh------hhhhhHHHHHHH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDL------VSVVLPELIRLR 663 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~------~~vl~~~~~~l~ 663 (701)
+ .+|...+..+.+++.+||..+|.+||+. .+++.|+|++--
T Consensus 236 ~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 236 I---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred C---------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 1 2333444568999999999999999995 799999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=358.57 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=200.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999984 66799999876542 224678999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 974 8988885432 45889999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Cccc-----c--
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTFS-----E-- 616 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~~-----~-- 616 (701)
.......||+.|+|||++.+ ..++.++|||||||++|+|+||++||............ +... .
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 12245578999999998876 45899999999999999999999999876543322110 1000 0
Q ss_pred ---ccCccCC--------CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 ---LLDPTVT--------GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 ---~ld~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..++... .+....+..+.+|+.+||+.||.+||++.+++.|+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0011110 01112345688999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.97 Aligned_cols=282 Identities=18% Similarity=0.189 Sum_probs=210.6
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++.... ....+.+|+.+++.+ +||||+.+++++.+ ..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999997 56679999987553 334689999999999 99999999998854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc-----EEEEeeccccc
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV-----SKISDVGLARL 542 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----~KL~DFGla~~ 542 (701)
|+ +|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998654 346899999999999999999999999 999999999999998887 99999999987
Q ss_pred cCCCCCccc-ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HH---HHHHHcCcccc
Q 005343 543 VPPSAADTI-TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH--QV---EQAIRNGTFSE 616 (701)
Q Consensus 543 ~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~---~~~i~~~~~~~ 616 (701)
+........ ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.... .. ...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 643322111 1112356789999999999999999999999999999999999999997532 11 11111111110
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcccccccCCCCCcccCCCCCCCh
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFENAENKNDNIVVTPGPYNSV 687 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (701)
........+ + .+.+++..||+.+|.+||++.+|+...-.-+...+........+.....|+|..+.
T Consensus 240 ~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~p~~~~ 305 (330)
T 2izr_A 240 PIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAV 305 (330)
T ss_dssp CHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTSCCCCCC---
T ss_pred CHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCCCcCCCCCcc
Confidence 000001112 2 69999999999999999999998753322223333333334445444555554433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=365.65 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=202.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC------CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY------GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~lV 465 (701)
..++|.+.+.||+|+||.||+|++.++.||||++.... .....+.+|+.++.+++||||++++++|.+. .++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 35689999999999999999999999999999996542 2234467789999999999999999998542 3899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc----------CCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN----------KPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
|||+++|+|.+++... .+++..+..|+.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999542 489999999999999999999998 8 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCch-------
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSH------- 603 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~------- 603 (701)
|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||....
T Consensus 174 DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 174 DFGLALKFEAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp CCTTCEEECTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred cCCcccccccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 9999987754321 112344689999999999876 356778999999999999999999986431
Q ss_pred -----------HHHHHHHcCccccccCccCCC-C-CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 604 -----------QVEQAIRNGTFSELLDPTVTG-W-PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 604 -----------~~~~~i~~~~~~~~ld~~~~~-~-p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.....+..... .+.... | +...+..+.+|+.+||+.+|.+||++.+++. .+.+|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~-~L~~l~ 317 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE-RITQMQ 317 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 11111111111 121111 1 2245566999999999999999999999974 555554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=364.80 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=203.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecCC--C--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPEY--G-- 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~-- 462 (701)
..++|.+.+.||+|+||.||+|++ .++.||||++........ ..+.+|+.++..++||||+++++++... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999997 456799999987654443 3588999999999999999999987432 2
Q ss_pred --ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 463 --CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 463 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
|+||||+++|+|.+++... .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 8999999999999998654 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---HcCccccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RNGTFSEL 617 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~~~~~~~ 617 (701)
+.+..... .........||+.|+|||++.+..++.++|||||||++|+|+||++||.......... .......
T Consensus 164 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 239 (311)
T 3ork_A 164 RAIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP- 239 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-
T ss_pred cccccccc---ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-
Confidence 87643321 1112345679999999999999999999999999999999999999998765433222 2211100
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
.... ...+..+.+++.+||+.+|.+||+..+++.+.|.++...
T Consensus 240 -~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 -SARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -HHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -cccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0001 112345899999999999999999999999999998543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=378.18 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=209.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+ .+..||+|++...... ....+.+|+.+++.++||||++++++|.+. .++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999998 4567999998765422 234589999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGla~~ 542 (701)
|||+.+|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999988654 35899999999999999999999999 99999999999998 568899999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
+.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||..... ....+..+.+. ...+
T Consensus 163 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~ 235 (444)
T 3soa_A 163 VEGEQ------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSP 235 (444)
T ss_dssp CCTTC------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCTT
T ss_pred ecCCC------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCcc
Confidence 64322 123456899999999999999999999999999999999999999976543 33444444432 1112
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.... .+..+.+|+.+||+.||.+||++.++|.|+|++-.
T Consensus 236 ~~~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 236 EWDT----VTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp TTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred cccc----CCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 2222 23458999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=384.86 Aligned_cols=264 Identities=24% Similarity=0.278 Sum_probs=209.8
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY 461 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 461 (701)
.++....++|.+.++||+|+||.||+|++.. +.||+|++.+.. ......+.+|+.++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444567889999999999999999999954 569999986521 12233488999999999999999999998554
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
.||||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 48999999999999999653 245899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcC
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNG 612 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~ 612 (701)
|+.+..... ......+||+.|+|||++. .+.|+.++|||||||++|||+||++||...+..+. .+...
T Consensus 222 a~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 222 CLKLMEDGT-----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CEECCTTSC-----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhhcccCCC-----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 987643221 1234568999999999886 56799999999999999999999999987654322 22111
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHHHh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRLRD 664 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l~~ 664 (701)
... +..| ......+..+.+|+.+||..+|++ ||++.+++.|+|++--+
T Consensus 297 ~~~-~~~p---~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 297 KER-FQFP---TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp HHH-CCCC---SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ccc-ccCC---cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 100 0011 111123345899999999988888 99999999999997433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=358.07 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=210.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999995 6679999997543 2345678899999999999999999998843 34899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE----cCCCcEEEEeecccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLAR 541 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~~KL~DFGla~ 541 (701)
|||+++|+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976655556999999999999999999999999 9999999999999 888899999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHH
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQ--------TGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQ 607 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~ 607 (701)
.+.... ......||+.|+|||++. +..++.++|||||||++|+|+||++||.... ....
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp ECCTTC-------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ecCCCC-------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 764432 124567999999999876 5778999999999999999999999995321 1111
Q ss_pred HHHcCccccc----------------cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 608 AIRNGTFSEL----------------LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 608 ~i~~~~~~~~----------------ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..+..... ..+.....+......+.+++.+||+.||.+||++.+++.|+-+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2221111100 001112345677788999999999999999999999999987664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=370.00 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=209.6
Q ss_pred cccCHHHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-----CCcEEEE
Q 005343 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-----HTNMVIL 454 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l 454 (701)
..|++.+.....++|.+.++||+|+||.||+|++ .+..||||++.... .....+..|+.+++.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 4555666667789999999999999999999999 45669999987432 33456788999999996 9999999
Q ss_pred eceec--CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC----
Q 005343 455 LGACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---- 528 (701)
Q Consensus 455 ~g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---- 528 (701)
+++|. +..|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99884 4458999999 999999986543 345899999999999999999999999 999999999999975
Q ss_pred ---------------------CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHH
Q 005343 529 ---------------------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGV 587 (701)
Q Consensus 529 ---------------------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGv 587 (701)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC---------CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 889999999999865322 24567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCchHHHHH--HHc--Cccc-------------cccCc--cCCCCCHH--------------------
Q 005343 588 VLLQLITARPAMGLSHQVEQA--IRN--GTFS-------------ELLDP--TVTGWPVE-------------------- 628 (701)
Q Consensus 588 il~elltG~~pf~~~~~~~~~--i~~--~~~~-------------~~ld~--~~~~~p~~-------------------- 628 (701)
+||+|+||++||......... +.. +.+. ...+. ....||..
T Consensus 248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 999999999999765532211 110 0000 00000 00011110
Q ss_pred HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 629 ~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....+.+|+.+||+.||.+||++.++|.|+|++
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 014578999999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=369.86 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=192.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|+.++||||++++++|.+. .++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 5678999999999999999999995 4569999997653 345688999999999999999999998543 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeeccccccC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGLARLVP 544 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGla~~~~ 544 (701)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999988543 45899999999999999999999999 999999999999975 8999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~~~~~~~~ld~~ 621 (701)
... .....+||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+.+. ...+
T Consensus 203 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~~~~- 273 (349)
T 2w4o_A 203 HQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISP- 273 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-CCTT-
T ss_pred ccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-cCCc-
Confidence 321 12456799999999999999999999999999999999999999965432 22233333221 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+....+..+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 274 ---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 274 ---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 22233456899999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.18 Aligned_cols=252 Identities=19% Similarity=0.334 Sum_probs=208.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+|+.++||||++++++|.+. .++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 568999999999999999999985 556999998765444456789999999999999999999998553 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--CCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~~ 546 (701)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 246899999999999999999999999 999999999999974 578999999999876443
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 624 (701)
. .....+||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+.+. ......
T Consensus 205 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~-- 274 (387)
T 1kob_A 205 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAF-- 274 (387)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTT--
T ss_pred c-------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccc--
Confidence 2 1234579999999999999999999999999999999999999998765432 223333221 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 275 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 275 --SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 12334689999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.10 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=191.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999884 56799999876543 3346789999999999999999999998554 489999
Q ss_pred ecCCCChhhHhcccC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 468 YMENGSLEDRLFQKD---NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 468 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886532 2245899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HH-cCccccccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IR-NGTFSELLD 619 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~-~~~~~~~ld 619 (701)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+||++||......... .. .+.......
T Consensus 160 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred CCc------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 321 12345678999999998876 46899999999999999999999999866543221 11 011100000
Q ss_pred c----------cCCC-------------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 620 P----------TVTG-------------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~----------~~~~-------------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+ .... .+...+..+.+|+.+||+.||.+||++.+++.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 0 0000 0011234689999999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.87 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=200.3
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc------eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC-Cce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT------SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY-GCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~------~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~l 464 (701)
.++|.+.+.||+|+||.||+|++..+ .||+|.+..... .....+.+|+.++++++||||++++++|.+. .++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 35799999999999999999998432 268888765432 3456799999999999999999999999554 479
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+.+|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999986543 46899999999999999999999999 9999999999999999999999999998875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
.... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||.... .....+..+...
T Consensus 169 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------ 238 (327)
T 3poz_A 169 AEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------ 238 (327)
T ss_dssp TTCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred CCcc----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC------
Confidence 4321 122344567889999999999999999999999999999999 999997543 334444443211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+...+..+.+++.+||+.+|.+||++.+++.+ +.++
T Consensus 239 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~-l~~~ 276 (327)
T 3poz_A 239 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKM 276 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH-HHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH-HHHH
Confidence 1223344568999999999999999999999865 3443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.82 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=199.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|++.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999994 5669999997654332 3568899999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 666655432 246899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCchHHH---HHHH-cCcccccc---
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPA-MGLSHQVE---QAIR-NGTFSELL--- 618 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~p-f~~~~~~~---~~i~-~~~~~~~l--- 618 (701)
.......||+.|+|||++.+.. ++.++|||||||++|+|+||..| |...+... .... .+......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1234568899999999987766 89999999999999999988765 55443221 1111 01100000
Q ss_pred ---------------CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 ---------------DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 ---------------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...........+..+.+|+.+||+.||.+||++.+++.|+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 0000111123345689999999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=376.61 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=209.1
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC-
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY- 461 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 461 (701)
++....++|.+.+.||+|+||.||+|++. +..||+|++.+.. ......+.+|+.++..++||||++++++|.+.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44456788999999999999999999995 4569999986521 12334588999999999999999999999654
Q ss_pred -CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 462 -GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
.|+||||++||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 48999999999999988542 4889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM----LGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTF 614 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~ 614 (701)
+.+.... .......+||+.|+|||++.... |+.++|||||||+||||+||++||...+... ..+..+..
T Consensus 216 ~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 216 MKMNKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp EECCTTS-----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred EeeccCC-----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 8764322 11235678999999999987655 8899999999999999999999998665432 22222110
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCC--CCChhhhhhHHHHHHHh
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRD--RPDLVSVVLPELIRLRD 664 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~--RPt~~~vl~~~~~~l~~ 664 (701)
.+..+.... .+..+.+|+.+||..+|.+ ||++.+|+.|+|++--+
T Consensus 291 -~~~~p~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 -SLTFPDDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp -HCCCCTTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred -cccCCCccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 011111112 2345899999999999998 99999999999997433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=373.03 Aligned_cols=267 Identities=17% Similarity=0.217 Sum_probs=205.6
Q ss_pred hhcCceeeeeeeec--CceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 392 ATDYFSISRKIGEG--GYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G--~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
..++|.+.+.||+| +||.||+|++. +..||||++....... ...+.+|+.+++.++|||||+++++|.+ ..|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999995 6679999997654222 3458889999999999999999999854 448
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986542 345899999999999999999999999 999999999999999999999999998755
Q ss_pred CCCCCc-ccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCcccccc
Q 005343 544 PPSAAD-TITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELL 618 (701)
Q Consensus 544 ~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~l 618 (701)
...... ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||........... .+.+..++
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 322111 111112234589999999999887 5799999999999999999999999975432211111 11111110
Q ss_pred Ccc-------------------------------------CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 DPT-------------------------------------VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 d~~-------------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.. ...++...+..+.+|+.+||+.||.+||++.++|.|+|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 000 0012223345689999999999999999999999999987
Q ss_pred H
Q 005343 662 L 662 (701)
Q Consensus 662 l 662 (701)
-
T Consensus 339 ~ 339 (389)
T 3gni_B 339 Q 339 (389)
T ss_dssp G
T ss_pred H
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.80 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=208.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~ 463 (701)
..++|.+.+.||+|+||.||+|++..+ .||||++.... ......+..|..+|..+ +||||+.+++++.+ ..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 357899999999999999999999654 59999987542 23456688999999988 89999999999854 448
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998654 35899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+.. ...+..+.+
T Consensus 172 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------- 238 (353)
T 2i0e_A 172 IWDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------- 238 (353)
T ss_dssp CCTT------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred ccCC------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 2211 1235678999999999999999999999999999999999999999766432 223333321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRLR 663 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l~ 663 (701)
.+|...+..+.+|+.+||..+|.+||+ +.+++.|+|++--
T Consensus 239 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 239 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 233344556899999999999999995 5999999988643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=365.30 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=198.2
Q ss_pred hcCceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCCC----CChHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDIS----QGPRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
.++|.+.+.||+|+||.||+|+. .+..||+|++..... .....+.+|+.+|+.++||||++++++|.+ .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 456799999976532 234457899999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 58999999999999998653 35889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccC
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLD 619 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld 619 (701)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+... ..+..+.+
T Consensus 170 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----- 238 (327)
T 3a62_A 170 ESIHDG------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----- 238 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred ccccCC------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 543221 12345689999999999999999999999999999999999999997665322 22222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+|| ++.+++.|+|++-
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 22333445689999999999999999 7889999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.84 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=209.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc--eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT--SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~--~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+.++ .||+|++..........+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 346799999999999999999999554 5999999877666778899999999999999999999998654 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeeccccccC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVP 544 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~~ 544 (701)
|+++++|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988654 35899999999999999999999999 9999999999999 788999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~ 622 (701)
... ......||+.|+|||++.+. ++.++||||||+++|+|+||++||...... ...+..+.+... ....
T Consensus 161 ~~~-------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 231 (277)
T 3f3z_A 161 PGK-------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP-EKDW 231 (277)
T ss_dssp TTS-------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-HHHH
T ss_pred Ccc-------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-chhh
Confidence 332 22456799999999987654 899999999999999999999999765533 223333332110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
. ..+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 232 ~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 L----NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred h----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0 22446899999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=361.32 Aligned_cols=259 Identities=27% Similarity=0.333 Sum_probs=201.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-----CChHHHHHHHHHHHhCC---CCcEEEEeceecC-
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-----QGPRQFKQEVEILGSMR---HTNMVILLGACPE- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-----~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~- 460 (701)
..++|++.+.||+|+||.||+|++ .++.||||++..... .....+.+|+.+++.++ ||||++++++|..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999997 456799999864331 22356788888887775 9999999999843
Q ss_pred ------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEE
Q 005343 461 ------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534 (701)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL 534 (701)
..++||||+. |+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 2479999996 69999885543 345999999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---Hc
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RN 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~ 611 (701)
+|||+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.......... ..
T Consensus 162 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 162 ADFGLARIYSYQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CSCSCTTTSTTCC-------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eeCccccccCCCc-------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999998764322 2245689999999999999999999999999999999999999997765433221 10
Q ss_pred -CccccccCcc-----------CCCC-----CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 -GTFSELLDPT-----------VTGW-----PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 -~~~~~~ld~~-----------~~~~-----p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.......+. .... ....+..+.+|+.+||+.||.+||++.++|.|+|++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 1100000000 0000 0123356899999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=366.19 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCC-----CCCChHHHHHHHHHHHhCCCCcEEEEeceecCC
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPD-----ISQGPRQFKQEVEILGSMRHTNMVILLGACPEY 461 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 461 (701)
+....++|.+.+.||+|+||.||+|.+. +..||+|++... .......+.+|+.+++.++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445778999999999999999999984 446999998643 223456799999999999999999999999654
Q ss_pred --CceEEeecCCCChhhHhcccC-------------------------------------CCCCCChHHHHHHHHHHHHH
Q 005343 462 --GCLVYEYMENGSLEDRLFQKD-------------------------------------NSPPIHWSIRFKIAAEIATA 502 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~a 502 (701)
.++||||+++|+|.+++.... ....+++..+..|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 489999999999999885210 01234677788999999999
Q ss_pred HHHHhhcCCCCeeecCCCCCCeeEcCCC--cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC--CCCCc
Q 005343 503 LLFLHQNKPEPLVHRDLKPANILLDQNY--VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGV 578 (701)
Q Consensus 503 L~~LH~~~~~~iiHrDLKp~NILl~~~~--~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~ 578 (701)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ..........||+.|+|||++.. ..++.
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN--GEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC--C--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCc--cccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 99999999999998766 899999999986632211 11223456689999999998865 67899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 579 KSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 579 ~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
++|||||||++|+|++|++||......... +..+... ...+... ..+..+.+|+.+||+.+|.+||++.+++.
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENPNYN----VLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSGGGG----GSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCcccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999999766543222 2222211 1111111 23346899999999999999999999999
Q ss_pred HHHHHH
Q 005343 657 PELIRL 662 (701)
Q Consensus 657 ~~~~~l 662 (701)
|+|++-
T Consensus 331 hp~~~~ 336 (345)
T 3hko_A 331 HPWISQ 336 (345)
T ss_dssp SHHHHT
T ss_pred Chhhcc
Confidence 999973
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.24 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=206.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+.. +.||+|++.... ......+.+|+.+|+.++||||+.++++|.+ ..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4679999999999999999999854 459999986532 2345678999999999999999999999854 44899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+.||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999998854 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHcCccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSH-----QVEQAIRNGTFSEL 617 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~-----~~~~~i~~~~~~~~ 617 (701)
.. .....+||+.|+|||++.. ..|+.++|||||||++|+|+||++||.... .....+....
T Consensus 168 ~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---- 236 (384)
T 4fr4_A 168 ET-------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---- 236 (384)
T ss_dssp TC-------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----
T ss_pred CC-------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----
Confidence 21 2356789999999999864 458999999999999999999999996432 1112222211
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-hhhhhhHHHHHHHh
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPD-LVSVVLPELIRLRD 664 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-~~~vl~~~~~~l~~ 664 (701)
..+|...+..+.+|+.+||+.+|.+||+ +.+++.|+|++-.+
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 1233334456899999999999999999 89999999886433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=386.84 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=198.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCC---CCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPD---ISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++... .......+.+|+.+++.++||||+.++++|.+ ..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999984 557999998753 22334567899999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+ ||||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999988554 358999999999999999999998 88 9999999999999999999999999998643
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
... ......+||+.|+|||++.+..|+.++|||||||+||+|++|++||..... ....+..+.+
T Consensus 301 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------- 366 (446)
T 4ejn_A 301 KDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------- 366 (446)
T ss_dssp C-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred CCC------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 221 123567899999999999999999999999999999999999999976543 2222322221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLR 663 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~ 663 (701)
.+|...+..+.+|+.+||+.+|.+|| ++.+++.|+|+.-.
T Consensus 367 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 367 -RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 12333445689999999999999999 99999999999743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.69 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=203.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||++++++|.+ ..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999985 56699999866544456679999999999999999999999854 34899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999996533 46899999999999999999999999 99999999999999999999999999987643321
Q ss_pred ccc--------ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHcC
Q 005343 549 DTI--------TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--------VEQAIRNG 612 (701)
Q Consensus 549 ~~~--------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--------~~~~i~~~ 612 (701)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 110 01112356899999999999999999999999999999999999998853211 1111110
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..|..++..+.+++.+||+.+|.+||++.+++. .|..++.
T Consensus 243 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~-~L~~l~~ 282 (310)
T 3s95_A 243 -----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH-WLETLRM 282 (310)
T ss_dssp -----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred -----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHHH
Confidence 012223345899999999999999999999864 5566544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.48 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=200.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356999999999999999999984 56799999876543 3457799999999999999999999998654 489999
Q ss_pred ecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeecccccc
Q 005343 468 YMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLV 543 (701)
Q Consensus 468 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~ 543 (701)
|+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 23356899999999999999999999999 9999999999999 45688999999999866
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~ 621 (701)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||....... ......... ....
T Consensus 178 ~~~~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 247 (285)
T 3is5_A 178 KSDE-------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN--YAVE 247 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCC-
T ss_pred CCcc-------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc--cccc
Confidence 4321 124567999999999875 568999999999999999999999997664322 222211111 0011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
... .+..+.+++.+||+.+|.+||++.+++.|+|++
T Consensus 248 ~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 248 CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp -CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 111 234588999999999999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=361.54 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=202.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||++++++|.+ ..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999983 334999999765432 24568999999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 246899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
.... .........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||..... ....+..+..
T Consensus 203 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 272 (325)
T 3kul_A 203 DDPD---AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------- 272 (325)
T ss_dssp -------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------
T ss_pred cCcc---ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-------
Confidence 4321 1122344567889999999999999999999999999999999 9999965543 2333333311
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+...+..+.+++.+||..+|.+||++.+++. .|..+
T Consensus 273 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~-~L~~l 311 (325)
T 3kul_A 273 -LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS-VLDAL 311 (325)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred -CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 1122334456899999999999999999999974 44444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=381.38 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=197.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecCC------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPEY------ 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 461 (701)
..++|.+++.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|+.++||||++++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999984 56699999976421 2245688999999999999999999998432
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
.|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3899999975 46665522 3889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFS 615 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~~ 615 (701)
++..... ......+||++|+|||++.+..|+.++|||||||+||+|++|++||.+.+...+... -|...
T Consensus 211 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eeecCCC-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9876432 123557899999999999999999999999999999999999999987654332211 01000
Q ss_pred ------------ccc--CccCCC-----------------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 616 ------------ELL--DPTVTG-----------------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 616 ------------~~l--d~~~~~-----------------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+ .+.... ........+.+|+.+||..||.+|||+.++|.|+|+..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 000000 00112456899999999999999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.67 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=206.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC-
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 460 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.+ +||||++++++|.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999873 234999999765322 235689999999999 89999999999854
Q ss_pred -CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
..|+||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 45899999999999999975432 235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH-- 603 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~-- 603 (701)
+.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||+| |++||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999987643221 112244567889999999999999999999999999999999 999997543
Q ss_pred HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 604 ~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.....+..+.. ...|..++..+.+++.+||+.+|.+||++.+++. .|.++..
T Consensus 313 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~-~L~~il~ 364 (370)
T 2psq_A 313 ELFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRILT 364 (370)
T ss_dssp GHHHHHHTTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred HHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHHH
Confidence 23333343321 1223344556999999999999999999999974 4555543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.54 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=211.6
Q ss_pred cccCHHHHHHhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCC-hHHHHHHHHHHHhC-CCCcEE
Q 005343 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQG-PRQFKQEVEILGSM-RHTNMV 452 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l-~HpnIv 452 (701)
..+....+....++|.+.+.||+|+||.||+|++. ++.||||++....... ...+.+|+.++..+ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 45566777778899999999999999999999853 2469999997654322 35689999999999 899999
Q ss_pred EEeceecC---CCceEEeecCCCChhhHhcccCC----------------------------------------------
Q 005343 453 ILLGACPE---YGCLVYEYMENGSLEDRLFQKDN---------------------------------------------- 483 (701)
Q Consensus 453 ~l~g~~~~---~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------- 483 (701)
+++++|.+ ..++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999854 25899999999999999965432
Q ss_pred -----------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 484 -----------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 484 -----------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch---HHHHHHHcCccccccCccC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH---QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~---~~~~~i~~~~~~~~ld~~~ 622 (701)
.. ........||+.|+|||++.+..++.++|||||||++|+|+| |++||.... .....+..+...
T Consensus 247 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------- 315 (359)
T 3vhe_A 247 PD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------- 315 (359)
T ss_dssp TT----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------
T ss_pred cc----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------
Confidence 21 122345678999999999999999999999999999999998 999997543 333444433221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
..|...+..+.+++.+||+.+|.+||++.+++.|.
T Consensus 316 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 316 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 12223345689999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.81 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=204.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEeec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEYM 469 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey~ 469 (701)
.++|.+.+.||+|+||.||+|.+ .+..||+|++.... ...+.+.+|+.++++++||||++++++|.+. .++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46799999999999999999999 55669999998654 4457799999999999999999999998654 48999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 9999999985432 46899999999999999999999999 9999999999999999999999999998764321
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p 626 (701)
........+|+.|+|||++.+..++.++||||||+++|+|+| |++||...... ...+..+.. . ..|
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~--~------~~~ 229 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--L------YKP 229 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--C------CCC
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc--C------CCC
Confidence 112345567889999999999999999999999999999999 99999765432 222333211 1 112
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2234468999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.94 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=201.2
Q ss_pred hcCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec----CCC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----EYG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~ 462 (701)
.++|++.+.||+|+||.||+|++ .++.||||++..........+.+|+.+++.++||||++++++|. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999985 35669999998665444567999999999999999999999883 345
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 89999999999999986543 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHHcCcc-------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE-QAIRNGTF------- 614 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~-~~i~~~~~------- 614 (701)
+..... .........+|..|+|||.+.+..++.++|||||||++|+|+||..|+....... ..+.....
T Consensus 164 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 164 LPQDKE---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccCCcc---eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 643321 1112234567888999999999999999999999999999999999987543211 11100000
Q ss_pred --ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 615 --SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 615 --~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+........|..++..+.+++.+||+.+|.+||++.+++. .+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~-~L~~l~ 290 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL-RVDQIR 290 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH-HHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH-HHHHHH
Confidence 000001111223444567999999999999999999999964 455543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=365.63 Aligned_cols=249 Identities=20% Similarity=0.249 Sum_probs=193.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..++|.+.+.||+|+||.||++++. ++.||||++.... .....+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999994 5669999997654 334678999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc--EEEEeeccccccCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV--SKISDVGLARLVPP 545 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--~KL~DFGla~~~~~ 545 (701)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999885533 5899999999999999999999999 999999999999987765 99999999974322
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHcCcccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK-SDLYSLGVVLLQLITARPAMGLSHQ------VEQAIRNGTFSELL 618 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-sDvwSlGvil~elltG~~pf~~~~~------~~~~i~~~~~~~~l 618 (701)
. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||..... ....+....+.
T Consensus 171 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 240 (361)
T 3uc3_A 171 H-------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--- 240 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC---
T ss_pred c-------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC---
Confidence 1 12245679999999999988887665 8999999999999999999975432 11112222111
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+.... .+..+.+|+.+||..+|.+||++.+++.|+|+.
T Consensus 241 ~~~~~~----~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 241 IPDDIR----ISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp CCTTSC----CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred CCCcCC----CCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 011111 234589999999999999999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.88 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=202.4
Q ss_pred Ccee--eeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 395 YFSI--SRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 395 ~f~~--~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.|.+ .+.||+|+||.||+|.+. +..||+|++..........+.+|+.+|++++||||++++++|.+. .+|||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3444 678999999999999984 567999999876544566799999999999999999999998553 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE--cCCCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL--DQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl--~~~~~~KL~DFGla~~~~~~ 546 (701)
+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 168 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 168 VDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999999886432 45899999999999999999999999 9999999999999 56789999999999877543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~ 624 (701)
. .....+||+.|+|||++....++.++|||||||+||+|+||++||...+.... .+....+. ........
T Consensus 243 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 314 (373)
T 2x4f_A 243 E-------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDEEFQD 314 (373)
T ss_dssp C-------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-SCSGGGTT
T ss_pred c-------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CChhhhcc
Confidence 2 12345799999999999999999999999999999999999999977654322 22222211 11111122
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
.+..+.+|+.+||..+|.+||++.+++.|+|++-...
T Consensus 315 ----~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 315 ----ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred ----CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 2346899999999999999999999999999985443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.60 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=200.0
Q ss_pred hcCceeeeeeeecCceeEEEEEECC--ce----EEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH--TS----VAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~--~~----vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+.. .. |++|++.... ......+.+|+.+++.++||||++++++|.+ ..++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 3579999999999999999999843 32 7888875543 2334568899999999999999999999954 4479
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+.+|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998643 246889999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
.... ........||..|+|||++.+..++.++|||||||++|+|+| |++||.... .+...+..+....
T Consensus 167 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----- 237 (325)
T 3kex_A 167 PDDK----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA----- 237 (325)
T ss_dssp CCTT----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC-----
T ss_pred cccc----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-----
Confidence 4322 112345678889999999999999999999999999999999 999997543 3444444443211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.|...+..+.+++.+||..+|.+||++.+++.+
T Consensus 238 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 ---QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112223357899999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=367.69 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=196.1
Q ss_pred hcCceee-eeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHH-HhCCCCcEEEEeceecC------CC
Q 005343 393 TDYFSIS-RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEIL-GSMRHTNMVILLGACPE------YG 462 (701)
Q Consensus 393 ~~~f~~~-~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~------~~ 462 (701)
.++|.+. +.||+|+||.||+|.+. +..||||++.. ...+.+|+.++ +..+||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 78999999999999985 55699999853 35678899987 45589999999998743 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeecc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGL 539 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGl 539 (701)
||||||++||+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 89999999999999996532 346899999999999999999999999 999999999999987 78999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHcCc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ------VEQAIRNGT 613 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~------~~~~i~~~~ 613 (701)
++..... ......+||+.|+|||++.+..|+.++|||||||+||+|++|++||...+. ....+..+.
T Consensus 211 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 211 AKETTSH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ccccCCC-------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 9865322 123566899999999999999999999999999999999999999975432 233444443
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.. ..+... ..+..+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 284 ~~~-~~~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 284 YEF-PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCC-CTTTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccC-CCcccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 321 111112 23345899999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=378.97 Aligned_cols=263 Identities=23% Similarity=0.222 Sum_probs=208.1
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecCC
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPEY 461 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 461 (701)
.++....++|.+.+.||+|+||.||+|++. ++.||||++.+... .....+.+|+.++..++||||++++++|.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344456788999999999999999999984 56799999865321 1223488999999999999999999998554
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
.||||||++||+|.+++.+.. ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 489999999999999996543 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHH
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-------TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIR 610 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~ 610 (701)
++.+..... ......+||+.|+|||++. ...|+.++|||||||++|||+||++||...+.... .+.
T Consensus 209 a~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 209 CLKLRADGT-----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CEECCTTSC-----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred heeccCCCc-----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 987644321 1224568999999999887 46789999999999999999999999977654322 222
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCC---CChhhhhhHHHHHHHh
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDR---PDLVSVVLPELIRLRD 664 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~R---Pt~~~vl~~~~~~l~~ 664 (701)
.... ....+ .++...+..+.+|+.+||. +|.+| |++.+++.|+|++--+
T Consensus 284 ~~~~-~~~~p---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 284 HYKE-HLSLP---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp THHH-HCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred hccc-CcCCC---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 1110 00001 1112234468999999999 99998 6999999999987433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.18 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=193.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCC-CCcEEEEeceecC----CC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMR-HTNMVILLGACPE----YG 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~----~~ 462 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|..+. ||||++++++|.. ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999984 567999998654322 2345789999999997 9999999999842 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|+||||++ |+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 89999996 689888854 35889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcc---------------cccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 005343 543 VPPSAADT---------------ITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606 (701)
Q Consensus 543 ~~~~~~~~---------------~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~ 606 (701)
+....... ......+..+||++|+|||++.+ ..|+.++|||||||+||||++|++||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64311100 01123456789999999998876 679999999999999999999999998765433
Q ss_pred HHHHc----Ccccc-----cc------------------CccCCC-CC------------HHHHHHHHHHHHHhhccCcC
Q 005343 607 QAIRN----GTFSE-----LL------------------DPTVTG-WP------------VEAALSIAKLALQCCELRKR 646 (701)
Q Consensus 607 ~~i~~----~~~~~-----~l------------------d~~~~~-~p------------~~~~~~l~~li~~cl~~~P~ 646 (701)
..... +.... +. ...... ++ ...+..+.+|+.+||..||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 22110 00000 00 000000 00 01234689999999999999
Q ss_pred CCCChhhhhhHHHHHH
Q 005343 647 DRPDLVSVVLPELIRL 662 (701)
Q Consensus 647 ~RPt~~~vl~~~~~~l 662 (701)
+|||+.+++.|+|++.
T Consensus 319 ~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 319 KRISANDALKHPFVSI 334 (388)
T ss_dssp GSCCHHHHTTSTTTTT
T ss_pred cCCCHHHHhCCHHHHH
Confidence 9999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=376.51 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=208.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++.+ ..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999985 6679999986532 2334678999999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999854 346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||...+. ....+..+.+.
T Consensus 169 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------- 234 (476)
T 2y94_A 169 GE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY------- 234 (476)
T ss_dssp TC-------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC-------
T ss_pred cc-------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC-------
Confidence 21 2345689999999999988775 7899999999999999999999976542 23334444321
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.|...+..+.+|+.+||..+|.+||++.+++.|+|++-
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 12223346899999999999999999999999999973
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.32 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=203.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++...... +.+|++++.++ +||||++++++|.+. .|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999985 556999999765432 45788888888 799999999998654 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC----CcEEEEeeccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN----YVSKISDVGLARL 542 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~----~~~KL~DFGla~~ 542 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+... +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988543 35899999999999999999999999 9999999999998432 3599999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHcCccccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS-----HQVEQAIRNGTFSEL 617 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~-----~~~~~~i~~~~~~~~ 617 (701)
+.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||... ..+...+..+.+...
T Consensus 170 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 170 LRAEN------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243 (342)
T ss_dssp CBCTT------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred CcCCC------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence 64321 1234568999999999998888999999999999999999999999742 233444555543211
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+...+..+.+|+.+||..||.+||++.+++.|+|+.-
T Consensus 244 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 -----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp -----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred -----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1111233446899999999999999999999999999953
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.77 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=209.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++++.+. .++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999984 567999998765422 235688999999999999999999998654 3899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc---EEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV---SKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---~KL~DFGla~~ 542 (701)
|||+++|+|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999888654 35899999999999999999999999 999999999999976554 99999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|++||..... ....+..+.+.. ..+
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 229 (284)
T 3kk8_A 158 VNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PSP 229 (284)
T ss_dssp CCSSC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CTT
T ss_pred cccCc-------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-Cch
Confidence 64322 12456799999999999999999999999999999999999999976543 233333333221 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
.... .+..+.+++.+||+.+|.+||++.+++.|+|++-+..
T Consensus 230 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 230 EWDT----VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp TTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred hhcc----cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 1122 2345899999999999999999999999999986443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=346.54 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=194.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCC----ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQ----GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+.++.||||++...... ..+.+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 468999999999999999999999999999998765422 24678999999999999999999999854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--------CCcEEEEeec
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--------NYVSKISDVG 538 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--------~~~~KL~DFG 538 (701)
||+++|+|.+++. ...+++..+..++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999883 246899999999999999999999988556889999999999986 7889999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--HcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--RNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~~~~~~~ 616 (701)
++..+.... .....||+.|+|||.+.+..++.++||||||+++|+|+||++||.......... ......
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 232 (271)
T 3dtc_A 162 LAREWHRTT--------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA- 232 (271)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC-
T ss_pred ccccccccc--------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC-
Confidence 998654321 234579999999999999999999999999999999999999998665433222 222111
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
...+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11223344568999999999999999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=351.59 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=197.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHh--CCCCcEEEEeceecC------CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS--MRHTNMVILLGACPE------YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~------~~~ 463 (701)
..++|.+.+.||+|+||.||+|.+.++.||||++... ....+.+|.+++.. ++||||+++++++.+ ..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 3568999999999999999999999999999998653 44567778888777 799999999998632 247
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH--------QNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
+||||+++|+|.+++.. ..+++..+..|+.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999932 36899999999999999999999 777 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITA----------RPAM 599 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG----------~~pf 599 (701)
|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||+|| ++||
T Consensus 156 Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQ--LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CCTTCEEEETTTTE--EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCeeeccccccc--ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999876433211 11123455899999999998876 456799999999999999999 8888
Q ss_pred CCc-------hHHHHHHHcCccccccCccCCC--CCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 600 GLS-------HQVEQAIRNGTFSELLDPTVTG--WPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 600 ~~~-------~~~~~~i~~~~~~~~ld~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
... ......+.... ..+.... .+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 432 11222221111 1111111 12356678999999999999999999999973
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.51 Aligned_cols=249 Identities=29% Similarity=0.417 Sum_probs=204.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--Cce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~l 464 (701)
..++|.+.+.||+|+||.||+|.+.. ..||+|++.... ......+.+|+.+++.++||||++++++|.+. .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 35679999999999999999999854 459999985432 12345689999999999999999999998654 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988654 35899999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~ 622 (701)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|++||....... ..+....+
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (279)
T 3fdn_A 161 SS--------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------- 224 (279)
T ss_dssp ---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred cc--------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence 22 1245579999999999999999999999999999999999999998665332 22222221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+|...+..+.+|+.+||+.+|.+||++.+++.|+|++-.
T Consensus 225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 1223334568999999999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=345.59 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=203.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+.+. .||+|++.... .....+.+|+.++..++||||++++++|.+. .++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356799999999999999999998655 69999997654 3457799999999999999999999999654 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999986542 35899999999999999999999999 99999999999999999999999999987644321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH--HHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQ--AIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~--~i~~~~~~~~ld~~~~~~ 625 (701)
.......+|+.|+|||.+.+..++.++||||||+++|+|+| |++||........ .+..+.. . ..
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~------~~ 226 (268)
T 3sxs_A 160 -----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR--L------YR 226 (268)
T ss_dssp -----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--C------CC
T ss_pred -----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC--C------CC
Confidence 12244567788999999998899999999999999999999 9999976654332 2222221 1 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
|...+..+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2223346899999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.97 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=206.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecCC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPEY--G 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 462 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999984 567999998765432 356799999999999999999999998554 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEeec
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDVG 538 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DFG 538 (701)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 899999999999999854 346899999999999999999999999 99999999999999887 79999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~ 616 (701)
++..+.... ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+.+.
T Consensus 165 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~- 236 (321)
T 2a2a_A 165 LAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD- 236 (321)
T ss_dssp TCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-
T ss_pred cceecCccc-------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc-
Confidence 998764321 1245679999999999999999999999999999999999999997654332 223322211
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.++.. +...+..+.+++.+||..+|.+||++.+++.|+|+.
T Consensus 237 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 237 -FDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp -CCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred -cChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00000 011234589999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=376.71 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=189.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec-------CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP-------EY 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~-------~~ 461 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|+.++||||++++++|. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999884 556999998765332 2356889999999999999999999983 23
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.|+||||+ +|+|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 48999998 6789988843 246899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccc---------------------ccccccccccCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHh-----
Q 005343 542 LVPPSAADTI---------------------TQYHMTTAAGTFCYIDPEYQ-QTGMLGVKSDLYSLGVVLLQLIT----- 594 (701)
Q Consensus 542 ~~~~~~~~~~---------------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDvwSlGvil~ellt----- 594 (701)
.+........ .....+..+||++|+|||++ ....|+.++||||||||||||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7743221100 01134567899999999975 56679999999999999999999
Q ss_pred ------CCCCCCCchHH-----------------------HHHHH-cCc--------------------cccccCccCCC
Q 005343 595 ------ARPAMGLSHQV-----------------------EQAIR-NGT--------------------FSELLDPTVTG 624 (701)
Q Consensus 595 ------G~~pf~~~~~~-----------------------~~~i~-~~~--------------------~~~~ld~~~~~ 624 (701)
|+++|.+.... ...+. -|. +.......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 77777553310 00000 000 00000000000
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.....+..+.+|+.+||..||.+||++.++|.|+|++--
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 011224568999999999999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=361.73 Aligned_cols=260 Identities=27% Similarity=0.341 Sum_probs=198.5
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-----hHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-----PRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
...++|.+.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||++++++|.+ .
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999984 5679999987543221 2468899999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 5899999975 888877543 346889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-Ccccc
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-GTFSE 616 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~~~~~ 616 (701)
.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||......... +.. +....
T Consensus 161 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPN------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCC------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred eccCCc------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 764321 123456899999999988654 5899999999999999999999999876543322 211 11100
Q ss_pred ccCc------------cCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 617 LLDP------------TVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 617 ~ld~------------~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+ .....| ...+..+.+|+.+||..+|.+||++.+++.|+|+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 0000 001111 122356899999999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=365.94 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=199.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY------ 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 461 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.+|+.++||||+.+++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999984 5679999986653222 35688999999999999999999998432
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 38999999 8899998854 35889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~ 614 (701)
++..... ....+||++|+|||++.+ ..++.++|||||||++|+|++|++||...+....... .|..
T Consensus 175 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9875321 245689999999998877 6799999999999999999999999987654332211 0110
Q ss_pred --------------------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 --------------------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 --------------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.......+..+....+..+.+|+.+||..||.+|||+.+++.|+|++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 000011111122233456899999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.63 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=203.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.++..+ +||||+++++++.+ ..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999994 6779999998654333 45688999999999 99999999999854 45899
Q ss_pred EeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC----------------
Q 005343 466 YEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---------------- 528 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---------------- 528 (701)
|||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996542 1246899999999999999999999999 999999999999984
Q ss_pred ---CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 005343 529 ---NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQ 604 (701)
Q Consensus 529 ---~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~ 604 (701)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 448999999999876432 234589999999998766 567899999999999999999988766554
Q ss_pred HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 605 VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 605 ~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
... +..+.+. ..|...+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 237 ~~~-~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 237 WHE-IRQGRLP--------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHH-HHTTCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHH-HHcCCCC--------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 433 3333332 122233446899999999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=354.70 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=199.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.+++.++||||++++++|.+. .++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999995 5679999987654332 34588999999999999999999998543 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998877432 45899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---------------
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--------------- 610 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--------------- 610 (701)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...........
T Consensus 156 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 S------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 11245679999999998875 6689999999999999999999999987654332211
Q ss_pred --cCcc-ccccCccCCCC-C-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 --NGTF-SELLDPTVTGW-P-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 --~~~~-~~~ld~~~~~~-p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+ .....+..... + ...+..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0000 00000000000 0 123345899999999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.54 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=207.0
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC-
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE- 460 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 460 (701)
....++|.+.+.||+|+||.||+|++.+ +.||||++....... ...+.+|+.+++.++||||++++++|.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3356789999999999999999999854 569999997654322 4568999999999999999999999854
Q ss_pred -CCceEEeecCCCChhhHhcccCC---------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDN---------------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 518 (701)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 45899999999999999966421 257899999999999999999999999 99999
Q ss_pred CCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 005343 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARP 597 (701)
Q Consensus 519 LKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 597 (701)
|||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999987643211 112245578999999999999999999999999999999999 999
Q ss_pred CCCCchH--HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 598 AMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 598 pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
||..... ....+..+... ..|...+..+.+++.+||+.+|.+||++.+++. .|.++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~-~L~~~ 333 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR-ILQRM 333 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHT
T ss_pred cCCCCChHHHHHHHhCCCcC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH-HHHHH
Confidence 9976543 33334444321 223334456899999999999999999999863 34443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.07 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=195.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCCh--HHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGP--RQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~--~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|.+.++||+|+||.||+|.+. ++.||||++........ ..+..|+..+..+ +||||++++++|.+. .++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999994 66799999876543322 2355566655555 999999999999554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+ +|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 789998886543 46999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
. ......||+.|+|||++.+ .++.++|||||||++|||++|.+|+....... .+..+..... ++
T Consensus 211 ~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~-------~~ 274 (311)
T 3p1a_A 211 G-------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQGYLPPE-------FT 274 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-HHTTTCCCHH-------HH
T ss_pred C-------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHhccCCCcc-------cc
Confidence 1 1244579999999998875 79999999999999999999976665444332 2332221110 11
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+++.+||+.+|.+||++.+++.|+|++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 12335689999999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.41 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=208.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.+.|.+.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457999999999999999999984 56799999976543 345779999999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998843 46899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~~ 625 (701)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ..+..+... ..
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 239 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP--------TL 239 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------CC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC--------CC
Confidence 12345679999999999999999999999999999999999999997654332 222222211 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|+.-.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 22233458999999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=359.78 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999985 5669999987654222 2245679999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 68988886543 45899999999999999999999999 9999999999999999999999999998653221
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H-cCcccc-----cc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R-NGTFSE-----LL 618 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~-~~~~~~-----~l 618 (701)
......+||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......... . .+.... ..
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 12345578999999998876 568999999999999999999999998765432211 1 011000 00
Q ss_pred C---------ccCC-----CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 619 D---------PTVT-----GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 619 d---------~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. +... ..+...+..+.+|+.+||+.||.+||++.+++.|+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0 0000 00012234688999999999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=380.21 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=209.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++.... ......+.+|+.+|+.++||||+.++++|.+ ..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999984 5679999986532 2334678899999999999999999999854 34899
Q ss_pred EeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||++||+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986543 2456999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCcccccc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGTFSELL 618 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~~~~~l 618 (701)
.... .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.... .+...+..+..
T Consensus 341 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~---- 410 (543)
T 3c4z_A 341 AGQT------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV---- 410 (543)
T ss_dssp TTCC------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----
T ss_pred CCCc------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----
Confidence 3321 1244689999999999999999999999999999999999999997542 23333332221
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRLR 663 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l~ 663 (701)
.+|...+..+.+|+.+||..+|.+||++ .+++.|+|++-.
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 2333445568999999999999999965 789999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.91 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=182.9
Q ss_pred Cceee---eeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecCC--CceEE
Q 005343 395 YFSIS---RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 395 ~f~~~---~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~lV~ 466 (701)
+|.+. +.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+. ||||++++++|.+. .|+||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 35554 78999999999999995 567999998643 3467889999999997 99999999999654 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---VSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~DFGla~~~ 543 (701)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999999653 46899999999999999999999999 99999999999997655 8999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---------HHHHHHcCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ---------VEQAIRNGTF 614 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~---------~~~~i~~~~~ 614 (701)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....+..+.+
T Consensus 160 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 160 PPDN------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred CCCC------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 4322 123456789999999999999999999999999999999999999975432 2233333332
Q ss_pred ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 615 ~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
... .+. ....+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 234 ~~~-~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 234 SFE-GEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp CCC-SHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred CCC-ccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 100 000 012345689999999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.80 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=195.4
Q ss_pred HhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
...++|.+.+.||+|+||.||+|.+ .++.||||++....... ...+.+|+.+++.++||||+++++++.+ ..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999988 45679999997654322 3457899999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE-----cCCCcEEEEeecc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL-----DQNYVSKISDVGL 539 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl-----~~~~~~KL~DFGl 539 (701)
||||++ |+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 5999988543 35899999999999999999999999 9999999999999 4556699999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Ccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~ 614 (701)
++.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||............ +..
T Consensus 184 a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 184 ARAFGIPI------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccCCcc------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 98764321 123456789999999998774 4899999999999999999999999876654332221 100
Q ss_pred ccccC-------------ccCCCCC------HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 SELLD-------------PTVTGWP------VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 ~~~ld-------------~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..... +...... ...+..+.+|+.+||+.||.+||++.+++.|+|++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 00000 0000000 012356899999999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.49 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=205.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||++++++|.+. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999995 5679999986654332 34578999999999999999999998544 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887633 235899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---------------
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--------------- 610 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--------------- 610 (701)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...........
T Consensus 178 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 G------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 123456799999999998775 789999999999999999999999987654332211
Q ss_pred ---cCccccccCccCCC-CC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhccccc
Q 005343 611 ---NGTFSELLDPTVTG-WP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFEN 669 (701)
Q Consensus 611 ---~~~~~~~ld~~~~~-~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~ 669 (701)
...+.....+.... .+ ...+..+.+|+.+||+.+|.+||++.++|.|+|++..+..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHH
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhh
Confidence 00011111111111 01 1234568999999999999999999999999999986654443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.52 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=206.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||++++++|.+ ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999953 345999998754322 23468899999999999999999999854 45
Q ss_pred ceEEeecCCCChhhHhcccC----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEE
Q 005343 463 CLVYEYMENGSLEDRLFQKD----NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKIS 535 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~ 535 (701)
++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 89999999999999997643 2245899999999999999999999999 9999999999999854 459999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcC
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNG 612 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~ 612 (701)
|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||+| |++||..... ....+..+
T Consensus 227 DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHS----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CCcccccccccc----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999998652211 1112244578999999999999999999999999999999998 9999976543 23333333
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
... ..+...+..+.+|+.+||+.+|.+||++.+|+.+.+.-..+
T Consensus 303 ~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRM--------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC--------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 211 12233345689999999999999999999999877665544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=362.96 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=196.1
Q ss_pred hcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCC--CcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRH--TNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++....... ...+.+|+.+|..++| |||+.+++++.+. .++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999988 45569999987654332 3568999999999987 9999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||| .+|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 995 588999999653 45889999999999999999999999 99999999999997 57899999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHH--HHc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQT-----------GMLGVKSDLYSLGVVLLQLITARPAMGLSH-QVEQA--IRN 611 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~pf~~~~-~~~~~--i~~ 611 (701)
... .......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.... ..... +..
T Consensus 160 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 160 DTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccc----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 321 112345689999999998864 678999999999999999999999997532 21111 111
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
... ...+|...+..+.+|+.+||+.+|.+||++.+++.|+|++.
T Consensus 236 ~~~-------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 236 PNH-------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp TTS-------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCc-------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 111 11223333346899999999999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.46 Aligned_cols=245 Identities=28% Similarity=0.494 Sum_probs=200.8
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCCh-------HHHHHHHHHHHhCCCCcEEEEeceecCCCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGP-------RQFKQEVEILGSMRHTNMVILLGACPEYGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~-------~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 463 (701)
.++|.+.+.||+|+||.||+|++ .++.||+|++........ ..+.+|+.+++.++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 47899999999999999999998 466799999876543322 568999999999999999999999988889
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc-----EEEEeec
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV-----SKISDVG 538 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----~KL~DFG 538 (701)
+||||+++|+|.+.+... ...+++..+..++.|++.||.|||+.+ .||+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999999888553 346899999999999999999999986 35999999999999987776 9999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHcC
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQ--QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ----VEQAIRNG 612 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~----~~~~i~~~ 612 (701)
+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|++||..... ....+...
T Consensus 175 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 175 LSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp TCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred ccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9975422 12456799999999998 455689999999999999999999999965431 12222222
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
... ...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 246 ~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111 1223344456999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.28 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=200.9
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
+.|.+.+.||+|+||.||+|++ .++.||||++....... ...+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999997 46679999997654332 2458899999999999999999999844 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+. |+|.+++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 68888775433 46899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCcc
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDPT 621 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~~ 621 (701)
...+||+.|+|||++. .+.++.++|||||||++|||+||++||...+..... +..+......
T Consensus 208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 274 (348)
T 1u5q_A 208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--- 274 (348)
T ss_dssp ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC---
T ss_pred ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Confidence 3457999999999874 567999999999999999999999999765543322 2222211111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+ +..+.+++.+||+.+|.+||++.+++.|+|+.
T Consensus 275 ~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 275 SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCC----CHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 1123 34589999999999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.15 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=203.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+.+. .||+|++.... .....+.+|+.++..++||||++++++|.+. .++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 456899999999999999999998654 69999997654 3457799999999999999999999999654 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999985532 35899999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~ 625 (701)
........+|+.|+|||++.+..++.++||||||+++|+|+| |++||...... ...+..+.. . ..
T Consensus 175 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----~---~~ 242 (283)
T 3gen_A 175 ----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----L---YR 242 (283)
T ss_dssp ----HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-----C---CC
T ss_pred ----cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-----C---CC
Confidence 112344567889999999998999999999999999999998 99999765432 223333211 1 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|...+..+.+++.+||+.+|.+||++.+++.+...-+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 2222346899999999999999999999987655443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=372.20 Aligned_cols=246 Identities=16% Similarity=0.154 Sum_probs=193.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC---CCChHHHHHHH---HHHHhCCCCcEEEEece------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI---SQGPRQFKQEV---EILGSMRHTNMVILLGA------ 457 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~---~~~~~~~~~Ei---~il~~l~HpnIv~l~g~------ 457 (701)
..++|.+.+.||+|+||.||+|++ .++.||||++.... ....+.+.+|+ .+|+.++|||||++++.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999997 46789999987542 23346789999 55566689999998843
Q ss_pred -ecC-------------------CCceEEeecCCCChhhHhcccCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 005343 458 -CPE-------------------YGCLVYEYMENGSLEDRLFQKDN----SPPIHWSIRFKIAAEIATALLFLHQNKPEP 513 (701)
Q Consensus 458 -~~~-------------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 513 (701)
+.+ ..|+||||+ +|+|.+++..... ...+++..+..|+.||+.||.|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 322 257999999 6899999965421 123456888899999999999999999
Q ss_pred eeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC-----------CCCchhhH
Q 005343 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-----------MLGVKSDL 582 (701)
Q Consensus 514 iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~sDv 582 (701)
|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 99999999999999999999999999985422 2245577 999999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 583 YSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 583 wSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|||||+||+|+||++||...... ..+..+. .....++ ..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~------~~~~~~~-~~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAAL------GGSEWIF-RSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------------CCSGGGG-SSCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccc------cchhhhh-hhccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999999654321 1111111 1112333 45899999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.07 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=206.3
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE-------CCceEEEEEeCCCC-CCChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDI-SQGPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~-------~~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
+...++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.++.++ +||||++++++|.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34567899999999999999999997 22359999997653 23456799999999999 99999999999854
Q ss_pred --CCceEEeecCCCChhhHhcccCCC--------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDNS--------------------PPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 518 (701)
..++||||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 458999999999999999654321 34899999999999999999999999 99999
Q ss_pred CCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 005343 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARP 597 (701)
Q Consensus 519 LKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 597 (701)
|||+|||++.++.+||+|||++..+..... ........||+.|+|||++.+..++.++|||||||+||+|+| |.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999986643221 112344567889999999999999999999999999999998 999
Q ss_pred CCCCch---HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 598 AMGLSH---QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 598 pf~~~~---~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
||.... .....+..+... ..|...+..+.+++.+||..+|.+||++.+++.+....+..
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 997543 334444443211 12223345689999999999999999999998765554433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=351.76 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=203.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999995 56799999987766667889999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999886533 35899999999999999999999999 99999999999999999999999999764311
Q ss_pred CcccccccccccccCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCc
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQ-----QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDP 620 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~ 620 (701)
.........||+.|+|||++ ....++.++|||||||++|+|++|++||...+..... +..+.....
T Consensus 170 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 242 (302)
T 2j7t_A 170 ----TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--- 242 (302)
T ss_dssp ----HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred ----cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc---
Confidence 11122345799999999987 4677899999999999999999999999866543322 222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+...+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 280 (302)
T 2j7t_A 243 ---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280 (302)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence 11223344689999999999999999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.10 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=206.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|++..........+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457999999999999999999984 667999999876544556789999999999999999999998554 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeeccccccC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVP 544 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~~ 544 (701)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988654 35889999999999999999999999 9999999999999 788999999999987543
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~ 622 (701)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....+..+.+. ...+.
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~- 230 (304)
T 2jam_A 161 NG--------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPF- 230 (304)
T ss_dssp CB--------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CCTTT-
T ss_pred CC--------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccc-
Confidence 21 12345789999999999999999999999999999999999999976543 23334444321 11111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 231 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 231 ---WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 1223446899999999999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=360.50 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=204.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++...... ....+.+|+.+++.++||||++++++|.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999984 567999998665432 24578899999999999999999998843
Q ss_pred --CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
..++||||+.+ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 24799999974 7777764432 45899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--H--cCc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--R--NGT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~--~~~ 613 (701)
+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......... . .+.
T Consensus 170 ~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99877533211 1223456789999999998876 558999999999999999999999998765432211 1 111
Q ss_pred cccccCccCC-------------C-CCHH-------HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 FSELLDPTVT-------------G-WPVE-------AALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 ~~~~ld~~~~-------------~-~p~~-------~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.....+... . .... ....+.+|+.+||+.||.+||++.+++.|+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 1111000000 0 0000 124588999999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.95 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=199.6
Q ss_pred hcCceee-eeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSIS-RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~-~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~ 466 (701)
.+.|.+. +.||+|+||.||+|.+ .+..||||++..........+.+|+.++.++ +||||+++++++.+ ..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578885 7899999999999987 4667999999877656677899999999985 79999999999854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc---EEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV---SKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---~KL~DFGla~~~ 543 (701)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999654 35889999999999999999999999 999999999999987765 999999999866
Q ss_pred CCCCC-cccccccccccccCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCch--------------
Q 005343 544 PPSAA-DTITQYHMTTAAGTFCYIDPEYQQT-----GMLGVKSDLYSLGVVLLQLITARPAMGLSH-------------- 603 (701)
Q Consensus 544 ~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~-------------- 603 (701)
..... ...........+||+.|+|||++.. ..++.++|||||||++|+|+||++||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 1111122345679999999998865 568999999999999999999999996542
Q ss_pred ---HHHHHHHcCccccccCccCCCCCH----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 604 ---QVEQAIRNGTFSELLDPTVTGWPV----EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 604 ---~~~~~i~~~~~~~~ld~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....+..+.+ .+|. ..+..+.+|+.+||..||.+||++.+++.|+|++
T Consensus 245 ~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 245 CQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 12233333322 1221 1234689999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=381.60 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=210.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|.+.+.||+|+||.||+|++. ++.||||++.... ......+.+|+.+|..++||||+.++++|.+ ..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999984 5679999986532 2345668899999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||++||+|.+++.... ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+++.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999886543 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCcccccc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGTFSELL 618 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~~~~~l 618 (701)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.... .+...+....
T Consensus 338 ~~~-------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~----- 405 (576)
T 2acx_A 338 EGQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----- 405 (576)
T ss_dssp TTC-------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-----
T ss_pred cCc-------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-----
Confidence 322 1245689999999999999999999999999999999999999997642 2333333221
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHHHh
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRLRD 664 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l~~ 664 (701)
..+|...+..+.+|+.+||..+|.+|| ++.+++.|+|++--+
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 122333445689999999999999999 789999999987433
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=375.65 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=197.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCC--------CChHHHHHHHHHHHhCCCCcEEEEeceecC-
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDIS--------QGPRQFKQEVEILGSMRHTNMVILLGACPE- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 460 (701)
..++|.+.+.||+|+||.||+|.+.. ..||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46789999999999999999999854 5699999865321 112248899999999999999999999854
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEee
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDV 537 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DF 537 (701)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred ceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 45899999999999998854 346899999999999999999999999 9999999999999654 45999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRN 611 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~ 611 (701)
|+++.+.... .....+||+.|+|||++. ...|+.++|||||||+||+|+||++||.... .....+..
T Consensus 287 G~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 287 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp STTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred ccceecCCCc-------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 9998764321 234568999999999875 3668899999999999999999999996532 23344444
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
+.+... ..... ..+..+.+|+.+||+.+|.+||++.+++.|+|++-.
T Consensus 360 ~~~~~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 360 GKYNFI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TCCCCC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCCCC-chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 433211 00011 123468999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.18 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=205.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecCC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPEY--G 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 462 (701)
.++|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||++++++|.+. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999995 667999998765322 356799999999999999999999998543 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEeec
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDVG 538 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DFG 538 (701)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 8999999999999998543 35899999999999999999999999 99999999999998776 89999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~ 616 (701)
++..+.... ......||+.|+|||++.+..++.++||||||+++|+|++|++||........ .+......
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 229 (283)
T 3bhy_A 158 IAHKIEAGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD- 229 (283)
T ss_dssp TCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-
T ss_pred cceeccCCC-------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC-
Confidence 998764321 12445799999999999999999999999999999999999999976654322 22222211
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..+. .+...+..+.+++.+||..+|.+||++.+++.|+|++-..
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 230 -FDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -CCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -Ccch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000 0012234589999999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.19 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=204.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++... .....+.+|+.++..++||||+++++++.+ ..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999985 667999998764 345779999999999999999999999854 3489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999988533 246899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cCccccccCccCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NGTFSELLDPTVTGW 625 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~~~~~~ld~~~~~~ 625 (701)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||........... .+..... ..
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~ 247 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF------RK 247 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------SS
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc------CC
Confidence 122456799999999999999999999999999999999999999986654433221 1111111 11
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 2223446899999999999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=347.94 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=185.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999998 56679999986432 22346789999999999999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++... ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999988543 346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
... ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..... .. ...
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----~~-~~~ 231 (278)
T 3cok_A 165 PHE------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVL-----AD-YEM 231 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS-----SC-CCC
T ss_pred CCC------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhh-----cc-cCC
Confidence 211 1234578999999999999999999999999999999999999997543211 1111110 00 122
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|...+..+.+++.+||..+|.+||++.+++.|+|+.-
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 3334456899999999999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.66 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=208.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++....... ...+.+|+.+++.++||||+++++++.+. .++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999995 4569999987654322 34688999999999999999999998554 4799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~i~~~~~~~~ld~~~~ 623 (701)
... ......||+.|+|||++.+..++.++||||||+++|+|+||++||........ .+..+.+
T Consensus 168 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 232 (294)
T 2rku_A 168 DGE------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------- 232 (294)
T ss_dssp TTC------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred Ccc------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------
Confidence 211 12446799999999999999999999999999999999999999987654322 2222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|...+..+.+++.+||+.+|.+||++.+++.|+|+.-
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 122233446899999999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=362.01 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=202.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--------ChHHHHHHHHHHHhCCCCcEEEEeceecCC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--------GPRQFKQEVEILGSMRHTNMVILLGACPEY 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 461 (701)
..++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346799999999999999999987 4567999999765421 233578899999999999999999999654
Q ss_pred --CceEEeecCCC-ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 462 --GCLVYEYMENG-SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 462 --~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
.++||||+.+| +|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 47999999777 999988543 45899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ 617 (701)
+++.+.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||...... ....
T Consensus 176 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~ 240 (335)
T 3dls_A 176 SAAYLERGK-------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAA 240 (335)
T ss_dssp TCEECCTTC-------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTC
T ss_pred cceECCCCC-------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------Hhhc
Confidence 998764332 1244679999999999988876 88999999999999999999999653221 0001
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. ..|...+..+.+|+.+||+.+|.+||++.+++.|+|++
T Consensus 241 ~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 241 I-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred c-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 1 11222344689999999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=346.65 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=204.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999984 66799999865433 3346789999999999999999999998543 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998843 346899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHcCccccccCccCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~~~~~~~~ld~~~~ 623 (701)
.........||+.|+|||.+.+..+ +.++||||||+++|+|+||+.||..... ....+..... .. +
T Consensus 160 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~-~--- 229 (276)
T 2yex_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YL-N--- 229 (276)
T ss_dssp ----EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TS-T---
T ss_pred ----chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--cc-C---
Confidence 1112345679999999999887775 7899999999999999999999975432 1222222211 00 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. ....+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 230 ~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (276)
T 2yex_A 230 P-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (276)
T ss_dssp T-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred c-hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence 1 112344589999999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.28 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=202.7
Q ss_pred CceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEeecC
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEYME 470 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey~~ 470 (701)
.|.....||+|+||.||+|.+ .+..||||++..........+.+|+.+++.++||||++++++|.+. .++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999998 4556999999876655667899999999999999999999998543 489999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeeccccccCCCCCc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~~~~~~~~~ 549 (701)
+|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++..+....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999976655556789999999999999999999999 999999999999987 8999999999998764321
Q ss_pred ccccccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ-AIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~-~i~~~~~~~~ld~~~~~~p 626 (701)
.......||+.|+|||++.... ++.++||||||+++|+|+||++||........ ....+.. ......+
T Consensus 178 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~ 248 (295)
T 2clq_A 178 ----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPEIP 248 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCCCC
T ss_pred ----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----ccccccc
Confidence 1124557999999999987654 89999999999999999999999964322111 1111110 0011223
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+++.+||..+|.+||++.+++.|+|++.
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 334456899999999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.14 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=207.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++.+. .++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999985 4569999986432 23346789999999999999999999998543 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999986543 5889999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~ 623 (701)
. ......||+.|+|||++.+..++.++||||||+++|+|++|++||....... ..+....+
T Consensus 167 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 229 (284)
T 2vgo_A 167 L--------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------- 229 (284)
T ss_dssp S--------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred c--------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------
Confidence 1 1234679999999999999999999999999999999999999997665332 22222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+|...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 122333456899999999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.43 Aligned_cols=251 Identities=25% Similarity=0.456 Sum_probs=193.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+.+ .||+|++....... ...+.+|+.+++.++||||+.+++++.. ..++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 46789999999999999999998765 49999997664332 3568999999999999999999998754 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 174 (289)
T 3og7_A 101 CEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS- 174 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc-
Confidence 9999999988543 346899999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~ 622 (701)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .....+..+.+... .
T Consensus 175 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 247 (289)
T 3og7_A 175 ---GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD----L 247 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----T
T ss_pred ---ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----h
Confidence 112234567999999999886 6678999999999999999999999996543 33444444443322 2
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2223344456999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.89 Aligned_cols=264 Identities=24% Similarity=0.272 Sum_probs=200.2
Q ss_pred HHHHHHhhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCC-----------hHHHHHHHHHHHhCCCCcEEE
Q 005343 386 IEEIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQG-----------PRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 386 ~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~-----------~~~~~~Ei~il~~l~HpnIv~ 453 (701)
+.++....++|.+.+.||+|+||.||+|.+ .+..||||++....... .+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677889999999999999999999987 56679999986644322 267899999999999999999
Q ss_pred EeceecC-------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 454 LLGACPE-------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 454 l~g~~~~-------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
++++|.. ..|+||||+. |+|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9998721 2389999997 6888877543 346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV 605 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 605 (701)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp CTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCCCEEEEecCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999997543221 2345678999999998876 67999999999999999999999999865432
Q ss_pred HHH---HHc-Cc--c-----------ccccCccCCC--------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHH
Q 005343 606 EQA---IRN-GT--F-----------SELLDPTVTG--------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELI 660 (701)
Q Consensus 606 ~~~---i~~-~~--~-----------~~~ld~~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~ 660 (701)
... +.. +. . ...+...... .+...+..+.+|+.+||+.+|.+||++.+++.|+|+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 211 110 00 0 0000000000 011224458999999999999999999999999998
Q ss_pred HH
Q 005343 661 RL 662 (701)
Q Consensus 661 ~l 662 (701)
+-
T Consensus 321 ~~ 322 (362)
T 3pg1_A 321 ES 322 (362)
T ss_dssp TT
T ss_pred hh
Confidence 74
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.86 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=192.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
..++|.+.+.||+|+||.||+|.+.. ..||+|++...... ..+.+.+|+.+++.++||||+++++++.+ ..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 45789999999999999999999843 34999998764322 23568999999999999999999999854 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999986542 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
... ........+|+.|+|||.+....++.++|||||||++|+|++ |.+||.... .....+..+...
T Consensus 168 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------ 236 (281)
T 1mp8_A 168 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 236 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred ccc-----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC------
Confidence 321 112234567889999999998999999999999999999997 999997543 223333333211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
..+...+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 12233445689999999999999999999997543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.67 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=194.5
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC-------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY------- 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 461 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999998 4667999998764322 234688999999999999999999998432
Q ss_pred -CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 462 -GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
.|+||||++ |+|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 389999996 57888773 24889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--cC--c---
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--NG--T--- 613 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~~--~--- 613 (701)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||...+....... .. .
T Consensus 175 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred ccccccc-------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 8653221 23456899999999999999999999999999999999999999987654332211 10 0
Q ss_pred -------------------c---------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 -------------------F---------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 -------------------~---------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+ .....+.....+...+..+.+|+.+||..||.+|||+.+++.|+|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 000000000011223567999999999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=351.84 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=199.5
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecC----CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~----~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++.. .....+.+|+.+++.++ ||||+.+++++.+ ..++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999988 456799999874 34577999999999997 9999999999854 34899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~~ 544 (701)
|||+.+++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999873 3788999999999999999999999 99999999999999766 89999999998765
Q ss_pred CCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHH---------------H
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSH-QVE---------------Q 607 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~-~~~---------------~ 607 (701)
... ......||..|+|||++.+ ..++.++|||||||++|+|+||+.||.... ... .
T Consensus 183 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCC-------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 432 1245679999999999877 679999999999999999999999984321 111 1
Q ss_pred HHHcCcccc------c--------cCccC-CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 608 AIRNGTFSE------L--------LDPTV-TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 608 ~i~~~~~~~------~--------ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+....... + ..... ...+...+..+.+|+.+||+.+|.+||++.++|.|+|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 111111000 0 00000 011112345689999999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=365.77 Aligned_cols=250 Identities=25% Similarity=0.278 Sum_probs=197.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC---CChHHHHHHHHH-HHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS---QGPRQFKQEVEI-LGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~---~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|++. +..||||++.+... .....+.+|..+ ++.++||||++++++|.+ ..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999995 45599999976532 223456777776 577899999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999988653 35888999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~ 622 (701)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.. ...+..+.+
T Consensus 191 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------- 256 (373)
T 2r5t_A 191 EH------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------- 256 (373)
T ss_dssp CC------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--------
T ss_pred cC------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Confidence 21 11235678999999999999999999999999999999999999999766532 222322221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCCh----hhhhhHHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDL----VSVVLPELIRLR 663 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~----~~vl~~~~~~l~ 663 (701)
.++...+..+.+|+.+||+.+|.+||++ .+++.|+|++--
T Consensus 257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 1222334468999999999999999997 588999887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=364.41 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=203.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++....... ...|.+|+.+|+.++||||++++|+|.+ ..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4568999999999999999999994 6679999987653221 2358899999999999999999999954 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999986532 35889999999999999999999999 999999999999999999999999999865332
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
. .........+++.|+|||.+..+.++.++|||||||++|||+| |.+||..... +...+..+...
T Consensus 267 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 334 (377)
T 3cbl_A 267 V----YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------- 334 (377)
T ss_dssp E----EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC--------
T ss_pred c----eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 1 1111122345778999999999999999999999999999998 9999976543 33334433211
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|..++..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~-~L~~i 372 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ-ELQSI 372 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH-HHHHH
Confidence 123334456899999999999999999999863 44444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.34 Aligned_cols=251 Identities=21% Similarity=0.380 Sum_probs=188.1
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECCc-----eEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecCC--
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDHT-----SVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPEY-- 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~~-----~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 461 (701)
...++|.+.+.||+|+||.||+|.+..+ .||||++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3457899999999999999999987433 699999876532 2346799999999999999999999998432
Q ss_pred C------ceEEeecCCCChhhHhcccC---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 462 G------CLVYEYMENGSLEDRLFQKD---NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 462 ~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
. ++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 2 79999999999999986532 2236899999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i 609 (701)
||+|||+++.+..... ........+|+.|+|||.+.+..++.++|||||||++|+|+| |++||..... ....+
T Consensus 177 kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp EECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EEeecccccccccccc----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 9999999987643221 111234567889999999999999999999999999999999 9999975432 22223
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+.. ...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 253 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 253 IGGNR--------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp HTTCC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hcCCC--------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 32221 1122333456899999999999999999877763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.51 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=208.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||++++++|.+. .++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999984 5679999986553 23466799999999999999999999999654 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~ 542 (701)
|||+.+|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999988543 45899999999999999999999999 9999999999999 5678999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~ 620 (701)
+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||...... ...+..+.+... .+
T Consensus 179 ~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~ 249 (484)
T 3nyv_A 179 FEASK-------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-LP 249 (484)
T ss_dssp BCCCC-------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-SG
T ss_pred ccccc-------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 75432 1245579999999998865 6999999999999999999999999876543 334444433211 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+ ...+..+.+|+.+||..+|.+||++.++|.|+|++-
T Consensus 250 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 250 QW----KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp GG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 11 123456899999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=372.29 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=203.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.+.|.+.+.||+|+||.||+|++. +..||+|++.... ......+.+|+.+|+.++||||++++++|.+. .|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999995 5569999987654 23456799999999999999999999999654 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGla~~~ 543 (701)
||+++|+|.+.+... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988654 35889999999999999999999999 999999999999975 456999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
.... .....+||+.|+|||++. +.|+.++|||||||++|+|++|++||..... ....+..+.+.. ..+.
T Consensus 190 ~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~ 260 (494)
T 3lij_A 190 ENQK-------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-DSPE 260 (494)
T ss_dssp BTTB-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CSGG
T ss_pred CCCc-------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Cchh
Confidence 4321 234568999999999876 5699999999999999999999999986653 333444443321 1122
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+... +..+.+|+.+||+.+|.+||++.++|.|+|++-
T Consensus 261 ~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 WKNV----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp GTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred cccC----CHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 2222 345899999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.46 Aligned_cols=257 Identities=18% Similarity=0.259 Sum_probs=205.8
Q ss_pred HHhhcCceee-eeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhC-CCCcEEEEeceecCC--
Q 005343 390 EAATDYFSIS-RKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSM-RHTNMVILLGACPEY-- 461 (701)
Q Consensus 390 ~~~~~~f~~~-~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-- 461 (701)
+...++|.+. +.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.++..+ .||||++++++|.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4456678887 89999999999999985 66799999876432 2356789999999999 469999999998554
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeec
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVG 538 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFG 538 (701)
.++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 48999999999999988543 3356899999999999999999999999 999999999999987 7899999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~ 616 (701)
+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||......... +......
T Consensus 180 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~- 251 (327)
T 3lm5_A 180 MSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD- 251 (327)
T ss_dssp GCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred cccccCCcc-------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-
Confidence 998764321 124467999999999999999999999999999999999999999766543322 2222211
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+ .+...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 252 ~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 252 YSEE----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred cCch----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 1111 11223445899999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.32 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=208.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+.+.||+|+||.||++.+. +..||+|++...... ....+.+|+.+++.++||||++++++|.+. .++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999995 456999998765322 235688999999999999999999998654 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988543 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~ 623 (701)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+.+
T Consensus 194 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 258 (335)
T 2owb_A 194 DG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------- 258 (335)
T ss_dssp TT------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------
T ss_pred Cc------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---------
Confidence 21 12245679999999999999999999999999999999999999998664332 22222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|......+.+++.+||+.+|.+||++.+++.|+|+.-
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 122233346899999999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=369.89 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=205.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC---CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||++++++|.+ ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 34679999999999999999999999999999998653 56789999999999999999999999743 35899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999997643 234789999999999999999999999 999999999999999999999999999854321
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.....+|+.|+|||++.+..++.++|||||||+||||+| |++||.... .+...+..+.. ...
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~~ 407 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDA 407 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------CCC
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence 123367889999999999999999999999999999998 999997543 33344444421 122
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|..++..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~-~L~~i 443 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE-QLEHI 443 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHH
Confidence 3344567999999999999999999999974 44444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=363.41 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=204.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++....... ...+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999996 5679999997764322 3568999999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999986543 588999999999999999999985 8 99999999999999999999999999875421
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCc-----cc------
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGT-----FS------ 615 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~-----~~------ 615 (701)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||............+. ..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 122456899999999999999999999999999999999999999975442211110000 00
Q ss_pred -------------------------cccCccCCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 616 -------------------------ELLDPTVTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 616 -------------------------~~ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
.+........+ ...+..+.+|+.+||+.+|.+|||+.+++.|+|++-.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 00000000011 112446899999999999999999999999999986553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.16 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=190.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC-h-HHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG-P-RQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~-~-~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
..++|++.+.||+|+||.||+|.+ .++.||+|++....... . ..+.++...++.++||||+++++++.+ ..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999998 56779999997653222 1 224455556888999999999999854 45899
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
|||++ |+|.+++... .....+++..+..|+.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 5887777542 2345799999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHcCccc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQ----QTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----QVEQAIRNGTFS 615 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----~~~~~i~~~~~~ 615 (701)
.... ......||+.|+|||++ .+..++.++|||||||++|+|+||++||.... .....+.....
T Consensus 161 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (290)
T 3fme_A 161 VDDV-------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP- 232 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-
T ss_pred cccc-------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-
Confidence 4321 12344799999999985 56678999999999999999999999997532 12222222211
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.. .+...+..+.+++.+||+.+|.+||++.+++.|+|++...
T Consensus 233 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 233 QL-------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CC-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred Cc-------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 11 0112334589999999999999999999999999998743
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=356.69 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=203.5
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC---
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--- 460 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--- 460 (701)
.++....++|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445678999999999999999999999 56779999987653 4457799999999999 89999999999843
Q ss_pred -----CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 461 -----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 461 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 4489999999999999986542 346889999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI- 609 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i- 609 (701)
|||++..+.... .......||+.|+|||++. ...++.++|||||||++|+|+||++||..........
T Consensus 172 Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 172 DFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp CCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred eCcCceecCcCc------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 999998664321 1124457999999999886 5678999999999999999999999997665443322
Q ss_pred -HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 610 -RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 610 -~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+...... ...+ +..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 246 ~~~~~~~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 246 IPRNPAPRLK---SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHSCCCCCS---CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred hhcCccccCC---cccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 222211111 1123 345899999999999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.48 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=196.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCC--CCcEEEEeceecC--CCceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMR--HTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~--~~~lV~ 466 (701)
.+|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|..++ ||||+++++++.. ..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999884 566999998765432 2356899999999996 5999999998744 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
| +.+|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 5688999998654 36888899999999999999999999 99999999999996 578999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHH--HHHHcC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQT-----------GMLGVKSDLYSLGVVLLQLITARPAMGLSH-QVE--QAIRNG 612 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~pf~~~~-~~~--~~i~~~ 612 (701)
.. .......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.... ... ..+..+
T Consensus 208 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 208 TT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred Cc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 21 112345689999999998765 468999999999999999999999997532 111 111211
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.. .. .+|...+..+.+|+.+||..+|.+||++.+++.|+|++..
T Consensus 284 ~~----~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NH----EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TS----CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cc----cC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 11 11 1222223468999999999999999999999999999853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=359.03 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=208.8
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC---------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceec
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACP 459 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 459 (701)
...++|.+.+.||+|+||.||+|.+.+ ..||||++...... ....+.+|+++++.+ +||||++++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 356789999999999999999999732 35999999766432 235689999999999 9999999999985
Q ss_pred C--CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCe
Q 005343 460 E--YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANI 524 (701)
Q Consensus 460 ~--~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NI 524 (701)
+ ..++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 4 45899999999999999976432 245899999999999999999999999 99999999999
Q ss_pred eEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005343 525 LLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH 603 (701)
Q Consensus 525 Ll~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 603 (701)
|++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |.+||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987643221 112344567889999999999999999999999999999999 999997654
Q ss_pred --HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 604 --QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 604 --~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.....+..+... ..+...+..+.+++.+||+.+|.+||++.+++.+ |.++..
T Consensus 299 ~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~-L~~~~~ 352 (382)
T 3tt0_A 299 VEELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED-LDRIVA 352 (382)
T ss_dssp HHHHHHHHHTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHHHH
T ss_pred HHHHHHHHHcCCCC--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH-HHHHHH
Confidence 233344433221 1222334568999999999999999999999764 555543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.85 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=200.0
Q ss_pred cCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC------CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 463 (701)
..|.+.+.||+|+||.||+|.+.. ..||+|++...... ....+.+|+.+++.++||||++++++|.. ..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458999999999999999999854 45999988654322 24568999999999999999999998743 248
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEEEEeeccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARL 542 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~ 542 (701)
+||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999553 45889999999999999999999976 3599999999999997 789999999999976
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcCccccccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNGTFSELLD 619 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~~~~~~ld 619 (701)
..... .....||+.|+|||++. +.++.++|||||||++|+|+||++||......... +..+.....
T Consensus 182 ~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 250 (290)
T 1t4h_A 182 KRASF--------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-- 250 (290)
T ss_dssp CCTTS--------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--
T ss_pred ccccc--------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc--
Confidence 53321 23457999999999876 45999999999999999999999999764433222 222211111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
++...+..+.+++.+||+.+|.+||++.+++.|+|++
T Consensus 251 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~ 287 (290)
T 1t4h_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence 1112224589999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=360.63 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=200.6
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
+...++|.+.+.||+|+||.||+|.+ .+..||||++..+... ..+|+.+|+.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44578899999999999999999998 4567999998655322 3579999999999999999998722
Q ss_pred ---------------------------------CCceEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHH
Q 005343 461 ---------------------------------YGCLVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFL 506 (701)
Q Consensus 461 ---------------------------------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~L 506 (701)
..++||||++ |+|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1469999997 5887777542 2345689999999999999999999
Q ss_pred hhcCCCCeeecCCCCCCeeEc-CCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHH
Q 005343 507 HQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYS 584 (701)
Q Consensus 507 H~~~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwS 584 (701)
|+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||++.+. .++.++||||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-------PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-------CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999 99999999999998 68999999999998764332 12455789999999987764 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCchHHHHHHHc----------------CccccccCccCC--C----CCHHHHHHHHHHHHHhhc
Q 005343 585 LGVVLLQLITARPAMGLSHQVEQAIRN----------------GTFSELLDPTVT--G----WPVEAALSIAKLALQCCE 642 (701)
Q Consensus 585 lGvil~elltG~~pf~~~~~~~~~i~~----------------~~~~~~ld~~~~--~----~p~~~~~~l~~li~~cl~ 642 (701)
|||++|+|++|++||......+..... ..+....-+... . .+...+..+.+|+.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999999876544332210 111111111111 1 122344568999999999
Q ss_pred cCcCCCCChhhhhhHHHHHH
Q 005343 643 LRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 643 ~~P~~RPt~~~vl~~~~~~l 662 (701)
.+|.+||++.+++.|+|++-
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHH
T ss_pred CChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.31 Aligned_cols=256 Identities=11% Similarity=0.048 Sum_probs=184.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhC--CCCcEEEEeceec------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSM--RHTNMVILLGACP------ 459 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l--~HpnIv~l~g~~~------ 459 (701)
...|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999984 5669999998765322 34577885444444 6999888553221
Q ss_pred --------------------CCCceEEeecCCCChhhHhcccCCCCCCChHHH------HHHHHHHHHHHHHHhhcCCCC
Q 005343 460 --------------------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR------FKIAAEIATALLFLHQNKPEP 513 (701)
Q Consensus 460 --------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~ 513 (701)
...|+||||++ |+|.+++..... .+++..+ ..++.||+.||.|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 23589999998 899999976432 3466666 788899999999999999
Q ss_pred eeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHH
Q 005343 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQ 591 (701)
Q Consensus 514 iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~e 591 (701)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC---------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999999875321 124467799999999987 679999999999999999
Q ss_pred HHhCCCCCCCchHHH-HHHHcCccccccCccC-CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 592 LITARPAMGLSHQVE-QAIRNGTFSELLDPTV-TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 592 lltG~~pf~~~~~~~-~~i~~~~~~~~ld~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
|+||++||....... ..+............. ...+...+..+.+|+.+||+.+|.+||++.+++.|+|++-.
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 999999997552110 0000000000000000 00112334568999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=342.64 Aligned_cols=254 Identities=20% Similarity=0.207 Sum_probs=200.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|.+ .++.||||++.... ....+.+|+.++..+ +|||++.+++++.+ ..++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356799999999999999999997 56779999986543 335688999999999 89999999998854 448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc-----EEEEeecccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV-----SKISDVGLAR 541 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~-----~KL~DFGla~ 541 (701)
||+ +|+|.+++.... .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 999999996543 35899999999999999999999999 999999999999987765 9999999998
Q ss_pred ccCCCCCccc-ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHcCccc
Q 005343 542 LVPPSAADTI-TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----QVEQAIRNGTFS 615 (701)
Q Consensus 542 ~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----~~~~~i~~~~~~ 615 (701)
.+........ .........||+.|+|||++.+..++.++|||||||++|+|++|++||.... .....+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7754322111 1122456789999999999999999999999999999999999999997532 111111111110
Q ss_pred cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 616 ~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
......... .+..+.+++.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 TPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccHHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000011112 23468999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.69 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=201.4
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC----CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE----YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+.++.||||++....... .+.+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4579999999999999999999999999999998764322 3468999999999999999999999854 348999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 9999999999996532 346899999999999999999999876 359999999999999999999999999875432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHcCccccccCc
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGV---KSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRNGTFSELLDP 620 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~---~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~~~~~~~ld~ 620 (701)
.....||+.|+|||++.+..++. ++|||||||++|+|+||++||........ ....+..
T Consensus 165 ---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 229 (271)
T 3kmu_A 165 ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR------ 229 (271)
T ss_dssp ---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC------
T ss_pred ---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC------
Confidence 13457899999999988765544 89999999999999999999976554322 2222211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...|...+..+.+++.+||+.+|.+||++.+++. .|.++
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~-~L~~l 268 (271)
T 3kmu_A 230 --PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP-ILEKM 268 (271)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHh
Confidence 1223334456899999999999999999999873 44443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=356.48 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=209.2
Q ss_pred ccCHHHHHHhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEE
Q 005343 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVIL 454 (701)
Q Consensus 383 ~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l 454 (701)
.+..+++....++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3445556667789999999999999999999875 356999998755322 23458899999999999999999
Q ss_pred eceecC--CCceEEeecCCCChhhHhcccC-------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 455 LGACPE--YGCLVYEYMENGSLEDRLFQKD-------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 455 ~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
++++.+ ..++||||+++|+|.+++.... ...++++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999854 4589999999999999986532 2246789999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|+|+| |.+||.....
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred EcCCCeEEECcCcccccccccc----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999998653221 1112244567899999999999999999999999999999999 8999976543
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
....+..+... ..+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 247 EQVLRFVMEGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23333333321 1223344568999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=358.12 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=207.3
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--------hHHHHHHHHHHHhC-CCCcEEEEece
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--------PRQFKQEVEILGSM-RHTNMVILLGA 457 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--------~~~~~~Ei~il~~l-~HpnIv~l~g~ 457 (701)
.....++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++..+ +||||+.++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999984 6679999997664221 34578999999999 89999999999
Q ss_pred ecC--CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 458 CPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 458 ~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
|.. ..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 854 448999999999999998643 35899999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccccCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HH
Q 005343 536 DVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT------GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQ 607 (701)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~ 607 (701)
|||++..+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...... ..
T Consensus 243 DfG~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 243 DFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp CCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCcccccCCCc-------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999998775432 2345689999999998763 35889999999999999999999999765432 22
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+..+.+.. ..+.... .+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 316 ~i~~~~~~~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 316 MIMEGQYQF-SSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHTCCCC-CHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHhCCCCC-CCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 333333211 0111111 234589999999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.25 Aligned_cols=263 Identities=23% Similarity=0.280 Sum_probs=196.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999985 456999999765432 23568999999999999999999999843
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 3489999995 699998843 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccc----------------ccccccccccCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHh---------
Q 005343 541 RLVPPSAADTI----------------TQYHMTTAAGTFCYIDPEYQ-QTGMLGVKSDLYSLGVVLLQLIT--------- 594 (701)
Q Consensus 541 ~~~~~~~~~~~----------------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDvwSlGvil~ellt--------- 594 (701)
+.+........ .....+..+||++|+|||++ ....|+.++||||||||||||++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 97743321100 01224677999999999975 56679999999999999999998
Q ss_pred --CCCCCCCch--------------------HHHHHHH-cCccc----------------cccCccCCCCC-----HHHH
Q 005343 595 --ARPAMGLSH--------------------QVEQAIR-NGTFS----------------ELLDPTVTGWP-----VEAA 630 (701)
Q Consensus 595 --G~~pf~~~~--------------------~~~~~i~-~~~~~----------------~~ld~~~~~~p-----~~~~ 630 (701)
|+|+|.+.+ .....+. -|... ..+ +.....+ ...+
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF-PHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS-CCCCCCCHHHHSTTSC
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC-CCCCCCCHHHHCCCCC
Confidence 445554321 0100000 00000 000 0000000 1234
Q ss_pred HHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 631 LSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 631 ~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+.+|+.+||..||.+||++.++|.|+|++-
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 46899999999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=365.64 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=206.9
Q ss_pred cccccccCHHHHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCC--------
Q 005343 378 NVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMR-------- 447 (701)
Q Consensus 378 ~~~~~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-------- 447 (701)
...|..+.+.+ ...++|.+.++||+|+||.||+|++. ++.||||++.... .....+.+|+.+|+.++
T Consensus 23 ~~~~~~~~~g~--~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 23 KGGYHLVKIGD--LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp C--CCSSCTTC--EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred CCCceEEehhh--hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCC
Confidence 33444444333 24578999999999999999999884 5669999997542 23456889999999985
Q ss_pred CCcEEEEeceec------CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCC
Q 005343 448 HTNMVILLGACP------EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLK 520 (701)
Q Consensus 448 HpnIv~l~g~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLK 520 (701)
||||+++++.|. ...|+||||+ +|+|.+.+.... ...+++..+..|+.||+.||.|||+. + |+|||||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDik 174 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIK 174 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCS
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 788999999874 2458999999 677777665432 34689999999999999999999998 8 9999999
Q ss_pred CCCeeEcCCC-------------------------------------------------cEEEEeeccccccCCCCCccc
Q 005343 521 PANILLDQNY-------------------------------------------------VSKISDVGLARLVPPSAADTI 551 (701)
Q Consensus 521 p~NILl~~~~-------------------------------------------------~~KL~DFGla~~~~~~~~~~~ 551 (701)
|+|||++.++ .+||+|||+++.....
T Consensus 175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----- 249 (397)
T 1wak_A 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----- 249 (397)
T ss_dssp GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----
T ss_pred HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----
Confidence 9999998775 7999999999876322
Q ss_pred ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------H---HHHHH-----------Hc
Q 005343 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------Q---VEQAI-----------RN 611 (701)
Q Consensus 552 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~---~~~~i-----------~~ 611 (701)
....+||+.|+|||++.+..++.++|||||||+||+|+||++||.... . ..... ..
T Consensus 250 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 325 (397)
T 1wak_A 250 ----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325 (397)
T ss_dssp ----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhc
Confidence 245579999999999999999999999999999999999999996432 1 11111 11
Q ss_pred Cccc-----------cccCc----------cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 612 GTFS-----------ELLDP----------TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 612 ~~~~-----------~~ld~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.+. .+.+. ....++...+..+.+|+.+||+.+|.+||++.++|.|+|++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 1110 00000 01135667778899999999999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=371.27 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=204.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-------------CChHHHHHHHHHHHhCCCCcEEEEec
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-------------QGPRQFKQEVEILGSMRHTNMVILLG 456 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~g 456 (701)
..++|.+.++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999985 45699999876432 23456899999999999999999999
Q ss_pred eecCC--CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---c
Q 005343 457 ACPEY--GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---V 531 (701)
Q Consensus 457 ~~~~~--~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~ 531 (701)
+|.+. .|+||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99654 48999999999999988654 35899999999999999999999999 99999999999998775 6
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHH
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAI 609 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i 609 (701)
+||+|||+++.+.... .....+||+.|+|||++. +.|+.++|||||||++|+|++|++||..... ....+
T Consensus 188 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp EEECCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC-------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999998764321 234568999999999876 5699999999999999999999999986653 33344
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+.+.... +.+.. .+..+.+|+.+||..+|.+||++.++|.|+|++-
T Consensus 260 ~~~~~~~~~-~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 260 EKGKYYFDF-NDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHCCCCCCH-HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HcCCCCCCc-cccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 444321110 11111 2345899999999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.34 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=191.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
.++|.+.+.||+|+||.||+|++. +..||||++...... ....|.+|+.++++++||||++++|+|.+ ..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999874 445999999765322 23568999999999999999999999954 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999998543 346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
.... .........+|+.|+|||++.+..++.++|||||||+||||++ |++||..... +...+..+..
T Consensus 199 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~------- 268 (373)
T 2qol_A 199 DDPE---AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------- 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-------
T ss_pred cCCc---cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 3321 1111233456788999999999999999999999999999998 9999965443 3333333321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..++..+.+++.+||+.+|.+||++.+++. .|.++
T Consensus 269 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~-~L~~~ 307 (373)
T 2qol_A 269 -LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS-ILDKL 307 (373)
T ss_dssp -CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred -CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH-HHHHH
Confidence 1112234456899999999999999999999974 44444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=371.12 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=204.9
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEe
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYE 467 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~E 467 (701)
+...++|.+.+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|+.++||||+++++++.+ ..++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 345678999999999999999999995 5679999998654 457789999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999996432 235788899999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 624 (701)
........+|+.|+|||++..+.++.++|||||||+||||+| |++||..... +...+..+.. ..
T Consensus 339 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~ 405 (454)
T 1qcf_A 339 -----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------MP 405 (454)
T ss_dssp -----HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------CC
T ss_pred -----eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence 111234457889999999999999999999999999999999 9999976543 3333433321 11
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.|..++..+.+++.+||+.+|.+||++.+|+
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 2233445689999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.56 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=204.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceec----CCCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACP----EYGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||++++++|. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999984 567999999765432 2356899999999999999999999873 23489
Q ss_pred EEeecCCCChhhHhcccC-CCCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 465 VYEYMENGSLEDRLFQKD-NSPPIHWSIRFKIAAEIATALLFLHQNK--PEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986542 3345899999999999999999999977 2359999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccC
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLD 619 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld 619 (701)
.+.... .......||+.|+|||.+.+..++.++||||||+++|+|+||++||..... ....+..+.+..
T Consensus 165 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 235 (279)
T 2w5a_A 165 ILNHDT------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 235 (279)
T ss_dssp HC---C------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred eecccc------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence 764321 112345789999999999999999999999999999999999999986543 333444444321
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+...+..+.+++.+||+.+|.+||++.+++.|.|+.
T Consensus 236 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 236 -----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 2223345689999999999999999999999877643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.98 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=204.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||++++++|.+ .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999872 256999999765422 23568999999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCC---------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 005343 462 GCLVYEYMENGSLEDRLFQKDN---------------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLK 520 (701)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 5899999999999999976432 234899999999999999999999999 9999999
Q ss_pred CCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005343 521 PANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAM 599 (701)
Q Consensus 521 p~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 599 (701)
|+|||++.++.+||+|||+++.+..... ........+|+.|+|||.+.+..++.++|||||||++|+|+| |.+||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999987643321 112344567889999999999999999999999999999999 99999
Q ss_pred CCch--HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 600 GLSH--QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 600 ~~~~--~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.... .....+..+... ..+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRM--------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCCcC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7543 233334433211 1223344568999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=372.80 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=206.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++.+. .++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999985 5679999986432 23467799999999999999999999998654 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGla~~~ 543 (701)
||+.+|+|.+.+... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999988654 35899999999999999999999999 99999999999995 5668999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||..... ....+..+.+... .+.
T Consensus 175 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~ 245 (486)
T 3mwu_A 175 QQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-LPQ 245 (486)
T ss_dssp CCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-SGG
T ss_pred CCCC-------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-Ccc
Confidence 4321 2345689999999998875 599999999999999999999999976654 2334444443211 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+. ..+..+.+|+.+||..+|.+||++.++|.|+|++-
T Consensus 246 ~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 246 WR----TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred cC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 11 23345899999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=362.81 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=197.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--------CCc
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--------YGC 463 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~~~ 463 (701)
.+|.+.+.||+|+||.||+|++. +..||||++..... .+.+|+++|+.++||||++++++|.. +.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999994 56799999865432 23579999999999999999998722 136
Q ss_pred eEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeecccc
Q 005343 464 LVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVGLAR 541 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFGla~ 541 (701)
+||||+++ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 666655331 23456899999999999999999999999 999999999999995 4678999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----------
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR---------- 610 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~---------- 610 (701)
.+.... .....+||+.|+|||++.+. .|+.++||||||||||||++|++||......+....
T Consensus 206 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 206 QLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp ECCTTC-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred hcccCC-------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 764322 12456789999999988664 799999999999999999999999987654332211
Q ss_pred ------cCccccccCccCCC--C----CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 611 ------NGTFSELLDPTVTG--W----PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 611 ------~~~~~~~ld~~~~~--~----p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+.....+.... | +...+..+.+|+.+||..+|.+||++.+++.|+|+.
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 11111111111111 1 122345689999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.87 Aligned_cols=240 Identities=22% Similarity=0.385 Sum_probs=195.2
Q ss_pred hcCceeeeeeeecCceeEEEEEECC---------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
.++|.+.+.||+|+||.||+|.+.. ..||+|++........+.+.+|+.+++.++||||++++++|.+ .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998743 3599999977655566789999999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc--------EE
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV--------SK 533 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--------~K 533 (701)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 589999999999999996532 34899999999999999999999999 999999999999998887 99
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHH-H
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAI-R 610 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~i-~ 610 (701)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+|| .+||.......... .
T Consensus 162 l~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 9999998754221 23457899999999887 7799999999999999999995 56666544322211 1
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
... . . .+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~-~-~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 232 EDR-H-Q-------LPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp HTT-C-C-------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcc-C-C-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 0 0 11111234889999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.41 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=199.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+++.++||||+++++++.+ ..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999984 6779999986532 2345678999999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998654 35889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ....+..+..
T Consensus 163 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (276)
T 2h6d_A 163 DGE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------- 228 (276)
T ss_dssp C--------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred CCc-------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------
Confidence 321 1234578999999999888765 6899999999999999999999976543 2223333321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..|...+..+.+++.+||+.+|.+||++.+++.|+|++
T Consensus 229 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 229 --YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 12223345689999999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=362.16 Aligned_cols=270 Identities=18% Similarity=0.224 Sum_probs=200.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-----------hHHHHHHHHHHHhCCCCcEEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-----------PRQFKQEVEILGSMRHTNMVI 453 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-----------~~~~~~Ei~il~~l~HpnIv~ 453 (701)
..++|.+.+.||+|+||.||+|.+.. ..||||++....... ...+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999999843 469999987653111 012344566677788999999
Q ss_pred EeceecCC------CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc
Q 005343 454 LLGACPEY------GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD 527 (701)
Q Consensus 454 l~g~~~~~------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~ 527 (701)
+++++.+. .+|||||+ +|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998442 58999999 99999998653 346999999999999999999999999 99999999999999
Q ss_pred --CCCcEEEEeeccccccCCCCCcc-cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-
Q 005343 528 --QNYVSKISDVGLARLVPPSAADT-ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH- 603 (701)
Q Consensus 528 --~~~~~KL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~- 603 (701)
.++.+||+|||+++.+....... .........+||+.|+|||++.+..++.++|||||||+||+|+||++||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998774332111 11112245679999999999999999999999999999999999999997431
Q ss_pred --HHHHHHH---cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhccccc
Q 005343 604 --QVEQAIR---NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLGFEN 669 (701)
Q Consensus 604 --~~~~~i~---~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~~~~ 669 (701)
....... ...+..++++.+.. ...+..+.+++..||..+|.+||++.+|+...-.-+...+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 1111111 11122222222210 1223468999999999999999999999754333344444443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.41 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=204.2
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEe
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYE 467 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~E 467 (701)
....++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+|+++++.++||||+++++++.+ ..++|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 3456789999999999999999999865 469999997654 456789999999999999999999999854 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999985421 125899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~ 624 (701)
. .......+|..|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..+.. ..
T Consensus 164 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 230 (279)
T 1qpc_A 164 Y-----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------MV 230 (279)
T ss_dssp E-----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CC
T ss_pred c-----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC--------CC
Confidence 1 11234567889999999998899999999999999999999 9999976543 2233333311 11
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+...+..+.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12233456899999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=344.15 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=204.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC----CCChHHHHHHHHHHHhCCCCcEEEEecee--cC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI----SQGPRQFKQEVEILGSMRHTNMVILLGAC--PE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~--~~ 462 (701)
.++|.+.+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++ .+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999984 4569999987542 23356799999999999999999999987 22 44
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+.+| |.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 8999999876 777665432 356899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCcccccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGM--LGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELL 618 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~l 618 (701)
+...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.. ...+..+.+
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---- 230 (305)
T 2wtk_C 159 LHPFAAD----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---- 230 (305)
T ss_dssp CCTTCSS----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----
T ss_pred cCccccc----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC----
Confidence 6432211 1234567999999999887644 478999999999999999999999866532 233333332
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.++...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 122233456899999999999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.11 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=204.9
Q ss_pred hcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYM 469 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 469 (701)
.++|.+.+.||+|+||.||+|.+ .+..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46799999999999999999998 45579999998654 345789999999999999999999999854 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 157 (267)
T 3t9t_A 86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 157 (267)
T ss_dssp TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH---
T ss_pred CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc---
Confidence 9999999986542 45889999999999999999999999 999999999999999999999999999876432
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--HHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQV--EQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~~p 626 (701)
.........+|..|+|||.+.+..++.++||||||+++|+|+| |++||...... ...+..+... ..|
T Consensus 158 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~ 227 (267)
T 3t9t_A 158 --QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------YKP 227 (267)
T ss_dssp --HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------CCC
T ss_pred --cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC--------CCC
Confidence 1112244567889999999998999999999999999999999 89999765432 2233333111 112
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+++.+||+.+|.+||++.+++. .+..+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~-~L~~l 262 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLR-QLAEI 262 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 223446899999999999999999999975 34444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=354.53 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=208.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCCh-----------------HHHHHHHHHHHhCCCCcEEEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGP-----------------RQFKQEVEILGSMRHTNMVIL 454 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~-----------------~~~~~Ei~il~~l~HpnIv~l 454 (701)
..++|.+.+.||+|+||.||+|.+.+..||||++........ ..+.+|+.+++.++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 357899999999999999999999888899999865432211 779999999999999999999
Q ss_pred eceecC--CCceEEeecCCCChhhH------hcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCee
Q 005343 455 LGACPE--YGCLVYEYMENGSLEDR------LFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANIL 525 (701)
Q Consensus 455 ~g~~~~--~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NIL 525 (701)
++++.+ ..++||||+++|+|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 999854 44899999999999998 432 224679999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCch
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGV-KSDLYSLGVVLLQLITARPAMGLSH 603 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~-~sDvwSlGvil~elltG~~pf~~~~ 603 (701)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|++||....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999875332 23456799999999999887 6766 9999999999999999999997653
Q ss_pred ---HHHHHHHcCccccccCcc--CC--------CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 604 ---QVEQAIRNGTFSELLDPT--VT--------GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 604 ---~~~~~i~~~~~~~~ld~~--~~--------~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....+..+......+.. .. ..+...+..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 333344433321110000 00 000233456899999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=354.74 Aligned_cols=263 Identities=20% Similarity=0.239 Sum_probs=193.5
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--C--
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--Y-- 461 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~-- 461 (701)
......++|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+++..+..++||||++++++|.. .
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456789999999999999999999985 5679999886653 334567788999999999999999999832 1
Q ss_pred -----CceEEeecCCCChhhHhcc-cCCCCCCChHHHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCCeeEcC-CCcE
Q 005343 462 -----GCLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALLFLH--QNKPEPLVHRDLKPANILLDQ-NYVS 532 (701)
Q Consensus 462 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~iiHrDLKp~NILl~~-~~~~ 532 (701)
.++||||+.+ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 4799999976 55444432 244557899999999999999999999 888 999999999999996 8999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--- 608 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--- 608 (701)
||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+|+||++||...+.....
T Consensus 172 kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp EECCCTTCBCCCTTS-------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEeeCCCceecCCCC-------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 999999998765332 12455789999999988654 4899999999999999999999999876533221
Q ss_pred HHc-Cc------------cc--cccCcc-------CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 609 IRN-GT------------FS--ELLDPT-------VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 609 i~~-~~------------~~--~~ld~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.. +. .. ...+.. ....+...+..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 110 00 00 000000 01111224567999999999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.81 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=186.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|.+.+.||+|+||.||+|.+ .+..||||++...... ....+.+|+.+|+.++||||+.+++++..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999998 4567999998765322 23568899999999999999999998843
Q ss_pred -CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 348999999 7899888743 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H-cCcc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R-NGTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~-~~~~ 614 (701)
++..... ....+||++|+|||++.+ ..++.++|||||||++|+|+||++||...+...... . .|..
T Consensus 179 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ccccccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9865321 245689999999998876 679999999999999999999999998765433221 1 0110
Q ss_pred cc-----ccC----------ccCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 615 SE-----LLD----------PTVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 615 ~~-----~ld----------~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.. +.. +.....+ ...+..+.+|+.+||..||.+||++.++|.|+|+.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00 000 0000111 112345899999999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=341.75 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=208.3
Q ss_pred hcCceeee-eeeecCceeEEEEEE----CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 393 TDYFSISR-KIGEGGYGPVYKAQL----DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~-~IG~G~fg~Vyk~~~----~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
.++|.+.. .||+|+||.||+|.+ .+..||||++...... ....+.+|+.+++.++||||+++++++.. ..++|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 45677776 999999999999986 3456999999875322 34568999999999999999999999844 44899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999998543 346899999999999999999999999 99999999999999999999999999987743
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
.... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||.... .....+..+...
T Consensus 163 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~------- 232 (287)
T 1u59_A 163 DDSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------- 232 (287)
T ss_dssp CSCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------
T ss_pred Ccce---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-------
Confidence 3211 112234567899999999988899999999999999999999 999997543 333344443321
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
..|...+..+.+++.+||..+|.+||++.+++.+.+.-+...
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 223344456999999999999999999999998766665444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=360.67 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=197.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC------C--Cc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE------Y--GC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~--~~ 463 (701)
..+|.+.+.||+|+||.||+|++. +..||+|++...... ..+|+.+|+.++||||++++++|.. . .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356999999999999999999994 445899887654322 2479999999999999999999822 1 46
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEEEEeeccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARL 542 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~ 542 (701)
+||||++++.+............+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999976544433322233456899999999999999999999999 99999999999999 799999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN---------- 611 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~---------- 611 (701)
+.... .....+||+.|+|||++.+. .|+.++|||||||+||+|++|++||...+........
T Consensus 192 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGE-------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CCTTC-------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCC-------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 64332 12456789999999988654 5999999999999999999999999876543322210
Q ss_pred ------CccccccCccCCC------CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 612 ------GTFSELLDPTVTG------WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 612 ------~~~~~~ld~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+....-+.... ++...+..+.+|+.+||..+|.+||++.+++.|+|++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 0111111111111 1122345689999999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.44 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=200.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--------CChHHHHHHHHHHHhCCCCcEEEEeceecC-
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--------QGPRQFKQEVEILGSMRHTNMVILLGACPE- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 460 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999984 46799999875431 112348899999999999999999999844
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC---cEEEEee
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY---VSKISDV 537 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~---~~KL~DF 537 (701)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 45899999999999998853 346899999999999999999999999 99999999999998765 4999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRN 611 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~ 611 (701)
|+++.+.... ......||+.|+|||++. ...++.++|||||||++|+|++|++||.... .....+..
T Consensus 162 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 162 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp TTCEECCCCH-------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred ccceeccccc-------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9998764321 123457999999999863 5678999999999999999999999996442 23334444
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.+... +.. +...+..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 235 ~~~~~~--~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 235 GKYNFI--PEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TCCCCC--HHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CccccC--chh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 432110 000 0112346899999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=356.57 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=198.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCCC-----
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEYG----- 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 462 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.+++.++||||++++++|....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999984 6679999997654332 356889999999999999999999984322
Q ss_pred ---ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 463 ---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 463 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
++||||+. |+|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 89999996 68887762 23899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----Ccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----GTF 614 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~~~ 614 (701)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........ +..
T Consensus 191 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp C-----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9865322 245678999999998877 67999999999999999999999999876533222110 000
Q ss_pred c-----------------cccCccCCC---CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 615 S-----------------ELLDPTVTG---WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 615 ~-----------------~~ld~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. .+....... .+...+..+.+|+.+||+.+|.+||++.+++.|+|++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 000000000 0112345689999999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=384.96 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=209.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCC---CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDI---SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~ 463 (701)
..++|.+++.||+|+||.||+|++.. ..||||++.+.. ......+..|..+|..+ +||||+.+++++.+ ..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35689999999999999999999954 459999987532 23456788999999987 79999999999855 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
|||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999654 35899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
.... ......+||+.|+|||++.+..|+.++|||||||+||||+||++||...+.. ...+..+.+
T Consensus 493 ~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------- 559 (674)
T 3pfq_A 493 IWDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------- 559 (674)
T ss_dssp CCTT------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-------
T ss_pred ccCC------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 3221 1235678999999999999999999999999999999999999999876542 233333321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCCh-----hhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDL-----VSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~-----~~vl~~~~~~l 662 (701)
.+|...+..+.+|+.+||+.+|.+||++ .+|+.|+|++-
T Consensus 560 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 560 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred --CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 2334445568999999999999999998 99999998864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=367.98 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=201.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhC------CCCcEEEEeceec--CC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSM------RHTNMVILLGACP--EY 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~--~~ 461 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++..+ +||||+.++++|. ..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999984 4669999997542 2345678899998887 5779999999984 44
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc--EEEEeecc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV--SKISDVGL 539 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~--~KL~DFGl 539 (701)
.|+||||+. |+|.+++.... ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 589999995 79999886543 345899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---Hc-Cccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---RN-GTFS 615 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~~-~~~~ 615 (701)
++..... ....+||+.|+|||++.+..++.++|||||||+||||+||++||...+...... .. +...
T Consensus 249 a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 249 SCYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CEETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ceecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9765321 245689999999999999999999999999999999999999998765432211 10 0000
Q ss_pred -----------cccC---------------------------------ccCCCC----CHHHHHHHHHHHHHhhccCcCC
Q 005343 616 -----------ELLD---------------------------------PTVTGW----PVEAALSIAKLALQCCELRKRD 647 (701)
Q Consensus 616 -----------~~ld---------------------------------~~~~~~----p~~~~~~l~~li~~cl~~~P~~ 647 (701)
.+++ +....| +......+.+|+.+||+.||.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0000 000011 0011345899999999999999
Q ss_pred CCChhhhhhHHHHH
Q 005343 648 RPDLVSVVLPELIR 661 (701)
Q Consensus 648 RPt~~~vl~~~~~~ 661 (701)
|||+.++|.|+|++
T Consensus 400 Rpta~e~L~Hpw~~ 413 (429)
T 3kvw_A 400 RMTPGQALRHPWLR 413 (429)
T ss_dssp SCCHHHHHTSTTTC
T ss_pred CCCHHHHhCChhhc
Confidence 99999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=351.07 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=188.5
Q ss_pred HhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceE
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLV 465 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV 465 (701)
...++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+++.++||||+++++++. +..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3467899999999999999999987 566799998865432 33456889999999999999999999984 445899
Q ss_pred EeecCCCChhhHhccc-----CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 466 YEYMENGSLEDRLFQK-----DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988541 23456899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSEL 617 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ 617 (701)
..+...... ..........||+.|+|||++.. ..++.++|||||||++|+|+||++||......... ...+.....
T Consensus 169 ~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred heeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 876433211 11112345679999999998866 56899999999999999999999999764322111 111111111
Q ss_pred cCcc-CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 LDPT-VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 ld~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.... ........+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 0000 00111123346899999999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.87 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=199.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC-------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY------- 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 461 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 578999999999999999999984 6679999997654322 35688999999999999999999998543
Q ss_pred -CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 462 -GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
.++||||+. |+|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 389999996 68887762 24899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHc-Cc--
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRN-GT-- 613 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~-~~-- 613 (701)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..... ... +.
T Consensus 174 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cCCCCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 865321 234578999999998877 67899999999999999999999999765532211 110 00
Q ss_pred ------------------cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 ------------------FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ------------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+.....+.+...+...+..+.+|+.+||..+|.+||++.+++.|+|++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000011112222344557999999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.04 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=204.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-------CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-------~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|.+.+.||+|+||.||+|.+ .+..||||++...... ....+.+|+.+++++ +||||++++++|.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 457899999999999999999986 2346999999865432 245689999999999 99999999999854
Q ss_pred CCceEEeecCCCChhhHhcccCC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDN---------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 45899999999999999976432 225899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch-
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH- 603 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~- 603 (701)
++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEcccccccccccccc----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999987654321 112244567889999999999999999999999999999999 999997543
Q ss_pred --HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 604 --QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 604 --~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
.....+..+.. . ..+...+..+.+++.+||..+|.+||++.+++.+.
T Consensus 254 ~~~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 254 DSKFYKMIKEGFR-M-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp SHHHHHHHHHTCC-C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhHHHHHhccCCC-C-------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 33333333321 1 11222344689999999999999999999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.49 Aligned_cols=265 Identities=25% Similarity=0.352 Sum_probs=212.4
Q ss_pred cccCHHHHHHhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEE
Q 005343 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMV 452 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv 452 (701)
..+...++....++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.++..+ +||||+
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 34556666667789999999999999999999862 256999999765432 234689999999999 799999
Q ss_pred EEeceecC---CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 005343 453 ILLGACPE---YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVH 516 (701)
Q Consensus 453 ~l~g~~~~---~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 516 (701)
+++++|.+ ..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 99999854 35899999999999999965432 123889999999999999999999999 999
Q ss_pred cCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-C
Q 005343 517 RDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-A 595 (701)
Q Consensus 517 rDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G 595 (701)
|||||+|||++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 247 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999987643221 112345568899999999999999999999999999999998 9
Q ss_pred CCCCCCc---hHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 596 RPAMGLS---HQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 596 ~~pf~~~---~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
++||... ......+..+.... .+...+..+.+++.+||+.+|.+||++.+++.|.-.-
T Consensus 248 ~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 248 ASPYPGVKIDEEFCRRLKEGTRMR--------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHHhccCccCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999653 23344444433211 1222344689999999999999999999998764433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.14 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=194.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc------eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT------SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~------~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
.++|.+.+.||+|+||.||+|.+..+ .||||++...... ....+.+|+.+++.++||||+++++++.+ ..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 46789999999999999999987432 4999999765432 23458999999999999999999999854 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998653 246899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
..... .........+|+.|+|||++.+..++.++|||||||++|+|+| |+.||..... +...+..+...
T Consensus 198 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----- 269 (333)
T 1mqb_A 198 EDDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----- 269 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----
T ss_pred ccccc---cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-----
Confidence 43221 1112234456889999999999999999999999999999999 9999965432 33333333211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
..+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 270 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122334568999999999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=341.03 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=203.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC---------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------- 460 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999995 6779999987543 457899999999999999999998732
Q ss_pred ---------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc
Q 005343 461 ---------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV 531 (701)
Q Consensus 461 ---------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~ 531 (701)
..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 2479999999999999986542 346899999999999999999999999 999999999999999999
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN 611 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~ 611 (701)
+||+|||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+.........+..
T Consensus 161 ~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT
T ss_pred EEECcchhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc
Confidence 9999999998764432 124457999999999999999999999999999999999999887544443333443
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.+. ...+..+.+++.+||..+|.+||++.+++.+.+.-
T Consensus 234 ~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 234 GIIS-----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp TCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3321 11233588999999999999999999998765544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.32 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=196.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec-----------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----------- 459 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----------- 459 (701)
.++|.+.+.||+|+||.||+|.+. ++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999995 5679999987654444567899999999999999999998863
Q ss_pred -----CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEE
Q 005343 460 -----EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSK 533 (701)
Q Consensus 460 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~K 533 (701)
...++||||+. |+|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 23379999997 699998842 45889999999999999999999999 99999999999997 577999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---H
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---I 609 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i 609 (701)
|+|||+++.+..... .........||..|+|||.+.. ..++.++|||||||++|+|+||++||......... .
T Consensus 162 l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYS---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EccCccccccCCCcc---cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999987643211 1112345578999999998765 67999999999999999999999999876543221 1
Q ss_pred HcCcc-------------cc-----ccCccC--CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 610 RNGTF-------------SE-----LLDPTV--TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 610 ~~~~~-------------~~-----~ld~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..... .. ...+.. ...+...+..+.+++.+||+.+|.+||++.+++.|+|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 10000 00 000000 00011234568999999999999999999999999999843
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.94 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=202.4
Q ss_pred hcCceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCC----CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDI----SQGPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
.++|.+.+.||+|+||.||+|+. .++.||||++.... ......+.+|+.+|..+ +||||+.+++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999998 45679999987542 13345678899999999 69999999998844
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 4589999999999999996543 5889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcC
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNG 612 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~ 612 (701)
+.+.... .......+||+.|+|||++.+ ..++.++|||||||+||+|+||++||.... .....+...
T Consensus 207 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 207 KEFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp EECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eecccCC-----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 8763221 112345679999999999885 347899999999999999999999996432 111122111
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
. ..+|...+..+.+|+.+||..+|.+|| ++.+++.|+|++-
T Consensus 282 ~---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 E---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred C---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 1 123334445689999999999999999 9999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.30 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=208.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC----CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+++++.++||||+++++++.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999995 5679999997543 2345678899999999999999999999843 33899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE----cCCCcEEEEeecccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKISDVGLAR 541 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~~KL~DFGla~ 541 (701)
|||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCc------hHHHH
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQT--------GMLGVKSDLYSLGVVLLQLITARPAMGLS------HQVEQ 607 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDvwSlGvil~elltG~~pf~~~------~~~~~ 607 (701)
.+.... ......||+.|+|||++.. ..++.++|||||||++|+|+||++||... .....
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp ECCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred EccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 764321 2345679999999998765 56888999999999999999999998531 12222
Q ss_pred HHHcCccccc----------------cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 608 AIRNGTFSEL----------------LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 608 ~i~~~~~~~~----------------ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+..+..... ..+.....+......+.+++.+||+.||.+||++.+++......+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 2222221110 001112344677788999999999999999999999976554444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.27 Aligned_cols=256 Identities=23% Similarity=0.270 Sum_probs=204.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEE---CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc------EEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL---DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN------MVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~---~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~-- 460 (701)
..++|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.++..++|++ ++.+++++.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999987 45679999986532 23456889999999987664 8999998854
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ------------ 528 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~------------ 528 (701)
..|+||||+ +++|.+++.... ..++++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 458999999 899999886543 346899999999999999999999999 999999999999987
Q ss_pred -------CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005343 529 -------NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGL 601 (701)
Q Consensus 529 -------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 601 (701)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH---------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC---------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCccc---------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 678999999999865322 2456799999999999999999999999999999999999999976
Q ss_pred chHHHHH--HH--cCcccc----------ccC-----------------------ccCCCCCHHHHHHHHHHHHHhhccC
Q 005343 602 SHQVEQA--IR--NGTFSE----------LLD-----------------------PTVTGWPVEAALSIAKLALQCCELR 644 (701)
Q Consensus 602 ~~~~~~~--i~--~~~~~~----------~ld-----------------------~~~~~~p~~~~~~l~~li~~cl~~~ 644 (701)
.+..... +. .+.+.. ... ......+...+..+.+|+.+||..+
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 5432211 11 000000 000 0001112345677999999999999
Q ss_pred cCCCCChhhhhhHHHHHH
Q 005343 645 KRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 645 P~~RPt~~~vl~~~~~~l 662 (701)
|.+||++.+++.|+|++-
T Consensus 317 P~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 317 PAKRITLREALKHPFFDL 334 (339)
T ss_dssp TTTSCCHHHHTTSGGGGG
T ss_pred cccccCHHHHhcCHHHHH
Confidence 999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=348.24 Aligned_cols=260 Identities=26% Similarity=0.368 Sum_probs=204.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCC--CChHHHHHHHHHHHhC---CCCcEEEEeceec----
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDIS--QGPRQFKQEVEILGSM---RHTNMVILLGACP---- 459 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~---- 459 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 45699999865432 2234577888887766 8999999999874
Q ss_pred ---CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 460 ---EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 460 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
...++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 23489999997 69999886543 345899999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHc-C
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRN-G 612 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~-~ 612 (701)
||+++.+... .......||+.|+|||++.+..++.++|||||||++|+|+||++||........ .+.. +
T Consensus 164 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccccccCC-------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999865321 123456899999999999999999999999999999999999999987654322 1110 0
Q ss_pred c-----ccc-----------ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 613 T-----FSE-----------LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 613 ~-----~~~-----------~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
. +.. ........++...+..+.+|+.+||..+|.+||++.+++.|+|++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 000 00000111122334568999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=357.19 Aligned_cols=260 Identities=25% Similarity=0.315 Sum_probs=202.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC-------C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE-------Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~ 461 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+|..++||||+++++++.. .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4578999999999999999999984 5569999997543222 3568899999999999999999998843 3
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+. |+|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 489999996 699988844 34899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHH-cCccc-
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIR-NGTFS- 615 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~-~~~~~- 615 (701)
....... ........+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...... ..... .+...
T Consensus 177 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGC---BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ecCCCCC---ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 7643211 1112345689999999997654 45899999999999999999999999765421 11111 00000
Q ss_pred ----------------cccCccCCCC---CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 616 ----------------ELLDPTVTGW---PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 616 ----------------~~ld~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
....+....| ....+..+.+|+.+||..+|.+||++.+++.|+|++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000000000 1122346899999999999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.46 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=198.8
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc-----eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec---CCCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT-----SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP---EYGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~-----~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~---~~~~ 463 (701)
..+|.+.+.||+|+||.||+|.+... .||+|.+...... ....+.+|+.++++++||||++++++|. ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45699999999999999999987322 3899998764322 2356899999999999999999999863 2448
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999998543 345789999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
..... ..........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||..... ....+..+...
T Consensus 179 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEY--YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGG--CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred cccch--hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 43221 11222355678899999999999999999999999999999999 6688765432 22233333211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|...+..+.+++.+||+.+|.+||++.+++. .+..+
T Consensus 252 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~-~L~~~ 289 (298)
T 3f66_A 252 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS-RISAI 289 (298)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 112223346899999999999999999999974 34444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.54 Aligned_cols=248 Identities=22% Similarity=0.354 Sum_probs=199.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC---c--eEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH---T--SVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~---~--~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
..++|.+.+.||+|+||.||+|.+.+ + .||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 45789999999999999999998732 2 399999876532 234568999999999999999999999855 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999986543 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--hHHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS--HQVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~--~~~~~~i~~~~~~~~ld~~ 621 (701)
... ........+|+.|+|||++.+..++.++|||||||++|+|+| |++||... ......+..+...
T Consensus 165 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 165 DED-----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------ 233 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred ccc-----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------
Confidence 321 112244567889999999998999999999999999999998 99999643 2333333333211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
..+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1122234468999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=349.49 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=198.2
Q ss_pred hcCceeeeeeeecCceeEEEEEECC--ce----EEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH--TS----VAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~--~~----vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
.++|.+.+.||+|+||.||+|.+.. .. |++|.+.... ......+.+|+.+++.++||||++++++|.+ ..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 4679999999999999999999843 33 5777775543 3346779999999999999999999999855 4579
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|++|+.+|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999986543 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
.... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||.... .....+..+...
T Consensus 169 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 238 (327)
T 3lzb_A 169 AEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------ 238 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred Cccc----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 3221 122344567889999999999999999999999999999999 999997543 334444433211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+...+..+.+++.+||..+|.+||++.+++. .|.++.
T Consensus 239 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~~~ 277 (327)
T 3lzb_A 239 --PQPPICTIDVYMIMRKCWMIDADSRPKFRELII-EFSKMA 277 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH-HHHHHH
Confidence 122334446899999999999999999999974 455543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=365.04 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=184.1
Q ss_pred cCcee-eeeeeecCceeEEEEEEC----CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec----CCCce
Q 005343 394 DYFSI-SRKIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP----EYGCL 464 (701)
Q Consensus 394 ~~f~~-~~~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~l 464 (701)
+.|.+ .++||+|+||.||+|++. +..||||++... .....+.+|+.+|+.++||||++++++|. ...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34776 458999999999999974 456999998754 33457899999999999999999999982 24489
Q ss_pred EEeecCCCChhhHhccc------CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE----cCCCcEEE
Q 005343 465 VYEYMENGSLEDRLFQK------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL----DQNYVSKI 534 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl----~~~~~~KL 534 (701)
||||+. |+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888777432 12235899999999999999999999999 9999999999999 77899999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH---------
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--------- 604 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~--------- 604 (701)
+|||+++.+..... ........+||+.|+|||++.+ ..++.++|||||||+||+|+||++||.....
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 174 ADMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999987643211 1122355789999999998877 4599999999999999999999999964432
Q ss_pred ---HHHHHHc-CccccccCccC------------------CCCCH---------HHHHHHHHHHHHhhccCcCCCCChhh
Q 005343 605 ---VEQAIRN-GTFSELLDPTV------------------TGWPV---------EAALSIAKLALQCCELRKRDRPDLVS 653 (701)
Q Consensus 605 ---~~~~i~~-~~~~~~ld~~~------------------~~~p~---------~~~~~l~~li~~cl~~~P~~RPt~~~ 653 (701)
+...+.. |.......+.+ ..+.. .....+.+|+.+||..||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111110 10000000000 00000 00335789999999999999999999
Q ss_pred hhhHHHHHH
Q 005343 654 VVLPELIRL 662 (701)
Q Consensus 654 vl~~~~~~l 662 (701)
+|.|+|+.-
T Consensus 331 ~L~hp~f~~ 339 (405)
T 3rgf_A 331 AMQDPYFLE 339 (405)
T ss_dssp HHTSGGGTS
T ss_pred HhcChhhcc
Confidence 999999973
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=351.50 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred hcCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--C--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--E--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~--~~ 462 (701)
.++|.+.+.||+|+||.||+|++ .+..||||++........+.+.+|+.+++.++||||+++++++. + ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999995 34569999998765444566999999999999999999999873 2 24
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 79999999999999986533 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----------------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV----------------- 605 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~----------------- 605 (701)
+..... .........||+.|+|||++.+..++.++|||||||++|+|++|.+||......
T Consensus 177 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 177 LPLDKD---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CCTTCS---EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred cccCCc---cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 754321 112234567889999999999999999999999999999999999998644321
Q ss_pred HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 606 ~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+..+. ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 254 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 254 LELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 11223344556899999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=370.78 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=204.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++.... .....|.+|+.+|++++||||++++|+|.+ ..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3567999999999999999999996 5679999997654 456789999999999999999999999954 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999996533 346899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 624 (701)
........+|+.|+|||++....++.++|||||||+||||+| |.+||.... .+...+..+.. ..
T Consensus 373 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~ 439 (495)
T 1opk_A 373 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------ME 439 (495)
T ss_dssp -----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------CC
T ss_pred -----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence 112234557789999999999999999999999999999999 999997543 23333433321 12
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.|..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~ 470 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 2334455689999999999999999999996
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.92 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=194.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHH--HhCCCCcEEEEeceec-----C--CC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEIL--GSMRHTNMVILLGACP-----E--YG 462 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il--~~l~HpnIv~l~g~~~-----~--~~ 462 (701)
..++|.+.+.||+|+||.||+|.+.++.||||++... ....+..|.+++ ..++||||+++++.+. . ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3478999999999999999999999999999998643 334555555554 4589999999997542 1 23
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc---------CCCCeeecCCCCCCeeEcCCCcEE
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN---------KPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~---------~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
++||||+++|+|.+++... .+++..+..|+.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 7999999999999999543 358899999999999999999998 7 99999999999999999999
Q ss_pred EEeeccccccCCCCCcc--cccccccccccCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCC-CCch
Q 005343 534 ISDVGLARLVPPSAADT--ITQYHMTTAAGTFCYIDPEYQQT-------GMLGVKSDLYSLGVVLLQLITARPAM-GLSH 603 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDvwSlGvil~elltG~~pf-~~~~ 603 (701)
|+|||+++.+....... .........+||+.|+|||++.+ ..++.++|||||||++|||+||..|| ....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998775332111 11122345679999999999876 45778999999999999999996544 3211
Q ss_pred -------------------HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 604 -------------------QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 604 -------------------~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.....+........+...... ....+..+.+|+.+||+.+|.+||++.+++. .|..+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~-~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEE-RMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHH-HHHHHHH
Confidence 111111111111111111111 2346667999999999999999999999974 4555543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=366.55 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=199.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEee
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEY 468 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey 468 (701)
...++|.+.+.||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||+++++++.+ ..++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehh
Confidence 345679999999999999999999965 469999998654 456789999999999999999999999865 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999996432 235889999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 625 (701)
.......+|..|+|||.+..+.++.++|||||||+||||+| |++||..... +...+..+.. ...
T Consensus 336 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------~~~ 402 (452)
T 1fmk_A 336 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPC 402 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCC
T ss_pred -----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCC
Confidence 11234457889999999999999999999999999999999 9999976543 3333443321 112
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
|..++..+.+++.+||+.+|.+||++.+++
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 334455689999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=353.08 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=201.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-------C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-------Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------~ 461 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+++.++||||+++++++.. .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999985 667999999654322 23457899999999999999999998743 3
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+. |+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 489999996 689988854 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccc----ccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cC
Q 005343 542 LVPPSAADTI----TQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NG 612 (701)
Q Consensus 542 ~~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~ 612 (701)
.+........ ........+||+.|+|||++.. ..++.++|||||||++|+|++|++||...+....... .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 7753321111 1112345689999999997654 6799999999999999999999999987654322211 01
Q ss_pred cccc------ccC----------ccCCC-----CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 613 TFSE------LLD----------PTVTG-----WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 613 ~~~~------~ld----------~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.... ... +.... .+...+..+.+|+.+||..||.+||++.+++.|+|++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000 000 00000 01123456899999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=348.81 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=199.9
Q ss_pred cCHHHHHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhC--CCCcEEEEeceecC-
Q 005343 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM--RHTNMVILLGACPE- 460 (701)
Q Consensus 384 ~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~- 460 (701)
+.........++|.+.+.||+|+||.||+|.+.++.||||++... ....+.+|.+++..+ +||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 334444455678999999999999999999999999999998543 334566677776665 99999999998743
Q ss_pred -----CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc--------CCCCeeecCCCCCCeeEc
Q 005343 461 -----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN--------KPEPLVHRDLKPANILLD 527 (701)
Q Consensus 461 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------~~~~iiHrDLKp~NILl~ 527 (701)
..++||||+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 348999999999999999543 589999999999999999999998 7 99999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCch------hhHHHHHHHHHHHHhC------
Q 005343 528 QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVK------SDLYSLGVVLLQLITA------ 595 (701)
Q Consensus 528 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~------sDvwSlGvil~elltG------ 595 (701)
.++.+||+|||+++.+...... .........||+.|+|||++.+..++.. +|||||||++|||+||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp TTSCEEECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCCEEEEeCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999876433211 1112245689999999999887776654 9999999999999999
Q ss_pred ----CCCCCCc-------hHHHHHHHcCccccccCccCCC-C-CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 596 ----RPAMGLS-------HQVEQAIRNGTFSELLDPTVTG-W-PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 596 ----~~pf~~~-------~~~~~~i~~~~~~~~ld~~~~~-~-p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..||... ......+..... .+.... + +..++..+.+++.+||+.+|.+||++.+++.+ |.++
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~-L~~l 329 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT-LAKM 329 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH-HHHH
T ss_pred cccccccHhhhcCCCCchhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH-HHHH
Confidence 6666422 112222221111 111111 1 23677789999999999999999999999854 3443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.24 Aligned_cols=257 Identities=26% Similarity=0.343 Sum_probs=192.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC---C--ceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceec---CCCce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD---H--TSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACP---EYGCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~---~--~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~---~~~~l 464 (701)
..|.+.+.||+|+||.||+|.+. + ..||+|.+..... .....|.+|+.++++++||||++++++|. ...++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35888999999999999999873 2 2489999875432 23457999999999999999999999873 24589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999998543 345789999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
..... .........+|+.|+|||++.+..++.++|||||||++|||+| |.+||.... .....+..+...
T Consensus 244 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 244 DKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 315 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------
T ss_pred ccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------
Confidence 32211 1112344567889999999999999999999999999999999 778886543 223333333211
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhc
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDL 665 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~ 665 (701)
..|..++..+.+++.+||..+|.+||++.+++.+.-.-+..+
T Consensus 316 --~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112233456899999999999999999999986444333333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=344.02 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=195.4
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC----------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---------- 460 (701)
.++|.+.+.||+|+||.||+|++ .+..||||++.... .....+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45799999999999999999998 46679999986432 234568999999999999999999998732
Q ss_pred -----CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEE
Q 005343 461 -----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKIS 535 (701)
Q Consensus 461 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~ 535 (701)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3479999999999999996532 45788899999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcc--------cccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH--
Q 005343 536 DVGLARLVPPSAADT--------ITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQ-- 604 (701)
Q Consensus 536 DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~-- 604 (701)
|||++..+....... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 999998764321000 001223456799999999998764 68999999999999999999 4433222
Q ss_pred -HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 605 -VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 605 -~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
....+...... + ...++...+..+.+++.+||+.+|.+||++.+++.|+|++.
T Consensus 236 ~~~~~~~~~~~~--~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 236 NILKKLRSVSIE--F---PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHSTTCC--C---CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHhccccccc--c---CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 22222222110 1 12233444556899999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.91 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=206.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---------ChHHHHHHHHHHHhCC-CCcEEEEeceec
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---------GPRQFKQEVEILGSMR-HTNMVILLGACP 459 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---------~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 459 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999994 567999999765321 1245789999999995 999999999985
Q ss_pred CC--CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 460 EY--GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 460 ~~--~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
+. .++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 54 48999999999999998653 35899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHH
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ------TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAI 609 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i 609 (701)
|++..+.... ......||+.|+|||++. ...++.++||||||+++|+|++|++||...... ...+
T Consensus 169 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 169 GFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp TTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cchhhcCCCc-------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 9998764322 124567999999999874 456899999999999999999999999765432 2333
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+.+.. ..+.. ...+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 242 ~~~~~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 242 MSGNYQF-GSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHTCCCC-CTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCCccc-Ccccc----cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 3333221 11111 22344689999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.06 Aligned_cols=252 Identities=13% Similarity=0.168 Sum_probs=202.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEE-----E--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC---CCcEEEEeceec-
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQ-----L--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR---HTNMVILLGACP- 459 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~-----~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~- 459 (701)
...++|.+.+.||+|+||.||+|. . .++.||||++... ....+..|+.++..++ |+||+.+++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 2 4567999999753 4667889999999987 999999999984
Q ss_pred -CCCceEEeecCCCChhhHhcccC--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--------
Q 005343 460 -EYGCLVYEYMENGSLEDRLFQKD--NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-------- 528 (701)
Q Consensus 460 -~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-------- 528 (701)
+..|+||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 45589999999999999996532 3456999999999999999999999999 999999999999998
Q ss_pred ---CCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 005343 529 ---NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV 605 (701)
Q Consensus 529 ---~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 605 (701)
++.+||+|||+|+.+.... ........+||+.|+|||++.+..|+.++|||||||++|||+||++||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~- 290 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG- 290 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-
T ss_pred ccccCCEEEeeCchhhhhhccC----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-
Confidence 8999999999997653211 11234567899999999999999999999999999999999999999853321
Q ss_pred HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 606 EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 606 ~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
+.. .+.......+ ....+.+++..|+..+|.+||...+.+.+.|..+.
T Consensus 291 ------~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 291 ------GEC--KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ------TEE--EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ------Cce--eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 111 1111122222 13458899999999999999887777777666653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.65 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=199.4
Q ss_pred hcCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC----
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY---- 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~---- 461 (701)
..+|++.+.||+|+||.||+|++ .+..||+|++..... .....+.+|+.+++.++||||++++++|.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34699999999999999999985 456699999976543 3456799999999999999999999998543
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 479999999999999985543 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----------------
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV---------------- 605 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~---------------- 605 (701)
.+..... .........||..|+|||++.+..++.++|||||||++|+|+||.+|+......
T Consensus 175 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 175 AIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp ECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 7754321 112234567889999999999999999999999999999999999886433211
Q ss_pred -HHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 606 -EQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 606 -~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...+..+. ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 252 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111111 11223344456999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.85 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=204.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 5678999999999999999999995 5669999997643 3456799999999999999999999998554 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998653 3356899999999999999999999999 9999999999999999999999999998765332
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~ 624 (701)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.... .....+..+.. ..
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 232 (288)
T 3kfa_A 166 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------ME 232 (288)
T ss_dssp S-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------CC
T ss_pred c-----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------CC
Confidence 1 12344567889999999999999999999999999999999 999997543 23333333211 11
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+...+..+.+++.+||..+|.+||++.+++.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 22233456899999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.35 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=200.2
Q ss_pred ceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC----CCce
Q 005343 396 FSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE----YGCL 464 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~l 464 (701)
|.+.+.||+|+||.||++.+ .++.||||++...... ....+.+|+.+|+.++||||+++++++.+ ..++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 59999999999999999876 4566999999876422 24568999999999999999999999854 2379
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998543 3899999999999999999999999 9999999999999999999999999998875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----------------HH
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV-----------------EQ 607 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-----------------~~ 607 (701)
.... .........||..|+|||++.+..++.++|||||||++|+|+||+.||...... ..
T Consensus 186 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 186 EGHE---YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TTCS---EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccc---ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 4321 111234556888999999999999999999999999999999999998754321 11
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+..+. ....+...+..+.+|+.+||+.+|.+||++.+++ ..|..+.
T Consensus 263 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell-~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI-PILKTVH 309 (318)
T ss_dssp HHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHH
T ss_pred HHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH-HHHHHHH
Confidence 112221 1122334445699999999999999999999997 3444443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.98 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=205.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.+ +||||++++++|.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999973 345999999765422 245689999999999 99999999999854
Q ss_pred --CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 45899999999999999965432 234899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|+| |++||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999987643221 112234567889999999988899999999999999999999 9999975542
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
....+..+... ..+...+..+.+++.+||..+|.+||++.+++. .+.++..
T Consensus 266 ~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-~L~~l~~ 318 (334)
T 2pvf_A 266 EELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRILT 318 (334)
T ss_dssp HHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred HHHHHHHhcCCCC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHHh
Confidence 22333333211 122333456899999999999999999999975 4455443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=341.56 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=196.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC---CCceEEeec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---YGCLVYEYM 469 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~~lV~Ey~ 469 (701)
.++|.+.+.||+|+||.||+|.+.++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 467999999999999999999999999999998754 355779999999999999999999998633 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999986532 223788999999999999999999999 999999999999999999999999998765322
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.....+++.|+|||.+.+..++.++||||||+++|+|+| |++||.... .....+..+.. ...+
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 236 (278)
T 1byg_A 171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAP 236 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------CCCC
T ss_pred ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCCc
Confidence 123467889999999999999999999999999999998 999997543 22223332211 1122
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+++.+||+.+|.+||++.+++. .+..+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~-~L~~i 271 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE-QLEHI 271 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHH-HHHHH
Confidence 334456899999999999999999999973 44444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.99 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=200.6
Q ss_pred hhcCceeee-eeeecCceeEEEEEEC----CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC-CCc
Q 005343 392 ATDYFSISR-KIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE-YGC 463 (701)
Q Consensus 392 ~~~~f~~~~-~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 463 (701)
..++|.+.+ .||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++.. ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 346788888 9999999999999652 3569999997654332 4569999999999999999999999944 348
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 35899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
...... ........+|+.|+|||++.+..++.++||||||+++|+|+| |++||..... ....+..+...
T Consensus 168 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----- 239 (291)
T 1xbb_A 168 RADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 239 (291)
T ss_dssp CTTCSE---EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred ccCCCc---ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 543211 111233457789999999998889999999999999999999 9999976543 33334433221
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|...+..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~-~L~~~ 277 (291)
T 1xbb_A 240 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL-RLRNY 277 (291)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHH
Confidence 223334456999999999999999999999874 44433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.10 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=193.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC--
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY-- 461 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 461 (701)
...++|.+.+.||+|+||.||+|.+.. ..||+|++....... ...+.+|+.+++.++||||++++++|.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 346789999999999999999998732 259999987654322 35689999999999999999999998542
Q ss_pred -----CceEEeecCCCChhhHhccc---CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEE
Q 005343 462 -----GCLVYEYMENGSLEDRLFQK---DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSK 533 (701)
Q Consensus 462 -----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~K 533 (701)
.++||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 28999999999999998532 23456999999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHH
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIR 610 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~ 610 (701)
|+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|+|+| |.+||.... .....+.
T Consensus 188 l~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 188 VADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp ECSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred EeecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 999999987643211 111234567889999999999999999999999999999999 889997543 2223333
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.+... ..+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 264 ~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 264 HGHRL--------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCC--------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCC--------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33211 1223334568999999999999999999999854
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.08 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=203.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEE-------CCceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--Y 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~-------~~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~ 461 (701)
..++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456899999999999999999984 234699999875432 234568999999999999999999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEE
Q 005343 462 GCLVYEYMENGSLEDRLFQKDN----SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKI 534 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL 534 (701)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 5899999999999999976432 245899999999999999999999999 99999999999998 4557999
Q ss_pred EeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHc
Q 005343 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRN 611 (701)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~ 611 (701)
+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..
T Consensus 185 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 185 GDFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp CCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred Cccccccccccccc----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999986532211 112244568999999999999999999999999999999998 9999976543 2333333
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+... ..+...+..+.+++.+||+.+|.+||++.+++.+.+.-..+
T Consensus 261 ~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 GGRM--------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC--------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 3211 11223345689999999999999999999999887766543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.27 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=189.9
Q ss_pred hcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCC-----------ChHHHHHHHHHHHhCCCCcEEEEec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQ-----------GPRQFKQEVEILGSMRHTNMVILLG 456 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l~g 456 (701)
.++|.+.+.||+|+||.||+|.+.. ..||||++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999953 45999998765422 1123677889999999999999999
Q ss_pred eecC------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC
Q 005343 457 ACPE------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 457 ~~~~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
++.+ ..++||||+ +++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9744 348999999 999999986543 6899999999999999999999999 99999999999998877
Q ss_pred --cEEEEeeccccccCCCCCc-ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--hHH
Q 005343 531 --VSKISDVGLARLVPPSAAD-TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLS--HQV 605 (701)
Q Consensus 531 --~~KL~DFGla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~--~~~ 605 (701)
.+||+|||+++.+...... ...........||+.|+|||++.+..++.++|||||||++|+|+||++||... ...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999877432211 11111225568999999999999999999999999999999999999999532 111
Q ss_pred -HHHHHcCccccccCccCCCC--CHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 606 -EQAIRNGTFSELLDPTVTGW--PVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 606 -~~~i~~~~~~~~ld~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
....... +...+...+..+ +...+..+.+++.+||..+|.+||++.+|+
T Consensus 269 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 269 AVQTAKTN-LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHHH-HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHh-hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1111111 000000000000 002334699999999999999999999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.37 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=204.1
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceec
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACP 459 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 459 (701)
+....++|.+.+.||+|+||.||+|.+.+ ..||+|++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999843 25999999765432 245689999999999 8999999999985
Q ss_pred C--CCceEEeecCCCChhhHhcccC-----------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE
Q 005343 460 E--YGCLVYEYMENGSLEDRLFQKD-----------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 460 ~--~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 526 (701)
+ ..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 4 4589999999999999986532 1346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH-- 603 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~-- 603 (701)
+.++.+||+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|+|+| |.+||....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSN----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTT----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred CCCCeEEECccccccccccccc----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 9999999999999986533211 112244567889999999999999999999999999999999 999997542
Q ss_pred -HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 604 -QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 604 -~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.....+..+... ..|...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 274 ~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 274 SKFYKLVKDGYQM--------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 333333333211 1122234468999999999999999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=335.05 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=199.4
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee---cCCCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC---PEYGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~---~~~~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|++ .++.||||++.... ....+.+|+.+++.++|++++..++.+ .+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 56679999987653 335689999999999999877766665 33448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~ 543 (701)
||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 999999985432 45899999999999999999999999 9999999999999 48899999999999876
Q ss_pred CCCCCccc-ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHcCccccc
Q 005343 544 PPSAADTI-TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH-----QVEQAIRNGTFSEL 617 (701)
Q Consensus 544 ~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~-----~~~~~i~~~~~~~~ 617 (701)
........ .........||+.|+|||++.+..++.++|||||||++|+|+||++||.... .....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54322111 1112356689999999999999999999999999999999999999997532 11111111111100
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.......+ +..+.+++.+||+.+|.+||++.+++. .|..+
T Consensus 239 ~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~-~l~~~ 278 (296)
T 3uzp_A 239 IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQ-LFRNL 278 (296)
T ss_dssp HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHH-HHHHH
T ss_pred hHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHH-HHHHH
Confidence 00001122 345899999999999999999999874 33333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.30 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=204.5
Q ss_pred ccCHHHHHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHh--CCCCcEEEEeceecC
Q 005343 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGS--MRHTNMVILLGACPE 460 (701)
Q Consensus 383 ~~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~ 460 (701)
.+++.-.....++|.+.+.||+|+||.||+|.+.++.||||++... ....+.+|++++.. ++||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3344444556678999999999999999999999999999998643 35668899999988 799999999999844
Q ss_pred ------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCeeE
Q 005343 461 ------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH--------QNKPEPLVHRDLKPANILL 526 (701)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~iiHrDLKp~NILl 526 (701)
..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 348999999999999999542 5899999999999999999999 777 9999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhC-----
Q 005343 527 DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITA----- 595 (701)
Q Consensus 527 ~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG----- 595 (701)
+.++.+||+|||++........ ..........||+.|+|||++.+. .++.++|||||||++|+|+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTT--EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred CCCCCEEEEECCCceecccccc--ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999987643321 111123556899999999998776 334789999999999999999
Q ss_pred -----CCCCCCc-------hHHHHHHHcCccccccCccCCC-C-CHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 596 -----RPAMGLS-------HQVEQAIRNGTFSELLDPTVTG-W-PVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 596 -----~~pf~~~-------~~~~~~i~~~~~~~~ld~~~~~-~-p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
..||... ......+....+ .+.... | .......+.+++.+||+.+|.+||++.+++.+
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcCcccHHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6677542 122222222221 122211 1 23566779999999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=336.59 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=193.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee---cCCCceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC---PEYGCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~---~~~~~lV~ 466 (701)
..++|.+.+.||+|+||.||+|++ .++.||||++.... ....+.+|+.++..++|++++..++.+ .+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 56679999876543 234588999999999999888777666 33448999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~ 543 (701)
||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999886432 35899999999999999999999999 9999999999999 78999999999999876
Q ss_pred CCCCCccc-ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHcCcccc
Q 005343 544 PPSAADTI-TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH------QVEQAIRNGTFSE 616 (701)
Q Consensus 544 ~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~------~~~~~i~~~~~~~ 616 (701)
........ .........||+.|+|||.+.+..++.++|||||||++|+|++|++||.... ....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-HHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc-ccccc
Confidence 54322111 1122346789999999999999999999999999999999999999996432 1111111 11110
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
........+ +..+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000001122 346899999999999999999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=335.79 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=199.7
Q ss_pred CceeeeeeeecCceeEEEEEEC--Cc---eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--CC-ceE
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HT---SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--YG-CLV 465 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~---~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~-~lV 465 (701)
.|.+.+.||+|+||.||+|.+. +. .||+|++...... ..+.+.+|+.+++.++||||++++++|.+ .. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4777899999999999999872 22 5999998764322 24568999999999999999999999843 22 799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999998543 346889999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
.. ...........+|+.|+|||.+.+..++.++|||||||++|+|+| |.+||...+ .....+..+...
T Consensus 177 ~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------- 247 (298)
T 3pls_A 177 RE--YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------- 247 (298)
T ss_dssp GG--GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-------
T ss_pred Cc--ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-------
Confidence 21 111222345678899999999999999999999999999999999 556665443 233334433211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+...+..+.+++.+||+.+|.+||++.+++. .+.++
T Consensus 248 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~-~l~~~ 285 (298)
T 3pls_A 248 -PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG-EVEQI 285 (298)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred -CCCccchHHHHHHHHHHccCChhhCcCHHHHHH-HHHHH
Confidence 112233446899999999999999999999974 44444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=372.25 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=198.6
Q ss_pred hcCceeee-eeeecCceeEEEEEEC----CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 393 TDYFSISR-KIGEGGYGPVYKAQLD----HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~-~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
.++|.+.. .||+|+||.||+|.+. +..||||+++.... ...+.|.+|+.+|+.++|||||+++|+|.+ ..++|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv 413 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 413 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence 34566666 8999999999999873 33599999987643 346789999999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999998543 346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
.... ........+|+.|+|||++.+..++.++|||||||+||||+| |++||.... .+...+..+..
T Consensus 489 ~~~~---~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------- 557 (613)
T 2ozo_A 489 DDSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------- 557 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------
T ss_pred CCce---eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 2211 111223456789999999999999999999999999999998 999997543 34444554432
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
...|..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1233344567999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.68 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=195.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.. .+..||||++....... ...+.+|+.+++.++||||++++++|.+ ..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999997 46779999997643322 3458899999999999999999999854 45899
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988642 23456899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHcCccccccCc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH----QVEQAIRNGTFSELLDP 620 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~----~~~~~i~~~~~~~~ld~ 620 (701)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .....+..+.+....
T Consensus 188 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 259 (310)
T 2wqm_A 188 SKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP-- 259 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC--
T ss_pred CCC------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc--
Confidence 321 11234578999999999999999999999999999999999999986432 233334444332211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHhcc
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~~~ 666 (701)
+...+..+.+++.+||..+|.+||++.+++ ..+.++....
T Consensus 260 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~il-~~l~~l~~~~ 299 (310)
T 2wqm_A 260 -----SDHYSEELRQLVNMCINPDPEKRPDVTYVY-DVAKRMHACT 299 (310)
T ss_dssp -----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHHHHHH
T ss_pred -----ccccCHHHHHHHHHHcCCChhhCCCHHHHH-HHHHHHHHhh
Confidence 112234589999999999999999999987 4666665543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.17 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=198.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC--Cce--EEEEEeCCCC-CCChHHHHHHHHHHHhC-CCCcEEEEeceecC--CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTS--VAIKVLGPDI-SQGPRQFKQEVEILGSM-RHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~--vAiK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~--~~~lV 465 (701)
++|.+.+.||+|+||.||+|++. +.. |++|.+.... ......+.+|+.++.++ +||||+++++++.+ ..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999974 443 5999887543 23455689999999999 99999999999854 34899
Q ss_pred EeecCCCChhhHhcccC-------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 466 YEYMENGSLEDRLFQKD-------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
|||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2347899999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i 609 (701)
||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|+| |++||....... ..+
T Consensus 182 kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp EECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999743211 11234467889999999998889999999999999999998 999997654322 222
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+. ....+...+..+.+++.+||..+|.+||++.+++.+...-+
T Consensus 255 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 255 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2221 11122334456899999999999999999999986544333
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=356.11 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=201.7
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-----------CCcEEEEeceec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-----------HTNMVILLGACP 459 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~ 459 (701)
.++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999997 46679999997532 23456889999999886 899999999984
Q ss_pred C------CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEc-----
Q 005343 460 E------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLD----- 527 (701)
Q Consensus 460 ~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~----- 527 (701)
. ..++||||+ +++|.+++.... ...+++..+..|+.||+.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 3 358999999 999999886543 34589999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--
Q 005343 528 -QNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-- 604 (701)
Q Consensus 528 -~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-- 604 (701)
..+.+||+|||+++.+... .....||+.|+|||++.+..++.++|||||||+||+|+||++||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999876422 2445799999999999999999999999999999999999999975431
Q ss_pred -------HHHHHH-cCccc---------------------cccC----------ccCCCCCHHHHHHHHHHHHHhhccCc
Q 005343 605 -------VEQAIR-NGTFS---------------------ELLD----------PTVTGWPVEAALSIAKLALQCCELRK 645 (701)
Q Consensus 605 -------~~~~i~-~~~~~---------------------~~ld----------~~~~~~p~~~~~~l~~li~~cl~~~P 645 (701)
....+. .+.+. .+.. .....++...+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 111111 01000 0000 00113456777889999999999999
Q ss_pred CCCCChhhhhhHHHHH
Q 005343 646 RDRPDLVSVVLPELIR 661 (701)
Q Consensus 646 ~~RPt~~~vl~~~~~~ 661 (701)
.+||++.+++.|+|++
T Consensus 323 ~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLK 338 (373)
T ss_dssp TTCBCHHHHHTCGGGT
T ss_pred cccCCHHHHhhChhhh
Confidence 9999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.60 Aligned_cols=263 Identities=28% Similarity=0.362 Sum_probs=204.1
Q ss_pred cCHHHHHHhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CC-----cEEEEe
Q 005343 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HT-----NMVILL 455 (701)
Q Consensus 384 ~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~ 455 (701)
|.+.......++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+..|+.++..++ |+ +|+.++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344444556789999999999999999999984 5669999997432 22456788999998885 54 489999
Q ss_pred ceec--CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh--cCCCCeeecCCCCCCeeEc--CC
Q 005343 456 GACP--EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ--NKPEPLVHRDLKPANILLD--QN 529 (701)
Q Consensus 456 g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~--~~~~~iiHrDLKp~NILl~--~~ 529 (701)
++|. +..|+||||+. |+|.+++.... ...+++..+..++.||+.||.|||+ .+ ||||||||+|||++ .+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTS
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCC
Confidence 8874 45589999995 69999886543 2458999999999999999999994 56 99999999999994 57
Q ss_pred CcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-
Q 005343 530 YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA- 608 (701)
Q Consensus 530 ~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~- 608 (701)
+.+||+|||+++.+... ....+||+.|+|||++.+..++.++|||||||+||+|+||++||...+.....
T Consensus 198 ~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 268 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268 (382)
T ss_dssp CCEEECCCTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CcEEEEeccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 88999999999876432 24568999999999999999999999999999999999999999876543221
Q ss_pred --HHc-Ccc---------------ccccC-----------------c---------------------cCCCCCHHHHHH
Q 005343 609 --IRN-GTF---------------SELLD-----------------P---------------------TVTGWPVEAALS 632 (701)
Q Consensus 609 --i~~-~~~---------------~~~ld-----------------~---------------------~~~~~p~~~~~~ 632 (701)
+.. +.. ..+.+ + ............
T Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (382)
T 2vx3_A 269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348 (382)
T ss_dssp HHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHH
T ss_pred HHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHH
Confidence 110 000 00000 0 000111233457
Q ss_pred HHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 633 IAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 633 l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.+|+.+||+.||.+|||+.++|.|+|++
T Consensus 349 ~~dli~~mL~~dP~~Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 349 FKDLILRMLDYDPKTRIQPYYALQHSFFK 377 (382)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCCChhhCCCHHHHhcCcccc
Confidence 89999999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.49 Aligned_cols=260 Identities=24% Similarity=0.292 Sum_probs=185.2
Q ss_pred HhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceec--------
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACP-------- 459 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~-------- 459 (701)
....+|.+.+.||+|+||.||+|.+ .+..||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3456899999999999999999998 56679999986654444567899999999996 999999999872
Q ss_pred C--CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 460 E--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 460 ~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
. ..++||||+. |+|.+++.......++++..+..|+.||+.||.|||+.+ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 1 1379999995 799998866444567999999999999999999999876 35999999999999999999999999
Q ss_pred ccccccCCCCCcccc------cccccccccCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 005343 538 GLARLVPPSAADTIT------QYHMTTAAGTFCYIDPEYQ---QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA 608 (701)
Q Consensus 538 Gla~~~~~~~~~~~~------~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~ 608 (701)
|+++.+......... ........||+.|+|||++ .+..++.++|||||||++|+|+||++||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999876543211100 0112255799999999988 567789999999999999999999999965443211
Q ss_pred HHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 609 i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+.+.. +..... ...+.+|+.+||+.+|.+||++.+++.+...-
T Consensus 262 -~~~~~~~---~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 -VNGKYSI---PPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----CCC---CTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcCcccC---Cccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111110 111111 22478999999999999999999998664433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=340.01 Aligned_cols=253 Identities=19% Similarity=0.265 Sum_probs=191.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~l 464 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++++.+ ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999984 6679999987654333 2568999999999999999999999854 4489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++++|.+++... .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998654 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccC
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTV 622 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~ 622 (701)
... ........||+.|+|||++.+..++.++||||||+++|+|+||++||...... ...+..... ..
T Consensus 186 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~ 254 (309)
T 2h34_A 186 DEK-----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP------RP 254 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCC------CG
T ss_pred ccc-----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCC------Cc
Confidence 321 11224567999999999999999999999999999999999999999876542 122222111 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCC-ChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRP-DLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RP-t~~~vl~~~~~~l 662 (701)
...+...+..+.+++.+||..+|.+|| ++.++ .+.|...
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l-~~~l~~~ 294 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL-SAAAHAA 294 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHHT
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH-HHHHHHH
Confidence 111223334589999999999999999 55555 5566554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.22 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=198.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC------CCc
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE------YGC 463 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 463 (701)
..++|.+.+.||+|+||.||+|.. .++.||||++..........+.+|+.+++.++||||+++++++.. ..+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999997 566799999876544455678999999999999999999999841 347
Q ss_pred eEEeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 464 LVYEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+||||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988653 23457899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCcc---cccccccccccCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHcC
Q 005343 543 VPPSAADT---ITQYHMTTAAGTFCYIDPEYQQTGM---LGVKSDLYSLGVVLLQLITARPAMGLSH----QVEQAIRNG 612 (701)
Q Consensus 543 ~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~----~~~~~i~~~ 612 (701)
........ ..........||+.|+|||++.... ++.++|||||||++|+|++|+.||.... .....+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 53211100 0011123456799999999887554 7899999999999999999999995321 122222221
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
. ..+. +...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 264 -~---~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 -L---SIPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -C---CCCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1 0111 12233468999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=341.55 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=204.5
Q ss_pred hcCceeeeeeeecCceeEEEEEE------CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC----CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL------DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE----YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~------~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~ 462 (701)
.++|.+.+.||+|+||.||+|.+ .+..||||++..........+.+|+.+++.++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35699999999999999999985 356699999987654556679999999999999999999998743 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 89999999999999996543 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HH---------------
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VE--------------- 606 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~--------------- 606 (701)
+...... ........+|..|+|||.+.+..++.++|||||||++|+|+||..||..... ..
T Consensus 195 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 195 LPQDKEY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CCSSCSE---EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccccc---cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 7543211 1112345678889999999988899999999999999999999998864321 11
Q ss_pred --HHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 607 --QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 607 --~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+..+. ....+...+..+.+++.+||+.+|.+||++.+++. .+..++
T Consensus 272 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~-~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL-RVDQIR 321 (326)
T ss_dssp HHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH-HHHHHH
T ss_pred HHHHhhcCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH-HHHHHH
Confidence 1111111 11123334456999999999999999999999873 455544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=344.49 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=201.6
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--C-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc------EEEEeceec--C
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--H-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN------MVILLGACP--E 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~--~ 460 (701)
..++|.+.+.||+|+||.||+|.+. + ..||+|++.... .....+.+|+.+++.++|++ ++.+++++. .
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999984 3 569999997532 23456889999999998766 888888774 3
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE--------------
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL-------------- 526 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl-------------- 526 (701)
..|+||||+ +|+|.+.+.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 458999999 677777775533 346899999999999999999999999 9999999999999
Q ss_pred -----cCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005343 527 -----DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGL 601 (701)
Q Consensus 527 -----~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 601 (701)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCcccccccc---------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 66889999999999864322 2456799999999999999999999999999999999999999986
Q ss_pred chHHHHHHH----cCcccc----------ccCc-----------------------cCCCCCHHHHHHHHHHHHHhhccC
Q 005343 602 SHQVEQAIR----NGTFSE----------LLDP-----------------------TVTGWPVEAALSIAKLALQCCELR 644 (701)
Q Consensus 602 ~~~~~~~i~----~~~~~~----------~ld~-----------------------~~~~~p~~~~~~l~~li~~cl~~~ 644 (701)
......... .+.+.. .... .........+..+.+|+.+||+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 553321111 011000 0000 000111234557999999999999
Q ss_pred cCCCCChhhhhhHHHHHH
Q 005343 645 KRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 645 P~~RPt~~~vl~~~~~~l 662 (701)
|.+||++.+++.|+|+.-
T Consensus 322 P~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTTSCCHHHHTTSGGGGG
T ss_pred hhhCcCHHHHhcChhhcC
Confidence 999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=368.92 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=205.4
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEE
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVY 466 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~ 466 (701)
++...++|.+.++||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|+.++||||++++++|.+ ..+|||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 33456789999999999999999999965 469999998654 456789999999999999999999999855 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+.+|+|.++|.... ...+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999996432 235889999999999999999999999 999999999999999999999999999876421
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~ 623 (701)
. ........+|..|+|||++....++.++|||||||+||||+| |+.||.... .+...+..+...
T Consensus 417 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 483 (535)
T 2h8h_A 417 E-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 483 (535)
T ss_dssp H-----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred c-----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 1 111234457889999999999999999999999999999999 999997553 333344433211
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..+..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 515 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 515 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12233445689999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.54 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=205.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC--CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI--SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.++++++||||+++++++.+. .++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999984 6679999986543 23456799999999999999999999998553 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC---CcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN---YVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~---~~~KL~DFGla~~ 542 (701)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999886543 5899999999999999999999999 9999999999999754 4799999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
+.... ......||+.|+|||.+.+ .++.++||||||+++|+|++|++||..... ....+..+.+... .+
T Consensus 174 ~~~~~-------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (287)
T 2wei_A 174 FQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-LP 244 (287)
T ss_dssp BCCCS-------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-SG
T ss_pred ecCCC-------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-ch
Confidence 64321 1234468999999998865 489999999999999999999999976543 2333444433211 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..... +..+.+++.+||..+|.+||++.+++.|+|++-
T Consensus 245 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 245 QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 11222 345899999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.16 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=176.4
Q ss_pred hhcCceeee-eeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC------CC
Q 005343 392 ATDYFSISR-KIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE------YG 462 (701)
Q Consensus 392 ~~~~f~~~~-~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 462 (701)
..++|.+.+ .||+|+||.||+|.+. ++.||||++... ..........+..+.||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357899965 6999999999999995 667999998643 2223333344677899999999998843 24
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeecc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGL 539 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGl 539 (701)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999986543 346999999999999999999999999 999999999999975 55699999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHHcCc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE------QAIRNGT 613 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~------~~i~~~~ 613 (701)
++..... ......||+.|+|||++....++.++|||||||++|+|++|++||....... ..+..+.
T Consensus 178 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 178 AKETTQN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ceecccc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 9865322 1245678999999999998899999999999999999999999996543211 1111111
Q ss_pred cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 614 ~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+ ....+.. ...+..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 250 ~-~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 Y-GFPNPEW----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CCCTTTS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred c-ccCchhh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 1 0011111 123446899999999999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.20 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=197.7
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC------ChHHHHHHHHHHHhC----CCCcEEEEece
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ------GPRQFKQEVEILGSM----RHTNMVILLGA 457 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l----~HpnIv~l~g~ 457 (701)
....++|.+.+.||+|+||.||+|.+ .+..||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999988 4567999999765432 123367799999998 89999999999
Q ss_pred ec--CCCceEEee-cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEE
Q 005343 458 CP--EYGCLVYEY-MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSK 533 (701)
Q Consensus 458 ~~--~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~K 533 (701)
+. +..++|||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 84 355899999 7899999999654 35899999999999999999999999 99999999999999 899999
Q ss_pred EEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcC
Q 005343 534 ISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLG-VKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNG 612 (701)
Q Consensus 534 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~ 612 (701)
|+|||+++.+.... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||....... . .
T Consensus 181 l~dfg~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~-~ 248 (312)
T 2iwi_A 181 LIDFGSGALLHDEP--------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---E-A 248 (312)
T ss_dssp ECCCSSCEECCSSC--------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---H-T
T ss_pred EEEcchhhhcccCc--------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---h-h
Confidence 99999998764321 2456799999999988777764 58999999999999999999997654321 1 1
Q ss_pred ccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 613 ~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.. .++...+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 249 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 249 EL---------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred cc---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 11 122233446899999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=348.19 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=195.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC----------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEE---------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD----------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI--------- 453 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~----------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~--------- 453 (701)
.++|.+.+.||+|+||.||+|++. +..||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 368999999999999999999985 456999998754 46889999999999999987
Q ss_pred ------Eeceec---CCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCe
Q 005343 454 ------LLGACP---EYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANI 524 (701)
Q Consensus 454 ------l~g~~~---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NI 524 (701)
+++++. ...++||||+ +|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 444443 3348999999 999999996542 346899999999999999999999999 99999999999
Q ss_pred eEcCCC--cEEEEeeccccccCCCCCcc-cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005343 525 LLDQNY--VSKISDVGLARLVPPSAADT-ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGL 601 (701)
Q Consensus 525 Ll~~~~--~~KL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 601 (701)
|++.++ .+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||+||+|+||+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998764322111 111123455899999999999999999999999999999999999999975
Q ss_pred ch----HHHHHHH--cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 602 SH----QVEQAIR--NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 602 ~~----~~~~~i~--~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
.. ....... ......+...... | ...+..+.+++.+||..+|.+||++.+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGH-W-IRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSC-E-ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccc-c-CCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 42 1111111 1111111111100 0 1123458999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.32 Aligned_cols=260 Identities=25% Similarity=0.303 Sum_probs=181.9
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHH-HHHhCCCCcEEEEeceecC--CCceE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVE-ILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+..|+. +++.++||||+++++++.+ ..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3578999999999999999999995 677999999765422 2334666666 6777899999999999854 34799
Q ss_pred EeecCCCChhhHhcc--cCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQ--KDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|||+.+ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999974 78777643 12245689999999999999999999998 8 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCcccccc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQ----QTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELL 618 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~l 618 (701)
+.... ......||+.|+|||++ .+..++.++|||||||++|+|+||+.||.........+.... . ..
T Consensus 176 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~-~~ 246 (327)
T 3aln_A 176 LVDSI-------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-K-GD 246 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-C-SC
T ss_pred ccccc-------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-c-CC
Confidence 64321 12344799999999998 466789999999999999999999999976543322222110 0 00
Q ss_pred CccCC-CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 619 DPTVT-GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 619 d~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
.+.+. ..+...+..+.+|+.+||..+|.+||++.+++.|+|+.-..
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 01111 11112344689999999999999999999999999998644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=372.84 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=194.0
Q ss_pred eeeeecCceeEEEEEEC----CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecCC-CceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLD----HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPEY-GCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~lV~Ey~~~g 472 (701)
+.||+|+||.||+|.+. ++.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+. .++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999762 345999999765432 246799999999999999999999999544 47999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 455 ~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 455 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 999999543 45899999999999999999999999 999999999999999999999999999887543211
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCCCHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
........+|+.|+|||++.+..++.++|||||||+||||+| |++||.... .+...+..+... ..|..+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------~~p~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCPAGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCCTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------CCCCCC
Confidence 112234467889999999999999999999999999999998 999997654 344445544321 223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
+..+.+|+.+||+.+|.+||++.+|+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 567999999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=336.51 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=191.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC---Cc--eEEEEEeCCCCC---CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD---HT--SVAIKVLGPDIS---QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~---~~--~vAiK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 463 (701)
.++|.+.+.||+|+||.||+|.+. ++ .||||++..... .....+.+|+.+++.++||||+++++++.+ ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 467999999999999999999863 22 489999876532 234568999999999999999999999854 458
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999986543 35889999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~ 620 (701)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |++||....... ..+...... .
T Consensus 172 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~- 244 (291)
T 1u46_A 172 PQNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---L- 244 (291)
T ss_dssp CC-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC---C-
T ss_pred cccccc---hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC---C-
Confidence 543211 112234567889999999998889999999999999999999 999997654322 222222111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 245 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112233456899999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.36 Aligned_cols=258 Identities=22% Similarity=0.255 Sum_probs=191.6
Q ss_pred hcCceeeeeeeecCceeEEEE-EECCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKA-QLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~-~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.+.|.+.+.||+|+||+||.+ ...++.||||++... ....+.+|+.+|..+ +||||+++++++.+. .++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 456777889999999999754 447888999998653 345688999999876 899999999998554 4899999
Q ss_pred cCCCChhhHhcccCCCCC----CChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-------------Cc
Q 005343 469 MENGSLEDRLFQKDNSPP----IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-------------YV 531 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-------------~~ 531 (701)
+. |+|.+++........ .++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 699999865432211 133345779999999999999999 9999999999999654 58
Q ss_pred EEEEeeccccccCCCCCcccccccccccccCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005343 532 SKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-------GMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH 603 (701)
Q Consensus 532 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 603 (701)
+||+|||+++.+...... ........+||+.|+|||++.+ ..++.++|||||||++|||+| |++||+...
T Consensus 167 ~kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999987543211 1112345689999999998865 668999999999999999999 999997654
Q ss_pred HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 604 ~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....+..+.+... ......+...+..+.+++.+||+.+|.+||++.+++.|+|+.
T Consensus 245 ~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 245 SRESNIIRGIFSLD--EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp THHHHHHHTCCCCC--CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhHHHHhcCCCCcc--cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 43344433332211 111112345667899999999999999999999999999973
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.10 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=196.3
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCC--CCcEEEEeceecCC--
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMR--HTNMVILLGACPEY-- 461 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~-- 461 (701)
+....++|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.++..++ ||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3345678999999999999999999884 566999998765432 2456899999999997 59999999998543
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 479999 5588999998653 36889999999999999999999999 999999999999965 899999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHH--
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-----------GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQ-- 607 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~-- 607 (701)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..... ...
T Consensus 175 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 175 QMQPDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp C------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccCccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 7643221 112235579999999998865 4789999999999999999999999975422 111
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+...... ..++...+..+.+++.+||+.+|.+||++.+++.|+|++.
T Consensus 251 ~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 251 AIIDPNHE-------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHCTTSC-------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHhcccc-------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 11111110 1122222346899999999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.44 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=202.0
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC------ChHHHHHHHHHHHhCC--CCcEEEEec
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ------GPRQFKQEVEILGSMR--HTNMVILLG 456 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~g 456 (701)
.+.....++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34455678899999999999999999998 5667999998765322 2245778999999996 599999999
Q ss_pred eecC--CCceEEeecCC-CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcE
Q 005343 457 ACPE--YGCLVYEYMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVS 532 (701)
Q Consensus 457 ~~~~--~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~ 532 (701)
++.+ ..++||||+.+ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9854 44899999976 8999998653 35889999999999999999999999 99999999999999 78999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN 611 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~ 611 (701)
||+|||+++.+... ......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...... ..
T Consensus 190 kL~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~- 257 (320)
T 3a99_A 190 KLIDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IR- 257 (320)
T ss_dssp EECCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HH-
T ss_pred EEeeCccccccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---hc-
Confidence 99999999876432 1234579999999999887765 78899999999999999999999765432 22
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.. . ++...+..+.+++.+||..+|.+||++.+++.|+|++
T Consensus 258 ~~~--~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 258 GQV--F-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp CCC--C-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred ccc--c-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 111 0 1112234589999999999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=330.77 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=181.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-h-HHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-P-RQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~-~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
.++|.+.+.||+|+||.||+|.+. +..||||++....... . ..+..+..+++.++||||+++++++.+ ..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999994 6679999997654222 1 234455567888899999999999854 348999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||+ ++.+..+.... ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 55565544332 24689999999999999999999995 8 99999999999999999999999999976543
Q ss_pred CCCcccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccc
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSEL 617 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ 617 (701)
.. ......||+.|+|||++. ...++.++|||||||++|+|+||+.||.... .....+..+....
T Consensus 178 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 249 (318)
T 2dyl_A 178 DK-------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL- 249 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-
T ss_pred Cc-------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-
Confidence 21 123457999999999984 5668999999999999999999999997532 1222222222111
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.+....+ +..+.+++.+||..+|.+||++.+++.|+|++-.
T Consensus 250 -~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 250 -LPGHMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp -CCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred -CCccCCC----CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 1111122 3458999999999999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.70 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=190.9
Q ss_pred hcCceeeeeeeecCcee-EEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGP-VYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~-Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
..+|.+.+.||+|+||. ||++...++.||||++.... ...+.+|+.+|+.+ +|||||++++++.+. .++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 45699999999999998 55566688899999986543 23467899999999 899999999998554 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-----CCcEEEEeecccccc
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-----NYVSKISDVGLARLV 543 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~~KL~DFGla~~~ 543 (701)
+. |+|.+++..... .+.+..+..|+.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 699998865432 3444556789999999999999999 999999999999943 346789999999876
Q ss_pred CCCCCcccccccccccccCCCccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHcCccccccC
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQ---TGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVEQAIRNGTFSELLD 619 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~i~~~~~~~~ld 619 (701)
..... ........+||+.|+|||++. ...++.++|||||||++|+|+| |.+||+........+..+....
T Consensus 174 ~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--- 247 (432)
T 3p23_A 174 AVGRH---SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL--- 247 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC---
T ss_pred cCCCc---ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc---
Confidence 43321 112235568999999999987 4567889999999999999999 9999976543333322222110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.....+......+.+|+.+||+.+|.+||++.+++.|+|+.
T Consensus 248 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 248 -DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp -TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred -cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 11111234455688999999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=365.32 Aligned_cols=262 Identities=25% Similarity=0.291 Sum_probs=204.8
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC--------C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE--------Y 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 461 (701)
.++|.+.+.||+|+||.||+|.+ .+..||||++...... ....+.+|+.+++.++||||+.+++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999998 4567999998765322 24568999999999999999999998633 3
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCc---EEEEeec
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYV---SKISDVG 538 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~---~KL~DFG 538 (701)
.++||||+++|+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 4899999999999999977666667999999999999999999999999 999999999999986654 8999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--------H
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--------R 610 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--------~ 610 (701)
++..+.... ......||+.|+|||++.+..++.++|||||||++|+|+||++||.......... .
T Consensus 170 ~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE-------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC-------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccc-------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 998764332 1245689999999999999999999999999999999999999996543222110 0
Q ss_pred cCcccccc---------CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 611 NGTFSELL---------DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 611 ~~~~~~~l---------d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
........ .+.....+...+..+.+++.+||..||.+||++.+++.|+|++-.+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 00000000 0111223445677899999999999999999999999999977643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=351.21 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=194.5
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEE-EEe--ceecCCCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMV-ILL--GACPEYGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~--g~~~~~~~lV~E 467 (701)
.++|.+.++||+|+||.||+|.+. +..||||++.... ....+.+|+.++..+.|++.+ .+. +...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999984 6679999887653 234588999999999875443 333 333555689999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeE---cCCCcEEEEeeccccccC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVP 544 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl---~~~~~~KL~DFGla~~~~ 544 (701)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999986432 45899999999999999999999999 9999999999999 688999999999998775
Q ss_pred CCCCccc-ccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHcCcccccc
Q 005343 545 PSAADTI-TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ-----VEQAIRNGTFSELL 618 (701)
Q Consensus 545 ~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~-----~~~~i~~~~~~~~l 618 (701)
....... .........||+.|+|||++.+..++.++|||||||+||+|++|+.||..... ....+....+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4322111 11123467899999999999999999999999999999999999999975321 11111111111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
......+ +..+.+|+..||+.+|.+||++.+|+.
T Consensus 238 ~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111222 346899999999999999999998874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=364.70 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=199.9
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC-CC
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE-YG 462 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 462 (701)
....++|.+.+.||+|+||.||+|.+.. ..||||++....... .+.+.+|+.+++.++||||++++|++.+ ..
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 465 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 465 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCce
Confidence 3345789999999999999999999842 349999887643222 3568999999999999999999999854 45
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 89999999999999986432 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLD 619 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld 619 (701)
+.... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||..... ....+..+...
T Consensus 541 ~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---- 611 (656)
T 2j0j_A 541 MEDST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 611 (656)
T ss_dssp CCC---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred cCCCc-----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 64321 122334567889999999999999999999999999999997 9999976543 22333333211
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
..|...+..+.+++.+||..+|.+||++.+++.
T Consensus 612 ----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123334456899999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.10 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=196.2
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CC
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++....++|.+.+.||+|+||.||+|.+.+ .||+|++..... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3444457889999999999999999999866 499999876532 223557899999999999999999999854 44
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 8999999999999998543 246899999999999999999999999 99999999999998 67999999999876
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT---------GMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRN 611 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~ 611 (701)
....... ..........||+.|+|||++.. ..++.++|||||||++|+|+||+.||...... ...+..
T Consensus 179 ~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 179 SGVLQAG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 5322111 11122345679999999998764 45899999999999999999999999765432 222333
Q ss_pred CccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 612 ~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
+........ .+ +..+.+++.+||..+|.+||++.+++
T Consensus 258 ~~~~~~~~~---~~----~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 258 GMKPNLSQI---GM----GKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp TCCCCCCCS---SC----CTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCcC---CC----CHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 322211111 12 23489999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=338.51 Aligned_cols=246 Identities=17% Similarity=0.142 Sum_probs=188.5
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC---ChHHHHHHHHHHHhCCC-Cc---------------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ---GPRQFKQEVEILGSMRH-TN--------------- 450 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~---~~~~~~~Ei~il~~l~H-pn--------------- 450 (701)
....|...+.||+|+||.||+|.+. ++.||||++...... ..+.|.+|+.++..+.| +|
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888999999999999999985 777999999854332 25679999999999987 21
Q ss_pred EEEE------eceec-------CCCceEEeecCCCChhhHhcc----cCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 005343 451 MVIL------LGACP-------EYGCLVYEYMENGSLEDRLFQ----KDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513 (701)
Q Consensus 451 Iv~l------~g~~~-------~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 513 (701)
++.+ +.++. ...+++|+++ +|+|.+++.. ......+++..++.|+.||+.||.|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111 11111 1225666655 7899988842 123446888999999999999999999999
Q ss_pred eeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccc----------cCCCCCchhhHH
Q 005343 514 LVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQ----------QTGMLGVKSDLY 583 (701)
Q Consensus 514 iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~~~~sDvw 583 (701)
||||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999865321 345678 999999998 666689999999
Q ss_pred HHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 584 SLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 584 SlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
||||+||+|+||+.||...... ..+..++. .....| ..+.+|+.+||+.+|.+||++.+++.|+|++-
T Consensus 302 SlGvil~elltg~~Pf~~~~~~------~~~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAAL------GGSEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGG------SCSGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchh------hhHHHHHh-hcccCC----HHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999765421 11111111 112233 45899999999999999999999999998864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.21 Aligned_cols=230 Identities=21% Similarity=0.313 Sum_probs=182.3
Q ss_pred hcCceee-eeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHH-HhCCCCcEEEEeceecC------CC
Q 005343 393 TDYFSIS-RKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEIL-GSMRHTNMVILLGACPE------YG 462 (701)
Q Consensus 393 ~~~f~~~-~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~------~~ 462 (701)
.++|.+. +.||+|+||.||+|.+ .+..||+|++.. ...+.+|+.++ +.++||||++++++|.+ ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 7899999999999998 456799999853 35678999998 66799999999998743 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeecc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGL 539 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGl 539 (701)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 89999999999999986643 346899999999999999999999999 999999999999998 88999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccC
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLD 619 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld 619 (701)
+.... +..++.++|||||||++|+|+||++||........ ...... ...
T Consensus 167 a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~-~~~ 215 (299)
T 3m2w_A 167 AKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKT-RIR 215 (299)
T ss_dssp CEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCC-SSC
T ss_pred ccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--hHHHHH-HHh
Confidence 86532 23467899999999999999999999976543221 111111 111
Q ss_pred ccCCCCCH----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 620 PTVTGWPV----EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 620 ~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.....++. ..+..+.+++.+||+.+|.+||++.+++.|+|++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 11112221 23456999999999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.53 Aligned_cols=242 Identities=18% Similarity=0.173 Sum_probs=189.8
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCC--------CChHHHHHHHHHHHhCC---------CCcEEEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS--------QGPRQFKQEVEILGSMR---------HTNMVILL 455 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~--------~~~~~~~~Ei~il~~l~---------HpnIv~l~ 455 (701)
.++|.+.+.||+|+||.||+|++.++.||||++..... .....+.+|+.+|+.++ ||||+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 46799999999999999999999999999999976532 22367899999999886 66666665
Q ss_pred ce-----------------e---------------cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHH
Q 005343 456 GA-----------------C---------------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503 (701)
Q Consensus 456 g~-----------------~---------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 503 (701)
+. | ....|+||||+++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 54 3 2345899999999987776633 4589999999999999999
Q ss_pred HHHh-hcCCCCeeecCCCCCCeeEcCCC--------------------cEEEEeeccccccCCCCCcccccccccccccC
Q 005343 504 LFLH-QNKPEPLVHRDLKPANILLDQNY--------------------VSKISDVGLARLVPPSAADTITQYHMTTAAGT 562 (701)
Q Consensus 504 ~~LH-~~~~~~iiHrDLKp~NILl~~~~--------------------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt 562 (701)
.||| +.+ ||||||||+|||++.++ .+||+|||+|+.+.. ...+||
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt 240 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFC 240 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEe
Confidence 9999 899 99999999999999887 999999999987632 234799
Q ss_pred CCccCcccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCchH----HHHHHHcCccccccCccCCCCCHHHHHHHHHHH
Q 005343 563 FCYIDPEYQQTGMLGVKSDLYSLGVV-LLQLITARPAMGLSHQ----VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLA 637 (701)
Q Consensus 563 ~~Y~aPE~~~~~~~~~~sDvwSlGvi-l~elltG~~pf~~~~~----~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li 637 (701)
+.|+|||++.+.. +.++||||||++ .+++++|.+||..... .........+.. ......+...+..+.+|+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---KCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---CCCSHHHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---ccchhhhhhcCHHHHHHH
Confidence 9999999998766 899999998777 7889999999954321 112222211111 111112345677899999
Q ss_pred HHhhccCcCCCCChhhhh-hHHHHH
Q 005343 638 LQCCELRKRDRPDLVSVV-LPELIR 661 (701)
Q Consensus 638 ~~cl~~~P~~RPt~~~vl-~~~~~~ 661 (701)
.+||+.+ |+.++| .|+|++
T Consensus 317 ~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 317 RTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHhccC-----CHHHHHhcCCCcC
Confidence 9999965 999999 999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=358.46 Aligned_cols=237 Identities=24% Similarity=0.282 Sum_probs=194.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecC--C-----
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPE--Y----- 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~----- 461 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.++.+++||||++++++|.+ .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999983 57799999875432 223468899999999999999999999843 2
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.||||||++|++|.+++.. .+++..+..|+.||+.||.|||+.+ ||||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 4899999999999887632 6899999999999999999999999 9999999999999986 89999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCcc
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~ 621 (701)
.+... ....||+.|+|||++.++. +.++|||||||+||+|++|.+||.... ...+
T Consensus 230 ~~~~~----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~-----------~~~~--- 284 (681)
T 2pzi_A 230 RINSF----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY-----------VDGL--- 284 (681)
T ss_dssp ETTCC----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE-----------CSSC---
T ss_pred hcccC----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc-----------cccc---
Confidence 76432 3457999999999887654 899999999999999999999985321 1111
Q ss_pred CCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 622 VTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 622 ~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
....+ ......+.+++.+||+.+|.+||+..+.+.+.|..+.
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 01111 1234568999999999999999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.84 Aligned_cols=225 Identities=11% Similarity=0.044 Sum_probs=175.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecC--CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPE--YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV 465 (701)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+|+.++..++||||+++++++.+ ..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 468999999999999999999995 67799999987654432 568999999999999999999999854 45899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||++|++|.+++.. . ........|+.||+.||.|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 245567889999999999999999 9999999999999999999998543
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccccCccCC--
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVT-- 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ld~~~~-- 623 (701)
|++ .++.++|||||||+||+|+||++||......... . .....+.....
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~--~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-A--PAERDTAGQPIEP 225 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-E--ECCBCTTSCBCCH
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-H--HHHHHhccCCCCh
Confidence 233 3788999999999999999999999754321000 0 00000000000
Q ss_pred -CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 624 -GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 624 -~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..+...+..+.+++.+||+.||.+| ++.+++. .|.++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~-~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN-LMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH-HHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH-HHHHHh
Confidence 0112334568999999999999999 9998863 555543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=291.04 Aligned_cols=180 Identities=18% Similarity=0.150 Sum_probs=124.5
Q ss_pred eecCceeEEEEEE--CCceEEEEEeCCCCCC----------ChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceEEe
Q 005343 403 GEGGYGPVYKAQL--DHTSVAIKVLGPDISQ----------GPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 403 G~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~----------~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV~E 467 (701)
+.|++|.+..++. -+..|++|++...... ..++|.+|+++|+++ .|+||+++++++.+. .|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4445554444433 4556999999765321 124599999999999 799999999999664 489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|++||+|.++|... .+++.. +|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 323 yv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp CCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred cCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999543 345554 48999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPA 598 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~p 598 (701)
....+.+||+.|+|||++.+ .+...+|+||+|+++++|.+|..+
T Consensus 394 ------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 ------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 12356789999999998865 567789999999998888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=268.40 Aligned_cols=187 Identities=16% Similarity=0.175 Sum_probs=147.2
Q ss_pred eeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCC--------hHHHHHHHHHHHhCCCCcEE--EEeceecCCCceEE
Q 005343 397 SISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQG--------PRQFKQEVEILGSMRHTNMV--ILLGACPEYGCLVY 466 (701)
Q Consensus 397 ~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~--------~~~~~~Ei~il~~l~HpnIv--~l~g~~~~~~~lV~ 466 (701)
...+.||+|+||.||+|...+..+++|......... .+.+.+|+++|++++||||+ .+++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446789999999999998889999999876543222 23479999999999999999 77777777889999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.. +..|+.|++.||.|||+.+ |+||||||+|||++. .+||+|||+++.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4579999999999999999 999999999999998 9999999999987442
Q ss_pred CCccccc-ccccccccCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 005343 547 AADTITQ-YHMTTAAGTFCYIDPEYQQT--GMLGVKSDLYSLGVVLLQLITARPAM 599 (701)
Q Consensus 547 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDvwSlGvil~elltG~~pf 599 (701)
....... ......+||+.|+|||++.. ..|+..+|+||..+-.++.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1111000 01246789999999999887 56888899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=216.75 Aligned_cols=147 Identities=15% Similarity=0.078 Sum_probs=116.5
Q ss_pred HHhhcCceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC------------------ChHHHHHHHHHHHhCCCCc
Q 005343 390 EAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ------------------GPRQFKQEVEILGSMRHTN 450 (701)
Q Consensus 390 ~~~~~~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~------------------~~~~~~~Ei~il~~l~Hpn 450 (701)
......|.+.+.||+|+||.||+|.+ .++.||||+++..... ....+.+|+.+|+.++|
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-- 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-- 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--
Confidence 33445678889999999999999999 4667999999754321 13458999999999994
Q ss_pred EEEEecee-cCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC
Q 005343 451 MVILLGAC-PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN 529 (701)
Q Consensus 451 Iv~l~g~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~ 529 (701)
+.+.+++ .+..|+||||++||+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ +
T Consensus 164 -~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 -LAVPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp -SSSCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred -CCcCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 5555544 245589999999999988 411 123469999999999999999 99999999999999 9
Q ss_pred CcEEEEeeccccccCCCCCcccccccccccccCCCccCccccc
Q 005343 530 YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572 (701)
Q Consensus 530 ~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 572 (701)
+.+||+|||+|+. +..|.|||++.
T Consensus 229 ~~vkl~DFG~a~~-------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE-------------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE-------------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE-------------------CCCCCHHHHHH
Confidence 9999999999864 33478898764
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=182.54 Aligned_cols=132 Identities=11% Similarity=0.125 Sum_probs=112.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCC-----CC-CCC-----C-CCC-----------hHHHHH
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHS-----SN-PRG-----R-PAT-----------NDELQK 76 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~-----~~-~~~-----~-~~~-----------~~~~~~ 76 (701)
..++||||+|+|+.|.+|++||+.++...|++|++|||.++. .. ..+ . +.. .+..++
T Consensus 4 ~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (162)
T 1mjh_A 4 MYKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 83 (162)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHH
Confidence 458999999999999999999999999999999999999763 11 111 1 221 145567
Q ss_pred HHHHHHHHHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 77 LFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 77 ~l~~~~~~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.|+.+...+...|++++..+.. |+|+++|+++|+++++|+||||+||++++.+.|+ |||+++|+++++ |||++|.
T Consensus 84 ~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~-GSv~~~vl~~~~--~pVlvv~ 158 (162)
T 1mjh_A 84 KMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL-GSVTENVIKKSN--KPVLVVK 158 (162)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS-CHHHHHHHHHCC--SCEEEEC
T ss_pred HHHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEe-cchHHHHHHhCC--CCEEEEe
Confidence 7888888888899999988887 7999999999999999999999999999999666 999999999998 9999997
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-21 Score=180.38 Aligned_cols=132 Identities=17% Similarity=0.107 Sum_probs=113.9
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCC---------CChHHHHHHHHHHHHHHhhcCC
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRP---------ATNDELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~~~~~v 90 (701)
+.++||||+|+|+.|..|++||+.++...|+.|++|||.++........ ...+..++.++.+...+...|+
T Consensus 4 ~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 83 (146)
T 3s3t_A 4 RYTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSA 83 (146)
T ss_dssp CCCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSC
T ss_pred ccceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4589999999999999999999999999999999999998742211100 0115667788888888888999
Q ss_pred -eeeEEEEEcCChhHHHHH-HHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 -LAREVVLQDIDVSSALIY-YVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 -~~~~~v~~~~~~~~~Iv~-~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++..+.. |+|+++|++ +|++.++|+||||++|++++.+.|+ ||++++|+++++ |||++|.
T Consensus 84 ~~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 84 PNLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAV-GSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSS-CHHHHHHHHHCS--SEEEEEC
T ss_pred cceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEE-cchHHHHhccCC--CCEEEeC
Confidence 99988888 699999999 9999999999999999999999666 999999999998 9999983
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-21 Score=179.85 Aligned_cols=130 Identities=17% Similarity=0.142 Sum_probs=112.7
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCC----CCCC---------CCCChHHHHHHHHHHHHHHhh
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSS----NPRG---------RPATNDELQKLFLPYRGLFAR 87 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~----~~~~---------~~~~~~~~~~~l~~~~~~~~~ 87 (701)
.++||||+|+|+.|.+|++||+.++...++.|++|||.++.. .... .....+..++.++.+...+..
T Consensus 2 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (147)
T 3hgm_A 2 FNRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATE 81 (147)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHh
Confidence 489999999999999999999999999999999999998642 0000 011126777889999999999
Q ss_pred cCCee---eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 88 KRILA---REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 88 ~~v~~---~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
.|+.+ +..+.. |+|+++|+++|+++++|+||||++|++++.+.|+ ||++++|+++++ |||++|
T Consensus 82 ~g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 82 LGVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLL-GSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TTCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCC-CHHHHHHHHHCS--SCEEEC
T ss_pred cCCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceee-ccHHHHHHhhCC--CCEEEC
Confidence 99988 877777 7999999999999999999999999999999666 999999999998 999987
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=178.14 Aligned_cols=132 Identities=14% Similarity=0.165 Sum_probs=111.7
Q ss_pred CCCEEEEEeC--CCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCC-------hHHHHHHHHHHHHHHhhcCC
Q 005343 20 ANAITAVAID--ADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPAT-------NDELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 20 ~~~~IlVavD--~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~v 90 (701)
..++||||+| +|+.|.+|++||+.++...|+.|++|||.++.......... .+..++.++.+...+...|+
T Consensus 14 ~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 93 (156)
T 3fg9_A 14 VYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRGV 93 (156)
T ss_dssp CCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred cCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4589999999 99999999999999999999999999999875321111111 15667788888888888999
Q ss_pred -eeeEEEEEcCChhHHHHHH-HHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 -LAREVVLQDIDVSSALIYY-VKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 -~~~~~v~~~~~~~~~Iv~~-a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++..+..+|+|+++|+++ |++.++|+||||++|++++.+ |+ |||+++|+++++ |||++|.
T Consensus 94 ~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~-~~-Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 94 NQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSK-IA-GAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp SSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSS-SC-SCHHHHHHHHCS--SEEEEEC
T ss_pred CceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccce-ee-cchHHHHHHhCC--CCEEEeC
Confidence 4888888768999999999 999999999999999999975 55 999999999998 9999983
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=181.28 Aligned_cols=132 Identities=14% Similarity=0.142 Sum_probs=110.0
Q ss_pred CCCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEE--EEecCCCCCCCC--------CCChHHHHHHHHHHHHHHhhc
Q 005343 19 TANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLL--HVRNHSSNPRGR--------PATNDELQKLFLPYRGLFARK 88 (701)
Q Consensus 19 ~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~ll--HV~~~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~ 88 (701)
...++||||+|+|+.|..|++||+.++. .++.|++| ||.++.....+. ....+..++.|+.+...+...
T Consensus 15 ~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 93 (163)
T 1tq8_A 15 SAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNA 93 (163)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTT
T ss_pred ccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4458999999999999999999999999 99999999 887653210110 011245678888888888888
Q ss_pred CCe-eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 89 RIL-AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 89 ~v~-~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
|+. ++..+.. |+|+++|+++|++.++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 94 gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSva~~vl~~a~--~PVlvV~ 157 (163)
T 1tq8_A 94 GAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRRAK--VDVLIVH 157 (163)
T ss_dssp TCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHHTT--CEEEEEC
T ss_pred CCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceee-ccHHHHHHHhCC--CCEEEEe
Confidence 998 8888887 7999999999999999999999999999999666 999999999998 9999997
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=174.66 Aligned_cols=127 Identities=17% Similarity=0.235 Sum_probs=109.3
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhc-cCCCCeEEEEEEecCCCCCCCC--------CCCh-HHHHHHHHHHHHHHhhcCCe
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNL-LNETSQYVLLHVRNHSSNPRGR--------PATN-DELQKLFLPYRGLFARKRIL 91 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~-~~~g~~v~llHV~~~~~~~~~~--------~~~~-~~~~~~l~~~~~~~~~~~v~ 91 (701)
++||||+|+|+.|..|++||+.++ ...++.|++|||.++....... .... +..++.++.+...+...|++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 689999999999999999999999 9999999999999874211000 0011 45667888888899889999
Q ss_pred eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 92 AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 92 ~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
++..+.. |+|+++|+++|+ ++|+||||++|++++.+ ++ ||++++|+++++ |||++|.
T Consensus 82 ~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~-~~-Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNK-IF-ASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSS-CC-CCTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHH-Hh-CcHHHHHHhcCC--CCEEEeC
Confidence 9988888 799999999999 99999999999999998 55 999999999998 9999983
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=177.92 Aligned_cols=132 Identities=14% Similarity=0.072 Sum_probs=110.5
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCC--CC-CCC-----------CC----hHHHHHHHHHH
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSN--PR-GRP-----------AT----NDELQKLFLPY 81 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~--~~-~~~-----------~~----~~~~~~~l~~~ 81 (701)
..++||||+|+|+.|.+|++||+.++...|+.|++|||.++... .. +.+ .. .+..++.++.+
T Consensus 4 m~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 83 (170)
T 2dum_A 4 MFRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEK 83 (170)
T ss_dssp CCSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHH
T ss_pred ccceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 45899999999999999999999999999999999999976421 10 111 11 14566788888
Q ss_pred HHHHhhcCCeeeE--EEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 82 RGLFARKRILARE--VVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 82 ~~~~~~~~v~~~~--~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
...+...|+.++. .+.. |+|+++|+++|+++++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 84 ~~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~-Gsv~~~vl~~~~--~PVlvv~ 155 (170)
T 2dum_A 84 AEEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFL-GSTVMRVLRKTK--KPVLIIK 155 (170)
T ss_dssp HHHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCC-CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCcccccee-chHHHHHHHhCC--CCEEEEc
Confidence 8888888999887 7777 7999999999999999999999999999999666 999999999998 9999998
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=178.19 Aligned_cols=133 Identities=17% Similarity=0.203 Sum_probs=101.8
Q ss_pred CCCCEEEEEeCCCc---------chHHHHHHHHHhccC---CCCeEEEEEEecCCCCCC----C-CCCC----------h
Q 005343 19 TANAITAVAIDADK---------SSQYAVKWAVDNLLN---ETSQYVLLHVRNHSSNPR----G-RPAT----------N 71 (701)
Q Consensus 19 ~~~~~IlVavD~s~---------~S~~Al~wA~~~~~~---~g~~v~llHV~~~~~~~~----~-~~~~----------~ 71 (701)
...++||||||+|+ .|.+||+||+.++.+ .++.|++|||.++..... . .... .
T Consensus 3 ~~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (175)
T 2gm3_A 3 SEPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNK 82 (175)
T ss_dssp --CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHH
T ss_pred CCccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHH
Confidence 34589999999999 999999999998754 588999999986532110 0 0101 1
Q ss_pred HHHHHHHHHHHHHHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeE
Q 005343 72 DELQKLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAV 151 (701)
Q Consensus 72 ~~~~~~l~~~~~~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V 151 (701)
+..++.++.+...+...|+.++..+.. |+|+++|+++|+++++|+||||+||++++.+.|+ |||+++|+++++ |||
T Consensus 83 ~~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~-Gsva~~vl~~a~--~pV 158 (175)
T 2gm3_A 83 AKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--CPV 158 (175)
T ss_dssp HHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC---------CHHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhc-CchHHHHHhCCC--CCE
Confidence 235677888888888889999988887 7999999999999999999999999999999666 999999999998 999
Q ss_pred EEEe
Q 005343 152 YIIS 155 (701)
Q Consensus 152 ~vV~ 155 (701)
++|.
T Consensus 159 lvv~ 162 (175)
T 2gm3_A 159 MTIK 162 (175)
T ss_dssp EEEE
T ss_pred EEEc
Confidence 9998
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=173.13 Aligned_cols=128 Identities=14% Similarity=0.161 Sum_probs=102.5
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC-CCC-CC-C----hHHHHHHHHHHHHHHhhcCC-ee
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP-RGR-PA-T----NDELQKLFLPYRGLFARKRI-LA 92 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~-~~~-~~-~----~~~~~~~l~~~~~~~~~~~v-~~ 92 (701)
.++||||+|+|+.|..|++||+.++...|+.|++|||.++.... .+. +. . .+..++.|+.+. ...|+ .+
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~g~~~~ 78 (137)
T 2z08_A 2 FKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEAR---ALTGVPKE 78 (137)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHH---HHHCCCGG
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHH---HHcCCCcc
Confidence 47999999999999999999999999889999999999853211 111 10 0 133444454443 33788 88
Q ss_pred eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 93 REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 93 ~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+..+.. |+|+++|+++|+++++|+||||++|++++.+.++ ||++++|+++++ |||++|.
T Consensus 79 ~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 79 DALLLE-GVPAEAILQAARAEKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp GEEEEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSS-CHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhh-ccHHHHHHhcCC--CCEEEeC
Confidence 888777 7999999999999999999999999999999666 999999999998 9999983
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=178.40 Aligned_cols=131 Identities=11% Similarity=0.091 Sum_probs=112.7
Q ss_pred CCCEEEEEeCC-CcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEE-E
Q 005343 20 ANAITAVAIDA-DKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVV-L 97 (701)
Q Consensus 20 ~~~~IlVavD~-s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v-~ 97 (701)
..++||||+|+ |+.|..|++||+.++...++.|++|||.++.... .....+..++.++.+...+...|+.++..+ +
T Consensus 23 m~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~v 100 (155)
T 3dlo_A 23 IYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGRT--KDEDIIEAKETLSWAVSIIRKEGAEGEEHLLV 100 (155)
T ss_dssp CCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTTS--CHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred ccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcc--cHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 45899999999 9999999999999999999999999999863211 111225677888999999999999888643 4
Q ss_pred EcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 98 QDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 98 ~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
..|+|+++|+++|++.++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 101 ~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 101 RGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIF-GSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp SSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEEC-CHHHHHHHHHCS--SCEEEEC
T ss_pred cCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEe-ccHHHHHHHhCC--CCEEEeC
Confidence 568999999999999999999999999999999666 999999999998 9999984
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.7e-20 Score=171.47 Aligned_cols=130 Identities=17% Similarity=0.119 Sum_probs=96.3
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCC----CCCC-C-----CChHHHHHHHHHHHHHHhhcCC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSN----PRGR-P-----ATNDELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~----~~~~-~-----~~~~~~~~~l~~~~~~~~~~~v 90 (701)
.++||||+|+|+.|..|++||+.++...++.|++|||.++... ..+. + ...+..++..+.+..++.+.|+
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 85 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTLGI 85 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 5899999999999999999999999999999999999987421 1111 1 1112223334444555666688
Q ss_pred e-eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 L-AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 ~-~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
. ++..+.. |+|+++|+++|+++++|+||||++|++++. .++ ||++++|+++++ |||++|.
T Consensus 86 ~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~~~-Gs~~~~vl~~~~--~pVlvv~ 146 (150)
T 3tnj_A 86 DPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLA-LLL-GSTANSVLHYAK--CDVLAVR 146 (150)
T ss_dssp CGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC---------C-CCHHHHHHHHCS--SEEEEEE
T ss_pred CcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcC-eEe-cchHHHHHHhCC--CCEEEEe
Confidence 7 4666666 799999999999999999999999999998 666 999999999998 9999997
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7e-20 Score=170.54 Aligned_cols=129 Identities=10% Similarity=0.089 Sum_probs=105.8
Q ss_pred CEEEEEeCCCcc--hHHHHHHHHHhccCCCCeEEEEEEecCCCCCC----CC----CCChHHHHHHHHHHHHHHhhcCC-
Q 005343 22 AITAVAIDADKS--SQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR----GR----PATNDELQKLFLPYRGLFARKRI- 90 (701)
Q Consensus 22 ~~IlVavD~s~~--S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~----~~----~~~~~~~~~~l~~~~~~~~~~~v- 90 (701)
++||||+|+|+. |..|++||+.++...|+.|++|||.++..... .. ....+..++.++.++.++.+.++
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 799999999999 99999999999999999999999998742111 11 11224556677778888877764
Q ss_pred --eeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 --LAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 --~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++..+.. |+|+++|+++|+++++|+||||+|| +++.+.|+ |||+++|+++++ |||++|.
T Consensus 82 ~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~-Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 82 EDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHR-PDITTYLL-GSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp GGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSS-CHHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeee-ccHHHHHHHhCC--CCEEEeC
Confidence 46777777 7999999999999999999999996 88888666 999999999998 9999983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5e-20 Score=189.98 Aligned_cols=136 Identities=18% Similarity=0.135 Sum_probs=106.4
Q ss_pred CceeeeeeeecCceeEEEEEE--CCce--EEEEEeCCCCCCC------------------------hHHHHHHHHHHHhC
Q 005343 395 YFSISRKIGEGGYGPVYKAQL--DHTS--VAIKVLGPDISQG------------------------PRQFKQEVEILGSM 446 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~--~~~~--vAiK~l~~~~~~~------------------------~~~~~~Ei~il~~l 446 (701)
.|.+.+.||+|+||.||+|.+ .++. ||||+++...... ...+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998 7888 9999976542111 12578999999999
Q ss_pred CCCcEE--EEeceecCCCceEEeecCC-C----ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh-hcCCCCeeecC
Q 005343 447 RHTNMV--ILLGACPEYGCLVYEYMEN-G----SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH-QNKPEPLVHRD 518 (701)
Q Consensus 447 ~HpnIv--~l~g~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiHrD 518 (701)
.|+++. .+++ ....+|||||+.+ | +|.+.... .++.....++.|++.||.||| +.+ |||||
T Consensus 128 ~~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HHTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred HhCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 877542 2332 2467899999942 4 66665422 234566789999999999999 888 99999
Q ss_pred CCCCCeeEcCCCcEEEEeecccccc
Q 005343 519 LKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 519 LKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 8999999999764
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=160.01 Aligned_cols=125 Identities=17% Similarity=0.180 Sum_probs=99.3
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecC-CCCCCCCC---------CChHHHHHHHHHHHHHHhhcCC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNH-SSNPRGRP---------ATNDELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~-~~~~~~~~---------~~~~~~~~~l~~~~~~~~~~~v 90 (701)
.++||||+|+|+.|..|++||+.++...|+.|++|||.++ +....+.. ...+..++.|+. ++...|+
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~ 78 (141)
T 1jmv_A 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLD---LAESVDY 78 (141)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHH---HHHHSSS
T ss_pred CceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHH---HHHHcCC
Confidence 4799999999999999999999999988999999999954 21111110 011333444443 4555688
Q ss_pred ee-eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 LA-REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 ~~-~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.+ +..+.. |+|+++|+++|+++++|+||||++ ++++.+ + ||++++|+++++ |||++|.
T Consensus 79 ~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~--l-gs~~~~vl~~~~--~pVlvv~ 137 (141)
T 1jmv_A 79 PISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK--L-MSSTRQVMNTIK--IDMLVVP 137 (141)
T ss_dssp CCCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH--H-HHHHHHHHTTCC--SEEEEEE
T ss_pred CceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh--h-cchHHHHHhcCC--CCEEEee
Confidence 76 455555 899999999999999999999999 999888 4 899999999998 9999997
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=170.85 Aligned_cols=132 Identities=10% Similarity=0.020 Sum_probs=103.1
Q ss_pred CCCEEEEEeCCCcc-------hHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCC---hHHHHHHHHHHHHHHhhcC
Q 005343 20 ANAITAVAIDADKS-------SQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPAT---NDELQKLFLPYRGLFARKR 89 (701)
Q Consensus 20 ~~~~IlVavD~s~~-------S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~ 89 (701)
..++||||+|+|+. |.+|++||+.++...++.|++|||.++.......+.. .+..++..+.+..++.+.|
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~g 212 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSADPTFQLSETIEARYREACRTFQAEYG 212 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC---------CHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccccCchhHHHHHHHHHHHHHHHHHHHHcC
Confidence 56899999999998 9999999999999999999999999874221111110 1112223344444566668
Q ss_pred Ce-eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 90 IL-AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 90 v~-~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+. ++..+.. |+|+++|+++|+++++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 213 ~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~-Gsv~~~vl~~~~--~pVLvv~ 275 (290)
T 3mt0_A 213 FSDEQLHIEE-GPADVLIPRTAQKLDAVVTVIGTVARTGLSGALI-GNTAEVVLDTLE--SDVLVLK 275 (290)
T ss_dssp CCTTTEEEEE-SCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCS-CHHHHHHHTTCS--SEEEEEC
T ss_pred CCcceEEEec-cCHHHHHHHHHHhcCCCEEEECCCCCcCCcceec-chHHHHHHhcCC--CCEEEEC
Confidence 85 5566666 7999999999999999999999999999999666 999999999998 9999997
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=151.30 Aligned_cols=120 Identities=13% Similarity=0.072 Sum_probs=96.6
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEe-cC-C--C--CCCCCCC-C------hHHHHHHHHHHHHHH-
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVR-NH-S--S--NPRGRPA-T------NDELQKLFLPYRGLF- 85 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~-~~-~--~--~~~~~~~-~------~~~~~~~l~~~~~~~- 85 (701)
..++||||+|+|+.|..|++||+.++...|+.|++|||. +. + . ...+.+. . .+..++.|+.+ ..+
T Consensus 3 ~~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~ 81 (138)
T 1q77_A 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKL 81 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHH
T ss_pred cccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHh
Confidence 357999999999999999999999999999999999999 63 1 1 0001111 1 13456677777 653
Q ss_pred -hhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 86 -ARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 86 -~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
...| .++..+.. |+|+++|+++|+++++|+||||+||+ ||+++|+++++ |||++|
T Consensus 82 ~~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~----------sv~~~vl~~a~--~PVlvv 137 (138)
T 1q77_A 82 TGSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS----------AYLCKVIDGLN--LASLIV 137 (138)
T ss_dssp HSCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG----------GGTHHHHHHSS--SEEEEC
T ss_pred hccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC----------chHHHHHHhCC--CceEee
Confidence 4556 77777766 89999999999999999999999986 99999999998 999997
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=171.88 Aligned_cols=128 Identities=12% Similarity=-0.017 Sum_probs=108.2
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC----CCCC---CC------------hHHHHHHHHHHH
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP----RGRP---AT------------NDELQKLFLPYR 82 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~----~~~~---~~------------~~~~~~~l~~~~ 82 (701)
++||||+|+|+.|..|++||+.++...|+.|+++||.++.... .+.. .. .+..++.++.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999899999999998753110 0111 00 144567888888
Q ss_pred HHHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCC-cccccccCCCcchhhcccCCCceeEEEEe
Q 005343 83 GLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRN-LLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 83 ~~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~-~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
..+...|+.++..+.. |+|+++|+++ +.++|+||||++|++ ++.+.++ ||++++|+++++ |||++|.
T Consensus 81 ~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~-Gs~~~~v~~~a~--~PVlvv~ 148 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGL-GSTADRVLRASP--VPVLLAP 148 (268)
T ss_dssp HHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSC-CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCcccccccc-chhHHHHHHhCC--CCEEEEC
Confidence 8888899999988887 7999999999 889999999999999 9998666 999999999998 9999997
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.2e-17 Score=170.46 Aligned_cols=132 Identities=14% Similarity=0.074 Sum_probs=110.0
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCC-----------hHHHHHHHHHHHHHHhhcC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPAT-----------NDELQKLFLPYRGLFARKR 89 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~ 89 (701)
.++||||+|+|+.|..|++||+.++...|+.|++|||.++.+........ .+..++.++.+...+...|
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 86 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAG 86 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 48999999999999999999999999999999999998753211111110 1344567777777778889
Q ss_pred CeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 90 ILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 90 v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+.++..+...|++.++|+++|++.++|+||||++|++++.+.++ ||++.+|+++++ |||++|.
T Consensus 87 v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~ 149 (319)
T 3olq_A 87 IQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIF-TPLDWQLLRKCP--APVWMVK 149 (319)
T ss_dssp CCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBC-CHHHHHHHHHCS--SCEEEEE
T ss_pred CeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccc-cccHHHHHhcCC--CCEEEec
Confidence 99999988458999999999999999999999999999999666 999999999998 9999998
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=8e-17 Score=170.11 Aligned_cols=137 Identities=19% Similarity=0.201 Sum_probs=109.7
Q ss_pred CcccccCCCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC-CCCCCC-------hHHHHHHHHHHHHH
Q 005343 13 SSANAITANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP-RGRPAT-------NDELQKLFLPYRGL 84 (701)
Q Consensus 13 ~~~~~~~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~-~~~~~~-------~~~~~~~l~~~~~~ 84 (701)
++.......++||||+|+|+.|..|++||+.++...|+.|++|||.++.... ...... .+..++.++.+...
T Consensus 11 ~~~~~~~~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 90 (309)
T 3cis_A 11 GSMSSGNSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKV 90 (309)
T ss_dssp -------CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHH
Confidence 3334445669999999999999999999999999999999999999753211 111111 14556778888888
Q ss_pred Hhhc-----CCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 85 FARK-----RILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 85 ~~~~-----~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+... |+.++..+.. |+++++|+++|+ ++|+||||++|++++.+.|+ ||++++|+++++ |||++|.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~ 160 (309)
T 3cis_A 91 VEQASLRAGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLL-GSVSSGLLRHAH--CPVVIIH 160 (309)
T ss_dssp HHHHCSSSCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCS-CHHHHHHHHHCS--SCEEEEC
T ss_pred HHHhcccCCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCcccccccc-CcHHHHHHHhCC--CCEEEEc
Confidence 8776 8999988877 799999999996 79999999999999999666 999999999998 9999998
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.3e-17 Score=168.41 Aligned_cols=121 Identities=17% Similarity=0.090 Sum_probs=109.1
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcC
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQDI 100 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~ 100 (701)
.++||||+|+|+.|..|++||+.++...|+.|+++||.++ +..++.++.+...+...|+.++..+..+|
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~-----------~~~~~~l~~~~~~~~~~~~~~~~~~~~~g 75 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR-----------RDHSAALNDLAQELREEGYSVSTNQAWKD 75 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS-----------SCCHHHHHHHHHHHHHTTCCEEEEEECSS
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc-----------HHHHHHHHHHHHHHhhCCCeEEEEEEeCC
Confidence 5899999999999999999999999999999999999873 23445666666677788999999988778
Q ss_pred ChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 101 DVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 101 ~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
++.++|+++|++.++|+||||++|++++.+.++ ||++.+|+++++ |||++|.
T Consensus 76 ~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~-gs~~~~vl~~~~--~PVlvv~ 127 (290)
T 3mt0_A 76 SLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAIL-TPDDWKLLRFAP--CPVLMTK 127 (290)
T ss_dssp SHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSC-CHHHHHHHHHCS--SCEEEEC
T ss_pred CHHHHHHHHHHhcCCCEEEEecccCCchhhccc-CHHHHHHHhcCC--CCEEEec
Confidence 999999999999999999999999999999666 999999999998 9999997
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.66 E-value=9e-17 Score=168.41 Aligned_cols=131 Identities=12% Similarity=0.102 Sum_probs=112.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCC---CCCCCC------hHHHHHHHHHHHHHHhhcCC
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNP---RGRPAT------NDELQKLFLPYRGLFARKRI 90 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~---~~~~~~------~~~~~~~l~~~~~~~~~~~v 90 (701)
+.++||||+|+|+.|..|++||+.++...++.|++|||.++.... .+.... .+..++.++.+...+...|+
T Consensus 21 m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 100 (294)
T 3loq_A 21 QSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGI 100 (294)
T ss_dssp TTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 458999999999999999999999999999999999999875321 111111 15667888999999999999
Q ss_pred eeeE-EEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 91 LARE-VVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 91 ~~~~-~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++. .+...|+|+++| +|++.++|+||||++|++++.+.++ ||++.+|+++++ |||++|.
T Consensus 101 ~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~ 161 (294)
T 3loq_A 101 KAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILL-GSVSEGVLHDSK--VPVYIFK 161 (294)
T ss_dssp EEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHH-CCHHHHHHHHCS--SCEEEEC
T ss_pred CcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceee-ccHHHHHHhcCC--CCEEEec
Confidence 9998 677238999999 9999999999999999999999777 999999999998 9999998
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-16 Score=165.80 Aligned_cols=122 Identities=12% Similarity=0.110 Sum_probs=109.6
Q ss_pred CCCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEE
Q 005343 19 TANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQ 98 (701)
Q Consensus 19 ~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~ 98 (701)
...++|+||+|+|+.|.+|++||+.++...++.|++|||.++.. .++.++.+...+.+.|++++..+..
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~-----------~~~~l~~~~~~l~~~~~~~~~~~~~ 236 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD-----------KTADLRVMEEVIGAEGIEVHVHIES 236 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC-----------CHHHHHHHHHHHHHTTCCEEEEEEC
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch-----------HHHHHHHHHHHHHHcCCcEEEEEec
Confidence 45589999999999999999999999988899999999998621 3456777777788889998887777
Q ss_pred cCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 99 DIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 99 ~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
|+++++|+++|++.++|+||||++|++++.+.|+ ||++++|+++++ |||++|.
T Consensus 237 -g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pvLvv~ 289 (294)
T 3loq_A 237 -GTPHKAILAKREEINATTIFMGSRGAGSVMTMIL-GSTSESVIRRSP--VPVFVCK 289 (294)
T ss_dssp -SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHH-HCHHHHHHHHCS--SCEEEEC
T ss_pred -CCHHHHHHHHHHhcCcCEEEEeCCCCCCccceee-CcHHHHHHhcCC--CCEEEEC
Confidence 7999999999999999999999999999999777 999999999998 9999997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=172.71 Aligned_cols=136 Identities=13% Similarity=0.140 Sum_probs=98.4
Q ss_pred CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC--------------ChHH--------HHHHHHHHHhCCCCcE
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ--------------GPRQ--------FKQEVEILGSMRHTNM 451 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~--------------~~~~--------~~~Ei~il~~l~HpnI 451 (701)
-|.+...||.|+||.||+|.. +++.||||+++..... .... ..+|...|.++.++++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 499999999999999999997 6778999998653210 0111 2346666666644433
Q ss_pred EEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-
Q 005343 452 VILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY- 530 (701)
Q Consensus 452 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~- 530 (701)
....-+.....+|||||++|++|..+.. . .....++.||+.+|.|||+.| ||||||||.|||++.++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 2111111234589999999988865431 1 123468899999999999999 99999999999998776
Q ss_pred ---------cEEEEeeccccc
Q 005343 531 ---------VSKISDVGLARL 542 (701)
Q Consensus 531 ---------~~KL~DFGla~~ 542 (701)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 388999997754
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.2e-16 Score=163.86 Aligned_cols=129 Identities=15% Similarity=0.157 Sum_probs=104.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCC-C-h---HHHHHHHHHHHHHHhh--cCCee
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPA-T-N---DELQKLFLPYRGLFAR--KRILA 92 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~-~-~---~~~~~~l~~~~~~~~~--~~v~~ 92 (701)
..++||||+|+|+.|..||+||+.++...++.|++|||.++.... .... . . +..++.++.+...+.. .|+.+
T Consensus 170 ~~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 248 (309)
T 3cis_A 170 QQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVS-EWPGIDWPATQSMAEQVLAERLAGWQERYPNVAI 248 (309)
T ss_dssp CCCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCT-TCSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCE
T ss_pred CCCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeeccccc-CCCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcE
Confidence 457999999999999999999999999889999999998763211 1111 1 1 3344455554444433 58888
Q ss_pred eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 93 REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 93 ~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
+..+.. |+|+++|+++|+ ++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 249 ~~~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~-Gsv~~~vl~~~~--~pVlvv~ 305 (309)
T 3cis_A 249 TRVVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLV-GSVGETVAQLAR--TPVIVAR 305 (309)
T ss_dssp EEEEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSS-CHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCcccccc-CcHHHHHHhcCC--CCEEEeC
Confidence 888776 799999999997 89999999999999999666 999999999998 9999996
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.1e-16 Score=165.03 Aligned_cols=132 Identities=14% Similarity=0.089 Sum_probs=104.5
Q ss_pred CCCEEEEEeCCCc-------chHHHHHHHHHhccCC--CCeEEEEEEecCCCCCCC--CCC-C-h----HHHHHHHHHHH
Q 005343 20 ANAITAVAIDADK-------SSQYAVKWAVDNLLNE--TSQYVLLHVRNHSSNPRG--RPA-T-N----DELQKLFLPYR 82 (701)
Q Consensus 20 ~~~~IlVavD~s~-------~S~~Al~wA~~~~~~~--g~~v~llHV~~~~~~~~~--~~~-~-~----~~~~~~l~~~~ 82 (701)
..++||||+|+|+ .|.+|++||+.++... ++.|++|||.++...... .+. . . +..++..+.+.
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMK 234 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHH
Confidence 4689999999998 5799999999999887 999999999987532211 111 1 1 11223344455
Q ss_pred HHHhhcCCe-eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 83 GLFARKRIL-AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 83 ~~~~~~~v~-~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++.+.|+. ++..+.. |+|+++|+++|+++++|+||||++|++++.+.|+ |||+++|+++++ |||++|.
T Consensus 235 ~~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~-Gsv~~~vl~~~~--~pVLvv~ 304 (319)
T 3olq_A 235 ELRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFL-GNTAEQLIDHIK--CDLLAIK 304 (319)
T ss_dssp HHHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHH-HHHHHHHHTTCC--SEEEEEC
T ss_pred HHHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCccccc-cHHHHHHHhhCC--CCEEEEC
Confidence 556677764 4556666 7999999999999999999999999999999777 999999999998 9999997
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=148.22 Aligned_cols=116 Identities=13% Similarity=0.054 Sum_probs=101.6
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEc
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQD 99 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~ 99 (701)
..++|+||+|+|+.|.+|++||..++...++.|+++||.++. +..++.++.+...+...|+.++..+..
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~----------~~~~~~l~~~~~~l~~~~~~~~~~~~~- 221 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP----------ARAEAWALEAEAYLRDHGVEASALVLG- 221 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH----------HHHHHHHHHHHHHHHHTTCCEEEEEEC-
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH----------HHHHHHHHHHHHHHHHcCCceEEEEeC-
Confidence 457999999999999999999999988889999999998751 355667788888888889999887776
Q ss_pred CChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 100 IDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 100 ~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
|+|+++|+++|+++ |+||||+ ++.+.|+ |||+++|+++++ |||++|.
T Consensus 222 g~~~~~i~~~a~~~--dliV~G~----~~~~~~~-Gs~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 222 GDAADHLLRLQGPG--DLLALGA----PVRRLVF-GSTAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp SCHHHHHHHHCCTT--EEEEEEC----CCSCCSS-CCHHHHHHHHCS--SCEEEEC
T ss_pred CChHHHHHHHHHhC--CEEEECC----cccccEe-ccHHHHHHhcCC--CCEEEeC
Confidence 79999999999998 9999999 5667555 999999999998 9999983
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.5e-12 Score=128.74 Aligned_cols=143 Identities=14% Similarity=0.105 Sum_probs=110.3
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecCC--CceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
..+.|.+...+|.|+++.||++...+..+++|+...........+.+|+.++..+. +.++..+++++.+. .++||||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred HhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 44678888999999999999998888889999987532233446899999999884 55666777766443 4799999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK-------------------------------------- 510 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 510 (701)
++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999987631 11223468899999999999821
Q ss_pred ------------------CCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 511 ------------------PEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 511 ------------------~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+..++|+|++|.|||++.++.+.|+||+.+.+
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 12389999999999998877778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.2e-10 Score=121.84 Aligned_cols=141 Identities=15% Similarity=0.242 Sum_probs=106.4
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeC--CCCC-CChHHHHHHHHHHHhCC--CCcEEEEeceecCC-----CceEEe
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLG--PDIS-QGPRQFKQEVEILGSMR--HTNMVILLGACPEY-----GCLVYE 467 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~--~~~~-~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~-----~~lV~E 467 (701)
..+.|+.|.++.||+....+..+++|+.. .... .....+.+|+.+++.+. +.++.++++++.+. .++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 46789999999999999888889999875 3221 22346889999999987 34566777777554 579999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK------------------------------------- 510 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------- 510 (701)
|++|..+.+.. ...++...+..++.+++..|..||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998775422 234678888899999999999999831
Q ss_pred ------------------CCCeeecCCCCCCeeEcCCC--cEEEEeecccccc
Q 005343 511 ------------------PEPLVHRDLKPANILLDQNY--VSKISDVGLARLV 543 (701)
Q Consensus 511 ------------------~~~iiHrDLKp~NILl~~~~--~~KL~DFGla~~~ 543 (701)
+..++|+|++|.|||++.++ .+.|.||+++.+-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 23599999999999998764 3689999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=2.1e-10 Score=116.52 Aligned_cols=136 Identities=15% Similarity=0.116 Sum_probs=97.3
Q ss_pred hcCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE--EEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM--VILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~--~~~lV~E 467 (701)
...|.+....+.|.++.||++... +..+++|+.... ....+.+|+.+++.+.+.++ ..+++++.+ ..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 345665444445666999999764 456999997654 23457899999998865444 346666544 3489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK------------------------------------- 510 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------- 510 (701)
|++|.+|. .. ... ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cC------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998873 21 111 2257788888888888753
Q ss_pred ------------------CCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 511 ------------------PEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 511 ------------------~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+..++|+|++|.|||++.++.+.|+|||.+.+
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998887778999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.1e-10 Score=119.09 Aligned_cols=181 Identities=18% Similarity=0.180 Sum_probs=120.9
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCc--EEEEeceecC-----CCceEEeecC
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTN--MVILLGACPE-----YGCLVYEYME 470 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~-----~~~lV~Ey~~ 470 (701)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..+|..+. +.. +..+++.... ..++||+|++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4569999999999864 56899986432 23456899999998873 322 2223333221 2378999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK---------------------------------------- 510 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 510 (701)
|.+|.+... ..++...+..++.+++..|..||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865432 23677778888999999999998621
Q ss_pred ---------------CCCeeecCCCCCCeeEcC--CCcEEEEeeccccccCCCCCcccccccccccccCCCc---cCccc
Q 005343 511 ---------------PEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY---IDPEY 570 (701)
Q Consensus 511 ---------------~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y---~aPE~ 570 (701)
+..++|+|++|.||+++. +..+.|+||+.+...++.. + ......+ ..|+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D---------l~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D---------FISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H---------HHTTCCTTTSCCHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H---------HHHHHhhccccCHHH
Confidence 124799999999999998 5678999999987653321 0 0001111 22221
Q ss_pred cc----C-CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 005343 571 QQ----T-GML---------GVKSDLYSLGVVLLQLITARPAM 599 (701)
Q Consensus 571 ~~----~-~~~---------~~~sDvwSlGvil~elltG~~pf 599 (701)
.. . +.. ....+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 10 0 111 12368999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.9e-06 Score=90.42 Aligned_cols=135 Identities=17% Similarity=0.193 Sum_probs=92.3
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC---cEEEEecee---cCCCceEEeecCCC
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT---NMVILLGAC---PEYGCLVYEYMENG 472 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~---~~~~~lV~Ey~~~g 472 (701)
...++.|....||+. +..+++|+-.. ......+.+|..+|..+.+. .+...+.++ ....++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888888999988 67789998532 12345689999999998642 122333333 22358999999998
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK------------------------------------------ 510 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------------ 510 (701)
.|.+... ..++...+..++.+++..|..||+..
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8866321 12345555666666666666666432
Q ss_pred ---------------CCCeeecCCCCCCeeEcC----CCcEEEEeecccccc
Q 005343 511 ---------------PEPLVHRDLKPANILLDQ----NYVSKISDVGLARLV 543 (701)
Q Consensus 511 ---------------~~~iiHrDLKp~NILl~~----~~~~KL~DFGla~~~ 543 (701)
+..++|+|++|.|||++. +..+.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 224699999999999987 444589999988754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.6e-06 Score=92.66 Aligned_cols=79 Identities=8% Similarity=0.047 Sum_probs=52.8
Q ss_pred eeeee-eecCceeEEEEEEC--------CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCC---CcEEEEeceecCC-
Q 005343 398 ISRKI-GEGGYGPVYKAQLD--------HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRH---TNMVILLGACPEY- 461 (701)
Q Consensus 398 ~~~~I-G~G~fg~Vyk~~~~--------~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~- 461 (701)
..+.| +.|..+.+|+.... +..+++|+..... ......+.+|+.+|+.+.. ..+.++++++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 78888999998765 5678999865432 1112457888888887742 2344566665433
Q ss_pred ----CceEEeecCCCChhh
Q 005343 462 ----GCLVYEYMENGSLED 476 (701)
Q Consensus 462 ----~~lV~Ey~~~gsL~~ 476 (701)
.++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 479999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5e-06 Score=90.27 Aligned_cols=74 Identities=16% Similarity=0.128 Sum_probs=51.1
Q ss_pred eeeeeecCceeEEEEEE--CCceEEEEEeCCCCC-------CChHHHHHHHHHHHhCCC--Cc-EEEEeceecCCCceEE
Q 005343 399 SRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDIS-------QGPRQFKQEVEILGSMRH--TN-MVILLGACPEYGCLVY 466 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~-------~~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~lV~ 466 (701)
.+.||.|.++.||++.. .+..++||....... .....+..|.++|..+.. |. +..++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 56899999999999965 456799998654321 223457889999987732 33 3355555666778999
Q ss_pred eecCCC
Q 005343 467 EYMENG 472 (701)
Q Consensus 467 Ey~~~g 472 (701)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=1.4e-05 Score=84.17 Aligned_cols=140 Identities=17% Similarity=0.200 Sum_probs=81.1
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-----CCcEEEEe-c----eecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-----HTNMVILL-G----ACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-g----~~~~~~~lV~Ey 468 (701)
...|+.|..+.||+....+..+++|+.... ...+..|+.++..|. .|.++... | ...+..++||+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 345666778999999887777999998752 344555666665542 34444311 1 123345799999
Q ss_pred cCCCChh--------------hHhccc-CCC--C--------CCChHHHH------------------------------
Q 005343 469 MENGSLE--------------DRLFQK-DNS--P--------PIHWSIRF------------------------------ 493 (701)
Q Consensus 469 ~~~gsL~--------------~~l~~~-~~~--~--------~l~~~~~~------------------------------ 493 (701)
++|..+. ..++.. ... + ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111111 000 0 01222110
Q ss_pred -HHHHHHHHHHHHHhh----------cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 494 -KIAAEIATALLFLHQ----------NKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 494 -~i~~qia~aL~~LH~----------~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
.+...+..++.+|+. ..+..++|+|+.|.|||++.++.+.|+||+.+.+
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345666663 1234599999999999998888899999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.2e-05 Score=80.03 Aligned_cols=132 Identities=16% Similarity=0.127 Sum_probs=89.5
Q ss_pred eeeecCce-eEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCC-CcEEEEecee--cCCCceEEeecCCCCh
Q 005343 401 KIGEGGYG-PVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH-TNMVILLGAC--PEYGCLVYEYMENGSL 474 (701)
Q Consensus 401 ~IG~G~fg-~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~--~~~~~lV~Ey~~~gsL 474 (701)
.+..|..| .||+.... +..+++|+-... ....+.+|..+|+.+.. -.+-.+++++ .+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987663 456899986432 34568899999988742 1233445554 3445899999999888
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP------------------------------------------- 511 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------------------------------------------- 511 (701)
.+.... .......++.+++..|.-||...+
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765422 112334566677777777775321
Q ss_pred ------------CCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 512 ------------EPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 512 ------------~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
..++|+|+.|.|||++.++.+-|+||+.+.+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999888778999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=4.2e-05 Score=83.70 Aligned_cols=77 Identities=14% Similarity=0.201 Sum_probs=48.6
Q ss_pred CCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCccccccccccccc--CCCccCcccccCCC---CCchhhHHHH
Q 005343 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG--TFCYIDPEYQQTGM---LGVKSDLYSL 585 (701)
Q Consensus 511 ~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~---~~~~sDvwSl 585 (701)
+..++|+|++|.|||++.++ ++|.||+.+.+-++.. ......+ ...|++|+...... -....++..+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-------Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-------DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRT 302 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-------HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-------HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHH
Confidence 34599999999999999877 9999999987643211 0011111 13466666554221 1223455678
Q ss_pred HHHHHHHHhC
Q 005343 586 GVVLLQLITA 595 (701)
Q Consensus 586 Gvil~elltG 595 (701)
...+|+.+++
T Consensus 303 ~~~~~~~y~~ 312 (420)
T 2pyw_A 303 IEQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 8888887764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00017 Score=74.44 Aligned_cols=78 Identities=18% Similarity=0.198 Sum_probs=56.5
Q ss_pred CceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC---cEEEEeceecCCCceEEeecC
Q 005343 395 YFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT---NMVILLGACPEYGCLVYEYME 470 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~~~lV~Ey~~ 470 (701)
...-...+|.|..+.||+.+. +++.|.+|+...........|..|...|+.|.-- .+..+++. +..++||||++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~ 93 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVD 93 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeec
Confidence 456678899999999999998 5788999987655444456788999999887421 12233333 34589999998
Q ss_pred CCCh
Q 005343 471 NGSL 474 (701)
Q Consensus 471 ~gsL 474 (701)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00012 Score=76.22 Aligned_cols=71 Identities=14% Similarity=0.184 Sum_probs=46.9
Q ss_pred eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEeec-CCCCh
Q 005343 399 SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEYM-ENGSL 474 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey~-~~gsL 474 (701)
.+.|+.|....+|+. ..+++|+....... .-...+|+.++..+....+ .++++++.+..++++||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 678999999999998 66899987653211 1123567777766632122 345566777789999999 65444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00026 Score=74.00 Aligned_cols=159 Identities=13% Similarity=0.181 Sum_probs=88.5
Q ss_pred cccCHHHHHHhhcCcee-----eeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-----CCcE
Q 005343 382 RKYTIEEIEAATDYFSI-----SRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-----HTNM 451 (701)
Q Consensus 382 ~~~~~~ei~~~~~~f~~-----~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnI 451 (701)
...+.+++......|.+ .+.|+.|....+|+....+..+++|+.... .....+..|+.++..+. -|.+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 34445555554444543 355777888999999887778999998763 12345667888777663 2333
Q ss_pred EEEe-c----eecCCCceEEeecCCCChhh--------------HhcccC-C--CC---C---CChHHHHH---------
Q 005343 452 VILL-G----ACPEYGCLVYEYMENGSLED--------------RLFQKD-N--SP---P---IHWSIRFK--------- 494 (701)
Q Consensus 452 v~l~-g----~~~~~~~lV~Ey~~~gsL~~--------------~l~~~~-~--~~---~---l~~~~~~~--------- 494 (701)
+... | ...+..+++|+|++|..+.. .++... . .+ . ..|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3211 1 11233478999998865321 111110 0 00 0 11222110
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 495 ---IAAEIATALLFLHQN----KPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 495 ---i~~qia~aL~~LH~~----~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+...+...+.+|+.. .+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455666532 233589999999999999877678999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00037 Score=73.11 Aligned_cols=137 Identities=15% Similarity=0.208 Sum_probs=86.4
Q ss_pred eeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC---CCcEEEEeceec--CCCceEEeecCCC
Q 005343 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR---HTNMVILLGACP--EYGCLVYEYMENG 472 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~--~~~~lV~Ey~~~g 472 (701)
-.+.|+.|.+..+|+....+..+++|+.... ....+..|...|+.|. ...+..+++++. ...++||||+++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3567999999999999888888999987542 3566889999988773 234555555543 4458999999987
Q ss_pred Chhh-----------HhcccCCCC-------------------CCChHHHH---HHHH----------------HHHHHH
Q 005343 473 SLED-----------RLFQKDNSP-------------------PIHWSIRF---KIAA----------------EIATAL 503 (701)
Q Consensus 473 sL~~-----------~l~~~~~~~-------------------~l~~~~~~---~i~~----------------qia~aL 503 (701)
.+.. .|+.....+ .-+|...+ ++.. .++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 122211100 11344322 1111 122222
Q ss_pred -HHHhhc-CCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 504 -LFLHQN-KPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 504 -~~LH~~-~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
..|... .+..+||+|+.+.|++++.++ +-|.||+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 234321 233599999999999999887 8899984
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00051 Score=75.40 Aligned_cols=72 Identities=17% Similarity=0.214 Sum_probs=49.7
Q ss_pred eeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey 468 (701)
.+.|+.|....||++... +..+++|+.... .....+..|..++..+...++ .++++.+.+ .+||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEE
Confidence 467888889999999874 356999988432 122566689999888743333 355666654 489999
Q ss_pred cCCCCh
Q 005343 469 MENGSL 474 (701)
Q Consensus 469 ~~~gsL 474 (701)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0017 Score=68.24 Aligned_cols=142 Identities=11% Similarity=0.083 Sum_probs=72.8
Q ss_pred eeeeecCcee-EEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCC--CcEEEEeceecCCCceEEeecCCCChh
Q 005343 400 RKIGEGGYGP-VYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH--TNMVILLGACPEYGCLVYEYMENGSLE 475 (701)
Q Consensus 400 ~~IG~G~fg~-Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~lV~Ey~~~gsL~ 475 (701)
+.|+.|+... +|+.... +..+++|....... ..+..|+.++..+.. -.+..++.+..+.++++||++.+..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 4565555444 6677664 66777776543321 234556666665532 123344555556668999999766654
Q ss_pred hHhccc---------------------C--CCCCCChHHHH-------H-H------------HHHHHHHHHHHh---hc
Q 005343 476 DRLFQK---------------------D--NSPPIHWSIRF-------K-I------------AAEIATALLFLH---QN 509 (701)
Q Consensus 476 ~~l~~~---------------------~--~~~~l~~~~~~-------~-i------------~~qia~aL~~LH---~~ 509 (701)
+.+... . ..+.+...... . + ...+...+..|. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 333110 0 01112211100 0 0 001112222221 11
Q ss_pred CCCCeeecCCCCCCeeEcCC----CcEEEEeeccccccC
Q 005343 510 KPEPLVHRDLKPANILLDQN----YVSKISDVGLARLVP 544 (701)
Q Consensus 510 ~~~~iiHrDLKp~NILl~~~----~~~KL~DFGla~~~~ 544 (701)
.+..++|||+.+.|||++.+ +.+.|.||+.+.+-+
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 24459999999999999874 688999999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=72.28 Aligned_cols=73 Identities=16% Similarity=0.138 Sum_probs=48.9
Q ss_pred eeeeeecCceeEEEEEECC--ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEeecCCCCh
Q 005343 399 SRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEYMENGSL 474 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL 474 (701)
.+.|+.|-...+|++...+ ..+++|+........ -...+|..++..|...++ .++++.+. ..+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--NGRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TEEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--CeEEEEeeCCccC
Confidence 4678888899999999876 779999875432111 112689999988865444 35667664 3469999987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0015 Score=70.34 Aligned_cols=141 Identities=16% Similarity=0.226 Sum_probs=82.5
Q ss_pred eeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc-EEEEeceecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN-MVILLGACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~lV~Ey 468 (701)
.+.|..|-...+|++... +..+++|+.... ......+.+|..+++.|.--+ ..++++++.+ .+||||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~ 131 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQY 131 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEEC
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEE
Confidence 356777888899999874 356899985332 234566779999998774212 2345666655 399999
Q ss_pred cCCCChhhH--------------h---cccC--CCCCC--ChHHHHHHHHHHHH-------------------HHHHHh-
Q 005343 469 MENGSLEDR--------------L---FQKD--NSPPI--HWSIRFKIAAEIAT-------------------ALLFLH- 507 (701)
Q Consensus 469 ~~~gsL~~~--------------l---~~~~--~~~~l--~~~~~~~i~~qia~-------------------aL~~LH- 507 (701)
++|..|... | +.-. ...+. -|.++.++..++.. .+.+|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998554311 1 1110 01112 24455555544322 233332
Q ss_pred ---hc-CCCCeeecCCCCCCeeEcCC----CcEEEEeeccccc
Q 005343 508 ---QN-KPEPLVHRDLKPANILLDQN----YVSKISDVGLARL 542 (701)
Q Consensus 508 ---~~-~~~~iiHrDLKp~NILl~~~----~~~KL~DFGla~~ 542 (701)
.. .+..++|+|+.+.|||++.+ +.+.|+||..|.+
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 22358999999999999876 7899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0011 Score=71.03 Aligned_cols=73 Identities=19% Similarity=0.296 Sum_probs=43.6
Q ss_pred eeeeeecCceeEEEEEECC----------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEe
Q 005343 399 SRKIGEGGYGPVYKAQLDH----------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYE 467 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~----------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~E 467 (701)
...|+.|....+|+....+ ..+++|+..... ........|..++..+...++ .++++.+ ..++||+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 4567888889999998754 578888865432 111124678888877642232 2444444 3579999
Q ss_pred ecCCCCh
Q 005343 468 YMENGSL 474 (701)
Q Consensus 468 y~~~gsL 474 (701)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.41 E-value=0.021 Score=59.38 Aligned_cols=140 Identities=15% Similarity=0.124 Sum_probs=78.7
Q ss_pred eeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCc--EEEEece-------ecCCCceEEeec
Q 005343 400 RKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTN--MVILLGA-------CPEYGCLVYEYM 469 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~-------~~~~~~lV~Ey~ 469 (701)
..|+ |....||+.... +..+++|+..... .....+..|..++..+.... +..++.. .....++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 888899998764 4579999987442 24567778888887774212 2333332 112236799999
Q ss_pred CCCChhh-----------H---hccc----C--CCCCCChHHH----HHH---------------HHHHHHHHHHHhhc-
Q 005343 470 ENGSLED-----------R---LFQK----D--NSPPIHWSIR----FKI---------------AAEIATALLFLHQN- 509 (701)
Q Consensus 470 ~~gsL~~-----------~---l~~~----~--~~~~l~~~~~----~~i---------------~~qia~aL~~LH~~- 509 (701)
+|..+.. . ++.. . ..+.+.+... ..+ ...+-..+..|...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754320 0 1110 0 0111222110 000 11111223333321
Q ss_pred ---CCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 510 ---KPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 510 ---~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
.+..++|+|++|.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234489999999999999 4 7899999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.87 E-value=0.028 Score=55.21 Aligned_cols=100 Identities=17% Similarity=0.141 Sum_probs=64.5
Q ss_pred CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 472 GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH-QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
-||.+.|...+ .|+++++.+.++.|.+.+|.-+- ...+ ..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc---------
Confidence 37888886654 57999999999999999987762 1121 1223447899999999876653 1110
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR 596 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~ 596 (701)
.....+.+||.+. ...+.+.=|||||+++|.-+--.
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456888763 34567888999999999988643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.016 Score=61.09 Aligned_cols=33 Identities=27% Similarity=0.334 Sum_probs=28.7
Q ss_pred CCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 512 EPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 512 ~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
..++|+|+.|.||+++.++.+.|.||+.+.+.+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 359999999999999988889999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.066 Score=58.34 Aligned_cols=140 Identities=14% Similarity=0.231 Sum_probs=83.5
Q ss_pred eeeeeecCceeEEEEEEC---------CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLD---------HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~---------~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey 468 (701)
++.|..|-...+|+.... +..+++++..... ...-...+|..+++.+..-++ .++++.+ ..++||+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PEGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CCCEEEEE
Confidence 456777888899999886 5779999864432 111224678888877742222 2344444 35799999
Q ss_pred cCCCChhhH--------------h---ccc-------C---CCCCCChHHHHHHHHHH-------------------HHH
Q 005343 469 MENGSLEDR--------------L---FQK-------D---NSPPIHWSIRFKIAAEI-------------------ATA 502 (701)
Q Consensus 469 ~~~gsL~~~--------------l---~~~-------~---~~~~l~~~~~~~i~~qi-------------------a~a 502 (701)
++|..|... | +.. . ...+..|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 998654210 0 000 0 11122344444443322 222
Q ss_pred HHHHhh---------------------cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 503 LLFLHQ---------------------NKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 503 L~~LH~---------------------~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+.+|.. ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333331 12234899999999999 7888999999998864
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=93.39 E-value=0.54 Score=48.91 Aligned_cols=97 Identities=6% Similarity=-0.051 Sum_probs=69.3
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCe-EEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEE
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQ-YVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQ 98 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~-v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~ 98 (701)
.+.+|+||+-|-..|.-++.++.......|.. |+++||.... .....+-.+.++.+|...||++..+-+.
T Consensus 23 ~~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~---------r~~s~~~~~~v~~~a~~lgi~~~v~~~~ 93 (317)
T 1wy5_A 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHML---------RESAERDEEFCKEFAKERNMKIFVGKED 93 (317)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCS---------STHHHHHHHHHHHHHHHHTCCEEEEECC
T ss_pred CCCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCC---------CcccHHHHHHHHHHHHHcCCcEEEEEEe
Confidence 34789999999999998888777665556778 9999997531 1233445667788899999987655432
Q ss_pred --------cCChh--------HHHHHHHHHcCCCEEEEccCCC
Q 005343 99 --------DIDVS--------SALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 99 --------~~~~~--------~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
+.++- ..+.++|++.+++.|++|.|..
T Consensus 94 ~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 94 VRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp HHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred chhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 11111 2456778999999999999854
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=93.19 E-value=0.26 Score=54.22 Aligned_cols=98 Identities=12% Similarity=0.105 Sum_probs=72.0
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEc
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQD 99 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~ 99 (701)
.+.+|+||+-|...|.-+|.++.......|-.|+++||..... .....+-.+.++.+|.+.||.+..+-+..
T Consensus 17 ~~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr--------g~~s~~~~~~v~~~~~~lgi~~~v~~~~~ 88 (464)
T 3a2k_A 17 EGAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR--------GRESEEEMEFVKRFCVERRILCETAQIDV 88 (464)
T ss_dssp CSSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC--------THHHHHHHHHHHHHHHHTTCEEEEEECCC
T ss_pred CCCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC--------ccccHHHHHHHHHHHHHcCCcEEEEEech
Confidence 3468999999999999888887776666688999999975411 13344556778889999999877654431
Q ss_pred --------CCh--------hHHHHHHHHHcCCCEEEEccCCC
Q 005343 100 --------IDV--------SSALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 100 --------~~~--------~~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
.++ ...+.++|++++++.|++|.|..
T Consensus 89 ~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 89 PAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp HHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred hhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 011 14566788899999999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.36 E-value=0.33 Score=52.23 Aligned_cols=29 Identities=24% Similarity=0.355 Sum_probs=24.9
Q ss_pred eeecCCCCCCeeE------cCCCcEEEEeeccccc
Q 005343 514 LVHRDLKPANILL------DQNYVSKISDVGLARL 542 (701)
Q Consensus 514 iiHrDLKp~NILl------~~~~~~KL~DFGla~~ 542 (701)
++|+|+.+.|||+ +.+..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=89.79 E-value=0.96 Score=49.30 Aligned_cols=90 Identities=10% Similarity=0.035 Sum_probs=62.1
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCC-eeeEEEE--
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRI-LAREVVL-- 97 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v-~~~~~v~-- 97 (701)
.++|+||+-|-..|.-++.|+.+. |..|+.+|+..... . .+-++.++.+|.+.|+ ++..+=+
T Consensus 10 ~~KVvVA~SGGlDSSvll~~L~e~----G~eViavtvd~Gq~-----~------~~ele~a~~~A~~lGi~~~~vvD~~e 74 (455)
T 1k92_A 10 GQRIGIAFSGGLDTSAALLWMRQK----GAVPYAYTANLGQP-----D------EEDYDAIPRRAMEYGAENARLIDCRK 74 (455)
T ss_dssp TSEEEEECCSSHHHHHHHHHHHHT----TCEEEEEEEECCCT-----T------CSCTTHHHHHHHHHTCSEEEEEECHH
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEEcCCC-----C------HHHHHHHHHHHHHhCCCeEEEEeChH
Confidence 479999999999999999999773 78999999975410 0 0113445555666665 3332211
Q ss_pred ------------------EcC------C------hhHHHHHHHHHcCCCEEEEccCCC
Q 005343 98 ------------------QDI------D------VSSALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 98 ------------------~~~------~------~~~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
++. . +.+.++++|++.++|.|+.|++++
T Consensus 75 ef~~~v~p~i~~na~y~~eg~rcY~l~t~~aRp~i~~~l~e~A~e~Gad~IAtGht~k 132 (455)
T 1k92_A 75 QLVAEGIAAIQCGAFHNTTGGLTYFNTTPLGRAVTGTMLVAAMKEDGVNIWGDGSTYK 132 (455)
T ss_dssp HHHHHHHHHHHHTCCCCEETTEECCCHHHHHHHHHHHHHHHHHHHTTCCEEECCCCTT
T ss_pred HHHHHhHHHHHcCCcccccCceecccCCcchHHHHHHHHHHHHHHcCCCEEEECCcCC
Confidence 211 1 146789999999999999999864
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=84.59 E-value=1.4 Score=47.82 Aligned_cols=95 Identities=9% Similarity=0.000 Sum_probs=62.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccC-CCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEE
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLN-ETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQ 98 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~-~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~ 98 (701)
.+.+|+||+-|...|.-++.++.+.... .|-.|+++||.... . ...++-.+.++.+|.+.||.+..+-+.
T Consensus 12 ~~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhgl------r---~~s~~~~~~v~~~~~~lgi~~~v~~~~ 82 (433)
T 1ni5_A 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGL------S---ANADAWVTHCENVCQQWQVPLVVERVQ 82 (433)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSC------C---SSHHHHHHHHHHHHHHTTCCEEEECCC
T ss_pred CCCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCC------C---cccHHHHHHHHHHHHHcCCcEEEEEec
Confidence 3578999999999999888877766555 68899999997531 1 123334566788899999987655443
Q ss_pred c----CCh---h-----HHHHHHHHHcCCCEEEEccCCC
Q 005343 99 D----IDV---S-----SALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 99 ~----~~~---~-----~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
. .++ + ..+.++|+ +++.|++|.|..
T Consensus 83 ~~~~~~~~e~~aR~~Ry~~l~~~a~--~~~~i~tgH~~d 119 (433)
T 1ni5_A 83 LAQEGLGIEAQARQARYQAFARTLL--PGEVLVTAQHLD 119 (433)
T ss_dssp CCCSSSTTTTHHHHHHHHHHHHTCC--TTEEEECCCCHH
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHh--hCCeEEeeccch
Confidence 1 111 1 11112222 478899988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.28 E-value=1.6 Score=42.57 Aligned_cols=116 Identities=9% Similarity=0.041 Sum_probs=74.1
Q ss_pred CCCCcEEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 446 MRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 446 l~HpnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
..||+.+..- +-.+..-++..|-...+...+- .-..++...+++++..|+....+++. -+|--|.|+||+
T Consensus 42 ~~~~~Fl~~~-I~e~eD~v~~~y~~~~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 42 QHSPYFIDAE-LTELRDSFQIHYDINDNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp SCCTTBCCEE-EEECSSEEEEEECCCTTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred ccCCcccceE-EEEcccEEEEEEEcCcccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 3678777442 2222223444443332222211 12346788999999999888755543 478889999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf 599 (701)
++.++.++|.-.|+-..++|. .++...=+-.+=|++..+++++..|
T Consensus 112 f~~~~~p~i~~RGik~~l~P~----------------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPL----------------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCC----------------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EcCCCCEEEEEccCccCCCCC----------------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999988875433221 1222223456888999999998877
|
| >2nz2_A Argininosuccinate synthase; amino-acid biosynthesis, aspartate, citrulline, ST genomics, structural genomics consortium, SGC, ligase; HET: CIR; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.50 E-value=3.9 Score=44.00 Aligned_cols=88 Identities=6% Similarity=0.028 Sum_probs=63.8
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCe-eeEEEEE-
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRIL-AREVVLQ- 98 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~-~~~~v~~- 98 (701)
.++|+|++-|-..|.-++.|+.+. |..|+.+||.... . +-++.++..|...|+. +..+-+.
T Consensus 5 ~~kVvvalSGGlDSsvll~lL~e~----G~eV~av~vd~g~------~-------~e~e~a~~~A~~lGi~~~~vvd~~~ 67 (413)
T 2nz2_A 5 KGSVVLAYSGGLDTSCILVWLKEQ----GYDVIAYLANIGQ------K-------EDFEEARKKALKLGAKKVFIEDVSR 67 (413)
T ss_dssp CEEEEEECCSSHHHHHHHHHHHHT----TEEEEEEEEESSC------C-------CCHHHHHHHHHHHTCSEEEEEECHH
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEECCc------H-------HHHHHHHHHHHHhCCCEEEEEeChH
Confidence 368999999999999999998774 7789999997541 1 1145666677777775 4433111
Q ss_pred ------------c----------CC------hhHHHHHHHHHcCCCEEEEccCCC
Q 005343 99 ------------D----------ID------VSSALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 99 ------------~----------~~------~~~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
. +. +...++++|++.+++.|+.|.+++
T Consensus 68 ef~~~~~~~~i~~~a~~e~~y~~g~~~aRp~i~~~l~~~A~~~Ga~~IatGh~~~ 122 (413)
T 2nz2_A 68 EFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGK 122 (413)
T ss_dssp HHHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCTT
T ss_pred HHHHHHHHHHHHhCcccccccccccccchHHHHHHHHHHHHHcCCCEEEECCcCc
Confidence 0 11 146788999999999999999985
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.13 E-value=2.8 Score=40.94 Aligned_cols=114 Identities=11% Similarity=0.079 Sum_probs=72.2
Q ss_pred CCCcEEEEeceecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCCee
Q 005343 447 RHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL-FLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 447 ~HpnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~-~LH~~~~~~iiHrDLKp~NIL 525 (701)
.||++-.-+..-.+...+.|+.-+++.-...+ ..++...+++++..|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCIVRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSSEEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCCCeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 67777333333333334445444333223333 23677888988888887666 4443 578889999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAM 599 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf 599 (701)
++.++.++|.-.|+-..++ |. .++..-=+-.+=|++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~~lp-----------------------P~-----e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLP-----------------------PD-----EWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETTTBS-----------------------SC-----SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCcccCC-----------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999888744332 21 1121122446888888899988776
|
| >1kor_A Argininosuccinate synthetase; ligase, riken structural genomics/proteomics initiative, RSGI, structural genomics; HET: ANP ARG; 1.95A {Thermus thermophilus} SCOP: c.26.2.1 d.210.1.1 PDB: 1j1z_A* 1j21_A* 1kh1_A 1kh2_A* 1kh3_A* 1j20_A* | Back alignment and structure |
|---|
Probab=80.22 E-value=5.8 Score=42.48 Aligned_cols=88 Identities=11% Similarity=0.152 Sum_probs=63.3
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCC-eeeEEEEEc-
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRI-LAREVVLQD- 99 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v-~~~~~v~~~- 99 (701)
++|+|++-|-..|.-++.|+.+.+ |..|+++||-... .+-++.++.+|...|+ ++..+-+..
T Consensus 1 ~kVvva~SGG~DSsvll~ll~~~~---g~~V~av~vd~g~-------------~~e~e~a~~~A~~lGi~~~~vvd~~~e 64 (400)
T 1kor_A 1 MKIVLAYSGGLDTSIILKWLKETY---RAEVIAFTADIGQ-------------GEEVEEAREKALRTGASKAIALDLKEE 64 (400)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHH---TCEEEEEEEESSC-------------SSCHHHHHHHHHHHTCSEEEEEECHHH
T ss_pred CcEEEEEeChHHHHHHHHHHHHhh---CCcEEEEEEeCCC-------------HHHHHHHHHHHHHhCCCeEEEEeCcHH
Confidence 479999999999999999987653 5689999997541 1124556667777777 444332210
Q ss_pred ----------------------CC------hhHHHHHHHHHcCCCEEEEccCCC
Q 005343 100 ----------------------ID------VSSALIYYVKNNSVGNIVAGGSSR 125 (701)
Q Consensus 100 ----------------------~~------~~~~Iv~~a~~~~~d~IV~Gs~g~ 125 (701)
+. ....+.++|++.+++.|+.|.++.
T Consensus 65 f~~~~~~~~i~~~~~~e~~y~~g~~~~R~~~~~~L~~~A~~~G~~~IatG~~~d 118 (400)
T 1kor_A 65 FVRDFVFPMMRAGAVYEGYYLLGTSIARPLIAKHLVRIAEEEGAEAIAHGATGK 118 (400)
T ss_dssp HHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCTT
T ss_pred HHHHhhHHHHHcCCccccccccCCccchHHHHHHHHHHHHHcCCCEEEECCCCC
Confidence 00 134688999999999999999986
|
| >3bl5_A Queuosine biosynthesis protein QUEC; PREQ1 biosynthesis, RNA modification, tRNA, hydrolase; 2.95A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=80.03 E-value=7 Score=37.53 Aligned_cols=90 Identities=10% Similarity=0.073 Sum_probs=59.8
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEc-C
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQD-I 100 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~-~ 100 (701)
++|+|++-|-..|.-++.++.+. +..|+.+||.... .. . + -.+.++.+|...|++...+-+.. .
T Consensus 4 ~~v~v~lSGG~DS~~ll~ll~~~----~~~v~~~~~~~~~-----~~-~-~----e~~~a~~~a~~lgi~~~~~~~~~~~ 68 (219)
T 3bl5_A 4 EKAIVVFSGGQDSTTCLLWALKE----FEEVETVTFHYNQ-----RH-S-Q----EVEVAKSIAEKLGVKNHLLDMSLLN 68 (219)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHH----CSEEEEEEEESSC-----TT-C-H----HHHHHHHHHHTTCCCEEEEECGGGG
T ss_pred CCEEEEccCcHHHHHHHHHHHHc----CCceEEEEEeCCC-----CC-H-H----HHHHHHHHHHHhCCCeEEEeChHHh
Confidence 58999999999998888887664 4679999998641 01 1 1 14556667777787665443321 0
Q ss_pred --------------------C----------hh-HHHHHHHHHcCCCEEEEccCCCC
Q 005343 101 --------------------D----------VS-SALIYYVKNNSVGNIVAGGSSRN 126 (701)
Q Consensus 101 --------------------~----------~~-~~Iv~~a~~~~~d~IV~Gs~g~~ 126 (701)
. .. ..+.++|++++++.|+.|.++.-
T Consensus 69 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~a~~~g~~~i~tG~~~dd 125 (219)
T 3bl5_A 69 QLAPNALTRNDIEIEVKDGELPSTFVPGRNLVFLSFASILAYQIGARHIITGVCETD 125 (219)
T ss_dssp GGSTGGGC--------------CCCCTTHHHHHHHHHHHHHHHHTCSEEECCCCC--
T ss_pred hhcccccccccccccccccCCCCceeechHHHHHHHHHHHHHHcCCCEEEEeccccc
Confidence 0 01 23358899999999999998643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 701 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 | |
| d2z3va1 | 135 | c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 { | 2e-04 | |
| d1tq8a_ | 147 | c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobac | 9e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 5e-63
Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 17/275 (6%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPD--ISQGPRQFKQEVEILG 444
++ E ++ ++IG G +G VYK + H VA+K+L Q + FK EV +L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 445 SMRHTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
RH N+++ +G +V ++ E SL L + IA + A +
Sbjct: 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGM 117
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+LH ++HRDLK NI L ++ KI D GLA + + + +G+
Sbjct: 118 DYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS----HQFEQLSGSI 170
Query: 564 CYIDPEY---QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
++ PE Q +SD+Y+ G+VL +L+T + + +Q I L P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VGRGYLSP 229
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
++ ++ +L +C + ++ +RP ++
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-57
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 17/271 (6%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGS 445
+E E + + ++G G +G V+ HT VA+K L S P F E ++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQ 64
Query: 446 MRHTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
++H +V L + ++ EYMENGSL D L + + +AA+IA +
Sbjct: 65 LQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMA 123
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
F+ + +HRDL+ ANIL+ KI+D GLARL+ + A
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPIK 175
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTG 624
+ PE G +KSD++S G++L +++T + I+N L
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----LERGYRMV 230
Query: 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P + +L C + R DRP +
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 25/293 (8%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS-VAIKVLGPDISQGPRQFKQEVEILGS 445
+ E + + K+G+G +G V+ + T+ VAIK L P + P F QE +++
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKK 68
Query: 446 MRHTNMVILLGAC-PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+RH +V L E +V EYM GSL + + + +AA+IA+ +
Sbjct: 69 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 505 FLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
++ + VHRDL+ ANIL+ +N V K++D GLARL+ + A
Sbjct: 128 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIK 179
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR--PAMGLSH-QVEQAIRNGTFSELLDPT 621
+ PE G +KSD++S G++L +L T P G+ + +V + G
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---- 235
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELIRLRDLGFENAEN 672
P E S+ L QC +RP + L + + ++ EN
Sbjct: 236 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-55
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 29/266 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILL 455
+ + IG+G +G V VA+K + D + + F E ++ +RH+N+V LL
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 66
Query: 456 GAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G +V EYM GSL D L + S + K + ++ A+ +L N
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
VHRDL N+L+ ++ V+K+SD GL + + T + PE +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALR 173
Query: 573 TGMLGVKSDLYSLGVVLLQLITAR--PAMGLS-HQVEQAIRNGTFSELLDPTVTGWPVEA 629
KSD++S G++L ++ + P + V + G + D G P
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD----GCPPAV 229
Query: 630 ALSIAKLALQCCELRKRDRPDLVSVV 655
++ C L RP + +
Sbjct: 230 ----YEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 1e-54
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 36/300 (12%)
Query: 384 YTIEEIEAATDYFS---------ISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDI 429
+T E+ A F+ I + IG G +G V L VAIK L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 430 S-QGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPP 486
+ + R F E I+G H N++ L G ++ E+MENGSL+ F + N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
+ IA + +L VHRDL NIL++ N V K+SD GL+R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA--RPAMGLSH- 603
+D T + PE Q SD++S G+V+ ++++ RP +++
Sbjct: 182 TSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 604 QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELIR 661
V AI P++ ++ +L L C + + RP +V L ++IR
Sbjct: 241 DVINAIEQDYRLPP--------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 389 IEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGS 445
+E D F ++G G G V+K + +A K++ +I Q +E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 446 MRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+V GA + E+M+ GSL+ L + I I K++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+L + ++HRD+KP+NIL++ K+ D G++ + S + GT
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTR 167
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
Y+ PE Q V+SD++S+G+ L+++ R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-54
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 26/279 (9%)
Query: 387 EEIEAATDYFSIS-RKIGEGGYGPVYKAQLDHTS----VAIKVLGPDISQG-PRQFKQEV 440
+++ D I+ ++G G +G V + VAIKVL + + +E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 441 EILGSMRHTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
+I+ + + +V L+G C LV E G L L K P S ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQV 118
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ + +L + VHRDL N+LL + +KISD GL++ + D +
Sbjct: 119 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG 172
Query: 560 AGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVEQAIRNGTFSE 616
+ PE +SD++S GV + + ++ +P + +V I G E
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P E + L C + DRPD ++V
Sbjct: 233 C--------PPECPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-54
Identities = 62/274 (22%), Positives = 114/274 (41%), Gaps = 20/274 (7%)
Query: 396 FSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+ ++IG G +G V+ + VAIK + + F +E E++ + H +V L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 455 LGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G C CLV+E+ME+G L D + + + ++ + +L +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
++HRDL N L+ +N V K+SD G+ R V T + PE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEVFS 175
Query: 573 TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALS 632
KSD++S GV++ ++ + + + + + + L P A+
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 230
Query: 633 IAKLALQCCELRKRDRPDLVSVVLPELIRLRDLG 666
+ ++ C + R DRP S +L +L + + G
Sbjct: 231 VYQIMNHCWKERPEDRPA-FSRLLRQLAEIAESG 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-53
Identities = 54/266 (20%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 396 FSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVIL 454
+ +++G G +G V + VAIK++ S +F +E +++ ++ H +V L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 455 LGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPE 512
G C ++ EYM NG L + L + + ++ ++ A+ +L
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 513 PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQ 572
+HRDL N L++ V K+SD GL+R V + + PE
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLM 174
Query: 573 TGMLGVKSDLYSLGVVLLQLITA--RPAMGLSH-QVEQAIRNGTFSELLDPTVTGWPVEA 629
KSD+++ GV++ ++ + P ++ + + I G P A
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--------PHLA 226
Query: 630 ALSIAKLALQCCELRKRDRPDLVSVV 655
+ + + C + +RP ++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 2e-53
Identities = 76/304 (25%), Positives = 127/304 (41%), Gaps = 49/304 (16%)
Query: 386 IEEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQG-PRQFK 437
+ +E + R IGEG +G V++A+ T VA+K+L + S F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 438 QEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKD------------- 482
+E ++ + N+V LLG C + CL++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 483 --------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKI 534
PP+ + + IA ++A + +L + K VHRDL N L+ +N V KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKI 181
Query: 535 SDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT 594
+D GL+R + + A ++ PE +SD+++ GVVL ++ +
Sbjct: 182 ADFGLSRNIYSADYYKAD----GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 595 --ARPAMGLSH-QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDL 651
+P G++H +V +R+G P L + L C DRP
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSF 289
Query: 652 VSVV 655
S+
Sbjct: 290 CSIH 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 28/268 (10%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTN 450
D++ I ++G+G +G VYKAQ TS A KV+ + + E++IL S H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V LL A ++ E+ G+++ + + + P+ S + + AL +LH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
NK ++HRDLK NIL + K++D G++ T + GT ++ P
Sbjct: 129 NK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------TIQRRDSFIGTPYWMAP 179
Query: 569 EYQQTGML-----GVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSELLDPT 621
E K+D++SLG+ L+++ P + + I L P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP- 238
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRP 649
+ W +C E R
Sbjct: 239 -SRWSSNF----KDFLKKCLEKNVDARW 261
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 24/286 (8%)
Query: 390 EAATDYFSISRKIGEGGYGPVYKAQLDHTS------VAIKVLGPDISQGPR-QFKQEVEI 442
E + + IG G +G VYK L +S VAIK L ++ R F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 443 LGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+G H N++ L G +Y ++ EYMENG+L+ F ++ + IA
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIA 120
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
+ +L VHRDL NIL++ N V K+SD GL+R++ T T +
Sbjct: 121 AGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT---TSGGK 174
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
+ PE SD++S G+V+ +++T + ++ + D
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----INDG 229
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELIRLRD 664
P++ +I +L +QC + + RP +V L +LIR D
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 34/270 (12%)
Query: 395 YFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD--ISQGPRQFKQEVEILGSMRHTN 450
+ +IG G + VYK T+ VA L ++FK+E E+L ++H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 451 MVILLGAC------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+V + + LV E M +G+L+ L + + + +I L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQ 126
Query: 505 FLHQNKPEPLVHRDLKPANILL-DQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
FLH P P++HRDLK NI + KI D+GLA L S GT
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--------FAKAVIGTP 177
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP---AMGLSHQVEQAIRNGTFSELLDP 620
++ PE + D+Y+ G+ +L++ T+ + Q+ + + +G D
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPD 650
+ ++ C K +R
Sbjct: 237 VAIP-------EVKEIIEGCIRQNKDERYS 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-52
Identities = 63/270 (23%), Positives = 102/270 (37%), Gaps = 27/270 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD--ISQGPRQFKQEVEILGSMRHT 449
+ + + IG G YG K + + K L + EV +L ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 450 NMVILLGACPEYG----CLVYEYMENGSLEDRLFQ-KDNSPPIHWSIRFKIAAEIATALL 504
N+V + +V EY E G L + + + ++ ++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 505 FLHQ--NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
H+ + ++HRDLKPAN+ LD K+ D GLAR++ GT
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKAFVGT 177
Query: 563 FCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDP 620
Y+ PE KSD++SLG +L +L P Q E IR G F +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--- 234
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPD 650
P + + ++ + L+ RP
Sbjct: 235 -----PYRYSDELNEIITRMLNLKDYHRPS 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-52
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 38/287 (13%)
Query: 379 VRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS----VAIKVLGPDISQG-- 432
+ + T+E+ +++G G +G V K VA+K+L + +
Sbjct: 3 LDRKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 51
Query: 433 PRQFKQEVEILGSMRHTNMVILLGAC-PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSI 491
+ E ++ + + +V ++G C E LV E E G L L Q +
Sbjct: 52 KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN---RHVKDKN 108
Query: 492 RFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTI 551
++ +++ + +L ++ VHRDL N+LL + +KISD GL++ + D
Sbjct: 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA---DEN 162
Query: 552 TQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA--RPAMGLS-HQVEQA 608
T + PE KSD++S GV++ + + +P G+ +V
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222
Query: 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ G P + L C +RP +V
Sbjct: 223 LEKGERMGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVE 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 72/277 (25%), Positives = 114/277 (41%), Gaps = 39/277 (14%)
Query: 382 RKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQF 436
R++ +E+ F I R +G+G +G VY A+ + +A+KVL + Q
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 437 KQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFK 494
++EVEI +RH N++ L G L+ EY G++ L +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTAT 110
Query: 495 IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554
E+A AL + H + ++HRD+KP N+LL KI+D G + P S
Sbjct: 111 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 159
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNG 612
TT GT Y+ PE + M K DL+SLGV+ + + +P + E I
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 613 TFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
F+ +P L + + RP
Sbjct: 220 EFT---------FPDFVTEGARDLISRLLKHNPSQRP 247
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 2e-50
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 26/288 (9%)
Query: 373 AMAYKNVRYRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS 430
AM + Y K+ +E ++ K+G G YG VY+ S VA+K L D
Sbjct: 1 AMDPSSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 55
Query: 431 QGPRQFKQEVEILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIH 488
+ +F +E ++ ++H N+V LLG C + E+M G+L D L + N +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVS 113
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
+ +A +I++A+ +L + +HRDL N L+ +N++ K++D GL+RL+
Sbjct: 114 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 168
Query: 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA 608
T A + PE +KSD+++ GV+L ++ T + + Q
Sbjct: 169 ---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 609 IRNGTFSELLDPTVTG-WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
ELL+ P + +L C + DRP +
Sbjct: 226 Y------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 23/267 (8%)
Query: 399 SRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMV 452
+ IG G +G VY L A+K L G QF E I+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 453 ILLGACPEYG---CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
LLG C +V YM++G L + + + ++P + I F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
+ VHRDL N +LD+ + K++D GLAR + D++ + T A ++ E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALE 204
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628
QT KSD++S GV+L +L+T P + + + LL P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE------Y 258
Query: 629 AALSIAKLALQCCELRKRDRPDLVSVV 655
+ ++ L+C + RP +V
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 20/262 (7%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD-ISQGPRQFKQEVEILGSMRHTN 450
+ + + + +GEG YG V A T VA+K++ P K+E+ I + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 451 MVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V G L EY G L DR+ + + ++ +++LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ HRD+KP N+LLD+ KISD GLA + + + + + GT Y+ P
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMCGTLPYVAP 174
Query: 569 EYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627
E + D++S G+VL ++ Q + +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 628 EAALSIAKLALQCCELRKRDRP 649
L + R
Sbjct: 235 AP----LALLHKILVENPSARI 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-50
Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 21/269 (7%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDI---SQGPRQFKQEVEILGSMR 447
+ K+G+G +G V + + D S VA+K L PD+ + F +EV + S+
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 448 HTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
H N++ L G +V E GSL DRL + + R A ++A + +L
Sbjct: 70 HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYL 127
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+ +HRDL N+LL + KI D GL R +P + + Q F +
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFAWC 181
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
PE +T SD + GV L ++ T + Q + P P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ I + +QC + DRP V++
Sbjct: 242 QD----IYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 39/290 (13%)
Query: 398 ISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGA 457
+ IG+G +G V++ + VA+K+ + + E+ +RH N++ + A
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 458 C------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP 511
LV +Y E+GSL D L + + K+A A+ L LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 512 E-----PLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+ HRDLK NIL+ +N I+D+GLA + GT Y+
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TDTIDIAPNHRVGTKRYM 179
Query: 567 DPEYQQTGM------LGVKSDLYSLGVVLLQLITARPAMGLSHQVE-------------Q 607
PE + ++D+Y++G+V ++ G+ + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 608 AIRNGTFSELLDPTVTGW--PVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+R + L P + EA +AK+ +C R + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 61/272 (22%), Positives = 105/272 (38%), Gaps = 27/272 (9%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEI 442
+I + ++ KIG+G G VY A VAI+ + E+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 443 LGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIA 500
+ ++ N+V L + + +V EY+ GSL D + + + E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126
Query: 501 TALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAA 560
AL FLH N+ ++HRD+K NILL + K++D G + T Q +T
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMV 177
Query: 561 GTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP---AMGLSHQVEQAIRNGTFSEL 617
GT ++ PE G K D++SLG++ +++I P + NGT
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
++ +C ++ R
Sbjct: 238 NPEKLSA-------IFRDFLNRCLDMDVEKRG 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 73/316 (23%), Positives = 123/316 (38%), Gaps = 51/316 (16%)
Query: 376 YKNVRYRKYTIEEI-EAATDYFSISRKIGEGGYGPVYKAQLDHTS-------VAIKVLGP 427
Y V +R+Y + E + + +G G +G V A S VA+K+L
Sbjct: 18 YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 428 DISQGPRQ-FKQEVEILGSM-RHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQK-- 481
R+ E++++ + H N+V LLGAC G L++EY G L + L K
Sbjct: 78 KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137
Query: 482 ------------------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPAN 523
++ + + A ++A + FL VHRDL N
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194
Query: 524 ILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLY 583
+L+ V KI D GLAR + + + A ++ PE G+ +KSD++
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVV----RGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 584 SLGVVLLQLITAR----PAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQ 639
S G++L ++ + P + + + I+NG + P A I +
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD--------QPFYATEEIYIIMQS 302
Query: 640 CCELRKRDRPDLVSVV 655
C R RP ++
Sbjct: 303 CWAFDSRKRPSFPNLT 318
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 1e-48
Identities = 63/267 (23%), Positives = 102/267 (38%), Gaps = 31/267 (11%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQFKQEVEILGSMR 447
FS R+IG G +G VY A+ S VAIK + Q + +EV L +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 448 HTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
H N + G LV EY + + K P+ + L +
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCY 565
LH + ++HRD+K NILL + + K+ D G A ++ P + GT +
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGTPYW 177
Query: 566 IDPEY---QQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTV 622
+ PE G K D++SLG+ ++L +P + + + + + +E
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQS 236
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRP 649
W C + +DRP
Sbjct: 237 GHWSEYF----RNFVDSCLQKIPQDRP 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-48
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 37/295 (12%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPRQ-FKQ 438
+ E + S + +G G +G V +A +VA+K+L P R+
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 439 EVEILGSM-RHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQK-------------- 481
E+++L + H N+V LLGAC ++ EY G L + L +K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 482 -DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540
D+ + + ++A + FL +HRDL NILL ++KI D GLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192
Query: 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMG 600
R + + + A ++ PE + +SD++S G+ L +L + +
Sbjct: 193 RDIKNDSNYVVK----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 601 LSHQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
V+ + P E + C + RP +V
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEM----YDIMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 29/289 (10%)
Query: 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQL-------DHTSVAIKVLGPDISQGPR-Q 435
Y +E E A + ++SR++G+G +G VY+ T VAIK + S R +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 436 FKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNS-------PP 486
F E ++ ++V LLG + ++ E M G L+ L + P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546
S ++A EIA + +L+ N VHRDL N ++ +++ KI D G+ R +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-- 184
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE 606
+T ++ PE + G+ SD++S GVVL ++ T E
Sbjct: 185 --ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 607 QAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
Q +R +++ + P + +L C + + RP + ++
Sbjct: 243 QVLRF-----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 1e-47
Identities = 68/283 (24%), Positives = 126/283 (44%), Gaps = 23/283 (8%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGP---RQFKQEVEILGSMR 447
+D + + +G GG V+ A+ H VA+KVL D+++ P +F++E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 448 HTNMVILLGAC------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
H +V + +V EY++ +L D + + P+ ++ A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
AL F HQN ++HRD+KPANI++ K+ D G+AR + S + G
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN---SVTQTAAVIG 176
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621
T Y+ PE + + +SD+YSLG VL +++T P V A ++ E P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIPP 234
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664
+ + + L+ +R + + +L+R+ +
Sbjct: 235 SARHE-GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 42/284 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS----VAIKVLGPDIS-QGPRQFKQEVEILGSM-RHT 449
IGEG +G V KA++ AIK + S R F E+E+L + H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQK-------------DNSPPIHWSIRFK 494
N++ LLGAC Y L EY +G+L D L + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 495 IAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQY 554
AA++A + +L Q +HRDL NIL+ +NYV+KI+D GL+R
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYV 181
Query: 555 HMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR--PAMGLSH-QVEQAIRN 611
T ++ E + SD++S GV+L ++++ P G++ ++ + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
G E P+ + L QC + +RP ++
Sbjct: 242 GYRLEK--------PLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-47
Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS------VAIKVLGPDIS-QGPRQFKQEVEILG 444
T++ + +G G +G VYK VAIK L S + ++ E ++
Sbjct: 8 ETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 445 SMRHTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
S+ + ++ LLG C L+ + M G L D + + ++ +IA +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGM 124
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+L + VHRDL N+L+ KI+D GLA+L+ +YH
Sbjct: 125 NYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPI 177
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVEQAIRNGTFSELLDP 620
++ E + +SD++S GV + +L+T ++P G+ ++ + G
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ--- 234
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV--LPELIR 661
P + + + ++C + RP ++ ++ R
Sbjct: 235 -----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-46
Identities = 62/272 (22%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS-----VAIKVLGPDISQGPRQ-FKQEVEILGSMR 447
+ + R IGEG +G V++ VAIK S R+ F QE +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 448 HTNMVILLGACPEYG-CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
H ++V L+G E ++ E G L F + + + A +++TAL +L
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
+ VHRD+ N+L+ N K+ D GL+R + S T Y + ++
Sbjct: 125 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWM 176
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLIT--ARPAMGLSH-QVEQAIRNGTFSELLDPTVT 623
PE SD++ GV + +++ +P G+ + V I NG +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------ 230
Query: 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P ++ L +C RP +
Sbjct: 231 --PPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 2e-45
Identities = 55/287 (19%), Positives = 114/287 (39%), Gaps = 29/287 (10%)
Query: 375 AYKNVRYRKYTIEEIEAATDY----FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD 428
Y +++Y + +E D+ + I ++G G +G V++ T A K +
Sbjct: 3 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 62
Query: 429 ISQGPRQFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPP 486
++E++ + +RH +V L A ++YE+M G L +++ + N
Sbjct: 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--K 120
Query: 487 IHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILL--DQNYVSKISDVGLARLVP 544
+ + ++ L +H+N VH DLKP NI+ ++ K+ D GL +
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ 604
P + + GT + PE + +G +D++S+GV+ L++ G +
Sbjct: 178 P-------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230
Query: 605 VEQ--AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
E +++ + + D +G + + R
Sbjct: 231 DETLRNVKSCDW-NMDDSAFSGISEDG----KDFIRKLLLADPNTRM 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 5e-44
Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVEILGSMRH 448
+ F + +GEG + V A+ TS AIK+L +E +++ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 449 TNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFL 506
V L E Y +NG L + + + AEI +AL +L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYL 124
Query: 507 HQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYI 566
H ++HRDLKP NILL+++ +I+D G A+++ P + Q + GT Y+
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----KQARANSFVGTAQYV 177
Query: 567 DPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624
PE SDL++LG ++ QL+ P ++ Q I +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------- 228
Query: 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR----LRDLGFENAENK 673
+P + L + L R + ++ + +EN +
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 2e-43
Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 40/278 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGP---------DISQGPRQFKQEVEI 442
+ + +G G V + T A+K++ ++ + +EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 443 LGSMR-HTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEI 499
L + H N++ L LV++ M+ G L D L +K + KI +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119
Query: 500 ATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTA 559
+ LH+ +VHRDLKP NILLD + K++D G + + P +
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLREV 169
Query: 560 AGTFCYIDPEYQQTGML------GVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRN 611
GT Y+ PE + M G + D++S GV++ L+ P Q+ I +
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
Query: 612 GTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
G + + P + L + ++ + R
Sbjct: 230 GNY-QFGSPEWDDYSDTV----KDLVSRFLVVQPQKRY 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 5e-43
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 29/281 (10%)
Query: 381 YRKYTIEEIEAAT----DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPR 434
++KY + +E DY+ I ++G G +G V++ T K +
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 435 QFKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIR 492
K E+ I+ + H ++ L A L+ E++ G L DR+ + +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEV 129
Query: 493 FKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS--KISDVGLARLVPPSAADT 550
+ L +H++ +VH D+KP NI+ + S KI D GLA + P D
Sbjct: 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 183
Query: 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QA 608
I + T + PE +G +D++++GV+ L++ +E Q
Sbjct: 184 IVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
Query: 609 IRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
++ + E + + EA + R R
Sbjct: 240 VKRCDW-EFDEDAFSSVSPEA----KDFIKNLLQKEPRKRL 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-42
Identities = 48/264 (18%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
+ + I+ +G G +G V++ + K + K+E+ IL RH N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 452 VILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
+ L + E +++E++ + +R+ ++ ++ ++ AL FLH +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 510 KPEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ H D++P NI+ + KI + G AR + P + Y
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------DNFRLLFTAPEYYA 171
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARP--AMGLSHQVEQAIRNGTFSELLDPTVTGW 625
PE Q ++ +D++SLG ++ L++ + Q+ + I N ++ +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-FDEEAFKEI 230
Query: 626 PVEAALSIAKLALQCCELRKRDRP 649
+EA + ++ R
Sbjct: 231 SIEA----MDFVDRLLVKERKSRM 250
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-41
Identities = 56/271 (20%), Positives = 92/271 (33%), Gaps = 26/271 (9%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNM 451
+ + + RKIG G +G +Y VAIK+ + Q E +I M+
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVG 64
Query: 452 VILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+ + C +Y +V E + + S +A ++ + + ++H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 509 NKPEPLVHRDLKPANIL---LDQNYVSKISDVGLARLVPPSAADTITQYHMTT-AAGTFC 564
+HRD+KP N L + + I D GLA+ + Y GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR-----NGTFSELLD 619
Y + DL SLG VL+ + + S ++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPD 650
G+P E A C LR D+PD
Sbjct: 239 VLCKGYPSE----FATYLNFCRSLRFDDKPD 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 1e-41
Identities = 46/268 (17%), Positives = 81/268 (30%), Gaps = 22/268 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ + R+IGEG +G +++ L++ VAIK Q + E + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 454 LLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEP 513
+ + G ++ A ++ + +H+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 514 LVHRDLKPANILLDQNYVS-----KISDVGLARLV-PPSAADTITQYHMTTAAGTFCYID 567
LV+RD+KP N L+ + + D G+ + P I +GT Y+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA-----IRNGTFSELLDPTV 622
+ DL +LG V + + I S L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 623 TGWPVEAALSIAKLALQCCELRKRDRPD 650
G+P E K L PD
Sbjct: 242 AGFPEE----FYKYMHYARNLAFDATPD 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 4e-41
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 44/291 (15%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS-------VAIKVLGPDISQGP-RQFKQEVEILGS 445
D + + +G G +G V +A VA+K+L + R E++IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 446 MRHTNMVILL-GACPEYG---CLVYEYMENGSLEDRLFQKDNSP-------------PIH 488
+ H V+ L GAC + G ++ E+ + G+L L K N +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 489 WSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548
+ ++A + FL K +HRDL NILL + V KI D GLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 188
Query: 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR----PAMGLSHQ 604
A ++ PE + ++SD++S GV+L ++ + P + + +
Sbjct: 189 ---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 605 VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ ++ GT P + + L C RP +V
Sbjct: 246 FCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 5e-41
Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 28/273 (10%)
Query: 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ-FKQEVEIL 443
++ E D + +G G + V A+ T VAIK + +G + E+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 444 GSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
++H N+V L + L+ + + G L DR+ +K ++ ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLD 118
Query: 502 ALLFLHQNKPEPLVHRDLKPANILL---DQNYVSKISDVGLARLVPPSAADTITQYHMTT 558
A+ +LH +VHRDLKP N+L D++ ISD GL+++ P ++T
Sbjct: 119 AVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-------SVLST 168
Query: 559 AAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSE 616
A GT Y+ PE D +S+GV+ L+ P + + I + E
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-E 227
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
P A E R
Sbjct: 228 FDSPYWDDISDSA----KDFIRHLMEKDPEKRF 256
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-41
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 14/276 (5%)
Query: 393 TDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-PRQFKQEVEILGSMRHT 449
++ IGEG YG V A + VAIK + P Q ++ +E++IL RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N++ + P + Y+ + L++ + + +I L ++H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
++HRDLKP+N+LL+ KI D GLAR+ P D +T T Y
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEYVATRWYRA 180
Query: 568 PEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWP 626
PE D++S+G +L ++++ RP H ++Q L P+
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--LGILGSPSQEDLN 238
Query: 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
L L K L + + L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 6e-41
Identities = 69/303 (22%), Positives = 122/303 (40%), Gaps = 43/303 (14%)
Query: 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ---FKQ 438
Y++++ F I R +G G +G V+ + H A+KVL +I +Q
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 439 EVEILGSMRHTNMVILLGACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
E +L + H ++ + G + + + +Y+E G L L + P A
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---YA 110
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
AE+ AL +LH +++RDLKP NILLD+N KI+D G A+ VP
Sbjct: 111 AEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VT 158
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTF 614
T GT YI PE T D +S G+++ +++ S+ ++ + I N
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
Query: 615 SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR---LRDLGFENAE 671
+P + L + R + ++ +++ +E
Sbjct: 219 R---------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 269
Query: 672 NKN 674
++N
Sbjct: 270 SRN 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 38/288 (13%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS---------VAIKVLGPDISQ-GPRQFKQEVEIL 443
D + + +GEG +G V A+ VA+K+L D ++ E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 444 GSM-RHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQK-------------DNSPPI 487
+ +H N++ LLGAC ++ EY G+L + L + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 488 HWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547
A ++A + +L +HRDL N+L+ ++ V KI+D GLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 548 ADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607
T ++ PE + +SD++S GV+L ++ T + VE+
Sbjct: 190 YYKKTTNGR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
+ +D P + + C RP +V
Sbjct: 246 LFKLLKEGHRMD-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 6e-40
Identities = 71/296 (23%), Positives = 114/296 (38%), Gaps = 34/296 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPD---ISQGPRQFKQEVE---ILGS 445
+ FS+ R IG GG+G VY + T A+K L + QG E ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 446 MRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+V + A P+ + + M G L L Q + AAEI L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
+H +V+RDLKPANILLD++ +ISD+GLA + GT
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTH 169
Query: 564 CYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITAR-PAMGLSHQVEQAIRNGTFSELLDPT 621
Y+ PE Q G+ +D +SLG +L +L+ P + + I T + ++
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-- 227
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR---LRDLGFENAENKN 674
P + + L + R + E+ R L ++ +
Sbjct: 228 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 30/285 (10%)
Query: 392 ATDYFSISRKIGEGGYGPVYKAQLDHTS---VAIKVLGPDISQG--PRQFKQEVEI---L 443
A + +IGEG YG V+KA+ VA+K + + P +EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 444 GSMRHTNMVILLGACPE-------YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIA 496
+ H N+V L C LV+E+++ K P + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 497 AEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHM 556
++ L FLH ++ +VHRDLKP NIL+ + K++D GLAR+ Q +
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMAL 172
Query: 557 TTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSE 616
T+ T Y PE DL+S+G + ++ +P S V+Q +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK--ILDV 230
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661
+ P WP + AL + + ++ D + + +L+
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLL 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 62/271 (22%), Positives = 97/271 (35%), Gaps = 31/271 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ---FKQEVEILG-SMRHT 449
F + + +G+G +G V+ A+ T+ AIK L D+ E +L + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
+ + E V EY+ G L + S AAEI L FLH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLH 120
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+V+RDLK NILLD++ KI+D G+ + T GT YI
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG------DAKTNTFCGTPDYIA 171
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTGW 625
PE D +S GV+L +++ + + E +IR +
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF---------Y 222
Query: 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVL 656
P L ++ R + +
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 24/226 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
++ ++ IG G +G VY+A+L + VAIK + Q R +E++I+ + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 454 LLGACPEYG--------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
L G LV +Y+ + ++ +L +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 506 LHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGTFC 564
+H + HRD+KP N+LLD + V K+ D G A+ + + +++ +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRYY 188
Query: 565 YIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR 610
D++S G VL +L+ +P V+Q +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 20/275 (7%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS--QGPRQFKQEVEILGSMRHT 449
+ F KIGEG YG VYKA+ T VA+K + D P +E+ +L + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 450 NMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLH 507
N+V LL LV+E++ + I + ++ L F H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 QNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYID 567
+ ++HRDLKP N+L++ K++D GLAR + + +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVVTLWYRAP 171
Query: 568 PEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPV 627
D++SLG + +++T R +++Q R F L P WP
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWP- 228
Query: 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
S+ + ++D +V + + L
Sbjct: 229 -GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 40/285 (14%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ--- 435
+R+ ++ DY+ ++G G + V K + T A K + ++ R+
Sbjct: 3 FRQENVD------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 56
Query: 436 ---FKQEVEILGSMRHTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWS 490
++EV IL ++H N++ L L+ E + G L D L +K +
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 113
Query: 491 IRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS----KISDVGLARLVPPS 546
+ +I + +LH + H DLKP NI+L V KI D GLA +
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQ- 604
GT ++ PE LG+++D++S+GV+ L++ P +G + Q
Sbjct: 171 N-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 605 VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
+ + E D + A + + R
Sbjct: 224 TLANVSAVNY-EFEDEYFSNTSALA----KDFIRRLLVKDPKKRM 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 400 RKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG-----PRQFKQEVEILGSMRHTNMV 452
+GEG + VYKA+ +T+ VAIK + R +E+++L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 453 ILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK 510
LL A LV+++ME + KDNS + S L +LHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 511 PEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEY 570
++HRDLKP N+LLD+N V K++D GLA+ T T Y PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYTHQVVTRWYRAPEL 171
Query: 571 QQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVEA 629
+ GV D++++G +L +L+ P + ++Q R F L PT WP
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR--IFETLGTPTEEQWPDMC 229
Query: 630 ALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661
+L + L +LI+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-37
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 29/285 (10%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQG--PRQFKQEVEILGSMRHTNM 451
+ KIG+G +G V+KA+ T VA+K + + + P +E++IL ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 452 VILLGACPEYG----------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
V L+ C LV+++ E+ S ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLN 128
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L ++H+NK ++HRD+K AN+L+ ++ V K++D GLAR S A T
Sbjct: 129 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNRVV 183
Query: 562 TFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFSE 616
T Y PE G DL+ G ++ ++ T P M + + Q G+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661
+ P V + + L + K Q +++ R + + +LI
Sbjct: 244 EVWPNVDNYELYEKLELVK--GQKRKVKDRLKAYVRDPYALDLID 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 7e-36
Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 39/274 (14%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQFKQEVEILG-SMRHTN 450
DY S+ +G G G V + T A+K+L Q + ++EVE+ + + +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66
Query: 451 MVILLGAC------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALL 504
+V ++ + +V E ++ G L R+ Q +I I A+
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 505 FLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
+LH + HRD+KP N+L N + K++D G A+ +TT
Sbjct: 126 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTPCY 175
Query: 562 TFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP------AMGLSHQVEQAIRNGTFS 615
T Y+ PE D++SLGV++ L+ P + +S ++ IR G +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY- 234
Query: 616 ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRP 649
E +P + E L + R
Sbjct: 235 EFPNPEWSEVSEEV----KMLIRNLLKTEPTQRM 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (336), Expect = 1e-35
Identities = 55/274 (20%), Positives = 104/274 (37%), Gaps = 20/274 (7%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS-VAIKVLGPDIS--QGPRQFKQEVEILGSMRHTN 450
+ + KIGEG YG VYKAQ ++ A+K + + P +E+ IL ++H+N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 451 MVILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ 508
+V L LV+E+++ + + + ++ + + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 509 NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDP 568
+ ++HRDLKP N+L+++ KI+D GLAR + + +
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPD 170
Query: 569 EYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPTVTGWPVE 628
+ D++S+G + +++ P + +Q +R F L P WP
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR--IFRILGTPNSKNWP-- 226
Query: 629 AALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
+ K + + I L
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-35
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 40/268 (14%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGP------RQFKQEVEILGSMR 447
+ + +G GG+G VY D+ VAIK + D + EV +L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 448 --HTNMVILLGAC--PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+ ++ LL P+ L+ E E + + + ++ A+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 123
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMTTAAGT 562
H ++HRD+K NIL+D N K+ D G L+ + T GT
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDFDGT 172
Query: 563 FCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDPT 621
Y PE+ + G + ++SLG++L ++ ++ +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---------- 222
Query: 622 VTGWPVEAALSIAKLALQCCELRKRDRP 649
+ + L C LR DRP
Sbjct: 223 ---FRQRVSSECQHLIRWCLALRPSDRP 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 61/282 (21%), Positives = 102/282 (36%), Gaps = 32/282 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS--QGPRQFKQEVEILGSMRHT 449
+ + +G G YG V A T VAIK L ++ +E+ +L MRH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 450 NMVILLGACPEYG--------CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
N++ LL LV +M G+ +L + + + ++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH---EKLGEDRIQFLVYQMLK 132
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
L ++H HRDLKP N+ ++++ KI D GLAR MT
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVV 180
Query: 562 TFCYIDPE-YQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSELLDP 620
T Y PE D++S+G ++ ++IT + S ++Q P
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI--MKVTGTP 238
Query: 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
+ EL K+D +++ P + L
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 63/304 (20%), Positives = 108/304 (35%), Gaps = 40/304 (13%)
Query: 383 KYTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGP---RQFK 437
K T+ + F + +G+G +G V + T A+K+L ++
Sbjct: 1 KVTMND-------FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 438 QEVEILGSMRHTNMVILLGACPEYG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKI 495
E +L + RH + L A + C V EY G L L ++
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA---RFY 110
Query: 496 AAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYH 555
AEI +AL +LH V+RD+K N++LD++ KI+D GL +
Sbjct: 111 GAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGIS------DGAT 161
Query: 556 MTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGT 613
M T GT Y+ PE + G D + LGVV+ +++ R + I
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 614 FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR---LRDLGFENA 670
+P + L + + R E++ + +++
Sbjct: 222 IR---------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
Query: 671 ENKN 674
K
Sbjct: 273 VQKK 276
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 22/271 (8%)
Query: 396 FSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNM 451
+ KIGEG YG V+KA+ T VA+K + D P +E+ +L ++H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 452 VILLGACPE--YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQN 509
V L LV+E+ + + + + I ++ L F H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 510 KPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPE 569
++HRDLKP N+L+++N K+++ GLAR + + +
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVVTLWYRPPDV 172
Query: 570 YQQTGMLGVKSDLYSLGVVLLQLITAR----PAMGLSHQVEQAIR-NGTFSELLDPTVTG 624
+ D++S G + +L A P + Q+++ R GT +E P++T
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVV 655
P + + + ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-32
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 39/263 (14%)
Query: 342 AQRLVELEAMKREIAELKAMQEEEEKKIVMEAMAYKNVRYRKYTIEEIEAATDYFSISRK 401
A++ E E++K +A+ K E+ KK ++ +++ F +
Sbjct: 6 AKKGSEQESVKEFLAKAK---EDFLKK-------WETPSQNTAQLDQ-------FDRIKT 48
Query: 402 IGEGGYGPVYKAQLDHTS--VAIKVLGPDISQGPRQ---FKQEVEILGSMRHTNMVILLG 456
+G G +G V + + A+K+L +Q E IL ++ +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 457 ACPEYGCL--VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPL 514
+ + L V EY+ G + L + AA+I +LH L
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 515 VHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG 574
++RDLKP N+L+DQ +++D G A+ + T GT + PE +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEALAPEIILSK 213
Query: 575 MLGVKSDLYSLGVVLLQLITARP 597
D ++LGV++ ++ P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 59/300 (19%), Positives = 109/300 (36%), Gaps = 35/300 (11%)
Query: 394 DYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDI----SQGPRQFKQEVEILG 444
+ F + + +G G YG V+ + A+KVL ++ + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 445 SMRHTNMVILLGAC---PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIAT 501
+R + ++ L L+ +Y+ G L L Q++ I EI
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV---GEIVL 140
Query: 502 ALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAG 561
AL LH+ +++RD+K NILLD N ++D GL++ G
Sbjct: 141 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-----DETERAYDFCG 192
Query: 562 TFCYIDPEYQQTGMLGV--KSDLYSLGVVLLQLITARPAMGLSHQVEQ--AIRNGTFSEL 617
T Y+ P+ + G G D +SLGV++ +L+T + + I
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR---LRDLGFENAENKN 674
+P E + L + + R E+ + + +++ K
Sbjct: 253 PP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 54/285 (18%), Positives = 102/285 (35%), Gaps = 23/285 (8%)
Query: 385 TIEEIEAATDYFSISRKIGEGGYGPVYKAQLDHTS--VAIKVLGPDIS--QGPRQFKQEV 440
TI E+ + + +G G YG V A T VA+K L ++ +E+
Sbjct: 12 TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 441 EILGSMRHTNMVILLGACPEYGCLVYE---YMENGSLEDRLFQKDNSPPIHWSIRFKIAA 497
+L M+H N++ LL L Y+ + L + +
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 498 EIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMT 557
+I L ++H ++HRDLKP+N+ ++++ KI D GLAR
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTG 177
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617
A + D++S+G ++ +L+T R + ++Q +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL--ILRLV 235
Query: 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662
P ++ S ++ K + ++ P + L
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-29
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 28/224 (12%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNM 451
+ + IG G G V A + +VAIK L ++ +E+ ++ + H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 452 VILLGAC--------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATAL 503
+ LL + LV E M+ + + D + ++ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGI 132
Query: 504 LFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTF 563
LH +HRDLKP+NI++ + KI D GLAR S + MT T
Sbjct: 133 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTR 182
Query: 564 CYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ 607
Y PE D++S+G ++ +++ + ++Q
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (286), Expect = 2e-28
Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 30/226 (13%)
Query: 381 YRKYTIEEIEAATDYFSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQ 438
Y + +E D + + RK+G G Y V++A ++ V +K+L P + + K+
Sbjct: 24 YESHVVEWGNQ--DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKR 78
Query: 439 EVEILGSMR-HTNMVILLGACPE----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRF 493
E++IL ++R N++ L + LV+E++ N + +
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 494 KIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVPPSAADTIT 552
EI AL + H ++HRD+KP N+++D ++ ++ D GLA P
Sbjct: 133 FYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----- 184
Query: 553 QYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARP 597
+ + PE + D++SLG +L +I +
Sbjct: 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 5e-26
Identities = 42/220 (19%), Positives = 86/220 (39%), Gaps = 25/220 (11%)
Query: 396 FSISRKIGEGGYGPVYKAQ--LDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVI 453
+ + RK+G G + V+ A+ +++T VA+K++ D + E+++L + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73
Query: 454 LLGAC---------------PEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAE 498
P +V + G L +K I +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 499 IATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVPPSAADTITQYHMT 557
+ L ++H+ ++H D+KP N+L++ + + +A L H T
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADL----GNACWYDEHYT 187
Query: 558 TAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARP 597
+ T Y PE G +D++S ++ +LIT
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 24/156 (15%), Positives = 46/156 (29%), Gaps = 19/156 (12%)
Query: 397 SISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDIS----------QGPRQFKQEVEILGS 445
+I + +GEG V+ +K + G F
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 446 MRHTNMVILLGACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLF 505
+ L G VY + N L + + K+ + ++ I +
Sbjct: 63 NEFRALQKLQGLAVPK---VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118
Query: 506 LHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541
+ +VH DL N+L+ + + I D +
Sbjct: 119 FYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Score = 39.9 bits (92), Expect = 2e-04
Identities = 21/133 (15%), Positives = 48/133 (36%), Gaps = 7/133 (5%)
Query: 26 VAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLF 85
+A D + ++ A + A ++ +++H + G P + L++ G+
Sbjct: 6 LAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVL 65
Query: 86 ARKR----ILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSL 141
R + + +L + + A++ + IV G L F +
Sbjct: 66 EEARALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLG-SQSQRV 124
Query: 142 LKSAPESCAVYII 154
+ AP C V ++
Sbjct: 125 VAEAP--CPVLLV 135
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} Length = 147 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.0 bits (87), Expect = 9e-04
Identities = 17/138 (12%), Positives = 35/138 (25%), Gaps = 12/138 (8%)
Query: 26 VAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATN---------DELQK 76
V D SS AV A + + + R + +
Sbjct: 10 VGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYE 69
Query: 77 LFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLD 136
+ + E AL+ +V G + + +
Sbjct: 70 ILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLG-S 128
Query: 137 LPSSLLKSAPESCAVYII 154
+P+++ + A V I+
Sbjct: 129 VPANVSRRAK--VDVLIV 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 701 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.88 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.87 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.83 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.79 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.17 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 94.5 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 89.13 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 87.68 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 81.63 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=428.85 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=212.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|++.+.||+|+||.||+|++. ++.||||++........+.+.+|+.+|+.++|||||+++++|.+ ..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 347999999999999999999974 66799999987665667789999999999999999999999844 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
++||+|.+++.+ ..+++..+..|+.||+.||.|||++| ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 999999987744 25899999999999999999999999 9999999999999999999999999999875432
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA---IRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~---i~~~~~~~~ld~~~~~~ 625 (701)
......+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+..... +..+... . ..
T Consensus 171 -----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------~-~~ 238 (293)
T d1yhwa1 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------L-QN 238 (293)
T ss_dssp -----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC------C-SS
T ss_pred -----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC------C-CC
Confidence 1235668999999999999999999999999999999999999999766543322 2222211 1 12
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
|...+..+.+|+.+||+.+|.+||++.+++.|+|++.
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 2334556899999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=427.90 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=203.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC-CChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS-QGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~E 467 (701)
.++|++.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|+.+|++++|||||++++++.+. .|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999985 56799999876542 2345689999999999999999999998554 479999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999843 346999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHcCccccccCccCC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~~~~~~~~ld~~~~ 623 (701)
........+||+.|+|||++.+..+ +.++|||||||+||||+||++||...... ...+...... .+
T Consensus 158 ----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---~~--- 227 (271)
T d1nvra_ 158 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LN--- 227 (271)
T ss_dssp ----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---ST---
T ss_pred ----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---CC---
Confidence 1122356789999999999988776 57899999999999999999999654322 1222221111 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. ....+..+.+|+.+||+.+|.+|||+.+++.|+|++
T Consensus 228 ~-~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 228 P-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp T-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred c-cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 1 122334688999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=422.01 Aligned_cols=246 Identities=29% Similarity=0.415 Sum_probs=209.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++.+.||+|+||.||+|++. ++.||+|++.+.. ......+.+|+.+|+.++|||||++++++.+. .++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999995 5569999986432 23456789999999999999999999999654 47999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998654 35899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
.....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.. ...+..+.+ .
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------~ 222 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------T 222 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------C
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------C
Confidence 124568999999999999999999999999999999999999999866532 233333322 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+|...+..+.+|+.+||+.+|.+|||+.+++.|+|+.-
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 23334456899999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=425.30 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC----CCceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~lV 465 (701)
++|++.+.||+|+||.||+|++. ++.||||++....... .+.+.+|+++|++++|||||+++++|.+ ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999985 5569999997764322 3458999999999999999999998843 24799
Q ss_pred EeecCCCChhhHhccc-CCCCCCChHHHHHHHHHHHHHHHHHhhcCC--CCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 466 YEYMENGSLEDRLFQK-DNSPPIHWSIRFKIAAEIATALLFLHQNKP--EPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~--~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|||+++|+|.+++.+. .....+++..++.++.||+.||.|||+.++ .+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988643 234569999999999999999999998652 3599999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCc
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDP 620 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~ 620 (701)
+.... ......+||+.|+|||++.+..|+.++|||||||+||||+||++||...+. +...+..+.+..
T Consensus 164 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---- 233 (269)
T d2java1 164 LNHDT------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---- 233 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred cccCC------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 74322 123457899999999999999999999999999999999999999976543 333444554322
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
.|...+.++.+|+.+||+.||.+||++.+++.|+|
T Consensus 234 ----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 234 ----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 22334456899999999999999999999999988
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=423.95 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=209.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.+.|++++.||+|+||.||+|++. +..||||++........+.+.+|+++|++++|||||+++++|.+ ..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357999999999999999999985 45699999987665666789999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.+.. .++++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 91 ~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--- 162 (288)
T d2jfla1 91 CAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--- 162 (288)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH---
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC---
Confidence 99999999876543 35899999999999999999999999 99999999999999999999999999976421
Q ss_pred cccccccccccccCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQ-----TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
........+||+.|+|||++. ...|+.++|||||||+||||+||++||...+.. ...+..+....+
T Consensus 163 ---~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 235 (288)
T d2jfla1 163 ---TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL---- 235 (288)
T ss_dssp ---HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC----
T ss_pred ---CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 112335678999999999874 456899999999999999999999999765432 222233322111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..|...+..+.+|+.+||+.||.+|||+.+++.|+|++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 12233445689999999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=420.41 Aligned_cols=256 Identities=25% Similarity=0.458 Sum_probs=204.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEee
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEY 468 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey 468 (701)
..++|.+.+.||+|+||.||+|++++ .||||+++.... ...+.|.+|+.+|++++|||||+++|++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 45789999999999999999998765 599999876542 334679999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~- 158 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS- 158 (276)
T ss_dssp CCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC-
Confidence 99999999986433 45899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~ 622 (701)
.........||+.|+|||++.+ +.|+.++|||||||+||||+||+.||.... .+...+..+... +..
T Consensus 159 ---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~~ 231 (276)
T d1uwha_ 159 ---GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PDL 231 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CCG
T ss_pred ---CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----Ccc
Confidence 1123456789999999998864 458999999999999999999999997543 333444444322 222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..++..+.+|+.+||+.+|.+|||+.+|+.+ +..|
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~-Le~l 270 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS-IELL 270 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH-HHHH
Confidence 23334445569999999999999999999999865 3444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=428.89 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=205.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
..++|+++++||+|+||.||+|++. +..||+|+++...... ...+.+|+.+|+.++|||||+++++|.+. .|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999984 5669999997764333 45789999999999999999999999554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||++||+|.+++.+.. .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999996543 58999999999999999999997 58 99999999999999999999999999986532
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-----cCccccc---
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR-----NGTFSEL--- 617 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~-----~~~~~~~--- 617 (701)
....+.+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+....... .+.....
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 123456899999999999999999999999999999999999999965432111000 0000000
Q ss_pred ----------------------------cCccCCCCC-HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 618 ----------------------------LDPTVTGWP-VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 618 ----------------------------ld~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
........+ ...+.++.+|+.+||..||.+|||+.+++.|+|++-.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000000 01234688999999999999999999999999998544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=416.68 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=207.4
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEee
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEY 468 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey 468 (701)
...++|++.+.||+|+||.||+|++++ +.||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ ..++||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence 345789999999999999999999964 579999997653 456789999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-
Confidence 99999999875432 235899999999999999999999999 9999999999999999999999999999875432
Q ss_pred cccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchH--HHHHHHcCccccccCccCCCC
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQ--VEQAIRNGTFSELLDPTVTGW 625 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~ 625 (701)
........||+.|+|||++.++.++.++|||||||+||||+|| +|||..... +...+..+... ..
T Consensus 164 ----~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~--------~~ 231 (272)
T d1qpca_ 164 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------VR 231 (272)
T ss_dssp ----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CC
T ss_pred ----cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------CC
Confidence 1223456899999999999999999999999999999999995 566655433 33344443211 12
Q ss_pred CHHHHHHHHHHHHHhhccCcCCCCChhhhhh--HHHH
Q 005343 626 PVEAALSIAKLALQCCELRKRDRPDLVSVVL--PELI 660 (701)
Q Consensus 626 p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~--~~~~ 660 (701)
|...+..+.+|+.+||+.+|.+|||+.+|+. ++|+
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2334456899999999999999999999974 4444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=411.10 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=197.7
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceec--CCCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACP--EYGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 470 (701)
++|.+.+.||+|+||.||+|++. ++.||||++.... ...+.|.+|+.++++++|||||+++|+|. +..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57999999999999999999995 4569999997653 45678999999999999999999999984 45689999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 99999988543 346899999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......||+.|+|||++.+..|+.++|||||||+||||+| |++||..... +...+..+.. ...|.
T Consensus 157 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------~~~p~ 225 (263)
T d1sm2a_ 157 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------CCCCT
T ss_pred ---eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--------CCCcc
Confidence 12234679999999999999999999999999999999999 5677765443 3333444321 11233
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.++..+.+|+.+||+.+|.+||++.+|+.+ |.++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~-L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ-LAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHH-HHHHH
Confidence 344568999999999999999999999865 55553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=414.22 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=199.6
Q ss_pred ceeeeeeeecCceeEEEEEECC--ceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC------CCceE
Q 005343 396 FSISRKIGEGGYGPVYKAQLDH--TSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE------YGCLV 465 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~~~--~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~lV 465 (701)
|++.++||+|+||+||+|++.. ..||+|++...... ..+.|.+|+++|++++|||||+++++|.+ ..++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677889999999999999954 46999988654322 23568999999999999999999999843 24899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc-CCCcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD-QNYVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~KL~DFGla~~~~ 544 (701)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ .+||||||||+|||++ .++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999654 36899999999999999999999876 3599999999999996 58899999999998653
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV---EQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~---~~~i~~~~~~~~ld~~ 621 (701)
.. .....+||+.|+|||++.+ .|+.++|||||||+||||+||++||...... ...+..+.....
T Consensus 167 ~~--------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~---- 233 (270)
T d1t4ha_ 167 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS---- 233 (270)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG----
T ss_pred CC--------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc----
Confidence 32 1245689999999998865 6999999999999999999999999754332 233333322111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
++...+.++.+|+.+||+.+|++|||+.+++.|+|++
T Consensus 234 ---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 ---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1122234589999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=417.41 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=205.5
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++.+.||+|+||.||+|++. +..||||++.... ......+.+|+++|++++|||||+++++|.+. .|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999984 5679999986432 23456799999999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||++||+|.+++... ..+++..+..++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988654 35899999999999999999999999 999999999999999999999999999987543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
.. .......+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.. ...+..+.+ .
T Consensus 162 ~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~ 228 (288)
T d1uu3a_ 162 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------D 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------C
T ss_pred Cc----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---------C
Confidence 21 12235668999999999999999999999999999999999999999866543 233333332 2
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+|...+..+.+|+.+||+.||.+|||+.+++.|.|.+
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~ 265 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH
Confidence 2333445689999999999999999999987766654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=419.40 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=193.7
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
..+.|++.+.||+|+||.||+|++. ++.||||++...... ....+.+|+.+|+.++|||||+++++|.+. .||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577999999999999999999985 556999998765432 345688999999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeecccccc
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLV 543 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGla~~~ 543 (701)
||++||+|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999543 46999999999999999999999999 99999999999994 5789999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCcc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPT 621 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~ 621 (701)
.... .....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...... ...+..+... ...+
T Consensus 161 ~~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~- 231 (307)
T d1a06a_ 161 DPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE-FDSP- 231 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC-CCTT-
T ss_pred cCCC-------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CCCc-
Confidence 4321 234568999999999999999999999999999999999999999766532 2333333321 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+...+..+.+|+.+||..+|.+|||+.+++.|+|++
T Consensus 232 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 232 ---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred ---cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 1123344689999999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=409.80 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=204.7
Q ss_pred hcCceeeee-eeecCceeEEEEEEC----CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceE
Q 005343 393 TDYFSISRK-IGEGGYGPVYKAQLD----HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~-IG~G~fg~Vyk~~~~----~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV 465 (701)
.++|.+.+. ||+|+||.||+|.+. +..||||+++..... ..+.|.+|+++|++++|||||+++|+|.+ ..+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lv 86 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 86 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEE
Confidence 356788874 999999999999873 335999999765433 24569999999999999999999999954 55899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++... ...+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987443 246899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~ 622 (701)
... .........||+.|+|||++.++.++.++|||||||++|||+| |++||.... ++...+..|...
T Consensus 162 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~------- 231 (285)
T d1u59a_ 162 DDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------- 231 (285)
T ss_dssp CSC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------
T ss_pred ccc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 321 1222345678999999999999999999999999999999998 899997543 344555555422
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..|..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 232 -~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 232 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 23344456789999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-49 Score=416.88 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=202.1
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
.|+.++.||+|+||.||+|++. +..||||++....... .+.+.+|+.+|++++|||||+++|+|.+ ..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999984 5569999997665333 2458899999999999999999999844 4589999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
||.+|+|..++... .++++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999997666433 46899999999999999999999999 99999999999999999999999999986532
Q ss_pred CcccccccccccccCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--HHcCccccccCccC
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQT---GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA--IRNGTFSELLDPTV 622 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--i~~~~~~~~ld~~~ 622 (701)
....+||+.|+|||++.+ +.|+.++|||||||++|||++|++||......... +..+.......
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 236 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--- 236 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC---
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC---
Confidence 234679999999998854 46899999999999999999999999766543322 22222211111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+ +..+.+|+.+||+.||.+|||+.+++.|+|+.
T Consensus 237 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 237 GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 122 34689999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-49 Score=411.75 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=194.0
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc-----eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceec--CCCce
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT-----SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACP--EYGCL 464 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~-----~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~l 464 (701)
.++|++.++||+|+||.||+|++..+ .||||.+...... ..+.|.+|+.+|++++|||||+++|+|. +..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 35689999999999999999998432 3888988665433 2456999999999999999999999994 34589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
|||||++|+|.+++... ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999987543 346899999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~ 621 (701)
...... .........||+.|+|||++.++.|+.++|||||||+||||+| |++||..... +...+..+..
T Consensus 180 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~------- 251 (299)
T d1jpaa_ 180 DDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR------- 251 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred CCCCcc-eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 432211 1112234568999999999999999999999999999999998 8999975543 3333443321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...|..++..+.+|+.+||+.+|.+||++.+|+. .|.++
T Consensus 252 -~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~-~L~~~ 290 (299)
T d1jpaa_ 252 -LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN-TLDKM 290 (299)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHH
T ss_pred -CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH-HHHHH
Confidence 1223344556899999999999999999999974 34443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-49 Score=421.80 Aligned_cols=252 Identities=19% Similarity=0.318 Sum_probs=210.7
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~Ey 468 (701)
.++|++++.||+|+||.||+|++. +..||||++..........+.+|+.+|++++|||||+++++|.+. .||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999984 566999999776544456789999999999999999999998554 4899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc--CCCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD--QNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~~KL~DFGla~~~~~~ 546 (701)
|+||+|.+.+... ..++++..+..|+.||+.||.|||++| ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999877443 346999999999999999999999999 99999999999997 6789999999999987543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 624 (701)
. ......||+.|+|||++.+..|+.++|||||||+||+|+||++||...+... ..+..+.+.. ...
T Consensus 183 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~---- 250 (352)
T d1koba_ 183 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-DED---- 250 (352)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-CSS----
T ss_pred C-------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Ccc----
Confidence 2 1345689999999999999999999999999999999999999998765433 3333333211 111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+...+..+.+|+.+||+.+|.+|||+.+++.|+|++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 1123344689999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-48 Score=420.16 Aligned_cols=252 Identities=19% Similarity=0.334 Sum_probs=210.0
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++........+.+.+|+.+|++++|||||+++++|.+ ..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999985 56799999977654556678999999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc--CCCcEEEEeeccccccCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD--QNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~~KL~DFGla~~~~~~ 546 (701)
|+||+|.+++... ...+++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 245999999999999999999999999 99999999999995 4689999999999987543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~~ld~~~~~ 624 (701)
. .....+||+.|+|||++.+..|+.++|||||||++|+|+||++||...+..+ ..+..+.+.. .....
T Consensus 180 ~-------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~-- 249 (350)
T d1koaa2 180 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-DDSAF-- 249 (350)
T ss_dssp S-------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-CCGGG--
T ss_pred c-------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Ccccc--
Confidence 2 1245689999999999999999999999999999999999999998665432 2333332211 01111
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+..+.+|+.+||..||.+|||+.+++.|+|++
T Consensus 250 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 250 --SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp --GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred --cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 12334689999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=412.89 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=204.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEE
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVY 466 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~ 466 (701)
...++|.+.+.||+|+||.||+|++. ++.||||+++.+. ...++|.+|+.+|++++|||||+++|+|.+ ..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34578999999999999999999995 5579999987654 456789999999999999999999999854 458999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+++|+|.+++.... ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 93 E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999986543 357899999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCch--HHHHHHHcCccccccCccCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH--QVEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~--~~~~~i~~~~~~~~ld~~~~ 623 (701)
.. .......||+.|+|||++.++.|+.++|||||||+||||+||. |||...+ .+...+..+.. .
T Consensus 169 ~~-----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--------~ 235 (287)
T d1opja_ 169 TY-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------M 235 (287)
T ss_dssp SS-----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------C
T ss_pred Cc-----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC--------C
Confidence 21 1234556899999999999999999999999999999999965 4554433 22334443321 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..|...+..+.+|+.+||+.+|++|||+.+|+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 22333445689999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=406.41 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=197.4
Q ss_pred eeeeecCceeEEEEEECC----ceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeecCCC
Q 005343 400 RKIGEGGYGPVYKAQLDH----TSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYMENG 472 (701)
Q Consensus 400 ~~IG~G~fg~Vyk~~~~~----~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~~~g 472 (701)
++||+|+||.||+|.+.+ +.||||+++...... .+.|.+|+.+|++++|||||+++|+|.+ ..+|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 479999999999998732 359999997654332 3569999999999999999999999954 458999999999
Q ss_pred ChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcccc
Q 005343 473 SLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADTIT 552 (701)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~ 552 (701)
+|.+++... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 93 ~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--- 163 (277)
T d1xbba_ 93 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 163 (277)
T ss_dssp EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---
T ss_pred cHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc---
Confidence 999988543 45899999999999999999999999 999999999999999999999999999877543221
Q ss_pred cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCCCHHH
Q 005343 553 QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWPVEA 629 (701)
Q Consensus 553 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p~~~ 629 (701)
........||+.|+|||.+.+..++.++|||||||++|||+| |++||.... .+...+..+... ..|..+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--------~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCCTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------CCCccc
Confidence 112345679999999999999999999999999999999998 899997654 334445544321 223344
Q ss_pred HHHHHHHHHHhhccCcCCCCChhhhh---hHHHHHH
Q 005343 630 ALSIAKLALQCCELRKRDRPDLVSVV---LPELIRL 662 (701)
Q Consensus 630 ~~~l~~li~~cl~~~P~~RPt~~~vl---~~~~~~l 662 (701)
+..+.+|+.+||+.+|.+||++.+|+ .+.|+.+
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 55689999999999999999999985 4445444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=410.29 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred cCceeeeeeeecCceeEEEEEECCc------eEEEEEeCCCC-CCChHHHHHHHHHHHhCCCCcEEEEeceecCC-CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT------SVAIKVLGPDI-SQGPRQFKQEVEILGSMRHTNMVILLGACPEY-GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~------~vAiK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~lV 465 (701)
++|++++.||+|+||.||+|.+..+ .||+|.+.... ....+.|.+|+.+|++++|||||+++|+|.+. .+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 4699999999999999999998433 48999887543 34467799999999999999999999999654 4799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+.+|+|.+.+... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 9999999999987654 356899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--hHHHHHHHcCccccccCccC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLS--HQVEQAIRNGTFSELLDPTV 622 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~--~~~~~~i~~~~~~~~ld~~~ 622 (701)
... ........||+.|+|||++.++.|+.++|||||||+||||+| |.+||... ..+...+..+...
T Consensus 164 ~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 232 (317)
T d1xkka_ 164 EEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 232 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-------
T ss_pred ccc----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 321 112344578999999999999999999999999999999999 78999754 3445555554321
Q ss_pred CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHH
Q 005343 623 TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPEL 659 (701)
Q Consensus 623 ~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~ 659 (701)
..|..++..+.+|+.+||+.+|.+|||+.+|+.+..
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 223344556899999999999999999999987743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=416.60 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=210.1
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV 465 (701)
.++|.+++.||+|+||.||+|++. +..||||++.+.. ......+.+|+.+|+.++||||++++++|.+. .|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999984 5669999987542 33457789999999999999999999999654 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
||||+||+|.+++.+.. .+++.....++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999886543 5788999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~ 623 (701)
.. ......+||+.|+|||++.+..|+.++|||||||+||||+||++||...+.. ...+..+.+
T Consensus 158 ~~------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--------- 222 (337)
T d1o6la_ 158 DG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------- 222 (337)
T ss_dssp TT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CC------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---------
Confidence 21 1235678999999999999999999999999999999999999999776542 233333322
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~ 661 (701)
.+|...+..+.+|+.+||+.||.+||+ +.+++.|+|++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 233444556899999999999999995 89999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=399.80 Aligned_cols=246 Identities=21% Similarity=0.354 Sum_probs=207.2
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEeecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEYME 470 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ 470 (701)
++|++.++||+|+||+||+|+++ ++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999995 4479999998754 456789999999999999999999999954 4489999999
Q ss_pred CCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCcc
Q 005343 471 NGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAADT 550 (701)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~ 550 (701)
+|+|.+++.... ..+++..+.+|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 999999875443 45889999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH--HHHHHHcCccccccCccCCCCCH
Q 005343 551 ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPV 627 (701)
Q Consensus 551 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~ 627 (701)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... +...+..+.. ...|.
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~ 224 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------LYRPH 224 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------CCCCT
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC--------CCCcc
Confidence 12345679999999999999999999999999999999998 8999986553 3333444321 12233
Q ss_pred HHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 628 EAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 628 ~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
..+..+.+|+.+||+.+|.+|||+.+|+.|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 3445799999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=407.62 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=208.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCCCCcEEEEeceecCC--C
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMRHTNMVILLGACPEY--G 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 462 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++.+.... ..+.+.+|+.+|++++|||||+++++|.+. .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999985 567999998654321 246799999999999999999999999654 4
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC----cEEEEeec
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY----VSKISDVG 538 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~KL~DFG 538 (701)
|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 8999999999999998654 35899999999999999999999999 99999999999998766 59999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHcCcccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIRNGTFSE 616 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~~~~~~~ 616 (701)
+|+.+.... ......||+.|+|||++.+..++.++|||||||+||||+||++||...+..+ ..+..+.+..
T Consensus 163 ~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred hhhhcCCCc-------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 998774332 2345689999999999999999999999999999999999999998665433 2333332210
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..+ .+...+..+.+|+.+||+.||.+||++.+++.|+|++-
T Consensus 236 -~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 236 -EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp -CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred -Cch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 000 01122346899999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=411.57 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=204.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc-------eEEEEEeCCCCC-CChHHHHHHHHHHHhC-CCCcEEEEeceecC--
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT-------SVAIKVLGPDIS-QGPRQFKQEVEILGSM-RHTNMVILLGACPE-- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~-------~vAiK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 460 (701)
..++|.+.+.||+|+||.||+|++.+. .||+|++..... .....+.+|+.+|.++ +|||||+++|+|.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 457899999999999999999998432 489999876532 3456789999999998 89999999999954
Q ss_pred CCceEEeecCCCChhhHhcccCC--------------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDN--------------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLK 520 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLK 520 (701)
..++||||+++|+|.++|..... ...+++..+..|+.||+.||.|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 45899999999999999965432 246899999999999999999999999 9999999
Q ss_pred CCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005343 521 PANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAM 599 (701)
Q Consensus 521 p~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 599 (701)
|+|||++.++.+||+|||+|+....... ........||+.|+|||++.++.|+.++|||||||+||||+| |++||
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhccccccCCeEEEeeccccccccCCCc----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999999999999999987643221 112345678999999999999999999999999999999998 89999
Q ss_pred CCch---HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHH
Q 005343 600 GLSH---QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPE 658 (701)
Q Consensus 600 ~~~~---~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~ 658 (701)
.... .+...+..+.. ...|...+..+.+|+.+||+.+|.+|||+.+|+.|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TTCCCSHHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6542 34444444321 123334455799999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-48 Score=409.93 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=206.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++++.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+. .|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999985 5679999986532 24456799999999999999999999998554 48999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||++||+|..++... ..+++.....++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999888544 35788888999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.. ...+..+.. .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------R 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------C
Confidence 24578999999999999999999999999999999999999999776543 233333332 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIR 661 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~ 661 (701)
+|...+..+.+++.+||..+|.+|| ++.+++.|+|++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 2233345689999999999999996 899999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=399.08 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=196.7
Q ss_pred hcCceeeeeeeecCceeEEEEEECCc------eEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC--CCc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHT------SVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE--YGC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~------~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 463 (701)
.+.|++.++||+|+||.||+|.+..+ .||||++....... ...|.+|+.+|++++|||||+++|+|.+ ..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45799999999999999999997432 59999997654332 3468999999999999999999999954 448
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
+||||+.+|+|.+.+.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998775433 46999999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCch--HHHHHHHcCccccccCc
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSH--QVEQAIRNGTFSELLDP 620 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~--~~~~~i~~~~~~~~ld~ 620 (701)
..... .........||+.|+|||++.++.++.++|||||||+||||+||. +|+.... .+...+..+..
T Consensus 161 ~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------ 231 (283)
T d1mqba_ 161 EDDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------ 231 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred cCCCc---cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC------
Confidence 54321 112234557899999999999999999999999999999999965 5554332 33444444421
Q ss_pred cCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 621 TVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 621 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...|..++..+.+|+.+||+.+|.+||++.+|+. .|.++
T Consensus 232 --~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~-~L~~l 270 (283)
T d1mqba_ 232 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKL 270 (283)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHH
T ss_pred --CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH-HHHHH
Confidence 1233344556999999999999999999999974 44444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=412.59 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=208.1
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHHhCCCCcEEEEeceecCC--CceEE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILGSMRHTNMVILLGACPEY--GCLVY 466 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~lV~ 466 (701)
++|++++.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+. .++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 5679999986432 23456789999999999999999999998554 47999
Q ss_pred eecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCC
Q 005343 467 EYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPS 546 (701)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~ 546 (701)
||+.+|+|..++.... .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986543 5899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCCC
Q 005343 547 AADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVTG 624 (701)
Q Consensus 547 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~~ 624 (701)
....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.. ...+..+.+ .
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------R 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------C
Confidence 24568999999999999999999999999999999999999999876543 223333322 1
Q ss_pred CCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHHH
Q 005343 625 WPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIRL 662 (701)
Q Consensus 625 ~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~l 662 (701)
.|...+..+.+|+.+||..||.+|+ ++.+++.|+|++-
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 2223344689999999999999994 8999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-47 Score=395.94 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=202.4
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCCh---HHHHHHHHHHHhCCCCcEEEEeceecCC------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGP---RQFKQEVEILGSMRHTNMVILLGACPEY------ 461 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 461 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++........ ..|.+|+.+|+.++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999984 66799999987654443 3589999999999999999999988432
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.||||||++||+|.+++... .++++..+..|+.||+.||.|||+++ ||||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 47999999999999988554 35899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHcCcccccc
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQ---AIRNGTFSELL 618 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---~i~~~~~~~~l 618 (701)
....... ........+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+..+. .+..+.....
T Consensus 160 ~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 160 AIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG-
T ss_pred hhccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc-
Confidence 6643221 12234567899999999999999999999999999999999999999987664433 2332221110
Q ss_pred CccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 619 DPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 619 d~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
..... .+..+.+++.+||+.||.+||+..+.|.++|.++++
T Consensus 236 -~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 236 -ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -GTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -hhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11112 234589999999999999999766677899999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=400.67 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=198.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEECCc-eEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC-CCceEEeec
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDHT-SVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE-YGCLVYEYM 469 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~~-~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~lV~Ey~ 469 (701)
..++|++.+.||+|+||.||+|+++++ .||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ ..++||||+
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~ 93 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 93 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEec
Confidence 357899999999999999999999654 69999997653 456789999999999999999999999954 458999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++.... ...++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999998886542 235899999999999999999999999 99999999999999999999999999987643321
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchH--HHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RPAMGLSHQ--VEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.......||+.|+|||++..+.++.++|||||||+||||+|| ++|+..... ....+..+... ..+
T Consensus 169 ----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--------~~~ 236 (285)
T d1fmka3 169 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------PCP 236 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------CCC
T ss_pred ----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------CCC
Confidence 123456799999999999999999999999999999999995 455554432 23334433211 223
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
..++..+.+++.+||+.+|++||++.+|+
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 34445699999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=400.26 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=195.8
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC-CCce
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE-YGCL 464 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~l 464 (701)
..++|++.+.||+|+||.||+|++.. ..||||.+....... ...|.+|+.+|++++|||||+++|+|.+ ..++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i 84 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 84 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence 35689999999999999999999843 248888886544332 3569999999999999999999999954 4589
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... .++++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999875433 46899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~ 621 (701)
... ........||+.|+|||++.+..|+.++|||||||+||||+| |.+||.... .+...+..+...
T Consensus 160 ~~~-----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------ 228 (273)
T d1mp8a_ 160 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 228 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred CCc-----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 321 122345678999999999999999999999999999999998 899997543 333444544321
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
..|...+..+.+|+.+||+.+|.+|||+.+|+.+ |..+
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~-L~~i 266 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ-LSTI 266 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH-HHHH
Confidence 2233445569999999999999999999999865 4443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=403.02 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=209.2
Q ss_pred HHHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceecC
Q 005343 389 IEAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACPE 460 (701)
Q Consensus 389 i~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 460 (701)
++...++|++.+.||+|+||.||+|++.+ +.||||+++...... ...|.+|+.+|++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 44467789999999999999999999743 469999987654333 3569999999999999999999999854
Q ss_pred --CCceEEeecCCCChhhHhcccC---------------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKD---------------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHR 517 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHr 517 (701)
..++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ ||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 5589999999999999986432 2335899999999999999999999999 9999
Q ss_pred CCCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-
Q 005343 518 DLKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR- 596 (701)
Q Consensus 518 DLKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~- 596 (701)
||||+||||+.++.+||+|||+|+.+.... .....+...||+.|+|||++.+..|+.++|||||||+||||++|.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEcccceEECCCCcEEEccchhheeccCCc----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999998764322 112235678999999999999999999999999999999999995
Q ss_pred CCCCCchH--HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 597 PAMGLSHQ--VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 597 ~pf~~~~~--~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
+||..... +...+..+... ..|...+..+.+|+.+||+.+|.+|||+.+|+ ..|.+|
T Consensus 241 ~p~~~~~~~e~~~~v~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~-~~L~~i 299 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFCSIH-RILQRM 299 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHT
T ss_pred CCCCCCCHHHHHHHHHcCCCC--------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH-HHHHHh
Confidence 78876553 33445555432 23344455789999999999999999999985 455554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-47 Score=394.07 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=208.0
Q ss_pred hcCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCC---------hHHHHHHHHHHHhCC-CCcEEEEeceecC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQG---------PRQFKQEVEILGSMR-HTNMVILLGACPE 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~---------~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 460 (701)
.++|++.+.||+|+||+||+|++ +++.||||++....... .+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999998 55779999987654322 124889999999997 9999999999965
Q ss_pred CC--ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 461 YG--CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 461 ~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
.. ||||||+++|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 44 8999999999999999653 36899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHH
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT------GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVE--QAIR 610 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~i~ 610 (701)
+++.+.... ..+..+||+.|+|||++.+ ..++.++||||+||+||+|+||++||...+... ..+.
T Consensus 156 ~a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp TCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred heeEccCCC-------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 999875432 2245689999999998753 347889999999999999999999998776432 2334
Q ss_pred cCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 611 NGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 611 ~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+... ...+.. ...+.++.+|+.+||+.+|.+||++.+++.|+|++
T Consensus 229 ~~~~~-~~~~~~----~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 229 SGNYQ-FGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp HTCCC-CCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hCCCC-CCCccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 44332 111111 23345689999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=395.53 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=199.5
Q ss_pred hcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC---CCceEEeec
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE---YGCLVYEYM 469 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~~lV~Ey~ 469 (701)
.++|++.+.||+|+||.||+|+++++.||||+++.+ ...+.|.+|+++|++++|||||+++|+|.+ ..++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 467999999999999999999999999999999754 455789999999999999999999999843 358999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.++|.... ...+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999986542 235899999999999999999999999 999999999999999999999999999865332
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch--HHHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH--QVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~--~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.....+|..|+|||++.++.++.++|||||||++|||+| |++||.... ++...+.++... ..|
T Consensus 157 ------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--------~~~ 222 (262)
T d1byga_ 157 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------DAP 222 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--------CCC
T ss_pred ------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------CCC
Confidence 234468899999999999999999999999999999998 788887543 334444444322 223
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
...+..+.+|+.+||..||.+||++.+++. .|.++
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~-~L~~i 257 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE-QLEHI 257 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHH-HHHHH
Confidence 334456899999999999999999999875 45554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=398.93 Aligned_cols=252 Identities=28% Similarity=0.341 Sum_probs=196.0
Q ss_pred eeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC-----hHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 398 ISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG-----PRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 398 ~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
.+++||+|+||+||+|++. ++.||||++....... ...+.+|+.+|+.++|||||+++++|.+ ..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999984 5669999987654222 2468999999999999999999999854 45899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+.++++..++ .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9888776655 33456888999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--c--Ccccc-----c-
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--N--GTFSE-----L- 617 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~--~~~~~-----~- 617 (701)
......+||+.|+|||++... .|+.++|||||||++|||+||++||......+.... + +.... .
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 123456899999999987654 589999999999999999999999987765443221 0 11000 0
Q ss_pred ------cCccCCCCCH-----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 ------LDPTVTGWPV-----EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ------ld~~~~~~p~-----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
........+. ..+..+.+|+.+||..||++|||+.++|.|+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 0000011111 2234689999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=404.46 Aligned_cols=247 Identities=25% Similarity=0.312 Sum_probs=206.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHHHHHHHH-hCCCCcEEEEeceecCC--CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQEVEILG-SMRHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~--~~lV 465 (701)
++|.+.+.||+|+||+||+|++. ++.||||++.+.. ......+..|+.++. .++|||||++++++.+. .|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999994 5669999996532 244556777877765 68999999999998554 4899
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPP 545 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~ 545 (701)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999986543 5788999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld~~~~ 623 (701)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|+||++||...+. +...+..+.+
T Consensus 156 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 220 (320)
T d1xjda_ 156 GD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------- 220 (320)
T ss_dssp TT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred cc------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21 223557899999999999999999999999999999999999999976553 2333443332
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChh-hhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLV-SVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~-~vl~~~~~~ 661 (701)
.+|...+..+.+|+.+||..+|.+||++. +++.|+|++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 22333445689999999999999999995 799999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=404.17 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=200.4
Q ss_pred hcCceeee-eeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHh-CCCCcEEEEeceecC------CC
Q 005343 393 TDYFSISR-KIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGS-MRHTNMVILLGACPE------YG 462 (701)
Q Consensus 393 ~~~f~~~~-~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~------~~ 462 (701)
.++|.+.. .||+|+||.||+|++. ++.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798875 5999999999999984 55699999853 3568899999765 589999999998743 34
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC---CCcEEEEeecc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ---NYVSKISDVGL 539 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~KL~DFGl 539 (701)
|+|||||+||+|.+++..+. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 89999999999999996532 346999999999999999999999999 999999999999975 56899999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccc
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSEL 617 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ 617 (701)
|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.. ...+... +
T Consensus 161 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~----i 229 (335)
T d2ozaa1 161 AKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----I 229 (335)
T ss_dssp CEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C----C
T ss_pred eeeccCCC-------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH----H
Confidence 98764432 234568999999999999999999999999999999999999999654321 1111111 1
Q ss_pred cCccCCCCC----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 LDPTVTGWP----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ld~~~~~~p----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.... ..+| ...+..+.+|+.+||+.+|.+||++.+++.|+|++
T Consensus 230 ~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 230 RMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp CSCS-SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred hcCC-CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 0000 1122 23456799999999999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=400.04 Aligned_cols=252 Identities=18% Similarity=0.292 Sum_probs=207.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
..++|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+|+++|+.++|||||+++++|.+ ..|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999985 5569999997653 334568899999999999999999999854 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC--CCcEEEEeeccccccCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ--NYVSKISDVGLARLVPP 545 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~--~~~~KL~DFGla~~~~~ 545 (701)
||+||+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999998543 236899999999999999999999999 999999999999984 45899999999987643
Q ss_pred CCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHcCccccccCccCC
Q 005343 546 SAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV--EQAIRNGTFSELLDPTVT 623 (701)
Q Consensus 546 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~--~~~i~~~~~~~~ld~~~~ 623 (701)
.. ......||+.|+|||.+.+..|+.++|||||||+||+|+||++||...+.. -..+..+.+. +..+...
T Consensus 157 ~~-------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 228 (321)
T d1tkia_ 157 GD-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-FDEEAFK 228 (321)
T ss_dssp TC-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-CCHHHHT
T ss_pred CC-------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CChhhcc
Confidence 21 234567899999999999999999999999999999999999999876543 2223333221 0001111
Q ss_pred CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 624 GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 624 ~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
..+..+.+|+.+||..||.+||++.+++.|+|++
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 1234589999999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-47 Score=409.29 Aligned_cols=250 Identities=26% Similarity=0.287 Sum_probs=200.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCC---CCChHHHHH---HHHHHHhCCCCcEEEEeceecC--CC
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDI---SQGPRQFKQ---EVEILGSMRHTNMVILLGACPE--YG 462 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~---~~~~~~~~~---Ei~il~~l~HpnIv~l~g~~~~--~~ 462 (701)
.++|++.+.||+|+||.||+|++. +..||||++.+.. ......+.+ |+.+++.++|||||+++++|.+ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999985 5669999986432 122233444 4677788899999999999855 44
Q ss_pred ceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 463 CLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 8999999999999999654 35788999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHcCccccccC
Q 005343 543 VPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQ--VEQAIRNGTFSELLD 619 (701)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~i~~~~~~~~ld 619 (701)
+... .....+||+.|+|||++.. ..|+.++|||||||+||||+||++||..... ..........
T Consensus 157 ~~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----- 223 (364)
T d1omwa3 157 FSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----- 223 (364)
T ss_dssp CSSS--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS-----
T ss_pred cCCC--------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----
Confidence 6432 2345689999999999875 5689999999999999999999999975431 1122221110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCC-----hhhhhhHHHHHH
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPD-----LVSVVLPELIRL 662 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt-----~~~vl~~~~~~l 662 (701)
....+|...+..+.+|+.+||..||.+||+ +.+++.|+|++-
T Consensus 224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 224 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp -CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 111223334456899999999999999999 699999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=395.03 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=200.5
Q ss_pred cCHHHHHHhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEE
Q 005343 384 YTIEEIEAATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVIL 454 (701)
Q Consensus 384 ~~~~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l 454 (701)
|...+++...++|.+.++||+|+||.||+|++.+ +.||||+++..... ..+.+.+|+.++.++ +||||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 4556666667889999999999999999999732 35999998765432 234578888888776 68999999
Q ss_pred eceecC---CCceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 005343 455 LGACPE---YGCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRD 518 (701)
Q Consensus 455 ~g~~~~---~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 518 (701)
++++.+ ..++|||||++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 998743 35899999999999999965421 345899999999999999999999999 99999
Q ss_pred CCCCCeeEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CC
Q 005343 519 LKPANILLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITA-RP 597 (701)
Q Consensus 519 LKp~NILl~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG-~~ 597 (701)
|||+||||+.++.+||+|||+|+....... ........||+.|+|||++.++.++.++|||||||++|||+|| .+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTT----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCccceeECCCCcEEEccCcchhhcccccc----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 999999999999999999999987643321 1223566899999999999999999999999999999999997 47
Q ss_pred CCCCc---hHHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhH
Q 005343 598 AMGLS---HQVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLP 657 (701)
Q Consensus 598 pf~~~---~~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~ 657 (701)
||... ..+...+..+.... .|...+..+.+++.+||+.+|.+|||+.+|+.|
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 236 PYPGVKIDEEFCRRLKEGTRMR--------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCC--------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78643 24445555554321 223334568999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=394.53 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=200.6
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|++++.||+|+||.||+|.+. ++.||||+++.... .....+.+|+++|++++|||||+++++|.+ ..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999984 66799999976542 235679999999999999999999999954 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+.+ ++.+++... ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 444444333 3456999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCccccccCc--
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFSELLDP-- 620 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~~~~ld~-- 620 (701)
.......||+.|+|||.+.... ++.++|||||||+||+|++|++||...+....... .+.......+
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 2235568999999999866655 58899999999999999999999987654433221 1111111000
Q ss_pred --------cCCCC---C-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 621 --------TVTGW---P-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 621 --------~~~~~---p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
....+ + ...+..+.+|+.+||..||++|||+.+++.|+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~ 287 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence 00000 0 11234688999999999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=392.52 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=201.2
Q ss_pred hcCceeeeeeeecCceeEEEEEEC---CceEEEEEeCCCCC--CChHHHHHHHHHHHhC---CCCcEEEEeceecC----
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD---HTSVAIKVLGPDIS--QGPRQFKQEVEILGSM---RHTNMVILLGACPE---- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~---~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~---- 460 (701)
.++|+++++||+|+||.||+|++. ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999984 34599999865432 2234577888887665 89999999998831
Q ss_pred ---CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEee
Q 005343 461 ---YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDV 537 (701)
Q Consensus 461 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DF 537 (701)
..+++|||+.+|++..... .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3479999998877654432 33456899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCc
Q 005343 538 GLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGT 613 (701)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~ 613 (701)
|+++.... .......+||+.|+|||++.+..|+.++|||||||+||||+||++||...+..+.... .+.
T Consensus 161 g~~~~~~~-------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF-------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG-------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhhcc-------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99876432 1234567899999999999999999999999999999999999999987654332211 000
Q ss_pred c----------------ccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 F----------------SELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 ~----------------~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
. ..........++...+..+.+|+.+||+.||.+|||+.+++.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 0 00000001112223345688999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=389.74 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=191.1
Q ss_pred cCceeeeeeeecCceeEEEEEECC-----ceEEEEEeCCCCCCC---hHHHHHHHHHHHhCCCCcEEEEeceecCC-Cce
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDH-----TSVAIKVLGPDISQG---PRQFKQEVEILGSMRHTNMVILLGACPEY-GCL 464 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~-----~~vAiK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~l 464 (701)
++|++.+.||+|+||.||+|+++. ..||||++....... .+.|.+|+.+|++++|||||+++|+|.+. .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 569999999999999999998732 258999987654322 35699999999999999999999999654 489
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccC
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVP 544 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~ 544 (701)
||||+++|+|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999886543 45899999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH--HHHHcCccccccCcc
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQVE--QAIRNGTFSELLDPT 621 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~--~~i~~~~~~~~ld~~ 621 (701)
..... ........||..|+|||++.+..++.++|||||||++|||+| |++||...+..+ ..+...... .+
T Consensus 163 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~---~~- 235 (273)
T d1u46a_ 163 QNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---LP- 235 (273)
T ss_dssp C-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC---CC-
T ss_pred cCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC---CC-
Confidence 44321 122345568889999999999999999999999999999998 899997665433 222222111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 622 VTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 622 ~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.+...+..+.+|+.+||..+|++|||+.+|+
T Consensus 236 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 236 ---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1223334689999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=392.04 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=198.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC------ChHHHHHHHHHHHhCC--CCcEEEEeceecC--
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ------GPRQFKQEVEILGSMR--HTNMVILLGACPE-- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~-- 460 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++...... ....+.+|+.+|++++ |||||+++++|.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999984 567999998754322 1234678999999996 8999999999855
Q ss_pred CCceEEeecCC-CChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-CCcEEEEeec
Q 005343 461 YGCLVYEYMEN-GSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-NYVSKISDVG 538 (701)
Q Consensus 461 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-~~~~KL~DFG 538 (701)
..++||||+.+ +++.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 44899999976 5777777543 35899999999999999999999999 999999999999985 5799999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcCccccc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGML-GVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNGTFSEL 617 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~~~~~~ 617 (701)
+|+..... ..+..+||+.|+|||++.+..+ +.++|||||||+||+|+||++||...+.. ..+..
T Consensus 157 ~a~~~~~~--------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----~~~~~--- 221 (273)
T d1xwsa_ 157 SGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----IRGQV--- 221 (273)
T ss_dssp TCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHCCC---
T ss_pred cceecccc--------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----hhccc---
Confidence 99875432 2356789999999999887765 67799999999999999999999865432 22221
Q ss_pred cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 618 LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 618 ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.++...+..+.+|+.+||..||.+|||+.+++.|+|++
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 11222334689999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.2e-46 Score=387.62 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=199.4
Q ss_pred cCceeeeeeeecCceeEEEEEEC-CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD-HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~-~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~Ey 468 (701)
++|.++++||+|+||+||+|++. ++.||||++..... .....+.+|+.+|++++|||||++++.|.+ ..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999984 56799999976542 235679999999999999999999999854 44899999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAA 548 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~ 548 (701)
+.++.+..+.. ....+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98776666552 3356999999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCccc--------
Q 005343 549 DTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGTFS-------- 615 (701)
Q Consensus 549 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~~~-------- 615 (701)
.......|++.|+|||.+.. ..++.++|||||||++|||++|++||...+..+...+ .+...
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 12345578999999998765 4579999999999999999999999986654332221 01000
Q ss_pred cc--cCccC--------CCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 EL--LDPTV--------TGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~--ld~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.. .+... ..++...+..+.+|+.+||..||++|||+.+++.|+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00 00000 011122345689999999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=390.35 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=200.5
Q ss_pred cCceeeeeeeecCceeEEEEEECCc----eEEEEEeCCCC-CCChHHHHHHHHHHHhC-CCCcEEEEeceecCC--CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHT----SVAIKVLGPDI-SQGPRQFKQEVEILGSM-RHTNMVILLGACPEY--GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~----~vAiK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~lV 465 (701)
++|++.+.||+|+||.||+|++.++ .||||.+.... ....+.|.+|+++|+++ +|||||+++|+|.+. .++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6799999999999999999998543 47888875443 23456799999999998 799999999999554 4899
Q ss_pred EeecCCCChhhHhccc-------------CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcE
Q 005343 466 YEYMENGSLEDRLFQK-------------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVS 532 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 532 (701)
|||+++|+|.++|... .....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998654 23467999999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCchHH--HHHH
Q 005343 533 KISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQV--EQAI 609 (701)
Q Consensus 533 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~~~--~~~i 609 (701)
||+|||+|+...... ......||..|+|||.+..+.|+.++|||||||++|||++|. +||...+.. ...+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEccccccccccccc-------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999998653211 123457899999999999999999999999999999999975 678655432 2223
Q ss_pred HcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 610 RNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 610 ~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.++.. ...|...+..+.+|+.+||+.+|++||++.+|+.+ |.++.
T Consensus 240 ~~~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~-L~~i~ 284 (309)
T d1fvra_ 240 PQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS-LNRML 284 (309)
T ss_dssp GGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHHH
T ss_pred HhcCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH-HHHHH
Confidence 33321 12333445579999999999999999999999865 55553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=387.34 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=198.6
Q ss_pred eeeeeecCceeEEEEEECCc-----eEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecC---CCceEEeec
Q 005343 399 SRKIGEGGYGPVYKAQLDHT-----SVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPE---YGCLVYEYM 469 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~~-----~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---~~~lV~Ey~ 469 (701)
.++||+|+||+||+|++.++ .||||+++..... ....|.+|+++|++++|||||+++|+|.+ ..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999998332 4899998754322 34569999999999999999999999743 347999999
Q ss_pred CCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCCCc
Q 005343 470 ENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSAAD 549 (701)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~~~ 549 (701)
++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988543 345778889999999999999999999 999999999999999999999999999987543221
Q ss_pred ccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHcCccccccCccCCCCC
Q 005343 550 TITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QVEQAIRNGTFSELLDPTVTGWP 626 (701)
Q Consensus 550 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~~~~i~~~~~~~~ld~~~~~~p 626 (701)
.........||+.|+|||.+.++.++.++|||||||+||||+||..||.... +....+..|... ..|
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--------~~p 256 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--------LQP 256 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--------CCC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 1222345679999999999999999999999999999999999776664332 223334444321 123
Q ss_pred HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 627 VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 627 ~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
..++..+.+|+.+||..+|++||++.+|+.+ |.++.
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~-L~~i~ 292 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR-ISAIF 292 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH-HHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH-HHHHH
Confidence 3344569999999999999999999999876 55553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=390.37 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=207.0
Q ss_pred HHHHhhcCceeeeeeeecCceeEEEEEEC-------CceEEEEEeCCCCCCC-hHHHHHHHHHHHhCCCCcEEEEeceec
Q 005343 388 EIEAATDYFSISRKIGEGGYGPVYKAQLD-------HTSVAIKVLGPDISQG-PRQFKQEVEILGSMRHTNMVILLGACP 459 (701)
Q Consensus 388 ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~-------~~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~ 459 (701)
+++...++|.+.+.||+|+||.||+|.+. ++.||||+++...... ...|.+|+.++++++|||||+++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34445688999999999999999999874 3569999997653222 235899999999999999999999984
Q ss_pred --CCCceEEeecCCCChhhHhccc-------CCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC
Q 005343 460 --EYGCLVYEYMENGSLEDRLFQK-------DNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY 530 (701)
Q Consensus 460 --~~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~ 530 (701)
+..++||||+++|+|.+++... .....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 4558999999999999988543 23345789999999999999999999999 99999999999999999
Q ss_pred cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCchH--HHH
Q 005343 531 VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITAR-PAMGLSHQ--VEQ 607 (701)
Q Consensus 531 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~~--~~~ 607 (701)
.+||+|||+|+.+.... .........||+.|+|||.+.++.++.++|||||||+||||+||. +||..... ...
T Consensus 171 ~~Kl~DFGla~~~~~~~----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CEEECCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred eEEEeecccceeccCCc----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999998763321 222335567899999999999999999999999999999999985 88876543 233
Q ss_pred HHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhh
Q 005343 608 AIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVL 656 (701)
Q Consensus 608 ~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~ 656 (701)
.+..+.. ...|..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 247 ~i~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 247 FVMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3444432 1223334456999999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=384.72 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=204.2
Q ss_pred hhcCceeeeeeeecCceeEEEEEECC---------ceEEEEEeCCCCCCC-hHHHHHHHHHHHhC-CCCcEEEEeceecC
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQG-PRQFKQEVEILGSM-RHTNMVILLGACPE 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~~-~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 460 (701)
..++|.+.+.||+|+||.||+|++.+ +.||||+++.+.... ...+.+|+..+.++ +|||||+++|+|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 45789999999999999999998633 359999998765432 35688899999888 89999999999955
Q ss_pred C--CceEEeecCCCChhhHhcccCC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCee
Q 005343 461 Y--GCLVYEYMENGSLEDRLFQKDN-------------SPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANIL 525 (701)
Q Consensus 461 ~--~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NIL 525 (701)
. .++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 3 4799999999999999965432 245899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005343 526 LDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSHQ 604 (701)
Q Consensus 526 l~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 604 (701)
++.++.+||+|||+++....... ........||+.|+|||++.++.|+.++|||||||+||||+| |.+||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ecCCCCeEeccchhhcccccccc----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999987643321 122355679999999999999999999999999999999998 7899975542
Q ss_pred --HHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHHh
Q 005343 605 --VEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLRD 664 (701)
Q Consensus 605 --~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~~ 664 (701)
+...+..+... ..|...+..+.+|+.+||+.+|.+|||+.+|+. .|.++-+
T Consensus 244 ~~~~~~i~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~-~L~~i~a 296 (299)
T d1fgka_ 244 EELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRIVA 296 (299)
T ss_dssp HHHHHHHHTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHHH
T ss_pred HHHHHHHHcCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH-HHHHHhh
Confidence 33344444221 222333456899999999999999999999974 5666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=385.53 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=199.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCC--CChHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDIS--QGPRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|+++++||+|+||+||+|++. ++.||||++..... .....+.+|+.+|+.++||||+.++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999984 56799999865532 345678999999999999999999998732
Q ss_pred --CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeec
Q 005343 461 --YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVG 538 (701)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFG 538 (701)
..|+||||+.++.+.... .....++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 347999999877665444 33456889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH--H--cCc
Q 005343 539 LARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI--R--NGT 613 (701)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i--~--~~~ 613 (701)
+++.+..... .........+||+.|+|||++.+. .|+.++|||||||++|||+||++||...+...... . .+.
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKN--SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeecccccc--cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9987754321 112233456899999999988765 68999999999999999999999997655432211 1 111
Q ss_pred cccccCccCC--------------CCCHH-------HHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 FSELLDPTVT--------------GWPVE-------AALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 ~~~~ld~~~~--------------~~p~~-------~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+......... ..+.. ....+.+|+.+||..||++|||+.+++.|+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 1111000000 00111 123567899999999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=385.12 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=194.9
Q ss_pred cCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHH--HHHHhCCCCcEEEEeceecCC------CceE
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEV--EILGSMRHTNMVILLGACPEY------GCLV 465 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei--~il~~l~HpnIv~l~g~~~~~------~~lV 465 (701)
..|.+.+.||+|+||.||+|+++++.||||++... ....+.+|. ..+..++|||||+++|+|.+. .|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45888999999999999999999999999998653 234444444 455678999999999998432 3799
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNK-----PEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
||||++|+|.++|.+. .++|..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999653 5899999999999999999999741 123999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCch-----------
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG------MLGVKSDLYSLGVVLLQLITARPAMGLSH----------- 603 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~----------- 603 (701)
+.+..... .........+||+.|+|||++... .++.++|||||||+||||+||.+||+...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 156 VRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTT--EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccCCCc--ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 87744321 122234567899999999987654 36789999999999999999998874311
Q ss_pred ------HHHHHHHcCccccccCccCCC-C-CHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHHH
Q 005343 604 ------QVEQAIRNGTFSELLDPTVTG-W-PVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRLR 663 (701)
Q Consensus 604 ------~~~~~i~~~~~~~~ld~~~~~-~-p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l~ 663 (701)
.....+..+ .+.|.+.. + +......+.+|+.+||..+|++|||+.+|+. .|.+++
T Consensus 234 ~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~-~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK-TLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH-HHHHHH
T ss_pred ccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH-HHHHHH
Confidence 112222222 22232221 1 2244556999999999999999999999864 455554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=385.35 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=196.6
Q ss_pred CceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEeceecC--------CCce
Q 005343 395 YFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGACPE--------YGCL 464 (701)
Q Consensus 395 ~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~~~l 464 (701)
.|..+++||+|+||+||+|++. ++.||||++..... .+.+|+.+|++++||||++++++|.. +.||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5899999999999999999994 55699999976542 23579999999999999999998732 1379
Q ss_pred EEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCC-cEEEEeecccccc
Q 005343 465 VYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNY-VSKISDVGLARLV 543 (701)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~KL~DFGla~~~ 543 (701)
|||||++|.+..+.........+++..+..|+.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976654444333344567999999999999999999999999 99999999999999764 8999999999876
Q ss_pred CCCCCcccccccccccccCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHc----C------
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQ-TGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRN----G------ 612 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~----~------ 612 (701)
.... .....+||..|+|||.+. ...|+.++|||||||++|||++|++||...+........ |
T Consensus 174 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCCc-------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 4332 234568999999999765 457899999999999999999999999766543322110 0
Q ss_pred ------ccccccCccCC------CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 613 ------TFSELLDPTVT------GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 613 ------~~~~~ld~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+....-+... ......+..+.+|+.+||..||++|||+.++|.|+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00000001000 11122344689999999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=387.35 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=196.1
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecCC------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPEY------ 461 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 461 (701)
..++|+++++||+|+||.||+|++. ++.||||++....... .+.+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999985 6679999997654322 34688999999999999999999998432
Q ss_pred --CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecc
Q 005343 462 --GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGL 539 (701)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGl 539 (701)
.|+||||+ +++|..++.. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 38999999 6677776532 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----cCc-
Q 005343 540 ARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR----NGT- 613 (701)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~----~~~- 613 (701)
|+..... .+..+||+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....... .+.
T Consensus 168 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 168 ARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238 (346)
T ss_dssp CEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeccCCc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence 9876432 356689999999998766 4578999999999999999999999977654322211 000
Q ss_pred -------------------cccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 614 -------------------FSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 614 -------------------~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
+.......+..........+.+|+.+||..||.+|||+.++|.|+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 000000111111122344678999999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=387.81 Aligned_cols=259 Identities=24% Similarity=0.283 Sum_probs=199.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC-ChHHHHHHHHHHHhCCCCcEEEEeceecCC------Cc
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ-GPRQFKQEVEILGSMRHTNMVILLGACPEY------GC 463 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 463 (701)
+++|+++++||+|+||+||+|.+. ++.||||++...... ..+.+.+|+.+|+.++||||+++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 567999999999999999999984 667999999765422 245688999999999999999999998432 24
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccccc
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLV 543 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~ 543 (701)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999998542 5899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHcC----cccc--
Q 005343 544 PPSAADTITQYHMTTAAGTFCYIDPEYQQT-GMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIRNG----TFSE-- 616 (701)
Q Consensus 544 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~~~----~~~~-- 616 (701)
.... .........+||+.|+|||++.. ..++.++||||+||++|+|+||++||............. ....
T Consensus 160 ~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDH---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGG---CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cCCC---ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 4332 12223456789999999998754 567999999999999999999999997665322221110 0000
Q ss_pred -------------ccCccCCCCCH-----HHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 617 -------------LLDPTVTGWPV-----EAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 617 -------------~ld~~~~~~p~-----~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...+.....+. .....+.+|+.+||..||.+||++.++|.|+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00000111111 1123588999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=377.74 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=206.6
Q ss_pred HhhcCceeeeeeeecCceeEEEEEECC-------ceEEEEEeCCCCCC-ChHHHHHHHHHHHhC-CCCcEEEEeceecC-
Q 005343 391 AATDYFSISRKIGEGGYGPVYKAQLDH-------TSVAIKVLGPDISQ-GPRQFKQEVEILGSM-RHTNMVILLGACPE- 460 (701)
Q Consensus 391 ~~~~~f~~~~~IG~G~fg~Vyk~~~~~-------~~vAiK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 460 (701)
...++|.+.+.||+|+||.||+|++.+ +.||||+++..... ....|.+|+.+++.+ +|||||+++|+|.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 345789999999999999999998732 35999999865432 234689999999999 69999999999954
Q ss_pred -CCceEEeecCCCChhhHhcccC---------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCe
Q 005343 461 -YGCLVYEYMENGSLEDRLFQKD---------------NSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANI 524 (701)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NI 524 (701)
..++|||||++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 4589999999999999986543 2336899999999999999999999999 99999999999
Q ss_pred eEcCCCcEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005343 525 LLDQNYVSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLIT-ARPAMGLSH 603 (701)
Q Consensus 525 Ll~~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 603 (701)
|++.++.+||+|||+++.+..... .......+||+.|+|||++.++.++.++|||||||++|||+| |.|||...+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCcccccccchheeccCCCc----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997754321 122355789999999999999999999999999999999999 677775443
Q ss_pred ---HHHHHHHcCccccccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 604 ---QVEQAIRNGTFSELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 604 ---~~~~~i~~~~~~~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.+...+..+.... .|...+..+.+|+.+||+.+|++||++.+|+. .|.+
T Consensus 253 ~~~~~~~~i~~~~~~~--------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~-~L~~ 304 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ-LIEK 304 (311)
T ss_dssp SSHHHHHHHHHTCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred HHHHHHHHHhcCCCCC--------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH-HHHH
Confidence 3445555543211 12223345899999999999999999999974 4443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-43 Score=374.87 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=197.6
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEeceecC----CCceE
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGACPE----YGCLV 465 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~----~~~lV 465 (701)
.++|+++++||+|+||+||+|++. ++.||||+++.. ..+.+.+|+.+|+.+. ||||+.++++|.. ..++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999984 667999998653 4567899999999995 9999999998842 34789
Q ss_pred EeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCC-CcEEEEeeccccccC
Q 005343 466 YEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQN-YVSKISDVGLARLVP 544 (701)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~KL~DFGla~~~~ 544 (701)
|||+.+|+|..+. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997654 35899999999999999999999999 9999999999999864 579999999998775
Q ss_pred CCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHH--------------
Q 005343 545 PSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQ-VEQA-------------- 608 (701)
Q Consensus 545 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~-~~~~-------------- 608 (701)
... .....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||..... ....
T Consensus 182 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 182 PGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp TTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCC-------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 432 23556899999999987765 479999999999999999999999864321 1110
Q ss_pred -HHcCcc------ccccCcc--------CC-CCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 609 -IRNGTF------SELLDPT--------VT-GWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 609 -i~~~~~------~~~ld~~--------~~-~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
...... ...+... .. ......+.++.+|+.+||..||++|||+.++|.|+||+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 000000 0000000 00 01122345689999999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=367.49 Aligned_cols=256 Identities=23% Similarity=0.269 Sum_probs=200.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCC--ChHHHHHHHHHHHhCCCCcEEEEeceecC--CCceEEe
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQ--GPRQFKQEVEILGSMRHTNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~lV~E 467 (701)
++|++++.||+|+||+||+|++. ++.||||+++..... ....+.+|+.+|+.++||||++++++|.+ ..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999984 556999999765433 24678999999999999999999999854 4479999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccccccCCCC
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLARLVPPSA 547 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~~~~~~~ 547 (701)
|+.+++|..++.. ...+++..+..++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999988877643 346789999999999999999999999 9999999999999999999999999998764332
Q ss_pred CcccccccccccccCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHHH----cCccc------
Q 005343 548 ADTITQYHMTTAAGTFCYIDPEYQQTGM-LGVKSDLYSLGVVLLQLITARPAM-GLSHQVEQAIR----NGTFS------ 615 (701)
Q Consensus 548 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~~i~----~~~~~------ 615 (701)
. ......+++.|+|||++.... ++.++|||||||++|||++|+.|| ...+..+.... .+...
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 1 224456788999999887665 699999999999999999999775 43332221111 01000
Q ss_pred --cc----------cCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 --EL----------LDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 --~~----------ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.. ........+......+.+|+.+||+.||++|||+.++|.|+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 00 00011112223345688999999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=377.68 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=191.9
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC--------
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE-------- 460 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 460 (701)
.++|+++++||+|+||+||+|++. ++.||||++....... ...+.+|+.+|++++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999985 6679999997664322 3458899999999999999999999842
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
+.|+||||+.++.+ ..+. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 33899999976544 4442 34789999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---H-------
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAI---R------- 610 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i---~------- 610 (701)
+..... ......+||+.|+|||++.+..+++++||||+||++|+|++|++||...+...... .
T Consensus 167 ~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 167 RTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hccccc-------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 865432 23356689999999999999999999999999999999999999997655332211 0
Q ss_pred --------------cCcc--c---------cccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHHH
Q 005343 611 --------------NGTF--S---------ELLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVVLPELIRL 662 (701)
Q Consensus 611 --------------~~~~--~---------~~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~l 662 (701)
.+.. . ....+.....+...+..+.+|+.+||..||++|||+.++|.|+|++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0 00000001112234567899999999999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=374.41 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=200.2
Q ss_pred cCceeeeeeeecCceeEEEEEE-----CCceEEEEEeCCCC----CCChHHHHHHHHHHHhCCC-CcEEEEeceecC--C
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL-----DHTSVAIKVLGPDI----SQGPRQFKQEVEILGSMRH-TNMVILLGACPE--Y 461 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~-----~~~~vAiK~l~~~~----~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~--~ 461 (701)
++|++++.||+|+||.||+|.. .++.||||++.... ....+.+.+|+++|++++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 24569999986542 1334668899999999976 899999999854 4
Q ss_pred CceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 462 GCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
.++||||+.+|+|.+++.... .++......++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 479999999999999986554 4677888899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHcCcccc
Q 005343 542 LVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG--MLGVKSDLYSLGVVLLQLITARPAMGLSHQ---VEQAIRNGTFSE 616 (701)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~---~~~~i~~~~~~~ 616 (701)
.+.... ........||+.|++||.+... .++.++|||||||+||+|+||++||..... ...... +....
T Consensus 178 ~~~~~~-----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~-~~~~~ 251 (322)
T d1vzoa_ 178 EFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKS 251 (322)
T ss_dssp ECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-HHHHC
T ss_pred hhcccc-----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcccC
Confidence 764321 2223566899999999988654 478899999999999999999999965431 111111 11000
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCC-----ChhhhhhHHHHH
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRP-----DLVSVVLPELIR 661 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----t~~~vl~~~~~~ 661 (701)
....|...+..+.+|+.+||..+|.+|| |+.+++.|+|++
T Consensus 252 -----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 252 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred -----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 0122334456799999999999999999 478999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-43 Score=367.05 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=189.9
Q ss_pred cCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcEEEEecee---cCCCceEEee
Q 005343 394 DYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNMVILLGAC---PEYGCLVYEY 468 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~---~~~~~lV~Ey 468 (701)
++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+|+++++.++|+|++.+++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999984 5679999987653 234588999999999888776665554 3344789999
Q ss_pred cCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEc---CCCcEEEEeeccccccCC
Q 005343 469 MENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLD---QNYVSKISDVGLARLVPP 545 (701)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~KL~DFGla~~~~~ 545 (701)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 667766664433 46899999999999999999999999 99999999999985 456799999999998754
Q ss_pred CCCcccc-cccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-----HHcCccccccC
Q 005343 546 SAADTIT-QYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQA-----IRNGTFSELLD 619 (701)
Q Consensus 546 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~-----i~~~~~~~~ld 619 (701)
....... .......+||+.|+|||.+.+..++.++|||||||++|||+||++||......... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3322111 22345678999999999999999999999999999999999999999654321110 00000000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 620 PTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 620 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
.... ..+.++.+++..||+.+|.+||++.++.
T Consensus 239 ~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 239 VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred Hhcc----CCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 0011 2234589999999999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=375.23 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=198.0
Q ss_pred hhcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCC--hHHHHHHHHHHHhCCCCcEEEEeceecC-------
Q 005343 392 ATDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQG--PRQFKQEVEILGSMRHTNMVILLGACPE------- 460 (701)
Q Consensus 392 ~~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~------- 460 (701)
..++|+++++||+|+||+||+|++. ++.||||++....... .+.+.+|+.+|+.++|||||++++++..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3678999999999999999999984 6679999998664332 3468899999999999999999998732
Q ss_pred CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEeeccc
Q 005343 461 YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISDVGLA 540 (701)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla 540 (701)
..+++|+|+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 23678888999999998843 35999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--c--Cccc
Q 005343 541 RLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTG-MLGVKSDLYSLGVVLLQLITARPAMGLSHQVEQAIR--N--GTFS 615 (701)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~i~--~--~~~~ 615 (701)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|++||...+....... . +...
T Consensus 169 ~~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccCc---------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 76422 23566899999999976665 568999999999999999999999976653322111 0 0000
Q ss_pred cc---------------cCccCCCCC-----HHHHHHHHHHHHHhhccCcCCCCChhhhhhHHHHH
Q 005343 616 EL---------------LDPTVTGWP-----VEAALSIAKLALQCCELRKRDRPDLVSVVLPELIR 661 (701)
Q Consensus 616 ~~---------------ld~~~~~~p-----~~~~~~l~~li~~cl~~~P~~RPt~~~vl~~~~~~ 661 (701)
.- ........+ ...+..+.+|+.+||..||.+|||+.++|.|+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 00 000000011 11234588999999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-41 Score=355.90 Aligned_cols=251 Identities=20% Similarity=0.228 Sum_probs=194.8
Q ss_pred hcCceeeeeeeecCceeEEEEEEC--CceEEEEEeCCCCCCChHHHHHHHHHHHhCCC-CcEEEEeceecC--CCceEEe
Q 005343 393 TDYFSISRKIGEGGYGPVYKAQLD--HTSVAIKVLGPDISQGPRQFKQEVEILGSMRH-TNMVILLGACPE--YGCLVYE 467 (701)
Q Consensus 393 ~~~f~~~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~--~~~lV~E 467 (701)
.++|.+.+.||+|+||.||+|++. ++.||||++.... ....+.+|+++++.+.| +|++.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999984 5679999986543 33457889999999975 898888887744 4489999
Q ss_pred ecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcC-----CCcEEEEeeccccc
Q 005343 468 YMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQ-----NYVSKISDVGLARL 542 (701)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~~KL~DFGla~~ 542 (701)
|+ +|+|.+++.... ..+++..+..++.|++.||.|||+.+ ||||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 789998875543 45899999999999999999999999 999999999999964 57899999999998
Q ss_pred cCCCCCcc-cccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HH--HHHHHcCcccc
Q 005343 543 VPPSAADT-ITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSH---QV--EQAIRNGTFSE 616 (701)
Q Consensus 543 ~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~---~~--~~~i~~~~~~~ 616 (701)
+....... .........+||+.|+|||++.+..++.++|||||||++|||+||++||.... .. ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 75433221 12223456789999999999999999999999999999999999999996432 11 11111111000
Q ss_pred ccCccCCCCCHHHHHHHHHHHHHhhccCcCCCCChhhhh
Q 005343 617 LLDPTVTGWPVEAALSIAKLALQCCELRKRDRPDLVSVV 655 (701)
Q Consensus 617 ~ld~~~~~~p~~~~~~l~~li~~cl~~~P~~RPt~~~vl 655 (701)
......... +.++.+++..|+..+|.+||+...+.
T Consensus 236 ~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 236 PLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp CHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 000011223 34689999999999999999987664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-38 Score=341.46 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=194.5
Q ss_pred cCceeeeeeeecCceeEEEEEE--CCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-----------CCcEEEEeceecC
Q 005343 394 DYFSISRKIGEGGYGPVYKAQL--DHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-----------HTNMVILLGACPE 460 (701)
Q Consensus 394 ~~f~~~~~IG~G~fg~Vyk~~~--~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~ 460 (701)
++|+++++||+|+||+||+|++ .++.||||+++.+. ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999998 46679999997653 22456788999998875 5788989888733
Q ss_pred ----CCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCC-----
Q 005343 461 ----YGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNY----- 530 (701)
Q Consensus 461 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~----- 530 (701)
..+++|+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 336777777665554444455566678999999999999999999998 77 99999999999998654
Q ss_pred -cEEEEeeccccccCCCCCcccccccccccccCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----
Q 005343 531 -VSKISDVGLARLVPPSAADTITQYHMTTAAGTFCYIDPEYQQTGMLGVKSDLYSLGVVLLQLITARPAMGLSHQV---- 605 (701)
Q Consensus 531 -~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~---- 605 (701)
.+||+|||.+..... .....+||+.|+|||++....|+.++||||+||++++|++|++||......
T Consensus 169 ~~~kl~dfg~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ceeeEeeccccccccc---------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 489999999976532 224568999999999999999999999999999999999999999643210
Q ss_pred -----HH-----------HHHcCcc-----------ccccC----------ccCCCCCHHHHHHHHHHHHHhhccCcCCC
Q 005343 606 -----EQ-----------AIRNGTF-----------SELLD----------PTVTGWPVEAALSIAKLALQCCELRKRDR 648 (701)
Q Consensus 606 -----~~-----------~i~~~~~-----------~~~ld----------~~~~~~p~~~~~~l~~li~~cl~~~P~~R 648 (701)
.. .+..+.. ..+.. +.....+...+..+.+|+.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 00 0000000 00000 00112334566779999999999999999
Q ss_pred CChhhhhhHHHHH
Q 005343 649 PDLVSVVLPELIR 661 (701)
Q Consensus 649 Pt~~~vl~~~~~~ 661 (701)
||+.++|.|+|++
T Consensus 320 pta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 320 ADAGGLVNHPWLK 332 (362)
T ss_dssp BCHHHHHTCGGGT
T ss_pred cCHHHHhcCcccC
Confidence 9999999999998
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.89 E-value=4.2e-23 Score=194.62 Aligned_cols=132 Identities=11% Similarity=0.162 Sum_probs=114.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCC--------C---C-CCC-----------hHHHHH
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPR--------G---R-PAT-----------NDELQK 76 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~--------~---~-~~~-----------~~~~~~ 76 (701)
+.++||||||+|+.|.+|++||++++...+++|+++||.++..... + . ... .+++++
T Consensus 2 m~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (160)
T d1mjha_ 2 MYKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 81 (160)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred CcCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHH
Confidence 3589999999999999999999999999999999999987641100 0 0 000 145567
Q ss_pred HHHHHHHHHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 77 LFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 77 ~l~~~~~~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.++.+...|...|+.++.++.. |+|++.|+++|+++++|+||||+||++++.+.|+ ||++++|++++| |||++|.
T Consensus 82 ~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-GS~a~~vl~~s~--~pVlvV~ 156 (160)
T d1mjha_ 82 KMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL-GSVTENVIKKSN--KPVLVVK 156 (160)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS-CHHHHHHHHHCC--SCEEEEC
T ss_pred HHHHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCccccccc-CcHHHHHHhcCC--CCEEEEc
Confidence 8888888899999999999998 7999999999999999999999999999999777 999999999998 9999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.5e-23 Score=202.51 Aligned_cols=163 Identities=15% Similarity=0.121 Sum_probs=120.6
Q ss_pred ceeeeeeeecCceeEEEEEE-CCceEEEEEeCCCCCC-------------C-----hHHHHHHHHHHHhCCCCcEEEEec
Q 005343 396 FSISRKIGEGGYGPVYKAQL-DHTSVAIKVLGPDISQ-------------G-----PRQFKQEVEILGSMRHTNMVILLG 456 (701)
Q Consensus 396 f~~~~~IG~G~fg~Vyk~~~-~~~~vAiK~l~~~~~~-------------~-----~~~~~~Ei~il~~l~HpnIv~l~g 456 (701)
+.+.++||+|+||.||+|.+ ++..||||+++..... . ...+.+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999997 5678999998653211 0 122467889999999999988876
Q ss_pred eecCCCceEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCeeEcCCCcEEEEe
Q 005343 457 ACPEYGCLVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKPEPLVHRDLKPANILLDQNYVSKISD 536 (701)
Q Consensus 457 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~KL~D 536 (701)
+. ..+++|||++++.+.. ++......++.|++.+|.|||+.+ |+||||||+|||+++++ ++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECC
T ss_pred ec--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEE
Confidence 64 3589999998765533 233445679999999999999999 99999999999999765 89999
Q ss_pred eccccccCCCCCcccccccccccccCCCccC------cccccCCCCCchhhHHHHHHHH
Q 005343 537 VGLARLVPPSAADTITQYHMTTAAGTFCYID------PEYQQTGMLGVKSDLYSLGVVL 589 (701)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~a------PE~~~~~~~~~~sDvwSlGvil 589 (701)
||+|......... .|+. .+.+ ...|+.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH--------------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765322111 1111 1122 35678899999986544
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.88 E-value=6.1e-23 Score=196.13 Aligned_cols=130 Identities=17% Similarity=0.207 Sum_probs=103.7
Q ss_pred CEEEEEeCCCc---------chHHHHHHHHHhccCCCC---eEEEEEEecCCCCCC-----CCC----------CChHHH
Q 005343 22 AITAVAIDADK---------SSQYAVKWAVDNLLNETS---QYVLLHVRNHSSNPR-----GRP----------ATNDEL 74 (701)
Q Consensus 22 ~~IlVavD~s~---------~S~~Al~wA~~~~~~~g~---~v~llHV~~~~~~~~-----~~~----------~~~~~~ 74 (701)
.|||||||+|. .|++||+||++++.+.|+ .|+++||.++..... ... ...+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 58999999986 799999999999998888 499999987642111 000 012566
Q ss_pred HHHHHHHHHHHhhcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 75 QKLFLPYRGLFARKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 75 ~~~l~~~~~~~~~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
.++|+.+...|...|+.++.++.. |+|+++|+++|++.++|+||||+||++++.|.|+ |||+.+|+++++ |||++|
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~l-GSv~~~vi~~~~--cpVlvV 157 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--CPVMTI 157 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC---------CHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCcc-CcHHHHHHhCCC--CCEEEE
Confidence 788999999999999999998888 7999999999999999999999999999999666 999999999998 999999
Q ss_pred e
Q 005343 155 S 155 (701)
Q Consensus 155 ~ 155 (701)
.
T Consensus 158 ~ 158 (171)
T d2gm3a1 158 K 158 (171)
T ss_dssp E
T ss_pred e
Confidence 8
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.87 E-value=6.4e-23 Score=187.70 Aligned_cols=130 Identities=15% Similarity=0.180 Sum_probs=105.6
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCCh----HHHHHHHHHHHHHHhhcCCeeeEEEE
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATN----DELQKLFLPYRGLFARKRILAREVVL 97 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~v~~~~~v~ 97 (701)
++||||||+|+.|++|++||++++...+++|+++||+++.....+....+ +..+++.+.+..++...++.....++
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 81 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 81 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccccchhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEEE
Confidence 79999999999999999999999999999999999998754333322222 22233333444445556776666666
Q ss_pred EcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 98 QDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 98 ~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
..|+|.++|+++|+++++|+||||+||++++.|.++ ||++++|++++| |||++|
T Consensus 82 ~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 82 LEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSC-BHHHHHHHHHCS--SCEEEE
T ss_pred EcCChHHHHHHHhhhhheeeEEeccCCCCccccccc-CcHHHHHHHhCC--CCEEeC
Confidence 669999999999999999999999999999999666 999999999998 999997
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.83 E-value=1e-20 Score=175.22 Aligned_cols=132 Identities=13% Similarity=0.084 Sum_probs=105.0
Q ss_pred CCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCC---------CCChHHHHHHHHHHHHHHhhcCCe
Q 005343 21 NAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGR---------PATNDELQKLFLPYRGLFARKRIL 91 (701)
Q Consensus 21 ~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~---------~~~~~~~~~~l~~~~~~~~~~~v~ 91 (701)
.++||||||+|+.|++|++||+.++...++.++++||.++....... ....+..++.++.++..+.+.|+.
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 84 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGAK 84 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHTTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTCC
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHhcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 48999999999999999999999998766555555554432111100 112256778999999999999987
Q ss_pred eeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 92 AREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 92 ~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
.....+..|+++++|+++|+++++|+||||++|++++.+.|+ ||++++|++++| |||+||.
T Consensus 85 ~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~-Gs~~~~ll~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 85 NVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRRAK--VDVLIVH 145 (147)
T ss_dssp EEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHHTT--CEEEEEC
T ss_pred cEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccccc-ccHHHHHHHhCC--CCEEEEe
Confidence 544455558999999999999999999999999999999767 999999999998 9999997
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.79 E-value=4.6e-20 Score=169.31 Aligned_cols=130 Identities=13% Similarity=0.059 Sum_probs=103.6
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCCh-------HHHHHHHHHHHHHHhhcCCee
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATN-------DELQKLFLPYRGLFARKRILA 92 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~v~~ 92 (701)
+.++||||+|+|+.|+.|++||+.++...|+.|+++||.++++......... ...++....+...+...+...
T Consensus 1 myk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (140)
T d1jmva_ 1 MYKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPI 80 (140)
T ss_dssp CCSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCC
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCce
Confidence 3589999999999999999999999999999999999998753211111110 111234455555666677776
Q ss_pred eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEEe
Q 005343 93 REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYIIS 155 (701)
Q Consensus 93 ~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV~ 155 (701)
...++.+|+++++|+++|+++++|+||||+||+++.. + ||++++|+++++ |||++|.
T Consensus 81 ~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~---l-gs~~~~li~~~~--~pVliVp 137 (140)
T d1jmva_ 81 SEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSK---L-MSSTRQVMNTIK--IDMLVVP 137 (140)
T ss_dssp CCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHH---H-HHHHHHHHTTCC--SEEEEEE
T ss_pred EEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCC---c-ccHHHHHHhccC--CCEEEEe
Confidence 6666767899999999999999999999999998653 4 999999999998 9999996
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.75 E-value=6.2e-19 Score=160.97 Aligned_cols=122 Identities=15% Similarity=0.076 Sum_probs=97.1
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCC------CCCCCCCh-------HHHHHHHHHHHHHHh
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSN------PRGRPATN-------DELQKLFLPYRGLFA 86 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~------~~~~~~~~-------~~~~~~l~~~~~~~~ 86 (701)
.-|+||||+|+|+.|++||+||+.++...|++|+++||+++... ..+.+... +..++.++.+...+.
T Consensus 3 ~mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~ 82 (138)
T d1q77a_ 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLT 82 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccc
Confidence 35899999999999999999999999999999999999975310 01111111 344555666666666
Q ss_pred hcCCeeeEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcccccccCCCcchhhcccCCCceeEEEE
Q 005343 87 RKRILAREVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLLTRKFRNLDLPSSLLKSAPESCAVYII 154 (701)
Q Consensus 87 ~~~v~~~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~~r~~~~gSva~~v~~~ap~~c~V~vV 154 (701)
..++.++..+.. |+|++.|+++|+++++|+||||+||++++.|.++ || .|||++|
T Consensus 83 ~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~-g~-----------~~~~liv 137 (138)
T d1q77a_ 83 GSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSAYLCKVID-GL-----------NLASLIV 137 (138)
T ss_dssp SCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHH-HS-----------SSEEEEC
T ss_pred ccceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCCcHHHHHhc-CC-----------CCCEEEe
Confidence 678888888887 8999999999999999999999999999999655 65 3777776
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2e-07 Score=92.46 Aligned_cols=148 Identities=14% Similarity=0.126 Sum_probs=100.7
Q ss_pred HHHHHhhcCceeeeeeeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCC-CCcEEEEecee--cCCCc
Q 005343 387 EEIEAATDYFSISRKIGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMR-HTNMVILLGAC--PEYGC 463 (701)
Q Consensus 387 ~ei~~~~~~f~~~~~IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~--~~~~~ 463 (701)
.++......|++.+..+.|+.+.||+....+..+.+|+...........+.+|...+..+. +-.+-.++.++ .+..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3455566778877765555567999998888889999887655445556788988887663 21122333433 33458
Q ss_pred eEEeecCCCChhhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhhcCC--------------------------------
Q 005343 464 LVYEYMENGSLEDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQNKP-------------------------------- 511 (701)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~-------------------------------- 511 (701)
+||++++|.++.+.... ......++.+++..|..||+...
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888664421 11223356666666777775321
Q ss_pred ------------------------CCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 512 ------------------------EPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 512 ------------------------~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
..++|+|+.|.|||++.++.+-|.||+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999887778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=6.5e-05 Score=78.95 Aligned_cols=75 Identities=17% Similarity=0.131 Sum_probs=51.5
Q ss_pred eeeeeecCceeEEEEEEC--CceEEEEEeCCC-------CCCChHHHHHHHHHHHhCC-C--CcEEEEeceecCCCceEE
Q 005343 399 SRKIGEGGYGPVYKAQLD--HTSVAIKVLGPD-------ISQGPRQFKQEVEILGSMR-H--TNMVILLGACPEYGCLVY 466 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~--~~~vAiK~l~~~-------~~~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~lV~ 466 (701)
.+.||.|....||+.... +..|++|.-... ..........|.+.|..+. + ..+..++.+..+..++||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence 457899999999999763 456888865431 1123345667888887662 2 345567777888889999
Q ss_pred eecCCCC
Q 005343 467 EYMENGS 473 (701)
Q Consensus 467 Ey~~~gs 473 (701)
|++.+..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.32 E-value=0.00027 Score=68.70 Aligned_cols=128 Identities=16% Similarity=0.154 Sum_probs=77.7
Q ss_pred eeeecCc-eeEEEEEECCce-EEEEEeCCCCCCChHHHHHHHHHHHhCCCCc--EEEEecee--cCCCceEEeecCCCCh
Q 005343 401 KIGEGGY-GPVYKAQLDHTS-VAIKVLGPDISQGPRQFKQEVEILGSMRHTN--MVILLGAC--PEYGCLVYEYMENGSL 474 (701)
Q Consensus 401 ~IG~G~f-g~Vyk~~~~~~~-vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~--~~~~~lV~Ey~~~gsL 474 (701)
.+..|.. +.||+...++.. +.+|...... ...+..|...|+.+.... +..+++++ ....++||+|++|-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 689999886554 7888765543 234677888887664322 33344444 3344799999988655
Q ss_pred hhHhcccCCCCCCChHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 005343 475 EDRLFQKDNSPPIHWSIRFKIAAEIATALLFLHQ---------------------------------------------- 508 (701)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~---------------------------------------------- 508 (701)
.+.. +.. ..++.++...|.-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3311 110 1122233333333332
Q ss_pred -----cCC----CCeeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 509 -----NKP----EPLVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 509 -----~~~----~~iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
..+ ..++|+|+.|.|||++.+..+-|+||+.+.+
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 1279999999999999887778999998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.0023 Score=64.11 Aligned_cols=155 Identities=11% Similarity=0.066 Sum_probs=79.9
Q ss_pred CHHHHHHhhcCceeeee-----eeecCceeEEEEEECCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCC-----cEEEE
Q 005343 385 TIEEIEAATDYFSISRK-----IGEGGYGPVYKAQLDHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHT-----NMVIL 454 (701)
Q Consensus 385 ~~~ei~~~~~~f~~~~~-----IG~G~fg~Vyk~~~~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~Hp-----nIv~l 454 (701)
+.+|+.....+|.+.+. |..|---+.|+...++..+++|+..... ....+..|++++..|... ..+..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 44566666667766443 3355557889999988889999986542 334566677777666322 22111
Q ss_pred e-c----eecCCCceEEeecCCCChhh--------------Hhcc----cCCCC--------------------CCChHH
Q 005343 455 L-G----ACPEYGCLVYEYMENGSLED--------------RLFQ----KDNSP--------------------PIHWSI 491 (701)
Q Consensus 455 ~-g----~~~~~~~lV~Ey~~~gsL~~--------------~l~~----~~~~~--------------------~l~~~~ 491 (701)
. | ........++.++.+..... .+.. ..... ......
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 1 01122234555554422210 0000 00000 000111
Q ss_pred HHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCeeEcCCCcEEEEeecccc
Q 005343 492 RFKIAAEIATALLFLHQ-NKPEPLVHRDLKPANILLDQNYVSKISDVGLAR 541 (701)
Q Consensus 492 ~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~KL~DFGla~ 541 (701)
....+..+...+.-.+. .-+..+||+|+.++||+++.+...-|.||+.|.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11222233333333332 123359999999999999998887899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.44 E-value=0.0035 Score=65.18 Aligned_cols=72 Identities=18% Similarity=0.260 Sum_probs=49.2
Q ss_pred eeeeeecCceeEEEEEECC---------ceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-EEEeceecCCCceEEee
Q 005343 399 SRKIGEGGYGPVYKAQLDH---------TSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-VILLGACPEYGCLVYEY 468 (701)
Q Consensus 399 ~~~IG~G~fg~Vyk~~~~~---------~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~lV~Ey 468 (701)
++.|+.|-.-.+|++...+ ..|.+++... ....-...+|..+++.+.-.++ .+++++|. ..+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS--GGRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--TEEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--CceEEEE
Confidence 3678888889999998743 3477777652 2333456789999888743343 36677775 4689999
Q ss_pred cCCCCh
Q 005343 469 MENGSL 474 (701)
Q Consensus 469 ~~~gsL 474 (701)
++|-.|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.17 E-value=0.0063 Score=61.37 Aligned_cols=133 Identities=18% Similarity=0.209 Sum_probs=73.2
Q ss_pred ceeEEEEEE-CCceEEEEEeCCCCCCChHHHHHHHHHHHhCCCCcE-----EEEece----ecCCCceEEeecCCCChhh
Q 005343 407 YGPVYKAQL-DHTSVAIKVLGPDISQGPRQFKQEVEILGSMRHTNM-----VILLGA----CPEYGCLVYEYMENGSLED 476 (701)
Q Consensus 407 fg~Vyk~~~-~~~~vAiK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~g~----~~~~~~lV~Ey~~~gsL~~ 476 (701)
--.||++.. +++.|++|+.+... ....++..|+..+..|....+ +..-|- .....+.+++++.|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999987 56779999987653 356778889988877742221 111111 1223367888887633210
Q ss_pred --------------Hhcc----c--CCCCC-------------------CChHHHHHHHHHHHHHHHHHhh----cCCCC
Q 005343 477 --------------RLFQ----K--DNSPP-------------------IHWSIRFKIAAEIATALLFLHQ----NKPEP 513 (701)
Q Consensus 477 --------------~l~~----~--~~~~~-------------------l~~~~~~~i~~qia~aL~~LH~----~~~~~ 513 (701)
.++. . ..... ++...+..+...+...+..+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0000 0 00011 1111111222222333333332 22345
Q ss_pred eeecCCCCCCeeEcCCCcEEEEeeccccc
Q 005343 514 LVHRDLKPANILLDQNYVSKISDVGLARL 542 (701)
Q Consensus 514 iiHrDLKp~NILl~~~~~~KL~DFGla~~ 542 (701)
+||+|+.|.|||++++ ..+.||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 35899998764
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=94.50 E-value=0.096 Score=49.10 Aligned_cols=99 Identities=6% Similarity=-0.045 Sum_probs=67.8
Q ss_pred CCCCEEEEEeCCCcchHHHHHHHHHhccCCC-CeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEE
Q 005343 19 TANAITAVAIDADKSSQYAVKWAVDNLLNET-SQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVL 97 (701)
Q Consensus 19 ~~~~~IlVavD~s~~S~~Al~wA~~~~~~~g-~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~ 97 (701)
..+++|+||+-|-..|..+|..+.......+ ..|+++||-... .+....-.+.++.+|...||++...-+
T Consensus 22 ~~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~---------r~~s~~~~~~~~~~~~~l~i~~~i~~~ 92 (216)
T d1wy5a1 22 SGERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHML---------RESAERDEEFCKEFAKERNMKIFVGKE 92 (216)
T ss_dssp SSCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCS---------STHHHHHHHHHHHHHHHHTCCEEEEEC
T ss_pred CCCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeeccc---------ccchhhhhhHHHHHHHhhhhhhhhhcc
Confidence 4568999999999999887776666544444 369999996431 122333345678889888988764333
Q ss_pred Ec--------CCh--------hHHHHHHHHHcCCCEEEEccCCCC
Q 005343 98 QD--------IDV--------SSALIYYVKNNSVGNIVAGGSSRN 126 (701)
Q Consensus 98 ~~--------~~~--------~~~Iv~~a~~~~~d~IV~Gs~g~~ 126 (701)
.. ... ...+.++|++.++|.|++|.|..-
T Consensus 93 ~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD 137 (216)
T d1wy5a1 93 DVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (216)
T ss_dssp CHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred chhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeeccc
Confidence 20 111 245678999999999999999643
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=89.13 E-value=0.25 Score=46.33 Aligned_cols=96 Identities=9% Similarity=-0.051 Sum_probs=63.3
Q ss_pred CCCEEEEEeCCCcchHHHHHHHHHhcc-CCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEE
Q 005343 20 ANAITAVAIDADKSSQYAVKWAVDNLL-NETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQ 98 (701)
Q Consensus 20 ~~~~IlVavD~s~~S~~Al~wA~~~~~-~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~ 98 (701)
..++|+||+-|-..|..+|..+.+... ..+..|+++||-... . .........+..+|...|+.+......
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~------r---~~s~~~~~~~~~~~~~~~i~~~i~~~~ 82 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGL------S---ANADAWVTHCENVCQQWQVPLVVERVQ 82 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSC------C---SSHHHHHHHHHHHHHHTTCCEEEECCC
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCC------C---cchhhhHHHHHHHHhhccCcceeeecc
Confidence 358999999999999888876666543 357899999997531 1 123344566788899999887654333
Q ss_pred cCChh----------HHHHHHHHHcCCCEEEEccCC
Q 005343 99 DIDVS----------SALIYYVKNNSVGNIVAGGSS 124 (701)
Q Consensus 99 ~~~~~----------~~Iv~~a~~~~~d~IV~Gs~g 124 (701)
..... ......+...+++.|++|.|.
T Consensus 83 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 83 LAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp CCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred ccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 11111 112234456788888888774
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=87.68 E-value=1.9 Score=39.10 Aligned_cols=92 Identities=9% Similarity=0.017 Sum_probs=55.2
Q ss_pred CEEEEEeCCCcchHHHHHHHHHhccCCCCeEEEEEEecCCCCCCCCCCChHHHHHHHHHHHHHHhhcCCeeeEEEEEcCC
Q 005343 22 AITAVAIDADKSSQYAVKWAVDNLLNETSQYVLLHVRNHSSNPRGRPATNDELQKLFLPYRGLFARKRILAREVVLQDID 101 (701)
Q Consensus 22 ~~IlVavD~s~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~v~~~~~ 101 (701)
.||+|++-|-..|.-++.++.+ .|..|++||+.... ... +...+........+......+...+....+
T Consensus 5 gKvvv~~SGG~DS~vla~ll~k----~g~~v~av~~~~~~------~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 73 (218)
T d2c5sa1 5 GKVMVLLSGGIDSPVAAYLTMK----RGVSVEAVHFHSPP------FTS-ERAKQKVIDLAQELTKYCKRVTLHLVPFTE 73 (218)
T ss_dssp EEEEEECCSSSHHHHHHHHHHH----BTEEEEEEEEECTT------TSC-HHHHHHHHHHHHHHGGGSSCEEEEEEECHH
T ss_pred CEEEEEecCcHHHHHHHHHHHH----cCCeEEEEEEeCCC------ccc-hHHHHHHHhhhccccccccccceEEeecch
Confidence 4899999999999877777654 37889999997531 111 222222222222333333334433332111
Q ss_pred h---------------------hHHHHHHHHHcCCCEEEEccCC
Q 005343 102 V---------------------SSALIYYVKNNSVGNIVAGGSS 124 (701)
Q Consensus 102 ~---------------------~~~Iv~~a~~~~~d~IV~Gs~g 124 (701)
. ...+.++|++.+++.|+.|.+-
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~G~~~ 117 (218)
T d2c5sa1 74 VQKTINKEIPSSYSMTVMRRMMMRITERIAEERNALAITTGESL 117 (218)
T ss_dssp HHHHHHHHSCGGGHHHHHHHHHHHHHHHHHHHTTCCEEECCCCS
T ss_pred hhhhhhhccccchHHHHHHHHHHHHHHHHHHHhccceEEeeeec
Confidence 1 2345678999999999999764
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=81.63 E-value=2 Score=38.92 Aligned_cols=99 Identities=9% Similarity=-0.057 Sum_probs=61.7
Q ss_pred CEEEEEeCCC--cchHHHHHHHHHhccCCCCeEEEEEEecCCC---CCCCCC-CCh---HHHHHHHHHHHHHHhhcCCee
Q 005343 22 AITAVAIDAD--KSSQYAVKWAVDNLLNETSQYVLLHVRNHSS---NPRGRP-ATN---DELQKLFLPYRGLFARKRILA 92 (701)
Q Consensus 22 ~~IlVavD~s--~~S~~Al~wA~~~~~~~g~~v~llHV~~~~~---~~~~~~-~~~---~~~~~~l~~~~~~~~~~~v~~ 92 (701)
.+|+|=.-.| =+-..||..|++ .|+.|+.|+|.++.. ...+.. ... .=..+-|..++.-++..|+.
T Consensus 6 ~~~lvWfr~DLRl~DN~aL~~A~~----~~~~vi~vyi~dp~~~~~~~~~~~~~~~~r~~fl~~sL~~L~~~L~~~g~~- 80 (204)
T d1np7a2 6 PTVLVWFRNDLRLHDHEPLHRALK----SGLAITAVYCYDPRQFAQTHQGFAKTGPWRSNFLQQSVQNLAESLQKVGNK- 80 (204)
T ss_dssp CEEEEEESSCCCSTTCHHHHHHHH----TTSEEEEEEEECGGGGSBCTTSCBSSCHHHHHHHHHHHHHHHHHHHHTTCC-
T ss_pred CcEEEEeCCCCccccHHHHHHHHh----cCCcEEEEEEECchHhcCcccccccccHHHHHHHHHHHHHHHHHHHhccch-
Confidence 4555544444 222357777764 467899999998741 111221 122 22334556666666777776
Q ss_pred eEEEEEcCChhHHHHHHHHHcCCCEEEEccCCCCcc
Q 005343 93 REVVLQDIDVSSALIYYVKNNSVGNIVAGGSSRNLL 128 (701)
Q Consensus 93 ~~~v~~~~~~~~~Iv~~a~~~~~d~IV~Gs~g~~~~ 128 (701)
.++.. |++.+.|.+++++++|+.|..- +.-+..
T Consensus 81 -L~v~~-G~~~~~l~~l~~~~~i~~V~~n-~~~~~~ 113 (204)
T d1np7a2 81 -LLVTT-GLPEQVIPQIAKQINAKTIYYH-REVTQE 113 (204)
T ss_dssp -EEEEE-SCHHHHHHHHHHHTTEEEEEEE-CCCSHH
T ss_pred -hhhhh-hhhHHHHHHHHHHhhhhheeee-ccccHH
Confidence 44666 8999999999999999998864 334433
|